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Severe community-acquired pneumonia in the intensive care unit
C Costa, I Gouveia, P Cunha, R Milheiro, A Bártolo, C Gonçalves,
A Carvalho, T Cardoso, S Martins, J Magalhães
HSO, Guimarães, Portugal
Critical Care 2005, 9(Suppl 1):P1 (DOI 10.1186/cc3064)
Introduction Community-acquired pneumonia remains a common
condition worldwide. It is associated with significant morbidity and
mortality. The aim of this study was to evaluate conditions that
could predict a poor outcome.
Design Retrospective analyse of 69 patients admitted to the ICU
from 1996 to 2003. Demographic data included age, sex and
medical history. Etiologic agents, multiorgan dysfunction, noso-
comial infections, SAPS II and PORT scores were recorded for
each patient. For statistical analysis we used a t test, chi-square
test and Mann–Whitney U test on SPSS®. A value of P less than
0.05 was considered significant.
Results Forty-seven patients were male and 22 patients were
female. Mean age was 52 years. Sixty-seven percent had serious
pre-morbid conditions including pulmonary disease (34.8%), cardiac
problems (36.2%), diabetes (13%) and chronic liver disease (5.8%);
40.6% were smokers, drug abusers or alcohol dependents. Sixty-
eight patients required invasive mechanical ventilation. The average
length of ventilation was 13.5 days, median 8 days. The mean SAPS
II score was 40.14 and the mean PORT score was 141. The
mortality rate was 27.5% (SAPS II estimated mortality, 35%).
Complications reported were ARDS (40.6%), septic shock (34.8%),
acute renal failure (2.9%), cardiac arrest (8.7%) and nosocomial
infeccions (46.4%). Mortality rates were higher for previous hepatic
(75%) and metabolic (33%) diseases. We found a close association
between crude mortality and SAPS II score (P = 0.003) and
development of complications (P = 0.0028). Respiratory dysfunction
(P = 0.006) and septic shock (P = 0.022) were most significantly
related to mortality. No significant differences were founded
regarding age, comorbidities, PORT score, etiologic agents,
nosocomial infections and length of invasive mechanical ventilation.
Conclusions Previous hepatic chronic disease was strictly related
to higher mortality as well as isolation of MRSA. ARDS and septic
shock predicted a poor outcome. SAPS II score was the best
severity indicator of mortality.
P2
Closed endotracheal suction system without periodic change
versus open endotracheal system
L Lorente, M Lecuona, J Villegas, M Mora, A Sierra
Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
Critical Care 2005, 9(Suppl 1):P2 (DOI 10.1186/cc3065)
Objective It is known that the closed tracheal suction system
(CTSS) produces less hemodynamic and gasometric deterioration
than an open tracheal suction system (OTSS). Use is limited
because no decrease in the incidence of ventilator-associated
pneumonia (VAP) was found and also because it is more
expensive. But, is daily periodic change of the CTSS necessary?
The aim of this study was to analyze the incidence of VAP using a
CTSS without periodic change versus an OTSS.
Methods It is a prospective study of ICU patients from 1 January
2004 to 31 October 2004. Patients who required mechanical
ventilation (MV) were randomized into two groups: one group was
suctioned with CTSS without periodic change and another group
with OTSS. An aspirate tracheal swab and a throat swab on
admission and afterwards twice weekly were taken. VAP was
classified based on throat flora in endogenous and exogenous
samples. The statistical analysis was performed by chi-square test
and Student’s t test, and we took P < 0.05 as a significant difference.
Results There were no significant differences between both groups
of patients (236 with CTSS without periodic change and 211 with
OTSS) in age, sex, diagnosis groups, APACHE II score, number of
aspirations per day and mortality. No significant differences were
found in the percentage of patients who developed VAP (13.98%
vs 14.02%), nor in the number of VAP per 1000 MV-days (14.13 vs
14.67). At the same time we did not find any differences in the
percentage of patients who developed exogenous VAP (0.96% vs
0.88%). In the patients who needed MV during 24 hours or more,
the aspiration cost was less expensive in the CTSS without periodic
change group than in the OTSS group ($1.89 × 1.53 vs $2.45 ×
0.71 per patient-day, P < 0.0001).
Conclusions We conclude that in our study the CTSS without
periodic change decreased the aspiration cost and did not modify
the VAP incidence.
P3
Ventilator-associated pneumonia caused by multidrug
resistant bacteria
M Sartzi, M Charitidou, A Panagiotakopoulou, C Michas, 
F Tsidemiadou, P Clouva-Molyvdas
‘THRIASSIO’ Hospital of Eleusis, Attica, Greece
Critical Care 2005, 9(Suppl 1):P3 (DOI 10.1186/cc3066)
Introduction The aim of the study was to investigate the
epidemiology, clinical characteristics and severity of ventilator-
associated pneumonia (VAP) caused by multidrug resistant
bacteria (Group I) and to identify possible differences from VAP
caused by sensitive pathogens (Group II).
Methods A prospective observational 2-year study of all ICU
patients who developed VAP. Age, gender, APACHE II score,
underlying disease, cause of ICU admittance, length of ICU stay,
duration of mechanical ventilation (MV) before the onset of VAP
and total duration of MV, VAP pathogens, day of VAP onset and
patient outcome were recorded. The Multi Organ Dysfunction
Score (MODS) and Clinical Pulmonary Index Score (CPIS) were
measured at the onset of VAP. Statistical evaluation was
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performed using the nonparametric Mann–Whitney test and
Pearson’s chi test.
Results During this 2-year period 240 patients were admitted to
the ICU. Fifty patients (20.8%) developed VAP. All VAP was late
onset. VAP was caused by multidrug resistant pathogens in 23
patients (Group I) and by sensitive bacteria in 27 patients (Group
II). ICU admittance (P = 0.27), underlying disease (P = 0.83) and
type of isolated bacteria (P = 0.53) did not differ between the two
groups. All the other results are presented in Table 1.
Table 1
Group I (n = 23) Group II (n = 27) P value
Men/women 17/6 21/6 0.75c
Age 59.8 ± 18.0a 60.7 ± 21.4a 0.6b
APACHE II score 20 (CI: 17.5–22.5) 21.1 (CI: 18.3–24) 0.71b
Outcome (deaths) 8 (34.8%) 4 (14.8%) 0.09c
CPIS 6.8 (CI: 6.6–7.0) 6.3 (CI: 6.1–6.6) 0.003b
MODS 8.9 (CI: 7.9–9.8) 4.6 (CI: 3.9–5.2) 0.0001b
Days of MV before VAP 16.1 ± 10.1a 17.8 ± 10.1a 0.11b
Total days of MV 40.1 ± 18.1a 36.7 ± 22.0a 0.37b
LOS in ICU 46 ± 21.2a 39.9 ± 23.9a 0.26b
LOS, length of stay; CPIS, Clinical Pulmonary Index Score; MODS, Multi
Organ Dysfunction Score; MV, mechanical ventilation; CI, 95% confidence
interval. aData presented as mean ± standard deviation. bMann–Whitney
test. cPearson’s chi test.
Conclusions Patients that developed VAP due to multiresistant
bacteria did not differ in their basic characteristics (age, gender,
APACHE II score, underlying disease and cause of admittance)
from patients that developed VAP due to sensitive strains. However,
MODS and CPIS at the onset of VAP were significantly higher in
patients with VAP caused by multiresistant bacteria. The difference
in outcome between the two groups, although not statistically
significant, may have reached significance if our sample was larger.
P4
Ventilator-associated pneumonia and Clinical Pulmonary
Infection Score validation in a Greek general intensive care unit
P Myrianthefs, K Ioannidis, M Mis, S Karatzas, G Baltopoulos
KAT Hospital, Athens, Greece
Critical Care 2005, 9(Suppl 1):P4 (DOI 10.1186/cc3067)
Background Ventilator-associated pneumonia (VAP) is a
significant clinical problem in the ICUs and accurate diagnosis
remains problematic. The purpose of the study was to examine the
characteristics of VAP in a general Greek ICU.
Methods We prospectively recorded the characteristics of VAP
for a period of 5 months in a seven-bed ICU. We collected 1032
ventilator days (VD) concerning 64 patients admitted to our ICU.
Data collected included demographics, VAP episodes, pathogens,
resistance characteristics and outcomes. We also validated the
Clinical Pulmonary Infection Score (CPIS) as a guide for VAP
diagnosis [1]. We defined VAP as having CPIS ≥ 6.
Results We included 64 patients admitted to our ICU (43 men) of
mean age 50.8 ± 4.6 years. Patients were admitted from the
emergency department, wards, other ICUs and the operating room
suffering from multiple trauma including head injury (25), stroke
(14), postoperative respiratory failure (10), heart failure (seven),
sepsis (five), and other medical conditions (three). We recorded
1032 VD. Twenty-one patients (21/64, 32.8%) developed VAP.
Four patients developed two separate episodes of VAP. We in
total recorded 25 episodes of VAP. The incidence of VAP was
24.2 episodes per 1000 VD. The duration of VAP until resolution
was 11.4 ± 0.9 days. The total duration of mechanical ventilation
(MV) was 29.7 ± 5.3 days and the mean duration of MV before the
development of VAP was 19.9 ± 4.8 days.
We identified multidrug resistant pathogens (Acinetobacter baumanii)
in two patients and one of them died due to VAP. We also identified
pathogens sensitive only to colistin (A. baumanii in eight patients and
Pseudomonas aeruginosa in two patients) in 10 patients, five of them






A. baumanii + P. aeruginosa 5
A. baumanii + Staphylococcus aureus 2
A. baumanii + fungi 1
Klebsiella pneumoniae + fungi 1
The VAP-attributable mortality was 23.8% (5/21). VAP was
successfully resolved in 20/25 episodes. Management of VAP was
guided according to culture results and in the case of multidrug
resistance or single antibiotic sensitivity by the use of combination
antibiotic therapy including meropenem, high-dose ampicillin-
sulbactam and collistin.
CPIS sensitivity was 82.7%, specificity was 89.2%, positive predictive
value was 73.2% and negative predictive value was 93.5%.
Conclusions VAP significantly contributes to morbidity and
mortality of critically ill ICU patients. However, VAP may be
successfully treated even in the case of multidrug resistance or
single antibiotic sensitivity by combination therapy. CPIS may be a
significant tool in the diagnosis of VAP in our ICU.
Reference
1. Singh N, et al.: Am J Respir Crit Care Med 2000, 162:505-511.
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Ventilator-associated pneumonia in neuromuscular,
tracheostomyzed patients
A Martini, N Menestrina, E Mantovani, B Allegranzi, G Finco, 
L Gottin
Ops Poloclinico GB Rossi, Verona, Italy
Critical Care 2005, 9(Suppl 1):P5 (DOI 10.1186/cc3068)
Objective Lower-tract respiratory infections are common events in
tracheostomyzed mechanically ventilated patients leading to a 10-
fold increase in mortality rate particularly in those patients with
severely compromized clinical conditions [1]. Our study aimed to
assess epidemiology and risk factors for colonization of respiratory
tract and development of ventilator-associated pneumonia (VAP) in
home-living, tracheostomyzed and mechanically ventilated patients
with neuromuscular disease.
Design A retrospective study.
Setting An ICU ambulatorial service for neuromuscular disease.
Patients Data of 27 patients (20 male) that underwent a routine visit
every 6 months, collected from 1995 until 2003, were analyzed.
Thirteen had amyotrophic lateral sclerosis (ALS) and one spinal
muscular atrophy (ALS-like group); seven had Duchenne’s dystrophy
(DMP), two congenital dystrophy, three metabolic dystrophy and one
supranuclear progressive paralysis (DMP-like group).
The median age was 54 years (interquartile range, 31–63). The




Thirteen patients had severe dysphagy and ineffective cough reflex,
12 of them were alimentated by percutaneous enteral gastrostomy
and one by nasal-gastric tube, ALS-like patients were more
frequently dysphagic than DMP-like patients (P < 0.01).
Low respiratory tract infections (LRTI) were defined in the
presence of cough or an abnormal increase of bronchial
secretions, with or without fever that required antibiotic therapy;
pneumonia was defined as LRTI with a new pulmonary infiltrate at
thorax radiography [2].
Measurements and main results VAP incidence was 52
episodes for 100 patients per year of MVP. The median MVP was
lower in dysphagic patients (33 months [20.75–70.50]) than in
non-dysphagic patients (120 months [80–156]) (P < 0.01) and in
ALS-like patients (33 months [24–73]) than in the DMP-like group
of patients (96 months [69.5–144]).
Dysphagic patients had an higher colonization incidence (Ci) (P =
0.01), LTRI incidence (LTRIi) (P = not significant), and VAP
incidence (VAPi) (P = 0.02) than nondysphagic patients, per
month of mechanical ventilation.
ALS-like patients had a higher Ci and VAPi than DMP-like patients
(P = not significant).
Bivariate analysis shown a positive correlation between Ci and
LTRIi and VAPi (P < 0.01 for both). MVP was negatively correlated
with Ci (P < 0.01) and VAPi, although the P value was 0.06.
Pseudomonas aeruginosa was the most isolated bacteria in
colonization (48%), LTRI (45%) and VAP (52%) episodes.
Conclusion VAP is a frequent event in our patients. Dysphagic
patients, although alimentated by gastrostomy, are more frequently
colonized and this enhances the risk to develop VAP more than in
nondysphagic patients. Patients ventilated for a long period seem
to develop a natural defence from colonization. The longer the
MVP, the less the patient is prone to be colonized and, likely, to
develop VAP. The risk of developing VAP is no different in ALS-like
and DMP-like disease although the dysphagy prevalence differs. A
bigger sample is needed to definitively prove this.
References
1. Niedermann MS, et al.: Nutritional status and bacterial binding
in the lower respiratory tract in patients with chronic tra-
cheostomy. Ann Intern Med 1972, 77:701-706.
2. Harlid R, et al.: Respiratory tract colonization and infection in
patients with chronic tracheostomy. Am J Resp Critical Care
1996, 154:124-129.
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Clinical characteristics of ventilator-associated pneumonia
patients and control patients
M Moock, LL Maia, ALC Meserami, CM Broncher, JL Oliveira,
SC Oliveira, JMO Orlando
ICU Hospital Geral de Pedreira, São Paulo, Brazil
Critical Care 2005, 9(Suppl 1):P6 (DOI 10.1186/cc3069)
Introduction Ventilator-associated pneumonia (VAP) represents
80% of all nosocomial pneumonia. The aim of this study is an
epidemiological, performance and outcome evaluation of an ICU,
focused in VAP.
Methods The study was performed in a 13-bed ICU located in São
Paulo, Brazil, during 2003. It was a retrospective study, where all
consecutive patients admitted were included. All data were
collected and analysed in a Brazilian system of performance and
quality in the ICU, called QuaTI®. Statistical analyses were done,
supported by the EpiInfo 2002 software. Clinical characteristics of
all patients were presented and then two groups were analysed
and compared: VAP group (n = 28) and control group (n = 231)
composed of ventilated patients who did not develop VAP.
Results From 11 January to 31 December, 483 patients were
admitted; 55.69%, were male; median age was 59 years, 362
medical and 121 surgical patients; medium length of stay was
8.91 ± 13.07 days. APACHE II median score was 11.78 ± 7.13;
mortality rate was 29.6% and standard mortality rate, calculated by
APACHE II, was 1.01. The rate of ventilated patients was 259/483
(53.62%). The VAP incidence was 10.81% and the rate was
10.84 per 1000 ventilator days. The infection agent was identified
in 15 patients by bronchoalveolar lavage or blood cultures. The
more prevalent were Pseudomonas aeuriginosa (6/28), Klebisiella
pneumoniae (2/28), Staphylococcus aureus (2/28).
Table 1
Characteristics VAP (n = 28) Controls (n = 231) P value
Age (years), median 57 66 0.10
% male 85.7 74 0.17
Medical 24 171 0.17
Surgical 4 60 0.17
ICU stay (days) 30.79 ± 18.06 12.25 ± 14.97 0.000
Ventilation days 27.61 ± 20.19 10.41 ± 13.21 0.000
APACHE II score 16.50 ± 5.77 13.96 ± 7.39 0.04
Death risk (%) 21.39 33.32 0.02
Mortality rate (%) 32.14 51.52 0.053
Conclusions VAP did not increase mortality but improved
ventilated days, ICU length of stay and assistance costs. The
APACHE II score was significantly higher in patients who
developed VAP. P. aeuriginosa was the predominant pathogen.
Reference
Rello J: Crit Care Med 2003, 31:2544-2551.
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Nosocomial pneumonia: impact of a very early antimicrobial
therapy
L Montesino, C Cazenave, X Jeusset, P Remi, M Thyrault, 
J Coudray
General Hospital of Longjumeau, France
Critical Care 2005, 9(Suppl 1):P7 (DOI 10.1186/cc3070)
Introduction Nosocomial pneumonia (NP) severely complicates
the course of mechanical ventilation. Although the need of an
appropriate antimicrobial therapy adapted from the results of
cultures from lower respiratory samples is well known, the best
moment to start it is yet to be defined.
Objective To assess the benefits of an appropriate antimicrobial
therapy started just after the direct sample examination versus after
the culture results.
Design and patients A retrospective cohort study including 50
NP cases, diagnosed on clinical examination, bronchoalveolar
lavage and protected specimen brush. Once the radiological and
clinical characteristics of the patient have been analysed, the
antimicrobial therapy modality is studied. Patients have been
separated into two groups, depending on the delay before the
antimicrobial therapy: just after the direct examination for group 1
(G1) and after the culture analysis for group 2 (G2).
Measurement and results For G1 the appropriate antimicrobial
therapy is started with a delay of 4.6 ± 2.5 hours after the direct
examination results, while for G2 this delay reaches 34.5 ± 22.5
hours. Hence, in 44 patients, initial antimicrobial therapy was
appropriate straightway and in the remaining six patients was
adapted on the results of culture. No differences have been
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noticed in terms of mortality (54% vs 53%, P = 0.91) and length of
stay in the intensive care unit (28.7 days vs 19.3 days, P = 0.16)
between the two groups. Both were similar regarding clinical and
radiological diagnosis, age and severity of the NP. However, in G2,
a significantly higher number of multi-resistant bacteria have been
found (87% vs 73%, P < 0.001) as well as a higher rate of
tracheal colonization within 48 hours after the fiberoptic
bronchoscopy (76% vs 60%, P < 0.001).
Conclusion For patients having a NP of moderate gravity, it is
possible to wait for the culture before the start of antimicrobial
therapy.
P8
Antibiotics for preventing infections in open fractures are
protective against ventilator-associated pneumonia
F Cancellieri1, G Gambale1, M Baldazzi2
1Ospedale Maggiore, Bologna, Italy; 2Universiità degli Studi,
Bologna, Italy
Critical Care 2005, 9(Suppl 1):P8 (DOI 10.1186/cc3071)
Introduction Early ventilator-associated pneumonia (VAP) remains
the commonest infection in ICUs, in trauma in particular. Controversy
exists on whether antibiotic prophylaxis for traumatic lesions
increases the respiratory infection rate and antibiotic resistance [1].
Methods Using the trauma registry and data from the infection
surveillance program, we reviewed major trauma cases: admitted
consecutively and directly to our unit in 4 years, with a stay longer
than 3 days that received no antibiotic at all or received
clindamycin-gentamicin from admission for open fractures.
Statistical analysis consisted of: Fisher’s exact test, Student’s t
test, multiple logistic regression.
Results Four hundred and eighty-two patients did not receive
antibiotics, 126 did, for 2.8 ± 1.8 days. Groups were not
statistically different in age, sex, injury severity score, Glasgow
Coma Score (GCS) at admission, prehospital intubation rate, days
of artificial ventilation and sedation, surgery, and transfusions.
Bivariate analysis of the groups with and without VAP (272 vs 336)
showed a statistically significant difference in injury severity score,
GCS, days of ventilation, prehospital intubation and antibiotic
treatment. Days of ventilation, anatomical severity of trauma and
antibiotic treatment were independently associated with VAP in a
logistic multivariate model. Antibiotics showed a protective effect
against VAP: odds ratio, 0.386; 95% confidence interval,
0.227–0.657. VAP in non-antibiotic treated patients was caused
by Staphylococcus aureus in 37.7% (4% methicillin-resistant S.
aureus [MRSA]) of cases, haemophilus in 25%, Gram-negative,
including pseudomonas, in 25.4%. In patients treated with
antibiotics S. aureus was isolated in 17.4% of cases (5.5%
MRSA), haemophilus in 30.4%, Gram-negative, including
pseudomonas, in 43.1%.
Table 1
Odds 95% CI, 95% CI, 
Variable P value ratio lower upper
Injury severity score < 0.01 1.027 1.006 1.047
Days on ventilator < 0.0001 1.241 1.188 1.296
Antibiotics yes/no < 0.001 0.386 0.227 0.657
Conclusion Seventy-two hours of antibiotic therapy for open third-
degree fracture is protective against VAP in trauma patients. When
VAP occurs after or during antibiotic treatment, isolations shift
towards haemophilus, pseudomonas or other Gram-negative
germs, not MRSA.
Reference
1. Hoth JJ: Prophylactic antibiotics adversely affect nosocomial
pneumonia in trauma patients. J Trauma 2003, 55:249-254.
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A simple program to reduce the incidence of ventilator-
associated pneumonia in a Brazilian intensive care unit
P Souza, M Lugarinho, A Martinez, L Felix
Hospital de Clinicas Niterói e Mário Lioni, Rio de Janeiro, Brazil
Critical Care 2005, 9(Suppl 1):P9 (DOI 10.1186/cc3072)
Introduction Ventilator-associated pneumonia (VAP) is very
important in ventilated patients. There are many procedures (more
or less 23) that could reduce VAP, but many of them are difficult or
expensive to use
Objectives To evaluate the efficacy of three simple measures, the
semi-recumbent position, ‘clean’ intubation and a protocol of
tracheal aspiration, in the incidence of VAP
Methods Our ICU has 12 adult beds. The period was the year
2003 and 2004 until October. We standardized the semi-
recumbent position at 45°, routine intubation and tracheal
aspiration in all patients under mechanical ventilation. Nothing
more changed. We compared the incidence of VAP in 2003 with
the data from 2001, 2002 and 2004.
Results Patients were similar by age, sex and APACHE II score.
The incidence of VAP was 28 and 22 per 1000 patient-days of
mechanical ventilation in 2001 and 2002. The incidence in 2003
was 10.7, almost 50% less than 2001/2002, and 7.4 in 2004. In a
study we had done in 2002, we identified in 80% of opportunities
that patients under mechanical ventilation were with the trunk
below 45°.
Conclusion To keep the patient under mechanical ventilation in a
semi-recumbent position is not difficult, as to standardize
intubation and tracheal aspiration. Unfortunately our doctors,
nurses and respiratory therapists were not aware of these
practices, although all of them know the rationale and advantages.
With these simple and inexpensive measures, we could reduce
significantly the incidence of VAP, around 50%. We must continue
the study, with many cases, to confirm the results.
P10
Risk factor analysis of pneumonias developing after open
heart surgery
Y Bicer, S Simsek, N Yapici, O Aydin, F Sogut, Z Aykac
Siyami Ersek Thoracic and Cardiovascular Surgery Center,
Istanbul, Turkey
Critical Care 2005, 9(Suppl 1):P10 (DOI 10.1186/cc3073)
Introduction Pneumonia after cardiac surgery have an important
role among the infections that originate from hospitals as they
increase mortality, morbidity and costs. To decrease the pneumonia
incidence after open heart surgery, we should analyse the risk
factors correctly and eliminate the preventable risk factors.
Methods In our study 1000 consecutive patients who had open
heart surgery since January 2002 in Siyami Ersek Thoracic and
Cardiovascular Surgery Center were followed about pneumonia
prospectively. Pneumonia is defined with Center of Disease
Control–ABD criteria. In identifications of microorganisms,
classical methods and BBL Chrystal Gram Positive ve BBL Gram
Negative (Becton Dickenson) kits were used. Data have been
analysed statistically in the SPSS for Windows 10.0 programme.
In univariant analysis a t test was used, in group variants chi square
tests were used. P < 0.05 was considered statistically significant.
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To determine the independent risk factors multivariant logistic
regression analysis was used.
Results In 991 patients, data were found suitable for the study.
The mean patients’ age is 57.6 ± 13 years. Demographic data of
the patients are shown in Table 1. The pneumonia ratio is 1000
device day/12.5. By univariant analysis age, emergency operation,
low EF, operation time, intubation time, respiratory interventions,
reintubation, enteral feeding, reoperation, resuscitation, presence
of any complication, readmission to the ICU, and usage of blood
derivatives are found to be the risk factors for pneumonia after
cardiac surgery. Independent risk factors of pneumonia













P value (95% CI)
Age > 68 years 0.028 1.06 (1.0–1.12)
Emergency operation 0.017 4.9 (1.33–17.93)
Entubation time 0.001 2.0 (1.1–3.17)
Respiratory intervention 0.005 4.8 (1.33–22.31)
Reintubation 0.0001 14.47 (3.46–60.41)
Blood usage 0.015 1.4 (1.0–1.8)
Readmission to ICU 0.005 3.2 (1.93–11.02)
Conclusion Nosocomial pneumonia is one of the most significant
infections among cardiac surgery patients in the postoperative
period. In different studies the frequency of nosocomial pneumonia
was found between 0.2% and 9.7% and the mortality rate between
23% and 51%. According to our study older age and emergency-
operated patients are under higher risk of pneumonia after cardiac
surgery. The risk factors like intubation time, enteral feeding, usage
of blood and blood derivatives must be controlled in preoperative,
intraoperative and postoperative periods.
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Perinatal risk factors for early onset neonatal infection
V Elvedji-Gasparovic, B Peter, T Klepac-Pulanic
KBC Zagreb, Petrova Klinika, Zagreb, Croatia
Critical Care 2005, 9(Suppl 1):P11 (DOI 10.1186/cc3074)
Introduction Neonatal infection and perinatal mortality rate are a
big challenge to neonatologists and obstetricians as well. Group B
streptococcal (GBS) infection is the most common early onset
(EO) neonatal infection with an incidence of 1–4 per 1000 live
born in the developed world.
Methods We studied the newborn infection rate before and after
American Academy of Pediatrics (AAP) Protocol implementation in
Croatia. The protocol for beta haemolytic streptococcal B infection
includes: intrapartum antibiotic prophilaxis with ampicillin and
gentamycin in preterm labour at < 37 weeks of gestation, premature
rupture of membranes at < 37 weeks of gestation, fever during
labour, ruptures of membranes >18 hours before delivery and
previous delivery of a sibling with invasive GBS disease.
Results Of 784 neonates admited to the NICU, between 1 January
2003. and 31 December 2003, 60 (14 per 1000 live born)
developed definite, culture confirmed, early onset (< 48 hours)
GBS infection and seven (two per 1000 live born) developed
probable infection (clinical signs consistent with EOGBS in a baby
under 48 hours old, colonised with group B streptococci).
Discussion Conatal infection increases the sensitivity of the foetal
brain to hypoxia and has later neuro risk sequelae to the newborn
child. Our data suggest that the incidence of GBS infection in our
country was considerably higher than in all current studies. Reasons
for that can be inadequate perinatal screen in some parts of the
country and no established policy for intrapartum antibiotic treatment
of women with antenatal risk factors. In our study more than 80% of
women who delivered neonates with EOGBS disease had at least
one of the risk factors. After the year 2000, when we started the
AAP Protocol, the incidence of infection decreased to 5/1000 live
born infants. The mortality from EOGBS dropped to 3%.
Conclusion It is very important to establish a basis for trials of
different strategies to reduce EOGBS infections in countries in
transition with low social and economy status. Our results
documented that the AAP Protocol for beta haemolytic
streptococcal B infection can significantly reduce perinatal
mortality of neonatal infection and sepsis.
P12
Urinary catheter-related infection in critically ill patients
L Lorente, C Henry, M Martín, M Mora
Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
Critical Care 2005, 9(Suppl 1):P12 (DOI 10.1186/cc3075)
Objective To determine the incidence and microorganisms
responsible for urinary catheter-related infection (UCRI) in critically
ill patients.
Methods It is a prospective study performed during 30 months of
the patients admitted to a 24-bed medical–surgical ICU of a 650-
bed university hospital. Urinary cultures were taken on admission
and twice weekly. UCRI were diagnosed according to CDC
criteria. UCRI were classified based on the onset moment as early
onset and late onset: early onset were those developed during the
first 4 days of the ICU stay; and late onset were those developed 5
days after ICU admission. The statistical analysis was performed
using the SPSS 11.0 program. Continuous variables are reported
as means and standard deviation, and categoric variables as
percentages.
Results A total of 1582 patients were admitted, 953 males
(60.24%). The mean age was 57.91 ± 18.83 years (median 63 years,
interquartile range 44–73 years). The mean APACHE II score was
13.95 ± 8.93 (median 14, interquartile range 10–19). Admission
diagnoses were: 737 (46.59%) heart surgery, 189 cardiological
(11.95%), 196 neurologic (12.29%), 185 trauma (11.69%), 120
respiratory (7.59%), 104 digestive (6.57%) and 51 intoxication
(3.22%). Mortality rate was 14.79% (234 patients). A total of 1392
patients (87.99%) needed a urinary catheter, during 12,556 days.
Of the 1392 patients, 72 (5.17%) developed 75 UCRI (late onset
in 54 cases and early onset in 21 cases). All UCRI were caused by
only a microorganism. The incidence density was 5.97 UCRI/1000
urinary catheter-days. The microorganisms responsible for UCRI
were the following: Escherichia coli (16), Pseudomonas
aeruginosa (seven), Morganella morganii (four), Klebsiella (four),
Available online http://ccforum.com/supplements/9/S1
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Citrobacter (five), Proteus mirabilis (three), Enterococcus faecalis
(eight), coagulase-negative staphylococci (seven), MSSA (two),
Candida albicans (12) and other fungi (seven).
Conclusions In our series, most UCRI had a late onset, were
caused by only a microorganism and were mainly due to E. coli
and C. albicans.
P13
Serial changes in ICU-acquired pneumonia pathogen after the
remodeling of the environment in a MICU
S Hong1, J Jung1, C Lim1, S Na1, J Ahn2, S Lee1, W Kim1, 
D Kim1, Y Koh1
1Asian Medical Center, University of Ulsan College of Medicine,
Seoul, South Korea; 2Ulsan University Hospital, Ulsan, South Korea
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Introduction The aim of the study was to observe effects of the
improvement of the patient’s care facility in a medical ICU (MICU)
on ICU-acquired pneumonia (IAP), especially caused by drug-
resistant bacteria including methicillin-resistant Staphylococcus
aureus, third-generation cephalosporin-resistant Acinetobacter
baumanii (ISAB), imipenem-intermediate sensitive A. baumanii
(IIAB), imipenem-resistant A. baumanii (IRAB), expanded-spectrum
beta-lactamase (ESBL), and imipenem-resistant Pseudomonas
aeruginosa (IRPA).
Methods All critically ill patients with clinically diagnosed IAP
between January 2001 and June 2002 (period 1 — before
remodeling), October 2002 and March 2003 (period 2 — after
remodeling) and October 2003 and March 2004 (period 3 — 1-
year follow-up after remodeling) were observed prospectively in the
28-bed MICU of a 2100-bed tertiary-care singer center. Clinical
suspicion of IAP was defined by a new and persistent infiltrate on
chest radiography associated with at least two of the following:
purulent secretions, temperature ≥ 38.5°C or < 36.5°C, and a
leukocyte count higher than 10,000/µl or lower than 4000/µl.
Results A total 1038 patients (355, 353 and 330) were admitted
to the MICU during the study periods. At each period, 48 (44
cases, 11%), 38 (34 cases, 8%), and 80 (60 cases, 18%)
episodes of clinically diagnosed IAP occurred (P = 0.160). The
mean age (62 vs 66 vs 63, P = 0.272), percentage of males (82 vs
82 vs 78, P = 0.800), and mean APACHE III score (67.3 ± 18.7 vs
70.1 ± 26.5 vs 77.7 ± 28.0, P = 0.148) were not different during
the study periods. Episodes of MRSA [13(30%) vs 12 (34%) vs
29 (37%)], ISAB [6 (13%) vs 1 (3%) vs 9 (11%), P = 0.243],
IRPA [2 (4%) vs 1 (3%) vs 9 (11%), P = 0.150], and ESBL [2
(4%) vs 5 (13%) vs 4 (5%), P = 0.180] were not different during
the study periods. Episodes of IIAB [4 (8%) vs 0 (0%) vs 0 (0%),
P = 0.006] and IRAB [5 (10%) vs 0 (0%) vs 1 (1%), P = 0.011]
were lower in periods 2 and 3 than in period 1. Duration of
mechanical ventilation (22.2 ± 13.1 days vs 24.1 ± 13.0 days vs
20.0 ± 13.1 days, P = 0.340), and mortality in the ICU (54.5% vs
44.1% vs 38.3%, P = 0.258) were not different during the study
periods. Use of carbapenem [9 (19%) vs 5 (13%) vs 29 (36%),
P = 0.011] and glycopeptide [13 (27%) vs 10 (26%) vs 45 (56%),
P = 0.001] were higher in period 3 than in periods 1 and 2, and
third-generation cephalosporin [21 (44%) vs 20 (53%) vs 19
(24%), P = 0.004] was lower in period 3 than periods 1 and 2.
Conclusion The incidence of IAP caused by drug resistant
bacteria was not affected by the improvement of the patient’s care
environment in the studied ICU. However, the incidence of IAP by
IRAB and IIAB has been decreased after the remodeling.
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Duration of infusions and blood stream infections in
polytrauma patients
Y Nalapko, N Kachur, D Dokashenko
State Medical University, Lugansk, Ukraine
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Introduction Central venous catheters (CVCs) are generally used
in ICU patients. Nevertheless, bloodstream infections are common
and dangerous complications of CVCs. The use of CVCs in ICU
patients has contributed to the majority of nosocomial bloodstream
infections caused by Staphylococcus aureus, Staphylococcus
epidermidis and Candida species. It was shown that more than
200,000 cases of CVC-related bloodstream infections occur
annually in the United States, with mortality of 12–25%.
Objective To evaluate the predictive value of the working time of a
central venous line as a risk factor of blood stream infections in
polytrauma patients.
Materials and methods In the period of 1 February 2002 to 30
November 2004, 451 patients with severe polytrauma were
admitted to the ICU of Lugansk District Hospital. All of them had
CVCs, and the average duration of stay in the ICU was 7.12 days
(6–21 days). The working time of the CVC (WT CVC) and
incidence of nosocomial blood stream infections were analyzed.
Patients who died on the first to third day of hospitalization were
excluded from the investigation as inappropriate to nosocomial
infection criteria.
Results WT CVC was measured as the duration of
infusions/transfusions during the first 7 days of the post-traumatic
period. The incidence of blood stream infections was 21 cases
(4.66%). All patients were divided into two groups: Group A, with
blood stream infections (21 patients); Group B, patients who have
no such complications (430 cases).
WT CVC in Group A and in Group B was 128.1 ± 11.5 hours and
87.5 ± 7.4 hours, respectively (P < 0.05).
Infusions of crystalloids, colloids, blood components and other
medications prolonged round-a-day and depended on severity of
injury, blood loss volume, and presence of multiple organ
dysfunction. Severity of injury measured by the Trauma Score was
8.5 ± 1.1 and 9.7 ± 1.0, respectively (P > 0.05). Blood loss was 2.2
± 0.6 l and 1.3 ± 0.2 l (P < 0.05), parameters of acute physiology
(by SAPS) were 12.8 ± 0.8 and 9.4 ± 1.0, respectively (P < 0.05).
Conclusion Thus, incidence of blood stream infections depends
on the duration of infusions/transfusions in the ICU. The WT CVC
is defined by statistically considered factors — blood loss volume
and severity of MODS. Severity of trauma is not a predictor of CVC
blood infections.
P15
Five years of nosocomial Gram-negative bacteremia in a
general systems intensive care unit
W Sligl, G Taylor, P Brindley
University of Alberta, Edmonton, AB, Canada
Critical Care 2005, 9(Suppl 1):P15 (DOI 10.1186/cc3078)
Objectives Nosocomial Gram-negative bacteremia in the critically
ill is associated with significant morbidity and mortality. This study
provides epidemiological and antimicrobial susceptibility data for
nosocomial Gram-negative bacteremia in a general systems ICU
over a 5-year period.
Methods Positive blood cultures from 1 January 1999 to 31
December 2003 were reviewed for microbial etiology and
susceptibilities. Patient charts were reviewed to determine the
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source of infection, time from admission to bacteremia, causative
organisms, antimicrobial susceptibilities, choice of empiric anti-
biotic therapy and outcome.
Results There were 1632 admissions with 45 nosocomial Gram-
negative bacteremias in 44 patients. Infection rates of 28.2/1000
admissions and 12.1/10 000 patient-days remained stable over
5 years. The mean patient age was 55.3 years (range 17–86 years);
27.3% of patients were female, and 72.8% were male. The
majority (95.6%) of bloodstream infections were monomicrobial,
with only one episode of polymicrobial bacteremia. Common
admitting diagnoses included respiratory failure, solid organ
transplant, post-surgery, and multi-trauma. Seven bacterial species
were identified; Pseudomonas aeruginosa and Enterobacter spp.
were most common. Sources of bacteremia included pneumonia
(48.9%), followed by central venous catheterization (22.2%). The
mean time from admission to hospital to development of
bacteremia was 32.9 days (95% confidence interval [CI]
0–100.9), and time from admission to the ICU was slightly less at
26.0 days (95% CI 0–90.1). Antimicrobial susceptibilities were
highest for imipenem, gentamicin, tobramycin, ceftazidime, and
piperacillin/tazobactam. Ciprofloxacin susceptibility was inferior to
imipenem, gentamicin, and tobramycin (P < 0.05). Empiric coverage
with an agent to which the microorganism was ultimately
susceptible was 89.2%. The mortality rate was 53.3% in the ICU,
and 60.0% for overall hospitalization, compared with an overall
mortality rate of 11.7% for the year 2004 in our ICU patients. The
average length of the ICU stay was 50.5 (95% CI 0–150.1) days
compared with 6.13 (95% CI 4.29–7.97) days for all-comers.
Conclusions Nosocomial Gram-negative bacteremia is associated
with marked morbidity and mortality in critically ill patients.
Significant resistance to ciprofloxacin was demonstrated. Empiric
treatment regimens should be based on unit-specific data.
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Epidemiology and etiology of nosocomial infections in a
surgical intensive care unit
B Gelfand, T Popov, V Karabak, B Belocerkovsky
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Medical University of Russia, Moscow, Russia
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Objectives To assess the epidemiology and etiology of nosocomial
infections (NI) and to identify patterns of antibiotic resistance in a
surgical ICU.
Setting The ICU of 1st Clinic Hospital, Clinic of Surgery, Moscow.
Methods From September 2002 to December 2004 we
conducted a prospective study and detected the most frequent NI
in patients admitted for more than 48 hours to the ICU. The
diagnosis of NI was defined according to CDC criteria. We also
evaluated antimicrobial resistance of isolated microorganisms. The
identification and susceptibility to antibiotics has been performed
in automated system MIC/ID panels as described by the NCCLS.
Results During the study 2083 patients were admitted to the ICU,
1379 patients stayed more than 48 hours in the ICU. A total of
242 infection episodes were diagnosed in 149 patients with
nosocomial infection (7.2%), 84 (56.4%) had a single infection, 48
(32.2%) had two infections, and 17 (11.4%) had three or more
infections. Pneumonia were the most frequently reported type of
infection (119 episodes, 49.1% of all cases of infection), followed
by intra-abdominal infections (68 episodes, 28.1%), wound
infections (28 episodes, 11.6%), laboratory confirmed
bloodstream infections (14 episodes, 5.8%), urinary tract
infections (eight episodes, 3%). About 43.0% infections were
associated with sepsis, 43.8% with severe sepsis and 4.5% with
septic shock, and 8.7% were not classified. The mortality rate for
the ICU-acquired infections after 6 weeks of follow-up was 45.6%.
Age ≥ 65 years (odds ratio [OR]: 4.08; 95% confidence interval
[CI]: 2.05–8.11; P < 0.001), APACHE II score > 20 (OR: 10.70;
95% CI: 4.74–24.50; P < 0.001), SOFA > 5(OR: 15.6; 95% CI:
6.50–37.86; P < 0.001) were independently associated with
mortality. The 246 isolated pathogens were represented by 92
Gram-positive cocci, 154 Gram-negative bacilli and 2% Candida
species. Staphylococcus aureus (20.3%) was the most frequently
isolated bacteria, followed by Acinetobacter spp. (18.3%),
Pseudomonas aeruginosa (14.6%), Klebsiella spp. (13.4%),
Enterococcus spp. (13.2%), Escherichia coli (8.1%). Resistance
to oxacillin was observed for 94% of S. aureus isolates, all isolates
were susceptible to vancomycin. The most active antimicrobial
agents: against Acinetobacter spp. were imipenem (91.1%),
ampicillin/sulbactam (64.4%); against P. aeruginosa were imipenem
(88.9%), ceftazidime (69.4%), amikacin (58.3%); against Klebsiella
spp. were imipenem (97%), amikacin (91%); against E. coli were
imipenem (90%), amikacin (95%), ciprofloxacin (50%).
Conclusions The NI rate during the period was 7.2%. The
mortality of the patients with a NI is 45.6%. Pneumonia were the
predominant type of infection. Staphylococci were the most
frequently isolated pathogens, with very high levels of MR.
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ICU stay promotes enrichment and dissemination of multi-
resistant coagulase-negative staphylococcal clones
C Agvald-Ohman, C Edlund, B Lund, J Struwe, G Hedin, 
H Hjelmqvist
Karolinska Institute, Huddinge, Sweden
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Introduction Patients in the ICU are prone to be colonized and
infected by multi-resistant bacteria [1,2]. It is previously known that
nosocomial infections are often preceded by cross-transmission
events [3].
The aim of the present investigation was to study the impact of the
patient’s length of ICU stay on the resistance patterns, clonal
diversity and dissemination of coagulase-negative staphylococci
(CoNS) within and between patients.
Methods Two groups of patients were studied, including 20
consecutive patients sampled within 2 hours from admission
(shortstayers, SS), and all patients treated for at least 5 days at the
ICU (longstayers, LS), available for sampling every second week
(n = 23). Sampling was performed from five sites: oropharynx, nares,
neck, axilla and perineum. A total of 868 CoNS isolates deriving from
LS patients and 403 isolates from SS patients were analyzed for
antimicrobial susceptibility, clonal diversity and dissemination
within and between patients. All 1271 CoNS isolates were tested
for antimicrobial susceptibility and subtyped to the clonal level
according to their phenotype with the PhenePlate™ (PhP) system
using PhP-CS plates (PhPlate Microplate Techniques AB,
Stockholm, Sweden) designed for typing CoNS. The clonal
relationship between CoNS isolates clustered as one phenotype
isolated from at least two patients was further confirmed by pulsed-
field gel electrophoresis.
Results The highest resistance rates were seen for oxacillin and
ciprofloxacin, being 92% and 83%, respectively. LS were at
significantly higher risk of being colonized with CoNS isolates
resistant against oxacillin, clindamycin, ciprofloxacin, gentamicin as
well as with multi-resistant strains. Genotyping revealed 16 clones
that colonized more than one patient. One of the clones was




Conclusion Prolonged ICU stay was significantly correlated to
decreased clonal diversity, increased endogenous dissemination of
resistant strains and cross-transmission. The results emphasize the
importance of barrier treatment and other hygienic measures,
especially in this vulnerable group of patients.
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Objective Bacteremia caused by Acinetobacter baumannii has an
increasing incidence among critically ill patients. However, it is not
clear whether it is associated with a higher mortality since
controversial results have been reported. Increased mortality rate
has been shown in some studies [1], whereas in others A.
baumannii bacteremia does not alter the outcome [2]. The aim of
this study was to evaluate the clinical impact of A. baumannii
bacteremia on the outcome of patients in our ICU.
Patients and methods During a 4-month period (August–
December 2004), in a 30-bed multidisciplinary ICU, patients who
developed A. baumannii bacteremia and control patients without
microbiological evidence of bacteremia were prospectively studied.
Matching of control patients (1:2 ratio) was made on the basis of
the APACHE II score (± 2 points) and diagnostic category.
Results During the study period, A. baumannii bacteremia was
diagnosed in 21 patients (59 ± 15 years, mean ± standard
deviation), admitted to the ICU (incidence 9.3 per 100
admissions). The APACHE II score in case and control patients
was 19.9 ± 4.5 and 19.6 ± 4.8, respectively. The median interval
from admission to the A. baumannii bacteremia was 10.5 days. A.
baumanii strains were resistant to all antibiotics but susceptible to
imipenem/cilastin and colistin. The ICU length of stay was 37
(23–51) days and 9 (1.8–16.2) days, median (95% confidence
interval), for case and control patients, respectively, P < 0.001.
Case patients had a longer duration of mechanical ventilation
versus control: 21 (9–53) days versus 5 (2–18) days, respectively,
P < 0.001. No differences between case and control patients were
found in gender and age. Patients with A. baumannii bacteremia
had significantly higher mortality than controls (38.1% vs 7.15%,
P = 0.004). Logistic regression analysis showed that risk factors
that were independently associated with adverse outcome were
the presence of bacteremia (odds ratio = 10.2, P = 0.013), and
multisystem organ failure (odds ratio = 20.9, P = 0.001).
Conclusions In this group of critically ill patients, after adjustment
for severity of acute illness, A. baumannii bacteremia was
associated with a significantly increased mortality rate compared
with matched control patients. Whether other factors contribute to
this increase has to be examined.
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Introduction The prevalence of carbapenem-resistant isolates of
Acinetobacter baumannii is increasing in Tunisian ICUs. The wide
use of antibiotherapy is implicated certainly in this mechanism of
resistance.
Objective The purpose of this study is to evaluate the evolution of
A. baumannii resistance after a new strategy of prescription
consisting of controlling and restriction of antibiotherapy
prescription.
Materials and methods Evolution of resistance of all A. baumannii
isolates is compared between 2001 (before antibiotherapy
restriction) and 2003–2004 (after).
Results See Table 1.
Table 1
2001 2003 2004 
% of resistance (n = 134) (n = 50) P (n = 63) P′
Ticarcilline 76 63 0.05* 77 0.8
Piperacilline 97 85 0.01* 81 10–3*
Ceftazidim 95 84 0.01* 79 8 × 10–4*
Carbapenem 37 37 0.36 25 0.09
Amikacine 85 70 0.28 68 6 × 10–3*
Netilmycine 30 31 0.86 31 0.7
Ofloxacine 95 87 0.04* 93 0.9
Ciprofloxacine 95 87 0.16 94 0.9
P, 2003 – 2001; P′, 2004 – 2001. * P < 0.05.
Conclusion With antibiotherapy restriction we have obtained a
significant reduction of resistance for piperacillin, ceftazidim and
amikacin. We have obtained also a decrease of carbapenem-
resistant isolates (37% vs 25%) but not significant enough if
compared with other countries (5% in New York and 11% in Brazil).
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Pseudomonas areuginosa isolates within the hospitalized
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Pseudomonas aeruginosa plays a predominant role as an
etiological agent involved in serious infections in burned patients.
Treatment of these infections is frequently complicated by
antibiotic resistance, a problem that has been increasing in recent
years.
The objective of this study is to analyse the epidemiological profile
and antibiotic susceptibility of P. aeruginosa isolates within the
burned patients admitted to our intensive care burn department.
During a period of 4 years (2000–2003), 828 burn patients were
admitted. Thermal burn (70%) was the most frequent burn,
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followed by electric (27%) and chemical (3%) burn. The population
examined had an average burn size of 44% of the body surface
with the mean age of 34 ± 17 years. One hundred and seventy
strains of P. aeruginosa were isolated in different samples from
burned patients. These isolates were identified using standard
microbiological techniques and their antibiotic susceptibility was
determined using the disk diffusion method recommended by the
French Society of Microbiology.
Over the study period, P. aeruginosa was isolated mainly from
cutaneous superinfections (59%), urine (21.7%), blood culture
(14.8%) and venous catheter culture (4.7%). P. aeruginosa was
the most common isolate from cutaneous pus (22.9%). Bacteremia
were mainly caused by Acinetobacter baumannii (16.5%) and
Staphylococcus aureus (15.5%). P. aeruginosa was only isolated
in 8.2% of bacteremia. The survey of antibiotic susceptibility of P.
aeruginosa showed that 60.9% of strains were resistant to
piperacillin, 53.4% to ceftazidime, 37.6% to imipenem, 70.6% to
cefsulodine, 59.3% to tobramycin, 80% to gentamicin, 62.4% to
amikacin and 53.4% to ciprofloxacin.
During this study period, a high resistance to antibiotics of P.
aeruginosa was observed. It is necessary to implement urgent
measures to prevent the spreading of these multi-resistant strains.
These measures include: sensible limitation of the use of
antimicrobial agent, strict disinfection and hygienic procedures.
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Introduction A high rate of nosocomial infections among patients
with severe multiple trauma including severe traumatic brain injury
and initial APACHE II score of 15 or more leads to increased
length of stay (LOS), costs and high mortality. That makes the
prevention of severe nosocomial infections one of the major
therapeutic interventions in these patients. Because of a high rate
of mixed nosocomial infections with high resistance to antibiotics it
is necessary to start antimicrobal therapy with extended-spectrum
antibiotics. Taking into account pharmacodynamics, pharmaco-
kinetics and microbiological features of carbapenems, they make
the best choice for these patients. In the case of MRSA infection it
is necessary to use the combination of carbapenem and
vancomycin.
Objective The goal of the study was to assess the influence of
maximal initial antimicrobal therapy with meropenem on mortality,
rate of nosocomial infections and LOS in the ICU in patients with
severe trauma including severe traumatic brain injury and initial
APACHE II score of 15 or more.
Results The study was performed in a general ICU from April
2003 to September 2004. All patients with severe trauma with
predominant severe traumatic brain injury and initial APACHE II
score of 15 or more were included in the study. We studied two
groups of patients. In the case of known or suspected nosocomial
infection, patients in the maximal antimicrobal therapy (MAT) group
(n = 16, APACHE II 19.88 ± 3.6) received meropenem 3–6 g/day
depending on body weight for 14 days. In the case of proven
MRSA infection, vancomycin 2 g/day was added. Patients in the
control group (n = 22, APACHE II 19.90 ± 3.7) with known or
suspected infection received initial antimicrobal therapy with
cefalosporines 3 or fluoroquinolones with change of antimicrobal
therapy according to microbiological data. The observed data did
not follow the normal distribution. Comparisons between groups
were performed using the chi-square test. Mortality in the MAT
group was 6.25% (1/16), and in the control group was 50%
(11/22), P = 0.002. Nosocomial infection rate (ventilator-
associated pneumonia, meningitis) was observed in 31.25% of
patients (5/16) in the MAT group and in 91% of patients (20/22) in
the control group, P < 0.001. LOS in the ICU did not differ
between groups (19.44 ± 3.1 in the MAT group and 18.09 ± 10.3
in the control group). But comparision between LOS among
survivors in the two groups revealed significant reduction in LOS in
the ICU in the MAT group (19.42 ± 3.2 in the MAT group and
25.54 ± 11.1 in the control group, P < 0.05).
Conclusions Initial antibiotic therapy with meropenem in patients
with severe trauma including severe traumatic brain injury and initial
APACHE-II score of 15 or more leads to a reduction in mortality,
nosocomial infection rate and LOS in the ICU.
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Introduction The characteristics and practices of ICUs
participating in the Belgian national surveillance program were
reviewed within the validation study. The main objective was to
better understand the hospital practices for nosocomial infection
prevention and the methodology used for the collection of
surveillance data.
Methods Forty-five ICUs were randomly selected through systematic
random sampling from a list of 1997–2001 participation-quarters
(3 months). The number of patients admitted to the hospital and to
the ICU was provided by the hospital administration as well as the
number of hospitalization-days. Data were collected, through a
questionnaire, from those responsible for data collection at each
institution.
Results Data from 44 ICUs were analyzed. The average
participation was six surveillance quarters (range 1–22). The ICUs
belong to hospitals admitting on average 2676 patients per
quarter. The average ICUs have 10.5 beds on average, and 88.6%
of them are medical/surgical ICUs. The average number of ICU
admissions was 217 patients per quarter (927 patient-days). The
mean length of stay within the ICU was 4.3 days. Specific
guidelines for pneumonia prevention were available in 75% of
ICUs; and for catheter-related bacteremia in 85.4%. A total 86.4%
of ICUs had specific guidelines for hemoculture procedures.
Systematic culture of sputum (surveillance cultures) was
performed by 77.3% ICUs, but with different periodicity. Catheter
tip culture was performed by 73.8% of the ICUs (2/3
systematically). Guidelines for the use of antibiotics were available
at 64% of ICUs while 15.8% of them allowed antibiotic use at the
doctor’s appreciation. Almost 70% of respondents prefer a patient-
based rather than a unit-based surveillance. On average two
persons are involved in surveillance (44% ICU doctor, 26% ICU
nurse, 6% infection control doctor and 18% IC nurse). It takes
20 min per patient.
Conclusions The study allowed identifying methodological
problems and areas for targeted training in order to improve the
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Background This presentation shows how, at the City Hospital, it
was possible to improve the quality of clinical practice in surgery
departments and ICUs.
Introduction Antibiotics play an important role in clinical practice.
The expenditure on these drugs is more than 50% of the total
expenditure for drugs at the hospital. Uncontrolled use of
antibiotics, in the environment of intolerably poor financing of the
hospitals in Russia, and the absence of adequate control of the
antibiotic prescriptions induce the growth of resistance in the
hospital microbial flora, and as a result the expenditure on drug
treatment increases.
Methodology An analysis of the antibiotics purchased by the
administration of the hospital was made in order to determine the
baseline proportions of the different classes of antibiotics in the total
structure in the year 2003. The analysis showed a high percentage
of beta-lactams in the structure of the antibiotics purchased (88%).
The data from the Diagnostic Laboratory Center of the city were
impressive: the level of Klebsiella pneumoniae producing the
enlarged-spectrum beta-lactamases reached a level of 92.5% in
the ICU. An analysis of patients’ data at the ICU and surgical
departments (in a cohort of 300) was made in order to evaluate the
quality and appropriateness of the antibiotic prescriptions. An
inappropriate choice of antibiotics, wrong dosage, or an incorrect
timing regime were revealed in 60% of cases. The protocols of
antibiotic prophylaxis and the strict rules of antibiotic prescriptions
in the ICU, prepared according to the data of evidence-based
medicine, were implemented.
Conclusion The system of governance of antibiotic prescriptions,
the monitoring of the microbial resistance in the ICU, and the strict
adherence to the protocols of antibiotic usage have gained approval
and enabled an improvement in the quality of treatment (from 60%
to 30%) and a reduction of the expenditure for antibiotics (40%).
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intensive care unit
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Introduction First-line choice of antibiotic treatment is an
important issue for successful outcome in surgical and trauma
patients. De-escalation strategy aims to improve the first choice of
antibiotic therapy, to improve outcome and to save money.
Setting A general ICU, 17 beds, annual admission approximately
800 patients.
Objective To compare rates of success and failure of the empiric
treatment of patients with usually prescribed antibiotics and the
use of carbapenems with subsequent de-escalation.
Method Taking data from flow-charts, we determined the most
frequently prescribed empiric antibiotics in our ICU during 2002
and calculated the rates of success and failure of the treatment.
We considered the failure an inadequate antibiotic therapy. As
shown in Table 1, there were two regimens used in 2002. The use
of mefoxin was quite disappointing with only a 30% success rate.
When other empiric antibiotic, or combination of antibiotics were
used the rate of success was slightly below 50%. This can be
partly explained with the high rate of surgical complications. In
2003–2004 we accepted for use the de-escalation strategy.
Starting empiric carbapenems (tienam in 106 patients, meronem in
31 patients), we obtained samples for the microbiological
laboratory from the sites of suspected infection. After receiving
positive results we de-escalated antibiotic therapy according to
susceptibility. The rate of success increased 11%, and the cases
of inadequate empiric therapy fell to 4.4% of cases. Mortality rate
decreased from 31% to 13%.
Conclusions Introducing de-escalation strategy into our clinical
practice showed promising results. The percentage of cases of
treatment failure (inadequate empiric antibiotic therapy) and the
mortality rate decreased significantly. We need a longer period to
confirm these result, as well as to analyze cost-effectiveness.
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Objective Our group developed an ovine model of Pseudomonas
aeruginosa sepsis associated with acute lung injury (ALI) [1]. The
aim of this study was to modify this model by the administration of
Ceftazidime (Cef) to simulate a more clinically relevant situation. In
addition we studied the effects of recombinant human activated
protein C (rhAPC), as well as an combined treatment of rhAPC
and Cef. This modification could be the basis for future studies
investigating new treatment strategies in sepsis.
Methods Thirty sheep (35–40 kg) were operatively prepared for
chronic study. After 7 days of recovery, sheep were randomly
allocated either to sham, control, Cef, rhAPC, or Cef + rhAPC
groups (n = 6 each). After a tracheostomy, ALI was produced and
P. aeruginosa were instilled into the lungs, following an established
protocol [1]. The sham group received the vehicle. The sheep were
studied for 24 hours in the awake state and were ventilated with
100% oxygen. The PaO2/FiO2 ratio was determined at baseline
(BL) and every 3 hours. Ceftazidime (3 g) was administered
intravenously 1 and 13 hours post injury. rhAPC was given as a
continuous infusion (24 µg/kg/hour), starting 1 hour post injury.
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Antibiotics Patients Success rate Escalation rate De-escalation Failure Surgical complication Death
2002, mefoxin 85 26 (31%) 41 (48%) – 24 (28%) 17 (20%) 31 (36.4%)
2002, other antibiotic 114 53 (46.5%) 30 (26.3%) – 15 (13%) 25 (22%) 30 (26.3%)
2003–2004, carbapenems 137 78 (57%) – 33 (24%) 6 (4.4%) 10 (7.3%) 18 (13%)
S11
The animals were resuscitated with Ringer’s lactate solution to
maintain filling pressures and hematocrit. Statistical analysis: two-
way analysis of variance and Student–Newman–Keuls post hoc
comparisons. Data are expressed as mean ± standard error of the
mean. Significance P < 0.05.
Results The PaO2/FiO2 ratio remained stable in sham (BL:
518.3 ± 12.7 vs 12 hours: 507.3 ± 18.8) animals. The control
group showed a significant decrease in PaO2/FiO2 ratio (BL:
496.8 ± 21 vs 12 hours: 83.5 ± 9.8). The Cef group also showed
a fall in PaO2/FiO2 ratio (BL: 524 ± 11.4 vs 12 hours: 173 ± 47),
as well as the rhAPC (541.3 ± 12.2 vs 12 hours: 150.7 ± 28.6)
group. In both groups there was a significant improvement of the
PaO2/FiO2 ratio compared with the control group. The PaO2/FiO2
ratio of the Cef + rhAPC group (525.4 ± 9.9 vs 12 hours:
335.8 ± 25.8) was significantly higher than all other injured groups.
Conclusion Since the application of Cef + rhAPC after ALI
associated with bacterial challenge improved pulmonary function
more than Cef or rhAPC alone, it underlines the importance of
antibiotic treatments for further studies in animal models of sepsis.
Acknowledgements Grant support from Shrine 8820, 8450, NIH
GM066312.
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Introduction Recent reports suggest that Clostridium difficile
colitis (CDAC) may be evolving into a more severe disease [1].
Over the past 2 years, an increased case fatality associated with
CDAC was noted as the admission rate to our adult tertiary ICUs
for this entity increased in a context of inhospital outbreak. This
CDAC outbreak occurred in a 682-bed regional hospital in
Quebec, Canada. All cases admitted to ICUs with a diagnosis of
life-threatening CDAC were systematically reviewed over a 20-
month period (between 1 January 2003 and 21 August 2004). The
following is a retrospective statistical analysis.
Results Until now, 41 cases of CDAC requiring intensive care
monitoring and treatment have been collected; 53.7% were of male
sex and the median age was 78 years (25th–75th %: 71–82). The
Charlson morbidity index was calculated for each patient for a
median of 4 (25th–75th %: 3–6). Patients were generally exhibiting
a sepsis profile with high-grade fever (median 39.20°C, 25th–75th
%: 38.7–39.4°C), and high leukocyte counts (median 28.15 ×
109/l, 25th–75th %: 20.8–43.7) at some time during the ICU stay.
Serum creatinine levels were elevated (median 204 µmol/l,
25th–75th %: 139–292 µmol/l). Shock status was diagnosed in
83% of the patients and catecholamines were mandatory in 53.7%
of the time for a mean duration of 3.4 days (± 0.47) in addition to
volume resuscitation. Patients were resuscitated during the first 72
hours following their ICU admission with a mean of 10.7 cm3
(± 986 cm3) of crystalloid solution, 586 cm3 Pentastarch solution
(± 92 cm3) and 231 cm3 of 25% albumin (± 75 cm3). Upon entry to
the ICUs, the APACHE II score was calculated and the median
obtained was of 24 (predicted mortality rate 49.7%). Furthermore,
the SOFA score was also obtained upon entry, 48 hours after
admission and every subsequent week. In the first 48 hours, the
total SOFA score increased in 26.8% and decreased in 31.7% of
the patients. Thirty-two percent of the population reached the
maximum cardiovascular SOFA score of 4 (i.e. norepinephrine
> 0.1 µg/kg/min). Twenty-two percent of patients went to the
operating room.
The overall observed mortality rate was 49%. An APACHE II score
upon entry of 22 or more and an age greater than 75 were both
associated with higher mortality with an adjusted odds ratio (OR)
of 7.6 (95% confidence interval [CI] 1.6–33.9, P = 0.01) and 4
(95% CI 1.06–15,1 P = 0.07). A trend toward higher mortality was
observed in patients with an increasing SOFA score within the first
48 hours of admission (OR 4.55, 95% CI 0.91–22.6, P = 0.1) and
high serum lactate levels (OR 18.8, 95% CI 0.97–362, P = 0.03
for lactates > 6.5) but no trends were noted regarding the Charlson
comorbidity index, the decision of surgery (colectomy for bowel
perforation vs refractory shock) or catecholaminergic drug use.
Discussion This case review reveals the existence of an outbreak
of CDAC with increasing case fatality and worsening outcome in
Quebec. Epidemiologic data will help in defining more efficient
preventive measures directed toward this nosocomial entity and
allowing early recognition in order to thwart severe illness.
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Background Bloodstream infections (BSI) have a worse outcome
when the microorganisms involved are antimicrobial resistant (AM-R),
compared with BSI with antimicrobial susceptible (AM-S) micro-
organisms. We evaluated whether this is also true in ICU patients with
acute renal failure who are treated with renal replacement therapy
(ARF-RRT), a particular severely ill cohort of ICU patients.
Methods All ARF-RRT patients with BSI admitted in our 54-bed
tertiary care ICU during the period 1995–2002 were included in
the study. Enteroccci were defined AM-R when resistant to
vancomycin, staphylococci when resistant to methicillin, Gram-
negative bacteria when resistant to ceftazidim, Pseudomonas
when resistant to ceftazidim, quinolones, piperacilin, or imipenem,
and Candida when resistant to fluconazole. Catheter-related BSI
and BSI of unknown origin were defined as primary BSI. Data are
presented as number (percentage) or median (interquartile range).
Results During the 8-year study period, 79 out of 1032 ARF-RRT
patients (7.7%) developed BSI, incurring 88 different micro-
organisms. AM-R was present in 50 patients (63%). Gram-positive
bacteria were more frequent in patients with AM-R BSI (72% vs
24%, P < 0.001), whereas Gram-negative bacteria (24% vs 53%,
P = 0.006) or Candida (2% vs 18%, P = 0.008) were less frequent.
A higher proportion of patients with AM-R BSI had primary BSI
(58% vs 17%, P < 0.001). Patients with AM-R BSI and AM-S BSI
had the same age (57 [42–67] years vs 62 [53–69] years,
P = 0.150), and APACHE II score on admission (26 [17–32] vs 28
[18–37], P = 0.338). Time to BSI after start of RRT was longer in
the AM-R group (11 [6–21] days vs 5 [1–19] days, P = 0.026).
Patients with AM-R BSI had a higher need for vasopressor therapy
(80% vs 52%, P = 0.008). Length of hospital stay was not
different (42 [26–73] days vs 31 [16–75] days, P = 0.528) as was
inhospital mortality (64% vs 72%, P = 0.443). Cox regression
analysis identified, after adjustment for various covariates, older
age (hazard ratio = 1.03 per year, 95% confidence interval:
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1.01–1.05, P = 0.02), and primary BSI (hazard ratio = 0.42, 95%
confidence interval: 0.21–0.85, P = 0.02) as associated with
hospital mortality. There was no significant association between
AM-R BSI and hospital mortality.
Conclusions In a subset of ICU patients with ARF-RRT, anti-
microbial resistance of microorganisms that caused BSI did not
affect mortality. After adjustment for various covariates, older age
was associated with higher mortality. In addition, primary BSI was
associated with lower inhospital mortality.
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Introduction Infectious pathologies are among the most prevalent
in the ICU and significantly influence the outcome of critically ill
patients. However, the emergency of resistant pathogens to
different antibiotics makes the choice of the initial treatment more
complex. In addition, inadequate empirical antibiotic therapy is
associated with a poorer outcome.
Objectives To evaluate the adequacy of antibiotic therapy in a
general ICU and to collect data about the microbial flora in order to
better adapt the empirical treatments.
Materials and methods Data were prospectively collected in a 12-
bed general ICU. The presence of infection was defined by the doctor
in charge of the patient. Inadequate antibiotic therapy was defined as
microbiological evidence of infection not covered by the chosen anti-
biotics, or by the finding of primary resistance to the antibiotics in use.
Results Data were collected in 80 consecutive patients. The main
site of infection was the lung (50%). The most prevalent
microorganisms were the Gram-negative (52%). The prevalence of
nosocomial infections was 60%. Empirical antibiotic therapy was
inadequate in 28 episodes (35%), and the most prevalent
microorganisms in this group were MRSA, Pseudomonas MR,
Stenotrophomonas maltophilia. The general mortality rate was 40%,
but the mortality rate among patients with inadequate antibiotic
therapy was 50%, but only 33% when adequate antibiotic therapy
(odds ratio = 3.09, 95% confidence interval 1.06–9.16). Risk factor
to an inadequate therapy was nosocomial infection (relative risk 2.07,
95% confidence interval 1.01–4.26). Other risk factors that showed
a non-significant trend were a delay to starting antibiotics greater
than 24 hours, immunosupression, septic shock and higher APACHE
II score. The number of empirical treatment schemes was 17.
Conclusion These preliminary data showed that there is an excess in
mortality rate when empirical therapy is inadequate. The inadequacy
of treatment was associated with nosocomial infections. There was an
exaggerated variability on the choice of empirical strategy.
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Background The clinical importance of systemic Candida infection
in critically ill patients is a well-documented fact. However, it is not
always true that early recognition of Candida infections followed by
early pre-emptive antifungal therapy has been routinely done. Lack
of an institutional written protocol for systemic Candida infections
may lead to delayed diagnosis and treatment of such infections. It
is expected that each institution has to establish its own clinical
path to ensure a standardized team approach to systemic Candida
infections to improve patient outcome.
Purposes One is to review indications of antifungal therapy and
evaluate the relationship between risk factors and values of beta-D-
glucan. Another is to test usefulness of risk factors to predict the
increased value of beta-D-glucan prospectively.
Patients and methods Clinical records of 43 patients who
received antifungal therapy for clinical diagnosis of systemic
Candida infections were reviewed. Risk factors (APACHE score,
Injury Severity Score [ISS], length of ICU stay, duration of
mechanical ventilation, total blood transfusion within 48 hours, total
parenteral nutrition, and signs of systematic inflammation), bacterio-
logical studies, and quantitative data of beta-D-glucan (Fungitec G
test MK, Seikagaku-kogyo, Japan) were analyzed. In a prospective
study, 38 patients were followed to test the hypothesis that the risk
factors (APACHE score >15 and ISS >16, ICU stay > 7 days, and
mechanical ventilation > 2 days) can predict increased levels of beta-
D-glucan (> 20 pg/ml), which validate pre-emptive antifungal therapy.
Results In a retrospective study, positive culture for Candida
remained low (37.2%); however, beta-D-glucan was increased
significantly (> 20 pg/ml) in 79.5% of patients. In patient with
APACHE score >15 and ISS >16, beta-D-glucan was increased in
78.4%. Beta-D-glucan was also increased in 79.0% of patients
who stayed in the ICU longer than 7 days. In prospective study,
26.3% (10/38) of patients eventually received antifungal agents.
Of these, eight patients (80.0%) fulfilled APACHE score >15, ISS
>16, and ICU stay > 7 days.
Discussion A certain combination of risk factors of systemic
Candida infections was useful to identify the patient group who
need pre-emptive antifungal therapy. Beta-D-glucan, which is a
useful serologic test for fungal infections, was useful to initiate
antifungal therapy in critically ill patients who fulfilled risk factors.
Conclusions APACHE score >15, ISS >16 and ICU stay
> 7 days were useful to discriminate patients who are prone to
develop systemic Candida infections. Beta-D-glucan (> 20 pg/ml)
is a useful clinical tool to initiate pre-emptive antifungal therapy in
such circumstances.
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Objective To determine the incidence of fungal colonization and
infection in critically ill patients.
Methods It is a prospective study during 30 months of the patients
admitted to the ICU during 24 hours or more. A throat swab,
tracheal aspirate and urine samples were taken on admission and
twice weekly. The fungal colonization and infection were
registered. Infections were diagnosed according to CDC criteria.
Infections were classified based on throat flora as: primary
endogenous (PE) when caused by germs that were already
colonizing the throat on ICU admission; secondary endogenous
(SE) when caused by germs that were not colonizing the throat on
the ICU admission but were acquired during the stay in ICU;
exogenous (EX) when caused by germs that were not colonizing
the throat. Infections were classified based on the onset moment
as: early onset (EO) (developed during the first 4 days of ICU stay)
and late onset (LO) (developed 5 days after ICU admission).
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Results A total 1582 patients were admitted, 953 males
(60.24%). Mean age was 57.91 ± 18.83 years. Mean APACHE II
score was 13.95 ± 8.93. Admission diagnoses were: 737
(46.59%) heart surgery, 189 cardiological (11.95%), 196 neurologic
(12.29%), 185 trauma (11.69%), 120 respiratory (7.59%), 104
digestive (6.57%) and 51 intoxication (3.22%). Mortality rate was
14.79% (234 patients). A total of 154 patients had fungal
colonization, 40 patients at ICU admission and 114 patients during
the ICU stay. Forty-eight fungal infections were documented (eight
EO and 40 LO; four PE, 40 SE and four EX): 19 urinary tract
infections (three EO and 16 LO; three PE, 13 SE and three EX),
12 pneumonias (two EO and 10 LO; one PE, 10 SE and one EX),
nine primary fungemias (two EO and seven LO; nine SE), six
surgical wounds (one EO and five LO; six SE) and two pressure
sores (0 EO and two LO; two SE). The 48 fungi responsible for 48
fungal infections were: 29 Candida albicans, 12 Candida
tropicalis, four Candida glabrata, two Candida parapsilopsis, one
Candida famata. Death occurred in 12/48 patients (25%) with
fungal infection: 3/9 (33.33%) fungemias, 5/12 (41.66%)
pneumonias and 4/27 (14.81%) other infections.
Conclusions Most fungal infections had a late onset, were
secondary endogenous and were due to C. albicans. The urinary
tract was the more frequent origin.
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Introduction Leptospirosis is in general a self-limited disease but it
can be associated with important complications such as multiple
organic dysfunction and high mortality [1,2].
Objective The goal of this paper is to evaluate the clinical
characteristics and the morbimortality of severe leptospirosis in
general ICUs from two general hospitals.
Methods All cases with the diagnosis of leptospirosis confirmed
by a blood macroagglutination test and admitted from 1990 to
2004 were studied. We analyzed their clinical and laboratory
characteristics, the occurrence of multiple organ dysfunction and
their mortality rate. We also compared survivors with nonsurvivors.
The quantitative variables have been compared by unpaired t test
and the qualitative variables by a chi-squared test.
Results We describe 57 adult patients, 40 ± 16 years, 47 men
and 10 women. The most frequent clinical manifestations were
fever (n = 52), myalgias (n = 51), jaundice (n = 49) and dyspnea
(n = 49). All patients showed some level of organic dysfunction:
respiratory (n = 51), renal (n = 46), hepatic (n = 45), cardio-
vascular (n = 35), hematologic (n = 32) and neurologic (n = 16).
The mortality rate was 40% (n = 23). The comparison from
nonsurvivors with survivors showed that they have higher
incidences of respiratory, cardiovascular and neurological failures
as well as higher levels of acidosis (P < 0.05).
Conclusions In endemic regions leptospirosis has to be
considered as a cause of multiple organic dysfunction with a high
mortality rate mainly when respiratory, cardiovascular or
neurological failures are present.
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Introduction Falciparum Malaria is a dreaded parasitic infection,
attacks all the organs in the human body cerebral, and chest
dysfunction is very common in the infection followed by kidneys
blood and so forth.
Hypothesis To study and compare the various treatment
modalities and the attendant complications of Falciparum Malaria
with or without concomitant Vivax in the intensive care unit. The
study is done to find out the best treatment to offer to patients
suffering with Facliparum Malaria infection and treat ongoing
multiorgan failure and to prevent further complication of the
dreaded parasitic infection.
Methods Retrospective study between 1993 and 1995 and
prospective study from 1996 to 2003 of patients having severe
malaria infection warranting intensive care management.
Results A total number of 181 patients. See Table 1.
Table 1
Number Died 
Year of patients (ARDS + MOF) Survived
1993–1996 39 29 (no quinine) 10 (quinine)
1996 9 5 (no quinine) 4 (quinine)
1997 19 7 (no quinine) 12 (quinine)
1998 14 7 (no quinine) 7 (quinine)
1999 15 5 (no quinine) 10 (quinine)
2000 24 10 (no quinine) 14 (quinine + artesunate)
2001 34 1 (no quinine) 33 (quinine + artesunate)
2002 19 2 (no quinine) 17 (quinine + artesunate)
2003 until March 8 Nil 8 (quinine + artesunate)
ARDS, acute respiratory distress syndrome; MOF, multiorgan failure.
Conclusions (1) Quinine has given good and consistent results.
Treatment must be initiated with quinine and must be given
intravenously. (2) Parasites may have developed resistance to a
multidrug regimen (mefloquine + others). (3) Quinine followed by
artesunate 120 mg bolus followed by 60 mg daily intravenously for
5 days (quinine + artesunate together) yielded good results. This is
the best that can presently be offered to patients with shock/
multiorgan failure.
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Introduction Zygomycosis caused by Rhizopus species (Rhsp) is an
aggressive and rapidly progressive opportunistic fungal infection in
immunocompromised patients. It comprises mucocutaneous,
rhinocerebral, pulmonary, urological and disseminated infections.
Predisposing factors are immunosuppression owing to severe
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diseases, immune defects or metabolic disturbances like diabetic
ketoacidosis. Rhizopus infections are characterized by angioinvasive
growth, necroses of infected tissue and perineural invasion. The
invasion of blood vessels is remarkable for a fungal infection. The
mortality of zygomycosis is very high, especially for disseminated
disease and if immunosuppression cannot be corrected.
Patients Patient 1 (female, 73 years): Delayed clinical course
according to infection of a hip-TEP and a femoropopliteal bypass
of the right leg, eventual exarticulation of the right hip joint,
pseudomonas pneumonia, severe sepsis caused by staphylococci,
acute respiratory distress syndrome, acute renal failure and
multiple use of antibiotics. Subsequent detection of Rhsp in the
bronchoalveolar lavage and treatment with amphotericin B for this
reason. Patient 2 (male, 68 years): Transplantation of kidney in
past medical history, presenting with acute renal failure and with
quite a few infections before. In the sequel development of
abscessing pneumonia on the right side with a pleural empyema.
Rhsp were detected by microbiological testing in the empyema
fluid. These findings required surgical intervention, resection of the
lower lobe of the right lung and, within the same operation, of the
renal graft because of rejection. The patient was treated with
Caspofungin because of Candidemia in addition to zygomycosis.
The further course was delayed by several septic phases. Patient 3
(male, 72 years): An insignificant past medical history with
appendectomy, secondary wound-healing; hypertension,
hyperlipoproteinemia. No hint for an immune defect. Operation
because of adhesion ilueus, postoperative severe septic shock
owing to peritonitis. After 1 month of intensive care therapy with
multiple lavages and antibiotics microbiologically proven abdominal
infection with Rhsp. All patients died later in spite of all efforts.
Discussion The very rarely seen zygomycosis caused by Rhsp
developed in patient 1 and patient 2 owing to immunosuppression —
in the first, iatrogenic induced by immunosuppressive drugs after
organ transplantation; in the second as a result of previous
immunosuppression and prolonged severe sepsis. Zygomycosis of
the third patient developed because of prolonged severe septic
shock without a hint of a immune deficit before.
In comparison with other mycoses, treatment of Rhsp infections
remains difficult. The affinity to blood vessels, where the fungi
multiply and their feature of vascular invasion with thrombosis and
infarction are complicating therapeutic efforts, which should
include surgical resection whenever possible and amphotericin B.
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Toxic epidermal necrolysis (TEN) is a devastating medication-
induced extensive epidermal detachment with a reported mortality
rate of 30–60% in adults. As in severe burns, fluid losses are
massive, and superinfection, impairment of thermoregulation,
excessive energy expenditure and alteration of immunologic
functions are usual complications. Moreover, mucous membrane
involvement increases morbidity. Previously reported data suggest
that age, total body surface area (TBSA) involvement, late
recognition and treatment of TEN are poor prognostic indicators.
The purpose of the clinical study was to evaluate the effects of
special intensive and nutritional management on the outcome of
patients with TEN.
Between 1988 and 2004 13 patients (five men, eight women, mean
age 51 years) were admitted to our department. Two patients were
in very poor condition at admission and died within 24 hours. They
were excluded from the clinical study. Patients had a TBSA skin
slough of 25–85% and a mean APACHE II score of 11.75.
Eleven patients were placed in a bacteria-controlled nursing unit,
wounds were treated with topical debridement and antimicrobial
medications. Nutritional therapy (enteral and/or parenteral) was
instituted after fluid and electrolyte replacement. The daily caloric
intake reached 146 kJ/kg body weight with a nitrogen–caloric ratio of
1:150. Enteral feeding (sip feeds, nasogastric tube, PEG) was forced
as early as possible. One patient had diabetes mellitus (NIDDM).
With the complex treatment of 13–26 days in the ICU, nine
patients recovered. Two patients died due to septic complications
(infected central venous catheter, extended gastrointestinal
mucousa involvement — mortality rate: 18%). In the last 8-year
period all the patients with TEN healed, only one patient (86-year-
old woman) died later due to acute myocardial infarction.
Our clinical experiences show that early recognition of TEN may
decrease the morbidity and mortality. The local and general
management of TEN should be carried out at an isolated, aseptic
unit of an intensive care department. The conventional therapy
combined with vigorous nutritional management may improve the
patients survival. Our results for a group of older patients with TEN,
with extensive skin and/or mucosal involvement suggest that age, a
delay in proper hospitalisation, steroids and early empiric antibiotic
treatment are associated with a poor prognosis.
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Background The clearance of antibiotics during continuous
venovenous hemofiltration (CVVH) is calculated by multiplying the
sieving coefficient (SC) (defined as the ratio of drug concentration
in the ultrafiltrate to plasma) and the ultrafiltration rate (Quf). For
most antibiotics the SC is unknown. It was suggested that the SC
can be substituted by the non-protein-bound fraction (fu). However,
fu values as reported in the literature are determined in healthy
volunteers and not during critical illness. We compared measured
and estimated CVVH clearance (ClCVVH) of five antibiotics.
Methods In 40 patients with ARF undergoing CVVH (predilution,
cellulose-triacetate filter, Quf 36 ± 8 ml/min), prefilter, postfilter
and ultrafiltrate samples were collected and drug concentrations
were determined by HPLC or by immunoassay. The prefilter
concentration (Cpre) was corrected using the dilution factor
(Qb/Qb + Qinf), where Qb is the blood flow rate and Qinf is the
substitution fluid infusion rate. The SC was calculated as follows:
SC = 2 × Cuf / (Cpre + Cpost).
Results Data (mean ± standard deviation) are presented in
Table 1. ClCVVH (ml/min) was calculated by multiplying the SC (or
the fu) and the Quf.
Table 1
Measured Measured Non-protein- Estimated 
Drug (n) SC ClCVVH bound fraction ClCVVH
Ceftazidim (4) 2.14 ± 2.64 75 ± 92 0.79 28 ± 1
Ciprofloxacine (16) 0.89 ± 0.33 31 ± 12 0.60 21 ± 1
Flucloxacilline (5) 0.37 ± 0.38 13 ± 14 0.20 7 ± 0
Fluconazol (9) 0.86 ± 0.09 30 ± 2 0.88 31 ± 1
Vancomycine (6) 0.71 ± 0.19 27 ± 5 0.70 28 ± 9
SC, sieving coefficient; ClCVVH, continuous venovenous hemofiltration
clearance.
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Conclusions Measured and estimated ClCVVH corresponded
well for fluconazol and vancomycine, but not for ceftazidim,
ciprofloxacine and flucloxacilline, possibly due to changes in
protein binding induced by critical illness or drug–membrane
interactions. Therefore, for antibiotics with a narrow therapeutic
range, monitoring drug concentrations remains mandatory.
P36
Ceftazidime reduces pulmonary hypertension in an ovine
model of sepsis following smoke inhalation injury
DM Maybauer1, MO Maybauer1, JF Fraser2, LD Traber1, 
P Enkhbaatar1, N Morita1, DL Traber1
1University of Texas Medical Branch, Galveston, TX, USA;
2University of Queensland, Brisbane, Australia
Critical Care 2005, 9(Suppl 1):P36 (DOI 10.1186/cc3099)
Objective Our group recently developed an ovine model of
Pseudomonas aeruginosa sepsis associated with acute lung injury
(ALI) [1]. The aim of this study was to modify this model by the
administration of Ceftazidime (Cef) to simulate a more clinically
relevant situation. This modification could be the basis for future
studies investigating new treatment strategies in sepsis.
Methods Eighteen sheep (35–40 kg) were operatively prepared for
chronic study. After 7 days of recovery, sheep were randomly
allocated either to sham, control, or Cef groups (n = 6 each). After a
tracheostomy had been performed, ALI was produced in the control
and Cef group by insufflation of 48 breaths of cotton smoke under
deep halothane anesthesia. Then, live P. aeruginosa were instilled into
the lungs via a bronchoscope [1]. The sham group received the
vehicle, 48 breaths of room air and 30 ml saline. Subsequently,
anesthesia was discontinued. The sheep were studied for 24 hours in
the awake state and were ventilated with 100% oxygen (tidal volume
15 ml/kg, 30 breaths/min). The mean pulmonary artery pressure
(MPAP) and pulmonary artery occlusion pressure (PAOP = wedge
pressure) were determined every 3 hours. Cef (3 g, intravenously)
was administered 1 hour and 13 hours post injury. The animals were
resuscitated with Ringer’s lactate solution to maintain filling pressures
and hematocrit. Lung tissues were taken after the experiment to
determine the bloodless lung tissue wet to dry weight ratio (W/D).
Statistical analysis: two-way analysis of variance, Student–Newman–
Keuls post hoc comparisons, significance P < 0.05.
Results MPAP and PAOP remained stable in sham animals. The
control group showed a significant increase in MPAP (baseline
[BL]: 19 ± 1 vs 24 hours: 31 ± 1) and PAOP (BL: 11 ± 1 vs 24 hours:
17 ± 1) versus BL over time. The Cef group also showed an
increase in MPAP (BL: 20 ± 1 vs 24 hours: 26 ± 1) and PAOP
(BL: 10 ± 1 vs 24 hours: 13 ± 1) vs BL, but this increase was
significantly lower in comparison with the control group. The fluid
balance (sham: –547 ± 38, control: +1266 ± 75, Cef: +382 ± 55)
was significantly higher in the control and Cef groups compared
with sham, but also significantly reduced in the Cef group
compared with the control group. However, the W/D ratio after
24 hours (sham: 5.0 ± 0.1, control: 5.8 ± 0.2, Cef: 5.7 ± 0.2)
increased significantly in the control and Cef groups compared
with sham, but was not statistically different between those groups.
Conclusion The application of Cef after ALI associated with
bacterial challenge reduced pulmonary hypertension and fluid
requirement. The addition of antibiotics to the protocol will make it
more clinically relevant and is a useful new approach for further
studies in this modified sepsis model.
Acknowledgements Grant support from Shrine 8820, 8450, NIH
GM066312.
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Continuous versus intermittent infusion of temocillin in
intensive care unit patients
K Claeysoone, V Basma, R Hens, F Van Bambeke, R De Jongh,
P Tulkens
ZOL, Genk, BE;UCL, Brussels, Belgium
Critical Care 2005, 9(Suppl 1):P37 (DOI 10.1186/cc3100)
Background and goal β-lactams are time-dependent antibiotics
and show little gain in activity once their concentration exceeds the
minimum inhibitory concentration about fourfold, which suggests
their administration by continuous infusion. We have studied the
stability, the compatibility with other drugs, and the pharmaco-
kinetics of continuous or intermittent administration of temocillin (a
β-lactam active against Gram-negative organisms).
Methods Temocillin was assayed by HPLC. Temocillin stability
was measured over 24 hours after its solution in water at 37°C.
Compatibility with several frequently used drugs on the ICU was
determined under conditions mimicking their clinical use.
Temocillin was measured in plasma samples from ICU patients
with normal renal function, randomly assigned to receive a
continuous (n = 6; 2 g every 12 hours; 5 day sample observation)
or intermittent (n = 6; 2 g over 30 minutes twice daily; consecutive
samples before and after dose 1 and 9) schedule.
Results Recovery after storage for 24 hours at 37°C of both R and
S isomers of temocillin exceeded 90%, which is better among
other studied β-lactams. Temocillin was compatible with most
frequently used drugs on the ICU with the exception of
clarithromycin, ciprofloxacin, meropenem, imipenem, piperacillin/
tazobactam, vancomycin, amoxicillin/acid clavulanic acid, propofol,
midazolam, piritramide, nicardipine, milrinone, and ranitidine. In
patients with normal renal function, plasma levels of temocillin were
above 50 mg/l in the continuous group, and 90% of the time above
the breakpoint of 16 mg/l with peak levels of 120 mg/l after the
first and ninth dose in the intermittent group.
Conclusion Temocillin can be used safely in the ICU, either with
an intermittent or continuous schedule. The latter may be preferred
based on pharmacodynamic considerations.
P38
Meropenem administration by intermittent infusion versus
continuous infusion for the treatment of nosocomial
pneumonia
L Lorente, S Huidobro, M Martín, M Mora
Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
Critical Care 2005, 9(Suppl 1):P38 (DOI 10.1186/cc3101)
Objective Mainly, beta-lactamic efficacy is determined by the
duration of time that concentrations remain above the minimum
inhibitory concentration (MIC). Some studies have found that the
administration of carbapenems by continuous infusion maintain
constantly concentrations above the MIC of susceptible organisms
over the course of therapy; but limited data exist on clinical efficacy
(only occasional observations have been made). The purpose of
this study was to evaluate the clinical efficacy of meropenem by
continuous infusion administration (CI) or by intermittent infusion
(II) for the treatment of ventilator-associated pneumonia (VAP)
caused by Gram-negative bacilli (GNB).
Methods An historic control group (1 July 2000–20 June 2002)
with VAP caused by GNB who received initial empiric antibiotic
therapy with meropenem by II (n = 18) was compared with a pros-
pective cohort of patients (1 July 2002–30 June 2003) treated with
meropenem by CI (n = 10), at a university hospital medical–surgical
Available online http://ccforum.com/supplements/9/S1
S16
ICU. VAP were treated during 14 days with two antibiotics:
meropenem (1 g/6 hours intravenously) plus another (aminoglyco-
side or quinolone). Antibiotic clinical effect was categorized as cure
or failure. Differences between groups were tested by means of
Student’s t test and exact chi-square by permutation, using Statxact
Software 5.0. We consider values P < 0.05 as a significant difference.
Results Significant differences were not found between both
groups of patients (15 with CI and 30 with II) in sex, age, APACHE
II score, diagnosis, microorganism responsible and organ
dysfunction severity assessed by the Sepsis-related Organ Failure
Assessment score. The CI group showed significantly greater
clinical cure than the II group (CI, 14/15 [93.33%] vs II, 19/30
[63.33%], P = 0.038) and smaller, but not significant, attributable
mortality to VAP (1 of 15 [6.66%] vs 7 of 30 [23.33%], P = 0.236).
Conclusions Our data suggest that administration of meropenem
by CI may have more clinical efficacy than administration by II for
the treatment of nosocomial pneumonia, but more studies are
required to confirm it.
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Continuous infusion versus intermittent infusion of
ceftazidime for the treatment of pneumonia caused by
Pseudomonas aeruginosa
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Objective Beta-lactamics antibiotics exhibit concentration-
independent bactericidal activity. Several studies have found that
ceftazidime by continuous infusion appears to optimise the
pharmacodynamic profile by constantly providing concentrations in
excess of the minimum inhibitory concentration of susceptible
organisms over the course of therapy. Limited data exist on clinical
efficacy by continuous infusion of ceftazidime. The purpose of this
study was to evaluate the clinical efficacy associated with the
administration of continuous infusion of ceftazidime (CI) and
intermittent infusion of ceftazidime (II) for the treatment of ventilator-
associated pneumonia (VAP) caused by Pseudomonas aeruginosa.
Methods An historic control group (1 July 2000–20 June 2002)
with VAP caused by P. aeruginosa who received initial empiric
antibiotic therapy with ceftazidime by II (n = 32) was compared
with a prospective cohort of patients (1 July 2002–30 June 2003)
treated with ceftazidime by CI (n = 15), at a university hospital
medical–surgical ICU. Patients were treated during 14 days with
ceftazidime, by CI (4 g/day) or II (2 g/8 hours), plus tobramycin.
Exclusion criteria was creatinine clearance < 60 ml/mn. Antibiotic
clinical effect was categorized as cure or failure. Differences
between groups were tested by means of Student’s t test and
exact chi-square by permutation, using Statxact Software 5.0.
Results Significant differences were not found between both
groups of patients (eight with CI and 12 with II) in sex, age,
APACHE II score, diagnosis and organ dysfunction severity
assessed by the Sepsis-related Organ Failure Assessment score.
The CI group showed greater clinical cure rate than the II group (8
of 8 [100%] versus 4 of 12 [33.33%], P = 0.004) and smaller
atributable mortality to VAP (0 of 8 [0%] versus 6 of 12 [50%],
P = 0.024). In addition, CI patients received one-third less daily
dose than those treated by II.
Conclusions These data suggest that ceftazidime administration
by continuous infusion may have more clinical efficacy that
intermittent infusion, in treatment of VAP caused by P. aeruginosa.
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Laparostomy versus laparotomy in severe abdominal
infection: microbiological assessment
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Introduction Mortality of severe abdominal infection, due to
peritonitis after anastomotic dehiscence, visceral organ necrosis or
necrotic pancreatitis, remains high. The efficacy of laparostomy in
damage control surgery and uncontrolled intra-abdominal infection
is controversial [1].
Methods We retrospectively reviewed the records of all patients
with severe abdominal infection secondary to peritonitis admitted
to the ICU of a university teaching hospital from 1998 to 2000. The
following information was collected: age, simplified acute
physiology score (SAPS II) and sepsis-related organ failure
assessment (SOFA) on admission, length of stay (LOS), ICU and
hospital outcome, type of bacteria, number of isolations and
haematogenous dissemination.
Results Thirty-nine critically ill patients were studied. The mean
age was 66.1 ± 16.9; the overall SAPS II at admission was
41.7 ± 14.6; the SOFA was 10.9 ± 4.3. A total of 13 laparostomy
were performed (group I). Twenty-six patients were undergoing a
laparotomy (group II). No differences regarding age (group I vs
group II 61.1 +± 12.7 vs 68.5 ± 18.1, P = 0.08), SAPS II
(41.8 ± 20.6 vs 41.5 ± 10.6, P = 0.65) and SOFA (11.8 ± 5.5 vs
10.4 ± 3.5, P = 0.49) were found. The duration of ICU stay was
longer in group I than in group II (44.4 ± 52.2 vs 19.8 ± 17.3,
P = 0.04). ICU mortality was equal between two groups (30.7%).
Hospital mortality was not statistically different between two
groups (38.4% vs 42.3%, P = 0.77). The number of positive
cultural specimens was 19 in both groups. Isolated micro-
organisms were: Gram-positive cocci (21% vs 26.3%), Pseudo-
monas aeruginosa (26.4% vs 31.6%), other non-fermenting Gram-
negative bacilli (21% vs 10.5%), Enterobacteriaceae (16% vs
10.5%), fungi (15.8% vs 15.8%). Two of five P. aeruginosa isolations
in Group I were multiresistant to available antibiotics and sensible
only to combinations. Four out of 13 patients in group I presented
candidemia compared with two of 26 patients in group II. Haemato-
genous dissemination was greater in group I (85.7% vs 50%).
Conclusions The laparostomy technique used in the management
of severe intra-abdominal sepsis appears to correlate with
significant ICU stay and costs. Prolonged antibiotic therapy and
frequent intra-abdominal procedures determine higher incidence of
infections caused by Gram-negative, enterobacteriaceae and
multiresistant pseudomonaceae. The incidence of fungal infection
is not influenced by surgical approach, but the ‘open abdomen’
strategy seems to facilitate dissemination.
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Logistic regressive analysis of potential prognostic factors for
pulmonary complications after abdominal surgery in elderly
patients
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To investigate potential prognostic factors and to predict extent of
risks for postoperative pulmonary complications by logistic
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regressive analysis, and to evaluate the role of non-invasive
ventilation in reducing the incidence of complications in elderly
patients. A stair-climbing test was carried out with ASA score,
FEV1, changes of SpO2 and HR noted at the same time. Logistical
regressive analysis based on these parameters were used to
assess the relation between potential prognostic factors and
postoperative complications. Patients with limited pulmonary
reserves were selected using the equation, and the protective
effect of non-invasive ventilation on these patients was assessed.
The incidence of postoperative pulmonary complications for high-
risk patients with non-invasive ventilation was 33.2%, and the
incidence of pulmonary complications for high-risk patients without
non-invasive ventilation was 67.7%. There was not a significant
difference between these two groups with low-risk (P > 0.05). The
mathematical model of logistic regressive analysis using the stair-
climbing testing combined with other parameters is a simple,
reliable method to predict the cardiopulmonary reserved function in
elderly patients. Non-invasive ventilation can effectively reduce the
incidence of postoperative pulmonary complications for high-risk
patients, but it has no effect on patients with low risk.
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Bariatric surgery postoperative management: complications in
a series of 278 patients admitted to an intensive care unit
M Knibel, F Muller, R Hatum, C Roderjan, E Guimarães, 
M Lugarinho, C Vasconcelos, A Vanzan, M Mattos
Sao Lucas Hospital, Rio De Janeiro, Brazil
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Introduction Morbid obesity is one of the most important public
health problems these days, and bariatric surgery became an
option to patients with body mass index of 35 or higher and
obesity-related complications (hypertension, diabetes, etc.).
Patients and methods We observed the postoperative period of
these patients in our ICU during 10 months (n = 278) and their
possible postoperative complications.
Results Found were athelectasy in 60%, surgical wound minor
bleeding in 2.5%, pulmonary embolism in 0.35%, pneumonia in
1.43%, acute renal failure in 1.07%, rhabdomyolisis in 2.8%,
peritonitis in 1.43%, respiratory failure in 2.5%, acute respiratory
distress syndrome in 1.07%, cardiac arrhythmia in 1.43%, gastro-
intestinal fistula in 2.5%, acute myocardial infarction in 0.72%,
lower gastrointestinal hemorrhage in 0.71%, and bowel
obstruction in 0.71%. The death overall rate was 1.43%.
Conclusions The most common postoperative complication was
athelectasy, showing the need for a respiratory therapist at the
bedside to perform non-invasive mechanical ventilation in the
immediate postoperatorium period. Peritonitis was the worst
complication, accounting for all deaths; the intensive care team must
be prepared to immediately recognize and manage these cases. The
results are in accord with those found in the recent medical literature.
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The role of the Shuttle Walking Test in predicting mortality and
morbidity post oesophagogastric surgery
P Whiting, P Murray, S Hutchinson, C Stoddard, R Ackroyd
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Critical Care 2005, 9(Suppl 1):P43 (DOI 10.1186/cc3106)
Introduction The Shuttle Walking Test (SWT) has been previously
shown to correlate well with patients’ maximal oxygen uptake (VO2
max) [1–3]. Older and colleagues demonstrated that an anaerobic
threshold of 911 ml/min/kg, in patients undergoing major abdominal
surgery, was an excellent predictor of mortality from cardio-
respiratory causes [4]. Patients undergoing oesophagogastric
surgery currently have a 30-day mortality of approximately 9% in
our institution and are all admitted to critical care postoperatively.
Our aim was to assess the value of a preoperative SWT in trying to
identify high-risk patients.
Method All patients listed for oesophagogastrectomy between
April 2002 and September 2004 undertook a SWT as a standard
part of their preoperative assessment. Routine anaesthesia,
surgery and critical care was provided guided by clinical require-
ments. Thirty-day mortality was compared retrospectively with
shuttle test data.
Results Thirty-nine patients undertook a SWT, and had surgery.
The mean age of the group was 64 years (range 44–81 years).
The mean SWT distance was 480 m (range 220–880 m). At the
30th postoperative day, 18 patients had been discharged home
(46.2%), 14 patients remained on the wards (35.9%), three still
required critical care (7.7%) and four patients had died (10.2%).
No patient with a SWT of greater than 350 m died within 30 days
of surgery. Patients with a SWT of 350 m and below had a 50%
30-day mortality.
Discussion This small patient group appears to be representative
of the oesophagogastric surgical population within our institution
(mortality 10.2% vs 9%). A SWT of 350 m appears to be a
sensitive marker of increased postoperative mortality in this
particular patient population. This finding is consistent with Lewis
and colleagues’ [2] data correlating SWT distance with VO2 max
and Older and colleagues’ [4] work on the anaerobic threshold and
perioperative outcome. Further evaluation is required, but using
this simple, cheap and reliable non-invasive preoperative test may
help to risk-stratify patients undergoing high-risk surgery. High-risk
groups may benefit from appropriately informed consent for
surgery but potentially also from preoperative cardiopulmonary
training and a focused utilisation of resources.
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dobutamine optimization of oxygen delivery in high-risk
surgical patients
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Introduction Preventing perioperative tissue oxygen debt
contributes to a better postoperative recovery. Whether the
beneficial effects of fluids and inotropes during optimization of
oxygen delivery (DO2) in high-risk surgical patients are due to
fluids, inotropes or the combination of the two is not known. We
aimed to investigate the effect of fluid optimization, without the use
of inotropes, on morbidity.
Methods A randomized controlled trial with pulmonary artery
catheter (PAC)-guided haemodynamic optimization in 50 high-risk
patients (elderly with coexistent pathologies) undergoing major
elective surgery. Therapy consisted of optimization during the
operation and 24 hours postoperatively using either fluids alone
(n = 25) or fluids and dobutamine (n = 25), aiming to achieve
supranormal values (DO2 > 600 ml/min/m2). Clinical complications
such as pulmonary edema and/or heart failure, acute myocardial
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infarction, bleeding, thrombosis, fistula and acute renal failure were
monitored.
Results Prevalence of pulmonary edema/heart failure significantly
increased in the fluid optimization group in comparison with the
dobutamine optimization group in the postoperative period (40%
vs 12%, relative risk [RR] 3.33, 95% confidence interval [CI]
1.04–10.7, respectively, P < 0.05). Clinical complications were
more frequent in the fluid optimization group than in the
dobutamine group (68% vs 28%, RR 2.43, 95% CI 1.22–4.81,
P < 0.05). The 30-day mortality rates were 8% in dobutamine
optimization group and 20% in the fluid optimization group (RR
2.5, 95% CI 0.53–11.70, not significant).
Conclusion In high-risk patients undergoing major surgery, PAC-
guided hemodynamic optimization using dobutamine determines
better outcomes, whereas fluids alone increase the incidence of
postoperative complications.
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Early goal directed therapy reduces morbidity and length of
hospital stay following high-risk surgery
R Pearse, D Dawson, J Fawcett, A Rhodes, M Grounds, 
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Introduction Several studies have described the successful use of
goal directed therapy to guide fluid and inotropic therapies in
patients at high risk of postoperative complications. This has mainly
been performed in either the pre-operative or intra-operative
period. It is unclear whether this is effective solely in the
postoperative period. The aim of this study was to evaluate the
effect of an early goal directed therapy (EGDT) protocol that does
not utilize the pulmonary artery catheter, when commenced
immediately after general surgery in patients at high risk of
complications.
Methods A prospective, randomized controlled trial in high-risk
surgical patients on a general ITU. Patients were randomized to
conventional treatment or EGDT for 8 hours immediately following
surgery. The goals for EGDT were to optimize volume status by
maximizing stroke volume with fluid challenges and then to
increase the oxygen delivery index (DO2I) to 600 ml/min/m2 with
dopexamine if required. Control group patients received fluid
guided by central venous pressure. Other therapeutic targets were
the same for both groups. Stroke volume and DO2I were measured
in both groups using lithium indicator dilution and pulse contour
analysis (LiDCOplus system). Postoperative complications were
predefined and patients were followed up for 60 days. Data are
presented as medians ± standard error or percentage.
Results One hundred and twenty-two patients (control = 60,
EGDT = 62) were randomized. There were no significant
differences between the two groups at baseline. Most patients
underwent gastrointestinal, vascular or urological surgery. Patients
in the EGDT group subsequently achieved higher DO2I than
controls (P < 0.0001) and more EGDT patients achieved a DO2I
of 600 ml/min/m2 (82% vs 42%, P < 0.0001). The DO2I target
was achieved as a result of increases in both stroke volume
(P = 0.02) and heart rate (P < 0.0001). The EGDT group received
more intravenous fluid (3015 ± 146 ml vs 2280 ± 164 ml,
P = 0.0006) and more EGDT patients received dopexamine (89%
vs 2%, P < 0.0001). The EGDT group developed fewer complica-
tions (0.7 vs 1.5 per patient, P = 0.002) and had a shorter hospital
stay (11 ± 3 days vs 14 ± 5 days, P = 0.002). Infectious
complications in the EGDT group were half that of the control
group (24 episodes vs 49 episodes, P = 0.0004). The EGDT
group utilized 640 less hospital bed-days. There was no difference
in 28-day (9.7% vs 10%) or 60-day (11.3% vs 11.7%) mortality.
Discussion EGDT immediately following general surgery in high-
risk patients reduces complications and length of hospital stay.
This approach is both practical and effective.
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Impact of a low postoperative central venous oxygen
saturation on postoperative morbidity
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Background Patients undergoing major surgery have an increased
oxygen debt that may affect postoperative outcomes. Current
strategies of perioperative hemodynamic optimisation necessitate
use of a pulmonary artery catheter. In patients with severe sepsis,
early goal directed therapy using a central venous catheter and
targeted to ScvO2 of 70% improves survival. This strategy is
untested in perioperative patients.
Aim To investigate whether a low postoperative ScvO2 is
associated with increased postoperative morbidity.
Methods Observational study from August to December 2003 in a
22-bed ICU-HDU of a tertiary referral cancer centre. ScvO2 was
analysed from blood collected from a central venous catheter at 2
and 12 hours after surgery in 83 patients undergoing major
resections for cancer. Patients were divided into two groups:
normal (ScvO2 ≥ 70% at both intervals) and low (ScvO2 < 70% at
one or both intervals). Central venous pH and base excess were
also noted. The ICU team managing clinical care was unaware of
the ScvO2 values. Outcomes studied were ventilator days, length
of ICU and hospital stay, ICU and hospital mortality, incidence of
anastomotic leak and incidence of complications (any of sepsis,
cardiovascular or respiratory complications, ICU stay ≥ 2 days or
ventilator days ≥ 2 days). Data were analysed using the unpaired
t test and chi-square test. Binary logistic regression (stepwise
forward conditional) was performed to determine the parameters
contributing to morbidity.
Results Fifty-one patients (62%) had a low ScvO2 at one or both
time intervals. Patients in the low group had significantly lower
ScvO2 at 2 hours (63.9 ± 8.9 vs 76.8 ± 5.8, P = 0.000) and
12 hours (68.7 ± 6.1 vs 76.2 ± 4.1, P = 0.000), respectively.
APACHE II scores within 24 hours of ICU admission were similar
(8.9 ± 2.7 vs 9.9 ± 2.7, P = 0.1). There was no difference in ICU
or hospital mortality (both 3 vs 0, P = 0.16) between the low and
normal groups, respectively. pH and base excess were not
different. Patients in the low group had more days on ventilator
(3.5 ± 6.1 days vs 0.59 ± 1.5 days, P = 0.009), and longer ICU
stay (5.6 ± 6.7 days vs 1.75 ± 2.6 days, P = 0.009) and hospital
stay (17.8 ± 10.5 days vs 13.7 ± 5.06 days, P = 0.002). They
required more colloid infusion postoperatively (682 ± 398 ml vs
228.4 ± 279 ml). There was no difference in the number of
patients requiring inotropes (1 vs 0, P = 0.1). Significantly more
patients in the low group developed postoperative complications
(56.8% vs 18.7%, P = 0.009) and anastomotic dehiscence (26%
vs 9%, P = 0.03). On logistic regression, only ScvO2 at 12 hours
(P = 0.012) affected morbidity.
Conclusions A low ScvO2 was associated with major post-
operative morbidity. The results of this observational, hypothesis-
generating study justify a prospective trial of perioperative goal
directed therapy.
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Can central venous oxygen saturation intermittently measured
within the first 24 postoperative hours of cardiac surgery
predict death?
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A Melo1, F Graça Aranha1, J Sabino1
1Pró-Cardíaco, Rio de Janeiro, Brazil; 2Hospital Clementino Fraga
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Background Central venous oxygen saturation (ScVO2) has been
considered an important parameter for follow-up, prognostic estimate,
and therapeutic target in the management of critically ill patients.
Objective To analyze the impact of ScVO2 on the postoperative
period of cardiac surgery, and to correlate it with inhospital death.
Three ScVO2 measurements were taken within the first 24
postoperative hours, and the overall mean was calculated.
Case series and methods A classic cohort of 132 consecutive
patients selected from January 2004 to August 2004 and divided
into the following two groups: Group I, death (n = 11, 8.3%); and
Group II, survivors. Blood samples were collected through a
central venous catheter properly positioned in the right atrium
according to a previously validated method. The ScVO2 measure-
ments were taken in the postoperative period as follows:
immediately (SV0), after 6 hours (SV1), and after 24 hours (SV2).
A mean of the three measurements was calculated (mSV).
Inhospital mortality was the occurrence of death during
hospitalization. The Student t test was used for statistical analysis.
Results The mean ScVO2 values of Group I compared with those
of Group II were as follows, respectively: SV0, 54.8% ± 12.6 vs
65.4% ± 8.9 (P < 0.0001); SV1, 56.6% ± 7.3 vs 68.5% ± 5.9
(P < 0.001); SV2, 61.1% ± 7 vs 69.3% ± 5.3 (P < 0.001); and
mSV, 57.3% ± 7.8 vs 67.7% ± 4.9 (P < 0.001). The distribution of
variation of ScVO2 was normal. The EuroScore was as follows: in
the total sample, 5.3 ± 3.6; in Group I, 8.7 ± 6.1; and in Group II,
5 ± 3.1 (P = 0.001). The predicted mortality was around 11%, and
the inhospital mortality was 8.3%.
Conclusions In the population studied, a lowest ScVO2 measured
within the first 24 postoperative hours and the EuroScore were
related to inhospital death.
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Introduction The frequently used parameters to predict weaning
failure (WF) from mechanical ventilation (MV) weaning parameters
have low predictive capacity. Although being the most common
cause of WF, early detection of respiratory muscle fatigue is
difficult. Central venous saturation (ScvO2) is a marker of oxygen
consumption and could be applied for detection of WF.
Objective To evaluate the predictive capacity of ScvO2 in
detecting WF or success.
Design A prospective observational clinical multicentric study in
three ICUs of Porto Alegre.
Methods Between August 2003 and December 2004, all patients
with more than 48 hours of MV, in the weaning process, were
submitted, after informed consent, to a spontaneous breathing trial
(SBT) of 30 min and followed during the next 48 hours. All patients
in the trial had arterial and venous gas analysis, and hemodynamic
(cardiac rate, systolic and diastolic pressure) and ventilatory
parameters (respiratory rate, tidal volume, f/VT index and maximal
inspiratory pressure) during the MV time and in the 30th minute of
SBT. The outcomes were reintubation and mortality rates.
Results Sixty-three MV patients were included, 55.5% male, mean
age 55.8 ± 18.6 years, APACHE II score 18.2 ± 6.3. Septic shock
was the most frequent diagnosis with 50.8% of cases; mortality
ICU rate in the period 22.2%; weaning failure with reintubation rate
31.7% and mortality higher in WF patients (75% vs 14%,
P < 0.001). ScvO2 at the 30th minute of SBT was lower in WF
patients (58.2 ± 7.1 vs 66.3 ± 5.4, P = 0.003). Hemodynamic and
mechanic ventilatory parameters were not able to predict WF or
mortality. The PaO2, SaO2 and ScvO2 values dropped comparing
the MV time and the 30th minute of SBT (110.1 ± 39.8 vs
95.8 ± 28.8, P < 0.01; 97 ± 2.4 vs 95.3 ± 3.7, P < 0.001; and
68.3 ± 7.3 vs 64.6 ± 8.6, P < 0.001, respectively). WF patients
had the most accentuated fall in these parameters (102.1 ± 38.5
vs 85.8 ± 20.1, P = 0.008; 96.9 ± 2.7 vs 94.2 ± 3.9, P = 0.001;
and 68.2 ± 7.4 vs 59.5 ± 7.3, P < 0.001, respectively).
Conclusion The reduction of ScvO2 values during SBT is
correlated with the outcome reintubation. This is probably due to
an increase in oxygen muscle consumption and not only correlated
to changes in oxygen muscle offer.
P49
Effects of optimizing cardiac output by fluid loading on the
indocyanine green plasma disappearance rate and splanchnic
microcirculation
S Sakka, D Hofmann, O Thuemer, C Schelenz, K Reinhart
Friedrich-Schiller-University of Jena, Germany
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Introduction Hypovolemia may be associated with splanchnic
hypoperfusion and reduced in liver blood flow and function. In
general, optimizing the cardiac preload to increase the cardiac
output — a major determinant of systemic oxygen delivery — is a
primary clinical goal. In this study, we tested the hypothesis that
increasing the cardiac output by optimizing the intravascular fluid
status leads to an improved regional (i.e. hepato-splanchnic) blood
flow and function as assessed by the indocyanine green plasma
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disappearance rate (ICG-PDR), which has been shown to be of
major prognostic relevance [1].
Methods With approval by our ethics committee and written patient
consent we prospectively studied 12 postoperative cardiac surgical
patients (mean age 66 ± 13 years) who underwent elective
coronary artery bypass grafting. All patients underwent extended
hemodynamic monitoring by a pulmonary artery and left atrial
catheter for clinical indication. Microcirculation within the splanchnic
area was assessed by gastric tonometry, and liver blood flow and
function were determined non-invasively by transcutaneous
measurement of ICG-PDR. All these patients who were considered
hypovolemic underwent hemodynamic optimization by infusion of
hydroxyethylstarch (130 kDa). Global and regional parameters were
measured at baseline and 1 hour after fluid challenge. All patients
received pressure-controlled mechanical ventilation and respirator
settings remained unchanged throughout the study. Data are
expressed as mean ± standard deviation. For statistical analysis, a
paired t test was used and P < 0.05 was considered significant.
Results Overall, 630 ± 130 ml hydroxyethylstarch were admini-
stered. In all patients, the cardiac index significantly increased
following fluid administration, on average from 2.8 ± 0.7 to
3.6 ± 0.6 l/min/m2 and the stroke volume index from 30 ± 7 to
38 ± 8 ml/m2, respectively. With respect to cardiac preload, the
central venous pressure significantly increased from 6 ± 2 to
12 ± 2 mmHg and the left atrial pressure from 5 ± 3 to
11 ± 3 mmHg, respectively. However, the ICG-PDR and PCO2
gap (difference between gastric mucosal and end-tidal CO2
tension) did not change significantly (i.e. from 21.2 ± 6.5 to
21.6 ± 6.5%/min and from 0.9 ± 0.5 to 1.0 ± 0.7 kPa).
Conclusion Optimizing cardiac output by fluid loading per se is
not associated with a significant change in ICG-PDR or gastric
mucosal PCO2. However, since ICG-PDR in all patients with a
value <18%min increased, we hypothesize that particularly
patients with an a priori low ICG-PDR may benefit from optimizing
cardiac index by fluid loading. Further studies are needed to test
this hypothesis.
Reference
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Introduction Tissue hypoperfusion with concomitant hypoxia is a
leading sign of septic shock. Despite increased DO2 after volume
administration, VO2 remains low. Our hypothesis was that in this
setting, lower CO2 output would also occur. We calculated
anaerobic output of CO2 and found its small proportion to
complete CO2 output.
Methods We measured the output of CO2 as well as the
venous–arterial difference in CO2 concentration (v–aDCO2) in 25
patients in septic shock. All patients were mechanically ventilated,
and the circulatory volume and pressure variables were monitored
and changed according to pulmonary catheter findings.
CO2 output was measured by use of our own technical innovation;
a 5 l balloon was placed on the expiratory outlet and the CO2
concentration was measured by standard capnograph. Minute
ventilation was measured by a volume monitor over an ascending
and a descending line.
Results In 10 survivors VCO2 was higher than in nonsurvivors at
the baseline (189 ± 10 vs 173 ± 14, P = 0.0005). The cardiac
index was also higher (3.1 ± 0.27 vs 2.7 ± 0.6, P = 0.03). There
was no significant difference in v–aDCO2 (7.3 ± 1.6 vs 7.3 ± 1.4,
P = 0.95).
During resuscitation VCO2 increased markedly in survivors
(P = 0.0004), whereas in nonsurvivors only an increasing trend
was noted, but it did not reach statistical significance (P = 0.12).
Conclusion We conclude that this simple and noninvasive test of
measurement of VCO2 in patients in septic shock may be useful in
early detection of metabolic disarrangements caused by hypoxia,
as well as outcome of disease. It may also be used as a measure of
treatment efficiency.
P51
What effect of vasoactive drugs on passive leg raising
response in critically ill patients?
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Introduction Passive leg raising (PLR) mimics the hemodynamic
effects of rapid fluid loading (FL) by shifting venous blood from the
legs towards the intrathoracic compartment and by increasing right
and left ventricular preloads.
Aim To test the effect of vasoactive drugs on PLR response.
Patients and methods During a period of 2 months (September–
November 2004) were enrolled all patients with sepsis or septic
shock under mechanical ventilation who needed FL. The hemo-
dynamic measures include heart rate, invasive arterial pressure,
pulse pressure (PP), venous central pressure in a supine position
and after leg raising (45°); before and immediately after FL of
300 ml saline solution.
Results Twenty-eight hemodynamics measures were made. All
patients were mechanically ventilated and deeply sedated. Age
55 ± 18 years, SAPS II 37 ± 17. The patients were divided into
two groups.
Group 1 (with vasoactive drug): nine measures, age 58 ± 15 years,
SAPS II 48 ± 26. The increase of PP after PLR is 4 ± 2.7 mmHg,
while the increase of PP after FL is 5 ± 3 mmHg.
Group 2 (without vasoactive drug): 19 measures, age 54 ± 19 years,
SAPS II 33 ± 10. The increase of arterial PP after PLR is
10 ± 8 mmHg while the increase of PP after FL is 8.3 ± 7 mmHg.
Discussion PLR predicts the effect of FL in all patients. It depends
in part on the volume of blood contained in the leg vessels. The PP
increase after PLR is more important in patients without vasoactive
drugs (10 ± 8 vs 4 ± 2.7 mmHg).
Conclusion PLR is a very simple technique to predict the effect of
FL. Its effects seem to be less important in patients with vasoactive
drugs.
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Respiratory variation of plethysmography signal with a pulse
oxymeter: new predictive parameters of fluid responsiveness?
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Introduction Respiratory variation of pulse pressure (∆PP) and of
time of pre-ejection (∆PEP) obtained from an arterial catheter have
been shown as reliable predictors of fluid responsiveness in
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mechanically ventilated patients on sinus rhythm. The curve of
plethysmography obtained from a pulse oxymeter allows one to
calculate respiratory variation of ‘pulsed plethysmography’
(∆PlethP) and of pre-ejection time (∆PEPPleth).
Aim To examine whether ∆PlethP and ∆PEPPleth could predict
volume responsiveness as well as ∆PP and ∆PEP calculated from
an arterial catheter.
Patients Nineteen patients with septic shock, fully adapted to the
ventilator and on sinus rhythm, were studied before and after a fluid
challenge.
Methods Pulsed plethysmography was defined by the amplitude of
the pulse oxymeter wave. The pre-ejection period was defined by
the time between the onset of the QRS and the onset of the blood
pressure curve for PEPKT and the onset of the plethysmography
curve for PEPPleth. The ECG, blood pressures and plethysmo-
graphy tracings were recorded simultaneously on a computer. The
respiratory variation of the parameters were calculated and
averaged from five respiratory cycles according to the following
formula: ∆P = [Pmax – min / Pmax + min / 2] × 100. Responders
were defined as patients who increased their cardiac output —
measured by Doppler transthoracic echocardiography — by more
than 15% after fluid challenge.
Results A strong correlation between the baseline value of the
studied indices and the changes in cardiac output was observed
(r = 0.86 and 0.85 for ∆PPKT and ∆PEPKT and r = 0.82 for both
∆PPPleth and ∆PEPPleth). Table 1 confirms the reliability of
∆PPKT and ∆PEPKT to discriminate responders from non-
responders. It also shows that the plethysmography indices give
similar information with similar threshold values.
Table 1
Sensibility and specificity: patients are fluid responsive if their
values are over the threshold value with a Se and Spe value shown
∆PPKT ∆PEPKT ∆PlethP ∆PEPPleth 
Threshold% 12% 4% 12% 6%
Se 92% 86% 88% 92%
Spe 100% 100% 100% 77%
Conclusion The use of respiratory variation of a digital
plethysmography signal (∆PlethP and ∆PEPPleth) is helpful to
assess fluid responsiveness in mechanically ventilated patients.
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CVP does not reflect changes in preload when optimal PEEP
is determined
I Tóth, T Leiner, A Mikor, T Szakmány, Z Molnár
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Objective High intrathoracic pressures during lung recruitment
and defining optimal PEEP may cause haemodynamic instability
due decreased venous return [1]. The aim of this study was to
evaluate volumetric (ITBV) and pressure (CVP) indicators of
preload during the manoeuvre.
Materials and methods Eighteen patients suffering from ARDS
were recruited. All patients were ventilated in pressure control
mode (FiO2 = 1.0, respiratory rate = 20, I:E = 1:1). Following basic
haemodynamic measurements and blood gas analysis (Tep)
alveolar recruitment was done: PEEP was set at 26 cmH2O, then
40 cmH2O of pressure amplitude was applied for 40 s (T26).
Optimal PEEP was then determined as follows: VT was reduced to
4 ml/kg, then the PEEP was reduced from 26 cmH2O by 2 cmH2O
every 4 min and the optimal PEEP was defined as 2 cmH2O above
the level of PEEP, where the PaO2 suddenly dropped by >10%.
After setting the PEEP at the optimal level, the ‘40/40’ manoeuvre
was applied again and the tidal volume was set as 6 ml/kg, end
point (Tep). Haemodynamic parameters were determined by
arterial thermodilution (PiCCO) during lung recruitment (T26), then
every 8 min until the end point was reached (Tep). Data are
presented as the mean ± standard deviation. For statistical
analysis a paired t test and Pearson’s correlation was performed.
Results The PaO2 improved significantly from T0 to Tep:
203 ± 108 vs 322 ± 101 mmHg, P < 0.001. While CI, SVI and
ITBVI increased as PEEP was reduced from 26 cmH2O (T0) to an
average of 15 ± 4 cmH2O (Tep), CVP decreased (Table 1). There
was a significant positive correlation between CI and ITBVI
(r = 0.699, P < 0.01), and a significant negative correlation
between CI and CVP (r = –0.294, P < 0.05).
Table 1
T26 Tep P
CI (l/min/m2) 3.6 ± 0.9 4.2 ± 1.1 0.003
SVI (ml/min/m2) 32 ± 8 36 ± 9 0.013
ITBVI (ml/m2) 794 ± 188 870 ± 423 0.279
CVP (mmHg) 24 ± 6 19 ± 5 0.001
Discussion As was expected, as PEEP dropped the CI improved
due to increased venous return. This increase in preload was
reflected by ITBV but not by CVP, which is in accord with findings
of a recent animal experiment [2]. These results suggest that CVP
cannot be relied on as a measure of preload during lung
recruitment or when defining optimal PEEP in ARDS.
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Introduction One of the most important problems in therapy of
critically ill patients is the assessment of preload responsiveness.
Echocardiographic measuring of respiratory variations of aortic
blood velocity in ventilated septic shock patients can accurately
predict the effect of volume expansion. On the other hand, it
remains unclear whether such respiratory variability is a common
physiological reaction to hypovolemia and whether its measurement
is applicable also in spontaneously breathing patients.
Aim To assess whether the respiratory variability of aortic peak
blood velocity (∆Vpeak) and the respiratory variability of the aortic
velocity time integral measured by continual Doppler (∆VTI) predict
preload responsiveness determined by a more than 15% increase
of cardiac index (CI) after volume expansion in spontaneously
breathing healthy volunteers.
Method ∆Vpeak, ∆VTI and CI were measured by transthoracic
echocardiography in 20 volunteers at baseline and after
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intravenous administration of furosemide (0.5 mg/kg). After diuretic
response, volunteers were randomized to rapid intravenous volume
expansion (group A) or to a group without volume expansion
(group B). With that, the final measurement was performed.
Results Hypovolemia induction was associated with a 30%
decrease of CI (P < 0.001). Correlation between CI decline and a
strong increase of ∆Vpeak (r = –0.490, P = 0.028) and ∆VTI
(r = –0.554, P = 0.011) was identified in both groups. In group A,
subsequent volume expansion was followed by a drop of ∆Vpeak
(from 16.04 ± 1.99 to 2.97 ± 1.65, P < 0.001) and ∆VTI (from
20.43 ± 5.13 to 3.43 ± 1.68, P < 0.001) and an increase of CI in
the last measurement strongly correlated with the value of ∆Vpeak
(r = 0.782, P = 0.008) and ∆VTI (r = 0.770, P = 0.009) before
volume expansion. Conversely, there was no statistically significant
change of ∆Vpeak, ∆VTI and CI in group B between the second
and the last measurement.
Conclusions ∆Vpeak and ∆VTI reflect changes of intravascular
volume status in healthy spontaneously breathing volunteers, and
predict preload responsiveness.
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Introduction We investigated whether the respiratory changes in
arterial pulse pressure (∆PP), an accurate indicator during
mechanical ventilation (MV), and in arterial systolic pressure (∆PS),
easy to calculate, could predict fluid responsiveness in
spontaneously breathing patients. The respiratory changes in
intrathoracic pressure during spontaneous breathing, reversed
compared with MV, could be insufficient to modify loading
conditions of ventricles. We thus also tested those indicators
during a forced respiratory cycle.
Methods We prospectively studied 32 spontaneously breathing
ICU patients (mean age: 61 ± 13 years) with clinical signs justify-
ing volume expansion (VE). Hemodynamic measurements were
performed during quiet respiration and during a forced respiratory
effort (f) at baseline and immediately after a 500 ml 6% hydroxy-
ethylstarch VE. Patients were then separated into responders (R)
(increase in stroke volume [SV] assessed by transthoracic
echocardiography = 15% after VE) and nonresponders (NR).
Results Before VE, ∆PP (13 ± 5% vs 7 ± 3%, P = 0.003) and
∆PS (10 ± 4% vs 6 ± 3%, P = 0.002) were higher in R (n = 19)
than in NR (n = 13). Receiver operating characteristic (ROC)
curve analysis showed that the forced respiratory effort did not
sensitize the method (∆PP f = 0.72 ± 0.09 vs ∆PP = 0.82 ± 0.08,
P = 0.048 and ∆PS f = 0.69 ± 0.10 vs ∆PS = 0.82 ± 0.08,
P = 0.045). No statistical difference was observed between ∆PP
and ∆PS ROC curves areas (0.81 ± 0.08 vs 0.82 ± 0.08,
P = 0.888). Using a threshold ∆PP baseline value of 12%, R and
NR were discriminated with 93% of specificity and 63% of
sensitivity. No relation was observed between ∆PP and ∆PS
baseline value and the increase of stoke volume during VE (r = 0.5,
P = 0.058 for ∆PP).
Conclusion In spontaneous breathing patients, ∆PP = 12%
predicts an increase in SV with high probability (92%) without
prejudging the importance of this increase. On the contrary, ∆PP
<12% does not allow one to predict fluid responsiveness.
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Objective To follow-up severe sepsis/septic shock patients using
echocardiographic parameters.
Setting and design A prospective study in a 14-bed medical/
surgical ICU.
Materials and methods In septic patients the following
parameters were obtained: left ventricular (LV) telediastolic
dimensions, LV shortening fraction (LVSF), cardiac output (CO) by
analysis of pulsed-wave Doppler at the LV outflow tract and inferior
vena cava (IVC) evaluation (maximum and minimum dimensions
and IVC index). Other parameters were also obtained: age, sex,
severity scores (APACHE II, SAPS II, SOFA, and MODS), serum
lactate levels, arterial pressure, heart rate, central venous pressure,
and need for renal replacement techniques. All data were obtained
on the first day of ICU admittance, and at days 2, 3, 5, and then
each 5 days. Only patients with three or more evaluations were
included. The data analysis was performed by dividing the patients
into two groups: survivors (group 1) and nonsurvivors (group 2).
Results Twenty-three patients were enrolled. Thirteen patients
died (group 2, 56.5%). In group 2 we observed a progressive, but
statistically nonsignificant, increase in CO, severity scores, and
serum lactate. The IVC index decreased in group 2 over the study
time with statistical significance (P < 0.05). The main feature of
patients in group 1 was a decrease in CO, severity scores and a
statistically significant increase in the IVC index. LV dimensions
changed in both groups, always not significantly and not linked to a
particular outcome or in a consistent manner. Several patients
presented with a decrease in LVSF at any time during the study,
not linked with any particular outcome, or to changes in CO.
Conclusion The fatal course of severe sepsis/septic shock was
characterized by a progressive increase in CO, severity scores and
serum lactate, although lacking statistical significance. A progres-
sive decrease in the IVC index was statistically significant in the
nonsurvivors group. Changes in LV dimension (enlargement) or
LVSF were not a constant feature, and we were not able to link
these changes to any particular clinical outcome.
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Assessment of left ventricular diastolic pressure in the
emergency room and intensive care unit: a new Doppler index
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M Slama2
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Introduction Assessment of left ventricular diastolic pressure
(LVDP) by transthoracic echocardiography (TTE) contributes to the
diagnosis of dyspnea in the emergency room and ICU. Classical
parameters are derived from mitral blood flow recorded using
pulsed Doppler (maximal velocity of early and late mitral wave: E
and A), mitral annulus movement using Doppler tissue imaging
(early lateral mitral annulus movement: Ea) and early left ventricular
inflow propagation velocity (Vp) using M-mode color Doppler.
Unfortunately, Doppler tissue imaging and M-mode color Doppler
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are not always available on echocardiography machines and these
measurements are also time-consuming.
Objective In this study, we propose a new simple index obtained
exclusively from mitral flow recorded by pulsed Doppler: E/DTE
(DTE: deceleration time of E).
Method We analysed the sensitivity and specificity of classical
indices of LVDP (E/A, E/Ea, E/Vp) and this new index in order to
determine their ability to discriminate cardiogenic and
noncardiogenic dyspnea.
One hundred and twenty-five patients with acute dyspnea were
studied by echocardiography (80 in the emergency room, 45 in the
ICU). Cardiogenic dyspnea was defined at hospital discharge on
the basis of clinical examination, classical echocardiographic
parameters, and clinical course during hospital stay.
Results Forty-four percent of patients were considered to have
cardiogenic dyspnea and 72% were in sinus rhythm allowing
interpretation of the E/A ratio.
Sensitivity and specificity of the parameters analyzed are presented
in Table 1 for all patients and for patients in sinus rhythm.
Table 1
Sensitivity and specificity: patients have cardiogenic dyspnea if the
values of the different parameters are over the threshold value
E/a E/Vp E/Ea E/DTE 
threshold threshold threshold threshold 
1.5a 2b 10b 0.5b
Se 27% 72% 75% 96%
Spe 89% 90% 87% 93%
aFor patients in sinus rhythm. bFor all patients.
Conclusion In conclusion, we demonstrated that E/DTE is a very
simple, rapidly recorded and highly sensitive and specific index to
discriminate cardiogenic and noncardiogenic dyspnea in patients
admitted to the emergency room or ICU with normal or altered left
ventricular systolic function, whether or not they are in sinus
rhythm.
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Background Not rarely in clinical routine it is highly difficult to
evaluate the volume status of a patient. Therefore, the attending
physician can revert to the following parameters in ascending order
concerning their invasive character: clinical signs (e.g. inspection
of mucosa, skin turgor, the filling of jugular veins, edemas of the
lower extremity, auscultation of the lungs), echocardiography,
various laboratory findings (e.g. packed cell volume, electrolytes,
fractional excretion of sodium), central venous pressure (CVP),
thermodilution and pulse contour analysis, respectively, as well as
pulmonary arterial wedge pressure.
Recent data suggest that the intrathoracic blood volume index
(ITBI) determined by thermodilution can be characterized as the
gold standard for the evaluation of a patient’s volume status.
However, in clinical routine the CVP, which has been used for
decades, is still the most frequently applied nonclinical parameter
for volume assessment. However, this is astonishing, because CVP
has hardly been tested on modern hemodynamic measurement
methods.
Aim It was therefore the aim of our prospective study to obtain
predictive values for the CVP — for ITBI values in a normal range,
as well as for ITBI values falling short of or exceeding the normal
range. In other words: Does the CVP still have entitlement or is it
more appropriate not to identify any CVP value as to identify one
that might be misleading concerning the clinical situation?
Methods In 42 patients of an internal ICU, 837 hemodynamic
measurements (respectively the average of three single
measurements) including CVP as well as ITBI in combination with
other thermodilution parameters (such as cardiac output index [CI],
stroke volume index [SVI], extravascular lung water index [EVLWI],
stroke volume variation) were determined using the PiCCO®
system (Pulsion, Munich). Twenty-four of the patients were male,
18 were female; age 60.6 years (± 13.5), APACHE II score of 22.6
on average. Statistics were analysed using SAS version 6.12.
Results CVP, 10.9 mmHg (± 5.4); ITBI, 967 ml/m2 (± 170); CI,
4.14 l/m2 (± 1.16); SVI, 1505 dyn s/cm5/m2 (± 514); EVLWI,
9.2 ml/kg (± 4.03).
A total 24.25% of the patients had ITBI < 850, resulting in a
positive predictive value (PPV) of CVP of 24.49% and a negative
predictive value (NPV) of 75.76% with regard to volume deficit. A
total 39.07% of the patients had ITBI > 1000, resulting in a PPV of
CVP of 37.74% and a NPV of 59.24% with regard to overfilling.
The PPV and NPV for normal ITBI values is 34.80% and 62.16%.
Two hundred and fifteen of 837 (25.70%) measurements were
performed under catecholamine therapy; 64 (29.77%) of them
were correctly classified with CVP, significantly less than for
measurements performed without catecholamine therapy (37.94%
accuracy; P = 0.031, chi-square test).
Conclusions CVP has low PPV and NPV with regard to superior
methods of preload assessment such as the ITBI. This low
predictive effect is even more pronounced in patients with
catecholamine therapy. In summary, volume assessment based
only on CVP should be a thing of the past.
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comparable with pressure readings from neck lines?
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Objective To evaluate whether femoral (femoro-iliac) venous
pressures are comparable with the central venous pressures
(CVP) obtained from neck lines. We hypothesised that there would
not be a clinically significant difference in the readings, in the
absence of intra-abdominal hypertension
Methods Simultaneous measurements were taken from ICU
patients who had both femoral and neck (superior veno-caval)
central catheters in situ. Only 20 cm femoral lines were considered
for the study. Hemodialysis catheters were included in the study.
On each occasion, measurements were taken by two independent
observers and recorded separately. Intra-abdominal pressures
were also measured by the intra-vesical method. We estimated a
difference > 2 cmH2O to be clinically significant
Results Thirty sets of readings were taken from 25 patients. Only
two sets had a difference > 2 cm. There was no statistically
significant difference between the two groups (P = 0.054, paired
t test). The femoro-iliac venous pressures correlated well with the
superior vena-caval CVP (r2 = 0.721, P < 0.01).
Conclusions Venous pressures from femoro-iliac central lines




The reliability of the central venous pressure measured via
catheter inserted in the abdominal vena cava inferior
M Cengiz, L Dosemeci, M Yilmaz, F Purnek Akin, A Ramazanoglu
University of Akdeniz, Antalya, Turkey
Critical Care 2005, 9(Suppl 1):P60 (DOI 10.1186/cc3123)
Objective In our study, we compared the central venous pressure
(CVP) measured via catheters inserted in the abdominal vena cava
inferior (aVCI) and vena cava superior (VCS) in intensive care
patients. The effects of mechanical ventilation, sedation and intra-
abdominal pressure (IAP) on CVP at both localisations were
evaluated.
Methods During a 1-year period, 49 critically ill patients in the ICU
were included in the study. In the patients in whom it was decided
to change the pre-existing catheter due to prolonged stay, recent
catheters were inserted in other localisations from the pre-existing
localisations (the recent CVC was inserted in the aVCI if the pre-
existing CVC was at the VCS, or the opposite). The pre-existing
CVC was kept in place for 24 hours and CVP measurements were
performed simultaneously via both of the catheters. IAP was
measured via urinary bladder and the sedation scores, ventilation
status, sedative drug use, PEEP values, peak and mean airway
pressures (PAP and MAP) were recorded during the CVP
measurements.
Results We performed 148 simultaneous measurements in 49
patients. The mean CVP values obtained from the aVCI and VCS
were 7.3 ± 2.9 mmHg and 6.4 ± 3.1 mmHg, respectively
(P < 0.01). CVP values obtained via the aVCI and VCI were similar
in 32.7% of the 123 measurements performed in mechanically
ventilated patients. Eight percent of the 25 CVP measurements
performed in spontaneously breathing patients were similar
(P < 0.05). In the CVP measurements performed during IAP
< 8 mmHg (n = 72) and IAP ≥ 8 mmHg (n = 76), the mean differences
between aVCI and VCS pressures were 1.04 ± 1.06 mmHg and
1.71 ± 1.4 mmHg, respectively (P < 0.01). Mean CVP values
obtained from the aVCI were higher when PAP ≥ 25 mmHg or
MAP ≥ 12 mmHg (P < 0.01). The CVP differences were ≥ 3 mmHg
at 26 (17%) of 148 simultaneous measurements.
Conclusions We found that mechanical ventilation, PEEP, PAP,
MAP and IAP were effective on the difference between CVP values
obtained simultaneously via two different routes. Although the
mean difference between the pressures obtained via the catheters
inserted in the aVCI and VCS (0.9 mmHg) were statistically
significant, the clinical importance of this difference may not be
important.
P61
Continuous pulse contour analysis after cardiopulmonary
bypass in cardiac surgery
M Sander, C von Heymann, A Foer, A Döpke, W Konertz, 
C Spies
University Hospital Charité, Berlin, Germany
Critical Care 2005, 9(Suppl 1):P61 (DOI 10.1186/cc3124)
Introduction Continous pulse contour analysis is an alternative to
the pulmonary artery catheter for continous cardiac index (CI)
measurement after cardiac surgery. However, it remains to be
determined whether pulse contour analysis has to be re-calibrated
after cardiopulmonary bypass (CPB). The aim of the study was to
compare continous pulse contour CI analysis after CPB and a
period of initial stabilisation with a simultaneous transpulmonary
thermodilution measurement of CI.
Method After ethical approval and written informed consent 50
patients were included into this prospective study. During
aortocoronary bypass surgery, CI was determined by a PiCCO
monitor (Pulsion Medical AG, Munich, Germany) in all patients.
Prior to surgery the continous pulse contour analysis was
calibrated by triple transpulmonary thermodilution measurement of
CI. In case of a deviation >10% of a measurement, five measure-
ments were performed and the highest and lowest were rejected.
After termination of CPB and initial stabilisation of the patient
(20 ± 2 min) continuous pulse contour CI was documented.
Simultaneously, the PiCCO monitor was re-calibrated by trans-
pulmonary thermodilution measurement and this CI was
documented as well. Statistical analysis was performed by the
method described by Bland and Altman.
Results After termination of CPB and initial stabilisation of the
patient, continous pulse contour analysis determined a CI of
3.1 ± 0.9 l/min/m2. After re-calibration, a CI of 3.6 ± 0.7 l/min/m2
was measured (P < 0.01). The mean bias between continous
pulse contour analysis CI and transpulmonary thermodilution
measurement of CI after CPB was –0.5 l/min/m2. Precision (2SD)
was 1.5 l/min/m2.
Conclusion Due to the broad distribution and the underestimation
of the CI after CPB, a re-calibration of the continous pulse contour
analysis is essential after weaning from CPB to prevent false
therapeutic consequences.
P62
Validation of a continuous cardiac output measurement using
arterial pressure waveforms
W McGee, J Horswell, G Janvier
Baystate Medical Center, Springfield, MA, USA; Medical City
Dallas Hospital, Dallas, TX, USA; CHU Bordeaux Group
Hospitallier Sud, Pessac, France
Critical Care 2005, 9(Suppl 1):P62 (DOI 10.1186/cc3125)
Introduction Intermittent bolus thermodilution cardiac output
(ICO) and continuous cardiac output (CCO) measurements with
pulmonary artery catheters (PAC) are the most commonly
preferred methods of cardiac output (CO) measurement for
guiding hemodynamic therapy in the clinical setting. A novel arterial
pressure cardiac output (APCO) measurement method requires
only access to a radial or femoral artery via a standard arterial
catheter and does not require use of venous access or injection of
a dilution medium for calibration.
Hypothesis/methods We hypothesize that APCO, which
measures CO via arterial pressure analysis, is reliable when
compared with ICO. We compared a prototype APCO system
(FloTrac™; Edwards Lifesciences, Irvine, CA, USA) with PAC
(Swan–Ganz®; Edwards Lifesciences, Irvine, CA, USA) routinely
used in clinical practice. APCO, ICO, and CCO data were
collected from a total of 36 patients (29 cardiac surgery, seven
ICU) from three centers (two USA, one France). Average age was
64.1 (± 14.4) years, and 72.2% of the patients were male.
Grouped measurements (252 data points) for APCO, ICO and
CCO were analyzed for bias, precision and correlation via Bland–
Altman analysis.
Results Bland–Altman analysis of the differences between CCO
and ICO and between APCO and ICO (Fig. 1) were conducted.
The analysis yielded a mean bias and precision (± one standard
deviation) of 0.8 ± 1.1 and 0.2 ± 1.3 l/min, respectively. APCO
trends correlated with ICO in 98% of all data points collected.
Conclusions Data show that the APCO method of CCO
measurement is reliable and correlates well with ICO
measurements when used in critically ill patients. The development
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of an accurate, less invasive, simple method of measuring CO may
contribute to the expansion of CO monitoring to critically ill
patients who currently are not monitored with a PAC.
P63
The PiCCO system: feasibility and complications of its use in
paediatric intensive care
F Valla, S Lansiaux
Hôpital Pédiatrique Debrousse, Lyon, France
Critical Care 2005, 9(Suppl 1):P63 (DOI 10.1186/cc3126)
Background and objectives The PiCCO system provides
haemodynamic evaluation and monitoring, using two different
techniques: transpulmonar peripheric arterial thermodilution and
pulse contour analysis. Paediatric literature is still limited. We
retrospectively analysed the use of the PiCCO system in our
paediatric intensive care unit, focusing on its feasibility and
complications.
Results During 16 months, we have used 26 Pulsiocath® (mean
patient weight 24 kg and age 80 months) versus 126 arterial
catheters (mean patient weight 15 kg and age 40 months).
Complications are presented in Table 1 (major complications
include thrombosis, peripheral necrosis and general infection;
minor complications include obstruction, temporary ischaemia or
oedema and local infection).
Table 1
Complications Pulsiocath® (n = 26) Arterial catheter (n = 126)
Major 2 2
Minor 2 31
Feasibility The first values could be measured on average 1 hour
after the decision of haemodynamic monitoring had been taken.
The use of the PiCCO system failed twice: once the patient died
before the first measures, and once because of an arterial stenosis
due to a previous catheterization. We encountered technical
difficulties with the 3 F Pulsiocath®, because of its weakness.
Conclusions The rates of complications are acceptable, in our
population characterized by haemodynamic dysfunction and small
artery diameters (two parameters known as risk factors for arterial
catheterization complication). Its feasibility is good, and technical
failure is rare. This technique therefore appears interesting in
paediatrics and moderately invasive, compared with other
techniques allowing haemodynamic monitoring. It encourages us
to extend its use in the paediatric population.
P64
Femoral central venous catheter (CVC) versus internal jugular
CVC for assessment of haemodynamic parameters by
transpulmonary thermodilution using pulse contour cardiac
output
S Grundler, L Macchiavello
University Hospital of Wales, Cardiff, UK
Critical Care 2005, 9(Suppl 1):P64 (DOI 10.1186/cc3127)
Objective To compare the intrathoracic blood volume index (ITBVI),
cardiac index (CI) and extravascular lung water index (ELWI) values
in critically ill patients as measured by transpulmonary
thermodilution (TPD) with the pulse contour cardiac output
(PiCCO) system, using a femoral central venous catheter (CVC)
versus conventional measurement using an internal jugular CVC.
Introduction There is no evidence that the use of femoral venous
access, instead of internal jugular venous access, for TPD
measurements significantly alters the haemodynamic parameters
obtained via PiCCO. We postulate that the ITBVI and ELWI differ
significantly depending on the CVC site used.
Design A prospective, controlled clinical study in an adult critical
care unit in a large tertiary-care teaching hospital.
Patients Five mechanically ventilated patients with sepsis/septic
shock (n = 4) and acute liver failure (n = 1). Participants had an
internal jugular CVC and femoral CVC or triple-lumen vascath in
place as part of routine management, as well as a femoral arterial
catheter connected to the Pulsion PiCCO system.
Materials and methods Haemodynamic parameters were
obtained by the TPD technique using bolus injections of 15 ml iced
saline solution via the internal jugular and femoral CVCs (order
randomly allocated). Bolus injections were performed in < 8 s and
all measurements were completed in less than 10 min. Where
applicable, haemofiltration was discontinued for the duration of the
measurements.
Results Ten separate sets of paired measurements were obtained
from five patients. The paired t test (SPSS 11) indicated that the
ITBVI was significantly overestimated by an average of 27%
(P < 0.001) when the femoral CVC was used for the injectate. The
CI was not affected by the site of the injectate and, in these
preliminary results, there was only marginal overestimation of the





Haemodynamic venous venous % 
parameter catheter catheter difference Significance
Intrathoracic blood 1059 1345 27 < 0.001
volume index (ml/m2)
Extravascular lung 14.2 15.8 12 0.049
water index (ml/kg)
Cardiac index (ml/m2) 4.05 4.06 <1 0.92
Available online http://ccforum.com/supplements/9/S1
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Bland–Altman analysis of the differences between arterial pressure
cardiac output (APCO) and intermittent bolus thermodilution cardiac
output (ICO).
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Conclusions In critically ill patients the TPD technique with
PiCCO using a femoral CVC may not provide as accurate or
reliable measures of the ITBVI and possibly the ELWI as
conventional measurement with an internal jugular CVC.
P65
The effect of continuous veno-venous haemofiltration on
PiCCO® haemodynamic parameters
N Mason, A Froude, B Holst, A Saayman, G Findlay
University Hospital of Wales, Cardiff, UK
Critical Care 2005, 9(Suppl 1):P65 (DOI 10.1186/cc3128)
Introduction It is known that measurement of the intrathoracic
blood volume (ITBV) is a more accurate estimate of cardiac
preload than pressure measurements using central venous or
pulmonary artery occlusion pressures. There is evidence to
suggest that therapy to reduce extravascular lung water may
improve outcome in the critically ill patient. The PiCCO®
monitoring system (Pulsion Medical Systems, Munich, Germany)
provides an estimate of the ITBV, extravascular lung water (EVLW)
and cardiac output (CO) via a thermodilution system. We
hypothesised that the use of continuous veno-venous haemo-
filtration (CVVH) during these measurements could affect the
PiCCO® system and give inaccurate results.
Methods Twenty-six patients (aged 20–81 years) were studied.
Patients were hypotensive, required haemodynamic monitoring and
were receiving CVVH for either renal failure or sepsis. Three
measurements of CO, ITBV and EVLW were recorded on and off
CVVH. The measurements were indexed for body surface area and
the mean of each set of three values recorded. Data were normally
distributed and analysed by paired t tests.
Results Results are presented in Table 1 and expressed as the
mean and 95% confidence intervals. There was no correlation
between CVVH pump speed, fluid exchange rate or use of
inotropes and pressors and the changes in cardiovascular
parameters on and off CVVH.
Conclusions Performing PiCCO® measurements with CVVH
running underestimates CO, underestimates ITBV and over-
estimates EVLW. These measurement errors could result in wrong
therapeutic decisions in the management of shocked patients.
PiCCO® measurements should be made with CVVH temporarily
switched
P66
Effects of vasodilation cardiac output measured by
PulseCOTM
K Yamashita1, T Nishiyama2, T Yokoyama1, H Abe1, M Manabe1
1Kochi Medical School, Kochi, Japan; 2The University of Tokyo, Japan
Critical Care 2005, 9(Suppl 1):P66 (DOI 10.1186/cc3129)
Introduction PulseCOTM (LiDCO Ltd, London, UK) is a continuous
cardiac output (CO) monitor using the pulse-contour method. The
pulse-contour method was defined as the method to determine CO
from characteristics of the arterial pressure waveform. However, the
arterial pressure waveform often changes during surgery because
of the arterial compliance changes using vasoactive drugs. These
factors may induce miscalculation of the CO by PulseCOTM. In the
present study, we investigated the effects of vasodilation induced
by prostaglandin E1 (PGE1) on CO measured by PulseCOTM in
comparison with CO measured by the bolus thermodilution method.
Patients and methods Twelve patients who underwent off-pump
coronary artery bypass grafting were enrolled in this study. Patients
who suffered from aortic valve stenosis and regurgitation were
excluded from the study. After premedication with oral diazepam
10 mg, anesthesia was induced and maintained with midazolam,
fentanyl and vecuronium. After induction, radial artery and
pulmonary artery catheters (Edwards Lifescience LLC, Irvine, CA,
USA) were inserted. The CO and systemic vascular resistance
(SVR) were measured after induction to calibrate the PulseCOTM
and, subsequently, 10 min after PGE1: (1) 0.01, (2) 0.02 and (3)
0.04 mg/kg/min infusion. CO by the standard thermodilution
method was measured using the VigilanceTM system. PulseCOTM
was initially calibrated with the value of CO measured by the
thermodilution method and no recalibration was performed during
the study. For the thermodilution method, the CO was measured
three times by injection of 0.2 ml/kg saline of less than 5 degrees
and the mean value was calculated.
Results Patients were eight males and four females, 68 ± 7 years
old, 156 ± 10 cm in height and 61 ± 7 kg in weight. SVR at
concentrations (2) and (3) were significantly lower than the control
value (Table 1). The correlation coefficient between the two
techniques at each point was: (1) R2 = 0.71, (2) R2 = 0.18, (3)
R2 = 0.41. The limits of agreement (bias ± two standard deviations
of bias) were: (1) 0.04 ± 0.91 l/min, (2) –0.31 ± 1.82 l/min, (3)
–0.49 ± 1.33 l/min.
Conclusions PulseCOTM might underestimate the CO when the
SVR is decreased significantly by infusion of PGE1 0.02 and 0.04
mg/kg/min in comparison with the CO measured by the bolus
thermodilution method.
Critical Care    March 2005 Vol 9 Suppl 1 25th International Symposium on Intensive Care and Emergency Medicine
Table 1 (abstract P65)
On CVVH Off CVVH 95% CI Diff Means P
Cardiac index (l/min/m2) 3.42 (3.10–3.74) 4.49 (4.08–4.91) –1.38 to –0.76 < 0.001
Intrathoracic blood volume index (ml/m2) 943 (873–1013) 1324 (1181–1467) –500 to –262 < 0.001
Extravascular lung water index (ml/kg) 11 (9–13) 9 (7–11) 1.3–2.8 < 0.001
CVVH, continuous veno-venous haemofiltration; 95% CI Diff Means, 95% confidence interval of difference of means.
Table 1 (abstract P66)
Prostaglandin E1, Prostaglandin E1, Prostaglandin E1, 
Control 0.01 mg/kg/min 0.02 mg/kg/min 0.04 mg/kg/min
Cardiac output by thermodilution (l/min) 3.2 ± 0.7 3.5 ± 0.9 3.9 ± 1.0 4.0 ± 0.9
Cardiac output by PulseCOTM (l/min) 3.2 ± 0.7 3.7 ± 0.8 3.6 ± 0.7 3.5 ± 0.6*
Systemic vascular resistance (dyne/s/cm5) 2099 ± 518 1900 ± 528 1743 ± 505** 1604 ± 355**
*P < 0.05 vs thermodilution, **P < 0.05 vs control.
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USCOM: an accurate system for cardiac output
measurement?
P Lichtenthal1, R Phillips2, J Sloniger1, J Copeland1
1University of Arizona, Tucson, AZ, USA; 2University of
Queensland, Brisbane, Australia
Critical Care 2005, 9(Suppl 1):P67 (DOI 10.1186/cc3130)
Introduction The CardioWest device (Syncardia, Tucson, AZ,
USA) is an FDA-approved, total artificial heart system designed to
sustain optimized hemodynamics in intractable heart failure
patients until suitable organ replacement can be effected. The
CardioWest consists of a pneumatic blood pump that delivers
accurately measured pulsatile flow to an implanted artificial heart
and the native circulation, and displays the delivered hemodynamic
parameters. The USCOM device (USCOM Ltd, Sydney, Australia)
is a novel non-invasive two-dimensional independent CW Doppler
device for assessment of right-sided and left-sided cardiac
hemodynamics. This study was to compare and validate the
hemodynamic values measured by the USCOM device with those
of the controlled CardioWest circulatory model and determine the
accuracy of the USCOM device in the clinical setting.
Methods Four hundred and sixty serial measurements on four
patients were made of right-sided and left-sided cardiac output
(CO), stroke volume (SV), and heart rate (HR) using the USCOM
device and compared with contemporaneous averaged values
recorded on the CardioWest. Flow cross-sectional areas were
determined from the CardioWest engineers and used to calculate
USCOM flow volumes.
Results Mean CO, SV and HR values by USCOM and
CardioWest were 7.26 ± 0.66 and 7.23 ± 0.57 l/min, 55.0 ± 4.6
and 54.6 ± 3.7 ml, and 132 ± 5 and 132 ± 4 bpm, respectively.
The mean differences between methods for CO, SV, and HR were
0.03 ± 0.49 l/min, 0.42 ± 3.66 ml, and –0.38 ± 3.7 bpm,
respectively, with mean errors between measures of 0.34%,
0.64% and –0.38%. See Table 1. There was a good correlation of
CO, SV, and HR measures by both methods without significant
difference (all P < 0.005).
Table 1
Mean values USCOM CardioWest
Cardiac output (l/min) 7.26 ± 0.66 7.23 ± 0.57
Stroke volume (ml) 55.0 ± 4.6 54.6 ± 3.7
Heart rate (bpm) 132 ± 5 132 ± 4
Conclusions This study confirms both the accuracy of flow
measurements using the USCOM device, and the feasibility of
obtaining reliable non-invasive cardiac output and other parameters
on patients in a clinical setting
P68
Survey of cardiac output monitoring in intensive care units in
England and Wales
B Esdaile1, R Raobaikady2
1Chelsea & Westminster Hospital, London, UK; 2St George’s
Hospital, London, UK
Critical Care 2005, 9(Suppl 1):P68 (DOI 10.1186/cc3131)
Background Haemodynamic monitoring is essential for the
management of critically ill patients. There are many methods of
monitoring the haemodynamic status of patients, and cardiac
output (CO) is one of the major determinants of organ perfusion.
Currently there are various techniques available in clinical practice
to measure CO in ICUs including pulmonary artery catheter (PAC),
oesophageal Doppler, lithium dilution cardiac output (LiDCO) and
pulse-induced contour cardiac output (PiCCO) studies. We
surveyed current CO monitoring practices in adult ICUs in England
and Wales.
Methods Adult ICUs in England and Wales were surveyed via
telephone. A senior member of the on-call ICU team was consulted
to ascertain their unit’s preferred CO monitoring techniques.
Results Two hundred and twenty-six adult ICUs were surveyed
and all the replies were recorded on paper (100% response). In
the majority of ICUs, PAC (76%) and oesophageal Doppler (53%)
devices are available. Among the other techniques 33% of the
ICUs use PiCCO and a further 19% use LiDCO systems for CO
monitoring (Table 1). Most of the ICUs (69%) have two or more
CO monitoring techniques available and oesophageal Doppler
(41%) was preferred as a first choice for CO monitoring. Only
20% of the ICUs regularly measure central venous saturation
(SvO2).
Table 1
Cardiac output monitoring technique availability in the ICUs in
England and Wales
Pulmonary artery catheters 76% (171/226)
Oesophageal Doppler 53% (120/226)
Lithium dilution cardiac output 19% (43/226)
Pulse-induced contour cardiac output 33% (74/226)
Others 8% (18/226)
Conclusion The majority of the ICUs have two or more CO
monitoring techniques available. The most popular technique for
CO monitoring in England and Wales is oesophageal Doppler.
This least invasive technique is now the preferred choice of the
intensive care physicians in England and Wales. Although PAC is
available in most ICUs, only 20% prefer to use them in critically ill
patients as the less invasive CO monitoring devices are becoming
more accessible.
P69
The use of pulmonary artery catheterization has declined
S Appavu, J Cowen, M Bunyer
University of Illinois College of Medicine, Rockford, IL, USA
Critical Care 2005, 9(Suppl 1):P69 (DOI 10.1186/cc3132)
Introduction Even without the proof of benefit by randomized
controlled trials, pulmonary artery catheterization (PAC) has been
in wide clinical use in critical care and cardiology since its
introduction in 1970. However, during the past decade, several
studies and editorials have questioned its safety and have
suggested increased risk of morbidity and mortality from its use.
During the same period, there were also publications supporting its
continued wide use. We hypothesized that these publications had
no effect on the frequency of use of the PAC. We performed this
study to determine whether or not there was a change in the use of
PAC, and if so in which direction and under what circumstances.
Methods We studied all the PACs performed during the years
2000 and 2001 in all the hospitals within the state of Illinois, USA.
We used the Illinois Health Care Cost Containment Council
database for the years of this study. We used the International
Classification of Diseases, ninth revision, Clinical Modification
(ICD9M) code for PAC to identify all the PACs performed in the
Available online http://ccforum.com/supplements/9/S1
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Illinois hospitals during 2000 and 2001. We then analyzed the
data based upon age, gender, hospital size, and regions of the
state using SPSS statistical software.
Results There were 1,636,046 hospital discharges in 2000 and
1,684,089 discharges in 2001 with the PAC rates of 3.65 and
2.98 per 1000 discharges, respectively. In spite of the increase in
the number of patients treated in 2001, there was an overall
decrease in the use of PAC by 943 (15.8%), from 5965 in 2000 to
5022 in 2001 throughout the state. Among patients older than 75,
there was a reduction of 297 (15.5%), from 1917 in 2000 to 1620
in 2001. Among patients 65–74 years of age, there was a
reduction of 364 (21%), from 1739 in 2000 to 1375 in 2001. The
largest reduction of 57% was seen in the age group of 0–17, from
21 in 2000 to nine in 2001. Among males there was a PAC usage
reduction of 522 (15%), from 3492 in 2000 to 2970 in 2001.
Among females there was a reduction of 421 (17%), from 2473 in
2000 to 2052 in 2001. Across the state, 10 large medical centers
had a 177 (20%) decline in PAC use, from 873 in 2000 to 696 in
2001. All the other hospitals had a 766 (15%) decrease from
5092 to 4326. Among the regions of the state, the city of Chicago,
the Rockford area, and the southern region of the state, close to St
Louis, had the largest reductions of 431 (39.4%), 199 (40%), and
94 (33.6%), respectively. The central region of the state had a
reduction of 15%.
Conclusion The use of PAC has decreased on the average of
15% in 1 year. The larger cities and metropolitan areas had a
greater decline of 40% in the use of PAC during the same period
of time, indicating rapid adaptation of new knowledge.
P70
Measurement of rate of pressure development (dP/dtmax)
based on femoral artery pressure waveforms: comparison
with left ventricular dP/dtmax
D Robert, S Cromheecke, I Rodrigus, S De Hert
University Hospital Antwerp, Edegem, Belgium
Critical Care 2005, 9(Suppl 1):P70 (DOI 10.1186/cc3133)
Background Recently, calculation of the rate of pressure
development (dP/dtmax) has been incorporated in the pulse
contour cardiac output (PCCO) software technology (Pulsion
Medical Systems, Munich, Germany).
Until now its measurement necessitated the presence of an
intraventricular pressure catheter. Since dP/dtmax represents a
relative load-independent measure of left ventricular function, its
availability using standard invasive monitoring technology may
provide additional information on the patient’s cardiac function. The
present study assessed the reliability of PCCO dP/dtmax under
different experimental conditions.
Methods In 40 coronary surgery patients a high-fidelity pressure
catheter was positioned in the left ventricular cavity and a 5-F
thermistor-tipped catheter (Pulsiocath PV2015L13) in the femoral
artery. Studies were performed before initiation of cardiopulmonary
bypass. PCCO dP/dtmax was compared with dP/dtmax measured
in the left ventricle under the following experimental conditions:
increase in cardiac load obtained by leg elevation, and increase in
blood pressure obtained by injection of calcium chloride.
Results A weak correlation was observed between absolute
dP/dtmax values measured by both systems (leg elevation:
r = 0.36, P = 0.001; calcium: r = 0.52, P < 0.001) (Bland–Altman
bias ± standard deviation: leg elevation: 81 ± 213; calcium:
93 ± 243). However, when changes in dP/dtmax with leg elevation
and with calcium administration were analyzed, a close correlation
was observed between both measurements (leg elevation: r = 0.9,
P < 0.001; calcium: r = 0.58, P < 0.001) (Bland–Altman bias +
standard deviation: leg elevation: 8 ± 30; calcium: 19± 99).
Conclusion The changes in PCCO dP/dtmax with a physiological
or pharmacological intervention closely correlated with the
changes in left ventricular dP/dtmax. These findings suggest that
PCCO dP/dtmax analysis may provide a valuable tool to guide
cardiac treatment. Further studies will have to elucidate whether
these findings also hold for other interventions.
P71
Comparison of non-invasive blood pressure versus radial
arterial catheter measurement in an intensive care setting
R Jackson, M Jonas
Southampton University, Southampton, UK
Critical Care 2005, 9(Suppl 1):P71 (DOI 10.1186/cc3134)
Introduction Many critical care patients are haemodynamically
unstable and have clinical therapy directed by measurements, such
as blood pressure. Surprisingly, there appears a failure to
appreciate that indirect devices (non-invasive blood pressure
[NIBP]) may be inaccurate in critically ill patients. This is
substantiated by several manufacturer’s legal disclaimers advising
against the use of NIBP devices except in normotensive patients
with normal heart rates and rhythms
Objectives To evaluate the accuracy of NIBP measurements in the
ICU and to investigate sources of error in arterial blood pressure
measurements
Methods In 47 ICU patients blood pressure was auscultated using
a mercury sphygmomanometer and then measured using two NIBP
devices (GE Marquette) and Dinamap (Critikon) The arterial line
fidelity was validated using a return to flow technique and its
harmonic/damping characteristics analysed using a recorded flush
test. The non-invasive methods were then compared using standard
statistical analysis with the arterial catheter measurements.
Results The mercury sphygmomanometer was the most accurate
when compared with the arterial line. Both automated devices had
unacceptable ranges in the intensive care setting with both
algorithms markedly overestimating at low blood pressures. Of the
29 waveforms analysed, 62% of the arterial waveforms had
inadequate dynamic responses.
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Conclusions The sphygmomanometer gave acceptable readings
versus the arterial catheter. Both NIBP algorithms were inaccurate
and unreliable in the intensive care setting, with a tendency to over-
read at low arterial pressures and under-read at high arterial
pressures. Damping characteristics of the arterial catheters are
frequently unfavourable.
P72
Sidestream dark field imaging: an improved technique to
observe sublingual microcirculation
C Ince
Academic Medical Center, Amsterdam, The Netherlands
Critical Care 2005, 9(Suppl 1):P72 (DOI 10.1186/cc3135)
Sublingual orthogonal polarization spectral (OPS) imaging has
revealed the central role of the microcirculation in the
pathophysiology, outcome and treatment of sepsis by its ability to
visualize the microcirculation in great detail under clinical
conditions. Of particular importance in this context has been the
response of the smallest microvessels, the capillaries. OPS
imaging illuminates the tissues with polarized green light and
measures the reflected light from the tissue surface after filtering
out the polarized portion of the reflected light. This filters out the
surface reflection of the tissues and allows the visualization of the
underlying microcirculation. Due to the reflected and emitted light
passing down the same light guide (mainstream), however, OPS
imaging is highly sensitive to internal scatter of light. This results in
limited visualization of the capillaries due to blurring. The technique
also requires high-powered bulky light sources, limiting its utility in
difficult conditions such as emergency medicine. In this
communication we introduce sidestream dark field (SDF) imaging
as a new way of clinical observation of the microcirculation. In this
modality a light guide imaging the microcirculation is surrounded
by light-emitting diodes (Fig. 1A, 1) of a wavelength (530 nm)
absorbed by the hemoglobin of erythrocytes so that they can be
clearly observed as flowing cells. Covered by a disposable cap
(not shown) the probe is placed on tissue surfaces. The
concentrically placed light-emitting diodes at the tip of the probe
directly penetrate deep into the tissue illuminating the
microcirculation. By not being in direct optical contact with the
sensing central core of the probe, no direct surface reflections
interfere with the image of the microcirculation. A five or 10 times
magnifying lens (Fig. 1A, 3) projects the image onto a video
camera (Fig. 1A, 2). This way of observing the microcirculation
provides clear images of the capillaries without blurring. The
deeper sublingual arterioles can also be clearly observed (Fig. 1B,
a). Improved image quality allows better computer automatic
analysis of the images and the low energy requirement of SDF
imaging further enhances its utility by allowing battery and/or
portable computer operation. It is expected that SDF imaging will
provide an improved imaging modality of the microcirculation in
various clinical scenarios.
Competing interest CI is CSO of Micro Vision Medical.
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Introduction Sublingual hemodynamic monitoring (with orthogonal
polarization spectral imaging) [1] and metabolic monitoring (with
capnography) [2] has revealed detailed information about the
microcirculatory and cellular dysfunction in sepsis and shock.
These techniques, however, give no information about oxygen
availability. To this end we hypothesized that NIRS and reflectance
spectrophotometry can be used to monitor sublingual oxygen
availability in a non-invasive and continuous manner. We tested this
hypothesis in patients during cardiac surgery with cardiopulmonary
bypass (CPB) as a clinical environment, where large changes in
blood flow and oxygen availability occur.
Methods NIRS and reflectance spectrophotometry were used to
measure the microcirculatory haemoglobin oxygen saturation and
haemoglobin concentration in deeper layers (0–23 mm;
InSpectra®; Hutchinson Technology, Arnhem, The Netherlands)
and superficial layers (0–8 mm; O2C®; Lea Medizintechnik,
Giessen, Germany), respectively. Measurements were made
before and just after (<15 min) CPB was initiated.
Results Group A (deeper layers, n = 9): six males, three females,
72 ± 6 years, BSA 1.83 ± 0.19 m2. Group B (superficial layers,
n = 11): five males, six females, 70 ± 8 years, BSA 1.81 ± 0.21 m2.
The microcirculatory haemoglobin oxygen saturation in group A
decreased significantly from 91.9 ± 5.0 to 86.8 ± 6.7% (P < 0.01),
whereas the microcirculatory haemoglobin oxygen saturation in
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(A) 1, green light-emitting diodes; 2, ccd camera; 3, magnifying lens.
(B) Sublingual sidestream dark field image showing arterioles (a) in the
microcirculation.
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group B showed a significant increase from 51.3 ± 4.8 to
62.6 ± 6.8% (P < 0.01). In both groups the systemic haemoglobin
concentrations decreased significantly after a switch to CPB (from
7.5 ± 1.0 to 5.3 ± 1.1 mmol/l, P < 0.01, respectively, from 7.4 ± 1.3
to 4.6 ± 0.9 mmol/l, P < 0.01). The sublingual haemoglobin concen-
trations measured by the different techniques in the different layers
showed, however, both a decrease in a similar manner.
Conclusion The deeper layers of sublingual tissue monitored by
NIRS showed a significant decrease of oxygen availability, whereas
the superficial layers showed a significant increase of oxygen
availability. It is suggested that redistribution of oxygen availability
during CPB can be monitored in this way. It is concluded that
monitoring sublingual oxygen availability by these techniques in
combination with orthogonal polarization spectral imaging and
sublingual capnography will provide comprehensive and integrative
information about the functional state of the sublingual
microcirculation.
Acknowledgement This study is supported by The Netherlands
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Introduction Near-infrared spectroscopy (NIRS) has recently been
utilized to monitor tissue perfusion in hemorrhagic shock. NIRS has
also demonstrated changes in tissue perfusion in severe sepsis.
NIRS combined with arterial and venous occlusion cuffing can be
used to noninvasively measure thenar and systemic oxygen delivery
(DO2I), and oxygen consumption (VO2I). We hypothesized that
DO2I and VO2I measured by NIRS in patients with severe sepsis
will be associated with severity of illness and will correlate with
DO2I and VO2I measured invasively and by metabolic cart.
Methods Septic patients (n = 10) were selected for the study who
met criteria for severe sepsis, had a pulmonary artery catheter, and
had family able to give written consent. Normal age-matched
control patients (n = 9) were enrolled for comparison. We
measured the mean arterial pressure (MAP), serum lactate, plasma
hemoglobin, mixed venous oxygen saturation (SVO2), and systemic
oxygen consumption via metabolic cart (metVO2I), and calculated
systemic oxygen consumption and delivery via pulmonary artery
catheter (paVO2I, paDO2I), thenar oxygen delivery (nir.thenarDO2I),
thenar oxygen consumption (nir.thenarVO2I), systemic oxygen
delivery (nir.sysDO2I), systemic oxygen consumption (nir.sysVO2I),
and mixed venous oxygen saturation (nirSVO2) in patients with
severe sepsis in a surgical ICU. The same data, without invasive
hemodynamic measurements, were measured once in volunteers.
NIRS data were collected from the thenar eminence using the
Inspectra system (Hutchinson Technology, Hutchinson, MN, USA).
A poor outcome was defined by multiorgan dysfunction 7 days
after the development of severe sepsis, death within 28 days of
severe sepsis, or both.
Results Healthy volunteers and septic patients were similar with
respect to age and sex. MAP and hemoglobin were decreased and
serum lactate increased in septic patients compared with healthy
volunteers. In septic patients, nirSVO2 correlated with SVO2
(P < 0.001), nir.sysVO2I correlated with metVO2I (P = 0.017), and
nir.sysDO2I correlated with paDO2I (P < 0.001). Interestingly,
paVO2I did not correlate well with metVO2I (P = 0.435). Of these
patients, 4/10 developed poor outcome. Patients with poor
outcomes had significant elevations of paDO2I (P < 0.001),
nir.thenarDO2I (P = 0.005), nir.sysDO2I (P < 0.001), and SVO2
(P < 0.001) compared with patients who did not develop poor
outcomes.
Conclusions NIRS measurements of SVO2 and DO2I correlated
with invasively measured values in patients with severe sepsis.
Interestingly, nir.sysVO2I correlated more closely to metVO2I than
did paVO2I. Dynamic NIRS values were predictive of outcomes.
This suggests a role for NIRS measurements of SVO2, DO2I, and
VO2I in patients in severe sepsis.
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A defining characteristic of sepsis is progressive blood flow
dysfunction in the microvasculature of organs remote to the original
site of injury. Previous work has established that microvascular
oxygen transport is compromised in sepsis due to a loss of
perfused capillaries. In a companion study to this project, which
investigated the role of leukocyte traffic in sepsis, it was observed
that increased transit times of leukocytes passing through the
capillary bed not only resulted in the occlusion of some capillaries,
but also served to cause some vessels to experience prolonged
periods of low flow. The objective of the present study was to
examine how the progressive loss of functional capillary density
(FCD) impacts oxygen transport and consumption in skeletal
muscle during sepsis. Hemodynamic and oxygen saturation data
from video recordings are incorporated into an experiment-based
mathematical model of oxygen transport in a three-dimensional
volume. This modeling helps to further our understanding of the
impact that capillary loss has on tissue oxygenation and
consumption. Sepsis was induced in rats by cecal ligation and
perforation (CLP). Rats received crystalloid fluid resuscitation to
maintain blood pressure and hematocrit at baseline levels.
Microvascular flow was observed in the extensor digitorum muscle
using a dual wavelength intravital video microscopy set-up. The
same field of view was recorded at 30 min intervals between 2 and
5 hours post CLP to follow the progression of capillary dys-
function. Individual capillaries were analyzed for oxygen saturations
and hemodynamics. As sepsis progresses we observed that
capillaries’ hemodynamic profiles transiently change between
normal, stopped and fast flow states. Although it has previously
been assumed that once a capillary becomes occluded flow is not
easily re-established, we observed that capillaries could suddenly
become reperfused after being occluded for up to 1 hour or more.
The occlusion of capillaries was found to decrease oxygen
saturations in nearby vessels by as much as 20%. Subsequent
recruitment of previously unperfused capillaries was shown to
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increase saturations in adjacent vessels by as much as 50%.
Changes in perfusion of adjacent vessels had a greater impact on
oxygen saturation than changes in hematocrit or velocity in the
vessel itself. At 2, 3 and 4 hours post CLP the percentage of
stopped flow vessels was 17%, 28% and 48% in CLP compared
with 13%, 13% and 20% in sham. The extent of FCD loss is
progressive over the course of the injury. However, it is important
to note that while the percentage of occluded capillaries increases,
the individual vessels constituting this percentage were variable.
Our study suggests that in this early stage where the FCD is in
transition, affected tissue experiences dynamic changes in tissue
oxygenation. This highlights the importance of understanding the
mechanisms responsible for this dynamic change in FCD.
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Increased leukocyte transit times through capillaries
contributes to maldistribution of flow
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Sepsis has been shown to result in a decrease in functional
capillary density (FCD) in animal models and in septic patients. We
have previously shown that increased numbers of stopped flow
capillaries result in a fall in capillary oxygen saturation [1,2]. The
goal of this study was to determine whether leukocytes played a
role in capillary occlusion. Our objective was to examine leukocyte
traffic within the microcirculation in the extensor digitorum longus
(EDL) muscle using fluorescently (rhodamine 6G) labeled
leukocytes and to correlate this with the loss of FCD seen in a
5 hour rat cecal ligation and perforation (CLP) model of sepsis. Ten
rats were randomized to sham (n = 5) or CLP (n = 5). The capillary
bed in the EDL muscle was observed using intravital video
microscopy. Functional capillary density was determined prior to
the loss of FCD at 1.5 hours after induction of sepsis or the sham
procedure. The location of all capillaries within a single capillary
network from arteriole to venule was mapped. At 4 hours
rhodamine 6G was injected and the same capillary network was
observed using fluorescence microscopy to determine which
capillaries contained flowing or stopped leukocytes and to
measure leukocyte transit times. Leukocytes were found to
preferentially traverse a subpopulation of capillaries in both sham
(40% of total capillary paths) and CLP animals (60%). In the sham
animals, 80% of the leukocytes traversed the capillary bed in <1 s
and only 7±4% of all capillaries had stopped flowing by 5 hours. In
CLP animals, leukocyte transit times increased significantly with
only 15% traversing in <1 s and 40% taking longer than 10 s (of
which half remained stopped for > 30 s). In CLP animals 45 ± 5%
of capillaries had stopped flowing by 5 hours; 63 ± 2% of these
capillaries were preferential flow paths for leukocytes. The slowing
of leukocytes through the capillary bed suggested the possible role
of selectins. Six CLP animals were treated with fucoidin, a
nonselective general inhibitor of selectins. Fucoidin prevented the
increase in leukocyte transit times and the loss of FCD at 5 hours,
indicating that selectins were involved in the slowing of leukocytes
in sepsis. Leukocytes play a significant role in the maldistribution of
capillary blood flow through the loss of perfused capillaries and
increased leukocyte transit times. Both effects probably cause a
concomitant fall in oxygen saturation in neighboring capillaries,
leading to periods of tissue hypoxia.
Acknowledgement This research was funded by a grant from the
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Objective We studied the effects of activated protein C (APC) on
the intestinal microcirculation during experimental endotoxemia in
rats using intravital microscopy.
Design A prospective, randomized, controlled animal study.
Setting Experimental laboratory of a university.
Animals Forty-four male Lewis rats.
Interventions The animals were divided into four groups. Group 1
served as control. Group 2 (lipopolysaccharide Escherichia coli
[LPS]) and group 3 (LPS + APC) received endotoxin infusion (15
mg/kg). In groups 3 and 4 (APC) 2 mg/kg Drotrecogin alfa
(activated) was administered. All animals underwent studies of
intestinal functional capillary density (FCD) and leukocyte
adherence on venular endothelium in the microcirculation of the
terminal ileum by intravital fluorescence microscopy (IVM).
Measurements and results APC reduced significantly the
number of firmly adhering leukocytes in V3 venules (416.5 ± 54.7)
and V1 venules (235.4 ± 59.8) (Fig. 1) as compared with LPS
(678.9 ± 144.4 in V3 venules; 374.5 ± 90.4 in V1 venules; Fig. 2).
The FCD (cm/cm2) in the mucosa of LPS rats receiving APC was
increased (172.2 ± 14.1) as compared with the LPS rats (143.1 ±
9.6, P < 0.05). The FCD of longitudinal and circular muscular
layers showed a better perfusion in rats treated with APC (172.2 ±
14.1 vs 167.4 ± 16.7) in comparison with untreated animals
(143.1 ± 9.6 vs 141.1 ± 15.2, P < 0.05).
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Conclusion APC administration in endotoxemic animals improved
microcirculatory perfusion. Moreover, APC treatment revealed anti-
inflammatory effects by reducing leukocyte adherence to the
endothelium.
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Reversal of lipopolysaccharide-induced hyporeactivity in rat
aorta and human mesenteric artery in vitro by orthovanadate
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Background Endotoxemia is characterised by vascular
hyporeactivity (VHR) that is partially caused by the excess of nitric
oxide (NO) production. The agent that affects Ca2+ transport or the
Ca2+ sensitivity of contraction may theoretically reverse VHR.
Methods The VHR was induced in vitro by incubating (for 6 hours)
rat aortal rings, with or without endothelium (± ENDO), or human
mesenteric arterial rings (HMA) endothelium intact (+ENDO), with
lipopolysaccharide Escherichia coli (LPS) (10–3 g/l). In addition,
the preparations (12 groups, n = 7 each) were preincubation
(10 min) with various concentrations of sodium-orthovanadate
(OV) (10–7, 10–6, or 10–5 M) and then the contractile response to
phenylephrine (PE) was examined in vitro.
Results We found that the presence of endothelium diminished
sensitivity to PE in rat aorta (+ENDO, EC50: 5.88 ± 0.11 vs
–ENDO, EC50: 6.84 ± 0.15, respectively), a result probably of an
overproduction of nitric oxide and potassium channel activation.
The preincubation with OV had no effect on sensitivity to PE in rat
aorta (± ENDO) and HMA (+ENDO) as compared with corres-
ponding controls (without OV [–OV]). However, preincubation with
OV increased maximal tension (Tmax) to PE, as compared with the
control (–OV). Tmax (kg/g, dry muscle), control versus OV
(concentration): rat aorta (–ENDO): 0.87 ± 0.19 vs 1.42 ± 0.23
(10–7 M), 1.56 ± 0.28 (10–6 M) and 2.33 ± 0.69 (10–5 M); rat
aorta (+ENDO): 0.88 ± 0.21 vs 1.53 ± 0.35 (10–7 M), 1.35 ± 0.30
(10–6 M) and 2.55 ± 0.68 (10–5 M); and human mesenteric artery
(+ENDO): 1.12 ± 0.23 vs 0.37 ± 0.14 (10–7 M), 2.06 ± 0.21
(10–6 M) and 3.00 ± 0.07 (10–5 M), respectively.
Conclusion These findings demonstrated that the VHR in rat aorta
and human mesenteric artery could be reversed by an inhibition of
calcium removal and/or inhibition of tyrosine phosphatase activity.
It should be verified whether in human preparations taken from
septic patients orthovanadate could have some beneficial effects
on vascular hyporeactivity.
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Introduction Vasodilatory shock is a major problem in intensive
care medicine. It is recently recognized that activation of vascular
potassium (K) channels may play an important role in sepsis-
induced vasodilation and attenuated sensitivity to noradrenaline.
Pharmacological K-channel blockade restores blood pressure and
improves mortality in animal models of sepsis. Human data are
lacking. We examined whether endotoxin administration to healthy
volunteers resulted in an attenuated noradrenaline sensitivity and
whether this effect could be restored by the K-channel blocker
tetra-ethyl ammonium (TEA).
Methods Human volunteers received 2 ng/kg Escherichia coli
endotoxin. The brachial artery was cannulated for infusion of drugs.
Forearm blood flow (FBF) was measured using venous occlusion
plethysmography. Noradrenaline was administrated intra-arterially
at 1, 3, 10, 30 ng/min/dl and the vasoconstrictive response to
noradrenaline was determined before endotoxin was administrated.
Four hours after endotoxin administration the noradrenaline dose–
response curve was repeated to determine the effects of endotoxin.
One hour later the K-channel blocker TEA was administrated intra-
arterially (1 mg/min/dl), after which the noradrenaline dose
response curve was determined again. During the experiments
continuous monitoring of heart rate and mean arterial pressure was
performed and blood samples were taken to determine effects on
standard laboratory values. Data are expressed as mean ±
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standard error of the mean. Differences were tested by analysis of
variance repeated measures or Student t test, as appropriate.
P < 0.05 was considered to indicate significance.
Results Endotoxin administration induced the expected flu-like
symptoms and fever (maximum temperature 38.3 ± 0.1°C,
P < 0.001). Mean arterial pressure decreased from 93 ± 2 to
79 ± 2 mmHg (P < 0.001) and the heart rate increased from
60 ± 2 to 95 ± 2 bpm (P < 0.001). After the administration of
endotoxin, leucocytes increased to 14.2 ± 0.6 × 109/l (P < 0.001)
and C-reactive protein increased to 36.0 ± 2.7 mg/l (P < 0.001).
Intra-arterial noradrenaline infusion decreased forearm blood flow:
percentage of baseline ratio (infused/noninfused arm), 100 ± 0%,
84 ± 4%, 70 ± 4%, 55 ± 4%, 38 ± 4%. Following endotoxin
administration, the noradrenaline-induced vasoconstriction was
attenuated: 100 ± 0%, 101 ± 4%, 92 ± 4%, 83 ± 6%, 56 ± 7%
(P < 0.001, pooled data, n = 25). Time control experiments (n = 6)
demonstrated excellent repeatability of the attenuated
noradrenaline response after the administration of endotoxin (see
Fig. 1, top). Intra-arterial infusion of the K-channel blocker TEA
almost completely restored the vasoconstrictive effect of
noradrenaline (see Fig. 1, bottom; n = 6, P = 0.045).
Conclusions In experimental human endotoxemia, noradrenaline
sensitivity is decreased. K-channel blocker TEA almost completely
restores the vasoconstrictive effects of noradrenaline. Our study
demonstrates that endotoxin-induced vascular K-channel activation
plays a major role in the observed attenuated sensitivity to
noradrenaline during human endotoxemia.
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Dose-dependent and temporal effects of pentoxifylline in a rat
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Introduction The methylxanthine pentoxifylline (PTX) is known to
increase intracellular cAMP concentrations by inhibiting
phospodiesterases. Despite beneficial in vitro effects its role in
acute hepatic failure (AHF) is controversial. Several studies have
demonstrated no benefit in the use of PTX in AHF, sepsis or shock.
Aims To investigate three hypotheses: (1) the use of PTX leads to
improved outcome in AHF; (2) this effect is dose dependent; and
(3) improved outcome is limited by temporal constraints. We will
compare PTX administration pre and post hepatic injury.
Methods We have previously described a robust and reproducible
model of AHF in the Wistar rat. The animals were randomly allocated
into five groups (each n = 10): Group I received 2 × intra-peritoneal
injections of thioacetamide (TAA) 8 hours apart (500 mg/kg).
Groups II and III were pretreatment groups: Group II was pretreated
with low-dose PTX (25 mg/kg body weight) and Group III was
pretreated with high-dose PTX (300 mg/kg) and received the TAA
protocol as in Group I. Groups IV and V were post-treatment groups.
All followed the protocol for Group I; however, 30 min prior to
receiving the second dose of TAA they received low-dose PTX
(Group IV) and high-dose PTX (Group V). Clinical, biochemical and
pathological analysis occurred at 24-hour time points.
Results Encephalopathy, blood ammonia levels and transaminitis
is significantly reduced by pretreatment with low-dose PTX (Group
II) (P < 0.05). A significant reduction in mortality is seen in Group II
where mortality at 96 hours is 30% compared with greater than
90% in the other pretreatment group (P < 0.005) and 70% in the
TAA-treated animals (P < 0.005). This reduction in clinical and
biochemical parameters is not seen in the post-treated groups.
Conclusion Low-dose pretreatment with PTX significantly improves
encehalopathy, biochemical markers of AHF and mortality
compared with controls (TAA only). Beneficial effects are, however,
negated if PTX is administered at high dose pretreatment or any
dose post-treatment with TAA, exacerbating hepatic injury,
increasing mortality and therefore demonstrating dose-dependent
and temporal constraints.
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Tumor necrosis factor increases the sensitivity of the
contractile apparatus in isolated mouse resistance arteries via
a calcium-dependent mechanism
Y Ouellette
Mayo Clinic College of Medicine, Rochester, MN, USA
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Introduction The myogenic response is the modulation of
resistance artery diameter in response to changes in luminal
pressure. It is thought to be an important determinant of peripheral
vascular resistance and therefore of arterial blood pressure. Since
altered peripheral resistance is known to occur during the systemic
inflammatory response syndrome (such as in sepsis), we suspect
that an abnormal myogenic response might be responsible. Our
main objective is to assess the effects of tumor necrosis factor
alpha (TNF-α) on the myogenic response of mouse mesenteric
resistance arteries and to determine the role of Ca2+ in this
response.
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Hypothesis TNF-α reduces the myogenic response in mesenteric
resistance arteries by reducing smooth muscle cell Ca2+ sensitivity.
Methods and results Vessels (external diameter ~150–200 µm)
were mounted on a pressure myograph and allowed to develop
myogenic constriction. After endothelial cell removal, baseline
measurements were obtained and measurements were repeated
1 hour after treatment with TNF-α (50 ng/ml). TNF-α resulted in
reduced myogenic tone at increasing luminal pressures (see
Fig. 1). To determine the role of Ca2+ in this response, the passive
internal diameter was measured in a Ca2+-free solution. TNF-α
significantly shifted the Ca2+–diameter relation to the right, as
assessed by stepwise increasing of extracellular Ca2+
(0–1.5 mmol/l) in depolarized skeletal muscle resistance arteries.
This suggests a decreased Ca2+ sensitization of the smooth
muscle cell contractile apparatus.
Conclusion We conclude that, in mouse mesenteric resistance
arteries, TNF-α treatment results in reduced myogenic tone that
may be due partly to decreased Ca2+ sensitivity. These results
suggests that the microvascular dysfunction seen during sepsis
could be due in part to a decreased myogenic response.
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Introduction Cardiopulmonary bypass (CPB) induces a systemic
inflammatory response (SIRS), which causes significant morbidity
or even mortality. Amiodarone (Amio) has shown to reduce
postoperative atrial fibrillation and also to reduce tumor necrosis
factor alpha (TNF-α) production in vitro. Whether Amio reduces
the post CPB SIRS is unknown
Hypothesis The present study sought to investigate the anti-
inflammatory properties of Amio after CABG using CPB.
Methods Twenty-two patients undergoing elective CABG were
randomly assigned to receive 600 mg Amio orally 7 days pre
surgery daily and 45 mg/hour intravenously for 48 hours after
initiation of CPB (10 patients, group 2) or placebo (12 patients,
group 1). Two patients in group 2 were excluded due to withdrawn
consent during the loading phase. The primary endpoint was the
C-reactive protein (CRP) curve (AUC) up to 96 hours, and
secondary endpoints were fibrinogen and WBC up to 96 hours
and TNF-α and IL-6 curves up to 48 hours post surgery,
respectively.
Results Baseline characteristics were not different between
groups (age 61 ± 8 vs 62 ± 10 years, male 7/8 vs 10/12, EF 576
vs 53 ± 7%, SAPS II score 19 ± 3 vs 21 ± 8, CPB duration
78 ± 15 vs 79 ± 17 min, group 2 vs group 1, P = not significant).
Amio did not reduce the postoperative CRP AUC when compared
with placebo (1579 ± 260 vs 1397 ± 617, P = 0.44; Fig. 1).
Furthermore, no significant differences in the AUCs of fibrinogen,
WBC, TNF-α and IL-6 were observed. Length of ICU and hospital
stay were not different between groups (2.4 ± 1.5 vs 2.7 ± 2.0 days,
P = not significant and 9.0 ± 1.4 and 13.3 ± 7.1 days, P = not
significant, group 2 vs group 1, respectively). There were no
deaths in either group.
Conclusions In this pilot study, there was no difference in the post
CPB inflammatory reaction between Amio-treated and placebo-
treated patients.
P83
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Introduction It is known that 5-hydroxytriptamine (5-HT)2A receptors
have some roles in vascular constriction, platelet aggregation, and
superoxide production by neutrophils. 5-HT2A receptor antagonists
are therefore expected to be effective for sepsis. The present study
was performed to investigate the effects of sarpogrelate, a 5-HT2A
receptor antagonist on endotoxin shock in rats.
Methods Male Sprague–Dawley rats were anesthetized with
halothane. Catheters were inserted into the femoral artery and the
femoral vein. Sarpogrelate 0, 3, or 10 mg/kg dissolved in 0.5 ml
clear water was administered intravenously followed by 10 mg/kg
endotoxin 5 min later. The blood pressure (BP), pulse rate (PR),
and survival rate were monitored for 4 hours in 20 rats at each
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dose. Arterial blood was drawn before, 2 and 4 hours after
endotoxin administration to measure IL-1β, IL-6, IL-8, IL-10, and tumor
necrosis factor alpha (TNF-α) (another eight rats at each dose).
Results The decreases in BP and PR were significantly bigger in
the 0 mg/kg group than the 3 mg/kg and 10 mg/kg groups.
Survival rates were significantly lower in the 0 mg/kg group than
the other two groups. IL-1β at 4 hours was significantly higher in
the 0 mg/kg group than the other two groups. TNF-α at 2 hours
was significantly lower in the 3 mg/kg group than the other two
groups. The data at 4 hours are presented in Table 1 as the
mean ± standard deviation.
Table 1
0 mg/kg 3 mg/kg 10 mg/kg
Blood pressure (mmHg) 45 ± 26 90 ± 18* 80 ± 21*
Pulse rate (beats/min) 105 ± 35 285 ± 25* 278 ± 29*
Survival rate 3/20 18/20* 15/20*
IL-1β (pg/ml) 244 ± 56 85 ± 33* 53 ± 15*
IL-6 (ng/ml) 6.8 ± 1.7 5.4 ± 1.8 7.1 ± 2.9
IL-8 (ng/ml) 46.0 ± 16.7 35.4 ± 9.7 38.4 ± 10.1
IL-10 (pg/ml) 844 ± 384 1047 ± 520 1163 ± 315
Tumor necrosis factor α (ng/ml) 2.2 ± 0.5 2.0 ± 0.9 2.1 ± 0.6
*P < 0.05 vs 0 mg/kg.
Discussion Pretreatment with sarpogrelate inhibited the decrease
in BP and PR and decreased mortality. Cytokine levels had big
variations, but sarpogrelate had a tendency to decrease IL-1β, IL-6,
IL-8, and TNF-α, and to increase IL-10. Sarpogrelate 3 mg/kg was
more effective than 10 mg/kg; probably 10 mg/kg decreased BP
more than 3 mg/kg. In the preliminary study, BP was dose-
dependently decreased by sarpogrelate and 30 mg/kg killed
animals. Therefore, sarpogrelate 3 mg/kg might be the choice.
Conclusion Intravenous sarpogrelate might be effective for
endotoxin shock.
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and puncture-induced sepsis
I Cinel, M Ark, H Kubat, T Karabacak, H Serinol, L Tamer, U Oral
Mersin University School of Medicine, Mersin, Turkey
Critical Care 2005, 9(Suppl 1):P84 (DOI 10.1186/cc3147)
We have previously demonstrated that following cecal ligation and
puncture (CLP) there is an increase in lung epithelial apoptosis in a
rat model [1]. On the other hand, it has been shown that the rho/rho
kinase pathway is involved in mechanisms of several aspects such
as endothelial cell dysfunction and apoptosis. However, the role of
rho kinase in the concept of sepsis-induced apoptosis has yet to be
elucidated. In this study, to investigate the possible contribution of
rho/rho kinase signalling in CLP-induced lung injury, rho kinase
expression and the possible protective effect of the administration
of an inhibitor of rho kinase, (+)-(R)-trans-4-1-aminoethyl-N-4-pyridyl
cyclohexanecarboxamide dihydrochloride monohydrate (Y-27632),
has been investigated in rats in this model.
Thirty-two male Wistar rats were randomly divided into four groups:
(1) sham, (2) CLP, (3) sham + Y27632, (4) CLP + Y27632.
Y27632 was administered at 1.5 mg/kg, intaperitoneally, 20 min
before performing operations. Twenty-four hours later, histo-
pathology and apoptosis were assessed by H&E and immuno-
histochemically by caspase-3 to demonstrate septic lung injury.
Additionally, expression of rock 1 and rock 2 proteins in lung tissue
was analyzed by western blotting, and the contribution of oxidative
damage was assessed by measuring the levels of thiobarbituric
acid reactive substances (TBARS) and the 3-L-nitrotirozin
(3-NT)/total tyrosine ratio.
The TBARS and 3-NT/total tirosine ratio levels in lung
homogenates were found to be increased (11.05 ± 0.31 vs
29.855 ± 2.87) (0.1485 ± 0.10 vs 0.281 ± 0.05) in the CLP
group compared with the sham group, and the administration of
Y27632 prevented their increase (8.86 ± 1.87) (0.178 ± 0.02)
significantly (P < 0.05). The number of apoptotic cells was
significantly lower in the CLP + Y27632 group than CLP group
and this finding was supported by caspase-3 expression in the
lung. Lung histopathology was also protected by Y27632 in CLP-
induced sepsis. Immunoblot experiments revealed the increased
expression of active fragment of rock 1 in the CLP group.
However, rock 2 expressions were similar in all groups.
In conclusion, since CLP induced active fragmentation of rock 1 and
rho-kinase inhibitor prevented peroxynitrite-mediated apoptotic lung
injury in this CLP-induced sepsis model, this suggests that rho-
kinase plays an important role in apoptotic lung injury. Our data
indicate that rock 1 or downstream components of this pathway may
be potential targets for the development of novel therapies in sepsis.
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Objective To describe the main haemodynamic parameters
obtained in patients with severe sepsis and septic shock, who died
several hours later.
Design A prospective, observational study, using transthoracic
echocardiography.
Setting A medical/surgical 14-bed ICU.
Materials and methods In the patients enrolled the following
echocardiographic parameters were obtained: left ventricular (LV)
telediastolic dimension, left ventricular shortening fraction (LVSF),
cardiac output (CO), by determination of the flow velocity integral
of the LV out-flow tract using pulsed-wave Doppler analysis, and
the determination of the inferior vena cava (IVC) maximal and
minimum dimensions, and the IVC index (maximum dimension –
minimum dimension × 100/maximum dimension). A CO between
2.4 l/min/m2 and 4 l/min/m2 was considered normal, as well as a
LVSF of 36 ± 6%. Based on the characteristics of CO and the IVC
index, we considered the following types of shock and/or
hypotension: cardiogenic (low CO and IVC index < 25%),
vasogenic (normal or high CO and variable IVC index), and
hypovolemic (low CO and IVC index > 50%).
Twenty-seven patients were enrolled, and divided into two groups:
group 1 consisted of patients with a haemodynamic evaluation up
to 6 hours before death (peri-mortem group, n = 14), and group 2
with a haemodynamic evaluation between 6 and 12 hours before
death (ante-mortem group, n = 13). In all patients was determined:
age, sex, arterial pressure, heart rate, APACHE II score, SAPS II,
SOFA, MODS, serum lactate, and central venous pressure (CVP).
Results Six patients in group 1 and three patients in group 2
presented a situation compatible with a cardiogenic type of
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hypotension. The remainder presented as a vasogenic type of
hypotension. Eight patients in group 1 presented LVSF < 30%, as
well as four patients in group 2 All severity scores of group 1 were
slightly higher, as well as serum lactate levels. The main results are
presented in Table 1, with means and standard deviation for each
variable.
Table 1
Parameter Group 1 Group 2
APACHE II score 40 ± 4 39 ± 9
SAPS II 95 ± 8 88 ± 9
SOFA 18.7 ± 1.7 16 ± 4
MODS 17.3 ± 2 15 ± 3.6
Serum lactate 11.7 ± 5.7 9.8 ± 5.6
Cardiac output (l/min/m2) 3692 ± 1254 2829 ± 958
Left ventricular shortening fraction (%) 32 ± 5.6 28.4 ± 7.3
Conclusions Septic shock presents as a vasogenic type until the
late disease course. A LV failure with a cardiogenic type of
situation characterizes better the later stages, up to 6 hours before
death occurs.
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Introduction We reported that the bronchial circulation contributes
to pulmonary function after acute lung injury with smoke inhalation.
But the observation period was 24 hours. We hypothesize that the
bronchial circulation plays a major role in the lung injury seen with
the combination of burn and smoke inhalation injury.
Method Merino ewes (n = 13) were surgically prepared for chronic
study. After a recovery (5–7 days) they were randomly divided into
three groups: (1) the bronchial artery was ligated (n = 5); (2) sham
group (n = 5), the bronchial artery was surgically exposed but left
intact without ligation; (3) the bronchial artery was exposed, not
ligated and the animals were not injured. One day after these
operations, under deep halothane anesthesia, two groups received
a tracheotomy and were subjected to a 40% third-degree flame
burn and insufflated with 48 breaths of cotton smoke inhalation or
were sham injured. All sheep were mechanically ventilated and
resuscitated by Ringer’s lactate for 48 hours. We confirmed the
ligation of the bronchial artery with microspheres. Statistics were
performed using repeated-measures analysis of variance for
repeated measurements and Scheffe’s post hoc comparisons was
used and P < 0.05 was considered significant. Data are expressed
as mean ± standard error of the mean.
Result After ligation (24 hours), blood flow of the bronchi
decreased to 24.48% of the baseline value. Pulmonary dysfunction
after the combined injury in the ligation group was significantly
reduced. Lung lymph flow, an index of pulmonary transvascular
fluid flux, was markedly increased in in the ligated and intact groups.
Ligation reduced this response (24 hours: sham 65 ± 5.0; ligation
15.5 ± 7.51; sham–sham 9.4 ± 5.6; 48 hours: sham 64.5 ± 16.5;
ligation 12.58 ± 5.743; sham–sham 7.25 ± 3.95 ml/hour). Ligation
also improved the PaO2/FiO2 ratio (24 hours: sham 270 ± 99.347;
ligation 390.381 ± 53.781; sham–sham 595 ± 13.856; 48 hours:
sham 132.5 ± 33.15; ligation 375 ± 62.253; sham–sham
592.33 ± 8.95). PMN production also decreased (24 hours: sham
32.5 ± 31.8; ligation 6.2 ± 2.2; 48 hours: sham 38.3 ± 46.2;
ligation 2.7 ± 2.6 × 106).
Conclusions Bronchial circulation plays a significant role in the
lung inflammation after combined burn and smoke inhalation injury.
Acknowledgements Supported by National Institutes of Health
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Objective To assess the feasibility and accuracy of measuring
mixed venous oxygen saturation (SvO2) through the left main
bronchus (SpO2trathea). The hypothesis that tracheal oximetry
readings are not primarily derived from the tracheal mucosa was
also tested. The pulmonary artery lies in close proximity to the
bronchus, with nothing but some connective tissues in the interval,
raising the possibility that an appropriately located and directed
bronchial oximetry probe might be able to derive oximetry readings
from the mixed venous system. The present study was undertaken
to test the feasibility of measuring SvO2 through the left main
bronchus (SpO2trachea), and to compare SpO2trachea with the
Swan–Ganz catheter SpO2 (SvO2catheter) and oxygen saturation
from pulmonary artery samples (SvO2blood) in hemodynamically
stable, well-oxygenated, anesthetized white swines. We also
tested the hypothesis that bronchial oximetry readings are primarily
derived from the pulmonary artery, not the tracheal mucosa.
Furthermore, the stability and accuracy of SpO2trachea was tested
by correlating the oximetry readings with altered SvO2 or with
internal environment instability.
Methods Twenty hemodynamically stable, well-oxygenated,
anesthetized white swine were studied. A Robertshaw double-
lumen tracheal tube was directed toward the left main bronchus
using a fibrobronchoscope. A single-use pediatric pulse oximeter
was attached to the left lateral surface of the tube. SpO2trathea,
Swan–Ganz catheter SpO2 (SvO2catheter) and oxygen saturation
from pulmonary artery samples (SvO2blood) were taken with the
intracuff pressure at 0–60 cmH2O. The intracuff pressure was then
set at 60 cmH2O, and changes of SvO2 were induced using three
different concentrations of inspiratory oxygen. The influence of the
changes on SpO2trathea, SvO2catheter and SvO2blood was
measured respectively at the same time.
Results SpO2trathea was the same as SvO2catheter and
SvO2blood at an intracuff pressure of 10–60 cmH2O, but was less
when the intracuff pressure was zero (P < 0.001 compared with
SvO2catheter or SvO2blood) in hemodynamically stable states.
The descending of SvO2 followed with decreased inspiratory
oxygen concentration. SpO2trachea agreed with SvO2catheter and
SvO2blood at each concentration with significant correlation
among them.
Conclusion Left main bronchus SpO2 is feasible and provides
similar readings to SvO2catheter and SvO2blood in hemo-
dynamically stable or low saturation states. Tracheal oximetry
readings are not primarily derived from the tracheal mucosa. The
technique merits further evaluation.
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Introduction The main strategy to restore organ perfusion in
critically ill patients is fluid administration, which increases the
likelihood of acquiring pulmonary edema with detrimental effects
on gas exchange. The thermal-dye dilution technique has been
used to measure extravascular lung water (EVLW). Recently, this
technique has been simplified using only the thermal indicator [1].
The relationship between EVLW and the PaO2/FiO2 ratio has been
sparsely studied and described as weak [2]. Oxygenation index
(OI) relates PaO2, FiO2, and mean airway pressure (Paw) by the
following formula: OI = Paw × FiO2 × 100 / PaO2 [3]. We are not
aware of publications correlating EVLW with OI.
Methods Simultaneous measurements of EVLW, arterial blood
gases and Paw were performed in mechanically ventilated patients
at different moments of their illness course. EVLW was measured
by a single transpulmonary thermodilution technique using a
PiCCO® monitor. The EVLW value was indexed (EVLWi) by the
predicted body weight [4]. PaO2/FiO2 and OI were calculated and
correlated with EVLWi using linear regression analysis with a 95%
confidence interval (CI).
Results We studied 21 patients, 20 with ALI/ARDS (age 64 ± 19
years, APACHE II score 24.4 ± 6.8, SOFA 10.3 ± 3.2, LIS
2.55 ± 0.57). Mean admission EVLWi, Paw, PaO2/FiO2 and OI
values were 14 ± 6.5 ml/kg, 17.8 ± 3.9 cmH2O, 186 ± 80 and
12.1 ±7.5, respectively. We obtained 152 EVLWi measurements
with simultaneous PaO2/FiO2 and OI values. A significant negative
correlation was found between EVLWi and PaO2/FiO2 (r = –0.53,
CI –0.63 to –0.40, P < 0.01) (Fig. 1). A significant positive
correlation was found between EVLWi and OI (r = 0.70, CI 0.60–
0.77, P < 0.01) (Fig. 2).
Conclusions There is a stronger correlation between EVLWi and
OI than with PaO2/FiO2. This finding emphasizes the importance of
incorporating Paw into the evaluation of patient oxygenation during
mechanical ventilation.
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Introduction We have previously shown that the desaturation
index (DI) and the calculated desaturation index (Dic) have a
statistical correlation with several indices of gas exchange and with
lung infiltrates on the thorax X-ray. However, the utility of the DI and
Dic as a diagnostic tool has never been tested. The aim of this
study is therefore to determine the capability of the DI and the DIc:
to identify acute lung injury (ALI) and/or acute respiratory distress
syndrome (ARDS) at the bedside.
Patients and methods Patients with and without ALI and/or acute
respiratory failure (ARDS) were followed during the period of
mechanical ventilation. Every morning, blood gases analysis and
thorax X-rays were taken and definitions for ALI/ARDS were
completed according to the American–European Consensus
Conference. We registered the positive end expiratory pressure,
inspired fraction of oxygen (FiO2) and arterial saturation by pulse
oximetry (SpO2) to calculate the Dic. Then, in order to determine
the DI, all patients were subjected to breathe 100% oxygen, with a
gradual reduction of the FiO2 to 21%, in steps of 20% lasting
8 min each, and at each step the SpO2 was registered (we stop
the maneover after reaching 85% of the SpO2). Finally, we
calculated the DI according our equation that has been described
previously. Two or more quadrants with infiltrates on the thorax X-
ray and PaO2/FiO2 ratio (adjusted to high altitude) lower than 221
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mmHg were considered positive for ALI/ARDS. The sensitivity and
specificity were calculated according to conventional equations.
Results During the study period, 198 ALI/ARDS definitions were
completed. Table 1 presents the sensitivity and specificity tests for
the DI and the Dic. Results are shown as the percentage and
confidence interval
Table 1
Pao2/FiO2 Thorax X-ray ALI/ARDS
DI sensitivity 0.86 (0.78–0.91) 0.77 (0.69–0.84) 0.87 (0.78–0.92)
DI specificity 0.84 (0.75–0.89) 0.85 (0.76–0.91) 0.83 (0.74–0.87)
DIc sensitivity 0.93 (0.87–0.97) 0.85 (0.77–0.90) 0.99 (0.95–1)
DIc specificity 0.82 (0.74–0.89) 0.85 (0.76–0.91) 0.93 (0.86–0.97)
ALI, acute lung injury; ARDS, acute respiratory distress syndrome; DI,
desaturation index; Dic, calculated desaturation index.
Conclusion We conclude that the DI and the DIC, which are non-
invasive indices, have an acceptable sensitivity and specificity to
identify ALI/ARDS patients at the bedside.
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Introduction Clearance of fluid from the alveolar spaces primary
depends on the active sodium transport across distal lung
epithelium. Some experimental studies supported a potential role
for the cystic fibrosis transmembrane conductance regulator
(CFTR), especially in the cAMP-mediated upregulation of fluid
clearance. Hypothetically, pharmacological inhibition of Cl–
channels could worsen lung edema by decreasing the clearance of
alveolar edema. In this study, we tested the affect of chloride
transport inhibition on lung edema formation in acute pneumonia.
Methods A mouse model of acute pneumonia was established
using IT instillation of Escherichia coli (107 cfu). Basal and
isoproterenol (0.1 mM)-stimulated alveolar fluid clearance were
studied using the in situ mice model. Glibenclamide (0.1 mM) or a
specific CFTR-inhibitor (100 mM CFTR-172) was instilled into the
lung to study the effects of CFTR blockade.
Results In response to cAMP stimulation by isoproterenol,
clearance was inhibited by glibenclamide or the CFTR-172
inhibitor (respectively, 12.2 ± 0.39% and 9.7 ± 3.5% versus 20.7
± 2.9% in the control group, P < 0.05). Four hours after bacterial
instillation, the lung wet-to-dry ratio and lung vascular permeability
as measured by the extravascular accumulation of 125I-albumin
were increased compared with the control group (respectively,
4.8 ± 0.18 g/g versus 3.8 ± 0.18 g/g, P < 0.05 and 61.8 ± 10.4 µl
versus 20 ± 5.9 µl, P < 0.05). No significant statistical change was
found among lung water and endothelial permeability in the
glibenclamide or CFTR-172 inhibitor group.
Conclusion These experiments indicated that the c-AMP-
dependent fluid clearance from the distal airspaces of the lung
involves chloride transport by CFTR. In vivo, we found no change
in pulmonary edema formation following E. coli intratracheal
instillation. These data suggest that chloride transport is not a
major mechanism in lung edema formation in a mouse model of
acute pneumonia.
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Background Although it is well known that beta-adrenergic agonist
improves alveolar fluid clearance (AFC) in several animal species, it
is not known whether beta-adrenergic agonist improves AFC in
infectious acute lung injury (ALI). This study is aimed at investigating
the effect of beta-adrenergic agonist (dobutamine) on AFC in rats
with infectious ALI and exploring the associated mechanism.
Methods Thirty-two male Sprague–Dawley rats were randomly
divided into four groups (normal control group, ALI group,
dobutamine control group, dobutamine treatment group). A rat with
ALI was induced by infusion of endotoxin intravenously. Alveolar
fluid clearance was measured by the single-nuclide tracer
technique. α-Rat epithelial sodium channel (α-rENaC), β-rENaC
and γ-rENaC mRNA expressions were measured by RT-PCR.
Results AFC of the ALI group was 14.0 ± 1.2%, which was
significantly lower than the normal control group (21.0 ± 3.9%),
the dobutamine treatment group (20.0 ± 3.8%) and the
dobutamine control group (26.6 ± 1.6%) (P < 0.05). AFC of the
dobutamine control group was significantly higher than the normal
control group, dobutamine treatment group and ALI group
(P < 0.05). α-rENaC and β-rENaC mRNA expressions of the ALI
group (1.4 ± 0.4 and 0.7 ± 0.8, respectively) and the dobutamine
treatment group (1.38 ± 0.13 and 0.71 ± 0.17, respectively) were
significantly higher than the dobutamine control group
(1.01 ± 0.14 and 0.58 ± 0.12, respectively) and the normal control
group (1.00 ± 0.28 and 0.44 ± 0.11, respectively) (P < 0.05).
There were no significant differences of α-rENaC and β-rENaC
mRNA expressions between the normal control group and
dobutamine control group, and no significant difference between
the ALI group and dobutamine treatment group (P > 0.05). γ-
rENaC mRNA expressions of the dobutamine control group and
dobutamine treatment group were 0.90 ± 0.19 and 0.97 ± 0.15,
respectively, which were significantly higher than normal control
group (0.69 ± 0.10) and the ALI group (0.7 ± 0.3) (P < 0.05).
There was no significant difference of γ-rENaC mRNA expressions
between the normal control group and the ALI group, and no
significant difference between the dobutamine control group and
the dobutamine treatment group (P > 0.05).
Conclusion Beta-adrenergic agonist may upregulate γ-rENaC
expression and improve AFC in rats with endotoxin-induced ALI. It
may be beneficial to increase AFC and reduce lung edema using
beta-adrenergic agonist in ALI patients.
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Objective To investigate the effect and the associated mechanism
of beta-adrenergic agonist on alveolar fluid clearance (AFC) in rats.
Methods Forty-eight Sprague–Dawley male rats were randomly
divided into six groups (normal control group, dobutamine group,
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amiloride [specific inhibitor of epithelial sodium channel] group,
dobutamine + amiloride group, dobutamine + atenolol [specific
beta-1 antagonist] group, dobutamine + ICI118,551 [specific
beta-2 antagonist] group). AFC was measured by the single-
nuclide tracer technique. Alpha-rat epithelial sodium channel
(alpha-rENaC), beta-rENaC and gamma-rENaC mRNA expressions
were measured by RT-PCR.
Results (1) AFC of the dobutamine group and dobutamine +
atenolol group were 26.6 ± 1.6% and 25.0 ± 5.3%, respectively,
which were significantly higher than the normal control group
(21.0 ± 3.9%) and dobutamine + ICI 118,551 group (21.0 ± 4.8%)
(P < 0.05). There was no significant difference of AFC between
the dobutamine group and dobutamine + atenolol group
(P > 0.05); and no significant difference of AFC between the
normal control group and dobutamine + ICI 118,551 group
(P > 0.05). (2) AFC of the amiloride group was 6.0 ± 2.8%, which
was significantly lower than the normal control group (P < 0.05).
(3) AFC of the dobutamine + amiloride group was 10.0 ± 2.3%,
significantly higher than the amiloride group (P < 0.05). (4)
Gamma-rENaC mRNA expression of the dobutamine group and
dobutamine + atenolol group was 0.90 ± 0.19 and 0.90 ± 0.09,
respectively, significantly higher than the normal control group
(0.69 ± 0.09) and dobutamine + ICI 118,551 group (0.68 ± 0.06)
(P < 0.05). There was no significant difference of gamma-rENaC
mRNA expression between the dobutamine group and dobutamine +
atenolol group; and no significant difference of gamma-rENaC
mRNA expression between the normal control group and
dobutamine + ICI 118,551 group (P < 0.05). There was no
significant difference of alpha-rENaC and beta-rENaC mRNA
expressions between each group (P > 0.05). (5) Gamma-rENaC
mRNA expression of the dobutamine + amiloride group was
0.70 ± 0.14, significantly lower than the dobutamine group and
dobutamine + atenolol group (P < 0.05).
Conclusion The amiloride-sensitive NaC pathway was important
for lung epithelium to actively transport alveolar fluid. The effect of
beta-2 adrenergic stimulation may upregulate gamma-rENaC
expression and also stimulate the amiloride-insensitive NaC
pathway to improve AFC in rats.
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Objective To determine the change of extravascular lung water
(EVLW) and the effect of positive end-expiratory pressure (PEEP)
and cardiac output (CO) on EVLW in sheep with early acute
respiratory distress syndrome (ARDS).
Methods The sheep ARDS model was induced by infusion of
endotoxin intravenously, then divided into the ARDS model group
(n = 12), PEEP group (n = 21) and dobutamine group (n = 13).
The PEEP group was divided into three subgroups: PEEP
5 cmH2O group (n = 7), PEEP 10 cmH2O group (n = 8) and
PEEP 15 cmH2O group (n = 6). EVLW was measured by the
single indicator thermodilution technique. The EVLW, hemo-
dynamics and lung mechanics parameters were observed at 6 hours
after the sheep ARDS model was induced, 2 hours after they
received mechanical ventilation with PEEP (5, 10, 15 cmH2O),
respectively, and 2 hours after CO increase > 50% of the base
value (induced by dobutamine infusion).
Results (1) When ARDS was induced in sheep, EVLW increased
from 12.8 ± 4.7 ml/kg to 18.1 ± 7.1 ml/kg (P < 0.01), and EVLW
had no significant change (P > 0.05) during the early phase of
ARDS (6 hours). The PaO2/FiO2 was 136.8 ± 34.9 mmHg at
ARDS 0 hours, which was higher than that before infusion of
endotoxin (444.3 ± 127.7 mmHg, P < 0.01). EVLW had no
relationship with PaO2/FiO2, but EVLW after the ARDS model was
induced had good correlation with PaO2/FiO2 (r = –0.501,
P < 0.001). When ARDS was induced, static lung compliance
decreased from 26.9 ± 8.4 to 16.4 ± 5.0 (P < 0.01). (2) After
mechanical ventilation with PEEP for 2 hours, EVLW values in the
PEEP 10 cmH2O group and PEEP 15 cmH2O group were
14.7 ± 4.5 ml/kg and 15.3 ± 3.7 ml/kg, respectively, which was
significantly less than that before applied PEEP (16.5 ± 4.7 ml/kg
and 18.4 ± 6.0 ml/kg, respectively; all P < 0.05). But EVLW in the
5 cmH2O group was no different during 2 hours PEEP application.
(3) After CO increase > 50% of the base value at 1 hour and
2 hours, EVLW values were 16.3 ± 4.9 ml/kg and 16.9 ± 6.9 ml/kg,
respectively, which did not differ from that of the base value
(15.1 ± 4.6 ml/kg; all P > 0.05).
Conclusions EVLW in ARDS sheep increased significantly and
remained at the same level during the early phase of ARDS. PEEP
had a marked effect on reducing EVLW and the increase of CO
induced by dobutamine did not significantly raise the EVLW.
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Aim The evaluation of the quality and surface active properties of
surfactant carried out in vitro in setting the bubble, that is pulsating,
with the use of a surfactometer (Pulsating Bubble Surfactometer).
Materials and methods Patients requiring mechanical ventilation
were enrolled to the study. All patients met the criteria for acute
lung injury (ALI) or acute respiratory distress syndrome, according
to the American–European Consensus Conference. Additionally,
the Lung Injury Score criteria to determine the severity and the
course of lung injury were used. Sixty-five patients were included in
the study — 45 with respiratory insufficiency, of the latter 30 with
indirect ALI and 15 with direct ALI. Twenty patients were included
in the reference group. All patients underwent bronchoscopy and
bronchoalveolar lavage. The procedures were carried out during
the first 24 hours of mechanical ventilation. Analysis of pulmonary
surfactant activity was carried out using Pulsating Bubble
Surfactometer (Electronetics Corp., USA). Changes of value of the
surface tension in the cycle compression–expansion, minimum
value of the surface tension, maximum value surface tension and
the hysteresis loop changes of the surface tension measured as
their area value changes were measured. The normalized
hysteresis area, the stability index and the rate of effectiveness of
reducing the surface tension were calculated.
Results Differences were seen between groups with direct ALI
and indirect ALI and the control group, with reference to separate
analyses parameters. Minimum value of the surface tension
(P < 0.001) and maximum value of the surface tension (P < 0.002)
were significantly lower in the control group, whereas the
normalized hysteresis area (P < 0.001), the stability index (P < 0.001)
and the rate of effectiveness of reducing the surface tension
(P < 0.02) were significantly higher.
Comparison of separate groups revealed significantly lower values
of the minimum value of the surface tension (P < 0.003), the
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normalized hysteresis area (P < 0.001), the stability index
(P < 0.007) and the rate of effectiveness of reducing the surface
tension (P < 0.003) in the group with direct ALI, compared with the
group with indirect ALI. There were no differences in relation to
maximum values of the surface tension (P = 0.135).
Conclusions (1) Pulmonary surfactant dysfunction was observed
in the early phase ALI. (2) Direct lung injury was associated with
higher impairment of surfactant function than indirect lung injury.
(3) Correlation exists between the level of the lung injury and
dynamic surface active properties of pulmonary surfactant.
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Alveolar fibrinolysis is not altered by mechanical ventilation in
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Introduction Mechanical ventilation (MV) aggravates pulmonary
inflammation in patients with acute lung injury. Pulmonary
inflammation is characterized by alveolar fibrin depositions, which
is the net result of increased thrombin-mediated generation of fibrin
and upregulation of plasminogen activator inhibitor (PAI), inhibiting
fibrin degradation. We recently showed that injurious MV (using
high pressures) induces PAI-1 upregulation in rats, thereby limiting
pulmonary fibrinolytic activity. In the present study we determine
the influence of MV on alveolar PAI-1 expression in humans with
healthy lungs.
Methods Patients with healthy lungs expected to be mechanically
ventilated for ≥ 5 hours (elective surgery) were randomized to a MV
strategy using either a tidal volume (VT) of 12 ml/kg and zero
positive end expiratory pressure (HVT/ZEEP) or VT 6 ml/kg and
10 cmH2O PEEP (LVT/PEEP). Bronchoalveolar lavage (BAL) was
performed directly after initiation of MV, and repeated in the contra-
lateral lung after 5 hours of MV. Pulmonary thrombin generation
was quantified by measuring thrombin–antithrombin complexes
(TATc) in the BAL fluid; fibrinolytic activity by determining plas-
minogen activator activity (PAA), PAI-1, and tissue-type plasmino-
gen activator (tPA).
Statistics Within groups, Wilcoxon signed-rank test; between
groups, Mann–Whitney U test. Data are presented as medians
with interquartile ranges.
Results Nine patients were randomized to HVT/ZEEP, 11 patients
to LVT/PEEP. There were no differences in baseline characteristics
or outcome. After 5 hours, patients ventilated with HVT/ZEEP
showed an increase in alveolar thrombin generation (TATc: 0.91
[0.82–0.98] ng/ml vs 0.75 [0.67–0.81] ng/ml at baseline,
P < 0.01), in contrast to those with LVT/PEEP (0.84 [0.74–0.91]
ng/ml vs 0.81 [0.72–0.87] ng/ml, not significant [NS]). Pulmonary
PAI-1 levels did not change (LVT/PEEP: 2.0 [1.6–2.2] ng/ml vs 1.9
[1.8–2.1] ng/ml, NS; HVT/ZEEP: 2.1 [1.8–2.1] ng/ml vs 2.0
[1.7–2.4] ng/ml, NS). Moreover, alveolar PAA was unaffected in
both groups (LVT/PEEP: 106 [102–113]% vs 100 [97–105]%,
NS; HVT/ZEEP: 102 [97–110]% vs 102 [100–104]%, NS),
although levels of tPA increased more with HVT/ZEEP MV
(LVT/PEEP: 0.84 [0.65–0.98] ng/ml vs 0.61 [0.55–0.63] ng/ml,
P < 0.001; HVT/ZEEP: 0.70 [0.70–0.90] ng/ml vs 0.50
[0.40–0.55] ng/ml, P < 0.01; between groups, NS).
Conclusion Despite upregulation of tPA, alveolar PAA is not
altered during 5 hours of MV in patients with healthy lungs.
Disturbed alveolar fibrin turnover during MV in healthy lungs seems
solely the result of activation of coagulation.
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extrapulmonary organs inflammatory response in an acute
respiratory distress syndrome rabbit model
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Objective To evaluate the influence of a lung protective ventilation
strategy on extrapulmonary organ inflammatory response in an
acute respiratory distress syndrome (ARDS) rabbit model.
Methods The ARDS rabbit models were duplicated by alveoli-
lavaged saline. The rabbit were divided into six groups: (1) normal,
(2) ARDS group, (3) low volume (VT) with best end-expiratory
pressure (PEEP) (LVBP), (4) normal volume with best PEEP
(NVBP), (5) low-volume with high PEEP (LVHP), and (6) high-
volume zero PEEP (HVZP). Tumor necrosis factor alpha (TNF-α)
and IL-10 levels in liver and intestine homogenates were measured
by ELISA and their mRNA expression was measured by RT-PCR.
Results In the LVBP group, the mRNA expression of TNF-α and
IL-10 in liver was lower than the NVBP, LVHP, and HVZP groups.
But there was no difference between LVBP and ARDS groups.
TNF-α mRNA expression in the LVHP group was higher than the
LVBP group in liver tissue, but significantly lower than the HVZP
group. Compared with the LVBP group, the TNF-α and IL-10
concentrations in liver were increased markedly in NVBP, LVHP,
and HVZP. But there was no difference between the LVBP and
ARDS groups. Live TNF-α and IL-10 concentrations were highest
in the HVZP group, which was higher than the LVBP and LVHP
groups. In the LVBP group, the mRNA expression of TNF-α and
IL-10 in intestine was lower than the NVBP, LVHP, and HVZP
groups. But there was no difference between the LVBP and ARDS
groups. As compared with the LVBP group, the TNF-α and IL-10
concentrations of intestine in NVBP, LVHP, and HVZP were
increased markedly, but there was no difference between the
LVBP and ARDS groups.
Conclusions A lung protective ventilation strategy can
downregulate inflammatory mediator expression in the liver and
intestine of ARDS rabbits and may prevent the occurrence of
multiple organ dysfunction syndrome.
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Persistent use of lower tidal volumes after a simple
intervention consisting of feedback and education
E Wolthuis1, R Determann1, M Vroom1, J Kesecioglu2, M Schultz1
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Introduction Use of lower tidal volumes (Vt) is recommended for
patients suffering from ALI/ARDS. We previously reported on a
simple ‘intervention’ aimed at lowering Vt (goal: Vt 6–8 ml/kg): this
intervention consisted of feedback and education on the use of
lower Vt, during which special attention was paid to the importance
of closely adjusting Vt to predicted body weight (PBW) instead of
actual body weight. This intervention resulted in a significant
decline of Vt in our IC [1].
Methods To determine the longstanding effects of the
aforementioned intervention: (a) we compared data on Vt before
feedback and education (June 2003, n = 50, period I) with Vt
15 months later (September 2004, n = 103, period III); (b) in
addition, we collected data on Vt of patients recruited in two
consecutive randomized controlled ALI/ARDS trials: the first trial
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was performed in the 10-month period before the intervention
(March 2002–December 2002, n = 12), and the second was
performed in a 10-month period after the intervention (July 2003–
May 2004, n = 8).
Statistical analysis Mann–Whitney test. P < 0.05 was considered
significant.
Results (a) Before intervention, Vt was 9.4 (IQR: 8.2–10.8) ml/kg
PBW; Vt declined shortly after the intervention and remained low
(7.7 [6.9–8.5] ml/kg PBW) 15 months after the intervention
(Fig. 1a); (b) Vt in the second randomized controlled trial was
significantly lower as compared with Vt in the first study on
ALI/ARDS patients (Fig. 1b).
Conclusions Feedback and education caused a persistent decline
in Vt in our IC. These results possibly underscore the use of PBW,
instead of actual body weight, to adjust Vt.
Reference
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Critical Care 2005, 9(Suppl 1):P98 (DOI 10.1186/cc3161)
Mechanical ventilation (MV) is the principle supportive care in
ALI/ARDS patients. MV can be associated with several negative
side effects and lung injury (VILI). In recent years several
randomized trials tried to focus the optimal ventilatory strategy in
ALI/ARDS patients aimed to avoid or minimize the VILI [1–3]. In
this study we evaluated how MV has been employed in recent
years in ALI/ARDS patients in our intensive care unit (eight beds).
We retrospectively collected data of all ALI/ARDS patients, from
2001 to August 2004. To be included in the study the patient must
to be ventilated for at least 48 hours without an unfavorable short-
term prognosis. Sixty-two patients were enrolled; the mean age
and the body mass index were not different between the years
(54 ± 17, 62 ± 12, 56 ± 16 and 55 ± 20 years and 24 ± 3, 24 ± 2,
25 ± 6 and 25 ± 4 kg/m2, respectively). The variables in Table 1
were not different at day 3 and day 7 between the four years. We
did not find any difference in our ‘local’ lung ventilatory setting
through the years regarding level of PEEP or tidal volume. Instead,
to set the tidal volume based on body weight we prefer to set
taking into account the airway plateau pressure.
Table 1
Year 2001 2002 2003 2004
Patients (n) 14 16 21 11
PaO2/FiO2 189 ± 74 134 ± 77 173 ± 64 146 ± 63
Tidal volume (ml/kg) 9.9 ± 1.9 8.5 ± 2.1 9.9 ± 1.8 10.1 ± 2.5
Airway plateau 26 ± 6 27 ± 6 27 ± 6 27 ± 4
pressure (cmH2O)
PEEP (cmH2O) 8 ± 3 10 ± 4 9 ± 4 9 ± 4
Primary ARDS 11 (79%) 12 (75%) 12 (57%) 3 (27%)
ICU stay (days) 35 ± 21 37 ± 28 36 ± 35 32 ± 25
Mortality 3 (21%) 8 (50%) 8 (38%) 3 (27%)
References
1. Acute Respiratory Distress Syndrome Network: N Engl J Med
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Introduction After cardiac surgery, pulmonary dysfunction may
develop as shown by a significant reduction of functional residual
capacity (FRC) after extubation [1]. We hypothesized that
ventilation according to the open lung concept (OLC) attenuates
FRC reduction after extubation.
Methods Sixty-three patients undergoing cardiopulmonary bypass
were randomly assigned into three groups: conventional mechanical
ventilation (CMV); OLC before, during and after cardiothoracic
surgery (early open lung [EOL]); and CMV during surgery, OLC on
the intensive care unit (late open lung [LOL]). The CMV group was
ventilated with low tidal volume (6–8 ml/kg) with 5 cmH2O PEEP.
During OLC ventilation, recruitment maneuvers were applied until
PaO2/FiO2 was above 50 kPa. This was maintained by the use of
sufficient levels of PEEP. FRC was measured preoperatively and 1,
3 and 5 days after extubation. Peripheral oxygen saturation (SpO2)
was measured after extubation, breathing room air. SpO2 < 91%
was defined as hypoxia. Serum IL-8 was measured after aortic
cross-clamp release. The variables were compared using analysis of
variance for repeated measurements.
Results Compared with the CMV group, FRC was significantly higher
in the EOL group. In the LOL group, FRC was only significantly higher
than the CMV group on the first day after extubation. In the CMV
group, 37% of the patients were hypoxic on the third day after
extubation, whereas none of the patients of both OLC groups. After
release of the aortic cross clamp, IL-8 decreased significantly faster in
the early OLC group compared with the CMV group.
Conclusion Especially early application of the OLC group
attenuated postoperative pulmonary dysfunction, measured by
FRC and the occurrence of postoperative hypoxemia. This is
probably founded on an attenuated pulmonary inflammation, as
shown by a faster decrease of serum IL-8 concentration during
early application of OLC.
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Introduction The effects of positive end-expiratory pressure
(PEEP) on liver function and blood flow in experimental and clinical
studies revealed non-uniform results. In this clinical study, we
investigated the effects of PEEP on liver function (indocyanine
green plasma disappearance rate [ICG-PDR]) and splanchnic
microcirculation as estimated by regional PCO2 (PRCO2) using
gastric tonometry.
Methods With approval by our local ethics committee and written
consent, we studied 14 patients after elective coronary bypass
surgery using extracorporal circulation (13 males, one female; age
48–74, mean 63 ± 7 years). All patients underwent extended
hemodynamic monitoring by a pulmonary artery catheter for clinical
indication. ICG-PDR and gastric mucosal PRCO2 were assessed
on ICU admission (PEEP 5 mbar), 2 hours after increasing PEEP
to 10 mbar and again after 2 hours at PEEP 5 mbar. In addition,
the cardiac index, central venous pressure (CVP) and left atrial
pressure (LAP) were measured. All patients were on pressure-
controlled ventilation and the inspiratory peak pressure was
adapted to maintain PaCO2 constant. Vasoactive drugs, blood
pressure, minute volume and sedation were kept constant.
Results The cardiac index significantly increased during the study.
However, there was a trend for ICG-PDR to change between the
different time points (P = 0.05). However, the difference between
regional and arterial PCO2 (PCO2-gap) significantly increased
following PEEP5 (1) and remained higher at PEEP5 (2) than at
PEEP5 (1) (Table 1).
Table 1
PEEP5 (1) PEEP10 PEEP5 (2)
CI (l/min/m2) 2.7 ± 0.5 3.0 ± 0.6* 3.1 ± 0.4*
CVP (mmHg) 8 ± 4 9 ± 3 8 ± 3
LAP (mmHg) 7 ± 3 9 ± 3 8 ± 3
PDR (%/min) 24.0 ± 6.9 22.0 ± 7.9 25.3 ± 7.8
PCO2-gap (kPa) 0.2 ± 0.9 1.1 ± 1.0* 0.9 ± 1.0*
*P < 0.05 vs PEEP5 (1) (analysis of variance).
Conclusion Increasing PEEP from 5 to 10 mbar was accompanied
with a trend towards a decrease in liver function and blood flow
(ICG-PDR). The changes in PCO2-gap were within the
physiological range and of no clinical relevance. An increase in
PEEP from 5 to 10 mbar can be applied without compromising
liver blood flow and function and splanchnic microcirculation.
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Purpose We analyzed during the whole respiratory cycle the
resistance, elastance, and flow dependence of resistance in ARDS
patients, at three levels of PEEP, using two different models: linear
modeling, and nonlinear modeling for flow dependence of resistance.
Methods Airway opening pressure (P), flow (V′) and volume (V)
signals were recorded in 18 patients with ARDS and in 15 patients
without known respiratory disorder (control group), all artificially
ventilated, at three levels of PEEP (0, 5, and 10 hPa). Data were
analyzed using multiple linear regression analysis according to the
equations: P = Ers*V + Rrs*V′ + Po, and (b) P = Ers*V + (k1 +
k2*Vα′)*V′ + Po, where Ers and Rrs represent the respiratory
system elastance and resistance, k1 the linear coefficient of
resistance, k2 the flow-dependent coefficient of resistance, and Po
the end expiratory pressure.
Results The respiratory resistance (controls: P = 0.01, ARDS:
P = 0.001), the linear coefficient of resistance (controls: P = 0.05,
ARDS P = 0.02) and the flow-dependent coefficient of resistance
(controls: P = 0.04, ARDS: P = 0.04) were diminished significantly
with the application of PEEP in both groups of patients, especially
at a high level of PEEP (10 hPa). All the measured mechanical
parameters were significantly higher in the ARDS group compared
with the controls.
Conclusion Mechanical ventilation with PEEP application in ARDS
patients is related to a decline of linear and nonlinear coefficients of
respiratory resistance, during the respiratory cycle. More complex
models accounting for the flow dependence of resistance may
improve the accuracy of measurements of respiratory mechanics
and offer more efficient mechanical ventilation in ARDS patients.
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Introduction Lung recruitment has been hypothesized to be an
important component of protective ventilatory strategy in acute
respiratory distress syndrome. Determination of optimal recruitment
strategies is limited by uncertainty regarding the relationship
between time, pressure, and recruitment at the alveolar level. In this
study, we assessed the temporal characteristics of alveolar
recruitment.
Methods Rats were subjected to saline lavage lung injury. In vivo
microscopy identified five separate alveolar sacs for which
individual recruitment pressures (RP) were determined by
increasing the continuous positive airway pressure (CPAP). The
time to recruitment was recorded upon application of three
pressures for a maximum of 120 s: RP, RP – 1 cmH2O, and RP –
2 cmH2O. Volume history was normalized before each pressure
application.
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Results No recruitment was observed in the 2-min time period with
a pressure of RP – 2 cmH2O. The time to recruitment was
significantly shorter with application of RP vs RP – 1 cmH2O
(Fig. 1). Significance was determined by a one-tailed, paired t test,
P < 0.03.
Conclusions We were able to directly observe recruitment
behavior that exhibited sensitivity around a critical opening
pressure with marked changes in time to recruitment with small
changes in pressure. This suggests that very small differences in
the airway pressures (as small as 1 cmH2O in this study) may have
dramatic alterations in lung recruitment.
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The effects of sustained inflation and post-inflation PEEP in
acute respiratory distress syndrome due to pneumonia and
traumatic lung contusion
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Objective To investigate the response to a sustained inflation (SI)
and post-inflation PEEP (PI-PEEP) in acute respiratory distress
syndrome (ARDS) due to pneumonia and traumatic lung contusion.
Methods Twenty-five patients with ARDS were enrolled
(pneumonia n = 13, lung contusion n = 12). During baseline
ventilation, 7 ml/kg tidal volume, 12–15 breaths/min respiratory
rate and an I:E ratio of 1:2 were used. SI was performed by 45
cmH2O continuous positive airway pressure for 30 s. PI-PEEP was
titrated decrementally starting from 20 cmH2O in order to find the
best PEEP. FiO2 was decreased under baseline ventilation. If the
peak inspiratory pressure exceeded 45 cmH2O with 20 cmH2O
PEEP, the PEEP was reduced by 1 cmH2O decrements. Blood
gas analyses were performed at baseline, 15th minute, first hour,
fourth hour and sixth hour after SI.
Results Demographic data are presented in Table 1. PI-PEEP
levels were set at 16.1 ± 1.6 cmH2O in the pneumonia group and
15.9 ± 3.1 cmH2O in the lung contusion group (P = 0.9).
Following SI, the PaO2/FiO2 ratio improved in all of the patients
(Table 2 and Fig. 1).
Table 1 (abstract P103)
Pneumonia Lung contusion Mann–Whitney U
APACHE II 20.7 ± 7.5 13.5 ± 9.0 0.01
LIS 2.75 ± 0.6 2.63 ± 0.5 0.7
MOF 6.2 ± 3.3 4.9 ± 3.8 0.2
Conclusions SI followed by high levels of PI-PEEP provided an
increase in arterial oxygenation in both ARDS forms. However, this
strategy was found to be more effective in improving arterial
oxygenation in the lung contusion group. This finding might
address the idea that physiopathology of two pulmonary insults of
ARDS presents in different forms.
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Table 2 (abstract P103)
Baseline 15th minute First hour Fourth hour Sixth hour ANOVA (P)
Pneumonia 111 ± 31 151 ± 53 179 ± 76** 183 ± 90** 175 ± 71* 0.0015
Lung contusion 106 ± 29 180 ± 66* 205 ± 70** 213 ± 92*** 213 ± 116*** 0.0002
* P < 0.05, ** P < 0.01 and *** P < 0.001.
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Introduction The adjustment of PEEP and tidal volume to the
lower inflection point and upper inflection point of the P–V curve,
respectively, has been proposed to optimize mechanical ventilation
in ARDS. Usually, the P–V curve is analyzed by eye from a graph,
with high variability. Venegas and colleagues [1] developed a
sigmoidal equation that fits remarkably well to P–V curves obtained
by the supersyringe method. Our objective was to determine
whether this equation is able to model P–V curves obtained by the
low flow method.
Methods The P–V curve was obtained by the low flow method
using a Servo Siemens 300 ventilator [2]. Pressure and flow
signals were obtained from the analog port (N81) and converted to
digital format through a PCMCIA card (Measurement Computing,
PC-CARD DAS 16/12). A program was developed to acquire,
display, save, and analyze pressure and volume signals from the
ventilator. The sigmoidal equation has four fitting parameters: (a)
lower asymptote (volume); (b) distance from lower asymptote to
upper asymptote (inspiratory capacity); (c) true inflection point
(pressure); and (d) range of pressure from (c) to the point of high
compliance. The equation is fitted to the P–V data by the least
mean square (LMS) algorithm to minimize the sum of squared
residuals. After iteration, the best fit correlation (R2) between real
curves and those obtained from the equation was calculated. From
the fitted equation, three points of interest were defined: the
inflection point (c), where the first derivative has a maximum and
the second derivative has a zero; the point of maximal compliance
increase (Pmci), where the rate of change of upward slope is
maximal or where the second derivative of the function has a
maximum (calculated as (c) – 1.317 (d)); and the point of maximal
compliance decrease (Pmcd), where rate of change of downward
slope is maximal or where the second derivative of the function has
a minimum (calculated as (c) + 1.317 (d)).
Results The inspiratory limb of low flow P–V curves were obtained
from six mechanically ventilated ARDS patients. The mean R2 value
between the ventilator volume signal and the volume predicted by
the fitted curves was 0.996 ± 0.002 (standard deviation).
Conclusions The sigmoidal equation described by Venegas and
colleagues fits well to P–V curves obtained by the low flow
method. Our system may contribute to improve the evaluation of
respiratory mechanics and to adjust mechanical ventilation settings
at the bedside in ARDS patients.
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Introduction In a multicenter study on respiratory mechanics in ALI
and ARDS [1] we observed phenomena most probably related to
time effects: change in compliance after a recruitment maneuver,
transient end-expiratory volume (Fig. 1) after changing PEEP, and a
transient change in shape of the P–V curve after a change in tidal
volume (Fig. 2). To gain a better understanding of temporal effects
we developed a mathematical model of the respiratory system to
investigate these phenomena.
Methods We extended the model of recruitment proposed by
Hickling [2] to include chest wall characteristics, FRC, and an
initial opening volume of alveolar units once recruited. Alveolar
units had a nonlinear compliance and were organized in a bronchial
tree structure. Depending on the position in the tree each lung unit
was exposed to a gravitational superimposed pressure from 0 in
the ventral compartment to a maximal value in the dorsal
compartment. Opening and closing pressures of lung units were
normally distributed with a modifiable mean and standard deviation.
Time dependency was modeled by including timing parameters for
recruitment and derecruitment of alveolar units similar to the
approach of Bates and colleagues [3].
Results In contrast to Hickling’s model, simulations with the
extended model produced realistic transients in volume.
Furthermore, transient changes in compliance were predicted by
the model. Modeling of recruitment and derecruitment as time-
Critical Care    March 2005 Vol 9 Suppl 1 25th International Symposium on Intensive Care and Emergency Medicine
Figure 1 (abstract P105)
Observed transient volume after switching from ZEEP to PEEP 18 in
an ARDS patient. End expiratory volume at ZEEP was defined as 0.
Figure 2 (abstract P105)
Transient in the shape of the P–V curve after an increase in tidal
volume.
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dependent phenomena allowed one to mimic the transients as
observed in ARDS patients.
Conclusion The shape of simulated P–V loops is influenced by
time effects only related to closing and opening of alveolar units.
Up to now, transient effects have been explained by viscoelasticity
and by mechanical inhomogeneity. From the present study we
conclude that timing effects during recruitment may be a third
mechanism of transient mechanical behaviour of the respiratory
system.
References
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Objectives To determine the different effect of prone-position
ventilation (PPV) in patients with acute respiratory distress
syndrome (ARDS) resulting from a pulmonary cause (ARDSp) and
that from an extrapulmonary cause (ARDSexp) on oxygenation,
respiratory mechanics and hemodynamics. To choose the duration
of ventilation in the prone position in the two groups.
Methods Nine ARDSp patients and seven ARDSexp patients
within 3 days of onset of ARDS were included in this study, which
were classified as two groups. Patients were placed in prone
position for 2 hours. The effect of different times (pre-PPV, PPV
0.5 hours, PPV 2 hours) on oxygenation, respiratory mechanics
and hemodynamics were observed. Lung computerized
tomography (CT) was obtained in both the supine position and
10 min after turning to the prone position.
Results Compared with pre-PPV, in ARDSp the PaO2/FiO2 was
not increased after 0.5 hours, and increased only after 2 hours in
the prone position (130.6 ± 36.2 mmHg to 165.1 ± 72.3 mmHg,
P < 0.05). But in ARDSexp, PaO2/FiO2 was significantly increased
after 0.5 hours and 2 hours in the prone position (116.5 ± 55.0 mmHg
to 163.2 ± 46.4 mmHg and 182.7 ± 87.7 mmHg, P < 0.05). After
0.5 hours in the prone position the responding ratio of ARDSexp
was higher than ARDSp (100% vs 11.1%, P = 0.0007). After
2 hours, no significant difference of responding ratio was found
between the two groups (85.7% vs 66.7%, P = 0.392). The
changes of the PO2 were similar to the PaO2/FiO2. The PCO2 and
the Cst,rs did not differ significantly between the prone position
and the supine position in the two groups. In ARDSp, the Raw was
10.8 ± 1.4 cmH2O/s/l in the supine position, and it was signifi-
cantly decreased after 2 hours in the prone position (8.4 ± 1.8
cmH2O/s/l) (P < 0.05). Chest CT scans of ARDSp and ARDSexp
patients were markedly different.
Conclusions PPV could be used to improve severe hypoxemia of
ARDS. It improved the PaO2/FiO2 ratio rapidly in ARDSexp, but
should prolong the period in ARDSp.
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Introduction Acute respiratory distress syndrome (ARDS) can
complicate liver transplantation (LT). Positive end expiratory pressure
(PEEP) and prone ventilation (PV) have theoretical adverse hepatic
effects. An adult paracetamol overdose required super-urgent LT.
Immediate postoperative hypoxaemia due to ARDS developed
(Table 1, i), as supported by FiO2/PaO2 ratio, bilateral pulmonary
infiltrates, and normal pulmonary artery occlusion pressures. PEEP
(15cm H2O) and PV improved gas exchange immediately (Table 1,
ii) and at 18 hours (Table 1, iii). Doppler examination of hepatic
vessels was normal. Discharge home was on day 41.
Table 1
Cardiac 
PaCO2 PaO2 Lactate index 
FiO2 pH (kPa) (kPa) (mmol/l) (l/min/m2)
i 1.0 7.15 6.4 6.0 12.3 4.30
ii 1.0 7.279 5.5 21.6 6.4 4.27
iii 0.5 7.408 5.8 11.3 3.2 3.06
Methods A telephone questionnaire to British LT intensive care
units about using PEEP and PV postoperatively after emergency LT.
Results Completed questionnaires were obtained from the six
other British LT intensive care units. All responders were
consultant intensivists. Four routinely set PEEP on the ventilator.
Three stated levels depended on oxygen requirements. One
routinely used PEEP irrespectively. Two used PEEP depending on
oxygen requirements. Two felt PV was ‘absolutely contraindicated’,
quoting an evidence base, alternative available measures, and
concerns regarding hepatic perfusion. No responder could recall
PV being used in this context.
Discussion Opinions regarding the use of PEEP post emergency
LT are mixed. Opinions of PV appear polarised. No units appear to
have used it in this context. Potential detrimental effects of PEEP
and PV in LT include reduced cardiac output and hepatic blood
flow. Increased intra-abdominal pressure with PV may compound
this. However, restoring cardiac output maintains normal liver
function and blood flow [1,2]. Positioning to allow abdominal
excursion minimises risk [2]. Concerns raised in the questionnaire
may be overstated. We suggest both modalities can be used
effectively, without detriment to donor liver or patient outcome.
Further research is required.
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Introduction In acute respiratory failure (ARF), in particular acute
lung injury (ALI) and respiratory distress syndrome (ARDS), change
Available online http://ccforum.com/supplements/9/S1
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from the supine position (SP) to the prone position (PP) or the use
of kinetic therapy can improve oxygenation by recruiting alveoli
situated in dorsal-dependent regions of the lung and by alteration
of the ventilation/perfusion ratio. The efficacy of this intervention
can be demonstrated by the course of oxygenation index. The aim
of our study is to compare prone position ventilation (PP) and
kinetic therapy (KT) in the first 5 days after intervention in patients
with acute respiratory failure.
Methods We studied n = 149 patients with ARF at a surgical ICU
in a university hospital using the American–European consensus
definition in a clinical follow-up design. The physicians on duty had
the freedom of choice to use PP or KT guided by their clinical
experience. One hundred and eleven patients (ALI: n = 18/ARDS:
n = 93; mean age 66 ± 13 [standard error] years) were ventilated
intermittently in SP and PP (135° left/right-side position) for at
least 6 hours per day for supportive treatment of respiratory failure.
Thirty-eight patients (ALI: n = 16/ARDS: n = 22; mean age
60 ± 16 [standard error] years) were treated with kinetic therapy
using the Rotorest®-bed (60° left/right side; KCI).
Data collection included, apart from baseline characteristics, the
individual oxygenation index of the patients in the course of the first
5 days after intervention. The individual oxygenation index before
and after intervention was compared with linear regression analysis
for each group (linear regression procedure and t test; SPSS®).
Results During conventional ventilation in the supine position there
was no significant improvement in oxygenation in both groups. The
mean oxygenation index (PaO2/FiO2) decreased until intervention
to 157.6 ± 0.48 mmHg in the PP group and to 165.8 ± 1.47 mmHg
in the KT group (mean ± standard error of the mean). Both forms of
positional changes lead to a distinct improvement of oxygenation:
after 120 hours the oxygenation index in the PP group was
219.67 ± 0.66 and in the KT group was 197.89 ± 2.07 mmHg.
Subsequent to intervention the PP group showed a more rapid and
significant increase of oxygenation index in comparison with the KT
group as the equations of linear regression show: y[PPV] =
4.4618 × X + 188.72 and y[KT] = 3.9349 × X + 160.47. Mortality
was 62.2% in the PP group and 63.2% in the KT.
Discussion In ARF the change of body position in the form of PP
and KT leads to an improvement of oxygenation. PP seems to have
a more rapid and marked effect than KT. It is remarkable that
mortality is nearly the same in both groups, despite the unequal
group size. PP is a comparatively simple strategy to treat the
heterogenity of ventilation and perfusion in ARF and needs no
special technical equipment, while KT is an advantageous
alternative in patients with contraindications for PP.
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The CT scan allows an accurate morphologic analysis of an
‘ARDS’ lung. In addition, with the spiral CT it is also possible to
perform a quantitative analysis using dedicated software. The
quantitative analysis is based on the strict correlation between the
X-ray attenuation in a given volume of tissue and the physical
density of that volume. The CT is determined by the percentage of
radiation that is absorbed by that volume.
However, due to the necessity of a manually drawing of the lung (i.e.
to include the lung and to exclude big vessels, trachea, pleural effusion,
etc.), it would be possible to increase the inaccuracy of the analysis.
The aim of this study was to evaluate the accuracy of analysis bet-
ween trained physicians (four medical doctor) and two radiologists.
We enrolled 12 intubated sedated paralyzed patients ALI/ARDS
patients (mean age 63.5 ± 16.9 years, BMI 24.1 ± 4.7 m2, tidal
volume 532 ± 195 ml, PEEP 11.2 ± 1.9 cmH2O, PaO2/FiO2
205 ± 57). The CT scan was done for clinical purpose, in static
conditions, at end expiration 5 or 15 cmH2O PEEP and at end
inspiration 45 cmH2O airway pressure. The exposures were taken
at 120 KV and 250 mA. The lung volume, weight and the
distribution of lung weight between the different parts was measured
using the ‘Maluna’ software (University of Mannheim, Germany).
The results show that the quantitative analysis, although requiring a
physician to manually draw the region of interest of the lung,
presents a high degree of accuracy.
Table 1
Physicians Radiologists
Total volume (ml) 3956 ± 1608 3598 ± 1654
Total weight (mg) 1419 ± 471 1391 ± 449
Weight hyperinflated 41 ± 79 41 ± 82
Weight inflated 442 ± 160 440 ± 164
Weight poorly 439 ± 269 419 ± 270
Weight not inflated 496 ± 350 489 ± 362
P110
A validation study of a new software for computed
tomography lung measurement
D Chiumello, M Cressoni, M Racagni, L Landi, A D’Adda, 
S Azzari, S Terragni
Policlinico IRCCS, Milan, Italy
Critical Care 2005, 9(Suppl 1):P110 (DOI 10.1186/cc3173)
The use of computed tomography (CT) in the management of
ALI/ARDS patients is quite common, due to the possible additional
clinical information and the influence on the patient’s treatment.
With the new spiral CT scan it is possible to measure the total lung
volume, the percentage of lung tissue and gas, there being a linear
correlation between the physical density and the CT coefficient of
attenuation.
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The aim of this study was to evaluate in vitro the new computer
program ‘Maluna’ (University of Mannheim, Germany) dedicated to
measuring the lung volume, weight and gas/tissue ratio.
A series of different known volumes of water (100, 500, 1500 and
2000 ml) were studied. In addition, the contrast material was
diluted with water to obtain solutions of increasing concentrations
(0, 0.5, 1, 1.5, 2.5 and 5%). The spiral CT was performed at 120
KV and 240 mA. Each CT section was manually delineated by a
physician. The total volume was computed as the total number of
voxels present in a given region times the volume of the voxels,
while the CT number was directly related to the physical density.
Figure 1 shows the Bland–Altman analysis between the known
volumes of water and the measured volumes by ‘Maluna’; Fig. 2
shows the linear regression between the CT attenuation coefficient
with increasing concentrations of contrast material in the solution.
These data show that ‘Maluna’ is able to correctly compute the
volumes and CT number.
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Critical Care 2005, 9(Suppl 1):P111 (DOI 10.1186/cc3174)
Computed tomography (CT) has been shown to provide accurate
measurements of lung tissue mass and volume. However, besides
the risk of moving the patient from intensive care to CT scan and
the high costs, the high radiological exposure to X-rays may limit
the possibility for relatively frequent CT acquisition. One chest CT
scan corresponds to 400 chest X-rays [1]. A possible solution to
reduce the X-ray exposure could to be perform only three lung
sections compared with the whole lung.
The aim of this study was to investigate the difference between the
three CT slices technique versus the whole lung in acquiring
clinical relevant data (i.e. hyperinflated, normally, poorly and not
inflated lung zones).
Thirty-four intubated sedated paralyzed patients with ALI/ARDS
(mean age 56.2 ± 18.2 years, BMI 23.7 ± 3.6 kg/m2, PEEP
11.2 ± 2.8 cmH2O, PaO2/FiO2 195 ± 81) were enrolled. Spiral CT
scan of the lung was acquired at 120 kV and 250 mA during an
end expiratory pause at 5 and 15 cmH2O PEEP. The lung CT
regions of interest were manually delineated on each image by
dedicated software (Maluna; University of Maanheim, Germany). The
three CT lung sections were selected at the apex, hilum and base.
The Bland–Altman analysis showed a bias of 0.001% with an
interval limits for agreement of 7.2% at 5 cmH2O PEEP and of
0.00001% with 98% at 15 cmH2O PEEP.
These data showed that the three CT scan technique provides an
adequate measure of the distribution of lung compartments while
strongly reducing X-ray exposure.
Table 1
PEEP 5 PEEP 15
Inflation Whole lung Three sections Whole lung Three sections
Hyper (%) 0.04 ± 0.1 0.05 ± 0.1 1.1 ± 0.1 1.2 ± 0.1
Normal (%) 26.5 ± 0.1 26.3 ± 0.1 38.7 ± 0.1 37.6 ± 0.1
Poor (%) 33.2 ± 0.1 33.6 ± 0.2 31.3 ± 0.1 31.6 ± 0.1
Not (%) 39.7 ± 0.2 40.0 ± 0.1 28.5 ± 0.1 29.6 ± 0.1
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Introduction Recruitment maneuvers (RM) to open the lungs and
PEEP titration to keep the lungs opened are believed to be an
important component of a lung protective strategy in ARDS. There
are scarce data assessing the occurrence of tidal recruitment (TR)
and the gas distribution throughout the lung parenchyma by
thoracic CT scan before and after maximal recruitment.
Objectives To analyze the occurrence of TR before and after
stepwise recruitment maneuver (SRM) and PEEP titration by
thoracic CT scan. To analyze the effects of the proposed maneuver
on gas distribution throughout the lung parenchyma.
Methods Ten ARDS patients under mechanical ventilation were
transported to the CT room and sequences of CT scans at expiratory
and inspiratory pauses were performed before and after a SRM. The
SRM consisted of 2-min steps of tidal ventilation with a fixed delta
pressure PCV = 15 cmH2O and progressive PEEP levels (10, 20, 25,
35, 45, 25, 20, 15, 10 cmH2O), RR = 10, I:E 1:1, and FiO2 1.0. At
equivalent PEEP levels, the amount of collapsed tissue as well as the
difference of collapsed tissue between inspiration and expiration (TR)
were compared (before versus after maximal SRM). The amount of air
content (ml) at end expiration — functional residual capacity (FRC) —
was calculated and compared before maximal recruitment at PEEP of
20 cmH2O and after maximal SRM at PEEP of 25 cmH2O.
Results See Figs 1 and 2. The TR difference is statistically
significant at PEEP 25 cmH2O (Wilcoxon P < 0.015). There was a
significant decrease of gas at FRC at non-dependent regions
(Wilcoxon P < 0.008) and a significant increment of gas at the
most dependent region with PEEP 25 cmH2O after maximal
recruitment (Wilcoxon P < 0.008).
Conclusion The TR decreased significantly only under PEEP of
25 cmH2O after the SRM (P < 0.0003), suggesting that the
application of SRM might be effective when accompanied by
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sufficient PEEP levels. Aeration of dependent portions of the lung
after maximal SRM with maintenance of sufficient PEEP levels to
keep the lungs opened (Wilcoxon P < 0.008) was associated with
deflation of non-dependent regions, rendering the gas distribution
more homogeneous.
P113
Gas exchange impairment induced by open suctioning in
ARDS: impact of permissive hypercapnia
M Caramez, E Miyoshi, R Scott Harris, A Malhotra, R Kacmarek
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Background and aims There is still controversy over the impact of
open suctioning (OS) on gas exchange and the duration of
suctioning. The goal of this physiologic study was to determine
whether hypercarbia occurs following the use of OS in a lung
lavage injured sheep and whether the level of baseline PaCO2 and
duration of suctioning impacts gas exchange.
Methods Six female sheep were lung injured by isotonic saline
lavage until their PaO2 dropped to 100 mmHg on an FIO2 of 1.0,
PEEP 5 cmH2O and VT 10 ml/kg. Then the VT was decreased to
6 ml/kg. RR was set to establish a PaCO2 of 40 mmHg or 80
mmHg. OS was performed on each animal. PaCO2 was randomly
adjusted to 40 mmHg and 80 mmHg and the suction time
randomly set at 10 s and 30 s. Before each of the four
experimental conditions animals received recruitment maneuvers of
40 cmH2O CPAP for 40 s to establish a volume history, following
by baseline for 15 min where FiO2 and PEEP were set based on
the ARDSnet FiO2/PEEP [1]. OS was performed using a 14 Fr,
TrachCare catheter at a pressure of –100 mmHg. Mean arterial
blood pressure, heart rate, pulmonary and arterial wedge pressure,
cardiac output, and arterial blood gases, were measured before,
1 min and then every 2 min after OS for 30 min.
Results During suctioning at 80 mmHg PaCO2 at both 10 s and
30 s suctioning times, the PaCO2 increased at 1, 15 and 31 min
post suctioning (P < 0.05). PaCO2 also increased at 1 min when
the baseline PaCO2 was 40 mmHg and the suction time was 30 s
(P < 0.05) (Fig. 1). PaO2 decreased 1 min post suctioning in all
conditions but recovered by 15 min. Hemodynamics did not
demonstrate any significance differences regardless of the
experimental condition.
Conclusions OS causes in a significant increase in baseline
PaCO2 during baseline hypercapnia and when suctioning is applied
for 30 s. OS regardless of conditions results in a decrease in PaO2
that recovers rapidly post suctioning.
Reference
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Background and goal Percutaneous tracheostomy (PCT) is a
well-established bedside procedure for critically ill patients (CIP).
Several techniques of airway control and ventilation during PCT
have been suggested. Standard mechanical ventilation (SMV)
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through an endotracheal tube (ETT) is widely used. Short fat neck
(SFN) is considered a relative contraindication for PCT, mainly
because of the possibility for airway complications during the
procedure: loss of airway control, massive air leak, and sudden
desaturation. We decided to examine our experience of airway
control and ventilation by SMV and by high-frequency jet ventilation
(HFJV) during PCT in the CIP with SFN and to determine which is
more effective and reliable.
Materials and methods From January 1998 to June 2000, a
group of 23 CIP with SFN underwent PCT by the Griggs
technique and SMV, and from July 2000 to November 2001 a
group of 25 patients underwent PCT by the same technique but
with HFJV. One trained team performed all the bedside PCT under
general anesthesia (GA). In the HFJV group, a Cook catheter was
inserted through the existing ETT into the upper part of trachea and
HFJV was initiated by the special ventilator AMS-1000
ACUTRONIC with the following parameters: FiO2 = 0.8–1.0, Vt =
160–200 cm3, I/E ratio = 0.5, respiratory rate = 100 bpm, driving
pressure = 1.6–2.6 bar. Then the ETT was withdrawn from the
trachea and larynx into the mouth along the ventilation catheter and
PCT was performed. When PCT was finished the Cook catheter
was removed together with the ETT. During PCT continuous
routine monitoring and repeated blood gases were performed.
Results There was no significant statistically difference between
the two groups in the sizes of the neck (mean 47.1 vs 47.3 cm,
median 47 vs 47 cm, range 45–51 vs 47–53 cm, P = 0.9) and
distance between the cricoid and sternal notch (mean 1.35 vs 1.37
cm, median 1.35 vs 1.5 cm, range 0.5–1.9 vs 0.5–1.9 cm, P = 0.8).
Duration of the procedure for the two groups was identical: mean =
10.7 min, median = 11 min, range = 10–12 min. When SMV was
used, only in 11 from 23 patients was it possible to create good
conditions for performance of PCT. Impaling of the ETT and cuff
rupture happened in one case, and displacement of the ETT into the
pharynx took place in three cases (due to a short larynx). Moderate
air leak from the larynx around the ETT accompanied almost every
procedure. Additional egress of air from the tracheotomy site during
the time of the dilation was the reason for pronounced desaturation
in seven patients. On the contrary, PCT with HFJV passed
smoothly: a small air leak from tracheotomy site during its dilation
did not influence the level of oxygenation, only an increase in
PaCO2 values within acceptable limits was found. The difference
between SMV and HFJV was statistically significant (P < 0.001).
Conclusion SMV cannot always supply the necessary conditions
for PCT in patients with SFN and there are possibilities for
development of serious complications. HFJV through a Cook
catheter provides optimal conditions for manipulation on SFN,
secures success of the procedure and prevents potential airway
complications
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Background Percutaneous tracheostomy (PT) is used in patients
who receive long-term invasive mechanical ventilation. There are
many different techniques in performing PT.
Aim The aim of this prospective study was to compare two
different PT techniques with early and late complications in
critically ill patients.
Methods After obtaining ethical committee approval, 60 adult
patients were assigned randomly into two groups. Forceps
dilatational PT and single-step dilatational PT were used in group F
and group P, respectively. Heart rate, blood pressure and
peripheral oxygen saturation, the level of tracheal entrance and
number of punctions, major and minor complications and duration
of the procedure were recorded during the procedure. Arterial
blood samples were taken before the incision and after
tracheostomy cannula was inserted, then pH, pCO2, pO2, HCO3,
BE, and SaO2 were recorded. The endoscopic examinations of the
cases were done during the procedure, at the decannulation time
and 1 month after decannulation. The t test, Mann–Whitney U test,
Wilcoxon signed rank test, chi-squared test and Kruskal–Wallis
test were used for statistical analysis.
Results The demographic data, duration of intubation time and
procedure time were similar in both groups. There were no
significant differences in hemodynamic data between the groups. It
was noticed that in both groups there was a decrease in pH
(P < 0.001) and an increase in pCO2 (P < 0.01). Tracheal ring
damage that was one of the minor complications in Group P was
significantly gretaer (P < 0.05). There were no significant
differences in major complications between the groups. In Group F
tracheal stenosis in one case and laryngotracheal separation in
another case were detected with endoscopic examination.
Conclusion The present study demonstrated that single-step
dilatational PT may be an alternative to forceps dilatational PT, but
we conclude that to maintain a decrease in complications
endoscopic visualisation could be used.
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Introduction The aim of our study was to create a method for
biomechanical experimental evaluation of the percutaneous
tracheostomy (PCT) technique and perform its assessment in
order to minimize possible trauma of cervical trachea inherent in
this procedure. Nowadays two techniques of PCT, Ciaglia and
Griggs, are employed.
Every technique is based on gradual tearing of the hole in the
cervical trachea by specially designed dilators. We suggested that
biomechanical study of the different stages of PCT will help to
understand all these processes and to clarify the reasons for
traumatic perioperative complications.
Materials and methods PCT by the Ciaglia technique (n = 10)
and by the Griggs technique (n = 10) were performed on fresh
dead pigs with body mass of 115 ± 3 kg. A Portex set of
instruments was used for the Griggs technique and a Cook set of
instruments for the Ciaglia technique. During PCT special
measurements were performed with the help of an electronic
dynamometer (MRC): piercing force applied on needle cannula,
penetrating force applied on 14 F dilator, pulling force applied on
branches of Griggs dilating forceps, pushing force applied on
Ciaglia Blue Rhino dilator, pushing force applied on distal end of
tracheostomy tube no. 8 with introducer (Portex set) and pushing
force applied on distal end of tracheostomy tube no. 8 loaded on
dilator (Cook set). On the base of these measurements calculation
of energy spent for these stages of PCT was made. At the end of
each experiment evaluation of cervical trachea was performed to
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measure the size of tracheotomy performed by the Ciaglia and
Griggs dilators.
Results Application of the Ciaglia dilator requested 1.54 times
more energy than the Griggs dilator forceps (P < 0.05). Formation
of tracheotomy by the Ciaglia dilator was more exact than by
Griggs forceps due to special markings on the dilator. The work
with Griggs dilating forceps requested more experience due to the
absence of any markings on the dilator. The most dangerous
moments of PCT for laceration of the cervical trachea were:
dilation of hole in the cervical trachea in the Griggs technique and
insertion of the tracheostomy tube loaded on the dilator in the
Ciaglia technique. The macroscopic appearance and transverse
diameter of tracheotomy performed by the Ciaglia and Griggs
techniques were the same despite the different instruments used
for dilation (P < 0.05)
Conclusions PCT by the Ciaglia and Griggs techniques has
almost similar biomechanical characteristics. In spite of the
difference in the design of dilators the final result of the two
techniques is the same. Both of them have dangerous moments. In
order to prevent laceration of the cervical trachea during PCT
some improvements must be made in instrumentation.
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Objectives Tracheostomy has been widely performed in the
intensive care unit and has many advantages when compared with
translaryngeal intubation. Our hypothesis was that tracheostomy
would also result in improved pulmonary function through changes
in respiratory mechanics and tracheabronchial touilette.
Study design A prospective, observational, clinical study. A
before-and-after trial of 65 patients undergoing tracheostomy.
Patients and methods A consecutive group of critically ill patients
requiring prolonged mechanical ventilation was included in the
study (15 July 2004–1 December 2004). Percutaneous
tracheostomy was performed using the dilatational forceps
technique described by Griggs. Respiratory mechanics (ventilator
settings, airway pressures) and arterial blood gases (PaO2,
PaCO2, pH) were measured before and after tracheostomy (at 24,
48 and 72 hours) in 65 patients. Calculated variables included
minute ventilation, dynamic and static compliances and PaO2:FiO2
ratio (Harowitz).
Results A total of 65 patients (with a mean age of 50.6 ± 20 years)
underwent tracheostomy a mean of 5 ± 2.6 days after admission.
The Glasgow Coma Scale score and Acute Physiology and
Chronic Health Evaluation II score were 8.3 ± 3.7 and 20.61 ± 5.3,
respectively. We could not find statistically significant differences
in respiratory mechanics, blood gases and pH after tracheostomy
when we considered all of the patients. Then, we evaluated the
results by dividing the patients into two groups according to the
Harowitz ratio. Forty-three patients had Harowitz ratio greater than
250 (396.5 ± 105.5) and 22 patients less than 250 (201.1 ± 36.5).
Both groups were analyzed with repeated-measures analysis of
variance and we found that the Harowitz ratio at 24 hours
(265.3 ± 71), 48 hours (269 ± 26) and 72 hours (274 ± 93)
improved significantly after tracheostomy individually (P = 0.002,
P = 0.018, P = 0.004, respectively) in the patients with a Harowitz
ratio less than 250.
Conclusion Our study showed that percutaneous tracheostomy
improves the PaO2:FiO2 (Harowitz) ratio in the mechanically
ventilated patients who had Harowitz ratio less than 250 before
tracheostomy, but does not improve it in the patients with Harowitz
ratio greater than 250.
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Background and goal The role of routine chest radiography
(CXR) following percutaneous dilatational tracheostomy (PDT) has
recently been questioned [1].
Materials and methods We have performed a prospective
observational study, on a mixed medical–surgical critical care unit,
on 110 patients undergoing PDT under bronchoscopic guidance
to assess the utility of routine postoperative chest radiography.
Data were collected on all patients undergoing PDT from 1
November 2003–14 December 2004. Two post-procedure CXRs
were reviewed and compared with those taken prior to PDT.
Significant findings were barotrauma (pneumothorax,
pneumomediastinum) and consolidation not noted on the pre-
procedure film. Post-procedural films reviewed were those taken
immediately after PDT and, to exclude the possibility of overlooking
evidence of minor barotrauma, one further film taken between 24
and 96 hours.
Results and observations One hundred and ten patients
underwent PDT; 83 (75%) were uncomplicated. Complications
were recorded in 27 (25%) patients. These included multiple
attempts at needle insertion (> 2), bleeding (> 3 soaked gauze
swabs), tracheal ring fracture, posterior tracheal wall injury, and
malplacement. Ninety-five (86%) patients had two post-procedural
CXRs reviewed. Fourteen (13%) patients had at least one CXR
reviewed after PDT. One patient had no CXR after PDT. New
abnormalities were noted on three (3%) post-procedure CXRs. No
new pneumothoraces were seen. Patients having uncomplicated
PDTs had no new CXR changes (Table 1).
Table 1
Number of New problem 
PDT complicated? CXRs reviewed on CXR
NO, n = 71 (65%) 2 0 (0%)
YES, n = 24 (22%) 2 3 (13%)
NO, n = 11 (10%) 1 0 (0%)
YES, n = 3 (3%) 1 0 (0%)
PDT, percutaneous dilatational tracheostomy; CXR, routine chest
radiography.
Conclusions Routine CXR following uncomplicated PDT
performed under bronchoscopic guidance is not warranted.
Concern that evidence of minor barotrauma may be missed on the
early post-procedural film is not bourne out by review of the film
taken 24–96 hours after the event. The role of CXR following PDT
appears to be restricted to those patients undergoing complicated
procedures. This will lead to reductions in both medical costs [2]
and exposure of staff and patients to ionising radiation.
References
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Objectives To identify the adverse events regarding handling of
the orotracheal cannula in the ICU and to evaluate its impact on
the patient’s severity and on the nursing workload.
Method Data were prospectively collected during a 3-month
period, in two general ICUs of a hospital in the city of São Paulo,
Brazil, using a file card to record the occurrences. Patient’s
severity and nursing workload were evaluated 24 hours before and
24 hours after the occurrence of the event, respectively, by means
of the Simplified Acute Physiology Score (SAPS II) and the
Therapeutic Intervention Scoring System-28 (TISS-28).
Results In the period of the study 212 patients were admitted, 47
(22%) of which were victims of 80 adverse events during the their
stay at the ICU. There was a total of 19 (24.0%) adverse events
regarding handling of the orotracheal cannula. Of these were
observed 14 (73.0%) not programmed withdrawals of the
orotracheal cannula, three (16%) blockages of the cannula for
secretion corks and two (11%) cuffs emptied. A statistically
significant difference was found both in the SAPS II (P < 0.042)
and TISS-28 (P < 0.001), evidenced before and after the event.
One verified reduction of the patient’s severity, but an increase on
the nursing workload as a consequence of these events.
Conclusions The results of this investigation reinforce the need for
investments to qualify professionals to work with critical patients as
a major measurement for safety nursing assistance and quality in
the ICU.
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Background As a technology to facilitate a difficult endotracheal
intubation (ETI), the TrachView Videoscope (TrVV) consists of a
narrow high-resolution fiberoptic cable whose tip is positioned at
the distal end of the endotracheal tube. The image is displayed on
a small portable bedside monitor.
Objective To determine the reported ease of use of the TrVV and
the accompanying percent improvement in assessment of the
glottic opening (POGO) score when operated by individuals of
varied levels of ETI experience.
Methods The study was conducted in two phases using a
mannequin model during an airway workshop for first-year, second-
year and third-year (R1, R2, R3) emergency medicine (EM)
residents with ETI experience and first-year and second-year
medical students with no ETI experience. In phase 1, after a 10-min
demonstration of the TrVV, EM residents assessed the POGO
score using direct laryngoscopy (DL) and sequentially compared it
with their observed POGO score using the TrVV. Phase 2
consisted of a crossover study with the medical students who
were randomized into two groups: a group first instructed in DL
and a second first instructed in TrVV. The students were given a
10-min demonstration of each technique and had two
opportunities to return the demonstration. The POGO scores
noted by the students were then recorded for each technique. The
groups were then crossed and the process was repeated.
Additional information collected from study subjects included
reported ease of use of the TrVV and improvement in ETI success.
Results In Phase 1, the overall median POGO score for DL was
50%, and the median POGO score for TrVV was 100%
(P < 0.001). The median differences in POGO scores (TV – DL)
were: 50% for R1s (n = 4), 50% for R2s (n = 10), and 25% for
R3s (n = 11). Of these, 86% (n = 24) reported that the TrVV was
‘easy’ to use and 11% (n = 3) were undecided. Only one reported
it to be ‘difficult’ to use. Most (82%; n = 23) reported that the TrVV
improved their ETI attempt, but 14% (n = 4) reported no
difference. In Phase 2, the overall median TrVV and DL POGO
scores (n = 34) were 75% and 25%, respectively (P = 0.004). The
median difference in POGO scores (TV – DL) for the two groups
were: 75% for Group 1 (DL first) and 50% for Group 2 (TrVV). Of
all participants, 68% (n = 25) ranked the TrVV as ‘easy’, 22%
(n = 8) were undecided, and 11% (n = 4) ranked the TrVV as
‘difficult’ to use. Meanwhile, 57% (n = 21) reported that it improved
their ETI attempts, 27% (n = 10) reported no difference, and 11%
(n = 4) reported ‘more difficulty’.
Conclusion The Trachview Videoscope can significantly improve
the POGO score assessment over direct laryngoscopy and, in the
laboratory setting, most operators report it to be an easy to use
technique that improves their intubation success, regardless of
level of experience.
P121
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Background and objective Tracheal intubation is a common
procedure for critically ill patients and may lead to local
complications such as tracheal destruction and post-intubation
stenosis. Utilization of the Nd-YAG laser can correct intraluminal
airway lesions including webs, granulation tissues and fibrous
bands. It decreases the hospitalization period, complications and
expenses and also saves the medical staff’s time and energy.
Materials and methods An uncontrolled clinical trial was
performed in post-intubation tracheal stenosis cases admitted to
the NRITLD between 1994 and 1999. Based on bronchoscopic
findings, patients with the following inclusion criteria underwent
laser therapy: length of stenosis less than 2 cm, tracheal lumen
diameter more than 5 mm and lesions with granulation tissue type.
Others candidated for surgery. Laser therapy was carried out by
fiberoptic bronchoscopy under local anesthesia. For those patients
with tracheal lumen diameter between 5 and 10 mm rigid broncho-
scopy was performed under general anesthesia.
Results Of the total 32 patients, 25 met the primary criteria for
laser therapy, from which 22 (88%) were completely cured.
Because of poor general condition, five of seven other patients
who had been referred for surgery also underwent laser therapy;
therefore, a total of 30 patients (93%) took advantage of this
technique. Overall, 23 patients were treated only with a laser, two
patients only with surgery and seven patients with a combination of
these two approaches.
Conclusions This trial revealed that if patients with post-intubation
tracheal stenosis are selected correctly, laser therapy could be
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Introduction In this retrospective study, we evaluated two different
modes of weaning: assisted spontaneous breathing (ASB) plus
CPAP with automatic tube compensation (Evita 4, Draeger
Medical, Germany) versus assisted spontaneous ventilation (ASV)
(Galileo Gold, Hamilton Medical, Switzerland) in 80 patients who
had undergone abdominal surgery. Our target was to assess
differences in weaning times using different modes of assistance.
Methods Forty patients were enrolled in two groups of weaning:
group A was treated with ASB and CPAP, and group B was
treated with ASV. Both groups after mechanical support
underwent a 2-hour T-tube ventilation before extubation and were
sedated with remifentanil beginning from 6 µg/kg/hour and titrated
to reach the Ramsay sedation scale 3–4 without the help of other
drugs; supplemental midazolam bolus was administered if the
patients were still agitated. The time of weaning and other events
during ASB or ASV (discomfort during ventilation, bad-adaptation)
were recorded in each patient.
Results We did not find a great statistical difference among the
two groups (20 ± 10.75 vs 21.6 ± 8.46, P = 0.3). We had three
cases of weaning failure with ASB and CPAP and five with ASV
after 30–36 hours from extubation. If the ventilator setting was
done following the patient requests, few signs of discomfort were
found (agitation, tachycardia, hypertension, etc.) and a good
patient–ventilator interaction can be granted using both methods
of ventilatory support.
Conclusion We did not find any statistical difference in the two
groups: times for weaning were almost the same. Our data cannot
suggest the use of a specific modality of weaning, because the
number of patients in the study is too small. But both ways of
assistance were well tolerated by the patients.
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Introduction Reintubation following failed extubation is an
independent predictor of prolonged ICU stay, morbidity and mortality.
Extubation criteria at the end of surgical procedures are similar to
those applied to critically ill patients in mechanical ventilation.
Patients and methods This prospective, observational, non-
interventional study was conducted in a teaching University
Surgical Clinic. Data from all consecutive patients that underwent
elective major abdominal operations by a single surgeon in a 6-
month period were recorded and examined. In all patients, 30 min
prior to the induction of anesthesia, a nasogastric tonometry
catheter was inserted and measurements were obtained by a
tonometer. At the end of the operation, the optimal goal was
successful extubation unless prevented by the patient’s general
condition. Patients were extubated when they complied with the
following criteria: patient alert and rested, arterial pH > 7.25, PO2
> 60 mmHg with FiO2 < 50% and positive end expiratory pressure
(PEEP) < 5 cmH2O, PCO2 < 50 mmHg, tidal volume > 5 ml/kg,
respiratory rate < 24/min, negative inspiratory force more than
–20 cmH2O, minute ventilation <10 l/min, stable hemodynamic
status, hemoglobin >10 mg/dl, presence of cough and no
excessive or thick secretions. Extubation failure was defined as the
need for reintubation within 24 hours.
Results Twenty-four consecutive patients (11 males, 13 females)
of mean age of 66.79 years (range: 27–85), who underwent
elective major abdominal operations, were included in the study.
Mean operative time was 3.16 hours (range: 1.8–4.5). Patients
were divided into two groups based on extubation outcome.
Twenty-two of the patients met the extubation criteria at the end of
the procedure and were therefore extubated. Three of these
patients required reintubation within the next hour due to acute
respiratory failure. One patient was not extubated due to acidosis
(arterial pH < 7.25, hypothermia: 35.5°C) and one other patient was
not extubated as his hemoglobin level had dropped to 8 mg/dl.
Consequently, 19 patients that were successfully extubated were
included in group I and five patients were included in group II.
Mean values of baseline measurements for pHi in the two groups
were similar (P = 0.773). In all patients, the mean pHi value at
induction of anesthesia compared with the means of 30-min and
60-min measurements differed significantly (P < 0.001). pHi values
decreased for the first 2 hours of operating time in a linear pattern.
Thereafter, pHi values appeared stable. No further decrease was
observed until the end of the operation. The mean pHi values at the
end of the operation between the two groups differed significantly
(P = 0.027, confidence interval: –6.175 to –0.408).
Conclusion Early detection of extubation failure in the operative
room will save time and will orient resuscitation efforts towards
more beneficial actions for the patient (hypothermia prevention,
volume depletion, hemodynamic stability).
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Low f/Vt ratio is associated with successful extubation in our
pulmonary patients
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Background Weaning from mechanical ventilation is usually
conducted in an empirical manner and a standardized approach
has not been developed. A variety of criteria have been proposed
as predictors of the success or failure of weaning attempts, among
them rapid shallow breathing — the ratio of respiratory frequency to
tidal volume (f/Vt).
Aims The aim of the study was to evaluate whether low f/Vt ratio
(< 105) is associated with successful extubation in our pulmonary
patients. We also wanted to find out whether there is a correlation
between low f/Vt ratio and our previous criteria: stable clinical
state, maximal inspiratory pressure > 25 cmH2O, vital capacity
>1000 ml, respiratory frequency < 35/min and also arterial blood
gas analysis.
Methods A prospective trial was conducted in 37 patients
receiving mechanical ventilation for more than 24 hours because of
acute respiratory failure in our intensive care unit because of
pulmonary disease: pneumonia (15 patients), chronic obstructive
pulmonary disease (nine patients), asthma (four patients),
bronchiectasis (four patients), fibrothorax (four patients),
pyopneumothorax (one patient). When patients were able to
breathe spontaneously we measured the respiratory frequency (f),
tidal volume (Vt), maximal inspiratory pressure (MIP), vital capacity
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(VC), minute ventilation (MV), PaCO2, PaO2 and calculated the
f/Vt. We measured criteria many times in each patient until
extubation.
Criteria for extubation were a stable clinical state of patient and all
three or at least two of three criteria: MIP > 25 cmH2O, VC >1000
ml and/or f < 35/min. Successful extubation was determined as
spontaneous breathing for at least 72 hours after extubation.
Results Data from 37 patients were obtained (51% women, age
30–84 years). Median duration of mechanical ventilation was
13 days, range 2–30 days. Thirty patients (30/37, 82%) were
extubated, all had ratio f/Vt less than 105. Among them 28 patients
(28/30, 93%) underwent successful extubation, two patients
(2/30, 7%) were reintubated because of laryngeal edema. Seven
patients (7/37, 18%) were not extubated, all of them had high f/Vt
ratio (>105). There was positive correlation between f/Vt and
respiratory frequency, and negative correlation between f/Vt and
vital capacity and between f/Vt and maximal inspiratory pressure.
No correlation was found between f/Vt ratio and PaCO2 (P = 0.7),
PaO2 (P = 0.7), FiO2 (P = 0.4).
Conclusions Low f/Vt ratio (<105) was associated with
successful extubation in our pulmonary patients. There was good
correlation between low f/Vt ratio and maximal inspiratory pressure,
vital capacity and respiratory frequency. There was no correlation
between f/Vt ratio and PaCO2 and PaO2 — blood gas analysis only
should not be a criterion for extubation.
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Objective The authors studied the changes in several haemo-
dynamic parameters during a weaning trial of a cohort of post-liver
transplant patients with a high cardiac output (CO).
Design and setting An observational, prospective study at a 14-
bed medical/surgical ICU.
Materials and methods Twenty-five patients were enrolled; all
presented cardiac index > 4 l/min/m2. The following parameters
were evaluated: heart rate (HR), mean arterial pressure, central
venous pressure (CVP), pulmonary capillary wedge pressure (Pw),
CO, systolic pulmonary artery pressure (SPAP) and diastolic
pulmonary artery pressure (DPAP), systemic vascular resistance 
Table 1
30 min 4–6 hours 
Parameter Ventilated post-discharge post-discharge
MBP (mmHg) 96.8 ± 10.2 97.1 ± 9.8 97.3 ± 9.9
MPAP (mmHg) 24.3 ± 3 23.6 ± 2.8 26 ± 3.2
HR (bpm) 97.6 ± 8.1 100.4 ± 9.2 75.5 ± 10.1
Pw (mmHg) 12.4 ± 3.9 13.4 ± 4 13.6 ± 3.8
CVP (mmHg) 12.6 ± 4.4 9 ± 3.1 9.9 ± 3.3
CI (l/min/m2) 4.9 ± 0.71 5.3 ± 0.82 5 ± 0.78
LVSWI (g m/m2) 57.8 ± 5.5 60.5 ± 8.2 57.9 ± 6.1
RVSWI (g m/m2) 8.1 ± 1.7 10.6 ± 1.5 12.3 ± 1.6
SVRI (dynes s) 1378 ± 190 1334 ± 202 1396 ± 197
PVRI (dynes s) 195 ± 21 158 ± 20 193 ± 17
MBP, mean blood pressure; CI, cardiac index.
index (SVRI), pulmonary vascular resistance index (PVRI), left
ventricular stroke work index (LVSWI) and right ventricular stroke
work index (RVSWI). The determinations were performed before
disconnection from mechanical ventilation, 30 min after dis-
connection and 4–6 hours after disconnection.
Results CVP decreased significantly after disconnection (–24% at
30 min and –20% at 4–6 hours), the CO remained unchanged,
inducing a marked and progressive increase in RVSWI. The
remaining parameters changed insignificantly. All patients were
successfully weaned from mechanical ventilation. The variation of
the parameters evaluated is presented in Table 1, with mean values
and standard deviation.
Conclusions The weaning from mechanical ventilation in patients
with high CO, particularly post-liver transplant patients, induces a
significant increase in RVSWI, and a decrease in CVP. From the
data presented, the clinical impact of this observation is not clear.
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Introduction Failure in weaning from mechanical ventilation (MV)
occurs in up to 25–30% of patients, being associated with high
mortality. Indexes predicting success can be very helpful clinically.
However, their predictive capacity is sometimes low and there are
controversies concerning which ones have to be used.
Objective To evaluate weaning predictor indexes in a group of
patients during weaning from MV.
Methods Patients under MV for at least 48 hours, submitted to a
spontaneous breathing trial (SBT) during 30 min, extubated
according to the clinical assistant physician’s decision and
followed for 48 hours, were included. They were evaluated
concerning age, sex, APACHE score, Glasgow score, causes of
ICU admission and mechanical ventilation, length of hospital and
ICU stay, time of mechanical ventilation, drugs used and clinical
characteristics. At the first and 30th minutes from SBT were
analyzed: arterial blood gases, hemodynamic parameters as arterial
blood pressure and cardiac rate, respiratory parameters as
respiratory rate (RR), tidal volume, rapid shallow breathing index
(f/VT), maximal inspiratory (PImax) and expiratory (PEmax)
pressures. Comparisons were made between two groups of
patients: success versus failure, defining failure as return to
mechanical ventilation in the first 48 hours.
Results Two hundred and one patients were studied. Overall
mortality rate was 16%. Return to mechanical ventilation occurred
in 32%. The most important differences comparing success with
failure groups were: lower mortality rate (12% versus 27%,
P < 0.01), shorter length of hospital and ICU stay (27 ± 21 versus
35 ± 21 days, P < 0.001 and 13 ± 12 versus 19 ± 14 days,
P < 0.001); less incidence of dyspnea (37% versus 58%, P < 0.001),
higher PaO2 at 30 min (100 ± 30 versus 88 ± 25 mmHg, P < 0.001),
lower RR at the first and 30th minutes (24 ± 6 versus 28 ± 7 bpm,
P < 0.001, and 24 ± 6 versus 30 ± 8 bpm, P < 0.001), lower f/VT
at first and 30th minutes (58 ± 31 versus 78 ± 45, P < 0.01 and
56 ± 38 versus 98 ± 74, P < 0.001), and higher PImax at 30 min
(42 ± 15 versus 36 ± 14 cmH2O, P < 0.05).
Conclusions In this group of patients a great number failed in the
weaning process showing, as expected, a higher mortality rate.
Parameters related to failure were longer length of hospital and
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ICU stay, higher incidence of dyspnea, higher respiratory rate and
f/VT index both at the beginning and at the end of the trial, and
lower level of oxygenation and lower PImax at the end of the trial.
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Introduction The discontinuation of mechanical ventilation
represents an important stage for patients in mechanical ventilation
in the ICU, and knowing how this procedure is being managed
make us better intensivist physicians. Our purpose in this study
was to determine some aspects of the patients that were being
weaned from mechanical ventilation in Brazil.
Methods A study of 1 day prevalence was done in 34 ICUs of
Brazil. In the questionaire answered by the ICUs, we present here
the modes of ventilation used in the weaning stage, the diseases
that were the reason for the indication of mechanical ventilation,
and some aspects about the patients with ventilator-associated
pneumonia (VAP).
Results The study evaluated 390 patients, with 215 patients being
in some kind of ventilatory support. Sixty-nine patients (69/215)
were in discontinuation of mechanical ventilation. The patients
were distributed as: PSV, 48 (48/69); SIMV + PSV, nine (9/69);
spontaneous, four (4/69); SIMV, three (3/69); PCV, three (3/69);
and VCV, two (2/69). The causes of admission in mechanical
ventilation of this group were COPD (1/69), neuromuscular
disease (2/69), coma (9/69), and acute respiratory failure (57/69).
On the day of the study, 38 patients were with pneumonia (38/69):
20 were with VAP, 11 were with nosocomial pneumonia and seven
were with community pneumonia. The medium times of mechanical
ventilation were, respectively, 39.2 days, 23.7 days and 8.3 days.
Conclusion About 32% of the patients in mechanical ventilation
were being discontinued. PSV was the principal mode used, while
acute respiratory failure was the main cause of mechanical
ventilation’s use. The incidence of VAP was 29%, and it was
related with the long median time of mechanical ventilation.
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Introduction Physiotherapists are routinely involved in the manage-
ment of patients in ICUs. Despite the necessity of physiotherapists
in the ICU, little scientific evidence exists as to the therapeutic
efficacy of their intervention. Physiotherapists are often involved in
the weaning process, in order to assist patients to maintain a good
respiratory function and prevent reintubation. Preliminary results
showed that the respiratory function was significantly improved
with chest physiotherapy immediately after extubation [1]. No other
studies have been carried out so far to support or reject the role of
physiotherapists in the weaning process.
The aim of this study is to investigate the short-term effect of chest
physiotherapy versus no physiotherapy following extubation, in
order to provide further scientific insight of its role in this area.
Patients and methods Twenty-four ICU patients with various
diagnoses were entered into the study as soon as they were
extubated. Profusely confused patients were excluded. Patients
eligible for the study were randomly allocated to two groups. The
first group (n = 12) was the experimental group where patients
received chest physiotherapy (upper and lower limb active
exercises, deep breathing exercises, chest percussion and
vibrations, huffing and assisted cough), and the second group
(control, n = 12) received instructions but no physiotherapy.
Outcome measures, which are described in Table 1, took place
immediately after extubation in both groups followed by chest
physiotherapy only in the experimental group. Following treatment,
patients in both groups were allowed to rest for 30 min and all
measurements were repeated in order to detect differences.
Results Wilkoxon rank tests revealed significant differences
between the two groups (Table 1). Specifically, patients in the
experimental group had significantly improved vital capacity
(P < 0.05) and Pimax (P < 0.05) following chest physiotherapy. No
significant differences were noted in any of the other outcome
measures. Furthermore, within-group comparisons revealed that
patients in the experimental group had significantly increased VC
(P < 0.01) and Pimax (P < 0.01) immediately after physiotherapy




Measurement group group t test
pH 7.4 ± 0.03 7.3 ± 0.01 Not significant
PO2 96.4 ± 33 100.13 ± 40 Not significant
PCO2 41.6 ± 9.4 48.9 ± 14 Not significant
SaO2 96.2 ± 3 91.9 ± 0.1 Not significant
Pimax –66 ± 33 –41 ± 23 P < 0.05
VC 1501 ± 536 997 ± 459 P < 0.05
Conclusion and discussion The results of the present study
revealed that standard chest physiotherapy resulted in significant
improvement of both the vital capacity and the maximum negative
inspiratory pressure in ICU patients immediately after extubation.
Despite the small number of patients, the presence of a control
group to count for time and learning effect indicate that chest
physiotherapy may have an important role in the success of
weaning. Future controlled studies with more patients and
additional outcome measures and categorization according to
diagnosis are necessary in order to further establish an evidence-
based physiotherapy practice in this area.
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Can high efficiency aerosol delivery continue after extubation?
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Background Aerogen is currently developing drug/device
combinations for delivery of drug to the lungs of mechanically
ventilated patients with efficiencies above 60%. When therapy
needs to continue post extubation, an aerosol delivery device of
similar efficiency is required to deliver the same drug dose.
Commercially available nebulizers with inhaled mass ranging from
6 to 30% would require several doses to achieve the same inhaled
mass. We modified the pulmonary drug delivery system (PDDS;
Aerogen) to provide similar drug delivery efficiencies to patients on
and off the ventilator.
Methods Three PDDS units were used to aerosolize albuterol
sulfate (2.5 mg) to simulated patients in both on vent and off vent
configurations (n = 3). On vent was simulated with a Puritan
Bennett 740 Ventilator with tidal volume of 500 ml, peak flow
40 l/min, ramp flow pattern, I:E ratio 1:2, and rate of 15 breaths/min
through an 8-mm endotracheal tube attached to a passive lung
model (Ingmar). The off vent configuration consisted of an adult
lung simulator (Hans Rudolph) with a tidal volume of 500 ml, peak
flow 28 l/min, and I:E ratio 1:2. The amount of drug deposited on
an absolute filter distal to the endotracheal tube and mouthpiece
was eluted and determined by reverse-phase HPLC with isocratic
elution and UV detection at 275 nm. The volume median diameter
(VMD) and geometric standard deviation of the aerosol were
determined by laser diffraction (Spraytech™ Malvern).
Results The percentage of total dose ± standard deviation
delivered to the test lung was 72 ± 11% on vent and 70 ± 0.3%
off vent. The mean VMD was 3.5 µm with a GSD of 2.1.
Summary Our in vitro results demonstrate that it is feasible to
provide comparable high-efficiency aerosol delivery to adult
patients whether on or off the ventilator. Additional studies with the
PDDS in vivo will be required to establish the in vitro/in vivo
correlations of this model.
Conclusion The Aerogen PDDS delivered > 60% of the total dose
to the airway of simulated adult patients during mechanical
ventilation and spontaneous breathing.
P130
High-dose versus low-dose nebulized albuterol in acute
asthmatic attack: a randomized double-blind clinical trial
A Hosseinnezhad, M Abbasi
Rasoul Akram Medical Center, Iran University of Medical Sciences,
Tehran, Iran
Critical Care 2005, 9(Suppl 1):P130 (DOI 10.1186/cc3193)
Introduction Asthma is a common condition, and seems to be
increasing in prevalence in most countries around the world.
Current guidelines for the treatment of patients with acute asthma
have recommended the use of inhaled beta-agonists to reverse
airflow obstruction. The optimal dose of albuterol for treatment of
acute asthma has yet to be established. Most American references
recommend a starting dose of 2.5 mg aerosolized albuterol every
20 min, while European authobities recommend higher doses.
Objectives The purpose of this study was to compare 2.5 mg with
7.5 mg nebulized albuterol for the treatment of acute asthma, using
spirometric data and arterial blood gas sampling.
Study design A double-blind randomized clinical trial.
Subjects We studied 106 patients older than 15 years who
presented to the emergency department with moderate to severe
acute asthmatic attacks.
Methods On enrolment, patients underwent baseline testing,
including initial spirometory/peak flowmetry and arterial blood gas
sampling. A standardized treatment algorithm was used for all
patients so they received oxygen and corticosteroid and underwent
cardiopulmonary monitoring. Patients then received in a
randomized, double-blinded fashion, nebulized albuterol at a dose
of either 2.5 or 7.5 mg over 20 min. Spirometry or peak flowetry
and ABG sampling were repeated after treatment. Measurements
were taken of FEV1, PEFR, FVC, PH, PCO2, PO2.
Results While there was no statistically significant difference in
pretreatment and post-treatment values between the two groups,
there was a both clinically and statistically significant improvement
in post-treatment values in each group.
Conclusion Overall, we may reach the conclusion that there is no
advantage in the routine administration of albuterol at doses higher
than 2.5 mg for adult patients with acute asthmatic attacks. It is
possible that there may be an advantage in the most severely
obstructed patients, although this study did not enrol enough
patients with very severe asthma to evaluate this.
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Should noninvasive positive pressure ventilation be used to
prevent post-extubation respiratory failure?
P Nery, A Vasconcellos, L Pastore, G Schettino
Sírio Libanês Hospital, São Paulo, Brazil
Critical Care 2005, 9(Suppl 1):P131 (DOI 10.1186/cc3194)
Rationale The length of mechanical ventilation and the need for
reintubation is associated with increased mortality. Weaning
protocols are used to reduce the length of invasive ventilation.
Noninvasive positive pressure ventilation (NPPV) has been
suggested to shorten the length of intubation or to treat respiratory
failure after extubation, but the study results are conflicting. We
believe that NPPV can be useful to reduce the reintubation ratio
when applied systematically and immediately after extubation in
patients at risk for developing post-extubation respiratory failure.
Objective To evaluate the use of NPPV immediately after
extubation as part of a weaning protocol.
Methods The data of consecutive patients mechanically ventilated
for > 2 days, and who have been extubated, were collected before
(pre-protocol group, 100 cases) and after the implementation of a
weaning protocol (protocol group, 100 cases) in a high-complexity
medical/surgical ICU. We compared the data of patients who used
NPPV to treat respiratory failure in the first 48 hours after
extubation (pre-protocol group) with the patients at risk for post-
extubation respiratory failure (mechanical ventilation > 4 days,
former T-trial failure, COPD and heart failure) who systematically
used NPPV to prevent post-extubation respiratory failure (protocol
group).
Results The population that used NPPV was similar in gender, days
of mechanical ventilation before extubation (8.17 ± 6.8 vs 7.72 ±
3.78 days, P = 0.26) and proportion of COPD patients (28% vs
14%, P = 0.14) in the pre-protocol and protocol groups. NPPV was
used in 70% of patients in the protocol group versus 28% of the
pre-protocol (P < 0.001), with a lower NPPV failure ratio
(reintubation < 48 hours) in proportion (10.7% vs 5.7%) but without
differences in statistical analysis (P = 0.18). The ICU mortality for
those patients who used NPPV was significantly lower in the
protocol group 3.4% versus 34.8% pre-protocol (P < 0.001).
Conclusion NPPV when used immediately after extubation, as part
of a weaning protocol for patients at risk for post-extubation
Available online http://ccforum.com/supplements/9/S1
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respiratory failure, is a safe intervention. Moreover, we report better
results when comparing this technique with NPPV used to treat
post-extubation respiratory failure.
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Evaluation of noninvasive mechanical ventilation with positive
pressure in the management of patients with difficult weaning
from invasive mechanical ventilation
C Trevisan1, S Vieira1, M Blom2, R Zancanaro2, L Cassel2, 
C Hahn2, P Pinheiro2
1Clinicas Hospital, Porto Alegre, Brazil; 2ULBRA, Canoas, Brazil
Critical Care 2005, 9(Suppl 1):P132 (DOI 10.1186/cc3195)
Introduction NPPV has been intensely investigated and used in
patients with acute respiratory failure of several etiologies. However,
recent studies have left several open questions with respect to the
benefits of its use in invasive mechanical ventilation (IMV) weaning.
A randomized controlled study has shown that NPPV has reduced
the IMV use time in patients with persistent failure in weaning.
However, some studies did not confirm these results.
Objective To evaluate the application of NPPV, using the Bilevel
mode, in patients with IMV weaning difficulties, characterized by
spontaneous ventilation failure during a spontaneous breathing trial
(SBT).
Methods All patients under IMV for more than 48 hours from June
2003 to July 2004 were submitted to a SBT. Those that failed
during the first 30 min of the T-piece trial, and without
contraindications to NPPV, were randomized to be back to IMV
(conventional treatment) or to be changed to NPPV. Contra-
indications to NPPV included patients with facial trauma or cranial
surgery, recent gastric or esophagic surgery, tracheostomy,
respiratory secretion excess, agitation and noncooperative behaviour,
and were excluded from the experiment. Inclusion in the experiment
has been authorized by signed informed consent. Prior to
subjecting the patient to the SBT we collected a sample of arterial
blood gases and a measure of maximal inspiratory pressure
(PImax) was taken. During spontaneous ventilation in the T-piece
trial, in the first and 30th minutes measurements of tidal volume
(VT), minute ventilation (Ve), respiratory rate (f), rapid shallow
breathing index (f/VT), heart rate and peripheral oxygen saturation
were taken. After randomizing to IMV or NPPV, patients were
followed clinically and evaluated concerning time of ventilation,
complications and mortality rate.
Results A total of 158 patients were submitted to a SBT. Among
patients that failed in the T-piece trial 43 patients were eligible for
this study, 21 being studied in NPPV and 22 in IMV. The mean age
of the NPPV group was 68 ± 15 years, and of the IMV group was
59 ± 17 years. The average of mechanical ventilation previous to
exposition to SBT was 7 days for the NPPV group and 8 days for
the IMV group. The values of Ve, VT, and PImax were similar in
both groups, in the first and 30th minute of ventilation in the T-
piece. The average ventilation support use time, after failure in the
T-piece, was 2 days for the NPPV group and 9 days for the IMV
group, with statistical significance (P < 0.05). Total mortality was
26% (four patients in IMV and seven patients in NPPV).
Considering the total number of complications, NPPV had a
protective effect (RR 0.205).
Conclusions From these preliminary data, we believe that NPPV
could be an effective treatment for patients presenting difficulties
in weaning from mechanical ventilation
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Is the success of positive pressure ventilation dependent on
the level of care?
A Zito, E Meleo, F Chiappini, G Corbo, S Valente, G Ciappi
Università Cattolica del Sacro Cuore, Rome, Italy
Critical Care 2005, 9(Suppl 1):P133 (DOI 10.1186/cc3196)
Objective To report our experience with positive pressure ventilation
(PPV), pressure support ventilation or assisted-controlled pressure
mechanical ventilation mode, delivered by face mask (nine
patients) or tracheostomy (one patient) in acute hypercapnic
respiratory failure (AHRF).
Design An observational study.
Setting A respiratory care unit.
Patients and intervention Ten patients with AHRF, related to
bronchial superinfection or pneumonia, were treated with PPV. The
mean (± standard deviation) PaCO2 and pH at entrance were,
respectively, 95.96 ± 12.86 mmHg and 7.29 ± 0.05.
Results PPV resulted in a significant improvement in PaCO2 (from
95.96 ± 12.86 mmHg to 73.72 ± 10.95 mmHg) and pH (from
7.29 ± 0.05 to 7.39 ± 0.05) within 2 hours. However, NIMV was
discontinued in three patients (33%) after more than 5 days and
endotracheal intubation was required because of inability to wean
(one patient) or to manage bronchial secretions (two patients).
In the other patients NIMV was effective in improving PaCO2 (from
95.96 ± 12.86 mmHg to 51.16 ± 11.75 mmHg) and pH (from
7.29 ± 0.05 to 7.40 ± 0.06). Five patients continued mechanical
ventilation at home.
Conclusion Application of PPV is feasible outside the ICU, also
when baseline pH should indicate admission to the ICU (pH
< 7.25 in three patients) or the respiratory intermediate care unit
(pH < 7.3 in one patient). Since all these patients but one avoided
endotracheal intubation, whereas two patients with pH > 7.3 were
intubated, arterial blood pH at entrance probably does not predict
success or failure and it is not suitable to decide the level of care.
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Effects of the domiciliary use of benzodiazepines on the
management of patients presenting to the emergency
department with exacerbations of chronic obstructive
pulmonary disease
C Antro, F Merico, L Lovera, E Migliore, E Scalabrino, V Gai
Osp. Molinette, Torino, Italy
Critical Care 2005, 9(Suppl 1):P134 (DOI 10.1186/cc3197)
Introduction The use of hypnotics for sleep disturbances has been
discouraged for patients with severe chronic obstructive pulmonary
disease (COPD), because of potential adverse effects on
ventilation. We evaluated the clinical impaction of benzodiazepine
use in patients presenting to the Emergency Department (ED) with
acute exacerbation of COPD.
Methods Of 317 consecutive patients presenting to the ED with
acute dyspnoea from March to September 2004, 47 were found
affected by exacerbations of COPD complicated by acute
respiratory failure. Diagnosis was based on the 2004 COPD
Guidelines of American Thoracic Society/European Respiratory
Society. A thorough investigation (through the pharmacologic
history collected from patient and/or caregivers and any available
medical record) was made on each patient about the habitual use
of hypnotics, particularly benzodiazepines, up until the day of
admission. We evaluated mortality at discharge, need for and
duration of invasive and noninvasive mechanical ventilation and
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hospital length of stay in patients taking benzodiazepines (BDZ+)
in comparison with those who did not (BDZ–).
Results Of 47 patients identified (28 males/19 females, mean age
74.7 years, APACHE II score 17.4 ± 5.3), 12 (25.5%) regularly
used benzodiazepines for insomnia. Table 1 presents the APACHE
II score, systolic blood pressure and arterial blood gas analysis of
the BDZ– in comparison with the BDZ+.
Table 1
APACHE II SBP PaCO2 PaO2 HCO3– PaO2/
scorea (mmHg) pH (mmHg) (mmHg) (mEq/l) FiO2
BDZ– 17.6 ± 4.8 144 7.32 63.1 63.1 30.1 243.4
BDZ+ 16.8 ± 6.6 130 7.33 64.6 49 33.5 216.3
P* 0.65 0.03 0.46 0.8 0.01 0.1 0.19
aMean ± standard deviation. * Student t test.
The mortality of BDZ+ was 16.6% versus 8.6% of BDZ– (χ2:
P = 0.43); no patient was intubated, but 66% of BDZ+ underwent
noninvasive ventilation versus 40% of BDZ– (χ2: P = 0.11). The
duration of noninvasive ventilation was 23 hours 22 min for BDZ+
versus 14 hours 9 min for BDZ–: a statistically significant
difference (χ2: P = 0.04). Hospital length of stay was 9 ± 5.5 for
BDZ+ versus 15.2 ± 10.5 for the BDZ– group (χ2: P = 0.06).
Conclusions In patients with exacerbations of COPD, domiciliary
use of benzodiazepines had no effect on mortality and hospital
length of stay, but seemed to cause a higher need for and
increased duration of noninvasive ventilation.
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Weaning from mechanical ventilation using remifentanil
versus midazolam–morphine analgo sedation: our experience
M Di Nardo, A Paperini, C Mosca, G De Durante, M Del Turco, 
F Giunta
University of Pisa, IV ICU, Department of Anesthesiology and
Intensive Care, Pisa, Italy
Critical Care 2005, 9(Suppl 1):P135 (DOI 10.1186/cc3198)
Introduction Remifentanil is a short-acting µ-opioid with a half-life
of less than 9–10 min, metabolized by plasmatic esterasis. In this
retrospective study, we evaluated the safety of remifentanil
sedation (RS) versus midazolam–morphine sedation (MM) in 80
patients undergoing abdominal surgery. Our target was to assess
whether RS is able to reduce times of weaning from mechanical
ventilation with respect to MM sedation.
Methods Eighty patients treated either with RS or MM were
enrolled in two groups. Remifentanil infusion started at dose of
6 µg/kg/hour and titrated to reach Ramsay Sedation Scale 3–5
without the help of other drugs; supplemental midazolam bolus
was administered if the patients were still agitated, instead MM
was administered at the dosage of 0.01 mg/kg/hour for morphine
and 0.03 mg/kg/hour for midazolam, to reach the same Ramsay
Sedation Scale. The time of mechanical ventilation, weaning and
adverse events (bradycardia, hypotension) were recorded in each
patient during treatment and for 3 days after extubation.
Results Times of mechanical ventilation were the same in the two
groups (94.68 ± 30.24 vs 91.04 ± 31.23, P > 0.05). Weaning
time is significantly lower using RS than MM (31.15 ± 25.45 vs
39.51 ± 25, P < 0.05) Adverse effects were instead a little bit
greater in the RS group than in the MM group (20% vs 12.5%).
Conclusion Remifentanil is well tolerated by the patients even
when used for long periods in the ICU with few adverse µ-opioid
effects compared with classical hypnotic-based sedation. Further-
more, remifentanil seems to decrease the time of weaning.
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Remifentanil versus sufentanil continuous infusion for
sedation in mechanically ventilated patients
G Costa, P Chiarandini, M Lugano, L Pompei, C Coccia, 
G Bertossi, F Ronga, N Fasano, G Della Rocca
Department of Anesthesia, University of Udine, Italy
Critical Care 2005, 9(Suppl 1):P136 (DOI 10.1186/cc3199)
Introduction The first objective of this study was to compare the
effectiveness of remifentanil and sufentanil as sedative agents in
mechanically ventilated patients to achieve a Ramsay sedation
score (RSS) of 2–3.
Methods Twenty (12 males, eight females) mechanically ventilated
(pressure support) patients requiring analgesia and sedation were
included in the study. Patients were assigned randomly to group R
(eight patients, remifentanil) or to group S (12 patients, sufentanil).
In group S at ICU admission sufentanil infusion was started at
0.003 µg/kg/min. In group R at ICU admission remifentanil infusion
was started at 0.05 µg/kg/min. As rescue dose a bolus of 1–2 mg
midazolam was administered to reach the predefined RSS or to
facilitate nursing procedures. If adequate sedation was not
reached after 6 hours or before, in the case of more than three
consecutive midazolam rescue dose administrations without reaching
the target RSS, the continuous infusion rate was increased up to
0.01 µg/kg/min in group S and up to 0.1 µg/kg/min in group R,
respectively. Neurological (RSS, GCS, VAS), hemodynamic (HR,
mAP) and respiratory (TV, PEEP/Paw, RR, PaO2/FiO2, PaCO2,
HCO3–) data were evaluated at a predefined step from the
induction of sedation (T0) and every 30 min (T30, T60, T90, T120)
and then during sedation maintenance every 6 hours (T6, T12,
T18, T24, T30, T36, T42, T48). After 48 hours the observation
ended. Statistical analysis was performed with the Kruskal–Wallis
test and comparisons with baseline values with the Dunn test.
P < 0.05 were considered statistically significant.
Results RSS during the study period are reported in Figs 1 and 2.
Sufentanil and remifentanil mean dosages administered were,
respectively, 0.003 ± 0.001 µg/kg/min (range from 0.0009 to
0.01) and 0.07 ± 0.03 µg/kg/min (range from 0.01 to 0.18). No
respiratory depression (RR < 8) was observed.
Conclusions These preliminary results show that either sufentanil
or remifentanil are effective and safe as analgosedative agents in
mechanically ventilated critically ill patients.
Available online http://ccforum.com/supplements/9/S1
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Remifentanil in neurosurgical patients in the intensive care
unit
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Introduction Remifentanil is a rapidly metabolized opioid analgesic
that is being increasingly used in critically ill patients [1,2]. Our
purpose was to evaluate the hemodynamic changes of sedated
neurosurgery patients in the ICU caused by remifentanil as well as
the time elapsed until the wakening in comparison with fentanyl
and morphine. Patients received remifentanil for more than 5 days
in continuous infusion.
Methods The study was conducted in the 12-bed ICU of a general
hospital. One hundred and fifty patients of both sexes were
included in the study. Their mean body weight was 77 kg. Mean
duration of the surgical intervention was 180 min. After their
admission to the ICU, patients were randomly assigned to three
groups. Patients in group A received remifentanil 9–10 µg/kg/hour,
in group B fentanyl 0.5–6 µg/kg/hour and in group C they received
morphine 0.03–0.15 mg/kg/hour. Every 24 hours, sedation and
analgesia were stopped for a neurological examination (Glascow
Coma Scale). All patients were sedated with propofol and they
remained sedated for 5 days at least. Parameters recorded were
cardiac rhythm, mean arterial pressure and time to recovery
(judged by spontaneous respiration).
Results See Table 1 for comparison of hemodynamic parameters
between the three groups. Recovery time was much shorter when
we compared the remifentanil group with the two other groups
(P < 0.001). A statistically significant difference was also observed
when we compared group B with group C (P < 0.001).
Conclusion We conclude that remifentanil is safe enough for
neurosurgerical patients under sedation in the ICU, and that the
weakening time is much shorter for patients receiving this
analgesic.
Table 1 (abstract P137)
Remifentanil Fentanyl Morphine
Bradycardia 3 (6%) 2 (4%) 2 (4%)
Hypotension 8 (16%) 6 (12%) 2 (4%)
Mean arterial pressure (mmHg) 76 74 75
Mean heart rate 68 70 71
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Risk factors, coma, and consequences of intensive care unit
delirium
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Objectives To establish risk factors for the development of
delirium in an ICU, to determine the effect of ICU delirium screened
with the Intensive Care Delirium Checklist on mortality and ICU and
hospital lengths of stay, and to clarify the comorbidity and clinical
effect of coma on the incidence of delirium and on outcome.
Design and setting Prospective study in a 16-bed university
hospital medical/surgical ICU.
Patients A total of 820 consecutive patients admitted to the ICU
for more than 24 hours.
Interventions Fifteen covariates, including medical history, severity
of illness on admission (APACHE II), laboratory values, and
medications were prospectively recorded for a total of 4707
patient-days (mean = 5.7 ± 7 days). All patients were screened a
minimum of three times daily. Follow-up to hospital discharge was
provided in all patients. Hospital length of stay, and hospital
mortality, were compared between delirium and non-delirium
patients. Comatose patients were arbitrarily separated into those
whose coma was transient (< 5 days) or lasting (5 days or more).
Results Hypertensive patients, smokers, and alcoholics were more
likely to develop delirium (odds ratios of 1.68, 1.56, and 1.77,
respectively). Delirium was independently associated with severity
of illness on admission; each additional point on the APACHE
score was associated with a 4% increase in risk of delirium. Coma,
regardless of its duration, increased the incidence of delirium (51%
and 54% for shorter and longer duration of coma, vs 20% in
patients with no coma, P < 0.05). The development of delirium was
not associated with benzodiazepine or opiate use. Patients who
developed ICU delirium were more likely to die in hospital (47%
compared with 37% in patients without delirium, P < 0.005), and
had a significantly longer length of stay (18 days compared with
13 days, P < 0.005). Mortality was proportional to severity of
illness on admission (APACHE), presence of diabetes, total length
of hospital stay and delirium occurrence.
Conclusion Delirium risk factors include tobacco and alcohol use,
a history of hypertension, and preceding ICU coma but not ICU
benzodiazepine or opiate use. Significant mortality and longer
hospital stay are attributable to this morbid condition. Awareness
of patients at risk may lead to better recognition and earlier
intervention.
Acknowledgement Partial funding ($18,000) for this project was
obtained from the Fonds de Recherche en Santé du Quebec.
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Evaluation of EM and orthopedic residents’ pain estimation
about patients with limb trauma who were visited in the
Emergency Department of Hazrat Rasoul Hospital
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Objective To evaluate pain estimation in the patients with limb(s)
trauma by EM and orthopedic resident in the Emergency
Department (ED) of Hazrat-e-Rasoul Hospital.
Patients and methods In a prospective study, 160 patients that
merely had limb(s) trauma and were admitted to the EM ward of
Hazrat Rasoul Hospital were included. Patients with GSC <15 —
due to every reason, like head trauma, drug overdose, and so on —
at the time of physical examination, and positive history of
analgesic use before ED arrival or history of drug or alcohol abuse,
were excluded from this study. At the time of the presentation to
the ED, first of all the patients marked the level of their pain on a
visual analogue scale (VAS) scale by supervision of the
researchers and then the EM and orthopedic residents marked the
pain level of every patient on a VAS, separately. The EM and
orthopedic residents select randomly from on-call residents.
Results Of 160 enrolled cases (65 females and 95 males), the
mean age was 32.05 ± 17.87 years. The mean of pain scores
determined by the patients was 6.41 ± 2.52. The mean of the
recorded pain scores by EM and orthopedic residents was 4.41 ±
1.83 and 4.05 ± 1.92, respectively. There was a significant
difference between the mean of patients’ scores and the mean of
pain scores determined by both the EM and orthopedic residents,
separately (P < 0.001); but there is no significant difference
between EM and orthopedic residents. Pain estimation of EM and
orthopedic residents in 20 cases were the same as the patient
pain score.
Conclusion According to previous studies, the only accurate
barometer in treating pain is the patient’s report, but in our center
pain treatment was done according to physicians’ estimation; our
study indicates that they underestimate the pain of their patients.
To properly sedate patients, the VAS should be included as a
routine part of vital signs and the pain score should be recorded,
especially for such patients who have pain and might need painful
procedures.
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Sedation in haemofiltered patients: a retrospective study of
compliance with the sedation policy
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Aim This study was designed to review sedation of critically ill
patients requiring haemofiltration and to assess the compliance
with our sedation policy.
Introduction Such patients are of particular concern as there is a
danger of accumulation of sedatives. The UCLH sedation scale
involves hourly assessment, –3 correlates with unrousable, –2
(roused by painful stimuli), –1 (roused by movement), 0 (roused by
voice), 1 (aware but calm), 2 (aware and comfortable), 3 (agitated
and restless). The sedation policy requires the following
interventions: at +3 or +2 the dose is increased; at +1, 0 or –1 (i.e.
the ‘target range’) no dose adjustment is attempted until three
consecutive scores are achieved within the target range when
dose reduction is attempted; at –2 or –3, sedation is stopped.
Method This retrospective study was conducted in a 22-bed,
mixed medical/surgical ICU in a teaching hospital. A total of 427
patients received haemofiltration between 10 September 2003
and 18 January 2004 for a total of 56,024 hours. The data for
these patients who were managed with continuous sedation
infusions were extracted using the UCLH Clinical Information
Management System (GE Medical-healthcare QS 5.6). The level of
compliance to our sedation policy was analysed by comparison
with the aforementioned rules. A chi-squared test was used for
statistical significance.
Results In 42% of oversedation hours (–2, –3) the sedative
infusion was not reduced (see Fig. 1). Where sedation scores fell
within the target range on three consecutive occasions sedation
infusions were decreased or stopped appropriately in 78% of
episodes. In undersedated hours (+2, +3), sedation infusions were
increased in 29% of episodes. Sedation scores within the target
range were achieved for 77.7% of the time, regardless of whether
or not sedatives were given. Furthermore, sedation scores shared
a similar distribution pattern in both sedated and unsedated hours
except that the +1 sedation score was more prevalent in
unsedated hours compared with sedated hours (1818 hours
[10.9%] vs 15,451 hours [39.2%]). Episodes of undersedation
were three times (3151 hours vs 1312 hours) more likely to be
treated incorrectly than correctly (P < 0.05). In oversedated
episodes, correct adjustment occurred > 3 times more often than
incorrect changes (27,810 hours vs 7900 hours) (P < 0.05).
Conclusion Our data suggest that when patients were
undersedated a reluctance to follow the sedation protocol by
increasing the sedative dose was seen. In contrast, when patients
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Does implementation of a goal sedation score improve
management of mechanically ventilated adults?
K Feeley1, A Gardner2, I Mitchell1, A Leditschke1
1The Canberra Hospital, Canberra, Australia; 2Cabrini Deakin
Centre for Nursing Research, Melbourne, Australia
Critical Care 2005, 9(Suppl 1):P141 (DOI 10.1186/cc3204)
Background Sedation management of mechanically ventilated
patients has been a source of concern for intensive care nursing
and medical staff worldwide in recent years. An earlier prospective
audit of 48 ventilated patients showed that our sedation
management was suboptimal. Patients were oversedated 45% of
the time, with the most frequent management strategy being use of
morphine and midazolam infusions. Despite this, 23% of patients
were physically restrained. A literature review suggested that a
move away from sedative infusions would reduce the length of
ventilation, length of ICU stay and tracheostomy incidence. Use of
sedation scales, setting of goal sedation scores and implemen-
tation of a nurse-initiated sedation protocol were also deemed best
practice.
Objective To determine whether introduction of a goal sedation
score would be associated with improved management of sedation
as indicated by a reduction in incidence of oversedation and in use
of physical restraints.
Method The study design was prospective and exploratory.
Following multidisciplinary staff training, an optimal sedation goal
score was set daily by senior medical staff and changed when
clinically indicated. Nurses titrated intravenous infusions of
analgesia and sedation with the aim of achieving the desired goal
sedation score. Sedation patterns were collected on 52 ventilated
patients. Institutional ethics approval was obtained.
Results The median APACHE II score was 19 (range 8–33);
median age was 65.9 years (range 18–88); sex ratio, male/female,
was 7:3. For patients ventilated for more than 5 days only sedation
patterns for the first 5 days are presented. The goal sedation score
was achieved in 45% of patient-hours, with only 7% of patient-
hours recorded as agitated. Incidence of oversedation was
unchanged from the previous audit (45% of time). Patients deemed
at risk of oversedation had a goal score compliance of 48.6%.
Patients at risk of undersedation had a goal score compliance of
34.4%. When compared with prior audit results, there was an
increase in the use of physical restraints from 11/48 (23%) to
21/52 (40%) (Fishers exact P = 0.086). Morphine and midazolam
infusion use was unchanged with use in 63% and 65% of patients,
respectively, and propofol was used in 73% of patients. Incidence
of deliberate self-extubation was 0.9/100 ventilated days, median
length of ventilation was 3.9 days and incidence of tracheostomy
was 7.6%.
Conclusion Despite a sedation goal score being set daily, patients
reached their goal score for less than one-half of ventilated hours.
Oversedation continued to be a problem and may be associated
with the frequent use of morphine and midazolam infusions.
Considering agitation appeared to be well managed, the increased
use of physical restraints is concerning. Due to the limited success
of use of goal sedation scores alone to improve sedation
management, we are now prospectively evaluating the use of a
sedation management algorithm in conjunction with goal scores.
P142
The Richmond agitation–sedation scale and bispectral index
during dexmedetomidine sedation
A Turkmen, A Altan, N Turgut, S Vatansever, S Gökkaya
SSK Okmeydani Training Hospital, Istanbul, Turkey
Critical Care 2005, 9(Suppl 1):P142 (DOI 10.1186/cc3205)
Introduction Patients require continuous reassessment of their
pain and need for sedation. The routine use of standardized and
validated sedation scales and monitors are needed. The bispectral
index (BIS) uses a monitor of cortical suppression to maintain the
optimal level of sedation and hypnosis. The Richmond agitation
sedation scale (RASS) has high reliability and validity in ICU
patients. We aimed to assess the correlation of the BIS with the
RASS during dexmedetomidine sedation.
Methods Eleven ventilated critically ill patients, aged 17–82
(50.09 ± 17.76) years, APACHE II score of 12.63 ± 3.90, SOFA
score of 3.27 ± 1.73, were enrolled in the study. Patients received
a loading dexmedetomidine infusion of 1 µg/kg over 10 min
followed by a maintenance infusion of 0.5 µg/kg/hour for 8 hours.
The efficacy of sedation was assessed using the RASS and BIS
monitoring. The Wilcoxon test and Spearman’s correlation analysis
were used for statistical analysis.
Results Significant correlations between RASS and BIS values
were found in this study (Table 1).
Conclusion RASS levels significantly correlated with BIS values
during dexmedetomidine sedation.
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RASS 1 RASS 2 RASS 3 RASS 4 RASS 5 RASS 6 RASS 7 RASS 8
BIS 1 r = 0.77, 
P = 0.005
BIS 2 r = 0.87, 
P = 0.0001
BIS 3 r = 0.84, 
P = 0.001
BIS 4 r = 0.84, 
P = 0.001
BIS 5 r = 0.94p, 
P = 0.0001
BIS 6 r = 0.85, 
P = 0.001
BIS 7 r = 0.92, 
P = 0.0001
BIS 8 r = 0.90, 
P = 0.0001
BIS, bispectral index; RASS, Richmond agitation sedation scale.
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The Critically Ill Adults scale
J Schoonderbeek, P van Leeuwen, B van der Hoven, D Tibboel,
M van Dijk
University Hospital Erasmus MC, Rotterdam, The Netherlands
Critical Care 2005, 9(Suppl 1):P143 (DOI 10.1186/cc3206)
Introduction An ICU stay is unfortunately associated with pain and
distress. For that reason, analgesics and sedatives are prescribed
in large quantities to critically ill adult patients. These patients are
often not able to express their pain or distress verbally due to
mechanical ventilation and sedation itself. But is treatment
adequate? Because no satisfactory pain and distress instrument
was found, the Critically Ill Adults (CIA) scale was developed
loosely based on the COMFORT scale. Nurses were trained to use
this scale. In this study the CIA was validated and cut-off scores
were determined to develop useful guidelines for clinical practice.
Method During a 3-month period, assessments were performed in
critically ill adult patients at an 18-bed general surgery/trauma
intensive care unit of the University Hospital in Rotterdam, The
Netherlands, a tertiary referral centre.
The newly developed CIA tool was tested and adjusted during a
prior pilot study. This study resulted in deletion of physiological
items and an awareness for polyneuropathy. The latter reduces
body movements and therefore influences pain behaviour. The final
CIA consists of five items (alertness, facial tension, muscle tone,
body movements and respiratory response) with a total score of
5–20 maximally. The CIA was assessed by the researcher or care
giving nurse and combined with a Numeric Rating Scale for pain
intensity and distress, either filled in by the observer or the patient
when self-report was feasible. The two instruments were compared
and the CIA was tested before and during handling in a subsample
of patients. Based on a large number of observations, cut-off
scores were determined to introduce treatment guidelines.
Results Inter-rater reliability of 46 nurses, researchers and intensivists
was excellent, with a median Cohen’s Kappa of 0.86. Internal
consistency of the CIA with five items was good (0.80). In 125
patients, 870 CIA and NRS scores were assessed and recorded in
the Patient Data Management System. When NRS pain or distress
was ≥ 4 (22.5% of all observations) the median CIA was 11 (IQR
10–13). When NRS pain or distress was below 4 the median NRS
pain or distress was 9 (IQR 6–10). The median score of 9 before
handling increased significantly to 11 during handling in 20 patients
(Mann–Whitney U test, P = 0.016). A cut-off score of 10 or higher
relates to good sensitivity of 0.84 and moderate specificity of 0.63.
Conclusions Despite beginning validity a major drawback was
seen in the relatively low cut-off scores. A score of 10 could be
observed when all items were scored 2, which is ‘normal’. Our data
suggest oversedation in these ICU patients. Further research by
implementation of a CIA-based algorithm should determine whether
or not this can be reduced in this specific patient population.
P144
Ketamine and propofol do not affect intestinal microcirculation in
the rat edotoxemia: experiments in a new model for intravital
microscopy
M Fogliata, T Feyerherd, D Pavlovic, M Gruendling, M Wendt, 
C Lehmann
Greifswald University, Greifswald, Germany
Critical Care 2005, 9(Suppl 1):P144 (DOI 10.1186/cc3207)
Background Intravital microscopy (IVM) imposes the particular
problem of the combined control of the body temperature of the
animal and control of the local temperature of the observed organ
or tissues. We constructed and tested a new tissue support
platform that employed a ‘hanging drop’ mechanism. Since
analgesic agents are often used in sepsis and could potentially
influence microcirculation, the effects of ketamine (10 mg/kg
intravenously [i.v.]) and propofol (10 mg/kg bolus + 10 mg/kg/hour,
i.v.) on intestinal microcirculation using fluorescent intravital
microscopy in an endotoxemic rat model (lipopolysaccharide
Escherichia coli [LPS] injection) were examined.
Protocol The animals (n = 49) were separated into six groups:
control group (just microscopy), animals received LPS, only
ketamine, ketamine + LPS, only propofol, and propofol + LPS. Two
hours after LPS (15 mg/kg i.v.) and/or drug injection the terminal
ileum was examined.
Available online http://ccforum.com/supplements/9/S1
Figure 1 (abstract P144)
Schematic representation of the cross-section of the tissue platform
disclosing the optical way.
Figure 2 (abstract P144)
Deep vessels (V3 venule) with sticking leucocytes (rhodamine stained)
taken in the animal pretreated with endotoxine.
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Results LPS injection did not affect the functional capillary density
in the longitudinal and circular muscular and the mucosal layers but
increased the number of firmly adhering leukocytes (stickers) in V3
venules (LPS vs controls; 491.2 ± 100.5 vs 187.3 ± 123.0 n/mm2;
mean ± standard deviation, P < 0.05) and in V1 venules (LPS vs
controls: 256.7 ± 49.7 vs 97.9 ± 27.5 n/mm2; P < 0.05). The
number of rolling leucocytes in V3 venules was also reduced in
LPS rats as compared with the control group (3.73 ± 2.7 vs
33.3 ± 28.2 n/min; P < 0.05). The levels of IL-1β, IL-6, IL-10 and
tumour necrosis factor alpha were significantly higher in the LPS
animals. The LPS induced changes were not affected by ketamine
or propofol administration.
Conclusion The ‘hanging drop’ technique prevented tissue
quenching, assured undisturbed microcirculation, provided stable
temperature and humidity, and assured a clear visual field. It was
found that LPS produced important microcirculatory changes.
However, neither ketamine nor propofol affected microcirculation in
endotoxemia in the rat and had no effect on the leukocyte
adherence, and therefore could be used for microcirculatory
studies.
P145
Ketamine and the coagulation response during and after
cardiopulmonary bypass
I Husedzinovic, S Barisin, N Bradic
Clinical Hospital Drubrava, Zagreb, Croatia
Critical Care 2005, 9(Suppl 1):P145 (DOI 10.1186/cc3208)
Introduction The inflammatory response and the coagulation-
fibrinolytic cascades are closely interconnected. Vascular injury
following cardiopulmonary bypass (CPB) may result in uncontrolled
platelet activation, thrombin generation, and disseminated
intravascular coagulation. Many of the anesthetic agents posses
immunomodulatory effects. The clinical implications of such effects
in the context of CPB remain unknown. Ketamine attenuates IL-6
response and production of the superoxide anion by neutrophils
after CPB, and reduces coronary uptake of neutrophils following
myocardial ishemia and reperfusion. We studied the effect of small-
dose ketamine on the coagulation response (antithrombin III,
fibrinogen, D-dimers, platelets) during and after CPB.
Methods In the preliminary prospective study report, we
randomized 30 patients who underwent open heart surgery into
two groups: K-group (n = 15), which received 0.5 mg/kg ketamine;
and P-group (n = 15), which received placebo. Serum samples
were collected before starting the operation (T0), after aorta clamp
releasing (T1), 30 min (T2), 2 hours (T3), 6 hours (T4), 12 hours
(T5), 24 hours (T6), and 48 hours (T7) after weaning from CPB.
Data (mean ± standard deviation) were tested by variance analysis.
Results Both groups were comparable for age, sex, and body
surface area. Differences of operative data (CPB and aorta cross-
clamping time) and postoperative data (ventilatory support, ICU
stay, blood transfusion) between groups were not significant.
Furthermore, there was no statistical significance between all other
collected data in this study.
Conclusion In this preliminary study, findings suggest that small
doses of ketamine do not possess any effect on the coagulation
response during and after CPB.
P146
Combined general and epidural anaesthesia improves
perioperative immune function
O Ahlers, I Kuerer, J Lenze, K Schulmeister, C Höhne, G Fritz,
K Falke, D Keh
Charite, Campus Virchow-Klinikum, Berlin, Germany
Critical Care 2005, 9(Suppl 1):P146 (DOI 10.1186/cc3209)
Background Intraoperative stress may impair perioperative
immune function. The hormones epinephrine, cortisol, and the
stress-associated anti-inflammatory IL-10 are known to inhibit Th1
helper cells. Interferon-gamma (IFN-γ), released mainly by Th1
cells, seems to be crucial for host resistance; abolished Th1
function (anergy) is associated with increased risk of infection and
mortality. We hypothesized that combined general and thoracic
epidural anaesthesia (TEA) reduces intraoperative stress during
major abdominal surgery preventing perioperative impairment of
Th1 cells.
Methods Fifty-four patients undergoing major abdominal surgery
were enrolled in a controlled, prospective, randomized, and single-
blinded study. The protocol was approved by the local ethics
committee. All patients were supported with an epidural catheter
before induction of general anaesthesia. In one group (n = 27), the
catheter was used for intraoperative analgesia (TEA-I); the other
group (n = 27) received systemic opioids during surgery (TEA-P).
Subsequently, epidural analgesia was used in both groups for
postoperative pain management. Blood samples were taken before
placing the epidural catheter, 2 hours after the beginning of
surgery, and at days 1 and 4 after surgery. IFN-γ and IL-10 were
measured in plasma and concanavalin-A (ConA)-stimulated blood
samples. Stress hormone levels of epinephrine and cortisol were
examined. Differences between the groups were analysed using
non-parametric tests, significance was defined by P < 0.05.
Results The plasma IFN-γ/IL-10 ratio in TEA-P was lower 2 hours
after the beginning of surgery (not significant). In ConA-stimulated
lymphocytes, the IFN-γ/IL-10 ratio was significantly decreased in
TEA-P from 2 hours after the beginning of surgery until day 1
(Fig. 1) (P = 0.005). This effect was mainly due to a significant
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decrease of IFN-γ in TEA-P, but not due to differences in IL-10
increase. Plasma levels of epinephrine (P = 0.022) and cortisol
(P = 0.015) were significantly higher in TEA-P during surgery.
Conclusion The intraoperative use of a thoracic epidural catheter
prevents stress-induced perioperative impairment of IFN-γ release.
Since IFN-γ plays a key role in host defence, the results may be of
clinical relevance for the postoperative course
P147
Influence of thiopentone and midazolam on monocyte
differentiation into dendritic cells
C Karcher, H Raidt, H Haeberle, H Dieterich, K Unertl, T Schroeder
University of Tuebingen, Germany
Critical Care 2005, 9(Suppl 1):P147 (DOI 10.1186/cc3210)
Background Dendritic cells (DC) play a major role in the innate
immune response by directing B lymphocytes and T lymphocytes.
We studied the contribution of DC to the immune suppression
during thiopentone and midazolam treatment. Previous in vitro
studies have shown negative effects of thiopentone on immune
function [1,2]. Clinical studies suggest that long-term sedation with
thiopentone contributes to an increased incidence of nosocomial
infections [3]. However, effects of thiopentone on DC have not yet
been elaborated.
Materials and methods We investigated the effects of clinical
doses of thiopentone and midazolam on the differentiation of
monocytes to dendritic cells in vitro. Monocytes were isolated from
buffy coats of healthy donors and cultured in the presence of GM-
CSF and IL-4 over 8 days. The cells were incubated with different
concentrations of thiopentone and midazolam, respectively. DC
were characterized through surface expression of CD1a, CD14,
CD16, CD40, CD80, CD83, CD86 and HLA-DR. Cell function
was quantified through FITC-dextrane phagocytosis by cytometry.
Results In contrast to midazolam, high concentrations of thio-
pentone (50–100 µg/ml) led to notable alteration in the morphology
and differentiation of DC. Typical morphologic characteristics like
spikes and cell clustering were absent. The surface expression of
CD1a was reduced by 83% (± 41%), CD40 by 93% (± 8%) and
HLA-DR by 68% (± 35%). Phagocytosis capacity of these cells
was decreased by 50% (± 33%).
Conclusion We conclude that differentiation from monocytes into
DC is affected by high concentrations of thiopentone but not by
midazolam. This may contribute to an immune suppression during
long-term thiopentone sedation.
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Propofol and methohexital comparably affect
polymorphonuclear leukocyte function in patients after cardiac
surgery
E Hüttemann, M Büttner, K Vogelsang, S Sakka
Friedrich-Schiller-University Jena, Germany
Critical Care 2005, 9(Suppl 1):P148 (DOI 10.1186/cc3211)
Background Experimental and clinical studies suggest that
anesthetics have a variety of negative side effects on
polymorphonuclear (PMN) leukocytes, which play a vital role in the
defense against invading bacteria. In this study, we analyzed the
effects of propofol and methohexital on PMN leukocyte function in
patients after cardiac surgery.
Patients and methods In this observational clinical study, we
studied 46 patients undergoing elective cardiac surgery who
postoperatively either received propofol (n = 29) or methohexital
(n = 17). Patients in the propofol group (P) (19 males, 10 females)
had a mean age of 65 ± 11 (range 36–80) years. In the
methohexital group (M) (12 males, five females) the mean age was
65 ± 8 (range 43–77) years. Both sedatives were administered
according to clinical requirements. PMN leukocyte function was
assessed as respiratory oxidative burst and expressed as the
percent of oxidating cells (normal 70–100%). Furthermore, the
mean fluorescence intensity (MFI) was determined as a measure of
intracellular uptake of bacteria. Both variables were assessed
before induction of anesthesia (MP1), on ICU admission after
cardiac surgery (beginning of sedative administration) (MP2),
6 hours after ICU admission (MP3) and 24 hours after beginning of
anesthesia (MP4). Patients’ demographics and measurement
results were compared by t test and analysis of variance for repeated
measures.
Results Both groups were well matched in terms of patient
demographics, age, body weight and duration of sedative
administration (P: 9.4 ± 5.4 hours vs M: 8.4 ± 5.6 hours). Within
both groups, respiratory oxidative burst significantly decreased
over time (MP1 and MP2 vs MP3 and MP4, respectively). For
comparison, respiratory oxidative burst at MP4 was significantly
higher for methohexital (82%) than propofol (72%). While
oxidation decreased between MP3 and MP4 for propofol, no
significant change was observed between these two time points
for methohexital. For MFI, a time-dependent decrease was found
for both drugs, without any difference between both groups.
Conclusions PMN leukocyte function is comparably depressed by
propofol rather than methohexital in patients after cardiac surgery.
P149
Effects of propofol versus methohexital on neutrophil function
and immune status in critically ill patients
S Sakka, A Jung, H Vogelsang, E Huettemann
Friedrich-Schiller-University Jena, Germany
Critical Care 2005, 9(Suppl 1):P149 (DOI 10.1186/cc3212)
Introduction Sedatives (i.e. propofol and methohexital) have a
variety of negative side effects on neutrophil leukocytes,
lymphocytes and monocytes, which all play a vital role in the
defense against invading microorganisms [1]. In this study, we
investigated these effects in critically ill patients with long-term
sedation.
Patients and methods In this observative clinical study, we
analyzed 21 critically ill patients with long-term sedation who either
received propofol (n = 12, APACHE II score 26 ± 4) or
methohexital (n = 9, APACHE II score 28 ± 6) after ICU admission.
Patients in the propofol group (P) (nine males, three females) had a
mean age of 55 ± 15 years. In the methohexital group (M) (eight
males, one female) the mean age was 48 ± 18 years. Both
sedatives were administered according to clinical requirements.
Neutrophil leukocyte function was assessed as phagocytosis and
respiratory oxidative burst activity. Furthermore, cellular markers of
monocytes and lymphocytes (CD3, CD4, CD8, CD19, CD57,
CD122) were assessed. Measurements were made on ICU
admission, day 3, day 7 and day 14 of drug administration.
Patients’ demographics and results were compared by
Mann–Whitney U test and one-way repeated-measures analysis of
variance with an all pair-wise multiple comparison procedure.
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Results Both groups were well matched in terms of age, height
and body weight. ICU length of stay was comparable (22 ± 7 days
vs 20 ± 9 days). Mortality was 0/12 and 2/9, respectively. Absolute
numbers of leukocytes and subpopulations were comparable
between both groups at each time point. We found no difference
in neutrophil oxidative burst and phagocytosis within and between
both groups at the different time points. With respect to
lymphocyte and monocyte CD marker expression, no differences
within each group and between the time points were found.
Conclusion Effects of methohexital and propofol on neutrophil
leukocyte function, expression of lymphocyte and monocyte
markers were not different in critically ill patients with long-term
sedation.
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HLA-DR expression on monocytes and the T-cell subset in
septic patients
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Introduction Sepsis is one major cause of mortality in the ICU,
despite increasing knowledge about its physiopathology, new
generation of antibiotics and an advance in supportive therapy [1].
Interaction between microorganisms and toxins produced an
activation of the immune system, resulting in release of
proinflammatory and anti-inflammatory cytokines. Recent studies
demonstrated an imbalance in the immune system during sepsis
due to a high level of antinflmmatory cytokines, with a decrease of
major histocompatibility leukocyte antigen (HLA-DR) on monocytes
and alteration on total lymphocyte phenotype frequency.
Aim To determine the time of HLA-DR expression in peripheral
blood monocytes, variation in the lymphocyte subset, and their
relationship with markers of inflammation, gravity score and
development of sepsis.
Design A prospective, longitudinal study.
Setting A university hospital ICU.
Patients Twenty consecutive medical patients admitted to the ICU,
13 with sepsis and seven noninfected, without haemopoietc
cancer, immunodepression and chronic therapy with steroids.
Interventions Daily SOFA score, IPS score and clinical sepsis
criteria as defined by the ACCP/SCCM were checked. Serum
procalcitonin, C-reactive protein, leukocyte antigens and
lymphocyte subset features were serially recorded every day after
arrival during all periods of stay in the ICU.
Measurements and results The percentage of HLA-DR on
monocytes was significantly depressed in septic patients, particularly
related to worsening of disease. In patients with septic shock the
lowest value of HLA-DR on monocytes was recorded; that value
increases with resolution of sepsis-correlated organ failure. The
area under the ROC curve for HLA-DR to discriminate sepsis was
0.86 (sensibility 94% and specificity 61% with cutoff 0.7). The
CD4/CD8 T-cell ratio was reduced in septic patients compared
with nonseptic patients; the nadir value was in patients with septic
shock as the HLA-DR value. Procalcitonin, C-reactive protein and
gravity scores were correlated with monocytic HLA-DR expression
and CD4/CD8 T-cell ratio.
Conclusion A decrease of monocyte expression of HLA-DR and
the CD4/CD8 T-cell ratio occurred during infection disease. In
septic shock signs of uncontrolled hyperinflammation are
contemporary with a severely depressed cellular response. HLA-
DR has a good sensibility and specificity to differentiate sepsis
from other noninfectious conditions in critically ill patients.
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Serum cholesterol level: is it a marker of sepsis?
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Background There is no ideal biomarker for sepsis. Recent
studies have linked cholesterol levels with critical illness [1]. This
study has been conducted to document the baseline cholesterol
level in critically ill patents and to correlate its trend with the
development, progression and outcome of sepsis.
Method Prospective analysis of laboratory and clinical data of 184
consecutive patients admitted to a 64-bed critical care unit (CCU)
of a tertiary care hospital in South India. Data collected were the
demographics, and the cholesterol level at the time of admission,
at the onset of sepsis (with or without multiorgan failure) and on
discharge from the unit. Sepsis was defined as per the 1992
ACCP consensus conference criteria. MOD scoring was done
daily. Patients who were admitted with sepsis and those who
developed sepsis during their stay in the unit were considered as
the study group, while those who did not develop sepsis acted as
the control group. Data were expressed as mean ± standard
deviation. The paired Student’s t test was used to compare the
total cholesterol levels between the two groups. Correlation
coefficient and logistic multiple regression analysis was performed
with the MOD score, cholesterol levels and mortality. P < 0.05 was
considered significant.
Results A total of 183 patients were enrolled into the study (study
group – 73 and control – 110). The mean age was 56.4 ± 18.7 years
and the male/female ratio was 1.8:1. The mean admission chol-
esterol was 212.5 ± 56 mg/dl, while the mean cholesterol level on
day 5 was 112.3 ± 34.5 mg/dl in the sepsis group and
179.4 ± 47.6 mg/dl in the control group. The lowest cholesterol
levels recorded were in patients who died in the study group:
101.3 ± 18.1 (n = 54). The cholesterol level at the time of discharge
from the CCU in the study group (n = 19) was 109.74 ± 20.7 and
in the control group (n = 102) was 201 ± 51.3
Discussion The drop in cholesterol levels during the CCU course
shows a correlation with the onset of a new infection and
development of sepsis. Lower cholesterol levels were associated
with increasing mortality. Convalescence/discharge from CCU was
associated with improvement in cholesterol levels.
Conclusion This study reveals the negative prognostic value of
hypocholesterolemia in critical illness. It is a sensitive marker for
onset of infection and sepsis.
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Serum lipoproteins: how important are they in septic shock
patients? Is there a relation to outcome?
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Introduction Decreased concentrations of serum lipoproteins
occur early in critically ill patients. Furthermore, very little is known
of the role that lipoproteins play in septic shock. Lipoproteins have
recently been associated with innate immunity. It is reported that
low values of lipoproteins are associated with low innate immunity
and poor prognosis. A prospective study was designed to evaluate
serum lipoproteins in septic shock patients and to investigate
possible relations to the outcome.
Methods A prospective study over a period of 1 year set in a six-
bed university hospital intensive care unit and in a five-bed medical
intensive care unit of a tertiary care hospital. Eighty-eight patients
were included in the study that met the ACCP/SCCM consensus
criteria for septic shock. Blood samples were collected from these
patients on days 1, 3, 6, 9, 12 and 15 or until discharge or death
and were analyzed for total cholesterol, high density lipoprotein
(HDL), low density lipoprotein (LDL) and triglycerides. Results are
expressed as mean ± standard deviation. Multiple level regression
analysis was used.
Results The group of patients were divided into survivors and
nonsurvivors. We had 33 patients in the nonsurvivor group and 55
patients that recovered from their septic shock. The mortality rate was
approximately 37.5%. The APACHE II scores for both groups were
similar with no significant difference during the study. Admission
values of serum lipoproteins showed no significant differences in
either group of patients. However, a statistically significant difference
was observed between the groups from day 3. Serum cholesterol,
HDL levels were significantly lower starting from day 3 and
triglyceride levels were significantly higher noted also from day 3 and
onwards. All serum lipoproteins showed statistically significant
differences between the two groups from day 6 and onwards. LDL
showed no significant difference between the two groups.
Conclusion In our study it was evident that low cholesterol and
low HDL levels as well as high triglyceride levels are significantly
related to poorer outcome in septic patients. All three variables
presented a significant difference between survivors and non-
survivors during the study.
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outcomes in patients hospitalized with community acquired
pneumonia
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Introduction Two small studies found prior statin use was
associated with decreased ICU admission and severe sepsis in
patients hospitalized with bacterial infection and decreased
mortality in bacteremic patients. These effects were postulated to
be due to anti-inflammatory effects of statins. We examined prior
statin use, plasma cytokine levels, and outcomes in a large cohort of
patients hospitalized with community acquired pneumonia (CAP).
Hypothesis We hypothesized that prior statin use would be
associated with: ICU admission, severe sepsis, and hospital
mortality; and altered plasma cytokine levels.
Methods This study was part of Genetic and Inflammatory Markers
of Sepsis (GenIMS), a prospective observational cohort study of
patients presenting to the Emergency Department with CAP in 28
US hospitals. Demographics, illness severity, and statin use within
7 days of presentation were determined at baseline and patients
were followed to determine rates of hospital and ICU admission,
severe sepsis, and hospital mortality. Plasma cytokine levels (tumor
necrosis factor, IL-6, IL-10) were obtained daily in hospitalized
patients. Outcomes were compared for prior statin (S) versus no
statin (No S) use in all hospitalized CAP patients and in those who
developed severe sepsis. Cytokine levels were assessed using a
mixed-model longitudinal analysis.
Results Of the 2320 patients enrolled, there were 1895
hospitalized with confirmed CAP. Of those, there were 426
(22.5%) S and 1469 (77.5%) No S patients. S patients were older
(72.2 vs 66.5 years, P < 0.001) and sicker, with higher comorbidity
(2.2 vs 1.9, P = 0.003) and APACHE III (58.2 vs 55.7, P = 0.01)
scores. S patients had increased rates of severe sepsis (51.9% vs
45.7%, P = 0.03), but similar ICU admission (18.3% vs 15.2%,
P = 0.13) and hospital mortality (3.3% vs 5.0%, P = 0.14). After
adjustment for age, gender, PSI, comorbidity, chronic organ
dysfunction, SOFA, and APACHE III scores, S patients had greater
odds of ICU admission (odds ratio [OR] 1.44, P = 0.02), but not
severe sepsis (OR 1.19, P = 0.20) or mortality (OR 0.71,
P = 0.28). Among those with severe sepsis, there were 221
(24.7%) S and 672 (75.3%) No S patients, with no baseline
difference between groups except for slightly less chronic organ
dysfunction in S patients (P = 0.01). S patients trended toward
lower mortality (6.3% vs 10.7%, P = 0.056) in univariate analysis,
but not after adjusting for baseline covariates (OR 0.68, P = 0.23).
Among those with severe sepsis, IL-10 (P = 0.03) and tumor
necrosis factor (P = 0.03), but not IL-6 (P = 0.91) were
significantly lower in S patients. There were no cytokine differences
in the larger hospitalized CAP cohort.
Conclusions In a large cohort of hospitalized CAP patients, both
proinflammatory and anti-inflammatory cytokine levels were lower in
S patients with severe sepsis, but we were unable to confirm the
protective effect of prior statin use for clinical outcomes seen in
smaller studies.
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Introduction During secondary peritonitis, intra-abdominally
formed fibrin entraps bacteria that are thereby difficult to eliminate
by host defence mechanisms. Activating fibrinolysis may have
beneficial effects on bacterial clearance and thus on inflammatory
responses. Systemic fibrinolysis has risks of major bleeding
complications. In this study, tissue-type plasminogen activator
(tPA) was administered topically 24 hours after induction of
peritonitis to examine the effects of fibrinolysis on local (abdominal)
and distant (circulatory and pulmonary) inflammatory responses
during polymicrobial peritonitis.
Methods C57BL/6 mice underwent cecal ligation and puncture
(CLP) or sham operation with, after 24 hours, relaparotomy and
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therapeutic peritoneal lavage with either saline or tPA (0.5 mg/ml).
Inflammatory response, coagulation and fibrinolysis were assessed
in peritoneal fluid, systemic circulation and lung compartments.
Results CLP increased bacterial load, neutrophil influx and activity,
coagulation and fibrinolysis compared with sham (all parameters
P < 0.01). Compared with saline lavage, tPA lavage reduced intra-
abdominal bacterial load, KC concentration and thrombin–anti-
thrombin complexes (all P < 0.05), and also reduced intra-
abdominal as well as pulmonary neutrophil influx and activity, and
clotting times (all P < 0.05). Mediator levels of fibrinolysis were not
significantly altered by tPA; histology showed less fibrin
deposititions concomitant with reduced peritoneal, liver and lung
damage after tPA lavage (P < 0.05). Mortality decreased from 50%
to 35% (P = 0.3). Different kinetics were seen when comparing
abdominal and pulmonary compartments.
Conclusions In this model of polymicrobial peritonitis, abdominal
activation of fibrinolysis by tPA lavage effectively reduced intra-
abdominal bacterial load, thereby reducing inflammatory responses
in abdominal and extra-abdominal compartments and remote fibrin
deposits and tissue damage. Different kinetics between peritoneal,
systemic and pulmonary compartments suggested compartment-
alised responses.
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Background In sepsis, one of the most important problems is the
modification of the hemostasis balance with activation of the
coagulation. This is due, in part, to increased expression of tissue
factor at the monocyte surface [1]. In these patients, we also
observe a systemic hypofibrinolysis [2]. However, it is known that
leukocytes have a profibrinolytic potential [3].
Aim To explore the role of monocytes in the fibrinolytic balance.
Materials and methods THP-1, a monocytoïd cell line, was
challenged or not with 10 µg/ml lipopolysaccharide during 4 hours,
before being introduced in an euglobulin clot lysis time assay,
measured by a new semi-automatic method [4]. Resting cells were
introduced in the assay at concentrations ranging from 0.25 × 106
cells/ml to 106 cells/ml and stimulated cells at the concentration of
106 cells/ml. Control without cells is the baseline. Statistics used
analysis of variance.
Results First, we observed a gradual diminution of lysis time with
resting cells, from 12% to 25% of the baseline, according to the
concentration of cells (n = 6; P < 0.001). Then, when we added
stimulated THP-1, we observed a greater diminution of lysis time:
31% of the baseline (n = 8; P < 0.001 from the baseline and
P < 0.05 from resting cells).
Conclusion Monocytes play a role in the fibrinolytic balance and
this role is enhanced when they are activated by lipopoly-
saccharide, like in sepsis. In the future, we will have to investigate
why monoyctes are responsible for such an antagonism, stimu-
lating coagulation and fibrinolytic processes, at the same time.
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Background C-reactive protein (CRP) is correlated with the risk of
multiple organ failure (MOF) and death in intensive care patients
[1]. CRP inhibits fibrinolysis by inducing plasminogen activator
type 1 release by endothelial cells [2]. We observed a link between
CRP and fibrinolysis at ICU admission [3].
Objective We aimed to evaluate the relationship between CRP
and fibrinolysis and the potential predictive value of fibrinolysis at
admission in the ICU on the development of MOF.
Methods Thirty-eight patients were enrolled. The plasma
fibrinolytic capacity was assessed by the euglobulin clot lysis time
(ECLT) determined by a semi-automatic method [4]. The ECLT,
CRP and the SOFA score were measured on admission (time 1)
and between the third and the fifth day (time 2) of the ICU stay.
Results The ECLT was higher in septic than nonseptic patients
(970 ± 928 min versus 503 ± 304 min [P = 0.042]). Platelet count
remained stable between the two times. We found a correlation
between ECLT on admission and SOFA score at time 2 (r = 0.67;
P < 0.001). There was no link between ECLT and the mortality rate
(P = 0.68). CRP was correlated with ECLT during the ICU stay
(time 1: r = 0.74, P < 0.001; time 2: r = 0.60, P < 0.001).
Conclusion The ECLT at admission could be a good predictive
marker for the development of MOF between the third and the fifth
day of the ICU stay.
A correlation exists between CRP and the ECLT during all the ICU
stay. This finding is compatible with a link between inflammation
and fibrinolysis and may explain the negative prognostic value of
high concentrations of CRP in critically ill patients.
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Introduction Sepsis, characterized by intense reaction of the
organism, due to infection, particularly of the inflammatory and
coagulation systems, is a common illness, of high cost treatment
and deaths. Thus, new technologies for the detection of sepsis
early-stages are urgently needed. Our objective was to identify
serum proteomic patterns that would distinguish sepsis patients
from healthy controls.
Materials and methods Six ICU patients that matched the criteria
(ACCP/SCCM) for sepsis diagnosis were selected: male/female,
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3/3; mean/range age of 81.1/68–89 years; mean LOS_ICU of
15 ± 25 days; 28-day mortality (dead/total/%) = 4/6/66%; mean
APACHE II score of 22 (20–26); and mean SOFA = 6 (5–8); VAP
(Pseudomonas aeruginosa, three patients) and CRBSI Staphy-
lococcus aureus, Staphylococcus epidermidis, Candida albicans
(one each). Serum samples were submitted to isoelectric focusing
of proteins in the first dimension with a nonlinear strip of pH 3–10
and in the second to 12.5% 2D-SDS-PAGE. Gels were stained
with Coomassie Blue and the final image analyzed using the Image
Master Platinum software (Amersham). Selected spots were cut,
washed, dried, swollen with trypsin solution and incubated for
16 hours at 37°C. The peptides were extracted, concentrated and
analyzed by mass spectrometry in a MALDI-TOF Voyageur DE-PRO
instrument (ABI). Peptide maps were processed (MS-Fit, Protein
Prospector) for protein identification in the NCBI Data Bank.
Results Image analyses of the gels showed the presence of spots
only in patients with sepsis (Fig. 1, arrows) and the presence of
other spots with different intensities in sepsis and controls. Peptide
mass fingerprinting of some of these spots identified actin, zinc-
finger protein, matrin 3, haptoglobin-2 and apolipoprotein A1.
Discussion Actin, a major component of the cytoskeleton, is found
in cellular injury as in apoptosis; zinc-finger protein is expressed in
cellular injury as a cytoprotective protein with anti-apoptosis
activity; matrin 3 functions in transcription and interacts with other
proteins of the cellular matrix; apolipoprotein A1 is capable of
directly inactivating endotoxin (protein–endotoxin interaction);
haptoglobin-2 is present during the acute phase reaction. These
findings justify the use of proteomic techniques as a screening tool
for the study of all stages of sepsis in high-risk patients.
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Acute lung injury/acute respiratory distress syndrome (ALI/ARDS)
is characterized by an important inflammatory reaction involving
both lungs, often spreading systemically. Pentraxin 3 (PTX3) has
recently been described as a mediator of the acute phase of innate
immunity. It belongs, together with C-reactive protein (CRP), to the
pentraxin superfamily. PTX3 is produced by endothelial cells,
fibroblasts, mononuclear phagocytes and dendritic cells in
response to primary inflammatory signals (IL-1, tumor necrosis
factor, LPS). Its involvement in the pathogenesis of ALI/ARDS
seems probable and potentially interesting for the pathophysiology,
the diagnosis and possibly the therapy of the syndrome.
We measured PTX3 levels, by an ELISA test, in the sera of 25
patients affected by ALI/ARDS. We also collected data related to
etiology, pulmonary mechanics, gas exchange, systemic
inflammatory involvement, microbiology, blood cells and the
outcome of these patients.
PTX3 was markedly elevated in all 25 patients (average
111.07 ± 192.01 ng/ml; range 4.94–922.91 ng/ml). In no patient
were PTX3 levels lower or equal to the physiological threshold of
2 ng/ml.
Levels of logPTX3 were significantly different between survivor and
nonsurvivor patients (1.465 ± 0.529 log ng/ml vs 1.950 ± 0.643
log ng/ml; P = 0.05).
Patients with two or more organ failures (besides the lung) also
had logPTX3 levels significantly higher than patients with just one
additional organ failure (1.936 ± 0.597 log ng/ml vs
1.423 ± 0.542 log ng/ml; P < 0.04). The same was true when
PTX3 levels in patients with septic shock were compared with
PTX3 levels in patients without shock (262.465 ± 350.727 ng/ml
vs 63.257 ± 70.261 ng/ml; P < 0.03).
PTX3 and logPTX3 were correlated with body temperature
(r = 0.56 P < 0.01; r = 0.51 P = 0.01) and with arterial blood pH
(r = –0.53 P < 0.01; r = –0.53 P < 0.01).
We have underlined a relationship between circulating levels of
PTX3 and some markers of the severity of systemic involvement.
PTX3 could be an indicator of the gravity of the systemic
inflammatory reaction and of unfavourable outcome in ALI/ARDS
patients.
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Objective Soluble haemoglobin scavenger receptor (sCD163) is a
macrophage-specific marker, and elevated levels have been
observed in patients with pneumonia and sepsis. The objective of
our study was to evaluate sCD163 as a diagnostic and prognostic
marker in patients with community acquired sepsis.
Design A prospective observational study.
Methods One hundred and ninety-four adult patients admitted to a
Department of Internal Medicine at a tertiary hospital with
suspected community acquired infections. Daily blood sampling for
sCD163 analysis was performed for up to 5 days. Laboratory
analyses were performed with a sandwich ELISA using polyclonal
rabbit anti-CD163 as the catching antibody and monoclonal anti-
CD163 as the secondary antibody. The patients were classified
according to SIRS criteria. The patients were divided in the
following groups: patients with no proven infection (n = 67, control
group), patients with possible infection (n = 21, not included in
analysis), patients with proven infection without SIRS (n = 25),
patients with sepsis (n = 52), patients with severe sepsis (n = 29).
Only one patient had septic shock. Twelve patients had
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bacteraemia. Demographic data, comorbidity, microbiological
aetiology, biochemical parameters, focus of infection, severity
score and mortality on day 28 were recorded.
Results The median age was 68 years (range 18–92). The
male–female ratio was 0.84. The mortality rate among infected
patients on day 28 was 3.8%. sCD163 concentrations are
presented as medians and range: 2.9 mg/l (1.22–12.65) in
patients with no proven infection, 3.75 mg/l (1.59–74.04)
(P = 0.04) in patients with infection without SIRS, 3.02 mg/l
(0.54–22.51) (not significant) in patients with sepsis, 4.05 mg/l
(1.71–28.4) (P < 0.01) in patients with severe sepsis, 4.92 mg/l
(2.66–28.4) (P < 0.01) in patients with bacteraemia.
Conclusions Elevated levels of sCD163 were observed in patients
with infection without SIRS, in patients with severe sepsis and in
patients with bacteraemia. The sepsis group had sCD163 levels
comparable with the noninfected control group. The highest levels
of sCD163 were associated with the presence of bacteraemia.
Further studies are needed to unravel the role of sCD163 in severe
infections.
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Measurement of granulocyte colony-stimulating factor and
IL-6, IL-8 and IL-10 as an early predictor for septic patients
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Introdcution Despite the great evolution in the treatment
modalities of sepsis, there is an unsatisfactory improvement in the
mortality rate. Cytokines play an important role in occurrence of
SIRS, sepsis and multiple organ failure. A series of proinflammatory
cytokines such as IL-1, IL-6, and IL-8 are secreted early in sepsis
followed by another group of anti-inflammatory cytokines such as
IL-10 and granulocyte colony-stimulating factor (G-CSF).
Objective This study was carried out to find the benefit of early
measurement of serum IL-6, IL-8, IL-10 and G-CSF for diagnosis of
sepsis and its impact on patient outcomes in septic patients.
Patients and methods Eighty patients (50 males and 30 females)
fulfilling the criteria of SIRS were categorized on admission
according to ACCP&SCCM definition into four groups: SIRS (26
patients), septic patients (26 patients), severe sepsis (14 patients),
and septic shock (14 patients). Their age ranged between 19 and
75 with a mean of 48.65 ± 17.33 years. IL-6 and IL-8 were
measured using ELISA and G-CSF using the immunoassay
technique at day 0 and after 48 hours. Culture from the site of any
infection was done at day 0 and at any time during patient stay if
severe signs of infection or septicemia developed. CBC, blood
gases and chest X-ray, APACHE II score and MOSD were done
daily.
Results Chest infection was the most common site of infection (48
patients, 60%), followed by mixed wound infection (10 patients,
12.5%) and abdominal sepsis (six patients, 7.5%), two patients
with urosepsis (2.5%) and source of infection can found in four
patients (5%).
A significant positive correlation was found between cytokine
levels, the scoring systems and blood cultures in the four groups.
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Introduction Endotoxin is a potent trigger of the inflammatory
cascade in critical illness. We have previously shown that
endotoxin activity levels (EAA) on admission to the ICU predict
adverse clinical outcomes.
Objective To determine the significance of changes in EAA values
over time in patients with critical illness.
Methods Data were extracted from the Multi-centre Endotoxin
Detection in Critical Illness trial database for patients who had a
minimum of three EAA values (consecutive or nonconsecutive)
during the first four ICU days beginning on ICU admission along
with associated clinical outcome data. Change in EAA over time
was defined qualitatively as an inflection in the curve generated by
plotting EAA values over time using the assumption of a normal
biologic polynomial distribution. Patients were grouped based on
having either zero, one, or two inflections in EAA over the 4-day
study period. Infection status was defined by the results of
bacteriologic cultures and subsequent Clinical Evaluation
Committee adjudication. The primary outcome measure was organ
dysfunction over time as defined by the area under the curve
generated by plotting MODS score against time (MODS burden)
calculated over a 4-day period (trapezoidal rule). Secondary
outcomes included ICU and hospital mortality.
Results In a total of 345 patients, 28 patients had zero inflections,
215 had one inflection, and 102 had two inflections. MODS
burden was significantly elevated in patients with two inflections
(MODS burden = 486 ± 232 MODS hours) as compared with
those with zero (MODS burden = 252 ± 214 MODS hours) or one
inflection (MODS burden = 386 ± 206 MODS hours) (P < 0.00001,
P = 0.001, respectively; three-way analysis of variance P < 0.00001).
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SIRS Sepsis Severe sepsis Septic shock
IL-6 (pg/ml) 168.48 ± 101.68 664.9.1 ± 281.67 1931.8 ± 458.4 3330.3 ± 726
IL-8 (pg/ml) 31.35 ± 8.17 75.68 ± 13.98 272.6 ± 65.5 390.6 ± 49.50
IL-10 (pg/ml) 121.6 ± 21.2 202.8 ± 61.9 470.9 ± 153.3 1070.7 ± 525.4
G-CSF (pg/ml) 36.22 ± 10.52 103.89 ± 26.99 173.9 ± 30.68 405.97 ± 77.2
Table 2 (abstract P160)
IL-6 (pg/ml) –ve blood culture 605.82 ± 572.14 IL-10 (pg/ml) –ve blood culture 201.18 ± 121.81
+ve blood culture 2879.49 ± 1017.87 +ve blood culture 897.35 ± 522.44
IL-8 (pg/ml) –ve blood culture 86.42 ± 84.15 G-CSF (pg/ml) –ve blood culture 83.07 ± 50.73
+ve blood culture 344.07 ± 108.17 +ve blood culture 338.9 ± 126.6
S69
EAA variability was predictive of organ dysfunction (MODS
burden) over time (P < 0.00264). MODS burden correlated with
both ICU mortality (P < 0.00001) and hospital mortality
(P < 0.0001). EAA variability was found to be independent of
infection status (P = 0.7915). The number of EAA inflections were
more predictive of outcome than the absolute EAA value
calculated as the total endotoxin activity load over the 4-day period
(AUC, trapezoidal rule) (univariate regressions, P < 0.00001,
P = 0.5440, respectively). In a separate study of 15 normal healthy
volunteers, EAA variability was shown to contain zero inflections in
all subjects studied.
Conclusions These data suggest that increased variability in
endotoxin activity is associated with worsening outcomes in the
critically ill. Our assumption of a normal biologic polynomial
distribution of endotoxin activity requires validation with more
frequent EEA sampling. Further studies are warranted to assess
whether the dynamic alteration of endotoxin activity may play an
important role in the ongoing inflammatory response and organ
dysfunction in the critically ill.
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Introduction In contrast with many acute and severe diseases
such as myocardial infarction, liver failure and renal failure, severe
sepsis lacks a specific biomarker. A useful marker of severe sepsis
will guide therapy by identifying which patients have the
pathological process of interest.
Objective To compare the rates of agreement between PCT and
lactate (LAC) assays with endotoxin levels in severely septic and
non-septic critically ill patients.
Methods Data were collected from stored frozen plasma samples
from a multicenter study evaluating the Endotoxin Activity (EAA)
Assay [1]. We evaluated test samples based on the presence of
clinical determination of severe sepsis where n = 17 had elevated
EAA levels and n = 7 had low EAA levels. There were n = 18 from
non-septic critically ill patients with low EAA values. We then
performed PCT and lactate assays on the same samples by
technicians who were blinded to EAA results and clinical
diagnosis. Overall percent agreement (weighted kappa statistic):
EAA vs PCT = 73.81% (0.462), EAA vs lactate = 40.5% (–0.247),
lactate vs PCT = 42.9% (–0.183) The EAA correctly identified 17
of 24 severely septic patients, thus showing a positive agreement
of 70.8%. The PCT and lactate assays correctly identified 15 and
six patients, respectively. The positive agreement with the
consensus definition of severe sepsis was 62.5% for PCT and
25% for lactate.
Table 1
PCT < 2.0 PCT > 2.0 LAC < 2.0 LAC > 2.0
EAA < 0.6 19 6 13 13
EAA > 0.6 5 12 12 4
LAC < 2.0 13 13
LAC > 2.0 11 5
Conclusions Both PCT and endotoxin are elevated in patients with
severe sepsis. The reported positive agreement with a clinical
diagnosis of severe sepsis provides evidence of their value as a
diagnostic marker. The poor positive agreement between lactate
levels and the presence of severe sepsis suggests this marker may
have other value such as for prognosis. Further study is required to
evaluate each of these markers as a measure of response to therapy.
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Objectives To evaluate the effectiveness of procalcitonin (PCT)-
controlled use of IgM-enriched immunoglobulin preparation in high-
risk children with congenital heart diseases after cardiac surgery
with cardiopulmonary bypass (CPB).
Methods During January–July 2004, 31 consecutive high-risk
pediatric patients were enrolled into the study. The age was 23
(19–30) months. Severe concomitant extracardiac pathologies
were registered in 22 (71%) of cases; 21 (68%) patients had
preceding cardiovascular operations. Patients who had PCT blood
plasma levels above 2 ng/ml on the first day after surgery (n = 28)
were randomized into two groups. These groups were comparable
by severity of initial condition, age and CPB time. IgM-enriched
immunoglobulin preparation (Pentaglobin; Biotest Pharma GmbH,
Germany) was administrated to the patients in the study group
(n = 15) in addition to standard treatment (first 3 days after
surgery, 5 ml/kg each day). Patients in the control group (n = 13)
received only standard treatment. PCT blood plasma
concentrations were measured by immunoluminometric method
(PCT LIA; BRAHMS Aktiengesellschaft GmbH, Germany). The
data are shown as median and 25th and 75th percentiles. The data
were compared by Mann–Whitney U test, P < 0.05 considered
statistically significant. Postoperative infections rates were
analyzed in studied groups.
Results None of the patients had exhibited any signs of infection
before surgery. Patients with PCT blood plasma levels less than
2 ng/ml on the first day after surgery (n = 3) had a smooth
postoperative period. PCT levels on the first day after surgery were
significantly higher in the control group in comparison with the
study group (7.77 [5.95–10.72] ng/ml and 3.60 [2.98–6.54]
ng/ml, respectively; P = 0.009). Postoperatively 1/15 (6.7%) of
patients in the study group and 5/13 (38.5%) of patients in the
control group suffered from infectious complications (study group:
urinary tract infection — one patient; control group: pneumonia —
two patients, pneumonia and sepsis — one patient, peritonitis with
multiorgan failure — one patient, urinary tract infection — one
patient). The rate of postoperative infectious complications was
significantly lower in the study group (P = 0.03). Two deaths in the
control group occurred due to sepsis (n = 1) and peritonitis with
multiorgan failure (n = 1).
Conclusions High PCT levels on the first day after surgery are
associated with high rates of infectious complications. PCT
monitoring allows one to select patients with systemic bacterial
inflammation after CPB. Early (on the first day after surgery)
administration of IgM-enriched immunoglobulin preparation




Evaluation of procalcitonin as a diagnostic and prognostic
marker in patients with sepsis, severe sepsis and septic shock
associated with ventilator-associated pneumonia
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Objectives Although the significance of procalcitonin (PCT) has
been evaluated for general populations of patients with sepsis
attributed to various infections, application as a marker of severity
with both diagnostic and prognostic implications in patients with
ventilator-associated pneumonia (VAP) has not been specifically
studied.
Methods Serum samples were collected on the first, third, fifth and
seventh days of symptoms from 68 patients with sepsis, severe
sepsis/shock (ASCP/SCCM 1992) and VAP. APACHE II and
SOFA scores were measured on the first day of the symptoms.
Patients were followed-up for 28 days for overall survival. PCT was
estimated in sera of patients by immunochemiluminometric assay.
Results Among 68 patients, 34 presented with sepsis, five with
severe sepsis and 29 with septic shock. Mean age (years,
± standard deviation) was 57.86 ± 18.85; 48 patients were male
and 20 female. APACHE II and SOFA (mean ± standard deviation)
were 18.28 ± 6.11 and 7.64 ± 3.24, respectively. After 28 days of
follow-up, 38 patients were alive and 21 have died. Mean PCT
concentrations (ng/ml) on days 1, 3, 5 and 7 in patients with
sepsis, severe sepsis and septic shock are presented in Table 1.
The mean ± standard error serum concentrations of PCT of
survivors at days 1, 3, 5 and 7 were 0.71 ± 0.19, 0.45 ± 0.09,
0.35 ± 0.05 and 1.42 ± 1.04, respectively. Respective values in
non-survivors were 1.83 ± 0.86 (P = not significant compared with
survivors), 2.63 ± 1.08 (P = 0.05), 3.61 ± 1.33 (P = not
significant) and 2.89 ± 0.99 (P = 0.02).
Table 1
Mean procalcitonin concentrations (ng/ml)
Day 1 Day3 Day 5 Day 7
Sepsis 0.73 0.53 0.92 0.50
Severe sepsis 0.61 0.55 0.83 0.99
Septic shock 1.45 1.88 1.93 3.54
Conclusions PCT is a crucial marker of overall survival in patients
with septic syndrome and VAP. This suggestion is further
supported by the fact that PCT correlates to the severity of disease
constituting an objective marker of sepsis.
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Introduction The endotoxin adsorption method (PMX-DHP: Toray
Industries, Inc., Tokyo, Japan) is used for treatment of patients with
sepsis and septic shock primarily caused by Gram-negative
infections in Japan. Procalcitonin (PCT) levels may be a good
marker of infection and levels exceeding 10 ng/ml occur almost
exclusively in severe sepsis. The aim of this study was to evaluate
PMX-DHP for severe sepsis or septic shock patients according to
PCT values. Patients were classified as a group in which PCT is
higher than 10 ng/ml (H group) or a group in which PCT is lower
than 10 ng/ml (L group).
Patients and methods This mode of blood purification is
principally applied on direct hemoperfusion therapy. Sixty-seven
patients (40 in H group, 27 in L group) were treated with PMX-
DHP. Sepsis was diagnosed according to the criteria of the
American College of Chest Physicians/Society of Critical Care
Medicine Consensus Conference Committee. The following
parameters (tumor necrosis factor alpha, IL-6, IL-8, IL-1ra, ICAM-1,
PAI-1 and PCT) were measured just before and immediately after
PMX-DHP. PCT was measured by immunoluminometric assay
(LUMI test PCT; BRAHMS Diagnostica, Berlin, Germany).
Results APACHE II score in the H group was 26.7 ± 7.6 and in
the L group was 24.7 ± 9.2, respectively. SOFA score in the H
group was 11.2 ± 3.8 and in the L group was 11.3 ± 4.2. The 28-
day all-cause mortality rate in the H group was 30% and was 33%
in the L group. These were no significant differences between the
groups. IL-6, IL-8, and IL-1ra in H group were remarkably higher
than in the L group. (Median IL-6, IL-8, and IL-1ra in H group were
7580 pg/ml, 646 pg/ml, 55,000 pg/ml, respectively, and in L
group were 462 pg/ml, 40 pg/ml, 3650 pg/ml, respectively.) PCT
in the H group showed a tendency to decline from 108 ± 120 ng/ml
to 94 ± 98 ng/ml before and after PMX-DHP. Especially, PCT of
the survival group in H group showed a significant decrease from
119 ± 138 ng/ml to 93 ± 102 ng/ml (P < 0.02). On the other
hand, PCT of the nonsurvival group in H group increased from
83 ± 58 ng/ml to 96 ± 91 ng/ml.
Discussion Serum PCT values were less than 0.1 ng/ml in healthy
individuals, but markedly increased, mostly due to extra-thyroid
production in cases of severe infection. Recent findings suggest
that sources of PCT may include liver cells and monocytes/
macrophages. PCT is consistently increased after endotoxin
injection, suggesting an association of endotoxin with septic shock
and high PCT serum concentration.
Conclusion Our results may suggest that PMX-DHP can reduce
various cytokines and serum PCT in the survival group.
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Background Community-acquired pneumonia (CAP) is routinely
treated with antibiotic courses of 10–14 days. Procalcitonin
(ProCT) is elevated in systemic bacterial infections, but remains
low in viral infections. Its potential as a tool to guide AB
prescription in lower respiratory tract infections has been shown
[1]. This study aims to evaluate ProCT stewardship to reduce AB
duration in patients with CAP.
Methods From a prospective, single-blinded, randomized study,
data of 200 patients with CAP were analyzed. The standard group
(n = 101) received antibiotics as generally recommended. In the
ProCT group (n = 99), ProCT levels were measured at days 4, 6
and 8 and antibiotic therapy was discontinued if levels were
< 0.25 µg/l, measured with a sensitive assay (Kryptor PCT,
BRAHMS, Germany). At baseline and at follow-up at 6 weeks, a
standardized work-up was performed.
Critical Care    March 2005 Vol 9 Suppl 1 25th International Symposium on Intensive Care and Emergency Medicine
S71
Results Baseline characteristics in both groups (Standard/ProCT)
were similar (P values of quality of life score [41 ± 22/43 ± 21],
temperature [38 ± 1/38 ± 1], leucocytes [13 ± 6/14 ± 7],
C-reactive protein [160 ± 95/142 ± 120] and ProCT [median:
0.4/0.6] were not significant). Fifty-eight percent of patients had a
high (class IV, V) pneumonia severity index. In the standard group,
the mean duration of antibiotic therapy was 14.2 ± 7.3 days as
compared with 6.2 ± 6.2 days in the ProCT group (P < 0.001). A
total 99.5% of patients underwent a follow-up. There were no
differences in clinical, radiographic and laboratory outcome data as
well as in mortality (14.5%) between groups.
Conclusions The duration of antibiotic treatment in patients with
CAP can be markedly and safely reduced using a ProCT-guided
treatment algorithm, with similar outcome. In view of the increasing
antimicrobial resistance and costs, these findings have important
clinical implications.
Reference
1. Christ-Crain M, et al.: Lancet 2004, 363:600-607.
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Objectives Early recognition of sepsis is of particular interest,
because this could expedite the initiation of early specific treatment
and could potentially improve patient outcome. The aim of this
study was to determine the value of procalcitonin (PCT), white
blood cell count (WBC), IL-6, terminal complement complex (C5b-
9) and C-reactive protein (CRP) in the prediction of postoperative
sepsis.
Methods In a prospective clinical observational study 72 non-
infected patients admitted postoperatively to an ICU who required
> 24 hours ICU treatment were recruited. Blood samples were
collected on the first, second, third, fifth, seventh and 10th day.
Each patient was examined daily for signs and symptoms of
infection. Values were given as median and interquartile range
(IQR). Diagnostic accuracy of the parameter determined at study
entry was expressed as the area under the receiver-operating
curve (AUC).
Results Of 72 recruited patients 11 developed postoperative
sepsis and 18 severe sepsis or septic shock. Infection was
microbiology proven in 22 of 29 patients (76%). The patients
enrolled had an age of 68 (21.5) years and an initial SOFA score
of 5 (4). After 28 days, 12 patients had died, 60 were survivors.
Table 1
Diagnostic performance of markers to predict sepsis on inclusion
day
PCT IL-6 C5b-9 WBC CRP
Cut-off value 2 150 600 12,000 150 
ng/ml pg/ml ng/ml mm–3 mg/ml
Sensitivity (%) 52 90 31 41 55
Specificity (%) 86 40 65 65 60
AUC 0.70* 0.80* 0.51 0.54 0.64
*P < 0.05.
Conclusion Our results indicate that in postoperative patients prior
to the onset of any clinical deterioration PCT may be a specific
predictive marker and IL-6 may be a sensitive predictive marker for
sepsis.
Acknowledgements This study was supported by grants from the
R&D RLBUH NHS Trust support fund and from the R&D fund of
the University of Liverpool.
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Objective Cardiogenic shock shows a high incidence of infections.
The preceding myocardial trauma and shock as well as bacterial
infection may trigger an inflammatory response. We investigated
whether different inflammation parameters can alternatively be
related to myocardial trauma/shock versus infection.
Patients Fifteen patients (10 males/five females), mean age
69 ± 10.5 years and mean APACHE III score 83.36 ± 14.1, were
enrolled in this prospective study. Cause of ICU admission was
cardiogenic shock due to myocardial infarction (MI). Inclusion
criteria were need of mechanical ventilation and vasopressor
support. All patients developed respiratory tract infections and
were treated with antibiotics.
Methods Measurements started on day 1 after MI and were
performed daily until day 10. Polymorphonuclear leukocyte (PMN)
functions were measured in fresh whole blood: PMN migration was
measured with a membrane filter method under FMLP stimulation;
ROS release with luminol-enhanced chemiluminescence under
PMA stimulation. Blood levels of PMN elastase, PMN blood count,
sL-selectin, IL-6, IL-10, PCT, CRP, neopterin; and the infarction-
related and shock-related parameters Troponin T and lactate were
measured with routine methods. Changes in the parameters over
time were determined with linear regression of log y.
Results Among the parameters, three groups of reactivity
emerged. Parameters of group I developed maximum reactions on
days 1, 2 or 3 after MI, and values decreased significantly over the
observation period. This group included PMN elastase, IL-6, PCT,
Troponin T and lactate. Group II parameters developed maxima
respectively minima on days 3, 4 and 5. This group included PMN-
ROS release and neopterin (maxima), and PMN blood count and
migration (minima). Parameters of group III showed maximum
values on days 2 or 3, but no significant decrease (CRP and
IL-10), or no distinct changes at all (sL-selectin). Infections
appeared on day X = 3.92 ± 1.25 standard deviation after MI.
Thus, top values of group II parameters coincided with the onset of
infection, while in group I high values followed immediately MI and
shock.
Conclusion PMN-elastase, IL-6 and PCT parallel Troponin T and
lactate can thus be considered to be triggered by myocardial
trauma and shock. They are no indicators of infection. Blood PMN
numbers, migration and ROS release as well as neopterin reached
minimum/maximum values around the clinical manifestation of
infection, suggesting associations with infections. Their decrease/
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Introduction Cardiopulmonary bypass (CPB) causes an
inflammatory response with clinical and biological changes. This
systemic inflammatory response syndrome (SIRS) is a result of
several stimuli such as exposure of blood to non-physiological
surfaces, surgical trauma, myocardial ischaemia-reperfusion and
endotoxin release. Because of this response, conventional clinical
and biological signs may be misled in the diagnosis of
postoperative complications, particularly infection. Procalcitonin
(PCT) is useful as a marker of infection. Further studies suggested
that PCT is an early, sensitive and specific indicator of infection but
recent investigations showed increases in other conditions
associated with systemic inflammation, such as severe trauma,
burns and heat stroke. The aim of this study was to determine the
normal profile of PCT during preoperative, peroperative and
postoperative (PO) periods in patients undergoing cardiac surgery
with cardiopulmonary bypass (CPB).
Methods We have measured serum PCT levels in 91 patients
undergoing elective cardiac surgery with CPB. PCT levels were
measured after induction of anaesthesia (baseline), after CPB and
PO days 1, 2, 3 and 4. The demographic data of all patients, cross-
clamping and bypass times, inotropic medication or intra-aortic
balloon pump (IABP) needs were recorded. Repeated-measures
analysis of variance was used for statistical analyses.
Results Baseline PCT levels were measured before the operation
(< 0.05 ng/dl) and all increased at the end of the CPB. The
increase in serum PCT levels had a peak on the first postoperative
day (P < 0.001) (Fig. 1). PCT levels were higher in some patients
whose cross-clamping and total bypass times were longer than
others or they needed inotropic agents or IABP. Repeated variant
analyses showed that there was a closed relationship between the
PCT levels and cross-clamp and total bypass times, need of
inotropic medications and IABP (Fig. 2).
Conclusion Although PCT is a useful marker of infection, it can be
affected from many factors (CPB itself, prolonged operation, cross-
clamping and bypass time, inotropic agent and IABP need, etc.)
during CPB. So PCT alone is not enough to decide for infection in
the early postoperative period in cardiac surgery patients.
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Introduction The aim of this prospective study was to determine
the prognostic value of serum levels of procalcitonin (PCT) in
patients early after cardiac surgery using cardiopulmonary bypass
(CPB). We studied whether PCT is useful as an early prognostic
marker in cardiosurgical patients with respect to complications and
infections and whether PCT is a specific marker for the occurrence
of infections.
Methods We studied 74 patients (mean ± standard deviation age,
65 ± 9) after elective cardiac surgery and daily until the second
postoperative day. Demographic data, operative data and clinical
endpoints (SIRS, infection and severe complication) were
documented. Complications were defined as circulatory failure,
respiratory failure, renal dysfunction, hepatic dysfunction, and
coagulation dysfunction.
Results SIRS occurred in 46 patients (62%), infection in four
patients (5.4%) and non-infectious complication in 35 patients
(47.2%). Circulatory failure occurred in 29 patients, respiratory
failure in 19 patients, renal failure in two patients, hepatic
dysfunction in six patients, coagulation dysfunction in eight
patients. Serum PCT concentrations increased in all patients with
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The procalcitonin (PCT) levels and distribution of measurement times:
A, baseline; B, after cardiopulmonary bypass; C, postoperative (PO)
day 1; D, PO day 2; E, PO day 3; and F, PO day 4.
Figure 2 (abstract P169)
Procalcitonin (PCT) levels in patients with and without intra-aortic
balloon pump (IABP).
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peak levels occurring on the first postoperative day (PCT1: 0.495
standard error of the mean [SEM] 0.068, PCT2: 2.62 SEM 0.42,
PCT3: 1.65 SEM 0.23). The serum PCT levels were increased in
patients with SIRS compared with patients with no-SIRS. Using
the Mann–Whitney U test we found a statistically significant
increase on PCT levels in patients with infection (P = 0.001) and in
patients with non-infectious complications (P = 0.005). PCT was
not significantly different in patients with infectious complications
in comparison with patients with non-infectious complications.
There was good correlation (Pearson correlation) between PCT
level and CPB duration, duration of aortic clamping and EURO
score.
Conclusion PCT is a valuable prognostic marker early after
cardiac surgery using CPB with respect to infection and severe
complications. However, PCT does not differentiate infectious and
non-infectious complications.
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Purpose To determine the role of the procalcitonin test in the
clinical and laboratory evaluation of the clinical severity and the
intensity of the systemic inflammatory reaction in patients with
different forms of acute pancreatitis.
Design A prospective study.
Patients The study covered 50 patients with acute pancreatitis of
various aetiologies. Patients were subdivided into five groups
depending on morphological and microbiological criteria: (1) 10
patients with acute interstitial pancreatitis (AIP); (2) 16 non-
operated patients with limited sterile pancreatic necrosis (LSN-N);
(3) six operated patients with limited necrosis (LSN-O); (4) six
patients with extensive sterile necrosis (ESN); (5) 12 patients with
infected forms of pancreatic necrosis (IPN).
Methods Plasma procalcitonin (PCT) concentrations were deter-
mined using an immunoluminometric method. The clinical severity
of the patients’ condition was evaluated with the help of the
integral APACHE II scale. Laboratory and instrumental techniques
of investigation were supplemented by calculations of the
leucocyte intoxication index.
Results The mean PCT concentration in infected forms of
destructive pancreatitis was markedly higher than in acute
interstitial pancreatitis or sterile pancreatic necrosis, at a level of
2.95 ± 0.84 ng/ml. The PCT concentration rose as the patient’s
condition became more severe, and as it evolved from an interstitial
form to infected pancreatic necrosis. A direct correlation was
established between the PCT concentration and the APACHE II
score (r = 0.56). A PCT concentration > 2 ng/ml is a threshold
level indicating infection of pancreatic tissue.
Conclusions The procalcitonin test is an objective criterion in the
complex evaluation of clinical severity in patients with acute
pancreatitis. Monitoring of the PCT concentration assists in the
early diagnosis of infective complications of acute pancreatitis, and
allows surgical and intensive-care treatment strategies to be
optimised in these patients.
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Aim To evaluate the diagnostic significance of procalcitonin (PCT)
in critically ill patients and to compare its changes with changes of
other acute phase reactants.
Methods In 45 patients a total of 188 investigations of orosomucoid,
alpha-1-antitrypsin, C-reactive protein (CRP), PCT, albumin, pre-
albumin, cholinesterase, number of leukocytes, platelets, fibrinogen
and indexed Quick’s test (INR) were carried out. The investigations
were repeated as requested by the clinical state. Also followed
were the results of haemoculture, bacteriological investigations,
the presence of the systemic inflammatory response syndrome
(SIRS), frequency of sepsis, severe sepsis, septic shock and the
number of organ failures. PCT was investigated by LUMItest-PCT-
kit (BRAHMS Berlin, Germany), and other parameters by routine
laboratory methods.
Results From all investigated acute phase reactants only PCT and
CRP offered the highest diagnostic and differentially diagnostic
value. Therefore only these two parameters are presented in the
following survey together with the number of leukocytes and
temperature. Based on the criterion of the presence of apparent
infection (no:yes [134:50 findings]) and positivity of bacteriological
cultivation (no:yes [42:143]), there was a significant difference in
PCT and temperature, but not in CRP or number of leukocytes. As
for haemoculture positivity (no:yes [169:16]), a significant
difference was only found for the temperature. For the presence of
SIRS (no:yes [52:142]), the differences were significant for PCT,
CRP, as well as for temperature and leukocytes.
MODS was divided according to the number of affected organs
into categories 1–4 (number of findings 47:56:63:12).The found
values: PCT (ng/ml) 0.9 ± 1.9, 1.4 ± 2, 3.2 ± 4.4 and 7.5 ± 5.9,
and CRP (mg/l) 108 ± 65, 195 ± 129, 191 ± 165 and 130 ± 62.
Out of all findings, 36 were classified as sepsis, 50 as severe
sepsis and 48 as septic shock. In following the order parameter, its
value in sepsis, severe sepsis and septic shock is presented. The
significance of differences on the 1% level is marked; it is for
sepsis:severe sepsis +, for sepsis:septic shock ++ and for severe
sepsis:septic shock +++; on the 5% level the same symbols are in
parentheses. Leukocytes (109/l): 11.8 ± 4.9, 16.0 ± 7.6,
13.9 ± 8.8 (+, ++). CRP (mg/l): 128 ± 86, 191 ± 148, 204 ± 155
([+], ++). PCT (ng/ml): 1.26 ± 2.31, 4.06 ± 6.46, 6.35 ± 11.91
(+, ++). Temperature (°C): 38.3 ± 0.7, 38.5 ± 0.8, 39.0 ± 1.2 (+,
++, +++).
Conclusion PCT helps to distinguish the gravity of the patient’s
state as shown by different values in sepsis and severe sepsis or
by its relations to MODS. The investigation of PCT is demanded
for more accurate diagnosis of infected patients and in case of
discrepancy between the clinical state and CRP.
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Introduction C-reactive protein (CRP) is a marker of inflammation
used to monitor the course of infection and inflammatory diseases.
Available online http://ccforum.com/supplements/9/S1
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In critically ill patients the presence of several confounding factors
very frequently covers up the site of infection. We aimed to
investigate whether serum CRP levels vary according to the site of
infection.
Methods Patients with sepsis, severe sepsis or septic shock were
included. Serum C-reactive protein was measured within the first
hours of ICU admission and day 1. Patients were classified
according to the site of infection.
Results One hundred and fifty-eight patients with sepsis, severe
sepsis and septic shock were included. Main sites of infection
were abdominal in 44.3%, the lungs in 39.8%, the urinary tract in
8.2% and the bloodstream in 3.8%. Median levels of serum CRP
on day 1 were 11.2 mg/dl, 14.3 mg/dl, 15.9 mg/dl and 20.3 mg/dl,
for the lungs, bloodstream, urinary tract and abdominal, respectively.
On day 1, CRP levels in patients with abdominal sepsis were
significantly higher than in those with pneumonia-induced sepsis
(21.6 ± 10.7 mg/dl vs 13.6 ± 10.3 mg/dl, P < 0.05).
Conclusion Serum CRP concentrations are higher in patients with
abdominal sepsis than in patients with pneumonia induced-sepsis.
P174
C-reactive protein as a marker of septic shock and outcome in
the intensive care unit
M Theodorakopoulou1, N Skabas2, M Lignos1, A Kandili2, 
S Ioannidou2, E Kavadia2, A Armaganidis1
1Attiko University Hospital, Athens, Greece; 23rd Hospital of Ika,
Athens, Greece
Critical Care 2005, 9(Suppl 1):P174 (DOI 10.1186/cc3237)
Introduction As an acute phase protein C-reactive protein (CRP)
is directly related to the inflammatory response and it has been
used to monitor the course of infection. The association of CRP
levels and septic shock are not known. In this study we will
examine the relationship of CRP levels to septic shock and to the
outcome.
Methods A prospective study on a six-bed ICU of a university
hospital and on a five-bed medical ICU of a tertiary care hospital.
Data were collected prospectively over a period of 1.5 years. Sixty-
eight patients were included in the study. Patient that stayed in the
ICU for less than 5 days were excluded from the study, as well as
patients that had infection at the time of admission. CRP, APACHE
II score, SOFA, WBC, platelets and use of inotropes were
recorded on days 1, 3, 6, 9, 12 and 15. Patients were followed up
for a septic episode up to day 15 and were followed up to their
discharge for outcome. All patients that were included in the study
met the ACCP/SCCM consensus criteria for sepsis and septic
shock. Serum CRP levels are expressed as mean ± standard
deviation.
Results The group of patients were divided into septic (n = 28)
and nonseptic (n = 40). Septic shock showed a strong relationship
to CRP levels. Twenty-eight patients (41%) developed septic
shock and all these patients had significantly higher CRP levels not
only upon admission (13.3 ± 8.9 mg/dl vs 5.2 ± 7.1 mg/dl), but the
high values persisted the following days as well. The overall
mortality rate was (27.8%). Nonsurvivors had significantly higher
CRP levels than survivors. Patients that showed further increase of
CRP on day 3 showed a higher mortality rate (64%) when
compared with patients that showed a reduction of CRP on day 3
(22%) and remained low. CRP values that remained high
(>15 mg/dl) after day 9 were associated with an even higher
incidence of death (72%). APACHE II and SOFA scores,
leucocyte count and platelets showed no significant relationship to
CRP on either groups. Furthermore, APACHE II and SOFA scores
were similar for both groups upon admission.
Conclusions In our ICU elevated CRP values upon admission
correlate strongly with increased risk of death. Persistently high
CRP values correlate with even poorer outcome. Moreover, CRP is
a good marker of septic shock. Overall, persistently high CRP
values are associated with longer stay in the ICU, with septic
shock, and with higher mortality. Since CRP seems to be a marker
of an ongoing inflammatory process, then following the trends of
such a marker might help in decision-making for further inter-
ventions on septic patients.
P175
Serial changes in soluble triggering receptor expressed on
myeloid cells in the lung during ventilator-associated
pneumonia
R Determann1, J Millo2, S Gibot3, M Vroom1, C Garrard2, 
M Schultz1
1Academic Medical Center, Amsterdam, The Netherlands; 2John
Radcliffe Hospital, Oxford, UK; 3Réanimaton Medicale, Nancy,
France
Critical Care 2005, 9(Suppl 1):P175 (DOI 10.1186/cc3238)
Introduction The diagnosis of ventilator-associated pneumonia
(VAP) remains a clinical challenge. Biological markers may facilitate
the diagnosis of VAP. The triggering receptor expressed on
myeloid cells (TREM-1) is a member of the immunoglobulin super-
family and is upregulated on phagocytes in the presence of
bacterial products. Soluble (s) TREM-1 in bronchoalveolar-lavage
fluid has been shown to be a promising biological marker for
pneumonia. In the present study we performed serial measure-
ments of sTREM-1 in lungs and plasma of patients who were at
risk of developing VAP.
Methods In a single-centre prospective study, a non-directed
bronchial lavage (NBL) was performed on alternate days in
patients expected to require mechanical ventilation for > 5 days. A
total of 28 patients were studied, nine of whom developed VAP.
Diagnosis of pneumonia required a combination of clinical features
plus microbiological confirmation. Levels of sTREM-1 were
measured in NBL fluid (NBLF) and matching plasma samples by
ELISA. Data are presented as medians (± IQR). Changes over time
were tested within each group separately using analysis of
repeated measures (linear mixed models). The P value in Fig. 1
denotes statistical significance.
Results Levels of sTREM-1 in NBLF (upper graphs) and plasma
(lower graphs) of patients without VAP (left graphs) and of patients
developing VAP (right graphs). In the first patient group ‘day 0’
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represents the day at which mechanical ventilation was initiated, in
the latter group ‘day 0’ denotes the day at which the diagnosis of
VAP was made clinically. The P value indicates statistical
significance of rise of local sTREM-1 levels.
Conclusion NBLF sTREM-1 levels significantly rise in ventilated
patients developing VAP. These results further confirm the
usefulness of sTREM-1 as a biological marker for VAP.
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Introduction In general, cells responded to stresses by the
following hierarchy: (1) stored mediator release reaction phase
(e.g. serotonin, histamine); (2) lipid mediator generation/release
phase (e.g. PGs, LTs, endocannabinoids); (3) genomic reaction
phase (e.g. self-defensive protein generation phase through NF-
κB, AP-1 activation). As the last response, we propose (4) high
mobility group box 1 (HMGB1) releases from necrotic cells.
In this study we present intracellular and intercellular dynamics of
HMGB1, and their roles in the pathogenesis in inflammation and
organ failures.
Methods and results We developed a specific and sensitive
HMGB1 assay by the ELISA method as presented elsewhere in
this congress (Yakabe K, et al., P177). Using this assay method,
we evaluated serum HMGB1 levels in patients with various
diseases. As a whole, the HMGB1 concentrations were elevated in
various diseases that were correlated to the severity of organic
cellular damages. These include infections, trauma, surgical
operations, malignancies, and so on. The marked increase of
HMGB1 (>10 ng/ml) was suggestive of presence of severe organ
damages. However, the increased level of HMGB1 was not always
sustained at higher levels and resultant lethality — because in some
cases we observed that the elevated levels of HMGB1 rapidly
decreased to subnormal or normal ranges with resulting recovery
of the illness. This result suggested the presence of degrading or
clearance mechanism of the protein. Thus, we examined the fate of
the increased level of HMGB1 in the circulation.
At present, we have identified at least three pathways to decrease
as well as produce the clearance of the circulatory HMGB1. The
first is the degradation of HMGB1 by plasmin. We found that
plasmin efficiently degraded HMGB1. The second way is the
endothelial-dependent HMGB1 degradation by protein ‘X’.
HMGB1 binds to endothelium and be degraded by ‘X’. The third
way is the binding of HMGB1 by specific binding sites on diverse
cells. These may include RAGE and proteoglycans. By these three
routes, HMGB1 may be efficiently sequestered from the circulation
and localized and enriched to the damaged tissue. The HMGB1 in
situ acted as a stem cell inducer resulting in repair of damaged
tissue/organ.
Discussion HMGB1 is released from most necrotic cells and
behaves as a ‘testament’ mediator because this protein may be
released in necrotic tissues including infection, injury and so on.
The localized HMGB1 may act as an immune adjuvant and stem
cell chemoatractant as recently described, and may play an
important role for self-defense and repair of damaged tissue.
However, if the HMGB1 released in cellular necrotic lesions
entered into the circulation, this may diffuse the inflammation, and
result in ‘metastasis’ of inflammation and organ failures. Therefore,
HMGB1 should be enriched in injury sites, inhibiting its diffusion.
We propose that this HMGB1 sequestering system is composed
of plasmin, syndecan and endothelium. When this HMGB1-
sequestering system is impaired, HMGB1 will enter into the
circulation and act as a mediator of organ failure.
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High mobility group box 1 (HMGB1) quantified by ELISA that
dose not cross-react with HMGB2
K Yakabe1, S Yamada1, M Kobayashi2, I Maruyama3
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Introduction Recently, high mobility group box 1 (HMGB1) was
identified as a late mediator of endotoxin lethality. Patients with
sepsis who succumbed to infection had increased serum HMGB1.
However, it revealed that HMGB1 and HMGB2, with extremely
high homology (81%) to HMGB1, coexist in the serum. We report
an ELISA method we have developed that measured only HMGB1
without simultaneous determination of HMGB2.
Methods We developed anti-HMGB1 polyclonal and anti-
HMGB1, 2 monoclonal antibody. We checked that developed
antibodies both cross-reacted with porcine, bovine, rabbit, rat and
mouse HMGB1 by western blotting because of more than 98%
identity in amino acid sequence between these kinds and human.
Using these antibodies, we developed a sandwich ELISA method
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to measure HMGB1 specifically but be insensitive to HMGB2 in
human serum. Using this method, we measured HMGB1 in
samples obtained from 44 patients with septic shock and
examined the following: (1) the participation of HMGB1 in septic
shock, (2) the correlation of cytokines and HMGB1 in septic
shock, and (3) the correlation of HMGB1 level and the therapeutic
effect of endotoxin adsorption therapy (PMX-DHP).
Results With this method, the detection limit was 1 and 0.3 ng/ml,
respectively, using the chromogenic substrate TMBZ and the
chemoluminescent substrate PS-atto. This assay system showed
85–108% recovery by external addition recovery test. (1) The
HMGB1 concentration in serum was significantly higher in the
septic shock death group than the survival group. In addition, there
appeared to be a positive correlation between serum HMGB1
concentration and SOFA score. (2) A negative correlation was
observed between serum HMGB1 and cytokine concentration. (3)
The HMGB1 concentration in serum decreased after PMX-DHP in
all cases. In particular, the serum concentration decreased
significantly after PMX-DHP in the survival group.
Discussion Using our assay method, HMGB1 was detected in the
blood of patients with septic shock. The results suggested that
HMGB1 plays an important role in aggravation of the condition in
septic multiple organ failure.
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High-mobility group box 1: role in ARDS
A Ishizaka1, S Hashimoto2
1Keio University School of Medicine, Tokyo, Japan; 2Kyoto
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Extracellular high-mobility group box 1 (HMGB-1), first isolated
approximately 30 years ago from the thymus as a chromosomal
protein and recognized as a transcriptional factor, has recently
been proposed as one of the late mediators of sepsis and
lipopolysaccharide (LPS) endotoxin acute lung injury (ALI) [1,2]. In
recent studies, HMGB-1 has been implicated in the development
of arthritis, activation of human monocytes, smooth muscle cell
chemotaxis, and induction of adhesion molecules in endothelial
cells. These observations suggest that HMGB-1 is a key mediator
of cell injury, and that its inhibition may be key in improving clinical
outcomes. We conducted a translational study to examine the
participation of HMGB-1 in the pathogenesis of ALI caused by
sepsis. To test the hypothesis that HMGB-1 plays a key role as a
late mediator, we first measured its concentrations and those of its
related compound, HMGB-2, in the blood and lungs of patients
presenting with septic ALI/ARDS, and in a murine model of LPS-
induced lung injury. We then studied the localization of the
extracellular HMGB-1 protein and examined the anti-inflammatory
effects of anti-HMGB-1 antibodies in our LPS-induced lung injury
murine model. The direct effects of HMGB-1 and HMGB-2 on the
lung were also examined. This study was performed to examine the
putative role of HMGB protein in the pathogenesis of ALI.
Observations were made (1) in 21 septic patients with ALI and 15
patients with normal lung function, and (2) in a mouse model, 24
hours after intratracheal instillation of lipopolysaccharide. The
concentrations of HMGB-1 were increased in plasma and lung
epithelial lining fluid of patients with ALI and mice instilled with
LPS. LPS-induced ALI was mitigated by anti-HMGB-1 antibody.
Although this protein was not detected in the plasma of control
humans or mice, the concentrations of HMGB-1 in lung epithelial
lining fluid or in bronchoalveolar lavage fluid were unexpectedly
high. The nuclear expression of HMGB-1 was apparent in epithelial
cells surrounding terminal bronchioles in normal mice, while its
nuclear and cytoplasmic expression was observed in alveolar macro-
phages in LPS-instilled mice. Lung instillation of HMGB-2 did not
cause as much inflammation as HMGB-1. Extracellular HMGB-1
may play a key role in the pathogenesis of clinical and experimental
ALI. However, its expression in normal airways is noteworthy, and
suggests that it also plays a physiologic role in the lung.
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Background and aim Cardiac surgery with cardiopulmonary bypass
(CPB) stimulates the synthesis of the proinflammatory cytokines
such as tumor necrosis factor alpha (TNF-α), IL-6, IL-8, and anti-
inflammatory cytokines such as IL-10. This study was intended to
analyze the effect of preoperative administration of dexamethasone
on gene expression of proinflammatory and antiinflammatory
cytokines and heat shock protein in the myocardium.
Methods Neonates (n = 22) scheduled for arterial switch operation
were double-blinded randomized to receive dexamethasone
(n = 11) (1 mg/kg) or saline (n = 11) given intravenously 2 hours
before induction of anesthesia. Biopsies were taken from the right
atrial appendage immediately before initiation of CPB. Myocardial
gene expression and synthesis of TNF-α, IL-1β, IL-6, IL-8, IL-10,
and of heat shock proteins HSP32, HSP90, and HSP70 were
detected by quantitative real-time RT-PCR and by western blot.
Results Proinflammatory and anti-inflammatory cytokines as well as
HSPs were expressed at the mRNA level. IL-6 and HSP70 were also
expressed at the protein level. Expression of mRNA encoding for
TNF-α, IL-1β, IL-6, IL-8, IL-10, and HSP32 were lower in neonates
treated with dexamethasone than in the others. In contrast,
expression of HSP70 mRNA and for HSP90 mRNA and protein
levels of IL-6 and HSP70 were not different between both groups.
Conclusion Our study shows for the first time expression of
proinflammatory and antiinflammatory cytokines and of HSPs in the
myocardium of human neonates undergoing cardiac surgery.
Dexamethasone given before cardiac surgery is associated with a
reduction of cytokine expression at induction of CPB. This might
provide myocardial protection.
P180
Pretreatment of dexamethasone before cardiopulmonary bypass
upregulates intrahepatic synthesis of IL-10 via the transcription
factors Sp1 and Sp3 and CCAAT/enhancer-binding protein
Q Ma, M Wöltje, K Schumacher, M Sokalska, 
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Background and aim IL-10 is an anti-inflammatory cytokine
produced by a variety of cell types including Kuffper cells and
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hepatocytes. A recent study showed that IL-10 gene expression
induced by endotoxin (LPS) in mouse macrophages is controlled
by the cooperation of the promoter-selective transcription factors
(Sp)1 and Sp-3 as well as by CCAAT/enhancer-binding protein β
(C/EBPβ). Dexamethasone (Dex) has been recommended during
cardiac surgery since it increases blood IL-10 levels during cardio-
pulmonary bypass (CPB) and reduces the release of proinflam-
matory mediators including tumor necrosis factor alpha. In an
experimental model of cardiac surgery, it reduces the production of
iNOS and COX-2.
This study was designed to identify the signaling pathways
involved in intrahepatic overexpression of IL-10 induced by
pretreatement by Dex before CPB.
Methods Animals were treated with Dex (1 mg/kg) (n = 9) or with
saline (n = 6) given intervenously before normothermic CPB.
Samples of liver tissue were taken before and 6 hours after CPB.
IL-10 mRNA was assessed by competitive RT-PCR. Protein levels
of IL-10, iNOS and COX-2 were assessed by western blot.
Phosphorylation of extracellular regulating kinase (ERK1/2) and of
the inhibitory protein of NF-κB (IkB) as well as nuclear protein
levels of C/EBPβ were also detected by western blot. Activation of
Sp1 and Sp3, C/EBPβ, NF-κB, and AP-1 were assessed by
electrophoretic mobility shift assay with supershift. Liver tissue
damage score was assessed by standard histology.
Results Pigs treated with Dex showed significantly higher
intrahepatic concentration of IL-10 and lower concentrations of
iNOS and COX-2 than the others. The former also showed lower
tissue damage score. This upregulation of IL-10 and down-
regulation of iNOS and COX-2 observed in the treated group was
associated with a higher activation of Sp1 and Sp3 as well as
C/EBPβ. Moreover, levels of phospho-ERK1/2 and of C/EBPβ in
nuclear extract were significantly higher 6 hours after CPB in pigs
treated with Dex than in the others. Activation of NF-κB and of
activator protein-1 was not significantly different between both
groups.
Conclusion Our results show for the first time that Dex
administration prior to CPB upregulates IL-10 via Sp1 and Sp3 as
well as throughout C/EBPβ activation. This leads to attenuation of
expression of iNOS and COX-2 and to hepatic protection.
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Background and aim Moderate hypothermia during CPB inhibits
intramyocardial tumor necrosis factor alpha (TNF-α) synthesis.
Since the expression of TNF-α and other inflammatory mediators
such as cyclooxygenase-2 (COX-2) and inducible nitric oxide
synthase (iNOS) is regulated by the NF-κB and activator protein
(AP)-1 pathways, this study was intended to analyze the effect of
moderate hypothermia during CPB on these signaling pathways in
the myocardium.
Methods Twelve young pigs were randomly mounted on
standardized CPB in moderate hypothermia or normothermia
(temperature 28°C or 37°C, respectively, n = 6 each group).
Myocardial probes were sampled from the right ventricle before,
during and 6 hours after CPB. Messenger RNA encoding for
TNF-α was assessed by competitive RT-PCR. Protein levels of
TNF-α, iNOS, and COX-2 were assessed by western blot.
Activation of NF-κB and phosphorylation of its inhibitory protein
IkBa, activation of AP-1 and phosphorylation of its complex c-Jun
as well as of mitogen-activated protein kinase (MAPK) p38 were
assessed by electrophoretic mobility shift assay with supershift
and/or western blot, respectively.
Results Both TNF-α mRNA and TNF-α protein were detected as
soon as 30 min after initiation of bypass in both groups. At that time,
expression of TNF-α mRNA and protein levels tended to be lower in
pigs operated on under moderate hypothermia than those operated
on under normothermia (P < 0.1, respectively). Moreover, pigs
operated on under moderate hypothermia showed lower expression
of TNF-α mRNA and protein levels that the others 6 hours after
CPB (P < 0.05, respectively). The course of the expression of
COX-2 but not that of iNOS during and after CPB paralleled that of
TNF-α. The activation of p38 MAPK and of its downstream effector
AP-1 was lower in animals operated on in hypothermia than in the
others (P < 0.05, respectively). In contrast, phosphorylation of IkB
and NF-κB activity were similar in both groups.
Conclusion This study shows that the inhibition of the
intramyocardial expression of TNF-α and of its secondary mediator
COX-2 related to moderate hypothermia during CPB is associated
with the inhibition of p38 MAPK–AP-1, but not of the NF-κB
pathway.
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Introduction Recent reports indicate that inducible nitric oxide
synthase (iNOS) can be detected in the serum of sepsis patients.
In order to study the potential clinical utility of iNOS, both an
analytical mass standard and an automated, specific immunoassay
have been developed. A subcloned cell-line derived from DLD-1
cells has been developed that can be induced to express high
levels of human iNOS. A prototype Access®-based immunoassay
has also been developed.
Methods DLD-1-5B2 mammalian cells were grown in tissue
culture using DMEM + 10% FCIII media. Cells were grown to
confluency and changed to induction media containing DMEM plus
interferon gamma, IL-1β and tumor necrosis factor alpha. Following
induction, cells were incubated in 5% CO2 at 37°C for
18–30 hours. INOS expression was evaluated with the prototype
immunoassay consisting of dual iNOS-specific monoclonal
antibodies and by production of nitric oxide (NO) as determined by
nitrite detection using the Griess assay. iNOS was extracted from
induced DLD-1 cells by freeze–thaw disruption.
Results Production of NO was not detected by the Griess assay
until 10 hours after induction. The production of NO increased
proportionally from 2.6 µM NO at 10 hours to 18.7 µM at
30 hours. Using the prototype immunoassay, iNOS was detected
in cell extracts at 2 hours after induction at a concentration of
2.4 ng per 106 cells. Levels increased steadily until reaching a
plateau of approximately 150 ng per 106 cells from 18 to
30 hours. While the iNOS immunoassay was much more sensitive
in detecting the early stages of iNOS induction than the
measurement of NO production, the increase in iNOS expression
was proportional to NO production over the first 18 hours post
induction, once NO became measurable.
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Summary DLD-1-5B2 cells can provide a stable source of human
iNOS. NO production is proportional to mass of iNOS produced
up to 18 hours in confluent, induced cells. Nominal values of iNOS
detected by immunoassay were based upon calibration with
commercial murine iNOS standards. Additional work is required to
optimize the prototype for clinical use. Purification, characterization,
and analytical mass assignment of iNOS from DLD-1-5B2 cells are
in progress to provide mass standardization for the iNOS immuno-
assay.
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Introduction It has been reported that hemoperfusion with a
column of polymyxin B immobilized on fibers (PMX-DHP)
ameliorates hyperdynamic circulation in septic shock and improves
survival rate. However, a variety of criteria for the introduction of
PMX-DHP in sepsis patients are used by a number of facilities,
standard criteria have yet to be established. We introduced PMX-
DHP using oxygen metabolism as an indicator, and evaluated the
effectiveness.
Subjects and methods Subjects consisted of 24 sepsis patients
(19 men and five women; mean age 60 ± 15.4 years) who had
undergone PMX-DHP between January 2003 and October 2004.
A thermodilution catheter was inserted into all patients. Mixed
venous oxygen saturation (SvO2), oxygen delivery index (DO2I),
oxygen consumption index (VO2I), and oxygen extraction ratio
(O2ER) were used as indicators of systemic oxygen metabolism,
and the PCO2 gap (gastric submucosal carbon dioxide partial
pressure minus the partial pressure of carbon dioxide in arterial
blood) measured by gastric air tonometry was used as the
indicator of tissue oxygen metabolism. These parameters were
measured before and 24, 48, 72, and 120 hours after PMX-DHP
introduction. The severity of infection was evaluated by the Acute
Physiology and Chronic Health Evaluation (APACHE) score.
Results Life expectancy: 18 patients survived; six died. APACHE
scores of survivors and non-survivors were 22 ± 4.0 and 24 ± 3.5,
respectively. There was no significant difference. In the survivors
SvO2, DO2I, VO2I, and O2ER had shifted to the normal range prior
to treatment. Pretreatment, the PCO2 gap was 17 ± 3.6 mmHg in
these patients, who presented markedly dysfunctional tissue
oxygen metabolism. However, this decreased over time, and at
120 hours after treatment the PCO2 gap had decreased
significantly, improving to values in the normal range. On the other
hand, the non-survivors also presented high PCO2 gap levels
before treatment, similar to the survivors. Although DO2I was within
the normal range, VO2I and O2ER were lower than normal.
Conclusion Although dysfunctional tissue oxygen metabolism
occurred in both the survivors and non-survivors, non-survivors also
presented dysfunctional systemic oxygen intake. These results
suggest that early-stage introduction of PMX-DHP is desirable,
when systemic oxygen metabolism is stable.
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Introduction We previously reported that early introduction of
hemoperfusion with an immobilized polymyxin B fiber column
(PMX-DHP) improved life expectancy. This time, we report that
early introduction of PMX-DHP eliminates humoral mediators and
improves pulmonary oxygenation.
Subjects and methods Thirty-six sepsis patients were the
subjects, consisting of 21 men and 15 women aged 62 ± 18.5 years.
A thermodilution catheter was inserted in each patient, and the
mixed venous oxygen saturation, oxygen delivery index, oxygen
consumption index, and oxygen extraction ratio were measured.
After it was confirmed that systemic oxygen metabolism was not
impaired, PMX-DHP was started. Patients with uncontrolled
infection were excluded from the study. The Acute Physiology and
Chronic Health Evaluation (APACHE II) score was used as the
index of severity, and survival of the patients was assessed after 1
month. The humoral mediators measured were IL-8 as a
chemokine, plasminogen activator inhibitor-I (PAI-1) as an index of
vascular endothelial cell activation, and polymorphonuclear
neutrophil elastase (PMN-E) as an index of neutrophil activation.
These mediators were measured before the start of PMX-DHP, and
at 24, 48, and 78 hours after the start. The PaO2/FiO2 (P/F) ratio
was used as an index of pulmonary oxygenation; it was measured
before the start of PMX-DHP, and at 24, 48, 72, 92, and 120 hours
after the start.
Results Due to the early introduction of PMX-DHP with oxygen
metabolism as the index, all the patients remained alive after
1 month. Before the start, the APACHE II score was 24 ± 2.0.
Before treatment, the IL-8 level was 54 ± 15.8 pg/ml, but it
decreased significantly from 48 hours onwards. PAI-1 was
133 ± 28.1 before treatment, but decreased significantly from
48 hours onwards. Similarly, PMN-E was also a high 418 ± 72.1
before treatment, but improved significantly from 48 hours
onwards. The P/F ratio was 228 ± 68 before treatment, but
improved significantly from 96 hours onwards.
Conclusion The mechanism of action of PMX-DHP is still not fully
understood, but the following findings were clarified from our
investigation. (1) Early introduction of PMX-DHP improves life
expectancy. (2) It is probable that changes of humoral mediators
inhibit vascular endothelial cell activation, neutrophil activation, and
chemokine activation. (3) It is probable that pulmonary oxygenation
is improved due to elimination of humoral mediators.
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Prehydration shifts the cytokine response towards a more
anti-inflammatory balance during human endotoxemia
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Introduction Animal experiments have shown that dehydration
significantly alters the effects of endotoxin administration. Clinical
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experience suggests that the administration of fluids in human
endotoxemia causes an attenuation of symptoms. In the present
study the effects of a standardised fluid protocol on symptoms,
inflammatory and hemodynamic parameters in human endotoxemia
are determined.
Methods With approval of the local ethics committee, 16 healthy
volunteers received 2 ng/kg Escherichia coli endotoxin (O:113).
After an overnight fast, seven subjects only received a continuous
infusion of 75 ml/hour glc2.5%/NaCl 0.45% solution during the
experiment (‘non-prehydrated group’), while nine subjects received
1.5 l the hour prior to the endotoxin administration and 150 ml/hour
during the course of the experiment (‘prehydrated group’). In order
to determine the inflammatory effects of the endotoxin CRP, white
blood cell count and cytokine concentrations were determined at
different time points. The course of body temperature was
determined and subjects were asked to score the severity of their
symptoms. Mean arterial pressure and heart rate were measured.
Results Prehydration reduced the inflammatory response after
endotoxin administration. The induction of the proinflammatory
cytokines (tumour necrosis factor alpha, IL-1β, IL-6, IL-8) was
attenuated by the prehydration. The prehydrated group tumour
necrosis factor alpha reached a peak value of 522 ± 63 pg/ml
(mean ± standard error) compared with 927 ± 187 pg/ml in the
non-prehydrated group (peak P = 0.04, analysis of variance [ANOVA]
repeated measures P = 0.046). In contrast, the anti-inflammatory
cytokine IL-10 demonstrated a trend towards higher values in the
prehydrated group (prehydrated 117 ± 18 pg/ml and non-
prehydrated 99 ± 18, P = not significant). The prehydrated group
developed a significantly lower fever (38.1 versus 38.8°C in the
non-prehydrated group, P < 0.05), scored significantly lower on
their symptom score (ANOVA repeated measures, P = 0.036) and
recovered sooner. Endotoxin administration induced a 15 ± 3%
and 15 ± 1% fall in MAP and an increase in heart rate (54 ± 2%
and 47 ± 3%) in the prehydrated and non-prehydrated group,
respectively. Both revealed no significant differences between
groups.
Conclusions We demonstrate that prehydration significantly shifts
the cytokine balance towards a more anti-inflammatory pattern in
human endotoxemia. This effect is associated with a reduction in
symptoms, whereas the changes in hemodynamic parameters are
not influenced by prehydration. To correctly interpret the
inflammatory effects of endotoxin in humans, the use of
prehydration should be standardized.
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Introduction Bone marrow stromal cells (BMSC) are progenitors
for bone, cartilage, hematopoietic stroma, adipocyte, brain and
neural cells. Recently some reports suggested that BMSC had a
potency of differentiating lung epithelial cells. In this study, we tried
to implant BMSC transvenously to a bleomycin-induced lung injury
model, and evaluate the differentiation of BMSC.
Materials and methods The study was approved by the
Institutional Review Boad. We used green fluorescent protein
transgenic rats (green rat, TgN[act-EGFP] OsbCZ-004; Japan
SLC Co.) as the BMSC donors, and SD rats as the bleomycin-
induced lung injury model for BMSC recipients (Japan SLC Co.).
Two days before BMSC implantation, bleomycin was injected
transtracheally by transient tracheostomy in recipient SD rats. 5-FU
(fluorouracil, antineoplastic agent) had been injected intra-
peritoneally into the green rats to increase the yield of BMSC. On
the experiment day, the green rats were anesthetized, and then
femurs were removed immediately, and a part of the bone cut to
obtain BMSC. At the same time, the surgery of recipient SD rats
was performed to identify and obtain the femoral veins, which were
cannulated and filled with heparinized saline. The collected BMSC
in a syringe were injected to recipient SD rats via the cannulated
femoral vein for implantation. For the control sham operation, saline
was injected instead of BMSC. Ten days, and 4 weeks after
implantation, recipient rats were sacrificed and the lungs were
fixed and examined.
Results We obtained well-proliferated BMSC. Then SMSC also
had microspheres with good proliferation. We showed the presence
of BMSC alive in the implanted lung tissue, and these BMSC
spread widely. In a short survival, we did not find the alveolar cells
expressing both SP-A and green fluorescent. In a long survival after
implantation, we found that some small population of implanted
BMSC expressed SP-A. The BMSC with histological SP-A-positive
were present out of the vessels.
Discussion We showed excellent viability of BMSC and presence
alive after transvenous implantation. We thought that the implanted
BMSC remain in the vessel or migrate to the alveolus, and then
some BMSC remaining in the vessel will migrate later and
differentiate to the alveolar cells, which will contribute to
constructing the injured lungs. Further studies are in progress to
clarify differentiation of BMSC to alveolar cells.
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Introduction We have previously shown that apoptotic and
myocardial mitochondrial respiratory abnormalities, occurring
during severe sepsis in a murine model, can be prevented by
overexpression of Bcl-2, a regulatory protein of mitochondrial
function. So, we sought to evaluate, in this model, a pharmaco-
logical modulation by cyclosporin A (CsA), a mitochondrial
permeability transition pore (MPTP) inhibitor, and by its non-immuno-
suppressive derivative N-methyl-4-isoleucin CsA (NIM 811).
Materials and methods Using a model of severe sepsis cecal
ligation and puncture (CLP) induced (21-gauge needle) in female
mice aged from 6 to 10 weeks, we studied the effects on 48-hour
survival, echocardiographic data, myocardial apoptosis (nuclear
apoptosis and caspase-3 and caspase-9 activation), and
myocardial mitochondrial respiration, of MPTP inhibitors: CsA and
NIM 811. A dose–response study was carried out with CsA in the
following groups: CLP mice (n = 15), CLP + CsA 2 mg/kg (n = 8),
CLP + CsA 10 mg/kg (n = 20), and CLP + CsA 100 mg/kg
(n = 5). CsA was administered postoperatively, during the 1 ml
subcutaneous injection for vascular filling. NIM 811 (dose of
2 mg/kg) was administered identically.
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Results Compared with sham, CLP mice present a low 48-hour
survival (32% vs 90%; P < 0.05), an increased shortening fraction
at H24, and a greater myocardial apoptotic activity. Forty-eight-
hour survival in septic mice is significantly improved with use of
CsA or NIM 811 (100% vs 32%; P < 0.05). Low (2 mg/kg) or
moderate (10 mg/kg) doses of CsA improve 48-hour survival.
Shortening fraction increases early at H6 in the CLP + CsA group,
and is normalized at H24. Myocardial nuclear apoptosis and
caspase-3 and caspase-9 activation are prevented by CsA and
NIM 811. We also observed, in the CLP group, an early increase of
oxygen consumption, at the complex IV level of the mitochondrial
respiratory chain. This was also prevented by MPTP inhibitors in
the CLP + CsA and CLP + NIM 811 groups.
Conclusion These results suggest that mitochondrial respiration
disruption could be responsible for myocardial dysfunction
occurring during severe sepsis. To our knowledge, this is the first
study addressing effects of NIM 811 in a severely septic animal
model. Thus, the mitochondrial permeability transition pore
constitutes a major target, and NIM 811 should be considered a
therapeutic agent of potential great interest.
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Background Poly (ADP-ribose) polymerase (PARP-1) over-
activation may lead to depletion of NAD+ and ATP within the cell
and proceed to necrotic cell death. Recently, published reports demonstrate high levels of PARP-1 activity in a model of porcine
hemorrhagic shock. There is also increased interest in hypotensive
resuscitation used for battlefield-wounded soldiers and trauma
patients. We wished to evaluate PARP-1 activity during a model of
porcine hemorrhagic shock with the hypothesis that PARP-1
activity will be increased using a hypotensive resuscitation strategy.
Methods Hemorrhagic shock was induced in splenectomized pigs
with a 35% controlled hemorrhage via IVC cannula. Pigs were
resuscitated to either normotensive (towards baseline) or
hypotensive (80 mmHg) pressures using hextend and LR. Muscle
and liver biopsies were taken prior to hemorrhage, after 90 min of
shock, and after resuscitation. PARP-1 activity in biopsies was
measured using chemical quantization of NAD+. Physiologic and
laboratory data collected during the experiment included blood
pressure, heart rate, mean arterial pressure, cardiac output, oxygen
delivery, oxygen consumption, and serum lactate.
Results Physiologic and laboratory parameters measured during
the experiment were consistent with hemorrhagic shock,
normotensive resuscitation and hypotensive resuscitation. PARP-1
activity increased from baseline with hemorrhage and returned
towards baseline with resuscitation (Fig. 1). PARP-1 activity during
normotensive resuscitation versus hypotensive resuscitation was
not statistically different (Fig. 2).
Conclusion PARP-1 activity in our porcine model of hemorrhagic
shock increases with the physiologic changes associated with
shock. PARP-1 activity decreases with resuscitation in both normo-
tensive and hypotensive resuscitation strategies. This provides
evidence in support of short-term hypotensive resuscitation for
hemorrhagic shock.
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Figure 1 (abstract P188)
Poly (ADP-ribose) polymerase (PARP-1) activity increased with
hemorrhage. With both normotensive and hypotensive resuscitation
PARP activity returned towards baseline.
Figure 2 (abstract P188)
Muscle poly (ADP-ribose) polymerase (PARP-1) activity during
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Background Alpha-1-acid glycoprotein (AGP) is a positive acute-
phase circulating colloid reported to have anti-inflammatory
properties. We have previously shown that hepatic leukocyte
recruitment at 6 hours of sepsis varies with the choice of fluid used
for resuscitation. Our objective in this study was to compare the
ability of AGP versus normal saline (SAL) or albumin (ALB) to
reduce the systemic inflammation associated with early sepsis.
Methods Human AGP and ALB were isolated and purified under
pyrogen-free conditions from plasma. Sepsis was induced in male
C57Bl/6 mice by cecal ligation and perforation (CLP) with an
18-gauge needle. Sham-operated (SHAM) and CLP mice received
2 ml subcutaneous saline before surgery. Mice received either
20 ml/kg SAL or 5 ml/kg of 3% AGP or 5% ALB in saline
(matched for molar weight) as an intravenous bolus after inducing
sepsis. The hepatic microcirculation was examined by intravital
microscopy 4 hours later. Pulmonary inflammation was assessed
by myeloperoxidase assay.
Results We have previously published that bolus SAL induces an
increase in leukocyte rolling within the hepatic microcirculation. A
similar finding was noted in the animals receiving saline in this
study. Surprisingly, in the colloid-resuscitated CLP mice this rolling
was reduced by 50%. In the central venules SHAM surgery did not
induce significant leukocyte adhesion. CLP mice receiving SAL
had a 30-fold increase in leukocyte adhesion, which was reduced
by 30% when mice were treated with ALB and by 60% in those
mice receiving AGP. Both colloids maintained sinusoidal perfusion
during sepsis but there was a 20% reduction in perfusion in the
SAL-treated CLP mice. Only treatment with AGP, however, was
able to reduce the sepsis-induced increase in sinusoidal leukocyte
adhesion to SHAM levels. At this early time point there was no
evidence of neutrophil sequestration within the lungs as measured
by myeloperoxidase assay.
Conclusions At 4 hours of sepsis there is evidence of hepatic but
not pulmonary inflammation. In this model of early sepsis, treatment
with a colloid significantly reduced the hepatic leukocyte–
endothelial cell interactions compared with saline resuscitation.
The presence of a glycosylated protein in the circulation appears to
be more beneficial than albumin in limiting the systemic
inflammatory response.
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Neonatal sepsis is frequently associated with activation of the
coagulation system. Generally, protein C levels are markedly
reduced in the majority of septic patients, being associated with an
increased risk of death. There is an activated protein C concentrate
licensed for the treatment of severe sepsis in adults. However, the
risk of severe bleeding may limit its use in neonates. Since the
likelihood to induce bleeding with the zymogen form of protein C
may be reduced, we therefore assessed both human and
recombinant murine protein C zymogen in a murine neonatal sepsis
model. In this model neonatal mice were challenged with viable
group B streptococci (GBS). The impact of this septic condition
on endogenous protein C levels was evaluated and the effect of
treatment with either recombinant murine protein C or human
plasma-derived (non-activated) protein C (Ceprotin®) investigated.
During severe GBS sepsis murine endogenous protein C levels
decreased over time in neonatal mice, resulting in a maximum
decrease of 30% at 16 hours after GBS challenge and returned
towards baseline at 30 hours. Concomitantly, there was an
increase in endogenous protein C activation up to 59% at 6 hours
after GBS challenge, returning to baseline levels at 16 hours.
Blocking endogenous murine protein C with an anti-mouse
monoclonal antibody increased the mortality rate significantly from
62% to 91%. Treatment of neonatal septic mice (n = 36) with
300 U/kg murine protein C subcutaneously 4 hours before GBS
challenge decreases the mortality rate significantly in severe sepsis
(LD90) to 64% (P = 0.002). Similarly, pretreatment with human
plasma-derived protein C (200 U/kg) 4 hours before GBS
challenge increased the survival rate significantly in severe septic
mice. Human plasma derived protein C at the dose of 200 IU/kg
was even effective given 18 hours after GBS challenge, leading to
a decrease of the mortality rate in severe sepsis from 87.5% to
48%. Despite the species differences human protein C zymogen
was activated to activated protein C and was detectable in the
circulation of mice, showing a slow and low in vivo recovery,
possibly due to the subcutaneous route of administration. This is
the first preclinical study where a beneficial effect of a non-
activated protein C could be shown in an animal model of severe
neonatal sepsis.
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Introduction Bacterial contamination has been estimated to occur
in 30–40% of patients with necrotizing pancreatitis. Development
of pancreatic necrosis mainly depends on the degree of
inflammation and microvascular circulation of the pancreatic tissue.
Translocation of bacteria from the gut is one of the most important
factors in the development of septic complications and mortality in
acute pancreatitis. We aimed to investigate the effect of activated
protein C (APC) on histopathology and bacterial translocation in
experimental acute necrotizing pancreatitis.
Materials and methods Forty-five male Sprague–Dawley rats
were studied. Rats were randomly allocated into three groups.
Acute pancreatitis was induced in Group II (positive control,
n = 15), and Group III (treatment, n = 15) by retrograde injection of
taurocholate into the common biliopancreatic duct. Group I rats
(Sham, n = 15) received normal saline injection into the common
biliopancreatic duct for mimicking the pressure effect. Group III
rats were treated with intravenous activated protein C 6 hours after
induction of pancreatitis. Pancreatic tissue samples were obtained
from all animals for histopathological examination when they were
sacrificed. Bacterial translocations to the pancreas, and
mesenteric lymph nodes were examined.
Results Acute pancreatitis developed in all groups, but not in
Group I (Sham), as indicated by microscopic parenchymal
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necrosis, fat necrosis and abundant turbid peritoneal fluid. The
pathologic score of the pancreatitis in the APC group
(10.31 ± 0.47) was lower when compared with the positive control
group (14.00 ± 0.52) (P < 0.001). Bacterial translocations to
mesenteric lymph nodes and to the pancreas in the group treated
with APC were significantly lower when compared with the control
group (P < 0.02, and P < 0.007, respectively).
Conclusion We suggest that beneficial effect of APC on
histopathology and bacterial translocation may be the results of
improving pancreatic microcirculation and anti-inflammatory effect
of APC.
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Aim To describe the first experiences on the use of protein C
concentrate (PC) in adult patients with severe sepsis and septic
shock and clinical contraindications to activated protein C (APC).
On the basis of the effectiveness demonstrated by the activated
form in sepsis and of the encouraging results expressed in the
literature of PC mainly about meningococcus fulminating
infections, we carried out an observational study on PC with 28-
day follow-up and a daily analysis of the hematochemical and
clinical parameters. Particular attention was paid to the variations in
the PC plasma levels, to the modifications of the coagulation
system, to the SOFA score as well as to the safety under bleeding
risk conditions. The study included 10 patients (seven females and
three males) either with severe sepsis (four patients) or septic
shock (six patients); one of them had DIC, with PC plasma levels
less than 50%. APC could not be administered because of clinical
reasons. Patients’ mean age was 63.5 years (43–78), the average
SAPS II was 51.8 (36–72), and the pathologies leading to sepsis
were lung infections (three patients), peritonitis (five patients), and
one patient with cutaneous and one patient with haematological
origin. The average time elapsed between the onset of the organ
failure and the beginning of treatment with PC was 27.7 hours
(12–42).
Results Mortality on day 28 was 30% (three deaths), in all patients
the PC plasma levels were brought again to the physiological
values. The bolus-dose delivered was the following: UI of protein C =
(100 – plasmatic basal level of PC) × body weight. It was followed
by a continuos infusion of 3 IU/kg/hour for 72 hours. Among the
parameters recorded during the PC infusion was observed in
particular a significant decrease of PDFs, a general rise of the
platelet count, and a reduction of the lactic acid levels. No adverse
reaction or bleeding complication were seen, even if most of the
patients’ coagulation was altered or at risk due to neurological
problems or repeated surgery.
Conclusions In our small number of patients, protein C
concentrate has proven to be safe and particularly useful in the
control of the coagulopathy triggered and sustained by sepsis.
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Introduction Drotrecogin alfa was licensed for severe sepsis in
Europe in patients with >1 organ failure (OF); in contrast to the
USA where it is licensed on the basis of APACHE II score > 24. At
our institution, the drug and therapeutics committee (despite ICU
representation) insisted that the drug should be reserved for
patients with an APACHE II score > 24 and >1 OF. Following
1 year of use, there was a concern that only one patient received
the drug. To investigate the reason for this, we conducted this
study to establish what proportion of patients fitted our criteria and
whether suitable patients were missed.
Aims To assess patients with APACHE II score > 24 for their
suitability for drotrecogin alfa therapy. To establish whether patients
met the inclusion criteria and exclusion criteria. Additionally, to
follow the outcome of those who were suitable for the drug.
Method Using the GE Medical Systems QS Clinical Information
System, the last 50 patients with APACHE II score > 24 were
identified from 23 March 2004 to 1 June 2004 (70 days). They
were retrospectively assessed to identify whether they met the
organ failure criteria from the Prowess study [1] and the SIRS
criteria [1]. Patients were deemed unsuitable if they did not have a
realistic chance of recovery on admission. This was reviewed by
the ICU pharmacist and clinical director. Infection was regarded as
those being treated with an antibiotic within the first 48 hours
(microbiologists advised on all antibiotic prescribing).
Results During the monitoring period, 222 ICU patients were
admitted. Of the 50 patients with APACHE II score > 24, 46% met
the SIRS criteria, 54% had >1 OF and 58% had signs of an
infection. Seventy per cent of patients had contraindications to
drotrecogin alfa use, the most common being active internal
bleeding, recent major surgery and GI bleeding within 6 weeks
(12% each). Only one patient (0.45% of admissions) met all the
suitability criteria. This same patient was the only case where the
drug was used; the patient initially rallied but died 7 days later.
Conclusion The single patient who fitted the criteria received the
drug, but did not survive. For severely septic patients, using the
criteria of APACHE II score > 24 and >1 OF for suitability of
treatment with drotrecogin alfa resulted in an extremely low
proportion of patients who were eligible for therapy. These criteria
should be reviewed so a wider population may benefit from this drug.
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The ENHANCE trial was an open-label, multi-national (25
countries) study of drotrecogin alfa (activated) (DrotAA) in 2378
patients with severe sepsis (systemic inflammatory response due
to acute infection and ≥ 1 sepsis-induced organ dysfunction of
≤ 48 hours duration). In Canada, 305 patients were enrolled at 18
sites. DrotAA was infused for 96 hours at 24 mg/kg/hour. Patients
continued to receive supportive care. Table 1 presents baseline
characteristics, bleeding events, and 28-day all-cause mortality for
Canadian and Global ENHANCE populations. Canadian patients
demonstrated higher disease severity at baseline by organ
dysfunction and APACHE II, yet had numerically lower mortality
and fewer infusion period serious bleeds than the Global
ENHANCE overall population. Comparison of laboratory and
severity variables between survivors and non-survivors using the
Wilcoxon two-sample test suggests that possible predictors of
survival in Canadian ENHANCE patients were: first day change in
creatinine; number of organ failures at baseline; pre-infusion
APACHE II score; and enrollment at PROWESS study sites. In
conclusion, differences were observed in disease severity and
outcomes in Canadian ENHANCE patients compared with the
overall trial sample.
Table 1
Baseline Canadian Global 
characteristics ENHANCE ENHANCE 
and outcomes (n = 305) (n = 2378)
Mean age, years (SD) 56.9 (17.2) 59.1 (16.9)
APACHE II ICU (SD) 25.3 (7.8) 22.0 (7.4)
# Organ failure (SD) 3.1 (1.2) 2.7 (1.1)
Baseline SOFA (SD) 10.9 (3.6) 9.7 (3.5)
Vasopressor use (%) 82% 74%
Mechanical ventilation (%) 90% 82%
Infusion serious bleed (%) 2.0% 3.6%
28-Day serious bleed (%) 3.9% 6.5%
Infusion ICH (%) 0.3% 0.6%
28-Day mortality (%) 22.6% 25.3%
SD, standard deviation.
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Background The PROWESS study has shown that the use of
recombinant human activated protein C (rhAPC) can reduce
mortality in severe sepsis [1]. The effect of this novel drug in a
Third World setting has never been explored. The aim of this study
is to see whether all the end points of the PROWESS study could
be reproduced in the Indian population.
Method A prospective, single-center observational study.
Consecutive patients who fulfilled the inclusion criteria of the
PROWESS study [1] were included into the study. The study
group was patients who received rhAPC. Patients who did not
receive rhAPC formed the control group. Data collected were
demographics, details of premorbid conditions and organ function,
markers of disease severity and infection. APACHE II scores were
recorded at baseline. Organ dysfunction was measured using
SOFA scoring. The primary end point was all-cause mortality at
28 days. Secondary end points were morbidity as measured by
SOFA scores and the incidence of adverse events. Data are
expressed as mean ± standard deviation. The results were
analysed using Fisher’s exact test and unpaired t tests. P < 0.05
was considered significant.
Results A total of 25 patients were enrolled into the study (study
group — 14 and controls — 11). Both groups were similar in terms
of age and sex distribution, demographics, comorbidities, baseline
APACHE II score, ventilatory and inotropic support and number of
organ dysfunction. In the study group only 27% had an APACHE II
score > 25. Treatment with rhAPC was started at a mean of
34.9 ± 21.9 hours from the onset of first organ dysfunction or
admission, whichever occurred earlier. The 28-day mortality in our
study was 36% in the study group as compared with 64% in the
controls. This was not statistically significant. There was an
improvement in the SOFA score on day 7 in 57% of the study
group and 36% of controls. The only adverse event noted was
bleeding. Minor bleeding was seen in 64% of the study group,
which was significantly higher than that in 18% of controls.
Conclusion This study is not powered to come to any definitive
conclusion. There was a trend towards decreasing mortality in
patients treated with rhAPC as compared with the controls and
there was also a decrease in morbidity in the study group as
assessed by the SOFA scores. The incidence of bleeding, even
though minor, was significantly higher in the study group. However,
unlike in the PROWESS study, only 27% of the study group had
an APACHE II score > 25 despite 43% of them having three or
more organ system failures. This brings up the question of whether
the APACHE II score can be used as a marker of severity of illness
in the Indian population? The high cost of the drug is a concern in
the Indian setting where most patients rely on their own resources
for funding such drugs. The only way these questions can be
answered is by having a well-designed and powered study
conducted in the Indian population.
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Although a large number of epidemiological sepsis studies have
been performed in Europe and the United States in the past years,
sound data for Germany are so far lacking. In the ‘Prevalence of
Severe Sepsis and Septic Shock in Intensive Care Units in
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Germany’ study, a prospective observational cross-sectional study,
the network gathered data from 454 randomly selected ICUs in
310 hospitals in Germany and screened 3877 patients —
according to the ACCP/SCCM Consensus Conference criteria —
by local 1-day visits of trained physicians from the 17 German
Competence Network Sepsis (SepNet) regional study centers.
Visits were randomly distributed over a 1-year period (2003) to
allow assessment of seasonal variations of sepsis prevalence. The
ICU sample was taken from a registry of all German hospitals with
ICUs (1380 hospitals with 2075 ICUs). Pediatric ICUs were not
considered. The study was completed in January 2004 and the
database was closed on 31 May. Seven percent of ICUs were
situated in university, 34% in university-affiliated and 53% in
general hospitals. Fifty-six percent of ICU directors were
anesthesiologists and 26% internists. An infection was
microbiologically documented in 22% and diagnosed by clinical
criteria alone in 12% of screened patients. Respiratory tract
infections were most common (52%), followed by intra-abdominal
(15%) and urogenital infections (7%). Gram-negative and Gram-
positive infections were nearly equally distributed (33% vs 35%);
in 16% a fungal infection was suspected. The prevalence of sepsis
was 12%, infection without SIRS was 7%, and severe
sepsis/septic shock was 11%. There were significant differences
in the prevalence of severe sepsis/septic shock over 1 year with
the highest prevalence in May/June 2003 (18%). The infection was
ICU acquired in 37%, hospital acquired in 20% and community
acquired in 35.5%. ICU mortality in patients with severe
sepsis/septic shock was 47% and hospital mortality was 54%.
Based on these findings the incidence of severe sepsis/septic
shock in German ICUs can be estimated as 75,000 cases per year
(110 per 100,000 inhabitants), comparable with the incidence of
acute myocardial infarction (143 per 100,000 inhabitants). With an
estimated 40,000 deaths per year, severe sepsis/septic shock is
the third most frequent cause of death in Germany after coronary
artery disease and acute myocardial infarction.
Incidence and mortality rate of severe sepsis and septic shock in
German ICUs are higher than reported in recent studies. This may
be due to the representative sample size, the more standardized
diagnostic criteria and a lower interobserver variability.
Acknowledgements Supported by the German Federal Ministry of
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Introduction Sepsis represents the major cause of death in the
ICUs all over the world. Many studies have shown an increasing
incidence over time and only a slight reduce in mortality. Many new
treatment strategies are arising and we should know our incidence
of sepsis and features.
Methods A prospective cohort study in 50 hospitals of all regions
of Brazil. The patients who were admitted or who developed sepsis
during the month of September 2003 were enrolled. They were
followed until the 28th day. The diagnoses were made in
accordance with the criteria proposed by ACCP/SCCM.
Demographic features, APACHE II score, Sepsis-related Organ
Failure Assessment (SOFA) score, mortality, sources of infections
and lengh of stay (LOS) were evaluated.
Results A total of 2419 patients were identified and 409 (16.9%)
filled the criteria of sepsis, severe sepsis or septic shock. The
average age was 61.9 years, 225 (55%) were male, and the overall
28-day mortality rate was 46.2%. The average APACHE II score
was 21 and the SOFA score on the first day was 7. The SOFA
score in the mortality group was higher on day 1 (8), and had
increased on day 3. We observed 326 episodes of sepsis, 118
(28.9%) patients with severe sepsis, and 210 (51.4%) patients
with septic shock. The mortality rate for sepsis, severe sepsis and
septic shock was 15%, 35.6% and 63.8%, respectively. The
average LOS was 16 days. The main source of infection was the
respiratory tract (71.6%). Gram-negative bacilli were more
prevalent (55.6%). Gram-positive cocci accounted for 32% and
fungi infections for 10.6%.
Conclusion A high incidence and mortality of sepsis in ICUs in our
country was observed. The high frequency of severe sepsis and
septic shock demonstrated a group at high risk of death. In order
to have a better use of the resources and to promote a reduction in
mortality in the next 5 years it is very important to identify our
specific features. After the final analysis of the database we intend
to give our contribution to a better understanding of sepsis in
Brazil.
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Introduction Despite advanced organ support, patients suffering
from severe sepsis still have a high mortality rate [1]. Recently, it
has been advocated to follow the ‘Surviving Sepsis Campaign’
(SSC) [2] to treat patients suffering from severe sepsis. Even
though it is unpredictable which patient will survive and for what
reason, an important amount of the ICU budget has to be invested
on drugs and supplies (DS). Therefore, the present study aimed to
determine the amount of money that our ICU (which is
administrated by public funds) has to invest on DS to treat a
patient suffering from severe sepsis.
Methods Data on costs for DS were recorded daily for every
patient admitted to the ICU from June to October 2004. Patients
with severe sepsis were separated from the main database. Costs
for each item of the SSC (including activated protein C) were
taken as independent variables, and the survey as a dependent
variable. We used the cost of each DS exactly as it was sold to our
institution. Costs are presented in Euros according to the currency
rate at 30 October 2004.
Results During the 5-month period, 211 patients were admitted to
the ICU. The treatment for severe sepsis according to the SSC
was affordable for all patients admitted to the ICU. The cost for DS
during this period was €327,026.36. Of all ICU patients, 37
(17.53%) suffered from severe sepsis and the DS cost for this
group was €146,513.10. Postoperative sepsis was observed in
18 patients (48.6%) while 19 (51.3%) were non-postoperative
sepsis; the cost for DS in these two groups was €58,294.61 and
€88,218.49, respectively. The total costs for DS to produce a
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43% survival on severe sepsis was €55,121.38; that is,
postoperative sepsis €30,253.91 and non-postoperative sepsis
€24,867.48. The cost for patients who died was €91,391.72.
Patients who died with non-postoperative sepsis had the highest
DS costs (i.e. €63,351.01). The investment to save 16 patients
was €63,357.02.
Conclusions In our ICU, and following the SSC guidelines, we
have to invest in every patient suffering from severe sepsis at least
€9157.07 to produce a 43% survival. That means, in the future,
any increase in survival with the same investment on DS may
reflect our best approach to treat severe sepsis.
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Background Poly(ADP-ribose)-polymerase (PARP) inhibition has
been beneficial in different models (sepsis, ischemia-reperfusion
[I/R], hemorrhage) where oxidative stress induced DNA damage
and subsequent PARP activation plays an important role. The
effect of PARP inhibition on DNA repair in this context, however, is
unknown. We therefore tested the effect of the selective PARP-1
blocker INO-1001 on DNA repair and cell senescence in a porcine
model of thoracic aortic cross-clamping.
Materials and methods After instrumentation, anesthetized and
mechanically ventilated pigs received vehicle (n = 9) or INO-1001
(n = 9, 2 mg/kg each before clamping and during reperfusion,
respectively). Norepinephrine (NE) was infused after declamping
as required to maintain mean arterial pressure ≥ 80% of the
preclamping level. Hemodynamic and metabolic data were
recorded before clamping as well as prior to and 2 and 4 hours
after declamping. The effect of INO-1001 on DNA damage and
repair (single-cell gel electrophoresis, ‘comet assay’) was
evaluated ex vivo in isolated lymphocytes (Ficoll gradient) that
were sampled immediately before clamping, subsequently exposed
to 4 bar of 100% O2 in a hyperbaric chamber (HBO) for 2 hours
and analyzed before as well as immediately 1 and 2 hours after
HBO. Surgery and I/R-related DNA damage in vivo was assessed
in whole blood samples taken before surgery, before clamping, and
before and 2 hours after declamping. At the end of the experiment
the spinal cord, gut, liver, and kidney tissue specimens were
sampled for immonuhistochemistry of cyclin-dependent kinase
inhibitor (p21 and p27) gene expression as a measure of cell
senescence. Data are median (minimum–maximum).
Results Significantly shorter NE infusion time (53 [23–93] vs 70
[41–83] min, P = 0.042) with reduced total NE doses (12 [6–19]
vs 22 [9–38] µg/kg, P = 0.034) were needed for hemodynamic
management in the INO-1001-treated animals. The time course of
both the HBO-induced and surgery and I/R-related oxidative DNA
damage was identical in the two groups. There were no differences
in p21 and p27 expression, either.
Conclusion The markedly reduced NE infusion time and dose
needed for post-I/R hemodynamic stabilization confirm the well-
known positive inotropic effect of selective PARP-1 blockers [1].
INO-1001 proved to be safe with respect to DNA repair and cell
senescence.
Acknowledgements Supported by the Alexander-von-Humboldt-
Stiftung (BH) and Land Baden-Württemberg, Germany (MG).
Reference
1. Szabó G, et al.: Shock 2004, 21:426-432.
P200
Rosiglitazone, a peroxisome proliferator-activated receptor-
gamma agonist, attenuates intercellular adhesion molecule-1
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Aim To investigate the effects of rosiglitazone (ROSI), a peroxisome
proliferator-activated receptor-gamma (PPAR-γ) agonist, on the
lung expression of intercellular adhesion molecule-1 (ICAM-1) and
cytokine-induced neutrophil chemoattractant-1 (CINC-1) in rats
with acute lung injury.
Methods Thirty-six anesthetized male Wistar rats were randomly
divided into six groups: DMSO control group, ROSI group,
GW9662 group, lipopolysaccharide (LPS) group, ROSI + LPS
group and GW9662 + ROSI group. Rats received either LPS
(6 mg/kg intravenously) or vehicle (saline, 2 ml/kg intravenously).
ROSI (0.3 mg/kg intravenously) or vehicle (10% DMSO) was
administered 30 min before treatment with LPS. The selective
PPAR-γ antagonist, GW9662 (0.3 mg/kg intravenously), was given
20 min before ROSI. Four hours after LPS injection, the wet/dry
lung weight (W/D) ratio, myeloperoxidase (MPO) activity,
malondialdehyde (MDA) and CINC-1 concentrations were assayed
in the lung tissues. Immunohistochemical analysis of ICAM-1
expression was also studied.
Results Pretreatment with ROSI attenuated LPS-induced increases
of the W/D ratio, MPO activity, MDA and CINC-1 concentrations
as well as the expression of ICAM-1 in the lung tissues (P < 0.01).
The specific PPAR-γ antagonist GW9662 significantly antagonized
the effects of ROSI.
Conclusion Pretreatment with ROSI significantly reduces
endotoxin-induced acute lung injury in rats; the mechanism may be
through activation of PPAR-γ accompanied by inhibition of ICAM-1
and CINC-1 expression.
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Objective To determine whether rosiglitazone, a peroxisome
proliferator-activated receptor-gamma (PPAR-γ) agonist, decreases
the severity of endotoxin-induced acute lung injury and to
investigate cellular mechanisms contributing to these effects.
Setting A university research laboratory.
Available online http://ccforum.com/supplements/9/S1
S86
Interventions Male Wistar rats were allocated into six groups (n = 6
for each group): (a) Sham-vehicle group: rats were treated with 10%
dimethyl sulphoxide (DMSO) (vehicle for rosiglitazone) 30 min prior
to saline; (b) Sham-rosiglitazone group: same as the Sham-vehicle
group except that rosiglitazone (0.3 mg/kg, intravenously [i.v.]) was
administered instead of DMSO; (c) Sham-GW9662 group: identical
to Sham-vehicle group except that GW9662 (0.3 mg/kg, i.v.) was
administered instead of DMSO; (d) LPS-vehicle group: rats were
treated with DMSO 30 min before they were challenged with
lipopolysaccharide (LPS) (6 mg/kg, i.v.); (e) Rosiglitazone-LPS
group: rats were treated with rosiglitazone 30 min before they were
subjected to LPS; (f) GW9662-rosiglitazone group: identical to
Rosiglitazone-LPS group, but GW9662 was administered 20 min
before rosiglitazone. Rats were killed at 4 hours after the injection of
LPS and the lungs were collected.
Measurements and results: Pretreatment with rosiglitazone
markedly attenuated the degree of (a) tissue injury and pulmonary
edema, (b) neutrophils infiltration and lipid peroxidation, (c)
expression of inducible nitric oxide synthase and production of
nitric oxide, (d) formation of nitrotyrosine in the lungs of LPS-
treated rats. The specific PPAR-γ antagonist GW9662 significantly
antagonized the effects of rosiglitazone.
Conclusions These findings support the view that rosiglitazone
and other potent PPAR-γ agonists may be useful in the therapy of
endotoxin-induced acute lung injury.
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A noninvasive bronchoscopic microsampling (BMS) probe was
developed to sample biochemical constituents of the epithelial
lining fluid in small airways. In this method, intratracheal saline
instillation is not required. Therefore, hypoxemia after BAL and
dissemination of airway infection can be avoided. We performed
the following two studies in acute respiratory distress syndrome
(ARDS) patients.
(1) BMS was applied in a control group of seven patients who had
hemoptysis or small solitary peripheral nodules but no hypoxemia
or other signs of acute inflammation and in four patients with
ARDS, to test whether BMS can ascertain the presence of acute
pulmonary inflammation without complications. Complications,
including a significant decrease in arterial oxygen saturation, were
observed neither during nor after BMS. In the ARDS, albumin,
lactate dehydrogenase (LDH), IL-6, basic fibroblast growth factor,
and neutrophil elastase concentrations in epithelial lining fluid were
significantly higher (P < 0.0001, P = 0.012, P < 0.0001, P < 0.0001,
and P < 0.0001, respectively) than in the control group.
(2) KL-6 is a pulmonary epithelial mucin more prominently
expressed on the surface membrane of alveolar type II cells when
these cells are proliferating, stimulated, and/or injured. We
hypothesized that high levels of KL-6 in epithelial lining fluid and
plasma would reflect the severity of lung injury in patients with
acute lung injury (ALI). Epithelial lining fluid was obtained at onset
(day 0) and day 1 of ARDS/ALI by BMS in 35 patients. On day 0,
KL-6 and albumin concentrations in epithelial lining fluid were
significantly higher than in normal controls (P < 0.001), and the
concentrations of KL-6 in epithelial lining fluid (P < 0.002) and in
plasma (P < 0.0001) were higher in nonsurvivors than in survivors
of ALI/ARDS. These observations were corroborated by the
immunohistochemical localization of KL-6 protein expression in the
lungs of nonsurvivors with ALI and KL-6 secretion from cultured
human alveolar type II cells stimulated by proinflammatory
cytokines. Because injury to distal lung epithelial cells, including
alveolar type II cells, is important in the pathogenesis of ALI, the
elevation of KL-6 concentrations in plasma and epithelial lining fluid
could be valuable indicators for poor prognosis in clinical ALI.
We are now performing proteomic analysis of ELF obtained from
ARDS to find key proteins for its pathogenesis.
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Introduction Ketoconazole has been shown in several clinical trials
to reduce the risk of developing ARDS in populations at risk.
Despite the clinical trials, its use remains limited.
Methods Literature review and synthesis.
Results Two small randomized controlled trials found that
Ketoconazole prevents the development of ARDS in mixed and
septic surgical ICU populations [1,2]. A third study examined the
effect of a guideline implementation for the use of Ketoconazole to
prevent ARDS and found that postguideline implementation rates
of ARDS were significantly lower than both historical rates and
rates in another hospital that did not implement the guideline [3]. A
historical case control study of Ketoconazole for prevention of
ARDS post-esophagectomy also found a significant reduction [4].
The ARDSNet trial examined the use of Ketoconazole in a
prospective design and found no difference in ARDS rates [5].
However, the majority (77%) of patients enrolled in the trial had
established ARDS (defined by PaO2/FiO2 ratio < 200). Ketoconazole
has been shown to reduce a number of mediators involved in the
development of acute lung injury and may therefore prevent ARDS
if given prior to the onset of severe ALI. The mechanism may
involve modulation of the cytochrome p450 enzyme system. Various
cytochrome p450 isozymes have been shown to be involved in the
inflammatory response that underlies acute lung injury.
Discussion The ARDSNet trial has had a negative impact on the
use of Ketoconazole for prevention of ARDS despite the stated
objective of the trial to examine the role of Ketoconazole in
treatment of early ARDS rather than prevention of ARDS. The use
of Ketoconazole has been further hampered by the lack of a
plausible biological mechanism.
Conclusions An adequately powered randomized controlled trial is
needed to assess the role of Ketoconazole in preventing ARDS.
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Background While inducible nitric oxide synthase (iNOS) is
believed to be the high-capacity NO-producing enzyme
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responsible for the detrimental hemodynamic alterations observed
during sepsis, the role of endothelial nitric oxide synthase (eNOS)
remains more obscure. Thus, it was the present study’s aim to
elucidate the influence of eNOS on hemodynamics in septic shock
using eNOS–/– mice in the clinically relevant polimicrobial cecum
ligation and puncture (CLP) model of sepsis.
Methods and results Prolonged survival was observed in
eNOS–/– mice (68 ± 25 hours vs 25 ± 6 hours in WT mice,
n = 12, P < 0.001). Chronic unselective NOS inhibition with
ethylthiourea (ETU) in eNOS–/– mice after sepsis induction
diminished this survival benefit, while ETU application in WT mice
after CLP led to slight improvement in survival time. Cardiac
output, studied by serial echocardiography, increased to a
maximum of 60% over baseline at 10 hours after sepsis induction
in WT mice but not in septic eNOS–/– mice and septic mice (WT
and eNOS–/–) treated by unselective NOS inhibition. WT CLP
mice were refractory to β-stimulation, while eNOS–/– CLP mice
responded comparably with sham-operated WT mice. Mean
arterial blood pressure was decreased by 25 ± 8 mmHg
(P < 0.001; n = 8) in WT CLP mice, with eNOS–/– CLP mice
showing no sign of hypotension. Contractility of isolated WT CLP
hearts was impaired by 35% (P < 0.001, n = 8), but hearts from
CLP eNOS–/– mice remained unaltered. While eNOS expression
remained stable, coronary flow studies indicated a high level of
eNOS activation secondary to sepsis.
Conclusion eNOS is a key player in the hemodynamics of sepsis.
Selective eNOS inhibition appears beneficial in this model of
sepsis with global nitric oxide synthase inhibition diminishing most
of the observed benefit.
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Introduction Severe acute pancreatitis (AP) remains associated with
a high mortality. In experimental AP the application of the bovine
hemoglobin solution HBOC-301 with and without IHD was able to
normalize pancreatic tissue oxygen tension [1,2]. The aim of this
study was to evaluate the therapeutic approach of volume therapy
with HES plus HBOC-301 with and without IHD with regard to the
histologic damage and survival time in pigs suffering from AP.
Methods After approval of the local animal ethics committee 33
pigs were anesthetized (FIO2: 0.3). AP was induced by
combination of cerulein and glucodeoxycholic acid. After induction
of AP animals were randomized and either isovolemicly
hemodiluted with 10% HES 200,000/0.5 plus HBOC-301 (+0.6 g/dl
plasmatic Hb; Oxyglobin, Biopure, USA) (IHD + HBOC group) or
received volume replacement without IHD with HES plus HBOC-
301 (+0.6 g/dl plasmatic Hb) (HBOC group), or were hemodiluted
with Ringer`s solution (IHD RINGER group) to a hematocrit (Hct)
of 15%. Six hours after therapy all animals were extubated, and
killed after 6 days at the latest. Two 5 µm slices from the
specimens of the pancreas were examined in a blinded manner
using a light microscope. The histopathologic findings were scored
as previously described quantifying acinar necrosis, fat necrosis,
inflammation and edema on a scale from 0 to 3 points [3]. The total
score was the sum of the median of two tissue areas (maximum
value 24). Statistical analyses: Kruskal–Wallis and Mann–Whitney
U test (P < 0.05).
Results The histopathologic tissue damage (Table 1) was higher in
the IHD RINGER group in comparison with the IHD + HBOC
group and the HBOC group. The survival rate at the end of the
observation period was higher in the IHD + HBOC group (10/11)
and the HBOC group (8/11) in comparison with the IHD RINGER
group (2/11) (P < 0.001).
Table 1
Histopathologic score (range 0–24) of two areas from the
pancreas, 
Acinar Fat Inflam- Total 
Group necrosis necrosis mation Edema score
IHD + HBOC 3 (0–5)† 1 (0–5) 3 (1–4)*† 4 (2–5) 11 (4–17)†
HBOC 3 (0–4)† 1 (0–3)† 4 (3–4) 4 (2–4) 12 (7–15)†
IHD RINGER 5.5 (4–6) 3 (1–5) 4 (3–5) 4 (3–5) 16 (14–20)
† P < 0.05 versus Ringer. * P < 0.05, IHD + HBOC group versus HBOC
group.
Implications In a former experiment application of HBOC-301
with and without IHD normalized pancreatic tissue oxygen tensions
[1]. The higher tpO2 is now reflected by less tissue damage and a
better outcome. The application of HBOC-301 deserves further
analysis to assess its potential in the clinical treatment of AP.
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Background The first-generation hetastarch remains the only
hydroxyethyl starch (HES) available for volume substitution in the
United States despite its controversial safety profile. The safety
and efficacy of a new HES, Voluven®, was assessed in this
investigation.
Patients and methods After local IRB approval and signed,
written informed consent, 100 adult patients scheduled for major
orthopedic surgery were randomly allocated to receive 6% HES
130/0.4 (Voluven®, n = 49) or 6% HES 450/0.7 (hetastarch,
n = 51) for intraoperative volume replacement in a double-blind
fashion guided by a predefined algorithm that included CVP-
guided therapy. HES volume served as the primary efficacy
variable. Safety variables were: calculated total red blood cell
(RBC) loss, minimum factor VIII activity and vW factor
concentration between the end of surgery and 2 hours later,
laboratory parameters, and adverse events through POD 28. The
treatment groups were compared for equivalence in efficacy and
superiority of HES 130/0.4 in safety.
Results Demographic data and other baseline characteristics of
the treatment groups were similar. Mean infused HES volumes
were equivalent between groups (1615 ± 778 ml for HES 130/0.4
and 1584 ± 958 ml for HES 450/0.7). Primary safety results are
presented in Table 1 (mean ± standard deviation; *P < 0.05).




RBC Factor VIII vW factor RBC 
loss (%) with (%) with use 
(l) >1 l HES >1 l HES (ml/kg)
HES 130/0.4 1.17 ± 0.63 88.7 ± 55.7 89.2 ± 40.4 8.0 ± 6.4
HES 450/0.7 1.31 ± 0.84 65.9 ± 39.4* 71.5 ± 36.9* 13.8 ± 12.9*
the HES 450/0.7 group (> 3 l HES 450/0.7 administered in all
cases). No coagulopathies were reported for HES 130/0.4.
Conclusion HES 130/0.4 (Voluven®) and HES 450/0.7
(hetastarch) are equally effective volume expanders in major
orthopedic surgery. HES 130/0.4, however, demonstrated a more
favorable safety profile including preservation of critical coagulation
factors and reduced requirement for transfusion of blood products.
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Introduction The fluid replacement therapy in septic shock is a
polemic issue, regarding the use of crystalloid versus colloid
solutions. Albumin is the more often used colloid solution. A recently
published study (SAFE study) showed no benefits in albumin versus
crystalloid use, for fluid replacement in shock patients.
Objective To analyse the septic shock subgroup in our study,
regarding the use of albumin as a fluid replacement solution and its
influence on mortality.
Patients and methods We conducted a prospective cohort study
in 50 hospitals of all regions of Brazil. The patients who were
admitted or who developed sepsis during the month of September
2003 were enrolled. They were followed until the 28th day or less
according to their discharge. The diagnoses were made in
accordance with the criteria proposed by ACCP/SCCM. We
evaluated demographic features, APACHE II, Sepsis-related
Organ Failure Assessment (SOFA) score, mortality, sources of
infections, microbiology and interventions. We also recorded
underlying diseases and length of stay.
Results A total of 2419 patients were identified and 409 (16.9%)
filled the criteria of sepsis, severe sepsis or septic shock. Two
hundred and ten patients (51.4%) formed the septic shock
subgroup, with a mean APACHE II score of 22 and a overall
mortality rate of 63.8%. Eighty-five patients (40.5%) in this
subgroup used albumin; 125 patients (59.5%) did not. Fifty-one
patients (60%) in the albumin group died; 34 (40%) were alive on
the 28th day. In the non-albumin septic shock patients subgroup,
one patient (0.8%) was transferred from the hospital and excluded
from the study; 83 patients (66.4%) died and 41 (32.8%) were still
alive after 28 days.
When we apply the binomial probability test, the mortality rate in
the albumin group is 66.93% versus 60% in the non-albumin
group. Using 60% as the expected mortality rate for both
subgroups (because it is the little one), P = 0.05. In the albumin
subgroup we had 44 females and 41 males; in the non-albumin
subgroup, 50 females and 75 males. The mean age and APACHE
II score were the same in both subgroups (61.98 years old and
20.88, respectively).
Conclusions We can see a trend towards not using albumin as a
fluid replacement solution in septic shock patients, a standard
therapy previously. Albumin really seems not to be a protective
therapy for these patients, since the mortality rate in both groups
(albumin and non-albumin users) are too close (actually, when the
statistical test is applied, we see a trend towards a greater
mortality rate in the albumin subgroup).
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Introduction Dermatomyositis (DM) is a rare disorder of variable
severity, ranging from mild weakness that is highly responsive to
corticosteroid therapy to a relentless downhill course with pulmonary
involvement that is unresponsive to all immunosuppressive modalities.
Method In this retrospective case series, we reviewed the clinical
presentation and outcomes of all DM patients who were admitted
to the medical intensive care unit (MICU) of a university-affiliated
general hospital from 1 January 2000 to 31 December 2004. All
had acute respiratory failure requiring mechanical ventilation (MV).
Results The nine patients had a mean age of 47.6 ± 12.4 (range:
27–66) years. The female to male ratio was 3.5:1. All were
diagnosed to have DM before MICU admission with median
duration of illness of 8 (range: 3–28) weeks. DM was classified as
classical (Peter and Bohan’s criteria) in six patients and amyopathic
(Sontheimer’s criteria) in three. Initial high-resolution computed
tomography thorax in eight patients showed pulmonary fibrosis (four
patients), interstitial/alveolar changes (two patients), and ground-
glass changes (two patients). All patients were negative for anti-Jo1
antibody, and none had an associated malignancy.
The mean PaO2/FiO2 was 109.2 ± 40.9 (range: 61.8–181.7)
mmHg. The median duration of hospital and MICU stay were 16
(range: 2–38) days and 13 (range: <1 to 37) days, respectively.
The median duration of MV was 10 (range: <1 to 37) days.
All chest radiographs showed bilateral lung infiltrates. Broncho-
alveolar lavage was performed on six patients, with findings of
pneumocystis cariini in one patient and mycobacterium
tuberculosis in another. All patients were treated empirically with
broad-spectrum antibiotics for pneumonia including cotrimoxazole
for Pneumocystis carinii on admission to the MICU. Immuno-
suppressive therapies in the MICU included high-dose systemic
corticosteroids in all, pulse methylprednisolone (five patients),
pulse cyclophosphamide (three patients), high-dose intravenous
immunoglobulin (one patient) and cyclosporine (two patients). All
patients died of respiratory failure with four having hypotension and
acute renal failure as contributing causes.
Conclusion DM with pulmonary involvement that required MV
carries an extremely high mortality. Early diagnosis and effective
immunosuppressive therapies for lung disease may help to improve
outcome in this high-risk group.
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Background Mortality in burn patients can be estimated by three
major risk factors for death: age > 60 years, total burned surface
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area (TBSA) > 40% and presence of an inhalation injury [1]. The
formula developed by Ryan predicts 0.3%, 3%, 33% and 90%
mortality when zero, one, two or three risk factors are present.
Objective A retrospective evaluation of the prognostic value of
these three risk factors in patients admitted to our burn unit over a
20-year period (May 1985–November 2004) (n = 1385).
Results Mean age was 32 ± 23 years. The mean %TBSA was
19 ± 18%. Inhalation injury was present in 166 patients (12%).
Overall mortality was 7%. When zero, one, two or three risk factors
were present, mortality was respectively 0.5%, 10%, 48% and




factors TBSA Inhalation Mortality mortality 
(n) Age > 40% injury (%) (%) 
Zero – – – 5/998 (0.5) 4/1314 (0.3)
One + – – 13/133 (9.8) 4/75 (5)
One – + – 5/82 (6.1) 1/31 (3)
One – – + 8/49 (16.3) 5/112 (4)
Two + + – 4/6 (66.7) 0/1 (0)
Two + – + 13/19 (68.4) 12/39 (39)
Two – + + 32/77 (41.6) 21/79 (27)
Three + + + 19/21 (90.5) 21/22 (95)
Conclusion Global mortality following burns is low. Nearly all
patients who died had at least one risk factor present. Given the
broad classes of this classification and the differences in age and
%TBSA between Ryan’s study and our population, this model
predicts mortality in a reliable but very coarse way.
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Background To determine mortality for children, aged 6
months–16 years, treated in pediatric intensive care units (PICUs)
or adult intensive care units (AICUs) or transferred from AICU to
PICU in Sweden.
Methods A retrospective, multicentre, 3-year cohort study. Name,
social security number, admission and discharge dates were
collected from March 1998 to March 2001, after securing ethics
committee approval. Using the national files of registration,
mortality could be assessed.
Results Fifty-five of 75 AICUs and all PICUs (n = 3) generated
data. A total of 5757 patients (male/female 1.3:1) were admitted,
estimated as > 90% of all patients of this period. A total of 1985
patients were primarily admitted to PICUs and 3772 patients to
AICUs. Of the latter, 90 patients were transferred. The 1-year
mortality for patients in AICUs, in PICUs or transferred was 2.8%





Additional deaths up to 3 years 86




Additional deaths up to 3 years 83
Late mortality, > 3–6.5 years 23
was 1 day in both ICU groups. Accountable days in ICUs was
6370.
Conclusion Overall 1-year mortality was relatively low (< 4%)
(male = female). However, we noted an elevated risk of death
beyond 3 years after discharge. The higher mortality in the small
transferred group could reflect a lack of available PICU beds.
Based on these figures six beds, with 100% usage, would meet
the total requirement of ICU beds for this age range in Sweden.
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Introduction Increasing numbers of patients with congenital heart
disease now survive to adulthood, requiring repeated surgical and
cardiological interventions that necessitate ICU admission [1].
There are little data in the literature regarding the ICU morbidity
and mortality in this patient population. We therefore evaluated the
ICU respiratory morbidity in patients with adult congenital heart
disease (ACHD).
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Prolonged vent, prolonged ventilation > 72 hours; US+pl drainage,
ultrasound and pleural drainage; CT thorax, computerised tomography
thorax; ext to NIV, extubation to non-invasive ventilation and
tracheostomy; ASD, atrial septal defect; VSD, ventricular septal defect;
AVSD, atrioventricular septal defect; TOF, Tetralogy of Fallot; TGA,
transposition of the great arteries.
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Methods A database (Medicus, High Wycombe, UK) was
interrogated for all patients admitted to the ICU of a cardiothoracic
tertiary referral centre during the period January 1997–2002 with
ACHD. Classification of ACHD complexity was according to the
modified Canadian Consensus Conference criteria. Patient
demographics, details of any surgical procedure and mortality were
extracted. Analysis of respiratory investigations and interventions
(Fig. 1) was performed.
Results Over the accounting period 342 patients with ACHD were
admitted (6.4% of total ICU admissions), of which 305 (90%) were
following cardiac surgery. Perioperative mortality was 3.3%.
Patients with simple ACHD had zero mortality, a low requirement
for respiratory investigations and interventions (Fig. 1a). Patients
with moderately complex and complex ACHD had a higher
mortality (10.6%) and significantly higher requirement for
respiratory investigations and interventions (Fig. 1b).
Conclusion Patients undergoing surgery for complex ACHD have
a significant requirement for respiratory investigations and
interventions. As the case mix is changing, with more complex
patients requiring intervention in adulthood, this has implications
for future planning of ICU ACHD care.
Acknowledgement SP is the BHF Jill Dando Adult Congenital
Cardiology Fellow.
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Introduction Current estimations suggest there are around
800,000 patients in the USA with congenital cardiac lesions
requiring specialist care [1]. Improved surgical and cardiological
interventions mean that numbers of patients with moderate-severe
congenital lesions will increase [2], resulting in increased
requirement for repeat surgery in adulthood. This is reflected by an
increasingly complex case mix requiring ICU admission. The
potential impact of this changing patient population upon ICU
resources has not been addressed.
Methods A database (Medicus, High Wycombe, UK) was
interrogated for all patients admitted to the ICU during the period
January 1997–2002 with adult congenital heart disease (ACHD),
which was classified as simple or complex according to the
modified Canadian Consensus Conference criteria. Patient
demographics, the length of ICU stay (LOS) and mortality were
extracted, and the severity of illness and intensity of intervention
calculated (APACHE II, TISS-28).
Results Of 5312 patients admitted during the accounting period,
342 had ACHD (6.4%). ACHD ICU mortality was 4.4%. Patients
with simple ACHD (32%) had APACHE II scores of 18.4 ± 4.8,
zero mortality, short LOS (1.8 ± 2 days), and low therapeutic
intervention (TISS-28 42.3 ± 10). Patients with complex ACHD
(68%) had similar APACHE II scores (18.5 ± 6.4, not significant)
but significantly higher mortality (10.6%), increased LOS
(3.9 ± 2 days, P < 0.05) and requirement for intervention (TISS-28
59.8 ± 13, P < 0.05). Overall mean cost per admission (TISS
score point 46.31, €67.0) was therefore significantly higher in the
more complex patients (simple €5101 ± 1340 vs complex
€15,623 ± 1742, P < 0.05).
Conclusion Improved survival of patients with complex congenital
heart disease to adulthood will have significant implications
(clinical and financial) in any ICU undertaking this work.
Acknowledgement SP is the British Heart Foundation Adult
Congenital Cardiology Fellow.
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Context HELLP syndrome (hemolysis, elevated liver enzymes, low
platelets) is a severe complication in late pregnancy. This disorder
complicates between 2% and 7% of gestations and is associated
with a high maternal morbidity ranging between 1% and 4%.
Objective We undertook this study to evaluate the repercussions
on maternal outcome in patients with HELLP syndrome and to
determine its clinical and biological characteristics.
Design A retrospective and analytical study.
Setting The intensive care unit of the National Hospital of
Neurology, Tunisia.
Sample Pregnant or postdelivery women who had HELLP
syndrome between January 1996 and December 2003.
Main measurements Analysis was made of maternal age, parity,
hypertension classification, gestational age at HELLP syndrome
diagnosis, alterations in laboratory test for HELLP syndrome, time
elapsed to discharge from hospital, maternal complications and
mode of delivery.
Results Twenty-three patients with HELLP syndrome were
selected. Mean age was 33 (26–40) years. The mean gestation
was 32 weeks, and 85% were delivered by caesarean section.
One patient had postpartum HELLP syndrome. Hypertension was
observed in all cases. Twenty-two women needed blood product
transfusions. A nadir platelet count of 50,000/µl was not an
independent risk factor for adverse outcome. The main
complication was acute renal failure. Five patients died; three of
them had a cerebral hemorrhage.
Conclusion The high maternal morbid–mortality of HELLP
syndrome requires management in a center where intensive
maternal care is available.
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Objective To profile severe pre-eclamptic (SPE) patients admitted
to an obstetric ICU, with regards to manifestations, interventions
and clinical outcome.
Methods Medical records of all SPE patients admitted from 2002
to 2004 to our ICU were retrospectively analysed.
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Results One hundred and four patients with SPE were admitted,
89% postpartum. This represents 38.5% of all obstetric
admissions to the ICU, and 0.23% of all deliveries in our hospital,
during the same period.
All except five patients (4.8%) received antenatal care, of which
40.4% were known pre-eclamptics on medication. The mean
gestational age at detection of SPE was 32.5 (0.4) weeks, with a
mean arterial pressure of 129.2 (1.7) mmHg.
Reasons for ICU admission in addition to SPE included pulmonary
edema (14.4%), oliguria (14.4%), hemolysis elevated liver enzymes
low platelet (HELLP) syndrome (18.3%), eclampsia (7.7%), and
intracerebral hemorrhage (1%). The incidence of eclampsia was
1.7 per 10,000 births.
Arterial lines were inserted in 64.4% and central venous catheters
in 18% of patients. Magnesium sulphate therapy was instituted in
69.2% of patients for a mean duration of 28.7 (2.6) hours. Forty-
seven percent of patients received intravenous and oral
antihypertensives, while 45% required oral antihypertensives only.
Nine patients (8.6%) received invasive mechanical ventilation for
29.6 (13.4) hours, and three patients (2.9%) required renal
replacement therapy.
The mean ICU length of stay was 46.5 (2.0) hours. Indications for
delivery in addition to SPE were worsening maternal biochemical
indices (42.3%), fetal distress (18.3%), pulmonary edema
(11.5%), impending eclampsia (16.3%), and eclampsia (3.8%).
Delivery was by emergency Caesarean section in 90.4%, and
vaginal delivery in 9.6%. Mean gestational age at delivery was 33.2
(0.4) weeks, with birthweight 1894 (81) g, and mean Apgar score
of 7 at 1 min, and 8 at 5 min. A total 14.4% of babies were small
for gestational age, and four perinatal mortalities occurred (0.09
per 1000 births). There were only two maternal deaths (0.04 per
1000 deliveries).
Conclusion SPE is a prevalent cause of maternal–fetal morbidity.
With improved obstetric and intensive care, the current incidence
of eclampsia (1.7 per 10,000 births) is one of the lowest in
published literature for a tertiary referral maternity hospital.
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Introduction A critically ill obstetric patient usually recovers rapidly
after delivery, resulting in a short length of stay (LOS), with a
reduced number of specific interventions in the ICU and a good
overall prognosis. Some authors therefore stated a possible
management of these patients on the delivery/labor floor or in high
dependency units.
Objective To measure nursing workload with the NEMS score [1],
evaluate whether management in the ICU was required (NEMS
> 20) and correlation with mortality.
Design A retrospective chart review study.
Setting An independent multidisciplinary ICU in a tertiary university
hospital.
Study period January 1996–June 2004.
Patients All obstetric patients (n = 590) admitted to the ICU.
Measurements and results Forty-nine patients were excluded
due to insufficient data. Mean NEMS was 27.1 ± 6.75 with values
ranging from 18 to 50. Mean NEMS for survivors was 25.8 ± 5.19,
mean NEMS for nonsurvivors was 37.75 ± 8.78 (P < 0.001). A
total 21.6% (n = 117) of our patients got a NEMS score < 20
(mean 18), among them 18 patients (15.4%) either increased their
NEMS the next day and then died, or lasted with the same NEMS
for a few days.
NEMS_H24 discriminated well with an AUROC of 0.855 ± 0.072,
but calibrated badly (Pr < 0.001). Also NEMS_H48 (after
excluding patients with LOS < 2 days) discriminated well
(AUROC = 0.977), and calibrated better than NEMS_H24 but still
insufficiently (Pr = 0.02).
Conclusion According to the NEMS score 81.7% of our patients
deserved to be hospitalized in the ICU. NEMS_H24 and
NEMS_H48 correlated with mortality. Fifteen percent of patients
with initial NEMS < 20 needed intensive monitoring for more than
1 day, and five patients died. We suggest a large admission policy
to a multidisciplinary ICU be encouraged for obstetric patients,
because monitoring is better and treatment of possible late
complications occurs earlier, a sole guarantee to reduce mortality.
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Introduction Pre-eclampsia is a disease unique to pregnancy that is
often associated with significant maternal morbidity and mortality,
especially when it is severe. The aim of this study was to evaluate
which indicators of severe pre-eclampsia were among the reasons
for ICU admission and their impact on the length of hospital stay.
Materials and methods We used a computerized database to
identify 444 women with pre-eclampsia–eclampsia among 32,382
deliveries from 1996 to 2003 in our institution. Of these, 24
women were admitted to the ICU because of severe pre-eclampsia
and were retrospectively included in our study. Maternal
demographic data included age, parity and medical history.
Gestational age, mode of delivery, days staying in the ICU and in
the ward, outcome of ICU admission and SAPS II score were
record for each patient. Indicators of severe pre-eclampsia on
admission to the ICU included a sustained BP of 160/110 mmHg
or more, proteinuria 4+ on qualitative assessment, oliguria
(< 20–30 ml/hour), renal insufficiency (creatinine level >1.3 mg/dl),
elevated liver enzymes, low platelet count (<100,000/µl), positive
testing for hemolysis, epigastric pain, headache, visual
disturbances and seizures. In the statistical analysis we used the t
test on SPSS®. Data were considered significant when P < 0.05.
Results The mean maternal age was 29 years. Twelve women
were nulliparous (50%). No women had history of chronic
hypertension. All 24 women underwent a cesarian delivery
because of severe pre-eclampsia at > 20 weeks of gestation,
except for one woman with pregnancy of 16 weeks. All 24 women
had at least one indicator of severity on admission to ICU that
included BP ≥ 160/110 mmHg (n = 13), elevated liver enzymes
(n = 13), low platelet count (n = 12), oliguria (n = 11), headaches
(n = 8), epigastric pain (n = 7), seizures (n = 6), renal insufficiency
(n = 2) and hemolysis (n = 2). The mean SAPS II score was 15.
Complications occurred in eight women. None of the women died.
The average length of stay was 3 days in the ICU and 10 days in
the ward. Indicators of severity related to longer hospital stay were
seizures (P = 0.002), epigastric pain (P = 0.004) and oliguria
(P = 0.004). No significant difference was found regarding other
severity indicators, SAPS II score and development of complications.
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Conclusions Our results have limited significance mainly because
of the sample size (n = 24). However, they may potentially guide
intensive care of these patients in order to shorten hospital stay
and reduce inherent morbidity and costs. Intensivists as well as
obstetricians should work closely toward this purpose.
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Introduction Measuring physiological status prior to ICU
admission could help refine prognosis after ICU discharge. The
literature lacks such studies.
Objective To determine the correlation between a New Simplified
Acute Physiology Score designed for obstetric patients before
their admission to the ICU and ICU mortality.
Design A prospective study, part of the Assessment of Prognosis
and Risk of Mortality in Obstetrics (APRiMO) study. Seventeen
physiologic and biologic parameters were measured, and
pathological intervals shifted to fit physiologic changes related to
pregnancy as described by Margaria [1] with a slight modification.
An aggregate score included the worst value for each parameter
during a maximum of 24 hours before admission to the ICU.
Patients were devided into two datasets: development (n = 350)
and validation (n = 191). Discrimination was assessed by the area
under the receiver operator characteristic curve (AUROC).
Calibration was assessed by Hosmer–Lemeshow (Pr) goodness-
of-fit C statistics. After validation of the overall score, we tried to
simplify it without altering its statistical power. Statistical analysis
was computed on SPSS 11.5 XP-Windows compatible. P < 0.05
was considered significant. Results are expressed by mean ±
standard deviation.
Setting Patients were first managed in a tertiary care obstetric
hospital, a referral center for high-risk pregnancies, with a level 3
neonatal ICU. Then they were transferred to our independant
multidisciplinary ICU.
Study period January 1996–December 2003.
Patients All obstetric patients (n = 541) transferred to the ICU.
Inclusion criteria: severe pre-eclampsia/eclampsia, HELLP
syndrome, stroke, and so on.
Measurements and results Obstetric complications accounted
for 70% of admissions. Mean age was 31.2 ± 5.9 years, Mean
term was 34.7 ± 4.5 weeks. The majority of our patients were
admitted after delivery. The mortality rate was 10.4% (n = 57). In
the development dataset, the SAPS-O discriminated (AUROC =
0.902) and calibrated (Pr = 0.524) well. The validation dataset also
discriminated (AUROC = 0.904) and calibrated (Pr = 0.895) well
(Fig. 1). A simplified model made with 7/17 parameters also
discriminated and validated well with, respectively, AUROC and Pr
in the same development and validation data of: AUROC 0.947
and 0.793; Pr 0.968 and 0.716.
Conclusion SAPS-O is correlated to ICU prognosis. This could
help adjust for lead-time bias, comparison between centers and
management policies.
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Introduction Outcome prediction in the critically ill obstetric
patient is controversial.
Objective To determine the applicability of SAPS II, APACHE II
and APACHE III-J scores calculated at day 1 of admission in
outcome prediction.
Design An open prospective data collection, as part of the
Assessment of Prognosis and Risk of Mortality in Obstetrics
(APRiMO) study. Discrimination was assessed by area under the
receiver operator characteristic curve (AUROC). Calibration was
assessed by Hosmer–Lemeshow (HL) C statistic. P < 0.05 was
considered significant.
Setting A multidisciplinary ICU.
Study period January 1996–December 2003.
Patients Obstetric patients (n = 541) admitted for at least 4 hours
in the ICU.
Measurements and results Mean age was 31.2 ± 5.9, mean term
was 34.7 ± 4.5 weeks. Seventy percent of admissions were
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Receiver operator characteristic curves of the severity scoring
systems’ admissions.
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obstetric complications. The mortality rate was 10.4% (n = 57).
The three scores discriminated (Fig. 1) and calibrated (Table 1)
well. APACHE III was the only score to calibrate well using original
mortality prediction equations (Table 2).
Table 1
Scoring Non- HL C 
system Survivors survivors AUROC statistics SMR
SAPS II 20.35 55.7 0.926 ± 0.04 0.399 0.96
APACHE II 7.07 21.2 0.918 ± 0.035 0.653 1.06
APACHE III 23.1 81.97 0.917 ± 0.045 0.73 1.43
Table 2
Scoring system AUROC HL C statistics
SAPS II 0.925 0.036
APACHE II 0.785 0.02
APACHE III 0.922 0.15
Conclusion The three scores are good discriminators.
Customization of the mortality prediction equations seems
necessary. APACHE III-J seems to be the best (adjustment by
adequate diagnostic categories).
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We examined outcomes for patients with ARF identified from a
national comparative audit of adult general ICUs in England, Wales
and Northern Ireland, the Case Mix Programme.
Of 276,731 admissions to 170 ICUs over an 8-year period ARF
was present during the first 24 hours of admission in 17,326
(6.3%), 66% were male. Oliguria and non-oliguria were determined
by UOP < 400 ml/day or > 400 ml/day. Table 1 presents age,
surgical status and mortality of the ARF patients. Mean APACHE II
score was 24.8 compared with 16.5 for all ICU admissions, and
was significantly higher in oliguric ARF (29.3) versus non-oliguric
(17.9). A total of 83.7% of admissions with ARF were non-surgical.
Both ICU and hospital mortality were significantly higher for
oliguric ARF compared with non-oliguric ARF. Factors predicting
increased mortality were: increasing age, male sex, chronic
conditions, CPR, IPPV, oliguria, prior hospital stay of 7+ days,
extremes of temperature, heart rate and respiratory rate, low MAP,
low pH, high A-aDO2, abnormal sodium, high potassium, low
albumin, low WBC and low Glasgow Coma Score. Surgery within
1 week of ICU admission conferred survival benefit.
The median ICU length of stay (LOS) was 4.1 days for ARF
survivors and 2.0 days for non-survivors, compared with 1.7 and
2.0 days, respectively, for all ICU admissions. Admissions with
ARF accounted for 9.3% of all ICU bed days. Median hospital LOS
was 31 days for ARF survivors and 8 days for non-survivors,
compared with 16 and 9 days, respectively, for all ICU admissions.
Oliguria was associated with longer LOS for survivors and shorter
LOS for non-survivors.
Table 1
All ARF Oliguric Non-oliguric
Number 17,326 5687 10,133
Mean age, years 63.2 63.5 63.1
Non-surgical 14,479 5005 8125
Elective surgery 961 187 717
Emergency surgery 1868 487 1280
ICU mortality 7508 (43.3%) 3176 (55.8%) 3387 (33.4%)
Hospital mortality 9725 (58.6%) 3850 (70.3%) 4770 (49.3%)
Although the predominant cause of ICU ARF is now non-surgical
the factors influencing survival remain unchanged. ARF occupies
ca. 10% of all ICU bed days and doubles both ICU and hospital
LOS in survivors.
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We examined outcomes for patients with ARF identified from a
national comparative audit of adult general ICUs in England, Wales
and Northern Ireland, the Case Mix Programme.
Over an 8-year period ARF was present during the first 24 hours of
admission in 17,326 of 276,731 admissions to the ICU. In 14,118
(81.5%) sufficient data were present to predict mortality using the
Stuivenberg Hospital ARF (SHARF), UK APACHE II, and Mehta
mortality prediction models. Discrimination was assessed by the
area under the receiver operating characteristic curve (ROC),
calibration by the mortality ratio (observed versus predicted
mortality), and overall fit by the R-statistic from Shapiro’s Q
representing the geometric mean of the probability assigned to the
true outcome.
Factors predicting > 50% increased mortality risk were: history of
chronic condition, CPR, IPPV, oliguria, prior hospital stay of 7+
days, MAP < 50 mmHg, acidosis, and reduction of GCS by 2. UK
APACHE II scores showed the best discrimination and calibration,
although the null hypothesis of perfect calibration was strongly
rejected (P < 0.001) by both the Hosmer–Lemeshow test and
Cox’s calibration regression. UK APACHE II and Mehta
underpredicted the number of deaths while SHARF T0
overpredicted (Table 1). SHARF T0 and Mehta’s model showed
poor overall fit by Shapiro’s Q, with an R value < 0.5.
Table 1
SHARF T0 MEHTA UK APACHE II
Discrimination AUC 0.632 AUC 0.693 AUC 0.740
Calibration MR 0.759 MR 1.223 MR 1.147
Fit, Shapiro’s Q R = 0.392 R = 0.487 R = 0.539
AUC, area under the ROC curve; MR, mortality ratio.
Although UK APACHE II scores performed best, none of the
existing mortality prediction models reliably predict those who will
survive to leave hospital following an episode of ARF in the ICU.
Traditional risk factors such as oliguria, CPR, LOS > 7 days prior
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to admission to ICU and extremes of physiology continue to be
associated with the greatest increased risks of mortality.
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Background Community-acquired pneumonia remains a common
and serious condition.
Methods We retrospectively evaluated patients with pneumonia
admitted to the medical intensive care unit (MICU) of Ewha
Womans University Hospital from 1 January 2000 through 31
December 2003. We excluded patients who died within 48 hours
after admission, were pretreated before admission or had
pulmonary tuberculosis or suspected nosocomial pneumonia.
Finally, 118 patients were included.
Results Mortality was 41.5% (49/118). At admission, survivors
had significantly higher white blood cell counts (P < 0.05), lower
serum potassium levels (P < 0.05), larger first 24-hour urine output
(P < 0.01), higher Glasgow coma scales (P < 0.001), and lower
Acute Physiology and Chronic Health Evaluation Score (APACHE
II) (P < 0.01) than non-survivors. During hospitalization, there was
significantly lower incidence of gastrointestinal (GI) bleeding in
survivors compared with non-survivors (P < 0.001). MICU stay
(P < 0.05) and days requiring mechanical ventilation (P < 0.001)
and intubation were significantly shorter in survivors compared with
those in non-survivors (P < 0.01). Tracheostomy was less
frequently performed in survivors compared with that in non-
survivors (P < 0.01). In survival analysis using Cox regression, GI
bleeding (relative risk [RR], 2.35; 95% confidence interval [CI],
1.24–4.48) and an APACHE II score of 20 or more (RR, 2.19;
95% CI, 1.21–3.96) were independently associated with death.
Conclusion In patients with severe pneumonia, mortality was still
high. GI bleeding during hospitalization as well as high APACHE II
score was related to mortality.
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Introduction The use of mechanical ventilation for acute
respiratory failure (ARF) in patients with cystic fibrosis (CF) has
long been discouraged because of a poor outcome in this group of
patients. However, new insights into ventilatory strategies and a
better life expectancy per se in CF patients necessitate regular re-
evaluation of this attitude. The most recent studies report a
mortality in adult CF patients requiring mechanical ventilation that
varies widely between 45% and 80%. Results in children are
reported as more favourable, but little is known about the long-term
pulmonary outcome of children with CF who required mechanical
ventilation for ARF already at a young age.
Objectives The goals of this study were threefold: to assess
outcome of assisted ventilation in CF patients with ARF; to identify
risk factors associated with a poor outcome; and to analyse
whether children with CF who required mechanical ventilation for
ARF at a young age had more pulmonary and CF-related
complications later in life compared with unventilated CF controls.
Design A retrospective cohort study.
Setting The study was performed at the University Medical Centre
Utrecht (Utrecht, The Netherlands) and at the Leyenburg Hospital
(The Hague, The Netherlands). These centres care for
approximately one-half of the Dutch CF population.
Methods Medical charts were reviewed of all CF patients who had
been admitted to the intensive care unit for ARF between January
1990 and August 2003. ARF was defined as a respiratory
deterioration requiring assisted ventilation, due to an acute illness
in a previously stable patient. Assisted ventilation could be either
non-invasive or invasive. Patients with chronic respiratory failure
with a slow progressive decline in lung function were not included.
To identify risk factors for mortality, the following data were
recorded: demographic data, body mass index, spirometric data,
mode of ventilation, sputum microbiology, history of hemoptysis or
pneumothorax, the presence of CF-related diabetes and the
presence of CF-related liver disease.
To analyse long-term outcome in children who survived assisted
ventilation for ARF, all unventilated age-matched and gender-
matched CF controls were identified. Lung function and the
presence of CF-related complications 5 years after admission to
the ICU were compared.
Results Thirty-two CF patients were included, five children (aged
2–18 months) and 27 adults (aged 15 years and older). All
children and 30% of the adults survived.
In the total population, age was a statistically significant risk factor
for poor outcome (P = 0.03). In the adult population, none of the
demographic and clinical data could predict outcome significantly.
In patients who had an episode of ARF in childhood, clinical
course and lung function 5 years after assisted ventilation was not
significantly different compared with their controls.
Conclusions CF patients aged 2 years or younger who are
ventilated because of ARF have a good prognosis and assisted
ventilation does not seem to affect lung function or development of
CF-related complications later in their lives. ARF in adult CF
patients still is associated with a high mortality. Risk factors for
poor outcome could not be identified.
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Outcome of septic shock in patients with malignancies and
neutropenia
D Furmanchuk
Belorussian Medical Academy for Postgraduate Education, Minsk,
Belarus
Critical Care 2005, 9(Suppl 1):P223 (DOI 10.1186/cc3286)
Background Septic complication remains an important influence
on survival rate in patients with malignancies. Bone marrow
suppression and neutropenia induced by chemotherapy determine
certain difficulties in early diagnose of sepsis, and lead to rapid
hemodynamics and respiratory disorders. The aim of this study was
to standardize most important issues in treatment of sepsis-
induced arterial hypotension and tissue hypoperfusion and to
estimate its influence on survival rate in patients with severe sepsis
and septic shock.
Materials and methods Sixty-two consecutive patients aged from
1 to 17 years old, with malignancies, neutropenia and sepsis
associated with hypotension, were followed in the ICU of the
Republican Center for Pediatric Oncology and Hematology. Thirty-
five patients treated from January 2000 to December 2001
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composed the retrospective group; the prospective group
consisted of 27 patients, treated from March 2003 to September
2004. Treatment protocol for septic shock therapy used EBM
principles and the design for the prospective group strictly
determined the following treatment options: hydroxyethyl starch
(HES) as a first choice for volume resuscitation; combination of
dopamine and norepinephrine for correction of arterial
hypotension; double-lumen catheter (or two central lines) for
dividing infusions of dopamine and noradrenalin from others;
mandatory use of arterial lines for invasive blood pressure
monitoring; and start-up of mandatory ventilation in all patients with
septic shock, even in patients with compensated blood gas status,
We compared the survival rate and survival probability during the
first 75 days after ICU admission. For the statistical analysis, the
chi-square test and the Caplan–Meyer method were used.
Results Survival probability measured by log-rank test during 75
days after ICU admission showed a significant difference. Using
our protocol, we also found a difference in maximal lactate level on
the day of admission, duration of arterial hypotension, length of ICU
stay and length of ventilation between two groups.
The overall ICU mortality rate was significantly different in the
retrospective and prospective groups — 81.3% and 53%,
respectively (P < 0.05).
Table 1
Retrospective Prospective 
Mortality rate group group P value
At first 24 hours 28% 7.6% 0.04
At day 7 80% 26.9% 0.001
At day 30 82.8% 53.8% 0.01
Conclusion Using the presented treatment protocol for septic
shock positively influenced mortality rate in the prospective group.
P224
A validation of different prognostic scoring systems in the
prediction of outcome in peritonitis
D Borisov, M Kirov, V Kuzkov, D Uvarov, E Nedashkovsky
Northern State Medical University, Arkhangelsk, Russia
Critical Care 2005, 9(Suppl 1):P224 (DOI 10.1186/cc3287)
Background and goal Early classification of patients with
peritonitis by means of scoring systems provides adequate
selection for surgical and therapeutic procedures and comparison
of different therapies [1]. We compared the prognostic value of
APACHE II and SAPS II scoring systems as well as the Mannheim
Peritonitis Index (MPI) for assessment of outcome in the patients
with diffuse bacterial peritonitis.
Materials and methods We enrolled 194 adult patients (mean
age 49.6 ± 19.5 years) with secondary diffuse bacterial peritonitis
in a prospective observational study during the period from 1999
to 2003. All patients were hospitalized in the ICU of the university
hospital. The scores according to APACHE II, SAPS II, and MPI
were assessed during 24 hours after admission to the ICU. The
predictive values of the scores were estimated using regression
analysis (coefficient of determination r2). The discrimination was
assessed using areas under the receiver operating characteristic
curves (AUCs). Standardized mortality ratios (SMRs) were
calculated. Variables were expressed as mean ± standard
deviation or 95% confidence interval and as relative frequencies.
Results and discussions The mean APACHE II, SAPS II and MPI
scores were 9.6 ± 8.4, 28.8 ± 16.7, and 23.9 ± 6.9, respectively.
The hospital mortality rate was 19.1% (37 patients). The predicted
mortality risk was 18.9%, 9.6%, and 33.6% for APACHE II
(diagnostic category weight for gastrointestinal perforation/
obstruction), SAPS II and MPI, respectively. The values of




standard deviation confidence interval SMR
APACHE II 0.87/12.1 0.87/0.82–0.92 1.01
SAPS II 0.89/11.7 0.82/0.76–0.87 1.99
MPI 0.38/24.3 0.85/0.79–0.90 0.57
The calibration was adequate for APACHE II and SAPS II scores.
The discrimination was good for all systems. The APACHE II score
had the most accurate overall mortality prediction, as reflected by
the SMR.
Conclusion In patients with diffuse bacterial peritonitis, APACHE II
is the most accurate prognostic scoring system as compared with
SAPS II and MPI.
Reference
1. Bosscha K, van Vroonhoven ThJMV, van der Werken Ch: Br J
Surg 1999, 86:1371-1377.
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APACHE III outcome prediction after esophagectomy
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B Afessa
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Critical Care 2005, 9(Suppl 1):P225 (DOI 10.1186/cc3288)
Introduction The Acute Physiology and Chronic Health Evaluation
(APACHE) III prognostic system has not been validated in patients
admitted to the ICU after esophagectomy.
Hypothesis APACHE III predicts hospital mortality after
esophagectomy.
Methods A retrospective review of all adult patients admitted to a
single thoracic ICU after esophagectomy between October 1994
and December 2003. Patient demographics, ICU admission day
APACHE III score, actual and predicted hospital mortality and
length of hospital and ICU stays were collected for the first ICU
admission only. Performance of the APACHE III prognostic system
was assessed by the Hosmer–Lemeshow statistic for calibration
and the area under the receiver operating characteristic curve
(AUC) for discrimination.
Results There were 924 esophagectomies performed during the
study period. Data are presented for the 483 patients that were
admitted to the ICU. Mean age was 63.9 years. Mean APACHE III
score on the day of ICU admission was 41.5 (standard deviation
18.1). Mean predicted (standard deviation) ICU and hospital
mortality rates were 3.01% (6.31) and 7.90% (11.0), respectively.
Median (interquartile range) lengths of ICU and hospital stay were
1.68 (0.79–3.79) and 13.52 (12.0–21.0) days, respectively.
Observed ICU and hospital mortality rates were 2.7% (13 of 483
patients) and 5.4% (26 of 483), respectively.
There were differences (P < 0.001) between survivors to hospital
discharge and non-survivors in age, acute physiology score and
APACHE III score. Predicted ICU and hospital survival rates on the
day of ICU admission were also different when survivors were
compared with non-survivors (P < 0.001). Although most patients
were male (82.6%), gender did not predict survival. The mean
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(95% confidence interval [CI]) ICU and hospital length of stay
ratios (observed/predicted) were 0.88 (0.76–1.00) and 1.01
(0.92–1.10), respectively.
The standardized ICU and hospital mortality ratios (95% CI), based
on APACHE III prediction, were 0.89 (0.41–1.38) and 0.68
(0.42–0.94), respectively. In predicting mortality, the AUC of
APACHE III prediction was 0.860 (95% CI 0.791–0.928) and the
Hosmer–Lemeshow statistic was 8.581 with a P value of 0.379.
Conclusions The APACHE III prognostic scoring system has good
discrimination and calibration in predicting hospital mortality of
patients admitted to the ICU following esophagectomy. The low
number of deaths may have influenced the statistical analyses.
P226
Multimodal strategies to improve APACHE II score
documentation
L Donahoe1, M Kho1, E McDonald1, M Maclennan2, S McIntyre2,
P Varga2, D Cook1
1McMaster University, Hamilton, Canada; 2St Joseph’s Healthcare,
Hamilton, Canada
Critical Care 2005, 9(Suppl 1):P226 (DOI 10.1186/cc3289)
Background The APACHE II score is used widely in the ICU
setting. In our phase I study [1], APACHE II scores collected by an
expert research coordinator and two research clerks were reliable
(intraclass correlation coefficient = 0.90, lower 95% confidence
interval [L-95% CI] = 0.85). However, we found substantial
variability in the Chronic Health Index (CHI) (0.67, L-95% CI =
0.53) and Glasgow Coma Scale, verbal component (GCS-V)
(0.42, L-95% CI = 0.25). To improve the reliability of the APACHE
II score, we conducted phase II, aimed at changing the behaviour
of ICU clinicians who are involved in documenting the APACHE II
score in practice.
Objective To educate ICU clinicians regarding two specific
components of the APACHE II score with suboptimal reliability:
CHI and GCS-V.
Design An educational quality improvement interventional project.
Population ICU clinicians, primarily bedside nurses.
Methods We convened a combined clinical and administrative
working group. In-person meetings, conference calls, and
electronic communication were used to generate ideas for
strategies that would efficiently serve our objective.
Results We implemented multimodal strategies to try to improve
ICU clinicians’ knowledge of, and compliance with, documentation
of CHI and GCS-V. Strategies were: re-structuring the Clinical
Information System Carevue (Philips, Andover, MA, USA), in-
service education, use of local opinion leaders, reminders, audit
and feedback, and support from the ICU Working Group (MDs,
Allied Health professionals, bedside RNs, RN manager, RN
educator, RN informatician [RNI]) who approved an improved CHI
policy. We reconfigured the Carevue workstation screens to
improve the visibility of CHI. In-services were conducted by an ICU
educator and RNI. Education focused on the CHI components,
GCS-V domain in intubated patients, and expectations for
documentation of these items. As local opinion leaders, RNs
(manager and charge nurses) prompted bedside nurses to
complete chronic health documentation for all new admissions.
We provided written information sheets, electronic resources, and
computer-generated electronic reminders at RN workstations and
on Carevue. The RNI provided regular, informal audit and feedback
to bedside RNs to reinforce timely documentation.
Conclusions These diverse methods were delivered over 1 year,
were multiply redundant to maximize the chance of behaviour
change, were led by an integrated team of clinical and
administrative managers, and were well accepted. We will next
proceed to phase III, a formal re-evaluation of the reliability of the
APACHE II score in our institution.
Reference
1. Crit Care Med 2004, 31(suppl):A68.
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Evaluation (APACHE II) and Simplified Acute Physiology
Score (SAPS II) in a Greek general intensive care unit
K Gkolfinopoulou, G Kouvatseas, A Armaganidis, U Dafni
National and Kapodistrian University of Athens, Greece
Critical Care 2005, 9(Suppl 1):P227 (DOI 10.1186/cc3290)
Objectives To determine the applicability of the Acute Physiology
and Chronic Health Evaluation (APACHE II) scoring system, as
well as that of the Simplified Acute Physiology Score (SAPS II) in
an interdisciplinary intensive care unit in Greece and to evaluate
the scores’ ability to predict hospital mortality.
Design A prospective cohort study.
Setting A mixed medical and surgical intensive care unit at a major
general hospital in the Athens Metropolitan area, Greece.
Patients A total of 309 adult patients, admitted to the ICU from
January 2001 to January 2002, were enrolled in the study.
Methods and results Data enabling the calculation of APACHE II
and SAPS II were collected for every patient on the day of
admission. Patients’ vital status at hospital’s discharge was
recorded. Probabilities of hospital death for patients were
estimated by applying APACHE II and SAPS II, and predicted risks
of hospital death were compared with observed outcomes. The
patients’ median age was 57 years old. The median APACHE II
score was 15, higher in the 105 female patients (16) than in the
204 male patients (15). The median APACHE II estimated
probability of death was 0.16 (0.2 for female patients and 0.14 for
male patients). The median APACHE II was lower in the 168
operative cases (14) than in the 141 medical ones (16). The
median APACHE II estimated probability of death was respectively
0.13 and 0.20 for the two groups. The median SAPS II score was
37 (40 for females and 36 for males, 35 for operative patients and
41 for medical patients). The median SAPS II estimated probability
of death was 0.2 (0.25 for females and 0.18 for males, 0.17 for
operative cases and 0.27 for medical cases). The overall goodness
of fit and the areas under the receiver operating characteristic
curve were assessed for the two scores.
P228
The impact of missing components of the Acute Physiology
Score on the standardized mortality ratio calculated by the
APACHE III prognostic model
B Afessa, M Keegan, O Gajic, R Hubmayr, S Peters
Mayo Clinic College of Medicine, Rochester, MN, USA
Critical Care 2005, 9(Suppl 1):P228 (DOI 10.1186/cc3291)
Introduction In the APACHE III prognostic model, a weight of zero
is given to missing and normal Acute Physiology Score (APS)
values. The standardized mortality ratio (SMR) is used to evaluate
the performance of an ICU. The objective of this study was to
determine the impact of missing APS values on SMR.
Methods The study involved a retrospective analysis of the
prospectively collected APACHE III database. The study
population included adults treated in four intensive care units of a
tertiary medical center with the APACHE III database. We obtained
the APACHE III predicted mortality rate and hospital outcome. We
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noted whether the first day values of the variables used to calculate
the APS were missing. We created eight categories based on the
number of missing values. We summarized descriptive data as
mean (standard deviation [SD]), median (interquartile range [IQR])
and percentage. We created a logistic regression model to
determine the association of the number of missing values with
hospital mortality by entering the number of missing APS variables
and the APACHE III predicted mortality rate as predictor variables.
P < 0.05 was considered significant.
Results We had 49,682 admissions during the study period.
Excluding patients who did not authorize their medical records to
be reviewed for research and those with four or less available
laboratory values, 42,607 patients were included in the study.
Patients’ mean (SD) age was 62.7 (17.3) years; 40,417 (94.9%)
were white and 24,294 (57.0%) were male. The overall predicted
and observed hospital mortality rates were 9.7% (4151/42607)
and 12.0%, respectively, with SMR (95% confidence interval [CI])
of 0.813 (0.789–0.838). The median (IQR) predicted hospital
mortality rate was 4.36 (1.65–13.20)%. Complete data were
available in 934 (2.2%) admissions. The predicted mean and
observed mortality rates as well as the SMR with the 95% CI for
each of the missing categories are presented in Table 1. Four or
more missing APS values were independently associated with
higher observed hospital mortality.
Table 1
Missing Observed dead Predicted dead SMR (95%CI)
Zero 183/934 (19.6%) 25.8% 0.76 (0.65–0.88)
One 565/3607 (15.7%) 19.6% 0.80 (0.73–0.87)
Two 952/9486 (10.0%) 13.7% 0.73 (0.69–0.78)
Three 978/11641 (8.4%) 10.4% 0.81 (0.76–0.86)
Four 753/8717 (8,6%) 9.8% 0.88 (0.82–0.95)
Five 579/6799 (8.5%) 9.5% 0.90 (0.82–0.97)
Six 127/1338 (9.5%) 10.1% 0.94 (0.79–1.12)
Seven or eight 14/85 (16.5%) 8.9% 1.85 (1.01–3.11)
Conclusions The majority of patients admitted to the ICU have one
or more missing laboratory values needed to calculate the APS
scores of the APACHE III prognostic system. When using such
prognostic systems to evaluate the performance of ICUs, the
number of missing values should be taken into consideration.
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Introduction The Mortality Probability Model (MPM II), developed
on an international sample of 12,610 patients in 1989–1990, is
used by Project IMPACT as a benchmarking tool. We updated the
model based on more recent (2001–2004) data.
Hypothesis and methods Project IMPACT data on 125,610
patients age >18 and eligible for MPM scoring were analyzed.
Multivariate analysis defined the relationship between hospital
mortality and standard MPM physiologic variables plus patient
type, location and lead time prior to ICU admission. The sample
was randomly split into development and validation sets.
Discrimination was assessed by ROC C statistic and calibration by
graphic display and Hosmer–Lemeshow goodness of fit.
Results Overall mortality was 13.8%. The logistic model for all
patients is presented in Table 1, and goodness of fit in Fig. 1. The
area under the ROC curve was 0.82. Lead time and location did
not influence outcome. Addition of a ‘zero-factor’ term for patients
with no risk factors other than age improved model performance.
Subgroup models (medical, coronary, trauma, neurosurgical,
elective and emergent non-neuro, non-cardiac and non-trauma
surgery) exhibit improved discrimination and calibration compared
with the main model, which is superior in calibration to the existing
MPM model.
Table 1
Variable Odds ratio Coefficients P value
Coma-stupor 5.37 1.680172 0.000
HR ≥ 150 1.77 0.570394 0.000
SBP < 90 2.49 0.9111615 0.000
Chronic renal 1.68 0.5179099 0.000
Cirrhosis 2.18 0.7804761 0.000
Metastasis 2.69 0.9889827 0.000
Acute renal 2.17 0.7752536 0.000
Arrythmia 1.08 0.0782759 0.000
Cerebrovascular 1.31 0.2679498 0.000
GI bleed 0.84 –0.1712258 0.003
IC mass 2.16 0.768795 0.000
Age 1.03 0.0302588 0.000
CPR w/in 24 hours 2.20 0.7888974 0.000
Mechanical ventilation 2.25 0.8123237 0.000
Med/unsched S 2.40 0.8760618 0.000
Zero factors 0.79 –0.2368908 0.007
Full code 0.46 –0.7693753 0.000
Constant NA –4.778739 0.000
Conclusions Severity-adjusted mortality has decreased over time.
Use of the updated model will allow more accurate assessment of
quality of care. Subgroup models further improve discrimination
and calibration and offer additional information in ICUs where the
case mix is unusual.
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Mortality prediction by hormonal profile versus APACHE score
assessment in critically ill patients
K Osman Hassan, S El-Maraghy, S El-Gengehy, D Ragab, 
K Abd El-Aziz, S Aref, H Mowafi, H Nagi
Cairo University, Egypt
Critical Care 2005, 9(Suppl 1):P230 (DOI 10.1186/cc3293)
Objectives To investigate hormonal changes during the acute
phase of critical illness, to analyze their relationship to severity, and
to evaluate their discriminating ability on critically ill patients’
outcome.
Design A prospective cohort study of patients requiring intensive
care.
Setting Adult medical, surgical and coronary care units in
Mansoura University Emergency Hospital.
Patients A total of 40 consecutive patients requiring intensive care
over a 5-month period and 10 healthy subjects of matched age
and sex were selected as references control subjects.
Interventions For each patient included in our study the following
was done. First, APACHE III score. Second, blood samples were
taken in three occasions, on admission, third and seventh days of
admission to the ICU. The plasma was separated and kept at
–80°C until time of analysis. The following hormones (cortisol,
growth hormone, thyroxin, and triiodothyronine hormones) were
determined by ELISA technique.
Measurements and main results The best discriminators of
patient outcome in descending order were the serum basal
cortisol, then APACHE III score, then thyroxine hormone, then
triiodothyronine on day 1 of admission with odd ratios of 11, 8.5,
3.2 and 2.85, respectively.
Conclusion Certain endocrinal parameters, mainly basal serum
cortisol level obtained during ICU admission, might be simple,
cheap and superior discriminators of patient outcome than the
APACHE III score.
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Serial evaluation of the Sequential Organ Failure Assessment
score in non-coronary medical patients
M Wehler, U Reulbach, E Hahn, R Strauss
University of Erlangen–Nuremberg, Erlangen, Germany
Critical Care 2005, 9(Suppl 1):P231 (DOI 10.1186/cc3294)
Introduction To determine the usefulness of daily Sequential
Organ Failure Assessment (SOFA) score [1] for prediction of
mortality in non-coronary medical ICU patients.
Patients and methods A prospective, observational study was
conducted from May 1997 to April 2001. Nine hundred and
nineteen consecutive adult patients admitted to the ICU for more
than 24 hours were included (10,164 patient days). The SOFA
score was calculated on admission and every 24 hours until
discharge.
Results Study patients had a mean age of 59 ± 17 (± standard
deviation) years; 70% were male, mean ICU length of stay was
11 ± 15 days, mean APACHE II score after 24 hours was 19 ± 10.
Initial, maximum and mean (sum of daily SOFA scores divided
through days of ICU stay) SOFA scores correlated well with
mortality in the ICU (25.7%). The ability of the SOFA to
discriminate between ICU survivors and non-survivors was
assessed using the area under the receiver operating
characteristic curve (AUC). The AUC was largest for the mean
SOFA score (0.90, 95% confidence interval: 0.88–0.93) and the
maximum SOFA score (0.88, 95% confidence interval:
0.86–0.91). A mean SOFA score of more than 7 corresponded to
a mortality of more than 83% versus 10% for a mean score of 7 or
less. When analyzing trends in the first 48 hours, regardless of the
initial score, the mortality was 56% when the score increased,
24% when it remained unchanged, and less than 20% when it
decreased.
Conclusion Sequential assessment of organ dysfunction during
the first few days of ICU admission is a good indicator of
prognosis. Both the mean and the maximum SOFA scores are
particularly useful predictors of ICU outcome. Independent of the
initial score, an increase in SOFA score during the first 48 hours
predicted in our sample a mortality rate of 56%.
Reference
1. Vincent JL, et al.: Intensive Care Med 1996, 22:707-710.
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Introduction The SOFA score is an excellent predictive marker of
outcome in sepsis; however, there are very few studies that relate it
to mortality in elderly patients with sepsis and septic shock.
Objective To assess the association of the SOFA score and other
factors related to mortality in elderly patients with severe sepsis
and septic shock.
Methods A 3-month prospective cohort study of 30 patients aged
≥ 65 showing severe sepsis or septic shock (Consensus
Conference of 1991). Arterial hypotension (systolic arterial
pressure < 90 mmHg) corresponded to the ‘time-zero’ of the study.
The variables used were: SOFA score on days 1, 3, 5, 7, 14, and
28, ∆SOFA (variation of the SOFA score on days 1 and 3),
APACHE II, Troponin I dosage, BNP and RCP, plasma glucose
levels, organ failures [1], the presence of previous cardiovascular
disease, assessment of dependence and cognitive deficit [2,3],
length of ICU stay, and need for mechanical ventilation. We used
Student’s t test and the Fischer Exact test for a statistical analysis.
We considered the significance level of 5%.
Results The mean age of patients, of whom 60% were females,
was 82 ± 9 years (minimum = 65, maximum = 99). The predominant
diagnosis was septic shock in 67% of the cases, while 33% of the
patients developed severe sepsis. On days 1, 3, 5, 7, 14, and 28,
the SOFA score presented mean values of 7, 6, 4, 3, 2, and 2,
respectively (minimum = 2 and maximum = 15), thus evidencing a
significant relationship between the SOFA score on day 1
(P = 0.0001) and day 3 (P = 0.001), including ∆SOFA score
(P = 0.043), and mortality. The number of failures was also
associated with mortality when two or more organic failures
(P = 0.001) were present. Age, gender, APACHE II, length of ICU
stay, dependence level, presence of cognitive deficit and/or
previous cardiovascular diseases, plasma glucose levels, troponin
I, BNP and RCP were not associated with the mortality.
Conclusion Mean SOFA average above 5 as well as SOFA
variation within the first 72 hours proved to be good predictive
markers in elderly patients with septic shock and severe sepsis.
The same occurred in the presence of two or more organic failures
during the course of sepsis.
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Background Central venous oxygen saturation (ScVO2) as well as
SOFA, have been considered important parameters for follow-up,
prognostic estimate, and therapeutic target in the management of
critically ill patients.
Objective To analyze the impact of ScVO2 on the postoperative
(PO) period of cardiac surgery (CS), for the inhospital mortality
predictive power of SOFA.
Methods A cohort of 132 consecutive patients selected from
January 2004 to August 2004 and divided into the following two
groups: GI, death (n = 11, 8.3%); and GII, survivors. Blood
samples were collected through a central venous catheter properly
positioned in the right atrium. The ScVO2 measurements were
taken in the postoperative period as follows: immediately (SV0),
after 6 hours (SV1), after 24 hours (SV2), and identified the lower
ScVO2 in each patient at the first 24 hours PO (SVL). SOFA was
also registered on the first day PO. Inhospital mortality was
considered when death occurred at any time during hospitalization.
The t test was used for statistical analysis, followed by six logistic
regression (LR), classification tables and ROC curves.
Results Considering the total of the sample amount (132
patients), the mean SOFA was 4.03 ± 2.35 considering a GI value
of 5.72 ± 3 and a GII value of 3.8 ± 2.2 (P = 0.012). ScVO2 mean
values and the t test results of GI compared with those of GII were
as follows, respectively: SV0 54.8 ± 12.6% vs 65.4 ± 8.9%
(P < 0.0001), SV1 56.6 ± 7.3% vs 68.5 ± 5.9% (P < 0.001), SV2
61.1 ± 7% vs 69.3 ± 5.3% (P < 0.001) and SVL 50 ± 10% vs
62.7 ± 7.6% (P < 0.001). After the LR and the classification table
have predicted a 50% mortality, the isolated SOFA score obtained
a 91.7% accuracy (AUCROC 0.683, P = 0.045, confidence
interval 0.499–0.867). From all the tested variables in LR with the
SOFA score, the one that obtained a greater accuracy was SV2
(93.9%, AUCROC 0.846, P < 0.001, confidence interval
0.737–0.954) with sensibility of 73% and specificity of 79% with a
likelihood ratio (+) 3.52 and (–) 0.34.
Conclusions The association between SOFA and ScVO2
collected at the 24th hour of PO creates a prognostic model with
better accuracy for predicting death at the first day of CS PO.
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Critical Care 2005, 9(Suppl 1):P234 (DOI 10.1186/cc3297)
Objective To assess mortality’s predictive factors in a cohort of
bone marrow transplanted (BMT) patients admitted to the ICU.
Design A retrospective study.
Setting A 12-bed medico-surgical ICU.
Patients Twenty-nine patients on a total of 430 BMT (7%) from
1986 and 2004 were admitted to the ICU. Median age was 43
years and 22 patients were male (76%). Three main groups of
underlying disease were found: three patients had acute myeloid
leukaemia, 16 had acute myeloid leukaemia following
myelodysplasia, 10 had lymphoproliferative diseases, 25 patients
were neutropenic (86%), and 23 had less than 20,000 platelets/ml
at admission to the ICU (79%). Nine had autologous transplant
(2.7% of all autologous) and 20 allogenic transplants (20.4% of all
allogenic). Numbers of supportive devices (such as mechanical
ventilation or haemodialysis) were taken into account.
The SOFA score was calculated every day in the ICU (SOFA 0 at
admission) and data were collected to calculate SOFA in the two
days preceding ICU admission (SOFA –1 and SOFA –2). Main
diagnoses at ICU admission were categorized as: acute respiratory
failure without infection (ARF) and sepsis-related ARF (SD) that
include severe sepsis and septic shock. Multivariate analysis with a
logistic regression was used to analyze relationship between
mortality and data regarding characteristics of patients, data
regarding modality of transplant and cause of ICU admission.
Univariate analysis was used to compare SOFA scores between
groups.
Main results ICU admission occurred 23 days after transplant
(median value), causes of ICU admission were: ARF (10%), SD
(83%), others (7%). Overall ICU mortality was 90%. Relationship
with mortality was found for allogenic versus autologous
(P = 0.04), neutropenic versus non-neutropenic (P = 0.03), cause
of ICU admission (SD vs ARF, P = 0.026).
The highest SOFA value, mean SOFA value, SOFA –2, SOFA
–1.0 and SOFA +1 were higher in patients who died in ICU. No
association was found between SOFA variation (differences from
SOFA –1 and SOFA +1 and, respectively, SOFA 0 and SOFA
+1). No relationship was found between mortality and number of
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supportive devices, presence of severe thrombocytopenia, and
underlying disease.
Conclusions Our data support previously known risk factors for
ICU mortality in BMT recipients. SOFA was confirmed to well
describe organ failure and predict mortality. No cutoff value was
found to be highly suggestive for bad prognosis. Non-neutropenic
autologous BMT recipients admitted to the ICU for non-sepsis-
related acute pathologic event has a relatively good prognosis.
P235
Outcome of patients with systematic lupus erythematosus in
the intensive care unit
A Alzeer, A Al-Arfaj
King Khalid University Hospital, Riyadh, Saudi Arabia
Critical Care 2005, 9(Suppl 1):P235 (DOI 10.1186/cc3298)
The objective of the study was to identify the causes, outcome and
prognosis of severe illness in patients with systematic lupus
erythematosus (SLE) requiring ICU care in a university hospital
over a 5-year period. The design was a cohort study. Forty-eight
SLE patients requiring ICU management over a 5-year period
(January 1997–December 2001) were studied prospectively. Of
48 patients, 14 (29.2%) died, predominantly with multiorgan
dysfunction syndrome (MODS). Patients whose APACHE II score
was ≥ 20 had higher mortality than those with APACHE score
< 20 (60% vs 7.1%; P < 0.01). All 18 patients whose health status
was rated as ‘good’ survived, while 46.7% of 30 patients whose
health was rated as ‘poor’ died (P < 0.01). Patients who had
thrombocytopenia associated with sepsis and/or disseminated
intravascular coagulopathy had the highest mortality (75%, 5-year
survival). In conclusion, SLE patients admitted to the ICU had a
lower mortality rate than some of the previous reports. Patients
with SLE with high APACHE score > 20, poor health status,
thrombocythopenia and MODS had poor prognosis in the ICU.
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The outcome and follow-up of trauma in elderly intensive care
unit patients
A Katsaros, V Gougoutas, S Karatzas, G Bartzis, P Athanasiou,
V Zidianakis, P Myrianthefs, I Pastos, G Baltopoulos
‘KAT’ Hospital, Athens, Greece
Critical Care 2005, 9(Suppl 1):P236 (DOI 10.1186/cc3299)
Introduction Geriatric trauma is steadily expanded, mainly as a
result of increased vehicle accidents. The outcome of geriatric
trauma is considered significantly worse in comparison with that of
younger people. Although the cutoff of age above which a patient
is grouped as a geriatric one on a pathophysiological basis is not
clear, patients above 65 years old are generally accepted as
belonging to the geriatric group. In Greece, trauma is a very
common disease and elderly patients are affected in a continuously
increased manner. In our retrospective study we have recorded the
incidence, ICU, hospital and home mortality as well as an approach
to the quality of life of geriatric trauma critically ill patients after a
period up to 5 years after ICU discharge.
Methods All multi-trauma patients over 65 years of age admitted in
a seven-bed university ICU during the period 2000–2004 were
recorded retrospectively. The collected data include: ICU mortality,
hospital mortality, home mortality, and gross estimation of quality of
life, 1–58 months after ICU discharge. For this estimation we used
a simplified questionnaire on the basis of that published by
Fernandez and colleagues [1], and the modified criteria are
presented in Table 1. Each of them had the answer ‘yes = 1 or no
= 0’ and the range can be between 0 and 10. The information for
the outcome of patients outside the hospital was taken by















Results During a nearly 5-year period (lasting from 2 March 2000
to 14 November 2004) 229 multi-trauma patients were admitted to
our seven-bed university ICU. Seventy of them (31%) were above
65 years old (mean ± standard error, 76.5 ± 8). Thirty-seven
(53%) (77 ± 9 years old) died inside the ICU. The remaining 33
(76.5 ± 6.6 years, range 66–89) were discharged from the ICU
and treated on different medical departments (surgical,
neurosurgical, etc.). Seven of them died during the hospital stay
outside the ICU. The outcome 1–58 months after ICU discharge
was recorded after telephone communication in 15 from the
remaining 26 patients. From those 15 patients, three died at home
and 12 (17% of the total 70 patients) are alive 32.6 ± 9.6 months
after discharge. Nearly all the alive stay at home and they have an
excellent quality of life on the basis of our simplified scale (with the
exception of one patient the mean value is 9.3 ± 1).
Conclusions Geriatric trauma has a poor prognosis with high ICU
mortality. In our study the ICU mortality of geriatric multi-trauma
patients was in accordance with the literature [2]. The follow-up of
these patients is difficult, at least on a retrospective basis, and in
our study we have obtained data from about two-thirds of the
whole number of hospital discharged patients. Surprisingly, the
quality of life in this restricted part of geriatric patients can be
characterized as very good or excellent.
Reference
1. Fernandez RR, et al.: Validation of a quality of life questionnaire
for critically ill patients. Intensive Care Med 1996, 22:1034-
1042.
2. Jacobs D: Special considerations in geriatric injury. Curr Opin
Crit Care 2003, 9:535-539.
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Trends of age utilization in intensive care unit resources are
matched by the population aging process in Brazil
M Rocha, D Schout, A Santoro, S Oliveira, M Knibel
Comite QuaTI — AMIB/DIXTAL, Sao Paulo, Brazil
Critical Care 2005, 9(Suppl 1):P237 (DOI 10.1186/cc3300)
Introduction The QuaTI System, sponsored by AMIB and DIXTAL,
is developing an important database for intensive care in Brazil.
The QuaTI System offers significant information for the
participating ICUs for their continuous improvement, and gives
data, although partial, of demographic characteristics of patients
seen at participant ICUs. In our country, there is a steady decline in
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natality and mortality in the past 30 years, showing an irreversible
and accelerated aging population process. Life expectancy at birth
is 68 years and expectation at 60 years is more 18 years on
average. In 1970, 5.07% of the population was older than 60; in
2000, 8.56%; and in 2002, 9.3%. In the South and Southeast,
10.2% of population are more than 60 years old.
Materials and methods The QuaTI System is formed by 54 ICUs.
Descriptive analysis of the database for the period January
2003–June 2004.
Results and discussion The database contains 17,620 records.
We observed a linear growing tendency for all age groups. In the
60–74 years old age group there is a more marked increase in
relation to those younger than 60 years old. Patients older than
75 years show an even more accentuated tendency, as shown in
Fig. 1. The conditions responsible for this increase are acute
myocardial infarction (Fig. 2) and femur fracture. In this database,
58.8% of all records are of patients older than 60 years, 28.7%
between 60 and 74 years old, and 30.1% older than 75 years.
These findings confirm the trends shown by populational studies in
Brazil and call the attention of ICU care providers to develop plans
to support this older group of patients with proper care.
P238
Hospital mortality associated with day and time of discharge
from intensive care units in the United Kingdom
S Harvey, H Wunsch, C Welch, D Harrison, K Rowan
ICNARC, London, UK
Critical Care 2005, 9(Suppl 1):P238 (DOI 10.1186/cc3301)
Background The day and time of admission to the ICU does not
affect subsequent hospital mortality in the United Kingdom after
adjustment for severity of illness [1]. An independent editorial
published alongside this study [2], commented that “time and day
of discharge from the ICU may have an even greater impact on
patient outcomes” because of reduced staffing levels and services
on the wards at weekends and at night.
Aim To investigate whether day or time of discharge is associated
with subsequent hospital mortality.
Design A retrospective cohort study.
Setting One hundred and seventy-two adult general (medical/
surgical) ICUs in England, Wales and Northern Ireland
participating in the Case Mix Programme.
Population A total of 174,361 consecutive admissions between
December 1995 and June 2004 discharged alive from the ICU to a
ward in the same hospital (not for palliative care).
Analysis The day of the week, defined a priori, commenced at
08:00 hours on one day to 07:59 hours the following day. Each
weekday was spilt into three time periods: day 08:00–17:59
hours; evening 18:00–23:59 hours; and night 00:00–07:59 hours.
Crude and case mix adjusted hospital mortality were calculated for
the day of the week and the time of day of discharge from the ICU.
Results After exclusions for APACHE II, 144,210 admissions to
172 ICUs were included in the analysis. Most patients were
discharged during the day (n = 113,595, 79%) compared with
evening (n = 26,345, 18%) and night (n = 4270, 3%). Discharges
were lowest on Sunday (n = 13,638) and highest on Friday
(n = 25,069). Selecting Wednesday (day of week) and day (time of
day) as reference, discharge on Sunday or Monday was
associated with higher crude hospital mortality compared with
Wednesday (Sunday odds ratio [OR] 1.12, 95% confidence
interval [CI] 1.04–1.20; Monday OR 1.19, 95% CI 1.11–1.26).
These were no longer significant after adjusting for case mix
(Sunday OR 1.04, 95% CI 0.96–1.13; Monday OR 1.02, 95% CI
0.96–1.09). Discharge in the evening and at night was associated
with higher crude hospital mortality compared with day (evening
OR 1.37, 95% CI 1.32–1.43; night OR 1.47 95% CI 1.34–1.61),
which was still significant after adjusting for case mix (evening OR
1.22, 95% CI 1.16–1.28; night OR 1.34, 95% CI 1.20–1.50).
Conclusion Hospital mortality is not associated with day of the
week of discharge from the ICU but is associated with time of day
of discharge. As previously reported, this is partly due to premature
discharges from the ICU occurring more frequently in the evening
and/or at night [3], but may also be due to discharged patients not
receiving the appropriate level/amount of care on the wards at
these times, possibly due to reduced staffing levels. Further
investigation is warranted.
References
1. Wunsch, et al.: Hospital mortality associated with day and
time of admission to intensive care units. Intensive Care Med
2004, 30:895-901.
2. Bell CM, Scales DC: Variation in intensive care unit outcomes
by day of week: no weak-end. Intensive Care Med 2004,
30:739-734.
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Monthly distribution of hospital discharges by age group: QuaTI
System, January 2003–June 2004.
Figure 2 (abstract P237)
Distribution discharge diagnosis: acute myocardial infarction by age
group, QuaTI System, January 2003–June 2004.
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predictors in secondary peritonitis patients
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Critical Care 2005, 9(Suppl 1):P239 (DOI 10.1186/cc3302)
Introduction Health-related quality of life (HR-QoL) is an important
patient outcome, playing a complementary role to both mortality
and long-term morbidity outcomes in the assessment and
measurement of treatment effects and hospital process. Our aim is
to determine predictive factors for the HR-QoL in patients with
secondary peritonitis. We evaluated patient, surgery and
postoperative characteristics to determine their roles in HR-QoL.
Methods Patients participating in an ongoing trial evaluating
surgical strategies for secondary peritonitis were consecutively
surveyed by questionnaire 6 months after initial laparotomy. Eighty-
three patients were asked to fill in the Euroqol-5 Dimensions (EQ-
5D) and Euroqol Visual analogue scale (VAS) measuring HR-QoL,
while their attending doctors assessed the Karnofsky performance
scale, measuring functional impairment, at the outpatients clinic.
Statistical analysis Univariate analysis was carried out using the
Mann–Whitney U test, the Kruskal–Wallis analysis of ranks and the
Wilcoxon rank test. Relationship significance was determined by
the Spearman’s rank correlation coefficient. Multivariate analyses
were done by general linear model main effects model, using
patient characteristics, disease characteristics and postoperative
characteristics.
Results The following factors were determined predictive in the
univariate analysis and were therefore added to the multivariate
analyses: age, gender, enterostomy, comorbidity (assessed by the
Charlson index), type of contamination, and finally length of
hospital stay (LOH) (LOH was used as a summary value to
represent, length of ICU stay, ventilation duration, and the number
of relaparotomies; as these were all highly correlated). Predictive
factors for worse HR-QoL measured by the VAS, determining
overall patient well-being, are: being female (β = –11.1,
P = 0.009); having an enterostomy (β = –8.8 P = 0.049); purulent
contamination (β = –11.0, P = 0.028); LOH stay (β = –14.5,
P = 0.042); and severity of comorbidity (β = –3.6, P = 0.063).
Predictive factors for poor mobility are: increasing age (P = 0.030);
being female (P = 0.026); having an enterostomy (P = 0.014); and
LOH stay (P = 0.019). Predictive factors for reduced ability to care
for oneself are: having an enterostomy (P = 0.031); and LOH stay
(P = 0.003). Predictive factors for limited ability to perform daily
activities are: having an enterostomy (P = 0.011); LOH stay
(P = 0.037); and severity of comorbidity (P = 0.018). Only being
female (P = 0.060) was predictive for reporting more pain.
Predictive factors for increased depression and anxiety are: being
younger (P = 0.005); purulent contamination (P = 0.010); and
faecal contamination (P = 0.003). LOH stay was the only
predictive factor for the Karnofsky performance scale (β = –25.2,
P < 0.001).
Conclusion Six months following initial surgery, it appears that
LOH stay and enterostomy are overall the most predictive factors
for HR-Qol and functional impairment in patients with secondary
peritonitis.
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Quality of life 6 months after discharge from an intensive care
unit
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Critical Care 2005, 9(Suppl 1):P240 (DOI 10.1186/cc3303)
Objective The objective of this study is to determine the quality of
life of patients 6 months after their discharge from the ICU and its
relationship to age, the APACHE II score during admission,
admitting diagnosis, and length of stay.
Design One hundred and forty-five consecutive patients were
admitted to the ICU from August 2001 to June 2003 and that
fulfilled the following criteria: age >18 years, an ICU stay longer
than 4 days, and place of residence Greece.
Of the 145 patients, 47 died within 6 months of their discharge
from the ICU, and from the rest 38 (20 men, 18 women)
completed the questionnaire and were included in the study.
Methods After telephone contact and briefing, a special question-
naire was sent by post. The questionnaire was completed by the
patient, or if he/she was unable to by his/her relative or the closest
person that was living with him/her. The questionnaire that was
used was the Short Form Survey 36. This questionnaire has a very
good reliability and validity and has been weighted for the Greek
language. It consists of 36 questions in eight health dimensions
that yield summary measures in two higher order clusters of mental
and physical health. Data analysis was performed using the non-
parametric Kruskal–Wallis test.
Results The average age of the participating patients was
56.71 years, the average APACHE II score at admission was
14.84 ± 7.23 and the average length of stay was 15.84 days.
Every health dimension was scored separately and received a
value from 0% to 100%. The lowest average score that was
recorded was 31% and concerned the physical role scale, while
the highest average score was 76% and concerned the bodily pain
scale. In the rest of the scales the scores ranged from 44% to
59%. In a model that compared quality of life scores for each
dimension separately, with age, with APACHE II scores at
admission, with length of stay and with admitting diagnosis to the
ICU, statistical significance was observed between age and
physical functioning (P = 0.015), vitality (P = 0.024) and social
functioning (P = 0.014).
Conclusions Limitations were noted in the physical role, that is the
parameter that evaluates social well-being, return to work and
participation in daily activities. Age was the only variable that
seemed to be related to physical functioning, that is the ability to
perform physical activities, social functioning, that is participating in
social activities, and vitality, the subjective feeling of tiredness and
exhaustion.
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Introduction Mortality from severe sepsis remains high despite
ongoing searches to improve treatment modalities. Patients may
survive sepsis at the cost of an impaired health-related quality of
life (HRQOL). We hypothesized that HRQOL decreases during
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severe sepsis and intensive care (IC) treatment and remains
impaired several months after IC survival and discharge.
Methods We performed a long-term prospective study in patients
with severe sepsis admitted to a 10-bed mixed IC unit in a 654-
bed university-affiliated hospital. Patients were included if they met
predefined criteria of severe sepsis and were admitted to the IC
unit for > 48 hours. A population of sex-matched and age-matched
healthy Dutch individuals served as control. The HRQOL was
assessed using the Short-form 36 (SF-36), a generic instrument
for measuring health status in different domains (i.e. physical
functioning, role-physical, bodily pain, general health, vitality, social
functioning, role-emotional, and mental health). Patients or proxies
completed this questionnaire in the first 48 hours of admission [1].
Patients with established sepsis completed the SF-36 at IC
discharge, hospital discharge, and 3 and 6 months after IC
discharge. Demographic data and admission severity of illness
(APACHE II score) were obtained. Statistical comparisons at
admission and at 6 months were done with t tests, changes over
time were assessed with both univariate and multivariate analysis
of variance.
Results Of the 170 patients with severe sepsis 95 could be
evaluated 6 months after IC discharge (eight patients were lost to
follow-up, 67 patients had died). In all dimensions of the SF-36,
HRQOL changed significantly over time in survivors of severe
sepsis (P < 0.05). These changes over time were not influenced by
age or admission APACHE II score. A distinct pattern of a sharp
decline during IC treatment and gradual improvement approaching
normal functioning at 6 months after IC discharge was found in
almost all HRQOL dimensions (i.e. physical functioning, role-
limitation due to physical, vitality, general health, emotional role,
social functioning, and mental health). Nevertheless, the average
SF-36 scores of survivors of severe sepsis were still lower in six of
the eight dimensions 6 months after IC discharge with the
exception of social functioning and bodily pain compared with a
normal population (all P < 0.05). Interestingly, the pre-admission
HRQOL of severe sepsis survivors was already lower in three of
the eight dimensions (role-physical, mental health and vitality) when
compared with HRQOL in the normal population (all P < 0.01).
Conclusion In survivors of severe sepsis, HRQOL showed a sharp
multidimensional decline during IC treatment and gradual improve-
ment approaching normal values 6 months after IC discharge. Pre-
admission HRQOL was already lower in severe sepsis survivors
than in the normal population. This interesting finding in view of the
risk of surviving sepsis warrants further research.
Reference
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Introduction Our study aimed at studying stress, anxiety and
depression symptoms of ICU patients while focusing on a
restricted pathology (i.e. patients with cardiac disease), and while
comparing the impact of stress between patients exposed to
different levels of medical information (i.e. informed bypass surgery
patients versus uninformed inaugural infarct patients) and to a
different perceived control of their medical treatment (i.e.
controlled uncomplicated stay vs uncontrolled complicated stay).
Materials and methods Thirty-two ICU patients not older than 75
were assigned to either one of four subgroups according to their
medical history: complicated bypass (CB), uncomplicated bypass
(UB), complicated infarct (CI) and uncomplicated infarct (UI). All
patients were examined twice. On Time 1 (2 days after discharge
from ICU) they answered stress (Perceived Stress Scale [PSS])
and post-traumatic stress questionnaires (the Impact of Events
Scale [IES]), the Hospital Anxiety and Depression Scale (HADS)
and the State subscale of the State-Trait Anxiety Inventory (STAI-T,
testing constitutive anxiety). On Time 2 (6 weeks later), they
answered the same scales minus the STAI-T. Assuming that
bypass patients are better informed than infarct patients, and the
fewer the complications the larger the sense of control, we tested
the hypothesis that CI patients would performed badly on our
scales whereas UB would do better.
Results On Time 1, overall results indicated poor levels of stress,
anxiety or depression. Yet UI patients steadily produced the lowest
scores of the sample, whereas bypass patients produced the
highest. UI patients thus presented less depressive symptoms on
the HADS (H = 8.335, P = 0.039). The STAI-T results also
showed a dissociation between those patients who experienced
complications (CI and CB) and those who did not (UI and UB):
self-rated ‘anxious’ patients were more numerous in the
‘complicated’ groups CI and CB (F = 4.614 and P = 0.005).
On Time 2, measures of stress remained low on the PSS. Yet
signs of post-traumatic stress (IES) emerged in bypass patients
(CB and UB) and to a lesser extent in CI patients, with significant
group effects in the avoidance scale (F = 2.286 and P = 0.036)
and in the total scale (F = 3.13 and P = 0.042) of the IES.
Conclusion Our results show mild signs of stress, anxiety or
depression shortly after release of ICU. Yet some consistent post-
traumatic stress affects bypass patients several weeks later. UI
patients steadily display the weakest symptoms of all. In contrast to
our initial hypothesis, ‘informed’ bypass patients presented the
strongest signs of stress, anxiety and depression, while the
‘control’ factor primarily impacts on infarct patients.
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Prevalence of symptoms related to post-traumatic stress
disorder during long-term follow-up in patients after surgical
treatment for secondary peritonitis
C Mahler, K Boer, C Unlu, M Vroom, B Lamme, D Gouma, 
C de Borgie, M Boermeester
Academic Medical Center, Amsterdam, The Netherlands
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Background Symptoms related to post-traumatic stress disorder
(PTSD) may occur after exposure to a traumatic event and are
clustered; symptoms of re-experiencing, symptoms of avoidance,
and hyperarousal symptoms. It is unknown to what extent
recovered peritonitis patients experience PTSD-related symptoms.
The aim of this study was to screen patients for persisting PTSD-
related symptoms 4–10 years after surgical treatment for
secondary peritonitis and to detect whether a difference is
observed in prevalence of PTSD-related symptoms in patients with
ICU admission and those without.
Methods An existing database of 278 patients surgically treated
for secondary peritonitis between 1994 and 2000 revealed that by
October 2003, 131 patients were alive of which 118 patients
could be tracked. A standardized validated questionnaire was
mailed. PTSD-related symptoms were measured by the Post-
Traumatic Stress Syndrome 10-Questions Inventory (PTSS-10)
and the Impact of Events Scale Revised questionnaire (IES-R).
PTSS-10 scores > 35 or IES-R scores > 39 were regarded as
Available online http://ccforum.com/supplements/9/S1
S104
fitting with PTSD-related symptoms. In addition, information
regarding the presence of traumatic memories was obtained.
Results The response rate was 88%; 101 questionnaires were
suitable for analysis (86%). The mean age of the responders was
58.3 (± 14.5) years and 59% was male. The mean follow-up
period after peritonitis was 7.2 (4.0–10.4) years. The mean
APACHE II score on admission and Mannheim Peritonitis Index
score at operation were 9.5 (± 5.2) and 22.0 (± 7.4), respectively.
Sixty percent of the patients had been admitted to the ICU for a
mean of 19 (± 16) days. Overall PTSS-10 scores and IES-R
scores were 25.4 ± 13.6 and 28.5 ± 31.7, respectively. According
to the PTSS-10 questionnaire, the overall prevalence of PTSD-
related symptoms was 23%. The symptoms were observed in 28%
of former ICU patients and in 15% of non-ICU patients (P = 0.21).
The IES-R revealed an overall prevalence of PTSD-related
symptoms in 29% of patients, 31% of former ICU patients versus
25% of non-ICU patients (P = 0.78). The concordance rate
between the questionnaires was 80%. Furthermore, the presence
of a traumatic memory was significantly related to the scores on
the PTSS-10 (P = 0.03) and on the IES-R (P = 0.04).
Conclusion Long-term follow-up of patients after admission for
peritonitis showed a prevalence of symptoms fitting with PTSD in
23–29%. In peritonitis patients, attention should be given to early
recognition of this presumably underestimated problem. Given the
size and duration of the problem, research is needed into
preventative measures.
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Introduction The families of critically ill patients constantly worry
about the welfare of their loved ones. To this end, we recently
established a guesthouse in close proximity to our ICU exclusively
serving the families of patients hospitalized in the unit. The purpose
of this study was to evaluate their response to this new service.
Methods The ICU comprises a 10-bed acute care unit and a four-
bed mechanical ventilation weaning unit. The guesthouse
comprises six single rooms, a communal kitchen and bathing
facilities, situated on the floor below the ICU. The guesthouse is
restricted to use by relatives of ICU patients. All families are
informed of this option at the first meeting with the ICU staff and
rooms are allocated when available (i.e. no specific criteria for
allocating a room are applied). Once a patient is no longer being
treated in the ICU, the room must be vacated. Questionnaires were
distributed to the first 80 families using the facility, after the
occupant had vacated the guesthouse. Where appropriate,
responses were graded on a scale of 1 (negative response) to 5
(very positive response).
Results The rate of return was 43/82 (52.4%). All the guests were
first-degree relatives of the patients. Mean traveling time from
home to the hospital was 1.26 hours (range, 0.25–3.5 hours). The
mean duration of stay was 19.69 (range, 2–120) days, and 31/40
(77%) respondents to this question stayed in the guesthouse for
the whole period. Two respondents used this service only on
Saturdays when religious Jews do not drive, whereas the
remainder used it intermittently. Forty guests (93.02%) gave as the
main reason for requesting a room a strong need to remain at the
hospital at all times. Thirty-eight (88.37%) felt that the continuous
presence of one family member at the hospital enabled other family
members to continue with their daily routine. The majority (55.81%)
graded the physical conditions of the guesthouse as 5/5, 37.2%
as 4/5 and 6.9% as 3/5. Regarding close contact with other
families, 23.2% felt this to have a very positive impact, 18.6% a
moderate impact, 34.1% felt it had no impact and 4.65% claimed
this had a negative effect. There was a very positive response both
to the way the ICU staff interacted with the guests (mean score
4.69) and to fulfilled expectations (mean score 4.41). Finally, 37%
felt a similar service should be provided to all families in the
hospital, 30% only in selected cases, and 30% only to families of
ICU patients.
Conclusion The positive feedback received is encouraging and
suggests that a definite need has been fulfilled. Efforts should be
made to open such facilities in other units in the hospital, especially
ICUs.
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staff
P Souza, M Lugarinho, A Santana, M Guianze, S Silva, L Félix
Hospital de Clinicas Niterói e Mário Lioni, Rio de Janeiro, Brazil
Critical Care 2005, 9(Suppl 1):P245 (DOI 10.1186/cc3308)
Objectives Humanization was introduced in our ICU in 1996. We
performed research with patients and relatives, but never audited
the staff’s opinion. Through research for the ICU staff (doctors,
nurses, respiratory therapists), we tried to create a profile of their
point of view and then to improve the re-humanization program.
Materials and methods Between January and March 2004, we
carried out research with 15 questions about our re-humanization
program, the profile of the interviewer and comments. The data
were analyzed and communicated by posters inside the ICU. Our
sample was 52 questionnaires.
Results The answer rate was 96.5%. The mean age was 28.7 years
old, 64.3% were female, 51.8% Catholics, and between
10 months and 5 years of labour time in the ICU. The idea and the
program of re-humanization is important for 95.4%, but around
50% did not know it in detail. Noise was a problem in 67.3%.
Relatives disturbed nurse’s work for 82.6%. For patients, stress
factors were fear (57.7%), anxiety (53.9%) and solitude (55.8%)
Conclusion Listening to the staff, we could improve re-
humanization and approximate who is involved. The staff has to
understand the importance of the process and be aware of
benefits from taking care with dignity.
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Protecting healthcare workers from SARS
C Gomersall, G Joynt, P Lam, T Li, F Yap
The Chinese University of Hong Kong, Shatin, Hong Kong
Critical Care 2005, 9(Suppl 1):P246 (DOI 10.1186/cc3309)
Introduction There are only limited data from which to estimate the
risk to ICU healthcare workers of acquiring SARS. We describe
our experience of infection of healthcare workers in our SARS ICU.
Methods The study was a retrospective audit of the outcome of
measures to prevent SARS infection among ICU staff. During the
study period (13 March–31 May) only patients with SARS or
suspected to have SARS were admitted to our ICU. Data
extraction was carried out by a trained research nurse. The
following data were collected: patient demographic data, duration
of invasive mechanical ventilation, place of intubation, ICU length of
stay, number of days with diarrhea and days from symptom onset
to ICU admission. Duration of exposure to SARS patients was
obtained from nursing and medical rosters. Infection control
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procedures evolved during the first few weeks of the epidemic. In
brief, the final protocol consisted of the following. All staff entering
the ICU were required to clean their hands and don a gown,
gloves, hat, face shield and fit-tested N95 or N100 mask. Initial fit-
testing involved a qualitative fit-test, with a subsequent quantitative
test for those who failed the qualitative test. Those staff for whom
an adequate fit could not be achieved with a N95 or N100 mask
were issued with powered air purifying respirators.
Results Sixty-seven patients with SARS were admitted, with eight
patients being admitted twice. The median (interquartile range
[IQR]) length of ICU stay was 13 (6–24) days. The mean (standard
deviation) number of days between symptom onset and ICU
admission was 9.5 (4.7) days. The median (IQR) age was 47
(36–59) years and median (IQR) APACHE II score 10 (8–13).
Thirty-two patients were ventilated for a median (IQR) of 14.5
(7–25) days. Total number of ventilated patient-days was 525
days. No patients received non-invasive ventilation. All patients
who were ventilated were intubated by ICU doctors, 28 in the ICU
and four in other areas of the hospital. Diarrhoea occurred in 55%
of patients. Thirty-five doctors worked in the ICU for a median
(IQR) of 284 (97–376) hours. One hundred and fifty-two nurses
and healthcare assistants worked for a median (IQR) of 119
(57–166) hours. Five ICU healthcare workers developed SARS
(2.67%, 95% confidence intervals 1.15–6.11). Four of these were
nurses and the fourth was a healthcare assistant. Three became
symptomatic in the first 10 days of exposure to patients with
SARS, strongly suggesting that they were infected in the first few
days of exposure. Three of the five were subsequently underwent
quantitative fit-testing of the N95 mask that they were using at the
time of infection. In all cases the fit was adequate.
Conclusion The incidence of SARS among healthcare workers in
our ICU was low despite a prolonged period of exposure to
patients with SARS. Three of five infections occurred when the
protective strategies were being developed and vigilance in the
correct use of protective equipment was probably lowest.
P247
Burnout syndrome among intensive care staff
M Cubrilo-Turek
Sveti Duh General Hospital, Zagreb, Croatia
Critical Care 2005, 9(Suppl 1):P247 (DOI 10.1186/cc3310)
Background Burnout is a syndrome of emotional exhaustion (EE),
depersonalization (DEP) and lack of personal accomplishment
(PA). The Maslach Burnout Inventory (MBI) is a widely used
psychometric instrument for measuring excessive job-related
stress in different working areas.
Objective To determine the existence of the burnout syndrome
among medical (MICU) and surgical (SICU) intensive care staff.
Methods A sample group of 41 nurses and emergency physicians
from the MICU and 30 from the SICU was tested anonymously by
MBI using a 22-item questionnaire. Statistical analyses were
carried out by X ± standard deviation, and Mann–Whitney rank
sum t test (P < 0.05).
Results Total scores (X ± standard deviation) of the MBI were
higher for the MICU (65.53 ± 6.78) than for the SICU
(55.7 ± 3.89) staff (P < 0.05). MICU staff showed a moderate
degree of EE (24.97 ± 11.25), DEP (6.06 ± 5.64), and PA
(34.44 ± 8.85). The same parameters showed better results
among the SICU staff; a low degree of EE (17.10 ± 5.27), as well
as a low level of MBI DEP (5.27 ± 5.08), and a moderate degree of
PA (33.70 ± 9.85). Between the groups statistically significant
differences were found for total MBI and EE (P < 0.05). There
were no significant differences between MICU and SICU staff for
DEP or PA parameters. Overall job burnout was represented in a
moderate degree.
Conclusion Early recognition of burnout as a result of prolonged
stress and frustration among intensive care staff contributes to
better professional behaviour, organizational structure changes in
the work environment and better health care quality for critically ill
patients.
P248
The use of a checklist to guide multidisciplinary rounds
improves the utilization of prophylactic and safety actions in a
closed intensive care unit
S Silva, G Schettino, R Conish
Sirio Libanes, São Paulo, Brazil
Critical Care 2005, 9(Suppl 1):P248 (DOI 10.1186/cc3311)
Background Checklist forms have been successfully used during
multidisciplinary rounds in an ‘open’ ICU to increase the use of
prophylactic and risk reduction interventions.
Objective To evaluate the benefits of using a checklist form in a
‘closed’ ICU to increase the utilization of prophylactic and safety
interventions.
Methods The data of the head of bed position, peak inspiratory
pressure during mechanical ventilation, deep vein thrombosis and
digestive bleeding prophylaxis were recorded for 2 weeks before
(n = 93 cases) and after (n = 72) the implementation of a checklist
(modified from [1]) to guide the multidisciplinary visit in the
morning, noon, and night in a high-complexity (22 medical/surgical
beds) ‘closed’ ICU.
Results The percentage of patients with head bed position > 30°
(49% vs 77%, P < 0.001) and the use of deep vein thrombosis
prophylaxis (61% vs 82%, P < 0.001) increased after the use of
the checklist during the rounds. Digestive bleeding prophylaxis
(93%) and limiting the peak inspiratory pressure < 35 cmH2O
(90%) were observed in almost all patients in the pre-checklist
period and this intervention did not increase their utilization (94%
vs 90%, respectively, P = 0.6).
Conclusion As previously demonstrated in ‘open’ ICUs, using a
checklist to guide the multidisciplinary rounds is helpful to increase
the utilization of prophylactic and safety interventions in a ‘closed’
ICU.
Reference
1. Pronovost P, Berenholtz S, Dorman T, Lipsett P, Simmonds T,
Haraden C: Improving communication in the ICU using daily
goals. J Crit Care 2003, 18:71-75.
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The monitoring of vital signs on adult medical wards
C Brown, K Daly, R Beale
Guy’s & St Thomas’ NHS Foundation Trust, London, UK
Critical Care 2005, 9(Suppl 1):P249 (DOI 10.1186/cc3312)
Aims Ward patients have been found to have abnormal vital signs
in the hours prior to ICU admission and preceding cardio-
pulmonary arrest. This study aimed to assess nursing staffs’
knowledge of vital signs, and whether they increase the frequency
of observations in response to abnormal values.
Method The study was performed over a 24-hour period on the
medical wards of a London hospital. Observations charts of 233
patients were audited; 634 sets of observations were documented.
Accepted normal values for this study were; temperature
36.0–37.4°C; heart rate 50–99 beats/min; systolic BP
100–179 mmHg; respiratory rate 10–19 breaths/min; SaO2
Available online http://ccforum.com/supplements/9/S1
S106
≥ 95%. Comparisons were made of the time interval between
observations when values were both within and outside the
defined range. To assess the knowledge of nursing staff,
questionnaires were given to 101 staff; 73 were returned (72%
response). The questionnaire had questions about normal values
for vital signs and the significance of deviation from these norms.
Results Comparisons of the intervals between observations are
presented in Table 1. Data are given as the mean interval in hours
with 95% confidence intervals. A Mann–Whitney U test showed a
significant difference in frequency of observations for increased
heart rate, increased temperature and decreased SaO2. No
significant difference was detected for abnormal respiratory rate or
BP. Performance on the questionnaire was poor; 56% of
respondents obtained less than 50%. Areas of concern were
oxygen therapy (12%), hypotension (15%), respiratory assessment
(23%), recognition of oliguria (31%) and normal respiratory rate
(49%).
Conclusion Ward staff failed to increase the frequency of
observation for abnormal respiratory rate and BP. Performance in
the questionnaire suggests that staff may not understand the
clinical significance of these vital signs.
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Prehospital emergency medicine and non-heart-beating
donors: is there a future together?
A Lufinha1,2, C Ferreira2,3
1Hospital Militar Principal, Lisbon, Portugal; 2Hospital São
Francisco Xavier SA, Lisbon, Portugal; 3Hospital Curry Cabral,
Lisbon, Portugal
Critical Care 2005, 9(Suppl 1):P250 (DOI 10.1186/cc3313)
Objectives One of the major questions for transplant coordination
teams in Portugal is how to expand the donors’ pool, in order to
satisfy the population needs. The use of non-heart-beating donors
(NHBD) could help to deal with this problem of organ shortage. In
addition to difficulties with legal and ethical acceptability, there are
concerns regarding medical safety, which prevent the widespread
use of these donors [1].
Methods Lisbon has an emergency medical service with a
response time under 10 min and all four Prehospital Emergency
Medical Teams (VMER) are able to perform all kinds of advanced
life support manoeuvres in situ and during transport to hospital.
We perform a retrospective study of all cardiopulmonary arrest
emergency calls (112 calls) assisted by our VMER, at Hospital S
Francisco Xavier, during 2003. Then, we analyse how many of
these cases could have ‘matched’ a protocol for uncontrolled
NHBD [2]; that is, patients who die outside of hospital and are
transported to hospital for organ donation.
Results In 2003, our VMER assisted 2266 emergency calls;
13.8% (312) were cardiopulmonary arrest (CPA) cases and
advanced cardiac life support was always performed. All major
trauma and drowning events, as well as patients older than
55 years of age, were excluded (total of 217) from this study. Only
16.9% (16) of the remaining CPA (95) were resuscitated (less
than our global average rate of 27%) and transported to the
hospital with return of spontaneous circulation. A total of 79 cases
resulted in patients who died outside of hospital and could have
been transported to the hospital for organ donation if there were a
protocol for NHBD in Portugal.
Conclusions An average rate of 25% of all CPA events assisted
by our VMER could have resulted in NHBD A specific protocol
must be developed in the near future because non-heart beating
programmes are a good option to increase the donors’ pool.
Current data suggest that organs and tissues obtained are of the
same or better quality than those obtained from encephalic death
donors [3].
References
1. Arias-Diaz J: Non-heart-beating donation: current state of the
art. Transplant Proc 2004, 36:1891-1893.
2. Protocol of NHBD. Madrid: Transplantation Care Unit, Hospital
Clinic San Carlos.
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Organ donation: a 10-year experience
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Critical Care 2005, 9(Suppl 1):P251 (DOI 10.1186/cc3314)
Introduction There is a growing disparity between patients placed
on a waiting list and those who are transplanted, and the number
of patients who die while on a waiting list is also increasing. A 10-
year retrospective chart review was performed on all organ donors
to define our current practice in order to propose initiatives to
increase our organ donor rate.
Results Seventy-seven charts were reviewed; mean age of donors
was 47 ± 16 years (range 16–82). A vascular accident (77%) was
the most common etiology of brain death. An organ donor
management protocol had not been developed. The majority of
patients (87%) had central venous pressure monitoring; only 21%
patients had a pulmonary artery catheter. Complications included
diabetes insipidus (DI) (74%), hypotension requiring inotropic/
vasoconstrictor support (88%) and hypothermia (100%) requiring
active warming measures; 9/10 patients who had no invasive
pressure monitoring were receiving inotropic support. The majority
of patients (47%) had an abnormal serum sodium with
hypernatremia as the most common abnormality. The mean number
of organs donated per donor was 3.29 ± 1.21; the kidney was the
most utilized (87%), followed by the liver (73%), heart (44%), lung
(18%), pancreas (8%) and intestine (1%). As the number of
inotropic support medications increased, there was a tendency for
the mean number of organs donated per donor to decrease
(P = 0.1; Table 1).
Conclusions Without an organ donor management protocol, there
was a considerable variation in the management of our organ 
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Table 1 (abstract P249)
Normal range (A) > normal range (B) < normal range (C) A vs B A vs C
Temperature 6.43 (5.89–6.97) 3.47 (2.64–4.31) 5.20 (4.05–6.35) 0.000 0.238
Heart rate 6.28 (5.78–6.78) 3.62 (2.70–4.55) 3.06 (0.61–6.74) 0.000 0.056
Blood pressure 5.79 (5.33–6.26) 5.37 (3.09–7.66) 3.63 (2.57–4.69) 0.710 0.126
Respiratory rate 6.29 (5.14–7.45) 5.76 (5.08–6.44) None recorded 0.380
Oxygen saturation 6.15 (5.61–6.71) Invalid category 4.79 (3.97–5.61) 0.000
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Table 1 (abstract P251)
Number of agents n Number of organs tx/donor
0 9 3.8 ± 1.3
1 32 3.7 ± 1.1
2 27 3.4 ± 1.3
3 8 3.3 ± 1.3
4 1 3
donors. Hypotension, DI and electrolyte disturbances were
common complications and many patients required fluid
resuscitation and inotropic support as well as pharmacological
treatment for DI. With the institution of an organ donor
management protocol that includes the administration of triple
hormonal therapy (thyroxine, vasopressin, glucocorticoid), we have
begun a prospective study to determine the impact of an organ
donor management protocol on organ donor complication rate, the
need for inotropic support and whether this will result in an
increase of number of organs per donor transplanted.
P252
Availability of organs for transplantation: a 15-year overview
on organ donation in the ULB network
F Hut1, I Senepart2, L De Pauw2
1CUB-Hôpital Erasme, Brussels, Belgium; 2CHU-Hôpital
Brugmann, Brussels, Belgium
Critical Care 2005, 9(Suppl 1):P252 (DOI 10.1186/cc3315)
Introduction Transplantation of solid organs has become a widely
performed and accepted procedure that is mainly restricted by the
availability of organs. The gap between the supply of organs and
the demand for transplantation is still increasing, resulting in longer
waiting times and increased mortality for patients waiting for a
transplant.
Method A retrospective analysis of donor and transplant data
charts was conducted over a 15-year period in the ULB network.
Results From 1990 until now, 1070 potential donors were referred
and 508 (47.4%) of them were used for transplantation. During the
study period, the mean age of the donors increased from 35 to
48 years, the percentage of trauma as cause of cerebral death
decreased from 42% to 20%, the retrieval rate for the abdominal
organs (kidney, liver, pancreas) remained stable whereas for the
hearts it dropped significantly.
Conclusion In the ULB network, despite a changing pattern in the
organ donors’ profile, the availablity of abdominal organs remains
constant. The situation in heart donation is alarming.
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Estimated weight and height of critically ill patients: how
reliable are these values in acutely admitted patients?
R Determann, E Wolthuis, M Vroom, M Schultz
Academic Medical Center, Amsterdam, The Netherlands
Critical Care 2005, 9(Suppl 1):P253 (DOI 10.1186/cc3316)
Introduction Patients’ weight (W) and height values (H) are often
unknown on acute admittance to the ICU. In the present study we
investigated: (a) whether estimated W&H are in agreement with
W&H values given by patients/relatives, and estimated H is in
agreement with measured H; and (b) whether body mass index
(BMI) and H influence estimated W&H values.
Methods One hundred consecutive acutely admitted patients
(from whom pre-admission W&H were unknown) were included.
W&H were recorded from medical/nurse ICU records (‘estimated
W&H’). Afterwards, patients or close relatives were asked for pre-
admission W&H (‘actual W&H’). In addition, H was determined
with a tape measure (‘measured H’). Patients were divided into four
BMI (calculated from actual W and measured H) groups and four
height groups. The mean difference was calculated to assess bias
between both methods. Ranges of 95% limits of agreement were
calculated to assess agreement between both methods for
individual patients. Statistics were by regression analysis.
Results (a) The mean difference (95% confidence interval)
between actual and measured H was 0.9 (0.3–1.4) cm. The mean
difference between estimated and measured H was 1.0 (–0.2 to
2.3) cm. The 95% limits of agreement were –4.6 to 6.4 cm and
–10.1 to 12.2 cm, respectively. The mean difference between
estimated and actual W was 1.8 (0.7–2.9) kg. The 95% limits of
agreement were –9.3 to 12.9 kg. (b) See Table 1 for data of
agreement between estimated and actual W for BMI subgroups.
See Table 2 for data of agreement between estimated and
measured H for height subgroups.
Table 1
BMI group < 20 20–24.9 25–29.9 ≥30 
(n = 12) (n = 35) (n = 39) (n = 14)
95% limits of –7.2 to –10.6 to –6.9 to –13.0 to 
agreement 15.1 cm 11.8 cm 10.7 cm 18.4 cm
Table 2
Height group <165 cm 165–174 cm 175–184 cm ≥185 cm 
(n = 18) (n = 31) (n = 40) (n = 11)
95% limits of –11.5 to –9.6 to –9.7 to –9.4 to 
agreement 13.0 kg 13.8 kg 12.1 kg 6.2 kg
Conclusions Estimated W&H match actual W and measured H of
acutely admitted ICU patients very well. W estimation is more
variable for the highest BMI group.
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Quality in the intensive care unit: a general intensive care unit
compared with a cardiointensive unit
P Souza, V Souza, N Nunes, L Tavares, W Alcântra
Hospital de Clinicas Niterói e Mário Lioni, Rio de Janeiro, Brazil
Critical Care 2005, 9(Suppl 1):P254 (DOI 10.1186/cc3317)
Objectives Nowadays, to improve quality is not only a challenge,
but a question of survival of an institution. There is no consensus
how to study quality in ICU. The objective was to study the
evolution of some variables that could improve outcome. The name
of the system is QuaTI, a Brazilian small animal; the name
remembers the word quality (qualidade, in Portuguese). We
compared a general ICU with a cardiointensive unit (CIU).
Materials and methods The period of study was January–October
2004. We studied, on a monthly basis, the following variables: age,
sex, length of stay in ICU (LOS), occupation rate (OR), real
mortality rate, invasive mechanical ventilation rate, accidental
extubation, pneumothorax by accidental punction and pressure
ulcers and casemix. We compared the results of a general ICU
with a cardiointensive ICU.
Results Our data are: age ICU = 60.6 years old vs CIU = 62.4
years old; sex ICU male = 53% vs CIU = 61.8%; LOS ICU = 5.3
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vs CIU = 3.8; OR: ICU = 93% vs CIU = 96%; real mortality rate
ICU = 14.5% vs CIU = 3,6%; invasive mechanical ventilation ICU =
25.6% vs CIU = 17.3%; accidental extubation ICU = 1.4% vs B
(CIU) = 0.8%; pneumothorax by accidental punction HCN (ICU) =
2.8 vs CIU = 0; and pressure ulcers HCN (ICU) = 3.7% vs CIU =
0.5; the casemix in the ICU was 33.3% neurologic, 19.4%
respiratory and 15.6% cardiovascular, and in the CIU the casemix
was 77.2% cardiovascular, 8.5% neurologic and 5.1% respiratory.
Conclusion The study of the performance of one ICU is difficult,
complex and expensive. The best way to know one specific
performance is to compare it with similar ICUs that have similar
resources and casemix. To compare a Brazilian ICU with a
European or American ICU is not ideal and could give equivocal
information that generates erroneous decisions. With QuaTI, we
begin a very interesting project that will create a Brazilian databank
on ICU performance.
In our study, the main difference is the casemix, with much more
neurologic cases in the ICU versus the CIU where predominant is
cardiovascular, 77.2%. The outcome of mortality is completely
different — 14.5% versus 3.6%. Our worse rates as pressure
ulcers could be explained by the casemix (more neurologic
patients), and the difference among the pneumothorax is explained
because in a CIU we usually do not make profound venous access.
The main importance is to have data and establish strategies for
improved quality and safety. The QuaTI works in this direction.
P255
Quality of care on an intensive care unit: using subjective
indicators as an analysis tool
M Knibel1, C David2, R Hatum1
1CardioTrauma Ipanema Hospital, Rio de Janeiro, Brazil; 2Federal
University of Rio de Janeiro, Brazil
Critical Care 2005, 9(Suppl 1):P255 (DOI 10.1186/cc3318)
Introduction The routine follow-up of objective quality indicators
(product analysis) and subjective quality indicators (service analysis)
has essential importance to adequate management of an ICU. It
allows continuous PDCA cycles (to plan, to do, to check and to act)
and the adoption of preventive and corrective measures, which is a
simple, dynamic and efficient management system.
Patients and methods We applied satisfaction questionnaries to
patients admitted from February to November 2003 and their
relatives. These questionaries generated the Patient Satisfaction
Index (PSI) and the Relative Satisfaction Index (RSI), by means of
the 17 patients’ answers and 10 relatives’ answers. The statistical
analysis used: Mann–Whitney test (to compare two groups in
which variables did not present a normal distribution),
Kruskal–Wallis analysis of variance (to compare three or more
groups), chi-squared test (to compare qualitative data between
each 5-month period), and Pearson coefficient (to measure the
correlation strength between PSI and RSI). We accepted
P < 0.005 as significance level. The software pack used was the
SAS® system.
Results Indexes general descriptive analysis: PSI 2.856 (mean
value), RSI 2.882 (mean value). PSI descriptive and statistical
analysis by month: no difference (P = 0.10). RSI descriptive and
statistical analysis by month: no difference (P = 0.005). PSI
descriptive and statistical analysis by 5-month period: no
difference (P = 0.31). RSI descriptive and statistical analysis by 5-
month period: no difference (P = 0.65). Correlation coefficient
between PSI and RSI: positive correlation (P = 0.0001 r = 0.516).
Conclusions Our management system was good in services issue
because: (1) the PSI mean was 2.856 and the RSI was 2.882 —
both above 2.5, our initial goal; (2) there was no significative
variance in the PSI between the months, which indicates a uniform
behavior of the service; (3) there was no significative difference in
the PSI and RSI measures between both 5-month periods, which
shows uniformity in the offered services; and (4) there was strong
association between PSI and RSI, which confirms that the ICU
team really sees patients’ relatives like clients, which means a good
quality of service.
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Managing performance in the intensive care unit: a new
system in Brazil
P Souza1, J Lain1, J Andrade1, M Lugarinho1, M Amaral2, R Turon1
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Critical Care 2005, 9(Suppl 1):P256 (DOI 10.1186/cc3319)
Objective The study of the performance of one ICU is still setting
up. There is no consensus about criteria to guarantee quality. To
analyse the performance of an ICU and to benchmark it with other
ICUs could be a valuable experience. The objective was to study
the performance of one ICU and, for benchmarking proposes, to
compare it with itself and against a standard composed of seven
other ICUs. The name of this system is QuaTI, a Brazilian small
animal; the name remembers the word quality (qualidade, in
Portuguese).
Materials and methods A group of intensivists supported by a
Brazilian producer of medical equipment (Dixtal) have created a
computer program that collects many variables that compose the
idea of performance.
We register, on a daily basis, variation of the data studied, the
mean value, the mean value of benchmarking (the same subject in
other ICUs), and control graphics (with upper limit and lower limit
of control covering a confidence interval of 95%). This information
is in one ICU computer covering a period of 16 weeks; every
3 months we receive a report with more complete analyses, and
after 12 months there is a special report with consolidated
information. The data are divided into management, clinical and risk
indicators. Each group of indicators are composed of some data;
for example, risk indicators are composed of the rate of patients
with some infection, rate of accidental extubation, rate of pneumo-
thorax by barotraumas, rate of pneumothorax by venous puncture,
and rate of pressure ulcers. The system has confidentiality, so you
only know your data and the benchmarking, but not the data from
one specific ICU. The databank is the domain of AMIB (Brazilian
Society of Intensive Medicine). We start using QuaTI at the end of
2001. There were 30 ICUs in the system at the end of 2002 and
56 at the end of 2003.
Results We could compare the performance of our ICU with
ourselves along time, every 3 months, each year and with data from
benchmark ICUs. With this information we know our comparative
performance and we can decide whether it is necessary to change
some processes on a real and comparative basis.
Conclusion The study of the performance of one ICU is difficult,
complex and expensive. The better way to know one specific
performance is to compare it with similar ICUs that have similar
resources and casemix. To compare a Brazilian ICU with a
European or American ICU is not ideal and could give equivocal
information that generates erroneous decisions. With QuaTI, we
begin a very interesting project that will create a Brazilian databank
on ICU performance.
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The value of daily routine chest radiographs in intensive care
patients
M Graat, E Wolthuis, G Choi, J Stoker, M Vroom, M Schultz
Academic Medical Center Amsterdam, The Netherlands
Critical Care 2005, 9(Suppl 1):P257 (DOI 10.1186/cc3320)
Introduction It is uncertain whether daily routine chest radiographs
(CXRs) truly affect the daily management of critically ill patients.
The consensus opinion of the American College of Radiology,
however, is that routine CXRs are indicated in all mechanically
ventilated patients (http://www.acr.org).
Methods The study was performed in a mixed surgical/medical
ICU. During a period of 6 months, routine CXRs were performed
next to CXRs on clinical indication (on-demand CXRs). During a
second phase of 3.5 months, the routine CXR was abandoned and
only on-demand CXRs were made. Questionnaires (on the back
side of each CXR request form) were completed for all CXRs,
addressing the indication and expected findings. The presence of
the following abnormalities was scored by the radiologist:
pulmonary abnormalities (atelectasis, major infiltrates, any
pneumothorax, pulmonary congestion or significant pleural fluid),
and abnormal position of any invasive device (tube, central venous
lines). Statistical analysis was by chi-squared test.
Results During the first 6 months, 5180 CXRs were made in 888
patients (3400 routine and 1780 on-demand CXRs). Of all routine
CXRs, only 221 revealed an unexpected abnormality (6.5%)
compared with 249 of the on-demand CXRs (14.0%) (χ2 = 79.42,
df = 1, P < 0.0001). These findings included (on the routine
CXRs) 1.2% malposition of the tube, 1.1% malposition of central
venous lines and 1.2% atelectasis, versus 1.8% malposition of the
tube, 1.8% malposition of central venous lines and 1.2%
atelectasis in the on-demand CXRs. In the second period, 1093
(all ‘by definition’ on-demand) CXRs were made in 425 patients. Of
these CXRs, 153 revealed an ‘unexpected’ abnormality (14.3%)
(χ2 < 0.0001, df = 1, P = not significant); these findings included
2.2% malposition of the tube, 2.7% malposition in central venous
lines and 2.8% pleural fluid.
Conclusion Compared with the first period, the number of on-
demand CXRs did not change in the second period. In addition,
the incidence and type of unexpected findings of on-demand
CXRs did not change. From this we can conclude that daily routine
CXRs may not be necessary for all ICU patients.
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Accidental catheter removal in the intensive care unit: a
prospective observational study
S Myatra, J Divatia, P Mehta, S Kalaniya, R Sareen
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Introduction Accidental catheter removal (ACR) is associated with
complications caused by the removal itself and by catheter
reinsertion. Hence determining the incidence is important to
implement preventive measures. The objective of the present study
was to analyse the incidence of ACR for all types of catheters in
the ICU.
Methods A prospective observational study in a 22-bed
medical/surgical ICU-HDU in a 550-bed tertiary cancer care center
on all consecutive adult ICU patients between 1 October 2004
and 30 November 2004. ACR was considered to be accidental
removal of a catheter either by the patient or by the ICU staff. The
incidences of ACR for all types of catheters per 100 catheters (%)
and per 100 catheter-days (%cds) were determined. Complica-
tions arising due to the ACR were noted. The nurse–patient ratio
during the ACR and daily was noted.
Results A total of 913 catheters were inserted in 147 patients for
a total of 3614 catheter-days. ACR occured in 43 catheters (4.7%,
1.19%cds) in 25 patients. The incidence of ACR was higher for
arterial than for central venous catheters (2.4 vs 0.7%cds). The
incidence of ACR for nonvascular catheters (%cds) was:
endotracheal tube 1.65; nasogastric tube 2.9; urinary catheter
0.17; thoracic drain 0.56; abdominal drain 0.53; epidural catheters
1.1; and neck drains 0. Four patients (9.3%) with accidental ETT
removal had transient arterial hypoxemia necessitating reintubation.
Twenty-six catheters (60%) – six ETT, seven arterial, 10
nasogastric, one thoracic and two others — needed reinsertion.
The daily median nurse–patient ratio was 0.36 (range 0.27–0.57),
and during ACR it was 0.38 (0–1).
Conclusion Our incidence of ACR was high for nasogastric tubes,
arterial lines and ETTs. Development and implementation of
improved protocols are essential to reduce the incidence of ACR in
these catheters. There was no obvious correlation between ACR
and nurse–patient ratio. To minimize ACR, it is necessary to monitor
its incidence carefully and to implement preventive measures.
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V Payen, A Maury, K Norbert, E Saliba, S Cantagrel
Hopital Gatien de Clocheville, Tours, France
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Background Adverse events can increase the mortality or
morbidity of patients hospitalized in ICUs. Their frequency in
paediatric or neonatal ICUs is between 8% and 45%. A survey of
these complications is an indicator to improve quality of care.
Objectives To evaluate by a prospective observational survey over
a 1-year period the frequency of iatrogenic complications in a
multidisciplinary paediatric and neonatal intensive care unit; to
examine their type, severity, associate factors that favour their
occurrence, and the role of medical staff and parents in
precipitation or detection of iatrogenic complications.
Patients All consecutive admissions of patients over a 1-year
period from October 2004 to October 2005 in a paediatric and
neonatal intensive care unit
Preliminary results After 1 month, 71 children were admitted,
53% in neonatal and 47% in paediatric ICUs. Seventy-five per cent
of all admissions were for medical reasons, 20% after surgery and
5% following trauma. There were 42 iatrogenic complications in 31
patients (44% of admissions). Peripheral venous catheter
complications represented the major adverse event (50%) with
81% of diffusion followed by skin oedema; respiratory events
involved 24% of complications and included accidental
extubations (69%) and laryngeal dyspnea (16%); bedsore were
found in 18% of adverse events; 7% of them are secondary to the
arterial or central venous catheter. Forty-six per cent were major,
7% were moderate and 47% were minor. No death was directly
due to complications. Human error was implicated in 46% of
cases; 46% of iatrogenic complications did not have any
explanation. They were related mostly to insufficient surveillance.
Precipitating staff members were nurses in 73% of times,
especially for minor events. They detected the majority of the
complications (81%).
Conclusion As in adult ICUs, iatrogenic complications are
frequent in paediatric and neonatal ICUs. Knowledge of adverse




Adverse events and death in patients with community-
acquired pneumonia in the emergency department of a major
university hospital in Brazil
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Introduction Adverse events (AEs), defined as unintended injuries
due to medical care, have been related to patient death. Urgent
care is an important AE risk factor.
Objectives This paired case–control study aimed to identify the
occurrence of AEs in patients with community-acquired pneumonia
(CAP) attending a medical Emergency Department (ED) of a
Brazilian major university hospital, disclosing the AEs categories
associated with death.
Methods We investigated 202 patients admitted for CAP from
March 1996 to September 1999. The cases comprised 101
consecutive deaths and the controls 101 discharged patients
matched for primary diagnosis and admission period. AEs,
detected by chart review, were classified regarding: severity
degree (major and minor), immediate cause, and professional
category. The association with death was analyzed by multivariate
conditional regression including variables related to demographic
features, severity on admission and care characteristics.
Results A total of 603 AEs were identified in 202 patients: 456
events (75.6%) in 85 cases and 147 (24.4%) in 55 controls. Two
hundred and twenty-four major AEs were detected: 201 events in
65 cases and 23 in 10 controls. Diagnostic procedures and
nursing activities accounted for 43.1% of all events. Nursing
(43.8%) and medical (36.5%) AEs were the main professional
categories of AEs detected in both groups. The occurrence of at
least one AE was associated with a higher risk of death, with
adjusted odds ratio (OR) estimates of 2.99 (95% confidence
interval [CI] = 1.09–8.17; P = 0.033). A stronger association with
death was found regarding major AEs (OR 6.05; 95% CI =
2.19–16.68; P = 0.001). Medical AEs and administrative AEs
were also associated with death, with adjusted OR estimates of
3.74 (95% CI = 1.40–10.00; P = 0.009) and 2.97 (95% CI =
1.12–7.90; P = 0.029), respectively.
Conclusions In summary, AEs predominated among the deceased
patients admitted with CAP. Diagnostic and therapeutic
procedures and nursing activities corresponded to the main AE
immediate causes. Regarding the professional involved, AEs
related to nurses and physicians predominated. The occurrence of
AEs was associated with a higher risk of death in CAP patients
admitted to a tertiary ED.
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Adverse medication events in the intensive care unit:
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Introduction Recent publications have focused on patient safety
and managing medications effectively [1]. Adverse reactions to
medicines and medication errors cost the National Health Service
(NHS) approximately £0.5 billion per annum [1]. To inform practice
and facilitate policy revision we explored medication errors in two
specialist cardiothoracic ICUs that utilise identical reporting
mechanisms.
Methods A retrospective analysis of the DATIX risk management
database was performed for the 3-year period January
2002–November 2004. These events were categorised using the
National Patient Safety Agency impact and consequence
classifications [2]. Events categorised as moderate or severe were
individually investigated and an individual risk reduction strategy
initiated.
Results During this 3-year period 114 medication-related adverse
events were reported. There were 9.5 events per 1000 ICU bed-
days. A toal 14.9% of events were categorised as moderate or
severe, while 85.1% were insignificant or mild.
Table 1
Event type (all) Number (% of total) Major events (%)
Prescribing 20 (18) 3 (3)
Supply 11 (9) 2 (2)
Mislabelling 18 (16) 1 (1)
Route/drug/dose 23 (20) 6 (5)
Freq/documentation 32 (28) 2 (2)
Controlled/K+ 4 (3) 3 (3)
Other 7 (6) 0 (0)
Conclusion The rate of adverse events is comparable with
published work (9.5 vs 10.4) [3] but there may be significant under-
reporting. However, it was considered that all major events were
avoidable. The current UK Medication Safety Initiative focuses on
strengthening the prescription, supply and administration of
medications in the hospital setting. This study suggests that
medication safety should be a priority in the ICU in 2005.
References
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Care. National Patient Safety Agency; 2004.
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Aim To ascertain whether a comparison of drug budget spending,
in comparable ICUs, could lead to a rationalisation of clinical
practice and budget savings.
Method Two similar ICUs were chosen, both with the same bed
numbers, similar patient groups, severity of admission (using
APACHE II scores) and length of stay. The pharmacy departments
cross-referenced the financial costs of all medications and
sundries used in both ICUs. Where any major financial differences
became apparent, the clinical practice related to these costs was
investigated.
Results This budget analysis highlighted several variations in
clinical practice. The main differences found were in sedation
practices, the use of neuromuscular blocking drugs, antimicrobial
prescribing practices and the use of differing haemofiltration
sundries. The standardisation of practice in these areas led to a
financial saving of over £30,000 in a year between the two units,
from a combined drug budget of approximately £300,000.
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Discussion This analysis facilitated discussion among the
multidisciplinary intensive care team in an effort to improve patient
care and save money at the same time. By analysing drug-
prescribing costs and comparing clinical practices, we have shown
that significant savings can be made. We were able to rationalise
clinical practice without any significant changes in current
management strategies.
Further differences in practice were also demonstrated by this
study. It is hoped that, following discussions with all concerned
individuals, further standardisations in practice and subsequent
cost savings can be made.
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Objective To set up a holistic critical care system.
Background Ramathibodi Hospital is a 1000-bed medical school,
tertiary care and referral center. The ICU of the Department of
Medicine was founded in 1980 and comprised six beds that
served the total 132 medical inpatient beds. The ratio of ICU:total
beds was thus 0.4:10. In 1990, the number of ICU beds was
extended to eight, which raised the new ICU:total bed ratio to
1:10. Such a proportion of ICU beds was apparently too small.
This resulted in a number of critical patients being treated in the
general medical wards with difficulties in raising and maintaining
the standards of critical and respiratory care. The unclear job
description also deteriorated working morale and led to a rapid
turnover rate among the nursing personnel.
Steps of development (1) In 1989–1990, attempts was made to
validate the precision of the APACHE II scoring system when
applied to our group of ICU patients. Among the 334 patients
tested, the APACHE II scoring system was proved to be valid and
the ICU performance as assessed by the Actual Death/Predicted
death ratio was 1.17. (2) To estimate the actual critical care beds
needed, the number of patients who were mechanically ventilated
in the general wards were recorded over years (1995–1996). The
data showed at least 12–20 patients were mechanically ventilated
outside the ICU each day — a number that indicated the minimum
additional critical care beds required. (3) In 1998, one of the 30-
bed general wards was renovated to be a 20-bed intermediate
care unit (IMU). The total inpatient beds was thus reduced by 10
and the new critical:total beds ratio was 2.5:10. Criteria of critical
patients’ admission pathways to the ICU or IMU were set. A critical
care team was formed to raise and maintain standards of patient
and equipment care, and to provide continued medical education
in critical care medicine. A number of indices of quality control
were also monitored and evaluated continuously.
Results Since October 1998, none of the patients who were
hemodynamically unstable and/or needed ventilatory support was
treated in the general ward. Despite the reduction of total inpatient
beds by 10, the total number of inpatient admission has increased
from 3742 in 1997 to 4657 in 2003 (24% increment). The
average hospital length of stay (LOS) of the Department of
Medicine has declined from 10.84 days in 1997 to 8.81 days in
2003 (18.7% reduction). The overall inpatient hospital mortality
has reduced from 17.37% in 1997 to 9.90% in 2003 (43%
reduction). The critical care unit performance as measured by the
Actual Death/Predicted Death ratio has reduced from 1.17 in
1990 to 0.76 and 0.72 in 2002 and 2003, respectively.
Conclusion Our holistic critical care system management not only
resulted in a better care of critical patients, but also led to an
overall improvement in department performance.
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The Leapfrog Group recommended that CABG surgery should be
done at high volume hospitals (> 450 per year) without
corresponding surgeon-volume criteria. Recent studies have
indicated that the effects of hospital volume are substantially
confounded by surgeon volume, and that high surgeon volume
(>125 per year) may be a more appropriate indicator of CABG
quality. We thus compared operative morbidity and mortality
outcomes for a low-volume hospital (LVH) (504 CABG,
2001–2003) served by five high-volume surgeons (161–285 per
year) with the corresponding Society of Thoracic Surgeons (STS)
national data over the same period. The LVH program implemented
‘best practice’ care including effective practice guidelines,
protocols, data acquisition capabilities, case review process,
dedicated facilities and support personnel (anesthesiology,
intensivists and pharmacists). Operative mortality was similar for
LVH and STS (OM: 2.38% vs 2.53%), and the corresponding LVH
observed-to-expected mortality (O/E = 0.81) indicated good
quality relative to the STS risk model (O/E <1). Also, these results
were consistent irrespective risk category: O/E was 0, 0.9 and
1.03 for very-low risk (<1%), low risk (1–3%) and moderate-to-
high risk (> 3%) categories, respectively. While postoperative leg
wound infections, ventilator hours, renal failure, and atrial fibrillation
were increased in the LVH, the length of stay was not. The
unadjusted Kaplan–Meier survival for the LVH cohort was 96%,
94%, and 92% at 1, 2, and 3 years, respectively. Our results
demonstrated that high-quality CABG care can be achieved at
LVH programs when served by high-volume cardiac surgeons. This
approach may prove a useful paradigm to ensure high-quality
CABG care and early efficacy at low-volume institutions (Table 1
shows predictors of 0-year to 3-year mortality; Cox regression).
Table 1
Variable B SE Wald P value Risk ratio 95% CI
CPB time 0.02 0.00 16.26 0.0001 1.15 1.08 1.23
(10 min)
All vein grafts 1.75 0.55 10.15 0.0014 5.74 1.96 16.82
Cerebrovascular 1.33 0.43 9.82 0.0017 3.79 1.65 8.72
disease
Age (per 0.06 0.02 8.28 0.0040 1.63 1.20 1.91
10 years)
Redo surgery 1.24 0.55 5.00 0.0254 3.46 1.17 10.26
Congestive 0.91 0.45 4.07 0.0435 2.48 1.03 6.00
heart failure
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Introduction In recent years, rising cost, new technology,
demographic shifts, and demands for higher quality have placed
pressure on Medicare, the largest part of US healthcare. The
consequence for the use of ICU services is unknown.
Hypothesis Use of ICU services is growing in the Medicare
population.
Methods We selected all Medicare Prospective Payment System
(PPS) hospitalizations from 1994 to 2001 and generated rates
using corresponding beneficiary files. We calculated total ICU
admission rates, rates per 1000 beneficiaries, and rates stratified
by age and medical versus surgical admission.
Results In 1994, there were 10.7 million Medicare PPS
hospitalizations, 2.2 million (20.5%) of which incurred ICU care. By
2001, hospitalizations increased 5.3% to 11.3 million, while ICU
admissions increased 14.5% to 2.5 million. After adjusting for
changes in the number of beneficiaries, hospitalizations fell 2.1%,
while ICU admissions increased 6.4%. Those ≥ 80 years saw the
greatest increase in ICU admission rates (41%), accounting for
33.4% of ICU admissions in 2001. Growth in ICU use was due to
increased medical admissions, which rose 18.9% while surgical
ICU admissions fell 4.7%.
Conclusions ICU use has been rising dramatically in Medicare,
especially in the elderly. This rise is occurring despite a reduction
in the number of hospitalizations per beneficiary.
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Objective To compare the hospital cost of intensive care patients
before and after the opening of an intermediate care unit.
Design A before–after prospective observational study.
Setting University-affiliated mixed ICU, intermediate care unit
(IMC) and standard wards.
Patients and participants A total of 1539 ICU stays were
admitted from January 2001 to December 2002; 786 ICU patients
were included in the study by taken a random sample. During the
period before opening the IMC 329 ICU patients were included,
and 457 ICU patients after opening the IMC.
Interventions Opening of a six-bed mixed IMC.
Measurements and results For each ICU patient, the following
cost data were collected: total hospital cost; divided into costs
during ICU stay, IMC stay and general ward stay. The total hospital
cost was computed from the first ICU admission to hospital
discharge. The cost of readmissions to the ICU, IMC and wards
during the same hospital stay were included. Comparisons
concerning costs were performed after logarithmic transformation,
to improve the symmetry of distributions. The mean total hospital
cost before opening the IMC was €12.961 (± 14.530) and after
opening the IMC was €16.513 (± 19.324) with a significant
increase of €3552 (P value = 0.01) (Table 1).
Table 1
Before After 
Before IMC After IMC P
IMC mean IMC mean value 
Costs (€) (n) (SD) (n) (SD) (logtrans.)
ICU stay 329 10,017 457 13,020 0.08
(13,317) (17,659)
IMC stay 0 0 138 2612 –
(4060)
Ward stay 236 4105 304 4065 0.12
(5924) (5095)
Total hospital 329 12,961 457 16,513 0.01
stay (14,530) (19,324)
Statistical relations between individual hospital cost and patient
characteristics were analysed (age, gender, mortality, surgical/
medical, kind of organ failure and nursing workload [TISS-28] of
admission day). After correction of these variables, the increases of
the hospital cost were explained by kind of organ failure (P = 0.08),
surgical/medical (P = 0.26), and nursing workload (TISS-28) of
admission day (P = 0.43).
Conclusion This study showed an increase of total hospital cost
after opening the IMC. A different patient population was admitted
to the ICU after opening the IMC. More surgical patients, higher
TISS score and the kind of organ failure varied between the
populations before and after opening the IMC. The mean cost
during the ICU stay per patient increased most (€3003).
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Background ICU Research Coordinators (ICURCs) represent a
growing membership in the Canadian Critical Care Trials Group
(CCCTG). The professional contribution of ICURCs to clinical critical
care research is profound, but has not been well characterized.
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Objective To describe the settings, studies, resources, tools, and
activities of Canadian ICURCs.
Methods We conducted a prospective observational time-in-
motion study of CCCTG ICURCs from 20 September to 15
October 2004. We generated items and domains in focus groups.
The instrument was formatted using both open and closed ended
responses. We piloted for comprehensiveness and clarity. We
obtained data on the setting, studies, tools and resources available
in each center, then used a weekly management log to document
activities under seven domains. Completed forms were faxed to the
Methods Center at St Joseph’s Healthcare and entered into an
Excel Spreadsheet for descriptive analyses.
Results Twenty ICURCs participated from 13 mixed ICUs (100%
university-affiliated hospitals with 440 ± 225 hospital beds and 23
± 11 ICU beds). Over 4 weeks in 13 ICUs, 104 ± 64 patients
were admitted, 74 ± 60 were screened and 9 ± 9 were enrolled in
studies. On average, there were 4.6 ± 2.1 peer reviewed, and
3.8 ± 3.5 industry studies; 5.8 ± 3.4 were RCTs, 2.8 ± 2.3 were
observational and 0.8 ± 1.2 were other designs. On average,
7.1 ± 5.8 studies enrolled adults and 1.5 ± 2.4 enrolled children.
These resources were accessed electronically: laboratory data
(100%), diagnostic images (53.8%), radiology reports (69.2%),
ECGs (15.4%) and clinical information systems (15.4%). Data
collection tools include: paper (100%), NCR paper (38.5%),
datafax (38.5%), laptop (7.7%), PDAs (0%), and Web-based
approaches (84.6%). Time spent in each of seven activities was:
study preparation (literature review, inhouse protocol development,
REB submissions and amendments, budget preparation, CRF
development and piloting, regulatory document assembly, in-
services), 16.5%; research conduct (screening, consent and family
meetings, pharmacy and other study supplies, data collection and
queries, conducting and preparing tests, AE and SAE reporting,
bedside protocol compliance), 44.1%; communication (email/
telephone calls/mail, staff education), 14.3%; management (team
meetings, multicentered management, screening and finance logs,
initiation audit and close-out visits), 13.5%; data management
(database creation and data entry, analysis), 3.9%; dissemination
(interim and final reports, conference preparation and presentation),
3.0%; and miscellaneous, 4.7%.
Conclusions CCCTG ICURCs work primarily in mixed university-
affiliated ICUs, conducting randomized trials in adults. The availability
of electronic resources is modest, and variable data collection
methods are employed. ICURCs engage in many activities to prepare,
implement, and manage investigations for critically ill patients.
Acknowledgements This study was funded by Father Sean
O’Sullivan Research Center and the Canadian Institutes for Health
Research.
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Introduction Following the recommendations of Comprehensive
Critical Care [1], outreach services have been implemented
nationally with the remit of avoiding admission to intensive care;
facilitating discharge of critically ill patients from Level 3 areas and
educating ward staff in critical care skills. This initiative consumes
significant resources, and to date there has been disappointing
evidence that this investment has been worthwhile in terms of
improving outcomes, reduction in cardiac arrests, and unplanned
admissions to intensive care.
Objective This audit aims to identify whether the implementation of
an outreach team has had an impact on inhospital cardiac arrest
rates and readmission rates to ICU.
Methods A retrospective analysis of the ICU and outreach
database was performed to quantify the readmission rate within 48
hours due to organ failure and the inhospital cardiac arrest rate. This
analysis was performed 1 year pre and post the implementation of a
dedicated nurse-led outreach team.
Results Cardiac arrest rate has reduced by 40% since the
introduction of the outreach service. The readmission rate within
48 hours with organ failure was less than 2%.
Conclusion We report a reduction in the cardiac arrest rate post
implementation of outreach, although this may be due to other
external factors. The readmission rate within 48 hours of ICU
discharge is low, reflecting an appropriate and effectively facilitated
discharge practice.
Reference
1. DoH: Comprehensive Critical Care: A Review of Adult Critical
Care Services. Department of Health; 2000.
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Introduction Outreach teams have recently been implemented
across the United Kingdom with a remit to deliver a specialist level of
assessment and intervention with the ward setting. These goals
include early identification of deteriorating patients to avert admission
to ICU; facilitating discharge from ICU and education of ward staff.
Objective An evaluation of a nurse-led outreach team to facilitate
the threefold remit of outreach in a specialist cardiothoracic unit.
Methods Establishment of a unique referral criteria to reflect the
specialist cardiothoracic casemix. One hundred per cent of Level 3
discharges are followed up and actively managed to facilitate early
discharge (including patient on intermittent haemofiltration, intermittent
CPAP, tracheostomies in situ and low levels of inotropic support).
Ward-based education programme. Electronic data collection.
Results Over 800 patients were reviewed over a 12-month period
encompassing more than 2000 patient assessments. Level 3
discharge follow-up increased to 100% from 45% prior to
establishment of a dedicated team. The overall readmission rate
has remained unchanged; however, the readmission rate within
48 hours with organ failure is below 2%, reflecting appropriate
discharge from Level 3. Forty-five per cent of patients showed
biochemical evidence of renal impairment post ICU discharge
requiring a longer stay on outreach.
Conclusion This evaluation has highlighted the increasing
dependency of patients managed outside of ICU. Facilitating ICU
discharge and follow-up of patients with renal and respiratory
impairment impacts significantly on ICU length of stay.
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Objective The number of physiological abnormalities predicts
mortality [1], so we defined a positive ‘Count Outreach Warning
Score’ (COWS) as three or more physiological abnormalities
Available online http://ccforum.com/supplements/9/S1
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(temperature < 35°C or > 39°C; saturation < 95%; urine output
below 30 ml/hour; heart rate > 99 or < 51, respiratory rate >19,
mental state V/P/U [i.e. not alert]). Could COWS forecast the need
for ‘step-up’ from normal ward care?
Method All observations on the 79 patients present on one
medical and one surgical ward over 7 days at the Chelsea and
Westminster Hospital, London were scored using COWS and also
the published scores EWS, MEWS and PART. A patient was
predicted ‘sick’ by a score given a positive result on any one set of
observations. Outcome was followed for 28 days. ‘Stepped-up’
care was prospectively defined as any of intensive care, high
dependency or outreach referral or admission, cardiac arrest,
death, or placement of a ‘do not resuscitate’ order. Confidence
intervals were calculated by constant chi-squared boundaries and
sensitivities compared with McNemar’s test.
Results Of 79 patients studied, 17 required ‘step-up’ from normal
ward care (Table 1). COWS appeared more sensitive at predicting
‘step-up’ (P = 0.06), with similar specificity to the other scores. In
four patients correctly identified by more than one score, COWS
became positive 4–24 hours earlier whereas only one patient was
identified by another score before identification by COWS.
Conclusion COWS forecast the requirement for ‘step-up’ care
earlier and with more sensitivity than previous scores.
Reference
1. Goldhill D, McNarry A: BJA 2004. 92:882.
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Objective To assess Spanish intensivists’ knowledge and use of
different electronic resources; the Internet, electronic mail, mailing
lists and portable electronic devices (PDAs).
Design A cross-sectional survey.
Participants Eight hundred and twenty Spanish intensivists were
contacted by hospital commercial delegates of a pharmaceutical
company. The survey was simultaneously published in electronic
forums.
Methods and results A total of 682 responses were obtained
(response rate: 73.9%). The Internet was used autonomously by
95.7% (n = 653) of responding physicians and 78.8% (n = 513)
were autodidactic in this field. Learning gaps were reported by
66.7% (n = 451) of the respondents and up to 58.3% (n = 398)
acknowledged at least two deficit areas. The responses from
female intensivists showed lower Internet use and greater learning
gaps in at least one area (odds ratio [OR] 2.44; confidence interval
[CI] 1.5–3.95).
The Internet was the second most frequent source for clinical
consultation (60.9%; n = 409), only preceded by peer consultation
with ICU colleagues (65.2%; n = 438). The most frequently visited
webpages were bibliographical databases (64.5%; n = 412) and
electronic journals (63.4%; n = 405). EBM pages were rarely
visited (18.9%; n = 421). In fact, the number of different types of
websites was the main factor associated with solving clinical
questions by the Internet (OR 1.37; CI 1.25–1.5).
Email correspondence was used by 92.4% (n = 630) of those
surveyed and 89.6% (n = 611) used it for professional purposes,
but 25.3% (n = 159) admitted to ignoring its full potential. Email
correspondence as a resource correlated inversely with age (OR
0.95; CI 0.92–0.99; P = 0.015).
Electronic mailing lists were used by 62.3% (n = 425) of the
intensivists. Of the remainder, 41.7% (n = 113) were not familiar
with them and 31.7% (n = 86) reported insufficient expertise to
manage them correctly. Only 20.1% (n = 136) own portable
electronic devices. However, 63.5% (n = 416) considered these
devices would be a useful tool for immediate consultations at the
bedside. Female respondents were less predisposed towards their
use (OR 2.44; CI 1.5–3.95; P = 0.0002).
An index of five punctuated items was elaborated to summarize in a
single variable the use of all resources: preferable access to the
Internet to solve clinical questions (one point); Internet consultation
two or more times per week (one point); electronic mailing list
consultation two or more times per week (one point); intensive
care mailing list consultation (one point); and use of at least one
medical software program in the PDA (one point). The variables
associated with a low score in this index were: female gender,
increase of age, educational character of the hospital and being a
resident physician.
Conclusions A majority of Spanish intensivists uses the Internet
and electronic mail. Important educational deficits exist and a clear
underuse of fundamental webpage sources has been observed.
Mailing lists and portable devices are not prevalent electronic
resources. Training courses and educational programs are needed
to encourage and facilitate the use of these resources and to
promote email lists. Special attention needs to be directed at
female intensivists who seem to be more reluctant to access these
resources.
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Critical illness polyneuromyopathy: a major problem in a
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Introduction Critical illness polyneuromyopathy (CIPM) constitutes
a significant cause of difficulty in weaning patients from the
ventilator, prolongation of their stay in the ICU and increased
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Test PART PART EWS EWS MEWS MEWS COWS COWS
Test says … ‘Sick’ ‘Well’ ‘Sick’ ‘Well’ ‘Sick’ ‘Well’ ‘Sick’ ‘Well’
‘Stepped-up’ 2 15 6 11 6 11 10 7
Normal care 0 62 2 60 2 60 2 60
Sensitivity 2/17 = 12% 95% CR 21–40 6/17 = 35% 95% CR 20–44 6/17 = 35% 95% CR 20–44 10/17 = 59% 95% CR 41–70
Specificity 62/62 = 100% 95% CR 98–100 60/62 = 97% 95% CR 92–99 60/62 = 97% 95% CR 92–99 60/62 = 97% 95% CR 92–99
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morbidity and mortality. No reliable global epidemiologic data exist
to define the overall prevalence and incidence of CIPM in ICU
patients.
Objectives To estimate the clinical incidence and prevalence of
CIPM in the general ICU setting.
Patients and methods From August to December 2004, 205
consecutive admissions in a 25-bed university general ICU were
evaluated. Thirty-four patients were discharged in less than
24 hours from admission and were excluded from the study. The
remaining 171 patients (119 males, 52 females, mean age:
52 ± 18 years) were assigned admission APACHE II (17 ± 8) and
SOFA (7 ± 3) scores and were evaluated for the development of
new onset polyneuromyopathy, detected by assessing muscle
strength reduction (by the Medical Research Council scale),
reduced/absent deep tendon reflexes, sensory involvement and
clinically evident muscle wasting. Biochemical parameters and
drug treatment were evaluated daily. Other possible causes of
acute weakness appearing after ICU admission were excluded.
Prevalence of CIPM was estimated clinically on two different
occasions. All continuous variables are presented as the mean ±
standard deviation.
Results Twenty (12%) out of the 171 enrolled patients developed
CIPM. One hundred and five patients (71 males, 34 females) had
an ICU stay of more than 7 days, with an admission APACHE II
score of 18 ± 7 and a SOFA score of 8 ± 3. Nineteen percent of
those patients developed CIPM. All affected patients had an ICU
stay of more than 7 days. Patients with CIPM (13 males, seven
females) had a higher admission APACHE II (21 ± 8 vs 16 ± 7;
P < 0.02) and SOFA (82 vs 7 ± 3; P = 0.05) score and a longer
ICU stay (29 ± 21 vs 12 ± 13 days; P < 0.001) than those without
CIPM (151 patients). The overall mortality rate was 22%. Thirty-five
percent of patients with CIPM died during their ICU stay,
compared with 21% of patients without CIPM. Regarding age, no
statistically significant difference was found among the two groups.
Prevalence of CIPM in the ICU was estimated to be 20%.
Conclusions Previous prospective studies have reported higher
incidence rates for CIPM by studying subgroups of patients with
severe sepsis/systemic inflammatory response syndrome. Our data
show a high incidence and prevalence of CIPM in a general
consecutive ICU population. This finding clearly illustrates the need
for a longer prospective study to investigate the pathophysiologic
mechanisms, as well as the risk factors involved.
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Propofol and thiopental for refractory status epilepticus in
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K Braun, O van Nieuwenhuizen
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Introduction Thiopental is commonly used as a last treatment
modality in case of refractory status epilepticus (RSE). Its side
effects are well known, but there is little information about the
frequency in which they occur and the impact they have on clinical
practice. Because of the adverse effects of thiopental, several
guidelines recommend propofol as an alternative therapy before
thiopental is started. However, propofol is associated with
potentially fatal outcome, and its efficacy in the treatment of RSE is
almost exclusively based on small case series and case reports.
Objective The purpose of this study was to assess safety and
efficacy of propofol and thiopental in the treatment of RSE in
children.
Setting A pediatric intensive care unit of a tertiary teaching
hospital.
Methods Retrospective data collection of all patients treated with
propofol or thiopental for RSE between January 1993 and January
2004. Before 1999, patients were treated with thiopental, when
phenytoin and high doses of midazolam had failed to terminate the
status. After 1999, propofol was administered systematically to all
children before thiopental was started, reserving thiopental for those
who suffered from side effects of propofol or did not respond to it.
The maximum dose of propofol never exceeded 5 mg/kg/hour.
Success and adverse effects of treatment were noted and short-
term seizure control and neurological outcome were assessed.
Results Thirty-three patients were treated for 34 episodes of RSE.
The effects of propofol and thiopental on seizure activity and short-
term neurological outcome are shown in Fig. 1. Propofol was used
on 22 occasions. Side effects were infrequent, of limited severity
and fully reversible. Mortality was low and attributed to the severity
of the underlying disorder. Twenty children were treated with
thiopental. Hemodynamic instability occurred in most patients, but
could be adequately managed with extra fluids and vasoactive
medication. The majority of patients developed fever, pleural
effusions and infiltrates on their chest X-ray, suggestive of
pneumonia. Bacterial cultures, however, often remained negative.
Conclusions Propofol is a safe and effective treatment option for
RSE in children. When treatment with propofol fails and thiopental
is indicated, a broad range of complications can be encountered.
We advise using propofol before thiopental is started.
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Therapeutic window of opportunity assessment in
antithrombotic therapy, using a glycoprotein IIb/IIIa inhibitor
(tirofiban), in an experimental model of acute ischemic
embolic stroke in rabbits
V Segura Lemus, R Alfaro Ponce, J Castellanos Gonzalez, 
R Tenze Epperson, F Sansivirini Valle, N Astacio Soria
Universidad Dr Jose Matias Delgado, Antiguo Cuscatlan, El Salvador
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Background Preliminary preclinical and clinical studies have
established efficacy in the use of GP IIb/IIIa inhibitors in the
treatment of acute ischemic stroke. This study was designed to
Available online http://ccforum.com/supplements/9/S1
Figure 1 (abstract 273)
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assess the therapeutic window of opportunity of tirofiban in stroke
and the risk of intracerebral hemorrhage (ICH).
Methods We conducted a randomized, double-blind, placebo-
controlled, experimental preclinical trial. Seventy-one male New
Zealand white rabbits were included in the study. Rabbits were
embolized by injecting an autologous fibrin-rich blood clot
incubated for 22 hours into the common right carotid artery. Rabbits
were divided into three groups (3, 6, and 9 hours of ischemia). Each
one was randomly divided into two subgroups, placebo and
tirofiban (0.4 µg/kg/hour) parenterally infused for 30 min. A
neuroscore was performed 24 and 48 hours postembolization.
Postmortem pathologic analysis measured infarct volume and ICH.
Results Analysis of variance analysis showed a significant
difference between the volumes of the 3 and 9 hours groups
compared with the 6 hours group (P = 0.005, power = 85.9%);
there was no significant difference between the placebo and
tirofiban subgroups (P = 0.552, power = 9.1%). No significant
difference was found among the three groups between placebo
and tirofiban (P = 0.109, power = 45.1). Incidence of ICH was
1.4%. Median analysis showed a rise of the infarcted volume in the
subgroups between 3 and 6 hours and a decline between 6 and
9 hours was more evident in the tirofiban subgroup. There was no
significant difference in neuroscores among subgroups.
Conclusions There is no statistical significant difference between
tirofiban and placebo in reducing the infarct volume, but the results
obtained give the impression that tirofiban used in longer periods
of ischemia (> 6 hours) starts to show an effect in reducing the
size of the infarct. This result points out that tirofiban administered
after 6 hours might reduce the infarct by blocking microthrombosis,
and protecting the penumbra area to convert in necrosis. No
significative difference was found in the clinical outcome. Tirofiban
does not increase the incidence of ICH. Further studies need to be
made to establish significant differences in order to obtain
conclusive results.
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Hemodynamic instability following bilateral carotid
endarterectomy
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Background Blood pressure (BP) and heart rate (HR) instability
following carotid endarterectomy (CEA) have been extensively
documented in the literature [1,2]. CEA has been associated with
disturbance of the baroreceptor control mechanism caused by
surgery in the carotid sinus region [1]. Smit and colleagues
reported bilateral carotid sinus denervation producing long-term
blood pressure variability [3]. In our study, we report finding
profound hemodynamic instability during the 24-hour period
following CEA on four patients who had undergone a previous
contralateral CEA (Group 1) and compare management of these
patients with five controls who underwent CEA without previous
contralateral CEA surgery (Group 2).
Methods All patients underwent general endotracheal anesthesia
with the same induction and maintenance regimen. BP and HR
were recorded continuously perioperatively and for 24 hours
postoperatively. Incidence of postoperative hypertension (HTN),
hypotension, bradycardia, maximal increase in HR and the
associated use of corrective medications were recorded.
Results The incidence of refractory hypotension and bradycardia
was higher in the bilateral CEA group (Group 1, n = 3/4), while in
the unilateral CEA group (Group 2) hypotensive and bradycardic
response was transient and readily reversible. All patients exhibiting
refractory hemodynamic instability in Group 1 required aggressive
management with sympathomimetic and parasympatholytic
medications for a period of 24–36 hours postprocedure in the
PACU and SICU. Hypertension was a prominent feature in three
patients in Group 2 (n = 3/5) while one patient in Group 2
developed cardiac dysrhythmia that required cardioversion. Only
one patient in both groups needed hospitalization longer than 72
hours on account of recurrent cardiac dysrhythmia.
Conclusion Not withstanding the small sample size, our results
indicate that bilateral CEA is associated with significant hemo-
dynamic instability and often requires aggressive pharmacotherapy.
Awareness, early diagnosis and prompt treatment improve out-
come and often single out patients who need closer follow-up
during the posthospitalization period. Our data showed that hemo-
dynamic instability does not significantly affect early discharge [4]
while intraoperative injection of bupivicaine at the carotid sinus
level does not reduce the level of postoperative hypotension.
References
1. J Vasc Surg 2002, 36:793-798.
2. Stroke 1996, 27:1167-1172.
3. Circulation 2002, 19:1329-1335.
4. Cardiovasc Surg 1998, 6:470-474.
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The aim of the study was the demonstration of risk factors in young
persons who have an acute disorder of the cerebral circulation.
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We examined 13 patients aged 42–49 years old and two children
(9 and 11 years old) with verified diagnosis of acute disorder of the
cerebral circulation by ischemic type during an acute period of the
disease. The control group consisted of 10 healthy persons aged
40–50 years old.
Homocysteine, erythropoietin and cytokine concentrations in the
blood serum were detected by the immunochemiluminescent
analyzer ‘IMMULITE’ (USA). The values of the lipid metabolism
(common cholesterol, different density lipoproteins, triglycerides, B
lipoproteins) were detected by the analyzer ‘HITACHI-912’
(Japan). To determine the rheologic properties of the blood we
investigated its viscosity by the rotation viscometer ABR-2
(Russia). Fibrinogen concentration was detected by the
coagulograph ACL-100 (Italy). The significant differences between
groups were detected by Student and Wilkoxon–Mann–Whitney
criteria.
The study resulted in the observation of moderate hyperhomo-
cysteinemia, atherogenic dislipidemia, blood rheologic properties
and erythropoesis, pathology, and immune system disorders.
Patients with hyperhomocysteinemia did not have common risk
factors; their ischemic stroke had pathogenetic features:
atherothrombotic subtype, with interrupted step onset and gradual
growing of the symptoms during several hours or days with
expressed neurological deficit. Examined children had a homo-
cysteine concentration in blood serum of 18.4 ± 10.4 µmol/l,
versus 4.66 ± 0.31 µmol/l in healthy children at the compared age.
The main risk factor in young persons with ischemic stroke’s
atherothrombotic subtype is thus an increased level of
homocysteine.
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Purpose The efficacy of thrombolysis, systemic t-PA or local
transarterial urokinase infusion in the ischemic stroke of acute
stage has recently been proved. However, the patients brought to
the stroke center during the ‘Golden time’ are still not numerous.
To elucidate this problem, we analyzed the process until
hospitalization after the onset of symptoms.
Methods The clinical subjects consisted of 335 consecutive
patients with ischemic stroke in the acute stage, hospitalized in our
hospital, between April 2003 and March 2004. We investigated
clinical course, especially, the time from the onset to the physical
examination, and radiological examinations (CT, MRI, MRA and/or
cerebral angiography). The mean age was 72.1 years. Among
them, 99 patients were classified as atherothrombosis, 72 were
cardiac embolism, 134 were lacunar infarction and 30 were
transient ischemic attack. Only seven patients underwent local
urokinase thrombolysis.
Results Eighty-six patients (25.7%) were hospitalized within
3 hours from the onset, and 135 patients (40.3%) were within
6 hours. Among these 135 patients, only 58 were admitted by
ambulance. We found the following results. The main reason for
the delayed admission is through another hospital, not the stroke
center. The patients denying their symptoms is not so rare. The
patients or their family often hesitate to request the emergency car.
Conclusions We should educate citizens more for the warning
signs of ischemic stroke and also the necessity of emergency
admission and therapy. In addition, we should justly build a core
stroke center in the district and centralize the patients.
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Background Cerebral dysfunction is frequently seen in septic
shock and correlates to outcome. The pathogenesis of the cerebral
dysfunction is unknown. We decided to study the effects of
experimental septic shock on cerebral damage, as evaluated by the
serum levels of S100B, a well-established marker for brain and
blood–brain barrier damage.
Materials and methods Endotoxemic shock was induced in 10
anesthetized domestic piglets by an infusion of Escherichia coli
endotoxin. Blood samples for hemoglobin and S100 B measure-
ments were taken at baseline and repeated hourly. After 6 hours,
the piglets were sacrificed. S-100B was measured by sandwich
ELISA.
Results All animals had very low S100B values at baseline. There
were significant increases in S-100B at 1–5 hours in comparison
with the baseline values. The increases in S100B were most
expressed at 3 hours, at which time point the levels were increased
up to ninefold (P < 0.05). Changes in hemoglobin levels reflected
an increased vascular permeability during endotoxemic challenge.
The magnitude of the increase in hemoglobin, was considerably
less expressed than those of S100B.
Conclusion Anesthesia does not per se induce these changes in
our pig model. The increase of S100B found in this study thus
shows that there is minor blood–brain barrier damage occurring
already during the first hours of porcine endotoxemic shock. Serum
samples of S100B may be an alternative to cerebrospinal fluids in
evaluating blood–brain barrier damage. Such sampling may, in
certain selected cases, even turn out to be of value in clinical
practice, as spinal puncture is hazardous to perform in patients
with coagulation disturbances (e.g. in septic shock).
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Background Delta opioid peptide [D-Ala2,D-Leu5]enkephalin
(DADLE) has been shown to play a role in neuronal protection
against hypoxic ischemia. However, the cellular mechanisms of
these actions of DADLE on neurons are not totally clear. Being an
in vitro model of brain ischemia, oxygen-glucose deprivation
(OGD) injury in rat brain slices has the advantages of both in vivo
and in vitro models, and therefore can imitate damages induced by
brain I/R injury in intact animals. In the present study, we examined
the protective mechanism(s) of DADLE against apoptosis using a
rat brain slice model. In addition, we determined whether delta-
opioid receptors are unique and have a specific role in
neuroprotection against OGD injury by activating the MAPK
pathway, specifically through delta2-opioid receptors.
Methods The brain slices were incubated with different
concentrations of DADLE after injury by OGD. Selective delta2-
opioid antagonist or selective inhibitor of ERK kinase was co-
incubated with or without DADLE. The effects of DADLE against
apoptosis in neurons were measured by the following biochemical
and morphological assays: LDH release, RT-PCR, western blot,
and TUNEL staining.
Results OGD caused LDH release in brain slices. DADLE
inhibited OGD-induced LDH release. Naloxone, and naltriben
methane sulfonate, partially suppressed the survival of brain slices
promoted by 10 µM DADLE. DADLE at lower concentrations (10–6
and 10–5 M) significantly suppressed Bax mRNA expression and
enhanced Bcl-2 mRNA expression. But with the increased
concentrations of DADLE, the ability to regulate apoptotic gene
expression was attenuated. DADLE induced ERK phosphorylation
in brain slices with the increase of concentrations. The withdrawal
of oxygen and glucose per se decreased the ERK phosphorylation.
In the absence of oxygen and glucose, DADLE at 10–5 M
concentrations could, however, increase the ERK phosphorylation.
Naltrindole reduced the degree of ERK phosphorylation induced
by 10–5 M DADLE. PD98059 abolished the DADLE-induced
phosphorylation of ERK in the condition of OGD. PD98059 not
only abolished the cell survival promoted by DADLE, but also
apparently led to a higher level of LDH release when compared
with the DADLE control.
Conclusions Our results suggest, therefore, that endogenous
opioid peptides may, at low concentrations, promote cell survival via
the MEK–ERK pathway, perhaps through delta2-opioid receptors.
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Introduction Transcranial Doppler ultrasonography (TCD) is a
well-established technique for detection of cerebral vasospasm in
patients with subarachnoid hemorrhage (SAH). The aim of our
study is to investigate whether there is a relationship between TCD
findings during the first 3 days after admission and the neurological
outcome of patients.
Materials and methods Sixty-seven patients (60 ± 12.9 years,
APACHE II score 18.2 ± 6.4) were included in our study. TCD
middle cerebral artery systolic (SV), diastolic, and mean flow
velocities and pulsatility index (PI) were measured daily following
SAH. Neurological evaluation was performed at ICU discharge
using the Glasgow Outcome Score (GOS). A GOS score of 1–3
was considered a pure outcome (group 1, n = 56), a GOS score
of 4 or 5 as a good outcome (group 2, n = 11).The Student t test
was used to compare the data and P < 0.05 was considered
significant.
Results See Table 1. At admission there was no statistically
significant difference between the two groups in their flow
velocities and PI. The patients with pure outcome (group 1)
exhibited higher systolic flow velocities and higher PI on day 3 after
admission.
Table 1
TCD findings during the first 3 days after SAH (mean ± standard
deviation)
Day 1 Day 2 Day 3
PI SV PI SV PI SV
Group 1 1.4 ± 0.6 74 ± 30 1.26 ± 0.4 88 ± 35 1.63 ± 0.6 106 ± 4
Group 2 1.17 ± 0.3 60 ± 18 1.21 ± 0.16 68 ± 8 1 ± 0.07 57 ± 9
P NS NS NS NS < 0.05 < 0.05
NS, not significant.
Conclusion The elevation of PI and systolic flow velocity on day 3
after admission seems to be related to pure neurological outcome
of patients suffering SAH probably due to early appearance of
vasospasm.
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head injury in Sweden: a randomised clinical trial concerning
effects and costs
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Background Mild head injury, defined as short-term loss of
consciousness and/or amnesia as a result of head trauma, is a
common problem in emergency departments worldwide. Acute
computed tomography (CT) in triage for admission as well as
inhospital observation is suggested as standard practice for these
patients. However, the outcome, safety and costs of the two
strategies is unclear. To address this question a randomised
controlled trial (RCT) was conducted.
Methods A multicenter, pragmatic RCT with 39 emergency
departments throughout Sweden participating to randomise the
2500 cases needed. Eligibility criteria Head trauma within the past
24 hours, age 6 years or older, confirmed or suspected amnesia or
brief loss of consciousness, GCS 15, normal neurological findings
and no associated injuries that require admission. Randomisation
Urgent CT for all patients, early discharge for home care if normal
findings. Admission for inhospital observation. Main hypotheses
Medical outcome — the CT strategy is safe and clinically equivalent
to one based on inhospital observation. Cost comparison — the CT
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strategy reduces costs for management of mild head injury in the
acute stage. Costs in the follow-up period are equivalent between
the strategies. Endpoints Medical outcome — patient function at
3 months (Glasgow Outcome Scale Extended). Cost comparison
— resource utilisation in acute and follow-up phase.
Results From May 2001 through January 2004, 2603 patients
underwent randomisation. Patient follow-up was completed in June
2004. Data on the primary endpoint (GOSE at 3 months) are
available for 97% of the cases. Data analysis and manuscript
preparation are currently under way.
Conclusions The OCTOPUS study has randomised over 2600
patients with mild head injury to acute CT to triage for admission or
inhospital observation. Results from the study regarding the
medical effects, safety and costs of the two strategies will be
available in late 2005. Data on group characteristics and practical
performance will be presented at ISICEM in March 2005.
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Purpose Assessment of the incidence of coronary complication
during post-trauma subarachnoïd hemorrhage (SAH).
Methods An open, double-blind, prospective study, during a
period of 15 months in the Department of Anesthesia and
Resuscitation of the National Institute of Neurology of Tunis.
Patients Thirty-five patients with head trauma in whom a CT scan
reveals a SAH on admission. Patients with cardiovascular history,
thorax trauma, neurological coma related to a vascular pathology
and non-neurological coma were excluded.
Results The mean age of patients is 39 ± 17 years; 85% had a
Glasgow Coma Scale < 8 on admission. The mean ISS was
27 ± 14, and 6% and 54% had a Fischer scale between 3 and 4,
on admission. Electrocardiogram changes in 57% of patients.
Troubles of repolarization are the most frequent; 94% of patients
presented this trouble on the third day. The mean duration of these
troubles is 4 ± 1 days. Over the three performed measurements,
total CPK was increased in 88% of patients, creatine kinase MB
isoenzyme was increased in 65% of patients and Troponin Ic was
elevated in 34% of patients in a certain time of the evolution with
an average of 0.068 (± 0.2). The peak of Troponin Ic occurred on
the third day with an average of 0.113 (± 0.338). The increase of
Troponin Ic is associated with a poor CT scan grade. The elevation
of Troponin Ic is correlated with T-wave anomalies in comparison
with those of the ST segment. But it is not correlated to creatine
kinase MB elevation. The T-wave troubles, which are more
frequent, therefore reflect better a myocardic lesion and Troponin
Ic compared with creatine kinase MB is a better indicator of
myocardic ischemia during SAH. In our department, no case of
mortality was related to a cardiac cause. The incidence of Troponin
Ic and T-wave troubles could be considered predictive factors of
mortality.
Conclusion According to this study, troubles of repolarization
during post-trauma SAH are frequent in the acute phase of the first
3 days. They could reflect a myocardic lesion as it is indicated by
the increase of Troponin Ic, which is associated with severe
neurological injuries.
P283
Multimodal neuroelectrophysiological studies to predict
outcome in paediatric patients with traumatic brain injury
M Gray, V Nenadovic, J Hutchison
Hospital for Sick Children, Toronto, Canada
Critical Care 2005, 9(Suppl 1):P283 (DOI 10.1186/cc3346)
Introduction A prognostic tool is needed in the early assessment
of paediatric patients with traumatic brain injury (TBI). The
combination of electroencephalography and evoked potentials may
help predict outcome.
Methods We enrolled patients with TBI admitted to the Paediatric
Critical Care Unit with an initial GCS of 12 or less. Patients had an
electroencephalogram (EEG), visual evoked potentials (VEPs) and
somatosensory evoked potentials (SEPs) done within 60 hours of
admission to the PICU, and repeated within 7 days. A CT scan
was done on admission. EEG, VEP and SEP were scored. The
EEG was analyzed for synchrony using the Hilbert transform.
Outcome was measured at 3 months using the Paediatric Cerebral
Performance Category Score (PCPC).
Results Seven patients aged 3–13 were enrolled. Lowest
recorded GSC ranged from 5 to 12. Three of the seven patients
developed intracranial hemorrhage. Four of the seven patients
sustained diffuse axonal injury; these patients had encephalopathic
EEG patterns. Children whose EEG had normal background
activity had better outcomes at 3 months. Those who regained
normal background activity on the second EEG had intermediate
outcomes. Children having the worst scores for EEG and SEP had
worst functional outcome. EEG score did not show a correlation
with change in the PCPC. Encephalopathic EEGs showed
increased synchrony compared with EEGs having a normal
background (Fig. 1). Increased SEP latency in cortical to cortical
relays correlated with poor functional outcome. SEP score did
correlate with change in the PCPC (Pearson coefficient r = 0.82,
P = 0.02). Children whose EEG showed attenuated occipital
background patterns had large-amplitude VEPs. Current scoring
systems for VEPs do not account for this observed increase.
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Figure 1 (abstract P283)
Synchrony pattern from EEG electrode C3 of patient 2 in the delta
frequency range. Red, maximal synchrony; blue, minimal synchrony.
Patient demonstrates synchrony between C3 and between electrodes
1–3, 8–11 and 18. Synchrony is pathological.
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Conclusions Our results indicate that SEP correlates directly with
outcome. EEG synchrony correlates with outcome. High-amplitude
VEPs may reflect neuronal hyperexcitability The significance of this
needs further investigation.
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Comparison of biochemical markers and transcranial Doppler
ultrasonography findings as early predictors of outcome in
patients with traumatic brain injury: preliminary report
I Rodini1, A Lavrentieva1, B Soulountzi1, C Fitili2, M Karvouniaris1,
M Bitzani1
1ICU, G Papanikolau Hospital, Theesaloniki, Greece; 2Microbiology
Department, G Papanikolau Hospital, Thessaloniki, Greece
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Introduction Early brain ischemia after traumatic brain injury (TBI)
is predictive of pure outcome. We investigated the time course of
biochemical markers of brain damage: serum neuron-specific
enolase (NSE) and protein S-100 (Pr S-100) during the first
5 days after the ICU admission. Brain hemodynamics were
synchronously assessed using transcranial Doppler ultra-
sonography (TCD). Each patient was examined with TCD, and the
maximum, mean, and the end diastolic velocities and pulsatility
index (PI) were evaluated.
Methods Eleven patients (aged 34 ± 14.7, APACHE II score
15.7 ± 9, SAPS II 25 ± 13.7) with TBI were included in this
prospective study. Paired arterial and jugular bulb blood
concentrations of NSE and Pr S-100 were measured daily for five
consecutive days and were correlated with neurological outcome
evaluated by GOS score. TCD middle cerebral artery velocities
and PI were also measured daily after admision and were
correlated with biochemical markers and outcome at ICU
discharge. The statistical analysis was performed using the
Wilcoxon U test and Spearman correlation test.
Results NSE and PrS-100 concentrations were significantly
higher in patients with poor outcome (GOS 1–3) than in patients
with good outcome (GOS 4–5) both in arterial as well as in jugular
venous blood samples during the first 5 days. There were
significant correlations between these biochemical indicies and the
neurological outcome of patients from day 2 after admission
(Pr S-100: r = 0.76, P = 0.02, NSE: r = 0.67, P = 0.03) that
persisted for the following 3 days. TCD findings were not
correlated neither with neurological outcome nor with biochemical
markers of brain damage.
Conclusion The biochemical markers of brain injury (NSE,
Pr S=100) seem to be better early outcome prediction parameters
than cerebral blood flow velocities and PI measured by TCD in
patients with TBI.
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Clinical progresses and radiological findings in patients with
head injury
K Ishii, K Kitajima
Oita University Faculty of Medicine, Oita, Japan
Critical Care 2005, 9(Suppl 1):P285 (DOI 10.1186/cc3348)
Purpose X-ray and computed tomography (CT) are currently the
most effective tools in the analysis of head trauma patients.
However, the standard for operation of X-ray and CT is still unclear.
We investigated the clinical courses and radiological findings in
patients with head injury, especially minor trauma.
Methods The clinical subjects consisted of consecutive 217
patients, treated by our emergency medicine between January
2003 and December 2004. Among them, Glasgow Coma Scale
(GCS) scores in 209 patients (96.3%) were 15. We investigated
their clinical courses and radiological findings (X-ray and CT).
Results Skull X-ray was performed in 90 patients (41.5%), and CT
was performed in 114 patients (52.5%). Skull fracture was shown
radiographically in six patients (2.8%), and abnormalities on the
initial CT were seen in four patients (1.8%). Two hundred and nine
patients with GCS scores of 15 had excellent prognosis except
two died. One died because of delayed epidural hematoma, and
the other because of crescendo cerebral swelling due to cerebral
contusion in the bilateral frontal lobe.
Conclusions Head trauma patients must be treated with attention
and should undergo X-ray and CT examinations, even in minor
injury.
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The clinical importance of bulbus juguli oxymetry
C Hoffmann, Z Marjanek, Z Kisvarga
Jávorszky Ödön Hospital, Vác, Hungary
Critical Care 2005, 9(Suppl 1):P286 (DOI 10.1186/cc3349)
Objective In our study, we attempted to determine those
representative clinical parameters that most exactly correlate with
the final outcome of intensive treatment requiring neurological
(ischaemic and haemorrhagic stroke) and neurosurgical (subdural
and epidural haematoma) cases.
Methods We observed 27 patients retrospectively. The cohort
was divided into a survivor group I (12 cases) and a non-survivor
group II (15 cases). We introduced a central venous canule into
the internal jugular vein in the direction of the bulbus juguli, and
collected blood samples every 6 hours, at every significant
alteration of physical status and at therapeutic intervention. We
monitored the cerebral perfusion pressure (CPP) and intracranial
pressure (ICP) continously, and measured the oxygen saturation of
a blood sample from the bulbus juguli (SvjO2) and the jugular
arteriovenous lactate gap every 6 hours, and the GCS every 8
hours. We registrated the change of intracranial structure by
computer tomography.
Results In group II (non-survivors) the SvjO2 and lactate gap
values were 83.83 ± 6.6% and 0.43 ± 0.06 mmol/l, in group I
(survivors) the respective values were 71.57 ± 6.26% and
0.2 ± 0.1 mmol/l. We could not find a patient in group II with a
GCS higher than 5. There was no significant difference in ICP and
CPP values between survivor and non-survivor groups
(13.6 ± 2.4 mmHg and 72.3 ± 8.4 mmHg versus 16.4 ± 8.1 mmHg
and 68.45 ± 4.6 mmHg).
Conclusion The bulbus juguli oxymetry is an invasive but cheap,
simple and with competent practical skills a safely applicable
monitoring method for the judgement of cerebral oxygenisation.
The SvjO2 and lactate gap values were determinative in the aspect
of final outcome.
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Prognostic value of specific neural enolase in head trauma
C Kaddour, N Baffoun, Z Haddad, M Hamdani
National Institute of Neurology, Tunis, Tunisia
Critical Care 2005, 9(Suppl 1):P287 (DOI 10.1186/cc3350)
Purpose Searching for a correlation between the plasma level of
specific neural enolase (SNE) and the prognosis of head trauma in
the short term.
Subjects and methods An open prospective study carried out in a
HUC of Tunis over 15 months including 35 patients with head
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trauma causing a subarachnoid hemorrhage. Criteria of non-
inclusion were age <15 years and 3 months, and head trauma
requiring neurosurgery. The management was standardized for all
patients to avoid secondary cerebral aggression caused by
systemic troubles, as recommended by Maas and colleagues.
Clinical basic neurologic survey and CT scan monitoring (Fischer
and Marshall classification) were repeatedly carried out. A cerebral
CT scan was systematically performed 48 hours after hospitali-
zation or in case of aggravation. A surgical operation was
performed throughout the period of the study whenever required
(orthopedics, digestive surgery, etc.). The plasma level of SNE was
measured on the first, third and fifth day of hospitalization, using
the ELISA technique with an immunoenzymatic method, sandwich
type (kit CanAg Diagnostics), in a Dias Orin automate (Eti-max
3000). (The normal value of enolase used as a reference in our
study was considered the average of 47 volunteers’ plasma level.)
Statistical analysis used the chi-squared test and variance analysis,
respectively, for qualitative and quantitative variables. Values are
expressed as means ± standard deviation.
Results Mean age: 39 ± 17 years; sex ratio = 4; 80% of patients
had a severe head trauma; mortality: 16 patients (45.7%); mean
level of SNE in a ‘reference population’ was 7.02 ± 3.86 µg/ml
with a statistically significant difference (P = 0.001) (pathologic
value above 12.5 µg/ml). Seventeen patients (48.56%) had a
pathologic SNE plasma level in the first day. All patients (nine)
whose SNE plasma level had still been elevated until the third or
the fifth day died. The plasma level was higher in patients who died
in comparison with that of surviving patients; 25.74 ± 22.39 µg/ml
vs 11.51 ± 4.56 µg/ml, with a significant difference (P = 0.032).
All dead patients had a higher plasma level of SNE on the fifth day,
six of them had a normal value in the first day and then it increased.
Patients whose GCS was < 8 had a first-day plasma level so far
higher, 24.89 ± 25.27 µg/ml vs 15.25 ± 11.6 µg/ml; but with no
significant difference. SNE plasma level was not correlated to the
importance of the subarachnoïd hemorrhage (Fischer classification).
Discussion The persistence of a high plasma level of specific
neural enolase or its elevation represents a short-term prognostic
factor. Severe patients have higher plasma levels with no
significant difference.
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S100B protein: a possible prognostic factor in patients with a
severe head trauma injury
P Lavicka, R Pikner, R Bosman, M Choc, I Chytra, O Topolcan
Faculty Hospital, Plzen, Czech Republic
Critical Care 2005, 9(Suppl 1):P288 (DOI 10.1186/cc3351)
Introduction S100B protein is a small protein that belongs to the
group of calcium binding proteins. It is present in high
concentrations in astroglia cells. The level of this marker increases
significantly with CNS damage. Normal value is 0–0.2 µg/l.
Aim The aim of our research was to evaluate a consequence of a
dynamic monitoring of the S100B protein levels for a prognosis of
patients with severe head trauma injury.
Method Thirty patients with severe head trauma injury were
prospectively monitored. All patients were admited to the
Emergency Department. The time period from injury to admission
was shorter than 6 hours. All patients had the initial CT scan of the
brain performed with a positive finding. We used these scoring
protocols: at admission GCS, APACHE II, at dismissal GOS,
Karnofsky Performance Score (KPS). S100B protein level was
done by LIA essay on a fully automated immunoanalyser (Liaison;
DiaSorin, Sweden).
Results We divided our patients into four groups according to
characteristics of the S100B protein levels. The average values of
the particular groups are given in Table 1: group A, patients with a
rapid decrease of the level; group B, patients with an increasing or
persistent high level; group C, patients with a repeated increase of
the level after a previous decrease; group D, patients with an initial
level above 5 µg/l.
Table 1
Patient Level Level Level 
Group Death number GCS APACHE GOS KPS 0 24 72
A 1 15 9 17 4 80 1.378 0.415 0.245
B 0 5 8 22 3 50 1.45 1.68 0.924
C 2 7 8 26 2,5 40 1.697 3.155 1.18
D 3 3 3 37 1 0 18 – –
Conclusion A rapid decrease of the level in the first 72 hours is
associated with a good prognosis. Increasing or persistent high
levels longer than 72 hours are associated with a poor prognosis.
A repeated increase level above 1 µg/l after a previous decrease is
associated with a poorer outcome. An initial level above 5 µg/l is
associated with death.
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Increased levels of serum S100B protein in critically ill
patients without brain injury
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Critical Care 2005, 9(Suppl 1):P289 (DOI 10.1186/cc3352)
Objective S100B, a calcium-binding protein produced and
released predominantly by astrocytes of the central nervous
system, has been established as a specific biochemical marker for
brain injury [1]. However, there is increasing evidence that S100B
release is also induced by other causes or even from tissue outside
the brain [2]. The aim of this study was to explore the possible role
and the utility of S100B in critically ill patients with respiratory
failure of various etiologies, but without brain injury.
Patients and methods Thirty-eight mechanically ventilated
critically ill patients aged 62 ± 17 years, 29 males, with respiratory
and/or organ failure, but with no evidence of brain injury or other
neurological disorder, were prospectively studied. Blood samples
for analysis of serum S100B protein were obtained from the radial
artery at the time of laboratory sampling and blood gas analysis.
For the determination of S100B, all samples were analyzed using a
commercially available immunoluminometric assay (LIASON;
Sangtec Medical, Bromma, Sweden). Blood gases and lactate
were analyzed using the ABL 625 analyzer (Radiometer
Copenhagen, Denmark) and then the arterial oxygen content was
calculated.
Results Serum S100B was measured in 16 medical and 22
surgical ICU patients with a SOFA score on admission of 8 ± 3.4.
Compared with the normal values (< 0.15 µg/l), almost all patients
exhibited increased serum S100B levels at least once
(0.56 ± 1.03 µg/l, mean ± standard deviation, range 0.04–9.25).
Pearson’s correlation showed a statistically significant relation
between S100B and Hb (P < 0.001), O2 content (P = 0.002), and
arterial lactate (P < 0.001). Multivariate analysis using a stepwise
logistic regression model showed that the lactate was an
independent variable (F = 9.6, P < 0.001), followed by O2 content
(F = –3.25, P = 0.02).
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Conclusions Serum levels of S100B protein are elevated in
critically ill patients and correlate with increased lactate levels, low
hemoglobin, and abnormal oxygen content. Further research
should determine the sources of this S100B release and evaluate
its significance as a possible marker of tissue hypoperfusion in the
ICU setting.
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Objective Heroin overdose could result in hypoxic-ischemic changes
with cerebral edema, ishemic neuronal damage and neuronal loss
due to central nervous depression with significant respiratory
depression and hypotension. Heroin overdose can cause cognitive
impairment, neurological deficits or even death. S100B, the
structural protein of astroglia, has already been shown to be a useful
neurobiochemical marker of brain damage in circulatory arrest,
stroke, traumatic head injury and carbon monoxide poisoning. The
aim of our study was to assess the possible role of S100B as a
biochemical marker of brain injury in heroin overdose.
Methods The prospective study included patients with heroin
overdose who were admitted to the Emergency Department (ED).
Patients were enrolled if they had a documented exposure to
heroin only. The physical and neurological examinations were
carried out on the scene and on arrival at the ED.
Neuropsychological testing was performed at the ED just before
the patient’s discharge. Blood samples for S100B determination
were drawn immediately after arrival at the ED. S100B
concentrations were measured with a commercial immuno-
luminometric assay. Blood samples were also analyzed for creatine
kinase, troponin I and creatinine level. A toxicology analysis of
patient’s blood or urine samples by gas chromatography coupled
to mass spectrometry was performed. The control group included
10 healthy volunteers. Data are presented as the mean. S100
levels between groups were compared using the Mann–Whitney U
test and the Pearson correlation coefficients were calculated for
S100B, creatine kinase, troponine I and creatinine levels. A P value
of less than 0.05 was considered significant.
Results A total of 20 patients with heroin overdose were enrolled.
The mean age of the study cohort was 24.5 years (range,
16–39 years). There were four women and 16 men. Heroin
overdose was unintentional in all patients. All patients were
unconscious on the scene and regained conciseness after
naloxone application. 6-Monoacetyl-morphine, a metabolite of
heroin, was detected in all patients. S100B levels of heroin
overdosed patients were significantly higher compared with
S100B levels of the control group (0.65 µg/l vs 0.07 µg/l,
P < 0.05). Twelve patients (60%) had elevated creatine kinase with
mean value 15.30 µkat/l (normal value 0.17–2.08 µkat/l) indicating
rhabdomyolysis and two (10%) of them also had elevated
troponine I (0.15 and 0.1 µg/l; normal value 0.06 µg/l) indicating
myocardial necrosis. No correlation was found between serum
S100B, creatine kinase, troponine I and creatinine levels
(P > 0.05). All patients survived and had no clinically detectable
neurological deficits on discharge. Psychological testing was
unsuccessful because the majority of patients refused testing.
Conclusion Heroin overdose is associated with elevated S100B
levels. S100B could be useful biochemical marker of heroin
overdose, but its clinical value to predict brain tissue damage with
neurological or cognitive deficits after heroin overdose should be
further evaluated.
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early and fast assessment of brain damage after cardiac arrest
C Crippa, G Larosa, R Dorizzi, A Merlini, E Pecci, E Polati, A Luzzani
Institute of Anesthesiology & Intensive Care, Verona, Italy
Critical Care 2005, 9(Suppl 1):P291 (DOI 10.1186/cc3354)
Background and purpose Early and accurate predictors of
neurological outcome in patients with hypoxic-ischemic encephalo-
pathy after cardiac arrest are needed in order to improve medical
decision-making. The aims of the present study were: to assess
serum S-100 protein and neuron-specific enolase (NSE) as early
markers of brain damage and outcome after cardiac arrest; and to
compare the diagnostic and prognostic power of these serum
markers to somatosensory evoked potentials (SSEP).
Design A prospective study. Clinicians were blinded to S-100 and
NSE results.
Setting The ICU of a university hospital.
Methods Twenty-five patients resuscitated from cardiac arrest
(CA) were assessed until they regained consciousness or until
death/permanent vegetative state. We correlated SSEP, S-100
protein and NSE serum concentrations with patient outcome.
S-100 protein and NSE serum concentrations were measured
using an automated chemiluminescent analyzer (Liaison; Diasorin,
Saluggia, Italy) in samples collected 24, 48, 72 and 168 hours
after the cardiopulmonary resuscitation (CPR); SSEP were
recorded at 48 hours and on day 7 after the CPR.
Results We enrolled 25 consecutive patients (17 males/eight
females, mean age 69 ± 17 years, mean APACHE II score
26 ± 4.5); eight of them regained consciousness. Median values of
NSE and S-100B serum concentrations were significantly
(Mann–Whitney U test) higher in patients who did not regain
consciousness compared with patients who regained conscious-
ness at all time intervals (NSE: 53 vs 24 µg/l at 24 hours; 137 vs
20 µg/l at 48 hours; 102 vs 16 µg/l at 72 hours, and 39 vs 6 µg/l
168 hours after CA; S-100B: 2882 vs 342.5 ng/l at 24 hours;
6514 vs 240 ng/l at 48 hours; 3125 vs 198 ng/l at 72 hours, and
610 vs 146 ng/L 168 hours after CA).
S-100B concentration cut-off of 776 ng/l at 24 hours was found
the best predictor of not regaining consciousness. The area under
the curve was 0.96 (95% confidence interval = 0.88–1.00);
specificity was 100%; sensitivity was 82.4%. NSE concentration
cut-off point of 45 µg/l at 48 hours was found the best predictor of
not regaining consciousness. The area under the curve was 0.87
(95% confidence interval = 0.72–1.00); specificity was 100%;
sensitivity was 81.2%.
High association between SSEP responses and outcome was
found at 48 hours (rho = 0.68, P < 0.001) and at 7 days (rho =
0.72, P < 0.001) (Spearman correlation).
Conclusions According to our study and previous reports [1,2]
biochemical markers, and especially S100 protein, provide reliable
information about patient outcome after acute global cerebral
ischemia. Moreover, we used a recently marketed analyzer that
makes available S-100 protein and NSE results within 1 hour; in
this way, clinicians can easily and promptly use them in the
management of the patient.
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Neuron-specific enolase level predicts survival of patients
after cardiopulmonary resuscitation
J Auer, R Berent, G Lamm, T Weber, M Porodko, C Punzengruber,
E Maurer, B Eber
General Hospital Wels, Austria
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Background The prediction of outcome in patients after prolonged
cardiopulmonary resuscitation (CPR) has enormous ethical and
socioeconomic implications. The present study investigated the
prognostic relevance of the early time course of serum neuron-
specific enolase (NSE) as a biochemical marker of ischemic brain
injury in individuals after CPR.
Methods and results NSE levels were assessed immediately after
restoration of spontaneous circulation (ROSC), 6 hours, 12 hours,
and 2 days following prolonged CPR from nontraumatic, normo-
thermic, inhospital or out-of-hospital cardiac arrest in eight male
and 12 female patients. The survival status was assessed during
the entire hospital stay.
NSE levels in survivors and nonsurvivors immediately after ROSC, 6
hours, 12 hours, and 48 hours after following prolonged CPR were
18.8 ± 13.8 µg/l, 18 ± 7.9 µg/l, 17.9 ± 10.1 µg/l, 14.4 ± 7.1 µg/l,
and 26.5 ± 15 µg/l, 49.3 ± 65.5 µg/l, 60.8 ± 72 µg/l, 86.5 ± 87.6 µg/l,
respectively. Nonsurvivors had significantly higher NSE levels 48
hours after ROSC than survivors (P = 0.03) and showed a strong
trend towards higher values during the entire time course following
CPR. NSE concentrations at 48 hours after ROSC of > 23 µg/l and
> 29.5 µg/l predicted death with a high specificity (95% and 100%,
respectively). In contrast, NSE levels of 15 µg/l or less at 48 hours
predicted survival with a high specificity (100%).
Table 1
Normal 
value Baseline 6 hours 12 hours 48 hours
NSE, 3–14 18.8 ± 13.8 18 ± 7.9 17.9 ± 10.1 14.4 ± 7.1
survivors (µg/l)
NSE, 3–14 26.5 ± 15 49.3 ± 65.5 60.8 ± 72 86.5 ± 87.6
nonsurvivors (µg/l)
P value – 0.23 0.2 0.11 0.03
Conclusion Serum NSE levels early after ROSC are valuable
additional parameters for the prediction of outcome in patients
after prolonged CPR.
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blood cells attenuate the brain damage after hypothermia
circulation arrest of rat
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Background It was proved that higher haematocrit (Hct) might
improve the function of brain after hypothermia circulation arrest
(HCA). In the present study we develop a new rat HCA model and
investigate whether retrograde cerebral perfusion of oxygenated
compacted red blood cells (RBC) could attenuate the brain injury
after HCA.
Methods A new rat HCA model was developed. Forty-eight rats
were randomly distributed into three groups: HCA alone group,
HCA combined with retrograde perfusion oxygenated compacted
red blood cell group (HCArcp group), and sham operation group
(sham op group); 16 rats in each group. All experimental group
animals underwent HCA for 90 min at 18°C. We evaluated the
brain injury after HCA with the light microscopy and electron
microscopy. By the immunohistochemistry and RT-PCR
techniques we measured the different expression of the C-Fos,
Bcl-2, Bax mRNA and protein between groups. Additionally we
measured the wet/dry ratio of the brain in order to evaluate the
edema degree after HCA.
Results The new HCA model of the rat we developed was
comparable with the clinical setting not only in terms of the
intubation and anesthesia method and materials employed, but
also in terms of the priming capacity in relation to body weight. The
numbers of degeneration and necrosis neurons in the
hippocampus CA1 and parietal cortex but not in the thalamus of
the HCA alone group were significantly greater than those of the
HCArcp group (P < 0.05). The mean score of mitochondrion of the
hippocampus CA1 in the HCA alone group was significantly higher
than that of the HCArcp group (P < 0.05). The expression of C-
Fos, Bax mRNA and protein in hippocampus CA1 and/or parietal
cortex area was higher in the HCA alone group than that of the
HCArcp group (P < 0.05). Expression of the mRNA and protein of
Bcl-2 was higher in the HCArcp group than that of the HCA alone
group (P < 0.05). The degree of edema after HCA between the
two experiment groups had no significant difference (P > 0.05).
Conclusion We made a new rat model of HCA comparable with
the clinical setting. Retrograde cerebral perfusion of oxygenated
compacted RBC is a safe and effective method to protect the
brain during HCA. Adjusting the gene expression related with
apoptosis might contribute to the neuroprotective effects of
retrograde oxygenated compacted RBC.
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Background Mild poresuscitative hypothermia improves
neurologic outcome after cardiac arrest. Animal studies indicate
that rapid induction of the target temperature may be even more
neuroprotecive. Currently available methods allow only slow
induction of hypothermia (less than 1°C/hour). A faster cooling
method could reduce neurologic morbidity and mortality.
Methods We evaluated safety and feasibility of venovenous
extracorporal cooling to induce mild hypothermia in a prospective
non-randomised single-center clinical study. Eleven patients with
witnessed out-of-hospital or inhospital cardiac arrest who remained
comatose after the restoration of spontaneous circulation were
treated with hypothermia induced with venovenous extracorporal
cooling via a double lumen catheter inserted into the v. femoralis.
After the induction phase, hypothermia was maintained at
32–34°C for 24 hours with a cooling mattress. The rewarming
phase lasted 12 hours. Primary endpoints were the time to reach
the target temperature (34°C) and the rate of complications in first
7 days.
Results Eleven patients were enrolled, age 19–78 years, seven
males. Average time to reach a temperature of 34°C was 75 min
(range 55–118 min, 95% confidence interval 63–86.5). Cooling
averaged 1.97°C/hour (range 1.57–2.58°C/hour, 95% confidence
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interval 1.76–18°C). No procedure-releated adverse events
occured. Four patients (36%) had Glasgow Outcome scale 1–2
14 days after the cardiac arrest.
Conclusion Extracorporeal venovenous cooling is a safe and fast
method for induction of mild hypothermia in patients who
underwent cardiac arrest. To prove the hypothesis that the faster
the induction of hypothermia the better neurologic outcome, a
much larger study is needed.
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Introduction Recent studies have shown that induced
hypothermia improves neurologic outcome in comatose survivors
of cardiac arrest (CA). Our goal was to develop, implement and
evaluate an evidence-based guideline for the management of
comatose survivors of cardiac arrest.
Methods A systematic review of the literature was conducted to
identify potentially relevant randomized clinical trials and
observational studies reporting on a strategy of therapeutic
hypothermia in comatose survivors of out-of-hospital CA. The
research design and methodologic quality of all studies meeting our
inclusion criteria were evaluated independently and in duplicate.
Results Three randomized clinical trials (RCTs) and six
observational studies were evaluated. Pooling the RCT data of
good neurologic outcome showed an odds ratio of 2.06 (95%
confidence interval 1.34–3.15; P = 0.001) favoring therapeutic
hypothermia strategy. Two RCTs support the use of a hypothermia
strategy for the management of patients with witnessed CA due to
ventricular fibrillation while one small RCT supports its use in
patients with pulseless electrical activity or asystole. Although most
studies used external cooling measures to induce and maintain
mild hypothermia (32–34°C), one study used a 30 ml/kg bolus of
cold (4°C) crystalloid during the induction of hypothermia. Duration
of cooling ranged from few hours to about 3 days. Cointerventions
in the evaluated studies were anesthetic agents, hemodynamic
support, mechanical ventilation, glucose management and
treatment of acute coronary syndrome. The evaluated trials were
used to develop a practice guideline. The guideline was
implemented during a pilot study to assess its feasibility. During
this pilot phase, 16 patients were treated. The patients’
characteristics and their outcomes data were comparable with the
results of the clinical trials.
Conclusion An evidence-based guideline for the management of
comatose survivors of cardiac arrest is helpful to disseminate the
strategy of induced hypothermia into clinical practice.
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Background and goal Mild therapeutic hypothermia (MH)
improves neurological recovery after prehospital cardiac arrest
(OHCA) [1] and has become a standard procedure in post-
resuscitative care. Our goal was to study the complications during
MIH [2].
Materials and methods We evaluated retrospectively 30 patients
after VF-OHCA with regard to complications associated with the
use of MIH. MIH was induced by use of a surface cooling protocol
and maintained for 12–24 hours. Incidence of koagulopathy,
electrolyte disorders, pneumonia (within 72 hours after admission),
leukopenia, pancreatitis, hemorrhage, elevated amylase and
arrhythmias requiring treatment were documented.
Results and discussion The median age of the patients was 60.5
years (32–75 years), with all patients (100%) having presumed
cardiac cause of OHCA and ventricular fibrillation/pulsless
ventricular tachykardia (VF/VT) as the initial ECG rhythm. All
patients were intubated at the scene. The presenting arrhythmias
during MIH were VF in one patient, VT in two patients and rapid
atrial fibrillation in four patients.
Table 1
Complication Incidence (%)
Hypokalemia 73 (n = 22)
Severe hypokalemia (< 3.1 mmol/l) 36.6 (n = 11)
Pneumonia 70 (n = 21)
Elevated amylase 53.3 (n = 16)
Arrhythmia 23.3 (n = 7)
Hyperkalemia during rewarming 3.33 (n = 1)
Elevated INR (1.3–1.6) 16.6 (n = 5)
Platelet reduction > 30% 10 (n = 3)





Conclusion MIH is a safe therapy when the clinician is aware of
the potential side effects. Electrolyte disorders during MIH and
pneumonia after MIH treatment should be anticipated and treated
pre-emptively.
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Introduction Resuscitative hypothermia after cardiac arrest has
been shown to improve neurological outcome and has been added
to the recommendations for the treatment of cardiac arrest patients
of the Task Force of the International Liaison Committee on
Resuscitation [1–3]. However, there is clearly a need for further
investigations. A population-based international database, the
European Resuscitation Council (ERC) Hypothermia After Cardiac
Arrest Registry (HACA-R), is on its way to provide sufficient data to
answer relevant study questions (see www.erchacar.org,
www.erc.edu). It was established in 2002 under the lead of the
ERC. The goals of the HACA-R are: to document information of all
patients with cardiac arrest admitted to one of the participating
centres; to set up relevant study protocols in close collaboration
with the clinicians of the ERC to further improve guidelines on
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application of mild therapeutic hypothermia; and to formulate
hypothesis on underlying causes of the benefits of mild therapeutic
hypothermia on neurological outcome of cardiac arrest patients.
Methods Protocols on baseline characteristics, details on cardiac
arrest, out-of-hospital procedures and events, cooling and
rewarming procedures, neurological and functional outcome
scores at discharge, information on possible adverse events and
death are documented.
Results From March 2003 to May 2004, 301 patients across 16
sites have been enrolled. Of all enrolled patients 93 (31%)
received endovascular cooling, 30 (10%) were cooled with other
methods, 178 (52%) acted as control, 75 (25%) were female, the
mean age was 60 (STD 15) years. A detailed analysis will be
conducted when a sufficient set of patient data has been
completed.
Conclusion With the effort of a growing number of participating
centres, the ERC HACA-R is expected to become a useful tool to
further elucidate scientific questions regarding resuscitative
hypothermia after cardiac arrest and to realize goals of the ERC.
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Background and goal Inadvertent hypothermia is not uncommon
in the immediate postoperative period and it is associated with
impairment and abnormalities in various organs and systems that
can lead to adverse outcomes. The aim of this study was to
estimate the incidence, predictive factors and outcome of core
hypothermia at admission to a surgical ICU.
Materials and methods All 185 adult patients who underwent
scheduled or emergency noncardiac surgery admitted to a surgical
ICU between April and July 2004. The tympanic membrane core
temperature (Tc) was measured on arrival on the ICU and every
2 hours until 6 hours after admission. The following variables were
also recorded: age, sex, body weight and height, preoperative
body temperature, ASA physical status, emergency or scheduled
surgery, magnitude of surgical procedure, anesthesia technique,
amount of fluids during anesthesia, use of temperature monitoring
and warming techniques, duration of the anesthesia, length of stay
in the ICU and in the hospital, and SAPS II score. The incidence of
core hypothermia at admission to the ICU and its 95% confidence
interval (CI) were calculated using the cutoff point of Tc < 35.0°C.
That was used to classify patients as either hypothermic or
normothermic. The two groups were compared to assess the
relationship between each clinical predictor and core hypothermia
using univariate analysis performed by simple binary logistic
regression with an odds ratio (OR) and its 95% CI.
Results The mean (± standard deviation) admission Tc was
34.69 ± 1.02°C. Incidence of core hypothermia on ICU admission
was 57.84%. Temperature monitoring (OR 0.185, 95% CI
0.053–0.651, P = 0.009), use of warming techniques (OR 0.473,
95% CI 0.258–0.865, P = 0.015) and higher previous body
temperature (OR 0.402, 95% CI 0.206–0.784, P = 0.007) were
significant protective factors against core hypothermia.
Significant independent predictors of hypothermia at admission
were the magnitude of surgery (OR 3.110, 95% CI 1.235–7.831,
P = 0.016 for medium surgery; OR 4.679, 95% CI 2.063–10.613,
P < 0.001 for major surgery), use of general anesthesia or
combined epidural and general anesthesia (OR 5.963, 95% CI,
1.891–18.804, P = 0.002 for general anesthesia; OR 22.50, 95%
CI 2.068–244.838, P = 0.011 for combined epidural and general
anesthesia), amount of crystalloids (OR 1.435, 95% CI
1.161–1.773, P = 0.001) and total blood administration (OR
1.575, 95% CI 1.142–2.170, P = 0.006), anesthesia longer than
3 hours (OR, 1.808; 95% CI, 1.002–3.263, P = 0.049) and SAPS
II scores (OR 1.028, 95% CI 1.004–1.052, P = 0.020). Twenty-
nine patients (15.70%) died during their hospitalization.
Hypothermia was not a risk factor for mortality, not at admission,
neither at 2, 4 and 6 hours after arrival on ICU. Statistically
significant independent risk factors for mortality were low body
weight (OR 0.970, 95% CI 0.941–0.999, P = 0.044) and low
body mass index (OR 0.895, 95% CI 0.815–0.982, P = 0.019),
emergency surgery (OR 7.109, 95% CI 2.902–17.419,
P < 0.001), major surgery (OR 5.500, 95% CI 1.133–26.690,
P = 0.034), high SAPS II scores (OR 1.105, 95% CI
1.067–1.144, P < 0.001), longer stay in ICU (OR 8.686, 95% CI
3.646–20.692, P < 0.001 for length of stay longer than 2 days)
and in the hospital (OR 1.024 per day, 95% CI 1.011–1.038,
P < 0.001).
Conclusions The incidence of patient hypothermia on arrival in
intensive care is very high but is not an independent factor for
mortality or for staying longer in the ICU. All efforts should be made
for preventing hypothermia that should include temperature
monitoring and more often use of methods of warming patients and
intravascular fluids.
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Introduction Hypothermia is a serious problem in many out-of-
hospital emergencies [1], one of them being (near-)drowning.
Hypothermia per se may threaten the patient, but it can also protect
vital organs [1,2]. Since severe hypothermia also impacts the
decision where to bring the victim for further treatment [2], exact
temperature measurement assumes crucial importance in this
context. The purpose of this trial was to determine the reliability of
the tympanic temperature measurement after immersion in water.
Materials and methods The trial was approved by the ethics
committee of the University of Ulm. In 28 volunteers aged 18–49
years sublingual (Fixotherm; Tradesell Europe, Eglharting, Germany)
and tympanal (First Temp Genius; Sherwood Medical, Sulzbach,
Germany) temperature measurements were taken before immersion
in water, immediately after the 45 min of immersion, and 15 min
after leaving the water. We measured the oral temperature once at
each of these three time-points. During immersion the volunteers
had to swim in a manner that provides a temporary submersion of
the ears. The control group consisted of 11 volunteers who had to
swim for the same time with their heads always above the water.
The trial was performed in an indoor swimming pool at 28°C water
temperature and 30°C air temperature.
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Results In both groups oral temperature time-dependently varied
within only 0.4°C. Tympanic temperature was significantly lower
after immersion compared with the baseline values in the
‘submerged’ group (Submerg) (33.7 vs 37.5°C, P < 0.001), while
no such effect was observed in the control subjects (37.6 vs
37.5°C, P = 0.31). At baseline, oral temperature was lower than
tympanic temperature in both groups (P < 0.001), while this
relation was reversed after immersion. This reversed response was
not detectable in the controls.
Conclusions The data suggest that in emergencies like near-
drowning, the use of infrared ear thermometry to measure body
(core) temperature should be cautioned.
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Hypothermia is defined as a core temperature less than 35°C,
which is commonly seen in patients with loss of consciousness
and trauma. It increases the mortality and morbidity due to impaired
cardiorespiratory function, peripheral vasoconstriction, bleeding
diathesis, metabolic acidosis, diminished hepatorenal function and
impaired immune response. We decided to investigate the
prevalence of hypothermia and its relationship with patient
outcome considering the problems mentioned and inadequate
attention to hypothermia.
This investigation was performed in 100 emergent patients who
presented to the ED of Rasol Akram Hospital. This discriptive study
was carried out during 4 months. We used a tympanic infrared
thermometer for patient detection upon arrival. Data were analyzed
by a statistical method (Student t test, chi-square test), and the
goal was to find the relation between patient core temperature and
their outcomes in emergent patients. Some other data such as
mortality and the need for critical care or ward admission were also
included.
Based on this study, hypothermia was detected in 35.3% of
patients. There was a significant correlation between hypothermia
and mortality (P < 0.002).
Hypothermia was more prevalent in patients who were died but
there was no significant correlation between hypothermia and the
need for critical care length of stay, although there was minimal
difference with normothermic patients.
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Background Tumor markers (TM) including alpha-fetoprotein
(AFP), carcinoembryonic antigen (CEA), CA 15-3, and prostate-
specific antigen (PSA) are serum markers for malignant diseases.
Previous studies investigating the effect of acute and chronic
inflammation, cardiopulmonary bypass surgery, and cardio-
pulmonary resuscitation (CPR) on levels of TM showed conflicting
results. CPR may result in a profound inflammatory response and is
frequently associated with severe tissue hypoperfusion. The
present study investigated whether AFP, CEA, CA 15-3, and PSA
are influenced by CPR.
Methods and results AFP, CEA, CA 15-3, and PSA (only in male
patients) were assessed immediately after hospital admission,
6 hours, 12 hours, and 2 days after prolonged CPR in eight male
and 12 female patients. Serum levels of AFP, CEA, CA 15-3 did
not change significantly after CPR. PSA levels increased
significantly with a peak 48 hours after CPR (3.3 ± 3.1 and
28.3 ± 30.5 ng/ml for baseline and 48 hours levels, respectively;
P < 0.001). AFP, CEA, CA 15-3, and PSA (in males) values above
the normal range were observed in 0%, 13.8%, 3.8%, and 46.9%
of all measurements, respectively. At least one value above the
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Mean (± standard deviation) serum levels of AFP, CEA, CA 15-3, and PSA
Normal 
values Baseline 6 hours 12 hours 48 hours
AFP (ng/ml) 0 – 15 3.2 ± 2.4 3.1 ± 2.4 6.2 ± 8.0 3.0 ± 2.5
CEA (ng/ml) 0 – 5 3.7 ± 3.5 3.7 ± 3.2 3.6 ± 3.0 3.6 ± 3.1
CA 15-3 (U/ml) 0–35 19.4 ± 9.7 18.7 ± 9.4 3.6 ± 3.0 16.5 ± 8.8
PSA (ng/ml) ≤ 70 years < 4.5 3.3 ± 3.1 6.2 ± 8.0 16.8 ± 25.0 28.3 ± 30.5
> 70 years < 6.5
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normal range was observed in 0%, 20%, 5%, and 75% of all
patients for AFP, CEA, CA 15-3, and PSA (in males), respectively.
Baseline values of AFP, CEA, CA 15-3, and PSA (in males) were
above the normal range in 0%, 15%, 5%, and 10% of all patients,
respectively. Levels for all markers did not differ significantly
between survivors and nonsurvivors.
Conclusions Prolonged CPR does not influence AFP, CEA, CA
15-3 serum levels, but is frequently associated with increases of
PSA. Thus, in contrast to PSA, interpretation of AFP, CEA, CA
15-3 serum levels is not influenced by recent CPR.
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Introduction CPR can avoid 25% of deaths especially out-of-
hospital cases. Cases of cardiac arrest are usually studied from
epidemiological aspects. This study is designed to guide us
through our Emergency Department (ED) and EMS managements.
Methods and materials In this observational cross-sectional
study, 195 patients admitted to the ED of Rasoul Akram hospital
during 11 month from June 2003 to April 2004 were included.
Age, sex, time, place, cause and witness of arrest, BLS/ALS, out-
of-hospital intubations, transportation vehicle, CPR outcome and
final status of patients were gathered in a data registration form.
Results The mean (± standard error of the mean) age was
59.33 ± 1.4, there was a significant difference in mean age between
males and females (P = 0.003). A total 41.5% of cases arrested in
the ED, 14.9% had no witness, 56.4% were transported to hospital
by ambulance, 53.3% received no life support before arrival and
13.3% had been intubated out of hospital. The first rhythm checked
in the ED was asystole in 73.3%. Cardiovascular problems
constituted 42.1% of causes. There was a significant difference in
cause of cardiac arrest between age groups (P = 0.000). A total
59.5% of CPRs were successful; there was no significant difference
in sex (P = 0.199) and age (P = 0.746) groups and different cause
categories. CO poisoning and hanging had maximal mortality
(100%). Age, sex distribution (P = 0.07), time of cardiac arrest,
place of collapse (P = 0.1), cause of arrest, being witnessed,
performed BLS/ALS (P = 0.7), intubations (P = 0.76), initial cardiac
rhythm, and transportation vehicle had no effects on patients final
status. CPR outcome (P = 0.000) and the cause of arrest
(P = 0.000) affected the final status of patients. Finally, 93.3% of
patients expired and 6.7% of patients were discharged from hospital.
Discussion Successful CPR was performed in the majority of
cases. But the overall prognosis was poor. The main determining
factor of final status was the cause of arrest.
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Background In as many as 40% of applicable out-of-hospital
cardiac arrest (OOHCA) cases, bystanders do not receive
instructions over the telephone from public safety dispatchers to
perform cardiopulmonary resuscitation (CPR) because the
bystanders report that the patient is ‘breathing’ due to the
presence of agonal respirations.
Objective To determine whether a new dispatcher assessment
protocol could better identify agonal breathing and thus more
cases of OOHCA that might benefit from CPR instructions.
Methods Study of all dispatcher-assisted OOHCA cases in a
large municipality (population 1.2 million) for the 8 months before
and 4 months after protocol implementation (November 2003). In
the protocol, the call-taker asks about gasping defined as either
‘slow, barely breathing’ or ‘slow, noisey/gurgling’. If unsure, the
caller places the telephone near the patient’s mouth and the
dispatcher listens for breathing, or the bystander is asked to state
each time the patient takes a breath.
Results Among 962 consecutive patients identified as having
OOHCA (57% male, 43% female; mean age 63 ± 17 years, range
17–106), the presenting rhythm was ventricular fibrillation or
pulseless electrical activity in 85% of those identified with agonal
breaths versus 46% without them (P = 0.002) and such presen-
tations had a higher rate of survival to hospital admission
(P < 0.0001). After protocol introduction, the percentage of
OOHCA patients thought to be ‘breathing’ normally fell from 28%
(168/599) to 19% (68/362; P = 0.0012). Also, in the 8 months
before the protocol, no patient had their agonal respirations
detected compared with 22 patients detected in the 4 months
afterwards (P < 0.0001). No adverse problems were reported from
the subsequent performance of CPR in these agonal breathing
cases.
Conclusion Introduction of a supplemental dispatcher assessment
protocol (that includes questioning about agonal respirations) can
significantly increase cardiac arrest detection over the telephone,
thus increasing the opportunity for dispatchers to provide CPR
instructions for those very patients who, in fact, may a higher
propensity for survival than the average OOHCA patient (i.e. those
with agonal respirations).
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Introduction Cardiopulmonary resuscitation (CPR) has a poor
survival rate that may in part be due to flawed technique and
training [1]. Recent recommendations for education and training
have been issued for staff with responsibility for resuscitating
patients [2]. These include ‘staff with patient contact should be
given regular resuscitation training appropriate to their expected
abilities and roles’, and ‘cardiopulmonary arrest should be
managed according to national guidelines’. The use of human
patient simulators has become increasingly common in medical
education [3]. Their use for exposing staff to high-risk complex
clinical situations such as CPR is advocated by the department of
health [4].
Aims and methods The aim of this study was to assess the
resuscitation skills of all trainee junior doctors rotating through a
20-bed adult critical care unit (ITU/HDU) against current UK
advanced life support (ALS) guidelines. Over an 18-month period,
trainees underwent a compulsory CPR competency assessment by
simulation testing, observed by two experienced ALS instructors
following a refresher seminar. The trainees were assessed on basic
life support (BLS), defibrillator safety and ALS skills in a scenario-
Available online http://ccforum.com/supplements/9/S1
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based format. Only candidates who passed each section were
assessed on the next. All trainees were active members of the
hospital cardiac arrest teams.
Results During the study period 32 trainees were assessed, of
which 25/32 (78%) held a valid ALS certificate. BLS testing was
inadequate in 2/32 (6%). Safety of defibrillation was failed by 7/30
(23%) of trainees. A full CPR scenario was given to 23 trainees. Of
these 7/23 (30%) failed the scenario. Of the group as a whole
16/32 (50%) required further training and re-testing. Of those
candidates who held a valid ALS certificate 10/25 (40%) failed the
competency based assessment and required further training and
re-testing.
Conclusions Junior medical staff require regular scenario-based
CPR training. This study demonstrates that skills acquired during
life support training are not retained and regular competency-based
assessment is required irrespective of previous resuscitation
training. Repeated scenario-based competency assessments
should be a compulsory requirement of all trainee posts.
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Introduction ILMA Fastrach is a good alternative to difficult
endotracheal intubation even by an untrained physician but has
never been studied in a out-of-hospital setting. Our aim was to
evaluate the efficiency of this device used by untrained nurses in
out-of-hospital cardiac arrest (OHCA).
Method After a brief instruction course and training on a
mannequin, 12 nurses used ILMA Fastrach during 71 OHCA(s)
resuscitation in a prospective open study. Procedure took place
under the supervision of a certified emergency physician while
ambulance officers applied basic life support. The ILMA size was
selected according to the manufacturer’s instructions and they
were lubricated before insertion. Effective ventilation after mask
insertion was verified by presence of ample chest movement and
correct intubation was verified by the physician (chest
auscultation) and by capnography. A digital voice recorder
recorded speed and success rates. After two unsuccessful
attempts, the physician performed classic intubation.
Results Effective ventilation after mask insertion was obtained in
97% (65/67); in the two unsuccessful cases, one was hanged and
one had a literalised larynx (these data were not collected in four
patients because of a recording problem). The rate of successful
endotracheal intubation was 75% (53/71) after the first attempt
and 89% (63/71) after the second. In the eight unsuccessful
cases, ventilation with the mask was effective. The total mean time
of intubation (since inclusion) was 148 s with a mean time of 53 s
to prepare the device. The physician easily intubated all the eight
remaining patients: a cephalic larynx was noticed in the five cases
(mask size 5 chosen), one was hanged, and no abnormalities were
in the two others.
Conclusion The ILMA Fastrach is a good alternative to classical
intubation by untrained nurse OHCA resuscitations. The patient
could be ventilated after mask insertion in most cases and the time
to perform intubation is short. However, 1 min is necessary to
prepare the device, so a good training and preparation of the
material is necessary. Results are not as favourable as in the
operative room and the effectiveness of ventilation with the mask
was not predictive of intubation. However, only two unsuccessful
attempts were permitted before classical intubation and the size
according to the weight was inadequate in five cases. A large
multicenter study is warranted to confirm these results.
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Background Passengers who have ventricular fibrillation aboard
commercial aircraft rarely survive, owing to the delay in obtaining
emergency care and defibrillation.
Methods In 2002, after the incorporation of automated external
defibrillators (AEDs) by other PAD initiatives, a major Latin
American House of Representatives (HR) began equipping its
major building (Chamber of Deputies) — 513 Representatives,
around 5000 people working and more than 20,000 people
transiting every day — with automated external defibrillators (Lp
500). We chose the healthcare professional (more than 30) as the
focus of the training program conducted according to the
guidelines of the American Heart Association in the use of the
defibrillator and applied the device when people had a lack of
consciousness, pulse, or respiration. The AEDs were also used as
a monitor for other medical emergencies, generally at the direction
of a physician. We placed a separate cardiac monitor without the
capacity for defibrillation, to be used when the strict definition of
cardiac arrest has not been met (Lp 12). The electrocardiogram
that was obtained during each use of the device was analyzed by
two physicians for appropriateness of use. We analyzed data on all
six instances in which the defibrillators were used between 1
February 2002 and 1 September 2004.
Results Automated external defibrillators were used for six
patients, including six patients in ventricular fibrillation with
documented loss of consciousness. Electrocardiographic data
were available for all patients. The administration of shock was
advised in all six patients who had electrocardiographically
documented ventricular fibrillation (sensitivity and specificity of the
defibrillator in identifying ventricular fibrillation, 100%). One patient
had atrial flutter with high-degree atrioventricular block. All six
episodes of ventricular fibrillation were properly treated with
establishment of a final rhythm potentially perfusional in five cases.
The first shock successfully defibrillated the heart in six patients
(100%). No complications arose from use of the automated
external defibrillator as a monitor in conscious passengers.
Of the six patients, four (66%) left the locality alive and three
(50%) were discharged home from hospital. In all cases the initial
rhythm was ventricular fibrillation.
Conclusions The use of the automated external defibrillator in the
HR is effective.
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Objective Synchronized cardioversion (SCV) is a useful and
reliable method of converting atrial or ventricular tachycardia to
sinus rhythm. It is a method of choice in patients who are at high
risk of the arrhythmia and therefore require urgent treatment.
Conscious patients must be well sedated.
Design and setting A prospective clinical investigation.
Patients and methods All adult patients (>18 years) were treated
by an emergency physician in the prehospital setting. Indications
for SCV were: arrhythmia with severe chest pain and/or shortness
of breath, congestive heart failure, pulmonary congestion,
decreased level of consciousness (reduced cerebral blood flow),
systolic blood pressure less than 90 mmHg, shock, or acute
myocardial infarction (AMI). Conscious patients were sedated or
anaesthetized with midazolam and morphine, etomidate or
propofol.
Results Over a period of 2 years, 22 patients have required SCV.
Indications for SCV included 10 (45.5%) patients with atrial
fibrillation (AF) with high risk, seven (31.8%) patients with
supraventricular tachycardia (SVT) and five (22.7%) patients with
ventricular tachycardia (VT) with pulse. Heart rates in AF and VT
were more than 150 beats/min and in SVT more than
200 beats/min. In all patients two or more adverse signs of tachy-
arrhythmia have been observed: congestive heart failure and/or
pulmonary congestion in eight (36.4%) patients, hypotension
and/or shock in 15 (68.2%) patients, severe chest pain or AMI in
10 (45.5%) patients; decreased level of consciousness in nine
(40.9%) patients. The SCV was successful in all cases (in 19
cases in the first shock with 100 J, in two cases in the second
shock with 200 J and in one case in the third shock with 360 J). All
patients were hospitalized and left the hospital without any
complications.
Conclusion SCV is a useful and safe method in treatment of
unstable tachyarrhythmia in a prehospital setting. This is very
important information, because in such situations the universal
recommendation of the ILCOR 2000 International Guidelines for
immediate cardioversion is the method of choice rather than a trial
of antiarrhythmics.
P308
Prehospital transcutaneous cardiac pacing in bradycardia and
asystole
C Febra, A Lufinha
Hospital S Francisco Xavier SA, Lisbon, Portugal
Critical Care 2005, 9(Suppl 1):P308 (DOI 10.1186/cc3371)
Background Transcutaneous external cardiac pacing (TECP)
provides a noninvasive, safe and rapid ventricular pacing, although
there is controversy on the results observed both in
hemodynamically significant bradycardia and asystole situations.
The purpose of this study is to examine the success of TECP in our
prehospital emergency medical team (VMER) practice, at Hospital
S Francisco Xavier.
Methods and results In this retrospective cohort study, we
examined 46 patients submitted to TECP between January 2001
and November 2004 with a median age of 68.6 years (40–94
years). The mean call-to-arrival time was 7.8 min, and cardiac arrest
was present at our arrival in 43.5% of the cases and bradycardia
with hemodynamic repercussion in 56.5%, manifested, p.e., as
syncope (61.5%), chest pain (23%) and/or dyspnoea (15.4%). In
the cardiac arrest situations, classic advanced cardiac life support
was always provided, resulting in electromechanical disassociation
(40%), asystole (15%) and complete AV blocking (15%), present
immediately before pacing. There was a survival rate in the field of
40% of these patients, of whom 75% were hemodynamically
stable at hospital admission. In the bradycardia cases, complete
AV blocking was the most common presenting rhythm (73%), the
mean heart rate was 33 ppm, and 76.9% of patients had shock
criteria. Atropine was used unsuccessfully in 61.5% of patients.
The TECP resulted in hemodynamic stability in 53.8%, death in the
field in 15.4% and sustained shock in 30.8%. The overall success
rate of TECP in these two groups, defined as hospital admission,
was 65.2%.
Conclusions In cardiac arrest events, TECP was associated with a
better survival rate on the field than our global survival rate on the
field (21%). This may be due to its utilisation mainly in
electromechanical disassociation and younger patients. TECP
results in a correct cardiac output in much of severe bradycardia
situations, allowing a stable transportation to the hospital where it
may be kept or changed by other pacing approaches.
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The Acute Coronary Syndrome (ACS) Recognition and Treatment
(EMERGE™) course is a 1-day (3 hours) course originally designed
to give doctors greater confidence and ability in the recognition
and management of adult patients who have ACS. It may also be
suitable for many other groups of health professionals. EMERGE™
was developed using principles common to many advanced life
support courses and incorporates aspects of clinical governance,
multidisciplinary education and interprofessional working. It
incorporates precourse reading, informal and interactive seminars,
and role-play during three clinically based scenarios. A novel
aspect of EMERGE™ is that participants undertake role
interchange during scenarios, thereby facilitating mutual
understanding. At all times during the course, participants are
encouraged to reflect on their actions and to pay particular
attention to detail.
Using initial and final theoretical written test, after the 3-month
courses (36 courses), we assessed the knowledge of aspects of
ACS among 900 doctors. The average (± standard deviation)
knowledge score was higher for those who had completed an
EMERGE™ course, pre-test (545 students) = 23.8 (8.44 ± 1.30)
points and post-test (834 alunos) = 25.3 (9.85 ± 2.12) points
(P < 0.05). In addition, those in the post-EMERGE™ group also
showed significantly better knowledge about ACS (85.6% [714
doctors]) acquired skills in treatment an ACS. We have
demonstrated evidence that doctors’ knowledge of ACS can be
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Introduction New-onset atrial tachyarrhytmia (AT) is frequently
seen in critically ill surgical patients (incidence 10.2%) and
associated with high mortality rate (23.4%). Whether this also
applies to medical ICU patients is unclear. In a follow-up study all
medical patients with AT were evaluated.
Methods In a 12-bed medical ICU, all consecutive patients with
AT were evaluated during a 4-month period. Characteristics,
response to treatment and outcome were registered. All patients
with AT were treated with MgSO4-amiodarone after correction of
predisposing factors; MgSO4 bolus (0.037 g/kg) followed by
continuous infusion (0.025 g/kg). Those with persistent AT
>110 beats/min after 1 hour were given intravenous amiodarone
(bolus 300 mg) followed by continuous infusion (1200 mg/24 hours).
Results One hundred and forty-seven patients were admitted for
medical reasons. AT was seen in 14 patients. The most common
reason for ICU admission was sepsis (nine patients). Patient
characteristics are presented in Table 1. Two patients converted
after fluid repletion. Ten patients received the treatment protocol.
Five patients converted after magnesium therapy, and addition of
amiodarone was given to five patients. All patients converted within
24 hours (median [range] 2.5 [1–19]). Ten patients died during
their hospitalization. Time between the onset of AT and death was
7.7 ± 5.5 days (mean ± standard deviation [SD]).
Table 1
Male/female 6/8
Age (mean ± SD) 64 ± 20 years
APACHE II (mean ± SD) 24 ± 8
Rhythm (AF/flutter/SVT) 11/1/2
Norepinephrine 11
MAP before/after AT (mean ± SD) 82 ± 13/65 ± 13 mmHg
Heart rate before/after AT 99 ± 19/148 ± 37 beats/min
Serum K+ (mean ± SD) 4.10 ± 0.5 mmol/l
Serum Mg2+ (mean ± SD) 0.85 ± 0.12 mmo/l
Conclusion The incidence of AT in this patient cohort was 14/147.
Mg-amiodarone is a highly effective regimen for conversion. Despite
this, mortality was high and therefore AT was not the cause of death
but rather an epiphenomenon. Compared with surgical patients,
medical patients had a much higher mortality rate.
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Background The diagnosis of acute myocardial infarction (AMI) in
critically ill patients is usually dependent on the presence of
ischemic changes on an electrocardiogram (ECG) and measure-
ment of biochemical markers such as troponin. Among patients in
the ICU, there is uncertainty surrounding the significance of
elevated troponin values, their relation to coronary ischemia and
infarction, and the prognostic and therapeutic implications.
Objective To document the prevalence and incidence of elevated
troponin levels in critically ill patients correlated with ECG findings
(presence of ischemic changes [AMI], non-ischemic ECG
changes, and normal ECG), and to evaluate the morbidity and
mortality outcomes of each of these categories compared with
patients with normal troponin values.
Methods We conducted a retrospective chart review of 198
patients from 261 critically ill patients admitted to a university-
affiliated, general medical–surgical ICU who were enrolled in a
prospective cohort study evaluating the prevalence and incidence
of deep vein thrombosis.
Data extraction We reviewed daily medical records during the
patient’s ICU admission for signs and symptoms of AMI, laboratory
and radiologic investigations, and collected morbidity and mortality
outcomes.
Results The prevalence of all elevated troponin levels was 36.4%;
19.2% had AMI (elevated troponin with ischemic ECG changes),
14.7% had elevated troponin without typical ischemic ECG
changes, and 1.5% had elevated troponin and a normal ECG. The
incidence of AMI over the ICU stay was 6.2%, of which 42% were
diagnosed with AMI on admission (i.e. they had recurrent AMI).
Morbidity (length of stay [LOS]) and mortality outcomes in patients
with elevated troponin and associated ECG findings compared
with patients with normal troponin are presented in Table 1.
Table 1
Ischemic Non-ischemic Normal Normal 
ECG ECG ECG troponin 
Outcomes (n = 45) (n = 30) (n = 3) (n = 104)
ICU LOS, 10 8 4 10
median (IQR) (8, 18) (4, 14) (3, 39) (6, 18)
Hospital LOS, 20 13.5 40 30
median (IQR) (11, 54) (10, 31) (12, 114) (15, 61)
ICU mortality, 15 11 1 21
n (%) (33.3) (36.7) (33.3) (20.2)
Hospital mortality, 20 13 1 35
n (%) (44.4) (43.3) (33.3) (33.7)
Conclusions Elevated troponin levels are common in the critically
ill, yet it is unclear under what circumstances they represent an
adverse prognostic marker for ICU and hospital mortality.
Additional studies are needed to determine the significance of
elevated troponin values in the presence and absence of ECG
changes, evaluating long-term outcomes and the efficacy of anti-
ischemic treatments in critically ill patients.
P312
Clinical determinants of severe bleeding complications in patients
with acute myocardial infarction treated with thrombolytic therapy
J Rossinen1, J Viita2, M Nieminen1, R Lassila1
1Helsinki University Hospital, Helskinki, Finland; 2Medical Faculty,
Turku, Finland
Critical Care 2005, 9(Suppl 1):P312 (DOI 10.1186/cc3375)
The aim of the study was to determine the frequency of bleeding
complications in a clinical setting, and to clarify the practise in
laboratory monitoring of haemostasis (TT%, APTT, HCR) in patients
with acute myocardial infarction who are treated with fibrinolytics. In
this clinical, retrospective series we included randomly 301 patients
who were treated during the years 2000–2003 due to acute
myocardial infarction in the Helsinki University Central Hospital. Two
hundred and forty (80%) of the patients were treated with a
thrombolytic therapy. Six (3%) patients received thrombolytic therapy
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despite them having an absolute contraindication, and 75 (31%)
received it while having a relative contraindication. The incidence of
cerebral bleeding during the first 48 hours was unexpectedly high
(2.5%). The incidences of bleeding complications are presented in
Table 1. The parameters of haemostasis could not predict bleeding
complications in our study, probably due to low rate of
measurements prior to fibrinolytic therapy. It is therefore important to
strictly follow the guidelines of thrombolytic therapy in patients with
acute ST-elevation myocardial infarction. Routines for laboratory
monitoring of haemostatic variables are to be implemented to
improve safety and early detection of bleeding complications.
Table 1
Thrombolysis group Non-thrombolysis group
Intracerebral bleed 6 (2.5%) 1 (1.6%)
GI haemorrhage 21 (8.8%) 3 (4.9%)
Unexplained bleed 24 (11%) 14 (23%)
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Restoring patency of infarct-related artery (IRA) is the ultimate goal of
all cardiologists. Such a goal can be achieved either pharmaco-
logically ‘using thrombolytic therapy’ or through percutaneous
coronary intervention (PCI). The latter needs a sophisticated setup, an
equipped cath lab and a skilled team. Such a system might not be
always available, and a full-dose thrombolytic therapy is the next best
alternative. There has recently been a trend towards ‘facilitated PCI’
whereby low-dose thrombolytic and/or antiplatelet therapies are used
prior to primary PCI, aiming at an early, complete, and sustained
epicardial flow and myocardial perfusion.
To compare the efficacy and safety of facilitated PCI with standard
primary PCI, we studied 40 patients with acute myocardial
infarction (AMI) divided into two groups, a study group consisting
of 20 patients (18 males, two females, mean age
46.3 ± 11.5 years), all received 750,000 u streptokinase combined
with GP IIb/IIIa receptor inhibitor ‘tirofiban’ 0.4 µg/kg/min over
30 min followed by 0.1 µg/kg/min over 48 hours. Twenty patients
(15 males, five females, mean age 54 ± 8.6 years) served as
control group (no thrombolytic nor antipaltelet therapy). Both
groups underwent PCI within (73 ± 18 min) from randomization.
Angiographic patency was expressed in terms of TIMI flow grading
system, ECG criteria comprised extent and rapidity of ST-segment
resolution, and laboratory criteria involved early peaking of CK-MB
within 12 hours from randomization. Besides clinical evaluation in
terms of major adverse cardiac events, echocardiographic
parameters (LVEDD and LVEF) were used to assess LV function
before and after PCI and monthly thereafter for 6 months.
Compared with the group subjected to PCI alone, those who had
preceding adjunctive pharmacological therapy ‘facilitated PCI’
exhibited significantly greater TIMI 3 flow (84% vs 60%, P < 0.05),
smaller LVEDD (5.0 vs 5.5, P < 0.05), significantly higher LVEF
(55.4% vs 50.7%, P < 0.05) and lower rate of MACE (0% vs
20%). Patients with facilitated PCI also exhibited significantly
higher ST-segment resolution (58% vs 45%, P < 0.05) and earlier
peaking of CK-MB (85% vs 35%) compared with control group.
In conclusion, facilitated PCI offers an excellent way of
circumventing the time delay preceding PCI that is frequently
encountered on hospital admission of patients with acute MI.
Through combining interventional, fibrinolytic and GP IIb/IIIa
inhibitor therapy, facilitated PCI provides more rapid, complete and
sustained patency of IRA than primary PCI alone without the
adverse effects of full-dose thrombolytic therapy and with a better
outcome in terms of lesser MACE and preserved LV function.
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Background It has been well established that restoration of
patency of an infract-related artery by percutaneous intervention as
early as possible in patients with recent myocardial infarction may
preserve left ventricular global function and also prevent LVEDV
progressive increase and remodeling,
Aim To evaluate and compare the effect of primary and delayed
PCI in patients with recent myocardial infarction (MI).
Methods Forty patients were included in the study with first
anterior MI; they were divided into group A who had the chance of
undergoing primary PCI within less than 12 hours of start of chest
pain with mean 5.4 hours and a door to balloon time of 1.6 hours,
and group B who due to out of hand circumstances neither
received thrombolytic therapy nor arrived at hospital within 12 hours,
but were scheduled as routine PCI with mean 20.7 days. The left
ventricular function and dimensions were assessed by serial
echocardiographic readings measuring LVEDV, LVESV, EF and
RWMI at 24 hours of admission and after 3 months and 6 months.
Results were expressed as mean ± standard deviation and
P < 0.005 was considered significant.
Results First echo results at baseline showed no significant
difference of LVEDV, RWMI and EF in both group A and group B,
that indifference was also remarkerable at echo done at 3 months
with P = 0.6, while at 6 months reading the LVEDV in group A
showed a significant decrease (115 ± 32.14 vs 138 ± 32.96,
P = 0.048). Ejection fraction difference between two groups were
not significant at baseline echo, but improved significantly at 3 and
6 months (58.5 ± 4.5 vs 55.2 ± 6.4, P = 0.046 at 3 months and
59.5 ± 6.81 vs 51.88 ± 10.7, P = 0.008 at 6 months,
respectively). RWMI results started to improve significantly from
3 months to 6 months in group A versus group B (1.27 ± 0.13 vs
1.38 ± 0.18, P = 0.032 at 3 months) but at 6 months there was no
further improvement with P = 0.6
Conclusion Although the recent evolvement and the theory of
opening of IRA whatever the timing, primary PCI has superiority in
preventing LV remodeling and preserving global LV function
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Objective To enhance the precision of the definition of acute
myocardial infarction (AMI), the European Society of Cardiology/
American College of Cardiology (ESC/ACC) recently updated the
Available online http://ccforum.com/supplements/9/S1
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diagnostic criteria for AMI. Given this change in AMI diagnostic
criteria, little is known about the current incidence of AMI in the
ICU and the associated clinical outcomes. We undertook a study
to inform these issues.
Design A prospective 2-month cohort study.
Setting A 15-bed closed university-affiliated medical–surgical ICU.
Methods We enrolled all consecutive ICU patients from 12 July to
12 September 2004. All aspects of patient management were at
the discretion of the ICU team, which was unaware of the study to
limit any influence on ECG or troponin test-ordering practices. As
clinically indicated, 12-lead ECGs were performed by a
technologist during the day, or by the ICU bedside nurse for
emergencies, during the evenings and weekends. We adapted the
Joint ESC/ACC redefinition of AMI for the ICU setting. Two
investigators independently classified all patients as AMI or no
AMI; discordance was resolved by discussion and criterion review.
We used Wilcoxon Two-Sample Rank Sum Test to test for
differences in continuous variables and Fisher’s Exact Test for
dichotomous variables.
Result We screened 117 ICU admissions but considered only the
first admission of two patients who were admitted twice. We
enrolled 115 patients aged 64.1 (± 17.2) years with an APACHE II
score of 21.9 (± 9.8); 83 (72.2%) patients were medical. Overall
ICU mortality was 21.7% and hospital mortality was 27.8%. Of 115
patients 93 (80.9%) patients had both at least one ECG performed
and one troponin measurement during ICU admission, seven (6.1%)
patients had at least one ECG performed but no troponin
measurement, 11 (9.6%) patients had at least one troponin
measurement but no ECG performed, and four (3.5%) patients had
neither an ECG nor troponin. Using the ESC/ACC criteria adapted
to the ICU setting, 24 of 115 (20.9%) patients developed AMI
(crude agreement between adjudicators was 88%).
Table 1
Outcome AMI (n = 24) No AMI (n = 91) P value
Duration of MV 2 (1–6) 2 (0–5) 0.32
Duration of ICU 4.5 (2–8) 4 (2–6) 0.62
ICU mortality 9 (37.5%) 16 (17.6%) 0.05
Hospital stay 18 (4.5–4.1) 12 (7–21) 0.34
Hospital mortality 12 (50%) 20 (22.0%) 0.01
Conclusion One-fifth of these medical–surgical critically ill patients
sustained an AMI. Patients with AMI had a significantly higher
mortality than those who did not. More research is needed on
appropriate AMI definitions in the ICU setting, risk factors,
detection methods, mechanisms of myocardial necrosis during
critical illness, optimal prevention and treatment strategies, and
long-term prognosis.
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Objective To investigate the clinical features of acute myocardial
infarction (AMI) in patients with cor pulmonale.
Methods Manifestations of AMI in 30 patients with cor pulmonale
(observation group) was compared with that of 171 patients with
AMI only (control group).
Results There were more smokers in the observation group than in
the control group (60.0% vs 35.1%, P < 0.05). The incidence of
chest pain in observation group was significantly lower than that in
the control group (16.7% vs 43.9%, P < 0.001), but the incidence
of dyspnoea was significantly higher than that in the control group
(50.0% vs 16.4%, P < 0.001). The serum albumin and ferrohemo-
globin were lower in the observation group than those in the
control group (33.2 ± 9.1 vs 37.8 ± 6.0 g/l, P < 0.01 and
127.2 ± 18.9 vs 134.9 ± 17.7 g/l, P < 0.05, respectively). Acute
pulmonary edema was more common in the observation group
than those in the control group (46.7% vs 22.2%, P < 0.01). Of 30
patients in the observation group 33.3% were accompanied with
serious lung infection but only 8.8% in the control group. The
mortality in the observation group was higher than that in the
control group (23.3% vs 13.5%, P = 0.161), but there was no
statistically significant difference between the two groups.
Conclusions Infection, anemia and hypoproteinemia are important
precipitating factors in acute myocardial infarction characteristic of
painlessness in patients with cor pulmonale. Acute left ventricular
failure can be the initial symptoms of AMI in patients with cor
pulmonale. Because of its high mortality and poor prognosis, more
attention should be paid to these symptoms.
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Introduction MI is one of the major causes of mortality and
morbidity worldwide. Our resources in approaching and treating
this entity are restricted due to financial causes. Studying the risk
factors helps to improve health services and to provide better care
where most needed.
Methods and materials In this observational longitudinal study
patients with diagnosis of acute MI admitted at Rasoul akram ED
during 21 months were included. The risk factors, primary and
secondary endpoint outcomes were registered on a form. Primary
endpoints were defined as death and need to CPR, and secondary
endpoints were defined as death, asymptomatic, CCU admission,
need to CPR, and angiography result when it was performed. Two
months later, secondary endpoints were followed-up by telephone.
Results One hundred and fifty-four patients were included.
Twenty-one percent of patients died. Low Hgb level (P = 0.037)
and leukocytosis (P = 0.011) are related to patient death. Mean
age was 70.5 ± 2.28 and 56.5 ± 1.06 years in dead and alive
patients, respectively (P = 0.000). Angiostenosis, previous MI and
heart failure increase the mortality risk to 10 times (P = 0.000), 3.8
times (P = 0.01) and 3.2 times (P = 0.003), respectively. Mean
interval time between appearance of the symptoms and fibrinolytic
therapy in ST-elevation MIs was 2.31 (± 0.22) hours, there was no
mortality when fibrinolytic therapy was started less than 0.5 hours
from symptoms, and only one mortality when it was started at less
than 1 hour. Sex distribution was not related to either primary or
secondary endpoint outcomes. There was no relationship between
patients’ 2-month survival and HTN, DM, HLP, dysrhythmia, blocks,
ST elevation, involved aspect of the heart and fibrinolytic therapy.
Discussion Mean age > 70 years, angiostenosis, previous MI,
heart failure, low Hgb level and leukocytosis are associated with
poor prognosis in MI patients. Early thrombolytic therapy
decreased mortality but has no effect on 2-month outcome.
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Objective To determine the association between haemoglobin
concentrations on admission and inhospital 30-day cardiac
mortality and complications among patients with acute myocardial
infarction during their hospital course.
Methods We conducted a retrospective study of data on 637
Chinese patients who were hospitalized with acute myocardial
infarction. Patients were categorized according to the haemoglobin
concentration on admission (<12 g/dl, mean ± standard deviation
10.5 ± 1.4 g/dl; 12–13.9 g/dl, mean ± standard deviation
13 ± 0.6 g/dl; 14 g/dl or greater, mean ± standard deviation
15.2 ± 0.9 g/dl), and data were evaluated to determine whether
there was an association between the haemoglobin concentrations
on admission and inhospital 30-day mortality and complications.
Complications were defined as cardiogenic shock, congestive
heart failure, arrhythmia, ventricular tachycardial or fibrillation and
pneumonia.
Results Patients with lower haemoglobin concentrations on
admission had higher inhospital 30-day mortality rates (P < 0.001).
Inhospital 30-day mortality was 21.4% in patients with
haemoglobin concentrations <12 g/dl, 11.6% in patients with
haemoglobin concentrations of 12–13.9 g/dl, and 5.3% in patients
with haemoglobin concentrations 14 g/dl or greater. The increase
in risk of complications associated with a low haemoglobin
concentration was more pronounced in patients with anaemia than
in patients without. Compared with patients with haemoglobin
concentrations 14 g/dl or greater, those with haemoglobin
concentrations <12 g/dl and 12–13.9 g/dl had more inhospital
complications, including arrhythmia, congestive heart failure and
pneumonia (40.5% versus 33.8% versus 23.1%, P = 0.001;
28.2% versus 20.0% versus 8.2%, P < 0.001; and 26.7% versus
8.4% versus 2.8%, P < 0.001, respectively). As expected, a signifi-
cant inverse correlation between haemoglobin concentrations and
ages was observed in the patients with acute myocardial infarction
(r = –0.51; P < 0.001).
Conclusions The traditional belief is that anaemic patients with
coronary artery disease are at high risk for myocardial ischaemia or
infarction because they cannot increase oxygen extraction or
augment coronary arterial flow. It is demonstrated in this study that
a low haemoglobin concentration on admission increases the risk
of death or serious complications in the patients with acute
myocardial infarction. There is a greater incidence of patients with
a low haemoglobin concentration on admission in the elderly
patient than that in the younger one.
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Objective We investigated the protective effects of isovolumetric
hemodilution and ischemia preconditioning against myocardial
injury due to reperfusion through a pig myocardial ischemia
reperfusion model.
Methods Eighteen mini-pigs were used in an acute myocardial
ischemia model. They were randomly divided into three groups,
with six pigs in each group: the control (group I, n = 6), ischemia
pre-treatment (group II, n = 6), ischemia pretreatment plus blood
dilution (group III, n = 6). Cardiac output (CO), saturation of mixed
venous blood oxygen (SvO2) and blood flow of coronary artery
were measured, and then the oxygen supply to the myocardium
and the oxygen consumption were calculated. The amount of
malondialdehyde (MDA), the superoxide dismutase (SOD) activity,
the creatine phosphokinase (CPK) and creatine phosphokinase
isoenzyme (CK-MB) were also determined 20 min and 60 min,
respectively, before and after the forceps clamping. A sample was
taken from the left atrial appendage to determine the rate of
expression of heat shock proteins Hsp70 mRNA.
Results When ischemia lasted for 20 min, the heart rate (HR) of
group I and group II slowed down dramatically while that of group
III accelerated slightly. The MAP, CI and SVR of all three groups
significantly decreased from control values (P < 0.01), but the
magnitude of decrease in groups II and III were lower than those of
group I (P < 0.05). Also the SVR of group III was significantly lower
than group II (P < 0.05). After reperfusion at 20 min and 60 min,
the HR of groups I and II was significantly lower than that of the
controls (P < 0.01). The HR of group III was significantly higher
than that of groups I and II (P < 0.05), but was not significantly
higher than the control value (P > 0.05). The decreased MAP and
CI of groups II and III were significantly lower than those of group I
(P < 0.05). In addition the SVR of group III was lower than groups I
or II (P < 0.05). The values of CPK, CPK-MB of all three groups
were significantly higher than the controls after reperfusion at 20
min and 60 min (P < 0.05–0.01, respectively). However, groups II
and III increased less than those of group I. The values of CPK and
CPK-MB in group III were lower than that of group II (P < 0.05).
The MDA value of group I was dramatically higher than that of
groups II and III after reperfusion at 20 min and 60 min (P < 0.05),
while the value of group III was lower than that of group II after
reperfusion at 60 min (P < 0.05).The expression of Hsp70 mRNA
in group II and group III was higher than that of group I (P < 0.05),
and Hsp70 mRNA in group III was higher than group II (P < 0.05)
after reperfusion at 20 min and 60 min.
Conclusion Isovolumetric hemodilution can increase the
protection of preconditioning against ischemic myocardial injury
caused by reperfusion.
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Background Critically ill patients are generally unable to report
ischemic chest pain due to decreased consciousness,
endotracheal intubation, and use of sedatives and narcotics. The
diagnosis of cardiac ischemia is therefore usually based on
elevated cardiac enzymes and typical ischemic changes on an
electrocardiogram (ECG). Although key management decisions
depend on ECG interpretation, the reproducibility of ECG
interpretation is unclear in the ICU.
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Objective To estimate the inter-rater and intra-rater reliability of ECG
interpretation for the presence of myocardial ischemia in critically ill
patients, with and without knowledge of troponin T values.
Design A prospective cohort study.
Setting A 15-bed medical–surgical university-affiliated ICU.
Patients Consecutive adults admitted to the ICU over a 2-month
period.
Methods We collated all consecutive 12-lead ECGs performed on
all patients during the study period. Using a structured, pre-tested
form, and blinded to patient data and each other’s ratings, two
internists interpreted each ECG. Two weeks later, both raters re-
interpreted the same ECGs, blinded to their previous interpretation
and unblinded to the troponin T values. We report results using
chance-independent agreement (phi), which generates less biased
agreement measures than chance-corrected agreement (kappa).
Discrepancies for the two primary outcomes (presence of
pathologic Q waves and the overall assessment of the presence of
myocardial ischemia) and 13 secondary outcomes (other ECG
abnormalities, such as ST segment changes) were resolved by a
third internist blinded to the two previous ratings but unblinded to
troponin T values.
Results We found variable inter-rater reliability of ECG
interpretation when raters were blinded to troponin T levels. We
report all values with the associated 95% confidence interval (CI).
For the two primary outcomes, agreement was substantial (phi
0.61 [95% CI 0.17, 0.85]) for the detection of pathologic Q waves
and slight (phi 0.10 [–0.06, 0.25]) for the overall assessment of the
presence of myocardial ischemia. For secondary specific ECG
changes, agreement was highest (phi 0.79 [0.64, 0.89]) for
detection of a new left bundle branch block (LBBB) and lowest
(phi 0.30 [0.003, 0.54]) for ST segment depression. When
unblinded to troponin T values, inter-rater reliability increased
slightly for each primary and secondary outcome. Intra-rater
reliability, assessed prior to and following knowledge of troponin T
levels, was high for detection of pathologic Q waves (phi 0.44
[0.08, 0.69] and 0.78 [0.68, 0.85], respectively), and new LBBB
(phi 1.0 and 0.95 [0.83, 0.98], respectively), but was lower for the
overall assessment of the presence of ischemia (phi 0.21 [0.06,
0.36] and 0.47 [0.34, 0.58], respectively).
Conclusions We found that the inter-rater and intra-rater reliability
of ECG interpretation for the overall detection of specific ECG
changes in critically ill patients was good but variable. However, for
the overall assessment of the presence of myocardial ischemia,
reliability was poor. Knowledge of troponin T levels appears to
improve the reliability of ECG interpretation. Further studies
evaluating the difficult diagnosis of myocardial ischemia in the
critically ill are required.
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Patient selection for the ventricular assist device
D Hall, P Vykaranam
Harefield Hospital, Harefield, UK
Critical Care 2005, 9(Suppl 1):P321 (DOI 10.1186/cc3384)
Introduction In addition to their use as a bridge-to-transplant, a
bridge-to-recovery and as destination therapy, ventricular assist
devices (VADs) are increasingly being used on patients ‘in
extremis’ as a salvage procedure, as a bridge to a long-term
device. We performed a retrospective analysis of the clinical
criteria for VAD insertion in patients who have received devices.
Methods Data were collected for all patients receiving a VAD in
the last year, excluding those patients with a previous transplant or
VAD. On each patient the following data were collected: age and
degree of urgency of referral, diagnosis and duration of illness, pre-
operative systems review within 24 hours of device insertion,
device inserted, and outcome.
Results Fifteen patients were included. Three groups of five
patients emerged based on the referral pattern and duration of
illness. Group 1, emergency (less than 2 weeks illness) —
ischaemic and postpartum cardiomyopathy, acute myocardial
infarction, myocarditis. Group 2, acute (less than 4 weeks illness) —
postpartum and dilated cardiomyopathy. Group 3, elective (assessed
for transplantation) — dilated and ischaemic cardiomyopathy. See
Table 1.
Table 1 
Group 1 Group 2 Group 3
Age (mean) 47.2 29.6 43.6
CI (mean) 1.2 1.3 1.4
LVEF (mean) 19% 16.6% 23.4%
Inotropes 5/5 4/5 4/5
IABP 1/5 0/5 1/5
Ventilated 2/5 0/5 0/5
Acidosis 5/5 0/5 0/5
Renal dysfunction 4/5 1/5 3/5
Liver dysfunction 4/5 3/5 5/5
Device Levitronix Heartmate I Jarvik 2000
Jarvik 2000 Heartmate I
Thoratec
Survival 1/5 4/5 5/5
Conclusion Once patients require inotropic support, early referral
is preferred. Recent onset renal and liver dysfunction due to poor
ventricular function will be improved with a VAD. The onset of a
metabolic acidosis is a predictor of poor outcome but a salvage
procedure is possible in most patients with acute ventricular
dysfunction.
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Prognostic factors of percutaneous cardiopulmonary support
therapy at Osaka City General Hospital, Japan
T Yoshida, M Satani, H Rinka, H Tamiya, T Murai, K Atagi, 
K Shimadzu, H Ujino, T Miyaichi, M Kan, A Kaji, K Haze
Emergency and Critical Care Medical Center, Osaka City General
Hospital, Osaka, Japan
Critical Care 2005, 9(Suppl 1):P322 (DOI 10.1186/cc3385)
Objective The aim of our study was to investigate the prognostic
factors in patients with cardio and/or respiratory failure who
received percutaneous cardiopulmonary support (PCPS) therapy
in the ICU.
Materials and methods The population was a total of 148
patients (105 adults, 13 children, 30 newborn infants) who
received PCPS therapy from July 1994 to June 2004. We
evaluated the patients’ ages, clinical characteristics, the number of
days of PCPS therapy, PaO2/FiO2, and hemodynamic parameters,
including base excess at the time of discontinuing PCPS. We
classified the cases into five groups considering the clinical
characteristics: cardiac disease, non-cardiac disease including
acute respiratory failure, postoperative cardiac failure, congenital
heart disease and operation-assisted cases (n = 58, n = 38, n = 18,
n = 28 and n = 6, respectively).
Results Seventy-three of the 148 patients could be taken off
PCPS; however, 37 of those 73 patients died within 4 weeks after
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removing the PCPS. The mortality was 76% (adults 78%, children
61%, newborn infants 90%). In 104 adult patients, those who
required PCPS for more than 7 days exhibited significantly poor
prognosis. In the five groups, mortality was 67%, 76%, 95%, 89%
and 33%, respectively. Patients who had less than –2 on the base
excess level and less than 200 on the PaO2/FiO2 level when the
PCPS was removed had significantly poor prognoses.
Conclusions A low PaO2/FiO2, a low base excess and a long
course of PCPS therapy are very poor prognostic indicators in
patients receiving PCPS therapy. PCPS therapy has been proven
effective in acute respiratory and cardiac failure cases, but we
suggest that PCPS therapy has to be carefully limited considering all
the clinical characteristics because the mortality rate is still so high.
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Practice of extracorporeal membrane oxygenation in adult
patients: a single-centre experience
R Tiruvoipati, S Chatterjee, C Harvey, G Faulkner, H Killer, 
A Sosnowski, R Firmin, G Peek
Glenfield Hospital, Leicester, UK
Critical Care 2005, 9(Suppl 1):P323 (DOI 10.1186/cc3386)
Extracorporeal membrane oxygenation (ECMO) is used as a
treatment modality in patients with severe but potentially reversible
cardiorespiratory failure that is not responding to conventional
treatments. Practice of ECMO for neonatal respiratory failure has
now become evidence-based practice supported by randomised
controlled trials. Efficacy of ECMO in treating adult patients with
severe respiratory failure is currently being investigated in a
multicentre randomised controlled trial in the UK — the CESAR trial
(www.cesar-trial.org). The aim of this study is to review the practice
of ECMO in adult patients and to identify complications of ECMO
associated with mortality.
This study is a retrospective review of case records, microfilms and
our database between August 1989 and May 2004. All adult
patients (aged 18 years or more) who received ECMO for severe
respiratory failure at our hospital were included. The indication for
use of ECMO in respiratory failure is a Murray score of more than 3
or a pH of less than 7.2 with uncompensated hypercapnoea not
responsive to conventional ventilation. Venovenous ECMO was
used in most of the patients with respiratory failure and venoarterial
ECMO was used in patients with primary cardiac failure.
Complications on ECMO were classified as mechanical (if the
complication was related to the ECMO circuit used) or patient
complications.
A total of 269 adult patients received ECMO in our unit. ECMO
was used for respiratory failure in 94% (pneumonia 54.6%, primary
ARDS 14.5%, secondary ARDS 8%, status asthamaticus 1.86%
and other causes in 15% of patients) and cardiac failure in 6% of
patients. Out of these, 42 patients were excluded from the analysis
as they were part of the CESAR trial. The over all survival to
discharge was 65%. Complete data on the complications were
available in 222 out of 227 patients. The incidence of mechanical
and patient-related complications were as follows.
Mechanical complications: clots in oxygenator 94 (42.3%), clots in
bladder 55 (24.8%), oxygenator failure 51 (23.0%), clots in bridge
47 (21.2%), cracks on connectors 18 (8.1%), pump malfunction
15 (6.8%), cannula problems 13 (5.9%), race way/tubing rupture 4
(1.8%) and air in circuit 2 (0.9%).
Patient-related complications: cardiac failure requiring inotropes
115 (51.8%), renal 102 (45.9%), infections 60 (27.0%), arrhyth-
mias 50 (22.5%), cannula site bleeding 32 (14.4%), metabolic 32
(14.4%), pulmonary 29 (13.1%), gastrointestinal haemorrhage 15
(6.8%), clinical brain death 8 (3.6%), hypertension requiring
vasodilator therapy 6 (2.7%), cerebral infarction 2 (0.9%), and
intra-cranial bleeding 2 (0.9%).
The mean number of complications is 3.06 (standard deviation
2.48) per patient. Multiple logistic regression analysis of these
complications revealed cannulation site bleeding, hypertension,
cardiac arrhythmias and pulmonary complications were indepen-
dently associated with mortality and none of the mechanical
complications were associated with mortality.
ECMO is a viable option in managing adult patients with severe but
potentially reversible respiratory and cardiac failure. Mechanical
complications of ECMO are not associated with mortality in such
patients. This may be because of the expert care of the ECMO
circuit by the dedicated ECMO specialists.
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Elevated plasma levels of troponin I in surgical patients:
analysis of risk factors and outcomes
M Alsahaf1, H Barker2
1Kingston Hospital, Kingston Upon Thames, UK; 2Royal Brompton
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Critical Care 2005, 9(Suppl 1):P324 (DOI 10.1186/cc3387)
A retrospective study of the application of troponin I assays in
postoperative patients admitted to the intensive care and high
dependency units in a busy district hospital was performed.
Preoperative patient demographics and cardiac risk factors, prior
medical history and type and urgency of surgery were correlated
with the results of troponin assays: only patient gender was
significantly associated, with more females having elevated serum
troponin I. Outcomes were worse when troponin I was raised, with
a significantly higher mortality and trend to more organ systems
failed. The study was limited by small size (47 patients) and non-
standardisation of the timing of troponin assay after admission. A
larger prospective study needs to be performed with assays at
agreed time or trigger points.
The patient cohort was derived from admissions to the ICU or high
dependency units (HDU) in a busy district general hospital during a
9-month period from January to September 2003. Data were
collected retrospectively from the biochemistry laboratory database
in order to identify those patients whose troponin I levels were
assayed during this period.
Serum troponin I was measured in 61 patients in the ICU or HDU
setting. Of these, 14 were medical patients with myocardial
infarction and were excluded from the study. The other 47 patients
were surgical and they form the cohort for this study. Patients
whose serum troponin was measured comprised 31 males and 16
females. Their mean age was 74 years (range 49–93, standard
deviation [SD] 10 years).
Among the 47 patients in whom a suspicion of myocardial
dysfunction had precipitated the laboratory test, 36 had abnormally
high serum levels of troponin I (troponin I > 0.05 units in our
laboratory). In none of these cases had there been any
demonstration of myocardial infarction on electrocardiography nor
echocardiography. The remaining 11 patients were classified as
having normal troponin I levels and no biochemical evidence of
myocardial injury.
All the patients in the normal troponin group were male, but the
other cohort comprised 16 females and 20 males. This was a
significant difference in sex distribution (P = 0.006, chi-squared
test) (Table 1).
Analysing the outcomes of patients with raised troponin levels
compared with those with normal values (summarised in Table 2),
the presence of an elevated serum troponin I was associated with
a shorter duration of stay although this did not reach statistical
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significance (P = 0.12, unpaired t test). This contrasts with their
having more organ failure as already defined: cases with abnormal
serum troponin I levels had a mean of 2.0 organ systems fail during
their stay in ICU/HDU, compared with 1.5 organ systems in the
normal troponin I group. However, the apparent difference
between the groups in numbers of organs failed did not achieve
significance (P = 0.35, t test).
Among those with normal troponin tests, two of 11 patients died.
This was a lower proportion than in the group with elevated serum
troponin levels, in whom 13 of 36 patients died. This was
statistically a highly significant difference (P < 0.001, chi-squared
analysis).
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Prognostic value of serum troponin levels in patients with
pulmonary embolism: a systematic review and meta-analysis
J Latour Pérez1, E Palencia Herrejón2, F Gordo Vidal3, 
B Sánchez Artola4
1Hospital General de Elche, Alicante, Spain; 2Hospital Gregorio
Marañón, Madrid, Spain; 3Fundación Hospital de Alcorcón, Madrid,
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Critical Care 2005, 9(Suppl 1):P325 (DOI 10.1186/cc3388)
Objective Patients with pulmonary embolism (PE) often show
elevated plasmatic troponin levels; this condition may be
associated with increased mortality and other adverse outcomes.
To clarify the possible association between serum troponin levels
and clinical outcome in patients with PE we performed a
systematic review of the literature.
Data source The search strategy included electronic search of
original studies in Medline, Embase, Cochrane Library, Pascal,
Medion and ISI Proceedings, manual retrieval of recovered
bibliographic references and personal communication with authors.
Study selection We selected inceptive cohort studies relating
baseline troponin levels and the occurrence of hospital mortality,
unfavourable clinical course or echocardiographic signs of right
ventricular dysfunction. The reviewers screened the articles
independently for eligibility and resolved disagreements by
consensus.
Extraction, quality assessment and results Data about odds
ratio (OR), sensitivity, specificity, likelihood ratios (LR) with
confidence interval (95% CI), study population, type of test assay
used (troponin T or troponin I), and methodological quality (using a
modified score after the Lijmer and Altman checklist) were
obtained independently in a duplicate form and disagreements
resolved by consensus. Concordance between reviewers was
assessed using the weighted kappa statistic. We explored
methodological, statistical and clinical heterogeneity, and built a
meta-regression model to explore threshold effects, constructed
the Summary Receiver Operating Characteristic (SROC) curves
and quantified the impact of study’s characteristics on the
magnitude of effects, using StatsDirect (v 2.3.7), SPSS (v 11.0.1)
and Meta-Disc (v 1.1.0) software.
Results We identified 13 studies, which included 1293 patients.
Agreement for quality assessment previous to consensus for each
pair of reviewers were 0.51 (95% CI 0.30, 0.72) and 0.74 (95%
CI 0.58, 0.90), respectively. The quality of recovered studies was
not optimal. The studies were relatively homogeneous for each
outcome, and there was no evidence of threshold effect or
publication bias. Overall weighted mortality was 14%. The
presence of high troponin levels identified a subgroup of patients
at high risk of: dying during the hospitalization (OR 6.20 [95% CI
4.04, 9.52]; area under SROC curve [AUC] 0.78 [CI 95% 0.73,
0.83]), showing echocardiographic signs of right ventricular
dysfunction (OR 8.04 [95% CI 4.40, 16.69]; AUC 0.80 [95% CI
0,77, 0,82]), and suffering an unfavourable clinical course (OR
14.58 [95% CI 6.82, 31.16]; AUC 0.84 [95% CI 0.75, 0.94]).
Normal troponin levels identified patients with favourable clinical
course (LR 0.23 [95% CI 0.13, 0.41]).
Conclusions Troponin levels are useful to stratify the risk in
patients with PE. In the individual patient, normal troponin levels
indicate a high probability of following a favourable clinical course.
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Pulmonary embolism in younger and older adults: clinical
presentation and comparison of right ventricular dysfunction,
a new prognostic echocardiographic index
N Parenti, S Bonarelli, A Fanciulli
M. Bufalini, Cesena, Italy
Critical Care 2005, 9(Suppl 1):P326 (DOI 10.1186/cc3389)
Introduction Previous reports suggested that clinical presentation
of pulmonary embolism (PE) could be different in younger as
compared with older patients and the presence of right ventricular
dysfunction (RVD) at echocardiography could identify a group of
PE patients with poor short-term prognosis. We tested these
hypotheses and compared in these two groups a new prognostic
echocardiographic index: the RVD.
Methods This is an observational retrospective study of 80
consecutive patients (40 younger, age ≤ 45 years; 40 older, age
> 45 years) admitted to the ED of an urban hospital from January
1996 to June 2003 for suspected PE, confirmed by high-
probability lung scan and/or spiral CT. All patients had
symptomatic PE and SBP ≥ 100 mmHg at presentation. A 2D
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Table 1 (abstract P324)
Total (mean ± SD) Normal TI (mean ± SD) Raised TI (mean ± SD) Normal TI vs raised TI
Urgency score (1–3) 1.9 ± 1.3 2.2 ± 0.4 2.1 ± 0.8 P = 0.88
Previous cardiac Hx (0–2) 0.4 ± 0.5 0.5 ± 0.7 0.4 ± 0.5 P = 0.58
Number of cardiac meds 1.4 ± 1.5 1.1 ± 1.9 1.5 ± 1.4 P = 0.81
Table 2 (abstract P324)
Total (mean ± SD) Normal TI (mean ± SD) Raised TI (mean ± SD) Normal TI vs raised TI
Length of stay 13 ± 18.3 22 ± 30 10.5 ± 12.1 P = 0.12
Number of organs failed 1.9 ± 1.2 1.5 ± 1.4 2.0 ± 1.2 P = 0.35
Dead 15/47 2/11 13/36 P < 0.0005
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transthoracic echocardiogram was performed on all patients within
24 hours of diagnosis of PE. The severity of PE was based on the
number of non-perfused pulmonary segments on lung scan or
spiral CT. We excluded patients with severe COPD, shock/hypo-
tension (SBP <100 mmHg) and/or chronic pulmonary hyper-
tension. We collected data of history, symptoms, signs, laboratory,
chest X-ray, ECG and echocardiographic findings. RVD diagnosis
was made with echocardiography, in the presence of right/left
ventricular end-diastolic diameter ratio > 0.7 in the parasternal long
axis view without RV hypertrophy. We used the Student t test or
Fisher’s exact test to compare the two groups.
Results Mean ages were 39 years (range 25–45 years) for
younger and 81 years (range 70–93 years) for older adults. After
comparison with older patients, younger patients had less typical
PE risk factors (in particular recent immobilization: 20% vs 35%,
P = 0.03; malignancy: 6% vs 36%, P < 0.001); less abnormal
ECG: 40% vs 70%, P < 0.001 (right BBB was the more frequent
abnormality in younger adults 30% vs 17%, P < 0.001); less
abnormal X-ray (20% vs 40%, P < 0.001); lower D-dimer levels:
mean of 875.8 µg/l vs 1889.7 µg/l in older adults (P < 0.05).
Among younger adults, the more frequent symptoms were:
dyspnoea (50%), chest pain (50% vs 30% in older, P = 0.006),
cough (20% vs 5% in older, P = 0.003), hemoptysis (15% vs 5%,
P < 0.03). At presentation, younger patients showed better
parameters, better air room ABG (PaO2, oxygen alveolar–arterial
difference). Two groups had similar severity of PE: mean of non-
perfused segments: 7.9 ± 3.1 standard deviation for younger
patients vs 9.2 ± 5.9 standard deviation for older patients
(P = 0.38). In two groups the number of patients with RVD was
very similar: 32.5% in older adults vs 30% in younger (P > 0.05).
Discussion Our study indicates that PE may present more subtly
among younger patients. These results could be explained by the
different pathophysiology and compensation of PE in younger
patients. To our knowledge no one has compared the RVD in these
two groups. Because of different pathophysiology and compen-
sation of PE in these two groups, we were surprised to find a
similar rate of RVD. Maybe the acute onset of PE does not allow
compensation in both populations. The main limitations of the
study were: few patients, incomplete data on etiology of PE in
younger patients (few laboratory tests on thrombophilias), and the
retrospective design of the study.
Conclusion This study suggests one should be careful of insidious
presentations of PE in younger patients and that RVD, a novel
prognostic echocardiographic index, could be used in younger
patients as in older patients.
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Pulmonary embolism originated from right heart chamber
thrombus: the diagnostic role of transesophageal
echocardiography
B Volgyes, M Mezei, R Szücs, A Tóth
Bajcsy Zs kh, Budapest, Hungary
Critical Care 2005, 9(Suppl 1):P327 (DOI 10.1186/cc3390)
Background Pulmonary embolism (PE) usually arises from the
thrombi originating in the deep venous system of the lower
extremities, pelvic or renal vein; however, it may rarely originate in
the upper extremity veins and the right heart chambers. Ninety per
cent of all pulmonary emboli arise from the deep venous system,
usually from the lower extremities. In symptomatic patients, venous
ultrasonography has a sensitivity of 95%, a specificity of 96%, a
positive predictive value of 97%, and a negative predictive value of
98%. Rarely the source of emboli may be the right atrium, or the
thrombi stagnate in the right heart chambers. Transthoracic or
transesophageal echocardiography may directly visualize embolized
thrombi (right heart chambers or central pulmonary arteries). The
incidence of PE is 0.5–1/1000 cases.
Materials and methods Eleven patients with massive pulmonary
embolism, age 36–91 (median 72) years, were treated in the ICU
between January 2001 and July 2004. Searching for the source of
embolism, venous ultrasonography of lower extremities and
transesophageal echocardiography (TEE) were performed. The
right heart chambers thrombus could be visualized with TEE; distal
embolization of the thrombus into the pulmonary vasculature was
suspected. The first and conclusive examination of massive PE is
TEE. The presence of intracardial thrombus was enough in itself to
indicate thrombolysis therapy. Eleven patients were treated in our
study with massive PE. All the patients received tissue plasmino-
gen activator (rt-PA), 100 mg over 2 hours, and continuous
echocardiographic monitoring demonstrated clot dissolution within
1 hour in all patients.
Results There was no re-embolism into the pulmonary vessels
during the thrombolysis. There was in one case moderate
haemorrhagic complication. One patient died in PE because of the
insufficiency of thrombolysis. Nine patients out of 11 should have
treated mechanical ventilation. Ten patients were discharged.
Conclusions Due to the low number of patients our statements are
tendency and nondescript. The right heart chamber thromboses
verified by TEE are effectively treated with rt-PA. Based on our
opinion the lysis activity of rt-PA was faster and more effective than
the treatment of streptokinase.
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The use of type brain natriuretic peptide in a cardiac surgery
postoperative context
A Rouge, RV Gomes, P Nogueira, M Fernandes, C Karam, 
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Background Several scientific publications have shown the
importance of the brain natriuretic peptide (BNP).
Objective To evaluate the BNP kinetics and its correlation with
oxyhemodynamic variables at the postoperative (PO) stage of
cardiac surgery (CS).
Methods A classical cohort was carried out with 22 patients
undergoing CS, who were consecutively selected from August
2003 to January 2004. The mean age of the patients was
65.7 ± 8.18 years, and three were females (13.6%). The type B
BNP was dosed before (Pre-BP), at the first hour (BNP 1) and the
sixth hour (BNP 6) PO. The laboratory and hemodynamic data
were also registered. The quantitative dosage of BNP was done by
the immunofluorescence method (Biosite Triage BNP test). The
results underwent statistical analysis with the following tests: chi-
square, Student t, Mann–Whitney, and Pearson, followed by
logistic regression and stepwise (likelihood ratio).
Results No significant difference among Pre-BNP and BNP 1 was
found (P = 0.84), but the opposite occurred when comparing pre-
BNP and BNP6 (P = 0.0004). BNP 1 was significantly related to
the first hour PAM (PAM 1), P = 0.023; with the (DELTAPP),
P = 0.292; Spearman rho = 0.475913, which produced the
possible correlation equations: PAM 1 hour = (89.8432 + 0.0356)
× BNP and DELTAPP = (12.7283 – 0.0087) × BNP. There was
no correlation between the use of VA (dobutamine or
noradrenaline) and the BNP 1 and BNP 6. The MODS was
correlated to BNP 6 (P = 0.01 and rho = 0.524) but no significant
correlation between the BNP 1 and the PO evaluated variables
was found. The BNP 1, BNP 6 and the BNP were not able to
Available online http://ccforum.com/supplements/9/S1
S138
predict a longer length of stay in the surgical ICU or greater MODS
at the third day.
Conclusion Preliminary data show a BNP kintetics curve at PO
CS, as well as a linear correlation among BNP 1 and PAM 1 hour
and DELTAPP and BNP 6. The MODS score was correlated to
BNP 6. The noncorrelation with the outcome variables may be
related to the sample size.
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Pro-B-type natriuretic peptide predicts mortality in critically ill
patients
B Meyer, M Huelsmann, G Delle Karth, P Wexberg, O Wagner,
G Heinz
Medical University of Vienna, Austria
Critical Care 2005, 9(Suppl 1):P329 (DOI 10.1186/cc3392)
Background Natriuretic peptides have emerged during recent
years as potent prognostic markers in patients with heart failure
and other cardiovascular diseases. Moreover, natriuretic peptides
show strong predictive value in patients with pulmonary embolism,
sepsis and renal failure. Also, first data imply that BNP is a good
predictor of outcome in a selected population (shock) of critically ill
patients.
Aim To test the hypothesis that N-terminal pro-B-type natriuretic
peptide (pro-BNP) serves as a prognostic marker in an unselected
cohort of intensive care patients.
Design A prospective, observational study at a tertiary ICU.
Methods Eighty-one consecutive patients (age 63 ± 16 years, male
n = 51, SAPS 2 score 49 ± 11, mechanical ventilation n = 50,
vasopressors n = 56, renal failure n = 19, postoperative n = 23)
admitted to the ICU during a 3-month period were evaluated.
Plasma samples of all patients were obtained upon ICU admission.
Pro-BNP was determined using commercially available kits (Roche
Diagnostics). Subgroup analyses comprised main diagnosis
(cardiologic/non-cardiologic and medical/postsurgery) and
presence and category of shock. Data were compared after
logarithmic transformation.
Results Pro-BNP levels were significantly higher in patients who died
(n = 17) than in ICU survivors (13,871 ± 19,869 vs 5304 ± 8211
pg/ml, n = 17 vs n = 64, P = 0.02). There was no significant
difference in pro-BNP between cardiologic and other medical
patients (9794 ± 14,379 vs 7099 ± 11,208, P = 0.91) but pro-
BNP was significantly lower in postoperative patients (3671 ±
6600 vs 9131 ± 14,090 pg/ml, P = 0.045, surgical and medical
patients, respectively). Patients presenting with shock showed
significantly higher levels of pro-BNP (14,321 ± 17,653 vs 5264 ±
8605 pg/ml, P < 0.001); however, no difference was observed
between cardiogenic and septic shock categories.
Conclusion Pro-BNP might be a strong predictor of outcome even
in an unselected population of critically ill patients.
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Elevated N-terminal pro-B-type natriuretic peptide levels and
normal left ventricular systolic function: an echocardiographic
study
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Introduction The neurohormone N-terminal pro-B-type natriuretic
peptide (NT-proBNP) has been shown to be a useful ‘rule-out’ test
for the diagnosis of left ventricular systolic dysfunction (LVSD). As
NT-proBNP plasma levels are related to left ventricular wall
tension, NT-proBNP may be elevated in the absence of LVSD.
Aim To evaluate echocardiographic abnormalities in patients with
elevated levels of NT-proBNP and clinical symptoms and signs
suggestive of LVSD but with normal LV systolic function on
echocardiography.
Methods Within two primary care trusts, NT-proBNP was
measured in 1054 patients over a 1-year period (September
2003–October 2004). To assess echocardiographic abnormalities
other than LVSD we retrospectively reviewed our digital archive
database.
Results NT-proBNP was elevated (>150 ng/l) in 744/1054
patients (70.6%), 42% male, median age 76 years (33–100
years). Of those patients with an elevated NT-proBNP 492/744
(66%) had an echocardiogram. A cut-off value of 150 ng/l was
used, sensitivity 0.97 (confidence interval [CI] 0.94–0.98),
specificity 0.45 (CI 0.41–0.48), positive predictive value 0.44 (CI
0.41–0.48), negative predictive value 0.97 (CI 0.94–0.98).
Three hundred and twenty-eight patients had normal LV systolic
function and an elevated NT-proBNP. Of these, echocardiographic
abnormalities were seen in 252/328 (77%). These included LVH
152/328 (46%), aortic stenosis 19/328 (6%), aortic regurgitation
48/328 (15%), mitral stenosis 11/328 (3%), mitral regurgitation
104/328 (32%), tricuspid regurgitation 80/328 (24%) with
significant pulmonary hypertension in 57/328 (17%), and 14
patients had a previous valve replacement. A significant pericardial
effusion was found in two patients.
Conclusion NT-proBNP is a useful tool in the ‘rule-out’ of LVSD.
When elevated, many clinically relevant pathologies other than
LVSD may be identified.
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left ventricular systolic dysfunction: what is the optimal cut-off?
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J Drury, M Stewart
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Introduction The neurohormone N-terminal pro-B-type natriuretic
peptide (NT-proBNP) is predominantly released from the left
ventricle in response to increasing wall tension, and is suggested
as a useful screening test for suspected left ventricular systolic
dysfunction (LVSD).
Aim To evaluate the predictive value of different NT-proBNP
reference cut-off values in patients with clinical symptoms and
signs suggestive of LVSD.
Methods NT-proBNP was measured in 1054 patients with clinical
symptoms and signs suggestive of LVSD over a 1-year period
(September 2003–October 2004). We retrospectively reviewed
our digital archive echocardiographic database.
Results An echocardiogram was performed in 549/1054 (52%)
patients. NT-proBNP was >150 ng/l in 744/1054 patients (71%),
42% male, median age 76 years (33–100 years) and > 500 ng/l in
411/1054 patients (40%), 50% male, median age 76 years
(33–100 years). ROC curves are shown for NT-proBNP cut-off
values of 150 ng/l, positive predictive value (PPV) 0.22
(confidence interval [CI] 0.19–0.25), negative predictive value
(NPV) 0.97 (CI 0.94–0.98), and 500 ng/l, PPV 0.3 (CI 0.26–0.35),
NPV 0.93 (CI 0.9–0.94), for the detection of LVSD.
At a cut-off value of 500 ng/l, NT-proBNP has a sensitivity 0.85 (CI
0.76–0.91), specificity 0.67 (CI 0.64–0.69), PPV 0.18 (CI
0.15–0.22), and NPV 0.98 (CI 0.97–0.99) at detecting moderate
to severe LV impairment.
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Conclusion NT-proBNP is a useful tool in the ‘rule-out’ of LVSD.
An NT-proBNP level of 500 ng/l has a similar negative predictive
value to an NT-proBNP level of 150 ng/l with improved positive
predictive value. This is particularly important in this population
where other confounding comorbidities are common.
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Pro-atrial natriuretic peptide in patients with sepsis, severe
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M Prucha1, R Zazula2, I Herold3, M Dostal4, B Kavka1
1Hospital Na Homolce, Prague, Czech Republic; 2Thomayer’s
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Introduction The natriuretic peptides are counter-regulatory
hormones involved in volume homeostasis and cardiovascular
remodeling. Both ANP and BNP are released by the heart in
response to several stimuli, the most prominent of which being
increased intravascular volume and increased intraventricular
pressure. Recently, interest has focused on their significance in
patients with sepsis and septic shock. A correlation between ANP
and IL-6 was found in patients with septic shock [1].
Objectives The present study aimed at examining: serum levels of
the stable midregional prohormone forms of ANP in patients with
sepsis, severe sepsis and septic shock; and correlations of
proANP with cytokines involved in the pathogenesis of the sepsis.
Patients and methods Serum concentrations of proANP were
determined using the immunoluminometric assay in 17 consecutive
patients admitted to the medical intensive care unit for sepsis (two
patients) severe sepsis (five patients) and septic shock (10
patients). ProANP levels as well as those of procalcitonin, IL-6,
IL-10 and lipopolysaccharide binding protein were measured at
day 1 and in the course of the stay at the intensive care unit.
ProANP was also determined in 12 healthy adults.
Results The median APACHE II score of surviving patients was
18; minimum 5, maximum 25; of non-survivors median APACHE II
score was 22.5; minimum 5, maximum 31 on day 1. Eight of the 17
patients died (47%). Significantly higher concentrations
(P = 0.001) of proANP were measured in survivors (412.1 pmol/l;
minimum 89; maximum 1486.1) and non-survivors (447.5 pmol/l;
minimum 201.8; maximum 1876) as compared with controls
(50.7 pmol/l; minimum 33.4; maximum 64.5). Significantly higher
concentrations (733.8 pmol/l; minimum 201.8; maximum 1876) of
proANP were in patients with severe sepsis and septic shock as
compared with patients with sepsis (399.9 pmol/l; minimum 89;
maximum 897), P = 0.0053. There were no differences of proANP
levels between survivors and non-survivors. There was no
significant correlation between proANP and cytokine levels
measured simultaneously.
Conclusions ProANP levels are elevated in the course of sepsis,
severe sepsis and septic shock. The ANP levels do not correlate
with the levels of PCT, IL-6, IL-10, LBP.
Reference
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Introduction Optimal monitoring of critically ill patients remains a
challenge. A noninvasive point-of-care test of blood hemoglobin
and hematocrit (Hb/Hct) levels may provide rapid patient
assessment, including the need for transfusion, less iatrogenic
blood loss and cost savings. A new, noninvasive device, the
OrSense NBM-100, was tested for continuous monitoring (CM) of
Hb/Hct in an ICU and postanesthesia care unit (PACU).
Objective The aim of this study was to evaluate the accuracy of a
new noninvasive Hb/Hct continuous monitor, compared with the
traditional laboratory technique in critically ill and postsurgery patients.
Materials and methods The NBM-100 device utilizes a finger-
base ring-like sensor using red–near infrared occlusion
spectroscopy to detect and analyze the Hb/Hct concentrations
and blood glucose level.
Study design Ten patients were enrolled (four females, six males,
ages 24–83): four in the PACU, and six in the ICU. The NBM-100
probe was placed on patients’ thumbs and assessed for 2–12 hours
of CM. NBM-100 output was provided every 10–15 min. Results of
the device were compared with arterial blood samples taken every
30–60 min and analyzed by blood gas machine (Nova Biomedical).
Results The NBM-100 showed Hb trend tracking for 54 hours of CM
(see for example Fig. 1). The mean absolute error was 1.0 g/dl (84
points, Hb range: 8.5–12.6 g/dl). An average bias of 0.3 g/dl was
Available online http://ccforum.com/supplements/9/S1
Figure 1 (abstract P331) Figure 2 (abstract P331)
Figure 1 (abstract P333)
NBM-100 hemoglobin (Hb) tracking versus spot Hb values in one
patient when calibrated with the first in vitro measurement.
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found between the two methods. When calibrated with the input of
the first in vitro measurement, the mean absolute error was 0.95 g/dl.
Conclusions The OrSense monitor can provide accurate,
noninvasive Hb CM in critically ill patients. This may be useful for
diagnosis and treatment of patients with significant Hb changes.
The device and sensor provided the capability of long-term CM
and early-trend information at the point of care. Particularly, the
device could be valuable in patients with wide Hb dynamic ranges
resulting from blood dilution and hemorrhaging.
Preliminary results of ongoing trials evaluating the NBM-100 in
other settings (e.g. intermittent Hb/Hct measurements in
hematology clinics and in blood banks) show a good agreement
between NBM-100 and standard invasive Hb/Hct measurement
methods. Further developments may enable noninvasive measure-
ment of glucose as well.
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Hematocrit of 20% versus 25% during normothermic
cardiopulmonary bypass for elective coronary artery bypass
graft surgery
C von Heymann, M Sander, A Foer, A Heinemann, J Braun, 
P Dohmen, W Konertz, C Spies
University Hospital Charité, Berlin, Germany
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Introduction Much debate still exists on the minimum level of
normovolemic hemodilutional anemia that is safe to maintain
oxygen delivery within the physiological range [1]. Normothermia
during cardiopulmonary bypass (CPB) raises the question of
adequate regional and whole body oxygen delivery under
conditions of hemodilutional anemia [2]. We performed a
prospective, controlled and randomized study to investigate
oxygen delivery, oxygen consumption and clinical outcome of
patients who were randomly allocated to a hematocrit of 20% or
25%, respectively, during normothermic cardiopulmonary bypass
for isolated CABG surgery.
Patients and methods After approval of the local ethical
committee and informed written consent 50 patients were
randomized to a hematocrit of 20 ± 1% versus 25 ± 1% during
normothermic CPB. Inclusion criteria were: informed consent,
isolated CABG surgery, age >18 and < 75 years, Hct > 36% and
bodyweight > 70 kg. Prior to CPB patients were subjected to
isovolemic hemodilution using HES130/0.4 (Voluven, Fresenius,
Germany). Outcome measures of this study were: blood lactate,
postoperative drainage loss and transfusion requirements,
incidence of organ dysfunction (neurological, cardiac, respiratory
and renal), stay in ICU (hours) and hospital stay (days).
Postoperative intensive care therapy followed a standardized
protocol. Statistical analysis was performed using the chi-squared
test and Fisher’s exact test for categorical and dichotomous
variables, respectively. The Mann–Whitney U test was applied for
intergroup comparison of continuous variables.
Results One patient had to be excluded from statistical analysis
due to clot formation in the autologous blood that had to be
discarded. Basic patient characteristics are presented in Table 1,
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Basic patient characteristics
Hematocrit 25% Hematocrit 20%
Median IQR Median IQR P
Age (years) 60 56–67 64 58–71 0.28
Gender (male/female) 25/2 22/0 0.50
Body mass index (kg/m2) 28.1 26.1–32.6 28.6 25.2–29.4 0.36
Preoperative hematocrit (%) 41.8 40.2–43.0 41.9 39.4–43.4 0.92
Duration of anesthesia (min) 300 285–320 305 290–325 0.28
Duration of surgery (min) 195 160–220 205 175–250 0.15
CPB time (min) 70 52–82 73 65–81 0.40
Cross-clamp time (min) 45 32–57 45 38–49 0.72
APACHE II score 14 11–19 17 12–20 0.18
Table 2 (abstract P334)
Outcome variables
Hematocrit 25% Hematocrit 20%
Median IQR Median IQR P
Hematocrit on admission to ICU (%) 25.8 24.0–26.9 23.5 20.8–25.3 0.04
DO2 on admission to ICU (ml/m2/min) 819 675–1089 787 665–948 0.43
VO2 on admission to ICU (ml/m2/min) 227 190–289 211 185–263 0.78
DO2 18 hours after admission to ICU (ml/m2/min) 991 743–1299 910 807–1032 0.66
VO2 18 hours after admission to ICU (ml/m2/min) 327 269–399 285 265–347 0.16
Blood lactate on admission to ICU (mmol/l) 1.4 1.1–2.1 1.4 1.1–2.0 0.95
Blood lactate 18 hours after admission to ICU (mmol/l) 1.4 1.1–2.1 1.8 1.2–2.2 0.69
Drainage loss (ml) 390 280–470 400 270–580 0.88
Transfused patients (n) 0 0% 2 9% 0.51
Agitated arousal reaction (n) 3 13% 3 14% 0.59
Myocardial infarction (n) 0 0% 0 0% 0.99
CK/CK-MB 0.05 0.04–0.07 0.05 0.04–0.08 0.99
Ventilator support (hours) 10 7–13 10 9–12 0.74
Creatinine 18 hours after admission to ICU (mg/dl) 0.86 0.80–1.08 1.02 0.82–1.13 0.65
Patients with acute renal failure (n) 1 4% 1 5% 0.73
ICU stay (hours) 23 22–25 23 21–35 0.87
Mortality (n) 0 0% 1 5% 0.47
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showing no significant differences between groups. Patients were
discharged from the ICU after a median 23 hours in both groups
(P = 0.87). Outcome variables were not significantly different
between groups (Table 2) and within the normal range. Duration of
hospital stay was not different between groups. One patient in the
20% group died of septic multiorgan failure due to pneumonia
occurring on day 3 after surgery.
Conclusion The results of our study showed that whole body
oxygen delivery was sufficiently maintained as blood lactate levels
were not different between groups. Clinical outcome after elective
CABG surgery was not impaired by an hematocrit of 20% during
normothermic CPB. Furthermore, lowering the safe degree of
hemodilutional anemia during CPB may prevent patients being
exposed to blood products.
References
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Anaemia at discharge from the intensive care unit is
associated with an inappropriate erythropoietin response
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Background and objectives The adoption of a restrictive
transfusion practice in our unit has led to a high prevalence of
significant anaemia during the ICU stay, which persists to level 3
(L3) discharge. There has been little research exploring the recovery
of anaemia following critical illness. We investigated the aetiology of
the anaemia in patients at discharge from intensive care.
Setting and patients An 18-bed general intensive care unit within
a tertiary hospital. Patients who required > 48 hours L3 care and
were anaemic at time of L3 discharge were recruited. Exclusion
occurred if renal replacement therapy or immunosuppression was
required at time of discharge, or if patients had a chronic
haematological abnormality.
Methods Haemoglobin (Hb) and erythropoietin (EPO) levels were
measured within 5 days of L3 discharge, along with the percen-
tage of hypochromic red cells (%HYPO), reticulocyte haemoglobin
content (CHr), reticulocyte count, ferritin and vitamin B12 and
folate levels.
Baseline characteristics Presented as median (first and third
quartiles); range. Twenty male and 10 female patients were
recruited with the following characteristics: age: 66.5 years (55.5,
77); 35–83. APACHE II score 21 (16, 24); 7–38. ICU length of
stay (LOS): 12 days (9, 23.25); 2–46.
Results Data are presented in Table 1.
Table 1
Parameter Median Range 
(normal value) (first quartile–third quartile) (minimum–maximum)
Hb (g/l) (>120) 92.0 (87.7–100.2) 78.0–120.0
EPO (mIU/ml) (< 55) 18.2 (9.1–25.9) 4.3–83.4
CHretic (pg) (> 28) 32 (30.2–33.8) 27.0–37.2
%HYPO (< 5%) 4.15 (2.2–6.9) 0.7–19.7
Reticulocyte × 109 107.2 (75.1–145.2) 47.1–331.3
Vitamin B12 (ng/l) (>170) 610 (416–1282) 203–1827
Folate (µg/l) (> 2) 5.7 (3.6–7.5) 2.3–12.6
Conclusions Anaemia persisting at ICU discharge is associated
with an inappropriate EPO response in the majority of patients. The
elevated reticulocyte count suggests that the erythropoietic
response has been initiated despite low EPO levels but this is
inadequate to correct anaemia. There is no evidence of vitamin
B12 or folate deficiency. The normal CHr suggests little evidence
of current functional iron deficiency but the elevated %HYPO in
40% of patients suggests that depleted iron stores may have
limited erythropoiesis at some point during the ICU stay. Further
work is required to determine factors contributing to the
inappropriate EPO response.
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Objective The aim of our study was to assess the efficacy of two
dosing schedules of recombinant human erythropoietin (rHuEPO)
in increasing hemoglobin (Hb) level and reducing the exposure to
allogeneic red blood cells (RBC) transfusion in critically ill patients.
Design A prospective, randomized, multicenter trial.
Settings A total of 13 intensive care units participated in the study.
Patients A total of 148 patients who met eligibility criteria were
enrolled.
Intervention Patients were randomly assigned to receive
intravenous (i.v.) iron saccharate alone (control group), i.v. iron
saccharate and subcutaneous rHuEPO 40,000 units once per
week (group A) and i.v. iron saccharate and subcutaneous
rHuEPO 40,000 units three times per week (group B). rHuEPO
was given for a minimum of 2 weeks or until ICU discharge or
death. The maximum duration of therapy was 3 weeks.
Results The cumulative number of RBC units transfused, the
average RBC units transfused per patient and per transfused
patient, the average volume of RBC transfused per day and the
percent of transfused patients were significantly higher in the
control group than those in groups A and B. No significant
difference was observed between group A and group B. The mean
increase in hematocrit (∆Hct) and Hb (∆Hb) from baseline to final
measurement were significantly higher in group B than those in
control group. ∆Hct was significantly higher in group B than that in
group A. ∆Hct in group A was significantly higher than that in
controls, whereas ∆Hb did not differ significantly between the
control group and group A.
Conclusion Administration of rHuEPO in critically ill patients
significantly reduced the need for RBC transfusions. The
magnitude of the reduction did not differ between the low and high
doses of rHuEPO, whereas there was a dose response of Hct and
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Methods Severely bleeding patients with blunt trauma were
randomised to rFVIIa (200 + 100 + 100 µg/kg) or placebo as an
adjunct to conventional treatment. Patients who had incurred both
blunt and penetrating trauma were included in this study. First trial
product injection followed the eighth RBC unit, with additional
injections 1 hour and 3 hours later. The new efficacy analyses were
performed on the patients surviving 48 hours or more after first
administration of the trial product.
Results Of 153 blunt trauma patients randomised, 117 were
eligible for the primary efficacy analysis (10 patients were excluded
because they did not receive the trial product due to death or
arrest of bleeding before transfusion of the eighth unit of RBC, and
26 patients were excluded due to death within the 48-hour period).
Total RBC transfusion was significantly reduced with rFVIIa relative
to placebo (estimated reduction of 2.6 total RBC units; 90%
confidence interval: [0.7; 4.6]; P = 0.02) (results previously
presented). The need for massive transfusion (> 20 RBC units,
inclusive of the eight predose units administered pre trial product)
was significantly reduced: 8/56 patients (14%) with rFVIIa versus
20/61 patients (33%) with placebo (P = 0.03), along with
significant reductions in 48-hour requirements for FFP and
platelets. The improved haemostasis was accompanied by a
significant decrease in ARDS (3/56 [5%] of rFVIIa-treated vs
11/61 [18%] of placebo-treated patients [P = 0.047]) as well as a
significant decrease in the risk of developing organ failure (either
MOF or ARDS: 5/56 [9%] of rFVIIa-treated vs 15/61 [25%] of
placebo-treated patients [P = 0.047]).
Conclusions Recombinant FVIIa improved clinical outcome (risk of
developing single or multiple organ failure, especially ARDS) in
severely bleeding blunt trauma patients. No safety issues were
identified.
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Introduction Activated recombinant coagulation factor VII (rFVIIa)
effectively prevents and controls bleeding in patients with
coagulopathy. Data show that rFVIIa may reduce blood loss and
eliminate the need for transfusion in patients with normal
haemostasis undergoing major surgery. We assessed the efficacy of
rFVIIa in patients with normal haemostasis undergoing repair surgery
of major traumatic fracture of the pelvis or the pelvis and acetabulum,
who were expected to have a large volume of blood loss.
Methods We performed a double-blind, randomised, placebo-
controlled trial involving 48 patients undergoing major pelvic-
acetabular surgery. Patients were randomised to receive an
intravenous bolus injection of 90 µg/kg rFVIIa or placebo as add-
on therapy at the time of the first skin incision. All patients also
received intraoperative salvaged red blood cells (RBC).
Results There was no significant difference in the total volume of
perioperative blood loss, the primary outcome variable, between
the rFVIIa and placebo groups (Table 1). In addition, there were no
differences between the two groups in the total volume of blood
components including salvaged RBC transfused, number of
patients requiring allogeneic blood components, total volume of
fluids infused, total operating time, time taken after entry to the
intensive care unit to reach normal body temperature and
acid–base status, and time spent in hospital. No adverse events, in




(n = 24) (n = 24) value
Total perioperative* 2070 1535 0.79
blood loss (ml) (431–6774) (714–7057)
Intraoperative (ml) 1598 1188 0.57
(331–6574) (514–6657)
Postoperative (ml) 240 370 0.022
(0–1210) (80–650)
Total perioperative blood 289 706 0.33
transfusion requirement (ml) (42–2365) (53–7138) 
Salvaged RBC (ml) 194 171 0.90
(0–935) (47–676)
Allogeneic RBC (units) 0 2 0.34
(0–4) (0–16)
Number of patients transfused 11 (46%) 16 (67%) 0.24
with allogeneic blood components
Data presented as median (range) when applicable. *Perioperative period
was defined as the intraoperative period combined with the 48 hours after
the first dose of rFVIIa or placebo.
Conclusions In patients with normal haemostasis undergoing
repair surgery of traumatic pelvic-acetabular fracture, the
prophylactic use of rFVIIa does not decrease the volume of
perioperative blood loss. Nevertheless, the use of rFVIIa appears to




Anti-Xa activity after subcutaneous administration of dalteparin
in intensive care unit patients with and without subcutaneous
oedema
M Rommers1, N van der Lely2, T Egberts1,3, P van den Bemt1,3
1Hospital Pharmacy Midden-Brabant, TweeSteden Hospital and St
Elisabeth Hospital Tilburg, The Netherlands; 2Intensive Care, St
Elisabeth Hospital, Tilburg, The Netherlands; 3Department of
Pharmaco-epidemiology and Pharmacotherapy, Institute of
Pharmaceutical Sciences, University of Utrecht, The Netherlands
Critical Care 2005, 9(Suppl 1):P340 (DOI 10.1186/cc3403)
Introduction Subcutaneous administration of low molecular weight
heparins (LMWHs) is efficient in the prevention of venous
Critical Care    March 2005 Vol 9 Suppl 1 25th International Symposium on Intensive Care and Emergency Medicine
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thromboembolism (VTE), which is a frequent complication in
critically ill patients. ICU patients often suffer from subcutaneous
oedema, due to the pathophysiology and large volumes of fluid
they require. Subcutaneous oedema may impair the absorption of
dalteparin, a LMWH, which is given by subcutaneous admini-
stration for VTE. To investigate whether indeed the absorption of
dalteparin is impaired because of subcutaneous oedema, we
compared the anti-Xa activity after subcutaneous injection of
dalteparin in ICU patients with subcutaneous oedema with ICU
patients without subcutaneous oedema.
Methods The study design is a non-randomised open parallel
group follow-up study. The study was conducted at the ICUs
(mixed medical–surgical) of two teaching hospitals in The
Netherlands, from January 2003 until November 2004. The
inclusion criteria were ICU patients with age >18 years,
subcutaneous administration of dalteparin 2500 IU once daily for
VTE prophylaxis. The exclusion criteria were use of vitamin K
antagonists, use of therapeutic doses of LMWHs or UFH, severe
liver failure, renal insufficiency, signs of disseminated intravascular
coagulation, use of vasopressors and/or inotropics. Anti-Xa
activities were determined at 0, 3, 4, 6, 8, 12 and 24 hours after
subcutaneous administration of dalteparin. Both the Cmax and
AUC(0–24 hours) values of anti-Xa activity were compared.
Comparison of continuous variables was done by Student’s t test.
The anti-Xa activity (Cmax and AUC(0–24 hours)) was compared
by the non-parametric Mann–Whitney test (mean ± standard error
of the mean). A P value of 0.05 is taken as the cut-off for statistical
significance.
Results Six ICU patients with and six ICU patients without
subcutaneous oedema were studied. The characteristics of the
index group were: age 57 years, male/female ratio 5/1, body mass
index at admission 22.7 kg/m2. The characteristics of the reference
group were: age 48 years, male/female ratio 5/1, body mass index
at admission 23.9 kg/m2. In the index group creatinine clearance
was lower compared with the reference group (81 vs 127 ml/min,
P = 0.57). Both mean creatinine clearances were within the normal
range. Sequential organ failure assessment score did not differ
between the index and reference groups (4 vs 5). Mean arterial
pressure was comparable between the index and reference group
(87 vs 90 mmHg) and within the normal range. Mean plasma
concentrations of factor anti-Xa activity were comparable in both
groups. The mean Cmax value was not different between ICU
patients with and without subcutaneous oedema (0.15 ± 0.02 vs
0.13 ± 0.03 IU/ml, P = 0.30). In the ICU patients with
subcutaneous oedema the mean AUC(0–24 hours) value was
higher (1.41 ± 0.34 vs 0.92 ± 0.11 hours IU/ml, P = 0.23).
Conclusions There is no difference in anti-Xa activity after
subcutaneous administration of 2500 IU dalteparin between ICU
patients with and without subcutaneous oedema. When compared
with values in healthy volunteers, critically ill patients seem to have
lower anti-Xa activity levels. This is found in recent studies as well.
More research is necessary to identify the proper dose and route
of LMWHs for VTE prophylaxis in ICU patients.
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Purpose Acute HIT usually precludes treatment with heparin.
Clotting factor concentrates that contain heparin have also been
regarded as contraindicated in these patients. Occurrence of HIT
is currently shifting towards severely ill patients. These patients
often require antithrombin (AT) substitution (e.g. for increased
consumption in DIC). AT may contain heparin from the manu-
facturing process. In this study we assessed by means of an
immunological assay whether heparin contaminations in AT can
trigger platelet activation by HIT antibodies. As only 30% of
heparins contain the AT binding pentasaccharide, determination of
FXa activity is not sufficient to detect immunological relevant
heparin concentrations.
Methods After thawing and heat inactivation, HIT sera were tested
in the 14C-serotonin release assay (14C-SRA) in the presence of
heparin or two AT batches at different concentrations (undiluted,
1/2, 1/4, 1/8, 1/16, 1/32, 1/64, 1/128; one batch unspiked, one
batch spiked with 1 IU heparin/ml) (Atenativ®; Octapharma AB,
Stockholm, Sweden). A reaction in the presence of AT was
considered positive if the 14C-SRA was > 20% with at least two of
four platelet donors.
Results Sera of 10 patients with documented clinical HIT were
investigated. Using the unspiked AT batch only one of 10 HIT sera
showed weak platelet activation in the 14C-SRA at a dilution of AT
of 1:16 but not at less diluted AT. This indicates a false positive
reaction rather than a real HIT-dependent platelet activation. With
the spiked AT batch the sensitivity of the assay was determined to
detect at least a concentration of 0.06 IU heparin/ml AT.
Conclusion The antithrombin concentrate we tested does not
contain ≥ 0.06 IU/ml heparin. Considering a worst-case scenario,
treating a HIT patient with 1000 IU Atenativ® might theoretically
result in a final heparin plasma concentration of maximally
0.2 × 10–3 IU/ml whole blood. It is unlikely that this amount of
heparin will cause adverse effects in a HIT patient.
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hemorrhagic shock
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Purpose Dilutional coagulopathy is a common complication in
severely injured patients and a consequence of blood loss,
administration of synthetic colloids and red blood cell concentrates
to compensate huge blood losses. This study was conducted to
assess whether substituting the combination of fibrinogen and pro-
thrombin complex concentrate (PCC) enables the reversal of
dilutional coagulopathy, and whether this treatment leads to a
reduction in further blood loss and mortality.
Methods Anesthetized pigs (n = 20) were instrumented for blood
sampling and hemodynamic monitoring. About 66% of the
calculated blood volume was withdrawn and replaced with hydroxy-
ethylstarch (130 HES 0.4). Then, pigs were randomized to receive
either 200 mg/kg fibrinogen and 35 IE/kg PCC (n = 10) or placebo
(n = 10). Thereafter, a standard liver laceration was performed to
induce uncontrolled hemorrhage. Modified thrombelastography was
used to assess the dynamics and quality of clot formation.
Results After hemodilution both groups showed statistically
significant increased clotting times (CT), clot formation times
(CFT), and decreased maximum clot firmnesses (MCF). After
fibrinogen and PCC administration, CT and CFT decreased
whereas MCF increased statistically significantly. Median blood
loss after liver injury was significantly smaller in the animals treated
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with clotting factor concentrates versus the placebo group:
240.0 ml (50.0–830.0) vs 1.800 ml (1.500–2.500) (P < 0.0001).
All animals, treated with fibrinogen and PCC survived, whereas
80% of the placebo group died after liver laceration (P < 0.0001).
Conclusion During hemodilution, substitution of fibrinogen and
PCC leads to an enhancement in coagulation and final clot
strength. This reversal of dilutional coagulopathy may reduce blood
loss and mortality when large amounts of colloids are needed to
maintain normovolemia during huge blood losses.
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The management of haemorrhage or risk of haemorrhage in
anticoagulated patients increasingly involves those providing
services for haemophilia. This is particularly so in the use of
prothrombin complex concentrates where experience of the use of
these products exists almost entirely within haemophilia centres. As
the majority of bleeding anticoagulated patients present to hospitals
that do not have haemophila centres, and where there is little
experience in the use of PCCs, there is clearly a need for practical
guidelines to guide use of these products. Clinicians must be made
aware of the potential benefits and risks of using concentrated
coagulation factors prepared from large plasma pools.
A key aspects of the safe use of PCCs is the careful selection of
the clinical indications for their use. Only those patients with or at
risk from life-threatening haemorrhage should be treated. And
where a licensed product is available, this should be used in
preference to those that are not.
Data are lacking on the comparative efficacy of products
containing factors II, VII, IX (FIX) and X against those lacking factor
VII. There is evidence to show that factor VII levels may be
extremely low in patients with high INRs, suggesting that
overanticoagulated patients may benefit more from PCCs
containing all four vitamin K-dependent factors.
The optimal dose of PCC required to reverse anticoagulation is not
fully established but does depend on the degree of the coagulation
defect. The experience of this group suggests that doses between
25 IU FIX/kg and 50 IU FIX/kg are effective.
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Background The number of patients anticoagulated with warfarin
has rapidly increased over the past decade. Although warfarin is a
highly effective anticoagulant agent, bleeding diathesis is not an
uncommon complication of this treatment. Approximately 1% of
these patients annually experience serious bleeding, and 0.5%
dies. Warfarin is a special drug, which interacts with many drugs
and food. These interactions of the drug make its therapeutic
monitoring very problematic.
Method The present study was performed at the Medical Intensive
Care Unit (MICU) of Gulhane School of Medicine between 1
January and 31 December, and 22 patients with hemorrhagic
complication-related warfarin usage were enrolled into the study.
All of the 22 patients had International Normalized Ratio (INR) > 4.
Results The average age was 69.7 years, and 66 (73%) of these
patients were women. Warfarin was most frequently prescribed for
chronic atrial fibrillation (55%). All of the patients with hemorrhage
due to warfarin toxicity had received concomitant drugs, which may
be responsible for the overactivity of warfarin. The INRs of 13
patients (59%) were ranged between 4.0 and 10.0, and for the
remaining patients were above 10.0. Epistaxis, hematuria, and
hemarthrosis (minor bleeding) has occurred in all patients with
INRs between 4.0 and 10.0, and these patients were given
according to our MICU protocols parenteral vitamin K replace-
ments. Patients were discharged from the MICU when hemostasis
was established, and vitamin K administration continued by
appropriate on an outpatient basis. Patients with INR of 10.0 and
above (n = 9) were treated with fresh frozen plasma transfusions
(2–5 units). Massive upper gastrointestinal bleeding was observed
in five (55%) of these patients, which were in the seventh–eighth
decades. One of them has died besides fresh frozen plasma and
erythrocyte transfusions and endoscopic procedures applied for
all. In one patient with INR of 13.4, bleeding from ears was
interestingly observed. The average length of ICU stay for all
patients was 3.2 days.
Conclusion Although the patients on warfarin treatment were
strictly monitored, hemorrhage is not an uncommon problem and
these patients need ICU support. Many patients receiving warfarin
therapy are treated with concomitant drugs that may interact with
the warfarin. The high percentage of patients taking drugs that may
increase the INR or bleeding risk is a reminder that bleeding events
are a probable adverse outcome of combining drugs that interact
with warfarin.
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Role of thromboelastography in septic patients treated with
coagulation inhibitor
A Giarratano, S Raineri, D Canzio
Azienda Ospedaliera Universitaria Policlinico, Palermo, Italy
Critical Care 2005, 9(Suppl 1):P345 (DOI 10.1186/cc3408)
Introduction Substitutive treatment with coagulation natural
inhibitors could be associated with severe bleedings in surgical
patients. We evaluate the role of thromboelastography (TEG) in
monitoring of septic patients during treatment with AT III and aPC.
Methods We enrolled all the patients admitted in ICU for more
48 hours with surgical severe sepsis associated with severe
deficiency of coagulation natural inhibitors. Two groups were
created. Group A treated with activated PC 24 µg/kg for 96 hours
and Group B with, in addition, AT III administered by the target
[(140 – AT III dosed) × BW (kg)]. TEG was registered before, at
the beginning, during the treatment every 12 hours and 24 hours
after the end of administration. We also registered the SOFA score
until discharge.
Results The clinical data and results are presented in Tables 1 and 2.
Conclusions TEG allows, at the bedside, the dynamic monitoring
of coagulation systems. APC has an anticoagulant and profibrino-
litic role without haemorrhagic effects and this is registered by
TEG. It is interesting to notice that the use of AT III and aPC in the 
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Table 2 (abstract P345)
24-hour after treatment
n SOFA r MA Ly 30
aPC 6 6 ± 3 8 ± 3 71 ± 22 6 ± 3
AT + aPC 4 7 ± 3 7 ± 4 75 ± 15 7 ± 2
septic patients has no haemorrhagic effects and this is also
confirmed by SOFA and by our preliminary data about 28-day
mortality. We believe that the TEG could solve a lot of problems
related to the correct timing of sepsis and to inhibitor treatment.
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Thromboelastography during treatment with activated protein C
E Panascia, G Castiglione, P Calabrese, S Saglimbene, B Panascia
Azienda Ospedali Vittorio Emanuele, Catania, Italy
Critical Care 2005, 9(Suppl 1):P346 (DOI 10.1186/cc3409)
Introduction Activated protein C (rhAPC) infusion increases
fibrinolysis, which is very difficult to evaluate with standard tests.
We used TEG to monitor the coagulation in our patients during the
infusion of rhAPC.
Materials and methods Six patients with severe sepsis were
treated with rhAPC (24 µg/kg/hour for 96 hours). TEG (ETEG
3000; Hemoscope Corp., Skokie IL, USA) was carried out on
native blood before (T0), at 24 hours (T1), 48 hours (T2), 72 hours
(T3), 96 hours (T4) during and 24 hours after the end (T5) of
rhAPC treatment. Analysis of differences between data was carried
out with the Student t test for paired data (differences statistically
significant for P < 0.05).
Results Data are expressed as the mean and standard deviation.
Results obtained are shown in Table 1 and Figs 1 and 2. * indicates
the statistically significant results.
Discussion TEG is a reliable tool for monitoring fibrinolysis during
rhAPC. Fibrinolyisis is more evident during the first 48 hours of
infusion, probably because of a new equilibrium in the coagulation
system reached after that period.
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Pretreatment During treatment
n SOFA r MA Ly 30 r MA Ly 30
aPC 6 9 ± 2 2 ± 1 76 ± 11 2 ± 1 18 ± 6 56 ± 22 9 ± 5
AT + aPC 4 9 ± 3 3 ± 2 77 ± 9 3 ± 1 19 ± 6 57 ± 17 11 ± 5
Table 1 (abstract P346)
T0 T1 T2 T3 T4 T5
R min 29.4 (16.6) 67.4 (70.6) 54.1 (33.6) 47.6 (15.2) 52.9 (34.3) 38.5 (43.6)
K min 11.7 (5.8) 21.4 (29.6) 14 (10.2) 18.5 (18.2) 19.4 (19.4) 23.1 (37.6)
MA mm 64.9 (12.4) 60.7 (20.9) 65.2 (19.6) 66.3 (22.6) 64.8 (18.3) 58.7 (21.5)
ANG ° 43.1 (13.4) 41.8 (22.6) 40.8 (15.7) 40.7 (23.2) 35.8 (20.6) 45.7 (25.7)
Ly 30% 1 (1.1) 30.5* (22.9) 30.8* (26.4) 7.4 (10) 22.8 (25.8) 5.4 (5.6)
Ly 60% 3.1 (3.3) 40* (22.6) 40.3* (26.6) 11.8 (14.6) 24.8 (32.1) 8.1 (4.7)
Figure 1 (abstract P346)
Figure 2 (abstract P346)
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Coagulation changes during pregnancy and delivery:
adjustment of reference ranges for thrombelastography and
for some laboratory tests is necessary
F Polak, H Bedrichova, P Kriz, L Bohacenkova, M Lips, 
A Parizek, J Kvasnicka
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Critical Care 2005, 9(Suppl 1):P347 (DOI 10.1186/cc3410)
Hypothesis The coagulation status in pregnant women is different
from the general population in so far that we must adjust the
reference range of coagulation tests for these women.
Objective To compare the coagulation parameters in pregnant and
parturient women to normal ranges used for the general
population. If there is a significant difference between these
groups, set new ranges for thrombelastography and/or coagulation
laboratory tests.
Participants Sixty healthy pregnant women (group HPW) were
divided into two subgroups: 30 in the third trimester (subgroup TT)
and 30 in the first period of delivery (subgroup FP).
Design and methods A prospective nonintervention study. In all
women we performed thrombelastography and coagulation
laboratory tests. Thrombelastography was performed from native
blood after activation by 1% cellite. Blood samples were obtained
from the peripheral vein, before any medical intervention.
Results The mean of all thrombelastographic parameters in the
HPW group was in the normal range set for the general population,
but mostly very close to a ‘procoagulation’ limit (mean time r
4.7 ± 1.7; time k 1.5 ± 0.5; alpha angle 69.6 ± 5.5; maximal
amplitude 71.3 ± 4.5; coagulation index 2.7 ± 1.8); there was no
statistically significant difference between subgroups TT and FP. In
laboratory tests, the majority of parameters was also close to the
‘procoagulation’ limit of the normal range and, in addition, three of
the parameters were outside the normal range (mean fibrinogen
5.2 ± 0.6; D-dimers 349.9 ± 138.6; protein S 42.4 ± 13.7). After
the statistical analysis we adjusted the reference ranges for
pregnant women. Some of our recommendations for thromb-
elastography are presented in Table 1.
Table 1
Time Time Alpha Maximal Coagulation 
r k angle amplitude index
Normal population 4–8 1–4 47–74 55–73 –3 to +3
Pregnant women 2–8 1–3 60–77 64–76 0–5
Conclusions For assessment of coagulation status by
thrombelastography and for some laboratory tests in pregnant and
parturient women, it is necessary to set new reference ranges that
are different from those for the normal population.
Acknowledgements Supported by grant IGA MZ No. NR/8157-3
and VZ 64165.
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Objectives Desmopressin is a synthetic analogue of vasopressin.
It leads to the release of vWF, FVIII-C, t-PA, P-selectin from
endothelium, microthrombus and thromboembolism. In this study,
the histopathologic effects of intravenous (i.v.) desmopressin given
both in normal and high doses on organs of rats were studied.
Materials and methods This study was performed in 5-month-old
female rats of WISTAR type with the consent of the Ethics
Committee of Experimental Animals. Three groups each consisting
of 10 rats were formed. Following anesthesia and catheterization,
the first group did not receive desmopressin (control).
Desmopressin was administered slowly by i.v. route to group 2 and
group 3 at 1.5 µg/kg and 4.5 µg/kg bolus doses, respectively. A
25 ml/kg/hour dose of 0.9% NaCl infusion was administered into
each group. After 4 hours, laparatomy and thoracotomy were
performed and the kidneys, pancreas, liver and heart were removed
with their vessels using normal procedures (without damaging the
stricture of the organs). These organs were examined
histopathologically. Appearances of specimens were graded and
evaluated statistically using the Mann–Whitney U test.
Results Normal findings were obtained in the histopathologic
examinations of the liver, kidneys and heart. But mild inflammation,
vacuolization, necrosis, microthrombus, and damage of
endothelium were determined in the pancreas examinations of all
groups. A significant difference was found in terms of the damage
of the endothelium between groups in the pancreas (group 1 <
group 3 and group 2 < group 3). In addition, a significant
difference was found between group 1 and group 2 (group 1 <
group 2) in vacuolization. A significant difference was not found in
the appearances of microthrombus, inflammation and necrosis
among groups.
Conclusions There is concern that desmopressin, used in the
treatment of diabetes insipidus, may cause formation of thrombus,
especially in the microvascular bed, and so this may result in
disorders in the perfusion of target organs. But in our study, even
though desmopressin was administered in high doses, it did not
cause thromboembolic damages in several organs and capillary
endothelium, and for this reason it can be used safely.
P349
Continuous hemodiafiltration for hypercytokinemia in tumor
lysis syndrome
M Nakamura, H Hirasawa, S Oda, H Shiga, K Matsuda, 
E Watanabe
Department of Emergency & Critical Care Medicine, Graduate
School of Medicine, Chiba University, Chiba, Japan
Critical Care 2005, 9(Suppl 1):P349 (DOI 10.1186/cc3412)
Tumor lysis syndrome (TLS) is a critical condition being presented
with hyperuricemia, electrolyte disturbance and acute renal failure,
and it is thought to be caused by massive release of cellular
breakdown products due to substantial destruction of tumor cells.
Some TLS patients develop multiple organ failure. Blood
purification, such as hemodialysis is often performed on patients
with TLS as a renal replacement therapy. We noticed that some
TLS patients also had hypercytokinemia and speculated that such
hypercytokinemia might be associated with the pathophysiology of
TLS. On the other hand, we reported that continuous hemo-
diafiltration using a polymethyl methacryrate membrane hemofilter
(PMMA-CHDF) can eliminate cytokines from the blood stream of
patients. We therefore applied PMMA-CHDF on four patients with
TLS with the expectation that PMMA-CHDF also can be an
effective treatment against hypercytokinemia in TLS patients. All
patients had hematological malignancy and received induction anti-
tumor chemotherapy. During the chemotherapy, they developed
hyperuricemia, hyperpotassemia and acute renal failure, and were
diagnosed to have TLS. Two of them developed multiple organ
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failure. In one patient the failing organs were the lung and kidney,
and in the other patient the failing organs were the heart, lung and
kidney. In all TLS patients, blood levels of tumor necrosis factor
alpha, IL-6 and IL-10 before the initiation of PMMA-CHDF were
102 ± 85 pg/ml, 1097 ± 546 pg/ml and 98 ± 83 pg/ml, respectively
(mean ± standard deviation). After 3 days of CHDF treatment,
blood levels of those cytokines were 37 ± 55 pg/ml, 326 ± 511 pg/ml,
and 9 ± 8 pg/ml, respectively. All cytokine levels were thus
significantly decreased with 3 days of PMMA-CHDF treatment
(P < 0.05, P < 0.05, P < 0.05, paired t test). After the PMMA-
CHDF treatment, their clinical conditions were improved, and all
patients survived. In one of these patients, the blood levels of each
cytokine before and after the PMMA membrane homofilter were
measured and the clearance of these cytokines was calculated. The
clearance of each cytokine is as follows; tumor necrosis factor alpha
13.9 ± 6.4 ml/min, IL-6 4.9 ± 2.4 ml/min, IL-8 21.6 ± 3.9 ml/min and
IL-10 11.1 ± 6.4 ml/min,. From those results, we conclude that TLS
could be caused by hypercytokinemia probably due to massive
tumor cellular breakdown by chemotherapy and that PMMA-CHDF
is an effective treatment for TLS patients not only as renal
replacement therapy, but also as a cytokine modulator.
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Introduction Heparin-induced thrombocytopenia type II is a
serious complication during heparin therapy. Treatment with
lepirudin is an alternative when anticoagulation is indispensable.
However, lepirudin accumulates in patients with acute renal failure
treated with renal replacement therapy. This might lead to an
increase in bleeding complications, longer ICU length of stay, and
more therapeutic interventions. We conducted a retrospective
study of all patients after cardiothoracic surgery that developed
acute renal failure, treated by continuous renal replacement
therapy, during a 17-month study period. We grouped the patients
according to anticoagulation with heparin or lepirudin, respectively,
and analyzed the groups for differences in length of ICU stay,
bleeding complications, scores (APACHE II, SAPS, TISS), and
mortality.
Methods One hundred and thirty-seven (7.2%) of a total of 1888
patients were treated with renal replacement therapy. Of those,
eight patients received lepirudin, due to confirmed heparin-induced
thrombocytopenia, and the remaining 129 patients were treated
with heparin. Continuous heparin and lepirudin treatment was
adjusted to an activated partial thromboplastin time of 1.5 times
baseline values. Age, sex, type of surgery, re-operation, transfusion
requirements, APACHE II score, SAPS score, TISS76 score,
length of ICU stay, and ICU mortality were recorded. Statistical
analysis was performed by chi-square test, likelihood ratio test, and
Wilcoxon–Kruskal–Wallis test, where appropriate. Data are
expressed as mean ± standard deviation, or median with
25th–75th percentiles.
Results Patients that were anticoagulated with lepirudin remained
significantly longer in the ICU (18 [13.5–53.25] vs 7 [3–16.5]
days; P = 0.013). Lepirudin-treated patients were transfused
significantly more frequently with packed red blood cells, and
pooled thrombocytes (packed red blood cells 7 [3–15] vs 17
[8.25–27] units; P = 0.037; pooled thrombocytes 3.5 [1–8.5] vs 1
[0–2] units; P = 0.025). Additionally, these patients had
significantly higher TISS scores (53 [44.75–62.25] vs 50
[44–53.5] adjusted for days; P = 0.046). Age, sex, number of re-
operations, APACHE II score, SAPS score, type of surgery, and
mortality did not differ significantly between the groups.
Conclusion Lepirudin treatment after cardiac surgery in patients
that develop acute renal failure, treated with continuous renal
replacement therapy, leads to longer ICU length of stay, higher
transfusion requirements, and more therapeutic interventions, and
thus higher costs.
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Renal replacement therapy for acute renal failure in the
intensive care unit is associated with a worse prognosis than
renal replacement therapy for end-stage renal failure
M Ostermann, R Chang
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Critical Care 2005, 9(Suppl 1):P351 (DOI 10.1186/cc3414)
Background Renal failure in critically ill patients is perceived as a
serious problem with high mortality.
Objectives To compare the outcome of ICU patients with renal
failure requiring renal replacement therapy (RRT) with that of
patients without renal failure (defined by a serum creatinine
<120 µmol/l) and to determine whether there is a difference in
outcome between ICU patients with acute renal failure (ARF)
treated with RRT and ICU patients with pre-existing dialysis-
dependent end-stage renal failure (ESRF).
Methods Retrospective analysis of the Riyadh ICU Program
database of 41,972 patients admitted to 22 ICUs in the United
Kingdom and Germany between 1989 and 1998.
Results Table 1 presents the characteristics and outcome of
patients with and without renal failure. Table 2 outlines the
association between the maximum number of other failed organ
systems (as defined by criteria of Knaus and colleagues, excluding
renal failure) and ICU mortality in ARF patients and patients with
ESRF.
Conclusions The need for renal replacement therapy in the ICU
was associated with an increased mortality. Patients who needed
RRT for ARF had a longer stay in the ICU and a significantly higher
mortality compared with patients who had RRT for pre-existing
ESRF. This difference in outcome was most probably due to other
factors, including number of associated failed organ systems.
Table 1 (abstract P351)
Total No renal ARF and ESRF 
population failure RRT and RRT
Number of patients 41,972 29,225 1787 797
Mean age (95% CI) 60.5 59 60 55
(60.3–60.6) (59–59.4) (60–61) (54–56)
Male sex (%) 63.5 61.8 67.4 59.6
Median APACHE II 13 11 23 21
score (day 1)
Length of stay in ICU (days) 2 1 10 2
ICU mortality (%) 13.7* 6.2* 54.6* 20.8*
Hospital mortality (%) 18.8* 10.3* 62.3* 34.5*
Standardized mortality 1.08 0.86 1.49 0.97
ratio (%)
* P < 0.0001.
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Table 2 (abstract P351)
ARF and RRT ESRF and RRT
Maximum Proportion Proportion 
number of ICU of ICU 
of other patients mortality patients mortality 
failed organs (%) (%) (%) (%) P value
0 9.7 12.1 42 2.7 < 0.0001
1 22.9 35.7 32.4 14.7 < 0.0001
2 34.0 56.8 16.7 48.1 NS
> 2 33.4 78.2 8.9 77.5 NS
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Objective To evaluate the effect on renal function in high
pulmonary flow infants under hypoxic therapy.
Patients and methods The patients were eight infants with heart
failure due to high pulmonary flow who needed to use nitrogen
before surgical correction. Nitrogen was administered through the
oxygen inlet line of a Servo 300® ventilator and FiO2 was kept in
the range 0.13–0.18. Creatinine clearance (CCr), CH2O, and
FENa were measured daily until the operation.
Results CCr increased from 30 ± 1.7 ml/min to 42 ± 24 ml/min,
while PO2 decreased from 47.4 ± 8.42 mmHg (FiO2 0.21) to
40.0 ± 6.06 mmHg (FiO2 0.16 ± 0.02).
Conclusion Hypoxic therapy for high pulmonary flow infants
improved creatinine clearance as well as pulmonary flow.
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Background Contrast-induced nephropathy (CIN) is frequently
found in ICU patients. Several recent studies have shown a
prophylactic effect of acetylcysteine (A) and theophylline (T). The
results are contradictory, however, and only one study has so far
compared the effects of both agents [1]. Nevertheless, this study
did not include a placebo group and was not restricted to patients
with impaired renal function.
Aim To compare the effects of A, T, a combination of A and T (A +
T) and placebo (P) in patients with impaired renal function.
Materials and methods Two hundred and fifty-four patients with
serum creatinine ≥ 1.3 mg/dl receiving ≥ 100 ml contrast-medium
(CM) were randomised to receive A (600 mg, p.o., b.i.d.; start
24 hours before CM), T (200 mg, i.v., 30 min before CM), A + T, or
P. Primary endpoint The incidence of CIN (increase of serum
creatinine ≥ 0.5 mg/dl within 48 hours). Secondary endpoint Time
course of serum-creatinine. Statistics Chi-square-test and
Wilcoxon-test, SAS software version 6.12.
Results Patients of groups A, T, A + T and P were comparable
with regard to baseline creatinine (1.49 ± 0.43 vs 1.53 ± 0.56 vs
1.57 ± 0.40 vs 1.69 ± 0.77 mg/dl; not significant [NS]), amount of
CM (192.5 ± 104.3 vs 240.2 ± 149.9 vs 222.7 ± 141.9 vs
207.6 ± 113.6 ml; NS) and incidence of other risk factors (RF)
such as diabetes and hypertension. The incidence of CIN was
4/62 (6.5%) in group A, 3/64 (4.7%) in group T, 7/66 (10.6%) in
group A + T, and 10/62 (16.1%) in group P. Overall, the incidence
was lower under prophylaxis (14/192; 7.3%) than under placebo
(10/62, 16.1%; P = 0.0386). Patients of group T had a
significantly lower incidence of CIN than patients under placebo
(P = 0.0348), whereas neither group A nor group A + T had a
lower incidence of CIN than group P.
Compared with baseline, serum creatinine levels significantly increased
after 48 hours in group A (1.54 ± 0.39 vs 1.49 ± 0.43 mg/dl;
P = 0.00986), group A + T (1.63 ± 0.41 vs 1.57 ± 0.40 mg/dl;
P = 0.0075) and group P (1.80 ± 0.85 vs 1.69 ± 0.77 mg/dl;
P = 0.00619). However, there was no significant increase in group
T (1.56 ± 0.55 vs 1.53 ± 0.56 mg/dl; NS).
Conclusions In patients with impaired renal function theophylline
significantly reduces the incidence of CIN, whereas acetylcysteine
alone or in combination with theophylline was not effective.
Reference
1. Intensive Care Med 2002, 28(suppl 1):S139.
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Introduction Insulin-like growth factor-1 (IGF-1) protein (7650 Da)
has a strong anabolic effect. Secretion of IGF-1 fails in a number of
pathologies, and this deficit can increase during renal replacement
therapy (RRT) procedures.
Materials Eleven patients (nine males/two females, mean age
49.5 ± 3.7 years) with multiple organ failure (MOF) were examined.
APACHE II score was 27.8 ± 0.6. Eight patients had sepsis
(72.7%). Ten patients underwent mechanical lung ventilation. Six
patients received an inotropic support (54.5%). The mortality rate
was 54.5%. Hemoprocessors ‘Prisma’ (Hospal, France) and
‘Aquarius’ (Edwards, Germany) were used for RRT. Retro-
spectively, two groups were selected: Group A (n = 5), treated by
hemofiltration (HF), with mean duration of procedures 57.1 ± 6.4
hours, effluent volume 66.0 ± 7.1 l/day; and Group B, treated by
hemodiafiltration (HDF), mean duration 49.1 ± 5.7 hours, effluent
volume 103.2 ± 3.5 l/day. IGF-1 levels were measured using an
ELISA assay (DRG, Germany).
Results During RRT procedures in Group A the plasma
concentration of IGF-1 fluctuated on average from 42.6 to
46.8 ng/ml, in Group B it ranged from 18.1 to 39.8 ng/ml (in
healthy men — 150–300 ng/ml). The concentration of IGF-1 in
effluent in both groups varied from 14.2 to 25.9 ng/ml and had no
statistically significant difference. Elimination of IGF-1 in Group A
during HF was 1389.4–1678.9 µg/day and in Group B during
HDF was 1741.3–2446.9 µg/day. Clearance IGF-1 was
21.6 ml/min during HF and 56.8 ml/min during HDF due to the
large volumes of effluent during the procedures.
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Conclusion A relative deficit in IGF-1 was found in patients with
MOF that possibly could be increased by intensive RRT. The
preliminary data show the necessity of early usage of this growth
factor in patients with MOF.
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Introduction Sotalol is a non-selective beta blocker with class III
antiarrhythmic properties. It is not protein bound and is mostly
excreted unchanged in the urine. Both peritoneal dialysis [1] and
haemodialysis [2] have been successful in treating Sotalol-induced
arrhythmias in the prescence of renal failure. Clearance of Sotalol
by continuous venovenous haemofiltration (CVVH) is not
described. We report a case of massive Sotalol overdose in which
CVVH was successfully used.
Patient A 53-year-old lady presented following a deliberate
overdose of Sotalol tablets. She was admitted to the ITU in
multiple organ failure requiring mechanical ventilation, vaso-
pressors and renal replacement therapy. CVVH was commenced
15 hours after the overdose using an exchange of 6000 ml/hour
(approximately 70 ml/kg/hour) on a Baxter ‘Aquarius’ machine.
High-flow CVVH was continued for 48 hours before reducing to
3000 ml/hour. CVVH was required for 21 days in total. The patient
was discharged home without significant morbidity 2 months after
admission.
Methods Paired plasma and filtrate samples were collected at
intervals during the first 24 hours of CVVH. These were analysed
for Sotalol concentration using a HPLC assay. Plasma clearance
was estimated using the formula C = UV / P, where C = clearance
(ml/min), U = filtrate concentration (mg/ml), V = filtrate volume
(ml/min) and P = plasma concentration (mg/ml).
Results See Table 1. Mean clearance = 67.00 ± 6.64 ml/min.
Table 1
Plasma Filtrate 
Time concentration concentration Clearance
15:30 0.0235 0.013 55.32
17:30 0.0156 0.0111 71.15
21:30 0.0177 0.0121 68.36
01:30 0.0142 0.0105 73.94
05:30 0.0114 0.0082 71.93
09:30 0.011 0.0074 67.27
13:30 0.01 0.0061 61.00
Conclusion Clearance of Sotalol by CVVH is significant and
should be considered as an adjunct in cases of Sotalol toxicity and
renal insufficiency. CVVH is likely to cause less cardiovascular
instability than the previously described methods [1,2] of
increasing drug clearance.
Acknowledgement The authors would like to thank Guy’s and St
Thomas’ Medical Toxicology Unit for their assistance with the
Sotalol assay.
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Background Acute renal failure (ARF) is a serious complication of
critical illness in the ICU. When ARF is severe enough to require
renal replacement therapy, mortality approaches 50%. To evaluate
interventions to prevent and treat renal failure in medical–surgical
critically ill patients, a better understanding of risk factors for ARF
in the ICU is needed.
Objective To determine the independent baseline and time-
dependent risk factors for ARF in a 15-bed medical–surgical
closed multidisciplinary ICU in Hamilton, Canada.
Design A prospective longitudinal cohort study.
Population Consecutive patients admitted to the ICU during 2001
for > 72 hours. Patients were excluded if they had an admitting
diagnosis of trauma, orthopedic surgery, cardiac surgery, or
pregnancy, or life support withdrawal. We identified all patients
requiring hemodialysis as prevalent (within 48 hours of ICU
admission) or incident (after 48 hours in ICU) cases of ARF.
Methods We recorded 49 potential risk factors for ARF on ICU
admission (e.g. pre-existing comorbidities such as diabetes) and
daily in the ICU (e.g. exposure to nephrotoxic antibiotics, ampho-
tericin, contrast media, NSAIDS, diuretics and vasopressors). We
also recorded strategies to prevent renal failure (e.g. N-acetyl-
cysteine before contrast media exposure). We conducted Cox
proportional hazard regression analysis to identify patients at risk
for ARF.
Results Among 261 admissions, 22 patients with chronic renal
failure were excluded. Of 239 eligible patients, 11 had missing
charts. Of 228 included patients, the mean age was 66.9 (± 15.3)
and the mean APACHE II score was 25.2 (± 8.5). Dialysis was
initiated within the first 48 hours of ICU admission for nine (3.9%,
95% confidence interval [CI] 1.8–7.4%) patients, and after
48 hours in the ICU for 14 (6.1%, 95% CI 3.4–10.1%) patients.
The only independent risk factor for prevalent ARF was being
transferred from another ICU (hazard ratio [HR] 5.6 [95% CI
1.0–30.5]). Vasopressors and/or inotropes (HR 18.2 [95% CI
1.5–220.3]) and amphotericin (HR 17.3 [95% CI 2.1–141.6])
were the independent risk factors for incident ARF.
Conclusions In this medical–surgical critically ill population, the
overall rate of ARF was 10% (prevalence 4%, incidence 6%).
Patients at highest increased risk for incident ARF were those
transferred from another institution; patients at highest risk for ICU-
acquired ARF were those who received vasopressors and/or
inotropes, or amphotericin.
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Objective To examine the etiologies of acute renal failure (ARF) and
to evaluate the hemodynamic and ventilatory data, mortality, ICU
and hospital stays and therapies of the patients with ARF. We
compared these parameters between the patients who had ARF at
ICU admission and those who developed ARF during their ICU stay.
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Methods Seven hundred and thirty patients admitted to the ICU
from January 2001 to January 2002 were retrospectively evaluated
in terms of ARF. A serum creatinine level of 2 mg/dl or more was
defined as ARF, and 72 patients were diagnosed as ARF. Among
72 patients with ARF, Group 1 (n = 47) consisted of the patients
who had ARF at ICU admission. Group 2 (n = 25) consisted of the
patients who developed ARF during their ICU stay.
Results There was no difference in the demographic data and
APACHE II scores between the two groups (P > 0.05). The
mortality rate of the patients who had ARF at ICU admission was
72%. The patients who developed ARF in the ICU had a mortality
of 68%. The mean durations of the mechanical ventilation, ICU and
hospital stay of the patients in Group 1 and Group 2 were
9.04 ± 10.9 and 9.7 ± 9.04 days, 10.6 ± 13.3 and 12.3 ± 9.6 days,
and 20.5 ± 20.6 and 17.5 ± 11.8 days, respectively. There was no
significant difference in terms of the mortality rate, ICU and hospital
stay, hemodynamic and respiratory data between the two groups
(P > 0.05). The mean serum creatinine levels were 4.4 ± 2.3 vs
3.2 ± 0.7 mg/dl (P < 0.01), and the mean serum lactate levels were
2.17 ± 2.8 vs 0.94 ± 0.9 mmol/l (P < 0.01). Hemodialysis was
required in 37.5% of all patients with ARF. The most frequent
reason causing ARF was sepsis (61%).
Conclusion The mortality rate of our critically ill patients with ARF
was approximately 70%, which is comparable with the results of
the literature. There was no significant difference in terms of
mortality and morbidity between patients who had ARF at ICU
admission and those who developed ARF during their ICU stay.
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Introduction Acute renal failure (ARF) is a serious complication of
pregnancy. It is associated with an increased mortality.
Objective To determine risk factors and outcome of peripartum
ARF.
Design Demographic and obstetric management (transfusion,
cesarean section, hysterectomy, anesthetic complications, etc.)
data were collected and analysed. ARF was defined as creatinine
levels ≥ 100 µmol/l and/or oliguria <150 ml/8 hours or < 500 ml/day.
Generalistic scoring systems (APACHE II, APACHE III) and organ
dysfunction scoring systems were calculated at admission and on
a daily basis. Data were computed on SPSS 11.5 XP-Windows
compatible. Results were expressed as means ± standard
deviation. Statistical analysis was based on the chi-squared test
and Student t test corrected by the Fisher exact test.
Setting A multidisciplinary ICU.
Study period January 1996–December 2003.
Patients Obstetric patients (n = 541) admitted in the ICU.
Measurements and results The mean age was 31.2 ± 5.9 years,
mean term was 34.7 ± 4.5 weeks. The major part of our patients
were admitted after delivery. Obstetric complications accounted
for 70% of admissions. Pre-eclampsia, eclampsia and peripartum
haemorrage were the leading causes associated with ARF. Overall
mortality was 10.4% (n = 57). ARF was noticed in 68 patients,
with a mortality of 33.8% (n = 23). The relative risk (RR) of
mortality when patients developed ARF was 4.7 with an odds ratio
(OR) of 6.6. We distinguished two populations: ARF with (Dial+)
(n = 22) or without (Dial–) dialysis (n = 46); mortality was respec-
tively 10/22 and 13/46. Mean scores for patients with and without
ARF were respectively: 41.1 ± 20.9 and 21.6 ± 13.7 for SAPS II;
16 ± 8 and 7.5 ± 6 for APACHE II and 63.3 ± 31.6 and
24.4 ± 23.8 for APACHE III (P < 0.01 for all scores). Renal failure
was usually associated with at least another organ dysfunction as
demonstrated by mean SOFA at day 1 (9.3 ± 4.5) whereas without
ARF it was 3.7 ± 3 (P < 0.001). Dial+ and Dial– respectively
showed an OR concerning mortality of 8.37 and 4.04 and a
respective RR of 6.33 and 3.93 compared with patients without
ARF. Persistant oliguria was the major cause of dialysis. A cut-off
point of creatinine at 300 µmol/l is associated with a RR of
mortality of 3.5 compared with patients that developed ARF with
lower creatinine levels.
Univariate analysis found that uterine atonia, transfusion, multiple
pregnancy and vaginal delivery were significantly associated with
ARF, whereas cesarean section showed an OR = 0.455. Multiple
regression analysis retained only transfusion prior to ICU
hospitalization as significantly associated with ARF. Oliguria and
the level of renal failure are predicting factors of mortality.
Conclusion ARF is associated with high mortality (> 30%).
Aggressive treatment and prevention of renal failure is necessary to
improve prognosis.
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Introduction In patients with intra-abdominal hypertension (IAH),
decreased urinary output is an early sign of renal impairment. The
exact mechanisms remain unknown, but decreased perfusion
pressure, increased pressure on the venous outflow tract, and
increased tubular pressure are possible explanations. Because the
abdominal perfusion pressure (APP = MAP – IAP) does not take
the increased tubular pressure into account, the filtration gradient
(FG = glomerular filtration pressure – proximal tubular pressure =
MAP – 2 × IAP) has been proposed as a better reflection of renal
pressure gradients.
Objective The aim of this analysis was to study the correlation
between urinary output (UO) and APP or FG at the individual
patient level in patients with normal serum creatinine, and to
compare the correlations between FG and UO with APP and UO.
Methods We studied 27 surgical ICU patients at risk for IAH.
Causes of intra-abdominal hypertension included primary and
secondary IAH. Median age was 60 years (IQR 36–74 years),
median APACHE II score on admission 13 (IQR 10–19).
IAP was measured transvesically after instillation of 20 ml saline.
IAH was defined as a sustained IAP >12 mmHg, according to the
World Society of Abdominal Compartment Syndrome guidelines.
The APP, FG and UO (expressed as ml/kg/hour) were calculated
for each IAP measurement. For each individual patient, the
correlation coefficient between urinary output and APP or FG was
calculated. When serum creatinine levels were above 1.2 mg/dl or
when patients were anuric at the moment of IAP measurements,
observations were not taken into consideration for analysis of the
correlation between the parameters studied.
Results Four hundred and thirty-one paired datasets were
available for analysis. Mean IAP in all observations was
13 ± 5.2 mmHg, mean APP 73 ± 16.0 mmHg and mean FG
60 ± 18.7 mmHg. IAH was present in 40% of the observations.
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There was no significant correlation between APP and UO in
24/27 patients, and no significant correlation between FG and UO
in 23/27 patients. When the correlation was significant for both
parameters, FG correlated better with UO than APP in all patients.
Conclusion In this sample of critically ill patients with normal
serum creatinine and at risk for IAH, there was no correlation at the
individual patient level in the majority of the patients. The
correlation between FG and UO was better than between APP and
UO when there was a significant correlation.
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Background Supplementation with omega 3 fatty acids (n3PUFA)
exerts immune-modulating and organ-protective effects, even after
short-term infusion in both postoperative and critically ill patients
[1,2]. The aim of this study was to evaluate dose-dependent effects
of a fish oil (FO) emulsion on the clinical course of patients with
different diagnoses. Primary study endpoint was survival; secondary
endpoints were length of hospital stay and use of antibiotics.
Materials and methods After approval by the National Board for
Drug Safety (BfArM) and the Institutional Ethics Board we analyzed
a database containing 661 patients from 82 German hospitals who
received total parenteral nutrition (TPN) for at least 3 days. The
cohort was divided into five groups according to the administered
FO dose (Omegaven, Fresenius Kabi).
Results The patients of this survey were 62 ± 17 years old (SAPS
II 32 ± 14). Diagnoses and patient numbers are shown in Fig. 1. In
multivariate analysis the absolute dose of FO per kg/day had a
2–20 times higher impact on respective outcome parameters than
the ratio of n3/n6 PUFA, which is considered to be a major
determinant of beneficial n3 effects in the current literature. TPN
including FO had most favourable effects on survival, infection rates
and length of stay when administered in doses between 0.1 and
0.2 g/kg/day. Diagnosis-related optimum FO doses are given in Fig. 1.
Conclusion FO administration may reduce mortality, antibiotic use,
and length of hospital stay. Individual optimum FO doses and
effect sizes are diagnosis dependent.
Acknowledgements The authors thank R Koch and J Novotny for
biomathematical advice.
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Background and aim Short-term fasting, although a common
prescription perioperatively, has been found to result in metabolic
impairment and severe alterations in the morphology and function
of the gut. Probiotics have been reported to stimulate epithelial
proliferation in the colon and thus might promote restoration of gut
mucosa after starvation. The aim of the present study was to
investigate the effects of probiotics on improving recovery of
colonic mucosal atrophy (expressed by the mucosal DNA content)
after short-term fasting in rats.
Materials and methods Twenty-four male Wistar rats were fasted
for 3 days and then, for the next 3 days, were fed with standard rat
chow or rat chow plus probiotics (Synbiotic 2000Forte; Medifarm,
Sweden), or given parenteral liquids with or without probiotics
orally. Six more rats were normally fed with standard rat chow for
6 days, and served as controls. Synbiotic 2000Forte contains 1010
CFU of each of Pediococcus pentoseceus 5-33:3, Leuconostoc
mesenteroides 32-77:1, L. paracasei ssp paracasei 19 and L.
plantarum 2362, as well as 2.5 g inulin, oat bran, pectin and
resistant starch. At the end of the 3-day refeeding period the entire
colon was opened longitudinally, and the mucosa stripped out,
weighed and assayed for DNA contents (µg/g tissue).
Results Three days’ feeding with rat chow plus probiotics or
parenteral liquids in combination with per oral probiotics was found
to significantly (P = 0.05) increase DNA contents in relation to rat
chow or parenteral liquids, respectively. However, it is of interest to
mention that there is no difference between mucosal DNA
contents in rats treated parenteral liquids plus per oral probiotics
and rats fed rat chow without probiotics.
Table 1
Rat chow + Parenteral + No fasting 
Rat chow probiotics Parenteral probiotics (controls)
3.15 ± 0.98 3.79 ± 0.82 2.47 ± 0.36 3.11 ± 0.53 4.91 ± 0.91
Conclusion The results of the present study led us to conclude
that probiotics enhance the recovery of gut mucosa after short-
term starvation-induced atrophy in rats.
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Background and aim Early probiotics administration was
suggested to reduce the incidence of infections and thus the
overall morbidity and mortality in surgical patients. The aim of this
prospective randomized clinical trial was to assess the effects of a
combination formula of probiotics and prebiotics (Synbiotic
2000Forte; Medifarm, Sweden) versus prebiotics only (fiber) in
critically ill, long-term mechanically ventilated trauma patients.
Materials and methods Patients were randomized to either
treatment for a 2-week treatment period. Synbiotic 2000 Forte
consists of 1010 CFU of each of Pediococcus pentoseceus 5-
33:3, Leuconostoc mesenteroides 32-77:1, L. paracasei ssp
paracasei 19 and L. plantarum 2362, as well as 2.5 g inulin, oat
bran, pectin and resistant starch. Blood samples were collected on
days 0, 4, 7 and 15 for measurements of CRP, PCT, MDA, tumor
necrosis factor alpha, IL-6. Days under ventilatory support, days of
total stay in the ICU, gut motility, antibiotic-associated diarrheas,
infections, and septic morbidity as well as overall mortality were
also recorded.
Results Patients were well matched regarding age and sex
distribution, APACHE II and Glasgow scores. From day 7, all
patients of the Synbiotic group exhibited a progressive reduction of
all inflammatory indexes in relation to the prebiotics only group
(P = 0.05). Similarly, they had a significantly shorter ICU stay and
days on mechanical ventilation (P = 0.04), less episodes of
antibiotic-associated diarrheas and less distension and cramps
after enteral nutrition, in relation to the prebiotics group. The overall
infection rate was 34% versus 90%, respectively, while three
patients from the prebiotics group died after sepsis and MODS.
Conclusion The administration of the Synbiotic 2000 Forte
formula in critically ill ventilated trauma patients favorably altered
the systemic inflammatory response and seemed to be associated
with measurable clinical benefits.
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Introduction Nutritional support with diets containing
eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA) and
antioxidants can improve lung microvascular permeability, oxygena-
tion and cardiopulmonary function, by modulating proinflammatory
eicosanoid (leukotriene B4, prostaglandin E, thromboxane B2)
production from arachdonic acid [1]. This kind of enteral diet can
improve gas exchange and clinical outcomes in comparison with a
standard control diet in patients with ARDS [2]. The scope of this
study is to investigate whether an enteral diet enriched with EPA,
GLA and elevated antioxidants can improve outcomes and reduce
all-cause mortality in patients with sepsis.
Materials and methods This abstract reports the preliminary
results of a prospective, randomized, controlled trial. Thirty patients
with clinical diagnosis of either sepsis, severe sepsis or septic
shock, and under mechanical ventilation were included in this work
and randomized for a high-fat, low-carbohydrate enteral nutrition
formula or an enteral diet enriched with EPA, GLA and elevated
antioxidants (Oxepa; Abbott Laboratories), isocaloric and
isonitrogenous to the control diet, differing only in its lipid
composition and level of antioxidant vitamins. The patients received
the enteral formula during mechanical ventilation in association
with the sepsis standard of care [3]. Enteral feeding was delivered
at a constant rate to achieve a minimum of 50% of Basal Energy
Expenditure (BEE) (Harris–Benedict equation) × 1.3 within the first
24 hours and, if well tolerated, a minimum of 75% of BEE × 1.3
within 72 hours of initiation of enteral feeding, until the complete
weaning from ventilator. At the time of hospital discharge, the
patients’ charts were reviewed to assess a number of outcome
variables. The primary outcome is 28-day all-cause mortality. We
perform the statistical analysis of the two dietary groups using a
one-way analysis of variance.
Results Septic patients fed EPA, GLA and elevated antioxidants
maintained higher oxygenation status (P = 0.001), more ventilator-
free days (P = 0.001), more ICU-free days (P = 0.02) and lower
mortality rates (P = 0.03).
Conclusions This study suggests that an enteral diet containing
EPA, GLA and elevated antioxidants can contribute to better ICU
and hospital outcomes of septic patients. This can be through a
downregulation on the synthesis of proinflammatory mediators that
contributes to restoring homeostasis of the septic patients. The
beneficial effects of this diet suggest that this enteral nutrition
formula would be a useful adjuvant therapy in the clinical
management of sepsis.
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Background In critically ill patients glutamine (GLN) becomes an
essential amino acid. Several studies showed a relationship
between GLN depletion and the increased nosocomial infection in
ICU patients. There are a kinetics profile of lymphocyte activation
from early (CD69) to late (CD25 and HLA-DR) cell surface marker
expression that relates directly to the ability to mount an effective
immune response to infectious agents. The purpose of the present
study is to investigate the effects of glutamine-supplemented
parenteral nutrition on lymphocyte subpopulations and the kinetics
profile of lymphocyte expression markers of activation, and
correlate it with the infectious morbidity in critically ill patients.
Patients and methods We performed a blind randomised,
controlled study of GLN-enriched parenteral nutrition (GLN-PN).
Twenty-eight critically ill patients were randomly assigned to two
groups of nutrition therapies, as either Dipeptiven® (0.40 g/kg/day)
supplemented parenteral nutrition (glutamine group n = 16) or an
isocaloric and isonitrogenous standard parenteral nutrition
Critical Care    March 2005 Vol 9 Suppl 1 25th International Symposium on Intensive Care and Emergency Medicine
S153
(standard group n = 12). Blood samples were obtained for
lymphocyte subpopulations (NK, CD3, CD4, CD8, CD56, CD19,
CD25, CD69 and HLA-DR) at the beginning and at the fifth and
10th day after standard TPN. Flow cytometry analysis was
performed immediately. Nosocomial infections from entry to
discharge from the ICU were determined.
Results Baseline data (age, sex and severity score — APACHE II)
were similar in the standard and glutamine groups. GLN-PN-
treated patients had less nosocomial infections (14 vs 25
nosocomial infectious episodes). The CD4/CD8 ratio showed an
increase from day 1 to day 5 in the GLN group. Mean lymphocyte
expression activation marker CD69 and HLA-DR are slightly
increased at day 5 in the standard group, while the later expression
lymphocyte activation marker CD25 is increased in the GLN group
(Fig. 1). The mortality in the ICU is increased in the standard group
(25 vs 12.5%).
Conclusions We conclude that in critically ill patients GLN-PN can
reduce the incidence of infectious complications and mortality.
This pilot study showed that the GLN-PN supplement improved
not only lymphocyte activation, but also regulatory mechanisms of
lymphocyte proliferation, illustrated by increased lymphocyte
expression surface marker CD25, compared with CD69 and HLA-
DR. This effect can apparently decrease nosocomial infections and
mortality in ICU patients.
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Introduction Managing fecal incontinence and diarrhea challenges
ICU staff to control the fecal output and to protect the skin. This
diverts resources from other vital patient needs. A new medical
device system (FMS) was developed in which an inflated balloon
retains a tube within the rectum while an external pouch collects
fecal material, offering an option for temporary continence in
subjects with uncontrolled diarrhea.
Hypothesis Safety and performance of an innovative system
(FMS) for managing fecal incontinence was evaluated in a
prospective non-comparative study in two ICUs.
Methods Ten subjects with diarrhea and incontinence in two ICUs
had the FMS inserted. Endoscopic proctoscopies of the rectal
vault assessed the condition of the anorectal mucosa pre-insertion
and post-removal. Investigators assessed ease of FMS insertion
and removal, device retention and leakage, patient comfort,
perineal skin condition and presence or absence of odor during
FMS use.
Results The FMS device performed well during use for 1–13 days
with no safety issues among any of the 10 subjects, although two
died during the study due to non-product-related illnesses. It was
judged easy to insert and to remove with easy-to-follow
instructions. All subjects retained the device without difficulty or
external securing devices for the duration of the study, except one
with a weakened internal sphincter who expelled it after 8 hours.
During a total of 65 daily assessments, nurses reported the FMS
effective and time efficient in managing fecal incontinence, with no
odor or discomfort reported and limited leakage. During FMS use,
perineal and buttock skin condition was maintained or improved in
all but one patient who developed patchy redness on the buttocks.
Conclusions The FMS was well accepted, performed well, with no
safety issues, for all patients and helped reduce the risk of perineal
and buttock skin breakdown.
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S Lobo, L Contrin, L Navegantes, S Orrico, M Queiroz, P Cury,
E Lira, A Carta, A Yamamoto, S Portella, J Vincent
Famerp — Hospital de Base, Sao José do Rio Preto, Brazil
Critical Care 2005, 9(Suppl 1):P366 (DOI 10.1186/cc3429)
Introduction The intestinal tract plays a central role in the protein
catabolic response after injury and infection. Tyrosine (an index of
overall proteolysis) and lactate release were evaluated in luminal
gut perfusate during ligation of the superior mesenteric artery
(SMA). The aim of this study is to determine whether tyrosine flow
from the intracellular compartment to the lumen could occur during
ischemia-induced gut injury.
Methods Fourteen anesthetized New Zealand rabbits were
allocated into two groups (group I: control, n = 5 and group II:
ischemia, n = 9). SMA (QSMA) and aortic (Qaorta) flows were
measured using ultrasonic flow probes. A segment from the ileum
was isolated using two multilumen tubes with inflated balloons to
delimit a closed segment to be perfused. In a second gut segment,
a tonometric catheter (TRIP® Tonometry Catheter; Datex, Finland)
was placed. Animals in group II were submitted to ligation of SMA
after baseline measurements. The concentrations of lactate and
tyrosine were determined in serum and gut luminal perfusate
(GLP). Tyronise was assayed by the fluorometric method as
previously described [1].
Results Lactate concentration significantly increased in GLP after
ligation of SMA (from 0.15 ± 0.05 mEq/l to 3.5 ± 1.2 mEq/l at
2 hours) in comparison with the control (from 0.18 ± 0.43 mEq/l to
0.22 ± 0.12 mEq/l at 2 hours) (P < 0.05). Luminal tyrosine signifi-
cantly increased during ischemia compared with the control at
2 hours (from 11.9 ± 8.9 mM/ml to 84 ± 22 mM/ml, group II; and
from 6.9 ± 2.9 mM/ml to 15.3 ± 13.8 mM/ml, group I; P < 0.05).
Conclusion Ischemia rapidly induces gut-derived proteolysis in
rabbits.
Reference
1. Waalkes TP, Udenfriend S: A fluorometric method for the esti-
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The impact of gastrointestinal failure on intensive care unit
mortality
A Reintam1, P Parm1, U Redlich2, L Tooding3, J Starkopf3, 
C Spies4, H Kern2
1Tartu University Clinics, Tartu, Estonia; 2DRK Kliniken, Berlin,
Germany; 3Tartu University, Tartu, Estonia; 4Charite
Universitätsmedizin, Berlin, Germany
Critical Care 2005, 9(Suppl 1):P368 (DOI 10.1186/cc3431)
Objective To determine the incidence of gastrointestinal failure
(GIF) in the ICU and its impact on mortality.
Methods A retrospective study on adult patients (n = 2588)
admitted to three ICUs (two ICUs at Berlin Charité, Germany and
one ICU at Tartu University Hospital, Estonia) during the year 2002
was performed. GIF was defined as documented gastrointestinal
problems (including food intolerance, gastrointestinal haemorrhage
and ileus). The risk ratio (RR) and odds ratio (OR) were calculated
to evaluate GIF as a risk factor of death.
Results A total of 252 patients (9.7%) developed GIF during the
ICU stay. We showed that in patients who develop GIF the risk of
death increases remarkably. The most dramatic rise in risk of death
occurred in elective cardiosurgical patients in Berlin, with risk ratio
23.4 and OR 31.82. The risk of death rose also in surgical and
medical emergency patients (RR 5.5; OR 9.21 in Berlin and RR
3.2; OR 7.67 in Tartu).
By evaluating patients according to their maximum SOFA score,
we demonstrated that patients with GIF had lower survival rates
compared with nonGIF patients. The incidence of GIF significantly
raised the risk of death in patients with SOFAmax <12 (P < 0.001;
Table 1), while in patients with SOFAmax of 12 or more points
differences between the GIF and nonGIF cohorts were not
significant.
Table 1
GIF survival, NonGIF survival, OR (95% CI) 
SOFAmax n (%) n (%) for death P
< 7 28 (82.4) 1711 (99.2) 26.19 (9.49–72.97) < 0.001
8–11 54 (73.0) 404 (89.8) 3.25 (1.77–5.99) < 0.001
12–14 49 (66.2) 70 (70.0) 1.19 (0.20–2.27) 0.624
>15 11 (15.9) 10 (30.3) 0.44 (0.16–1.17) 0.118
Conclusions Development of GIF has an impact on ICU mortality.
Using GIF together with the SOFA score might be helpful for
estimating the risk of death in ICU patients. Further studies are
needed for establishing a proper definition of GIF.
P369
Incidence of gastrointestinal failure in intensive care unit
patients: retrospective and prospective study
A Reintam1, P Parm1, H Kern2, J Starkopf1
1Tartu University Clinics, Tartu, Estonia; 2DRK Kliniken, Berlin,
Germany
Critical Care 2005, 9(Suppl 1):P369 (DOI 10.1186/cc3432)
Objective To describe the incidence of gastrointestinal failure
(GIF) and ICU performance according to GIF in a comparison of
two studies.
Design A retrospective study of year 2002 and a prospective
study in 2004.
Patients A total of 468 adult patients of surgical and medical
emergency were admitted to the ICU of Tartu University Hospital in
2002 and 201 patients were admitted in 2004. Patients’ mean
APACHE II score at admission was 13.7 in 2002 and 16.4 in
2004, the mean SOFA score at admission was 6.8 and 6.7 points,
respectively. Sixteen percent of patients in 2002 and 19% in 2004
were transferred from other hospitals. A total 20.0% and 17.5%,
respectively, were reanimated before admission.
Measurements For 2002, data from patients’ charts were
retrospectively recorded in a computerized database. In 2004 an
existing database was used in a prospective manner. In both
studies GIF was defined as documented gastrointestinal problems
(including food intolerance, gastrointestinal haemorrhage and
ileus) in patient data. Comparative analysis was performed with the
chi-square test.
Results Incidence of GIF was 15.6% in the retrospective study
and 29.9% in the prospective study (P < 0.001). Patients with GIF
had significantly higher mortality, longer ICU stay (Table 1) and
longer mechanical ventilation period. Mortality of GIF patients was
67.1% in 2002 and 51.7% in 2004 (P = 0.051), while overall
mortality was 28.2% versus 24.4% (P = 0.343).
Table 1
GIF GIF NonGIF NonGIF 
alive dead alive dead
Number of patients (%)
2002 24 (32.9) 49 (67.1) 312 (79.0) 83 (21.0)
2004 29 (48.3) 31 (51.7) 123 (87.2) 18 (12.8)
ICU days, mean ± SEM
2002 15.0 ± 2.3 10.8 ± 1.6 4.4 ± 0.3 3.0 ± 0.7
2004 17.0 ± 3.9 8.9 ± 2.3 6.0 ± 0.6 0.8 ± 0.1
Conclusions Gastrointestinal failure is a relevant clinical problem
with high mortality, prolonged ICU stay and mechanical ventilation.
Without special attention, part of the GIF cases remain unnoticed.
Development of universal definition and further studies are
therefore needed.
P370
Effects of dobutamine on hepatic metabolism in paediatric
patients evaluated by LiMON®
C Cecchetti, C Tomasello
Hospital Bambino Gesu, Rome, Italy
Critical Care 2005, 9(Suppl 1):P370 (DOI 10.1186/cc3433)
Introduction Multiple organ dysfunction syndrome (MODS) is a
major therapeutic challenge for intensive care physicians treating
critically ill patients. The mortality rate in MODS still exceeds 50%
despite recent improvements in supportive treatment in the
intensive care unit. Abnormal perfusion of the liver can persist after
resuscitation in critically ill children, leading to hepatic dysfunction.
Since systemic haemodynamic measurements provide a poor
estimate of splancnic blood flow, specific tools are required to
assess the adequacy of tissue perfusion and oxygenation in
critically ill children. These tools have allowed detection of
splancnic hypoperfusion even in the absence of altered systemic
hemodynamics.
Aim To evaluate the effects of dobutamine on hepatosplacnic
perfusion and hepatocytic clearance in critically ill children.
Patients and methods After resuscitation involving volume
expansion with NaCl 0.9%, 14 haemodynamically stable patients
(median age: 9 years, median weight 28 kg, height 140 cm) were
given an infusion of 6 µg/kg/min dobutamine for 1 hour. Hepato-
cytic clearance was assessed with plasma disappearance rate of
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indocyanine green (PDR dye) elimination at basal time (B0) and
after 1 hour (B1). All measurements of PDR dye were made before
dobutamine infusion and 1 hour after dobutamine infusion. Analgo-
sedation was standard with remifentanyl (0.25 µg/kg/min)–
midazolam (0.03 mg/kg/hour) and all patients were in mechanical
ventilation with standard settings: pressure controlled with peak
inspiratory pressure < 20 cmH2O, mean airway pressure 10 cmH2O,
PEEP 5 cmH2O.
Results In all patients at baseline the PDR dye was: median
28.8% (range: 37–23.09%); PDR dye changed significantly after
dobutamine infusion: 35.9% (range: 28.1–49.8%), with an
increase in PDR dye of 22.14%. Haemodynamic values showed:
baseline PVC median value 5 (range 2–14), mean blood pressure
(MBP) 70 mmHg (range 47–84), HR 110 beats/min (range
78–150); after dobutamine infusion PVC median value 6 (range
4–15), MBP 84 mmHg (range 65–96), HR 121 beats/min (range
93–145)
Discussion We have used the indocyanine green (ICG)
elimination technique to asses hepatic perfusion. This approach
relies on the assumption that hepatic elimination of ICG is flow-
dependent. Variations in the plasma ICG disappearance rate
therefore directly reflect variations in hepatic blood flow. In
summary, our preliminary data show that dobutamine increases
hepatocytic clearance in critically ill children.
P371
Therapeutic application of the molecular adsorbent
recirculating system in chronic severe hepatitis patients
complicated with multiorgan failure
X Hu, Y Zhou, Y Zhao, M Liao, M He, M Wang
Department of Severe Liver Diseases, Guangzhou No 8 Hospital,
Guangzhou, China
Critical Care 2005, 9(Suppl 1):P371 (DOI 10.1186/cc3434)
Objective The aim of this study is to evaluate the therapeutic
effectiveness of the molecular adsorbent recirculating system
(MARS) in patients with chronic severe hepatitis complicated with
multiorgan failure.
Methods The present study randomized 82 patients of chronic
severe hepatitis complicated with multiorgan failure into a MARS
therapy group of 40 patients and the remaining 42 patients of the
control group, respectively. One hundred and ten sessions of
MARS treatments were performed with an average of 2.75
sessions per patient. All were evaluated clinically by the model for
end-stage liver diseases (MELD) and liver function, hemogram,
ammonia lever, coagulopathy, BUN and creatinine levels before
and after treatment.
Results MARS therapy resulted in remarkable improvement of the
prognosis assessment model of MELD (27.1 ± 2.81 to
19.5 ± 3.66, P < 0.01) and finally benefited the improved survival
in the MARS group (19/40, 47.5% vs 10/42, 23.8% of the control
group, P < 0.05), clinically presented in significant therapeutic
effectiveness in hepatic encephalopathy or brain edema, renal
dysfunction, obstinate ascites as well as reversal development of
systematic inflammatory response syndrome and improvement of
hemodynamic and respiratory function by selective elimination of
accumulated metabolic toxins and management of electrolyte, fluid
and acid–base balance with a safe record.
Conclusions MARS therapy can be applied safely as preferable
liver support for liver failure patients in therapeutic management for
complications and multiorgan failure.
P372
Control of intra-abdominal pressure in severe acute pancreatitis
with continuous hemodiafiltration using a polymethyl
methacrylate membrane hemofilter and colloid fluid therapy
K Matsuda, H Hirasawa, S Oda, H Shiga, M Nakamura, E Watanabe
Department of Emergency and Critical Care Medicine, Graduate
School of Medicine, Chiba University, Chiba, Japan
Critical Care 2005, 9(Suppl 1):P372 (DOI 10.1186/cc3435)
Aim It is generally accepted that vascular permeability is increased
by the pathologic effects of various humoral mediators, leading to
reduction of circulating blood volume and fluid collection in the
abdominal cavity, or intestinal edema in the early stage of severe
acute pancreatitis (SAP). The hyperpermeability-induced patho-
physiological conditions thus increase the intra-abdominal pressure
(IAP), and eventually cause intra-abdominal hypertension (IAH).
IAH causes organ dysfunctions such as respiratory failure,
circulatory failure, and renal failure, and such a condition is referred
to as abdominal compartment syndrome. If the causative humoral
mediators can be removed and the vascular permeability can be
normalized, the administration of oncotic agent can increase
colloid osmotic pressure (COP) and reduce IAP. We have claimed
that continuous hemodiafiltration using a polymethyl methacrylate
membrane hemofilter (PMMA-CHDF) can remove various humoral
mediators from the blood stream and that PMMA-CHDF and
colloid fluid administration can reduce interstitial edema. The
present study was undertaken to investigate the efficacy of PMMA-
CHDF and colloid fluid therapy for the control of IAP in SAP.
Patients and methods Fourteen patients with SAP who were
treated with PMMA-CHDF and colloid fluid therapy in the period
from May 2000 to December 2003 were included in this study.
IAP, COP and the blood level of IL-6 were measured for the initial
3 days. The correlations between the degree of the changes in IAP
(dIAP), COP (dCOP), IL-6 (dIL-6) and cumulative water balances
(CWB) for the initial 3 days were investigated.
Results There was significant and positive correlation between
IAP and the blood level of IL-6 before the treatment (r = –0.75,
P < 0.01). There was also significant and negative correlation
between the blood level of IL-6 and COP before the treatment
(r = 0.75, P < 0.01). The blood level of IL-6 significantly decreased
and COP significantly increased with 3 days of PMMA-CHDF and
colloid fluid therapy. IAP also decreased significantly and
380 ± 2350 ml water could be removed from the patients for the
initial 3 days. There were significant and negative correlations
between dCOP and dIL-6, and between dIAP and dCOP
(r = –0.65, r = –0.70, P < 0.05). On the contrary, there was no
significant correlation between dIAP and CWB.
Conclusions These results indicate that IAP significantly
correlates with the blood level of IL-6 and COP in patients with
SAP, and that PMMA-CHDF and colloid fluid therapy can
significantly decrease the blood level of IL-6, increase COP and
effectively reduce IAP. We thus conclude that PMMA-CHDF and
colloid fluid therapy can control IAP in patients with SAP, and that
it should be applied in the early stage of SAP.
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Impact of abdominal banding on splanchnic organ perfusion
P Suk, M Masek, M Fencl, V Sramek
St. Ann’s University Hospital, Brno, Czech Republic
Critical Care 2005, 9(Suppl 1):P373 (DOI 10.1186/cc3436)
Introduction Abdominal banding is still recommended by some
surgeons to prevent eventeration after abdominal surgery. We
Available online http://ccforum.com/supplements/9/S1
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assessed the impact of increased abdominal pressure (IAP)
caused by abdominal banding on perfusion of splanchnic organs,
ventilation and hemodynamics.
Methods The study protocol was approved by the local EC. Five
mechanically ventilated patients after major abdominal surgery
were studied. IAP, gastric tonometry (pCO2gap) with a tonometry
module (Datex Ohmeda, Finland), plasma disappearance of
indocyanine green (ICG-PDR) noninvasively with LiMON (Pulsion
Medical Systems, Germany), pulmonary compliance (C-dyn) with a
spirometry module (Datex Ohmeda, Finland), hemodynamics and
diuresis were recorded (T1). Then IAP was increased by 10 mmHg
with an abdominal belt and data measured after 60 min (T2). Then
the abdominal bandage was released and a control measurement
was done after 60 min (T3). Data are presented as median (range).
Friedman analysis of variance was used for statistical analysis and
P < 0.05 was considered significant.
Results IAP increased from 12 (3; 15) to 19 (10; 21) mmHg. After
release of banding, IAP decreased to 11 (4; 15) mmHg. PgCO2
increased from 1.61 (1.39; 1.93) kPa (T1) to 2.70 (2; 3.15) kPa
(T2) and stayed increased at 2.43 (1.25; 3.10) kPa (T3) (showed a
trend). ICG-PDR decreased from 19.1 (7.5; 39.3)%/min to 15.8
(7.7; 20.5)%/min (T2) and increased to 18.2 (6.0; 22.9)%/min
(T3) (not significant). C-dyn decreased from 67 (32; 80)
ml/cmH2O to 56 (26; 66) ml/cmH2O and slightly improved to 59
(32; 70) ml/cmH2O (showed a trend). HR, MAP, CVP, CO
(measured in three patients) and diuresis did not change.
Conclusion An increase in IAP caused by abdominal banding can
compromise splanchnic organ perfusion and respiratory function in
surgical patients.
Acknowledgement Supported by IGA of the Czech Ministry of
Health 7144-3.
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A comparison of the effect on gastric emptying of propofol or
dexmedetomidine in critically ill patients
D Memis, D Dokmeci, B Karamanlioglu, A Turan, M Ture
Anaesthesiology, Edirne, Turkey
Critical Care 2005, 9(Suppl 1):P374 (DOI 10.1186/cc3437)
Background Propofol and dexmedetomidine are widely used for
sedation in the ICU, but there are limited data on the effects on
gastric motility. In our study, we were to establish whether or not
the propofol and dexmedetomidine effect of gastric emptying is
preserved in critically ill patients
Method The study involved 24 critically ill, enterally fed adult
patients. Each patient received enteral feeding via a nasogastric tube
at 50 ml/hour throughout the 5-hour study period — either propofol
2 mg/kg/hour (n = 12, Group P) or dexmedetomidine 0.2 µg/kg/hour
(n = 12, Group D) intravenously over 5-hour infusion. Gastric motility
was measured indirectly by analysis of the absorption over time 1.5 g
paracetamol administered into the stomach at the start of the study
period. At the beginning and end of the study, the residual gastric
volume and pH were measured. The rate of gastric emptying is
proportional to the area under the line plot of serum paracetamol
concentration over 120 min (AUC120).
Results The gastric residual volume measured at the end of
propofol infusion (11.33 ± 4.84) was found to be higher when
compared with the volume measured before infusion
(19.33 ± 11.33) and after dexmedetomidine infusion (9.17 ± 4.54).
But, there was no difference between groups in the gastric
emptying time (AUC 120 894.53 ± 499.39 vs 1113.46 ± 598.09,
Group P and Group D, respectively).
Conclusion In patients with high gastric residual volume,
dexmedetomidine infusion can be the preferred sedative agent.
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Does diabetes mellitus affect the mortality and morbidity rates
after coronary artery bypass surgery?
Y Bicer, N Yapici, Y Altuntas, F Izgi, O Aydin, Z Aykac
Siyami Ersek Thoracic and Cardiovascular Surgery Center,
Istanbul, Turkey
Critical Care 2005, 9(Suppl 1):P375 (DOI 10.1186/cc3438)
Introduction Although diabetes mellitus (DM) is one of the major risk
factors of developing atherosclerosis, its effects on mortality and
morbidity after cardiac surgery are still not clear. We aimed to
determine the effects of DM on hospital mortality and morbidity rates.
Methods A total of 1245 consecutive patients undergoing
coronary artery operations with or without cardiopulmonary bypass
from September 2003 to July 2004 were followed to determine
risk factors on mortality and morbidity in patients with diabetes and
nondiabetes. The statistical analysis was realised by it test for
parametric variables and chi-square test for nonparametric
variables. P < 0.05 was considered statistically significant.
Results Twenty percent of all patients were diabetics. According
to demographic data and coexisting diseases, there were
significant differences between the diabetics and nondiabetics, in
sex (female), body mass index (obesity), carotid arterial disease,
hypertension, preoperative urea and creatinine levels (P < 0.001).
Although we found that the inotropic usage of the diabetics were
significantly higher (P < 0.005), there were no differences in
operation, bypass and cross-clamping time between the two
groups, In the ICU period, we could not find any difference in
intubation time, blood products usage, reoperation and ICU stay.
Duration of hospital stay was significantly longer in diabetics
(P < 0.01). Postoperative complications and mortality rates are
presented in Table 1.
Conclusion It was interesting to see that although there were no
differences in operative and postoperative data between the two
groups, factors that could affect the morbidity and the mortality
rate were significantly higher in diabetics. In our opinion this was
because diabetics unfortunately have more coexisting diseases
such as hypertension or renal insufficiency.
Table 1
Postoperative complications and mortality rates
Diabetics Nondiabetics 
Complication (%) (%) P value
Stroke 6 0.6 < 0.001
Renal problems 6.5 2.4 < 0.001
Total infection 7.7 5.1 0.1
Profound surgical site infection 1.2 1.8 0.5
Superficial surgical site infection 3.2 1.1 < 0.001
Mortality 4.8 2.1 < 0.01
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Hyperglycemia and mortality in high-risk surgical patients
A Tasiou, M Christodoulou, E Lykoudi, A Vlachou, N Maguina
Critical Care Department, Konstantopoulio General Hospital Agia
Olga, Athens, Greece
Critical Care 2005, 9(Suppl 1):P376 (DOI 10.1186/cc3439)
Introduction Hyperglycemia and insulin resistance are common in
critically ill patients, even if they have not previously had diabetes
mellitus. Maintenance of normoglycemia with insulin reduces
mortality and morbidity of critically ill patients.
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Study objective To investigate the relationship between hyper-
glycemia and intensive care mortality in a group of surgical critically
ill patients.
Methods We prospectively studied 21 patients (seven females, 14
males, aged 66 ± 14 years old) admitted to a general ICU after
high-risk non-cardiac surgery. The exclusion criteria were: known
prior diabetes mellitus requiring insulin therapy and hemodynamic
instability before or during surgery and during the first hour after
admission to the ICU. Demographic data, serum chemistries, type
of operation, length of ICU stay (LOS) and mortality were
recorded. APACHE II score, blood glucose levels (minimum and
maximum levels), PaO2/FiO2 ratio, heart rate and mean arterial
pressure were recorded upon admission to the ICU.
Results Non-survivors (n = 4) had higher minimum blood glucose
levels (217 ± 69 mg/dl vs 128 ± 46, P < 0.005) and higher maximum
blood glucose levels (270 ± 120 mg/dl vs 192 ± 61 mg/dl,
P < 0.05) compared with the survivors (n = 17). The ICU LOS
(17 ± 11 days vs 4 ± 3 days, P < 0.001) and days of mechanical
ventilation (17 ± 11 days vs 3 ± 3 days, P < 0.001) were longer for
non-survivors compared with survivors. The APACHE II score on
admission was higher for non-survivors than for survivors (22 ± 4
vs 15 ± 9, P < 0.05). Non-survivors (n = 4) had similar PaO2/FiO2
ratio levels (202 ± 172 mmHg vs 234 ± 99 mmHg in survivors,
P = non-significant). There was no statistically significant difference
in mean arterial pressure and heart rate.
Conclusion Elevated blood glucose levels during the first 24 hours
of the ICU stay are associated with a higher mortality rate in stable
surgical patients.
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Admission hyperglycemia increases mortality in burns
A Messaadi, K Bousselmi, T Lahouali, S Oueslati
Aziza Othmana Hospital, Tunis, Tunisia
Critical Care 2005, 9(Suppl 1):P377 (DOI 10.1186/cc3440)
Introduction Stress hyperglycemia is a common event in acute
critical illness. Hyperglycemia may contribute to morbidity and
mortality after burns. The purpose of this study was to assess the
incidence of admission hyperglycemia in burn patients and its
repercussion on mortality rates.
Patients and methods A survey of the medical records from
January 2000 to January 2004 identified 855 patients. Only
unknown diabetic patients with admission blood glucose levels
>1.4 g/l were considered. The group of hyperglycemia patients
(H+) was compared with a control patient group deemed to have
normal glucose level and the same epidemiological data (H–). Data
analysis was performed with EpiInfo software
Results Admission hyperglycemia was observed in 8.6% of
patients (74/855 admissions). Only 15 patients had the benefit of
insulin therapy. Epidemiological characteristics and gravity scores
where similar in the two groups, H+ and H–, as shown in Table 1.
The mortality rate in group H+ (46%), however, was significantly
higher than in group H– (28.4%), P = 0.04.
Table 1
H+ (n = 74) H– (n = 74) P
Age 43 ± 19 43 ± 20 0.9
Sex ratio 1.15/1 1.15/1
TBSA 39 ± 24 36 ± 25 0.24
ABSI 8 ± 2.6 7.8 ± 3 0.34
I BAUX 83 ± 27 81 ± 25 0.7
UBS 94 ± 70 82 ± 25 0.28
Conclusion Admission hyperglycemia was observed in 8.6% of
our patients. It is a bad prognosis factor in burn patients. Only an
aggressive insulin therapy allowing a strict control of blood glucose
level can reduce the mortality rate in this group.
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Intensive insulin therapy does not change the inflammatory
response in non-diabetic patients undergoing elective
coronary artery bypass grafting
C Hoedemaekers, P Pickkers, M Netea, M van Deuren, 
J van der Hoeven
University Hospital Nijmegen, The Netherlands
Critical Care 2005, 9(Suppl 1):P378 (DOI 10.1186/cc3441)
Introduction Strict control of plasma glucose in diabetic and non-
diabetic patients has been shown to improve outcome in several
clinical settings. A large randomized trial in critically ill patients
treated with intensive insulin therapy resulted in a 42% reduction in
mortality compared with conventional treatment. In patients with
acute myocardial infarction, maintenance of blood glucose levels
below 11.9 mmol/l has been shown to increase the success rate of
thrombolysis, to preserve myocardial function and to improve long-
term outcome. There is extensive evidence that glucose can
stimulate the production of proinflammatory cytokines such as
tumour necrosis factor (TNF) and IL-6, with no effect on the anti-
inflammatory cytokine IL-10. We hypothesized that strict glucose
regulation results in modulation of cytokine production, resulting in
a change in cytokine balance from a proinflammatory state to a
more balanced anti-inflammatory condition.
Methods We performed a randomized, controlled study in 20 non-
diabetic patients undergoing elective coronary bypass surgery.
Cardiopulmonary bypass increases proinflammatory and anti-
inflammatory cytokines and is associated with the development of
SIRS. After surgery patients were randomly assigned to intensive
insulin therapy (to maintain blood glucose between 4.4 and
6.1 mmol/l) or conventional insulin therapy (only instituted when
blood glucose exceeded 11.1 mmol/l). At 0, 1, 2, 4, 8, 12, 16, and
24 hours after admission to the intensive care unit, plasma samples
and samples from the tubes draining the mediastinal cavity were
drawn. In these samples levels of the proinflammatory cytokines
TNF and IL-6 and the anti-inflammatory cytokine IL-10 were
measured by ELISA.
Results Both patient groups were comparable with respect to
demographics, clinical characteristics and operative data. In the
intensive treatment group glucose levels were significantly lower
compared with the conventionally treated group. The cumulative
insulin dose was significantly higher in the intensive therapy group.
No differences were found in levels of TNF, IL-6 and IL-10 in
plasma samples or in fluid draining the mediastinal cavity between
both groups. Levels of IL-6 and IL-10 were significantly higher in
mediastinal fluid samples compared with plasma samples,
suggesting a compartmentalized production of cytokines. No
differences in TNF levels between plasma and mediastinal fluids
were found.
Conclusions The protective effect of intensive insulin therapy in
critically ill patients is not related to a change in cytokine balance
from a proinflammatory to an anti-inflammatory pattern. Systemic





Blood glucose control during cardiac surgery: an evaluation of
a fixed versus a variable insulin regime
A Vohra, A Chan, N Odom
Manchester Royal Infirmary, Manchester, UK
Critical Care 2005, 9(Suppl 1):P379 (DOI 10.1186/cc3442)
Introduction Intensive insulin therapy (blood glucose < 6.1 mmol/l)
may reduce mortality after cardiac surgery (by 42%) [1]. An
effective regime would keep blood glucose < 6 mmol/l for 80% of
the time; < 8 for 90% of the time and <12 for 99% of the time, and
no hypos (< 3.0).
Method Ninety elective heart surgery patients were recruited, and
randomly allocated a ‘Fixed’ regimen (F) (Table 1) or a ‘Variable’
regimen (V) (Table 2) (n = 45). Blood sugars were recorded 1–2
hourly postoperatively for 48 hours. In each patient the mean and
standard deviation were calculated. Episodes of hypoglycaemia
(< 3 mmol/l), and mild (6.1–8.0), moderate (8.1–12) or severe
(>12) hyperglycaemia were identified.
Table 1 (abstract P379)
Blood sugar (mmol/l) Infusion rate (IU/hour) Additional bolus (units)





Results and conclusion The variable better controlled blood
glucose (V = 6.5 ± 0.74; F = 7.0 ± 0.90) (P = 0.004) especially in
patients with a high BMI (> 25) (Fig. 1). There were more hypos in
F (n = 4) than V (n = 1). Glucose < 6 mmol/l was found for 33% of
the time in F, 48% in V; < 8 mmol/l for 75% in F and 82% in V;
<12 mmol/l for 99% in F and 99% in V.
Reference
1. Van den Berghe G, et al.: Intensive insulin therapy in the criti-
cally ill patients. N Engl J Med 2001, 345:1359-1367.
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Accuracy of blood glucose measurements in the intensive
care unit
F Staric, U Kovacic, B Ozek, R Kaps
General Hospital Novo Mesto, Slovenia
Critical Care 2005, 9(Suppl 1):P380 (DOI 10.1186/cc3443)
Introduction Strict glucose control in critically ill patients may
improve survival. According to the Van den Berghe protocol
frequent glucose measurements are needed. In the original
protocol, however, measurements are made by a blood gas
analyzer that is not accessible to our unit. Measurements in the
core chemistry laboratory are time and staff consuming and
unpractical because of a time delay of about half an hour.
According to some other protocols, bedside glucometry is a
proposed solution, which is easily accessible and not time
consuming. In our preliminary phase of adopting the afore-
mentioned protocol we observed some clinically suspected cases
of hypoglycemia, which were not confirmed by the bedside
glucometry. However, glucose measurements in the core
laboratory confirmed our suspicion. The question arouse whether
bedside glucose measurements are accurate enough to be
performed in so strict a protocol as that of Van der Berghe.
Methods The blood samples were obtained by arterial line.
Capilary blood was taken simultaneously. Analysis was performed
by the core chemistry laboratory in arterial plasma as the gold
standard (GS). Arterial whole blood and capillary blood samples
were analysed by four bedside glocometers: Accu-Chek Active
(ACA), Accu-Check Inform (ACI), HemoCue (HC) and Gluco
Touch (GT). Results were compared with the GS and presented
as the correlation coefficient. Data were expressed as the percent
of difference to GS and the precision for each glucometer was
expressed as the percent of data in the range of ± 10%. The
proportion of overestimated values was calculated for each group
and the difference between the groups was evaluated by chi-
square test. The average percent of difference to GS for all
overestimated values for each group was calculated and
expressed as the mean ± SD. The difference between the groups
was tested by analysis of variance.
Results One hundred and forty series of measurements were
performed from blood samples of four male and four female
critically ill patients. The correlation coefficients and the precision
as already defined for each group (a — arterial, c — capillary) were:
ACAa — 0.91 and 53%; ACIa — 0.96 and 93%; HCa — 0.91 and
44%; GTa — 0.93 and 13%; ACAc — 0.91 and 2%; ACIc — 0.94
and 91%; HCc — 0.91 and 42%; GTc — 0.85 and 25%. The
proportion of overestimated values for ACAa, ACIa and HCa were
27%, 30% and 23%, respectively, and this was significantly less
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Blood sugar (mmol/l) Start rate (IU/hour) Sugar falling > 2/hour Sugar fall 0.5–2/hour Sugar stable Sugar rising > 0.5/hour
> 9.1 4 No change No change Increase by 50% Double rate
6.6–9.0 2 Decrease by 30% No change Increase by 50% Increase by 50%
5.1–6.5 1 Decrease by 50% Decrease by 30% No change Increase by 50%
3.0–5.0 0 Decrease by 80% Decrease by 50% Decrease by 30% No change
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than in the GTa group (98%, P < 0.05). The average percent of
difference to the GS of all overestimated values in groups ACAa
and GTa were 16 ± 15% and 30 ± 20%, which is significantly
greater than in groups HCa and ACIa (4 ± 3% for both; P < 0.05).
Conclusion In the settings where measurements by blood gas
analyzers are not possible and core chemistry laboratory data have
an unacceptable time delay, AccuCheck Inform measurements are
accurate enough to be performed in strict protocols. HemoCue
seems also to be acceptable because of its low probability of
overestimating the glucose level. The other two analyzers proved to
be inaccurate. The best way to obtain a blood samples is an
arterial line; however, one should be aware of physiologic and
analytic reasons for discrepancy between results from plasma and
whole blood samples. Capillary blood sampling is inaccurate,
especially in circumstances such as septic shock.
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Introduction Intensive insulin therapy has been shown to improve
outcomes in critically ill patients [1]. We evaluated a protocol
aimed at achieving a blood glucose concentration of 4–6 mmol/l
[2] in patients in an adult cardiothoracic intensive care unit.
Methods Records of 552 consecutive patient admissions over a
6-month period were reviewed and compared with 523 patients
admitted over a similar time prior to introduction of the protocol.
Results Age (median 64 years), sex and APACHE II scores
(median 12) and reasons for admission were not significantly
different between the groups. Use of intravenous insulin infusions
increased from 57% to 87% of patients (P < 0.01) and median
insulin infusion rate increased from 0.4 to 1.6 units/hour
(P < 0.01). The mean glucose concentration decreased from 8.3
to 7.2 mmol/l (P < 0.01) and the hyperglycaemic index [3] decreased
from 2.2 to 1.1 mmol/l.
Intensive care length of stay decreased from 1.8 to 1.0 days
(median, P < 0.01). Intensive care mortality was not significantly
different (4.2% [post] vs 5.2% [pre], P > 0.05). There were no
significant differences in requirements for blood transfusion, use of
inotropes, haemofiltration or the number of patients with bilirubin
concentration > 32 µmol/l. The area under the curve for C-reactive
protein concentrations corrected for length of stay was significantly
lower in the intensive insulin protocol group (89.6 vs 62.0 mg/l,
median, P < 0.01).
Conclusion The mean glucose concentration was not in the target
range despite a significant increase in insulin administration. In this
observational study the use of an intensive insulin protocol was
associated with decreased C-reactive protein concentrations and
shorter intensive care unit length of stay. Tighter control of glucose
concentrations may be necessary to achieve other previously
described benefits of intensive insulin therapy [4].
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Background Intensive insulin therapy to keep glycaemia at
80–110 mg/dl reduced mortality and morbidity in a surgical ICU. It
is not known whether these findings are applicable to a medical
ICU. Continuous glucose monitoring (CGM) might improve adjust-
ment of insulin therapy.
Aims To assess whether insulin regimens (subcutaneous [s.c.] vs
intavenous [i.v.]), based on discontinuous glucose monitoring, are
adequate in achieving euglycaemia in a medical ICU. Secondary
outcome measures were the influence of glycaemia on
inflammatory, renal, and metabolic parameters.
Methods So far, 28 patients (male/female: 16/12, mean age
64 ± 16 years, non-diabetic/type 2 DM/type 1 DM: 16/9/3, i.v. vs
s.c. insulin: 13/15; median APACHE II score: 20, range 12–32,
SOFA score 6 [2–15]; 10 septic shock patients) were recruited in
a single-center, prospective, observational study. Forty-eight-hour
CGM was initiated within 3 days after admission at ICU, using a
subcutaneous glucose sensor (GlucoDay®; Menarini Diagnostics)
and compared with arterial blood glucose samples.
Results During 48-hour continuous monitoring, glycaemia was
>140 mg/dl in 37 ± 28% of the time, and < 60 mg/dl in 5 ± 10%
of the time. Target glycaemia (80–110 mg/dl) was reached in only
25 ± 16% of the time. The mean insulin dose per day was 72 units
(range 0–276). Patients on s.c. insulin spent more time at
glycaemia >110 mg/dl (70 ± 27% vs 47 ± 16% on i.v. insulin,
P = 0.016), but similar time at glycaemia < 60 mg/dl. Patients with
septic shock had higher insulin needs (119 ± 90 vs 46 ± 55 units/day,
P = 0.013), and tended to spend less time at glycaemia
>110 mg/dl (47 ± 22 vs 66 ± 25%, P = 0.062). Diabetic patients
spent more time at hyperglycaemia (%time >140 mg/dl: 51 ± 27
vs 26 ± 24%, P = 0.019). Patients who died at ICU had a higher
SOFA score (9 ± 4 vs 6 ± 3, P = 0.027), a higher lactate
(P = 0.003), a higher ferritin (P = 0.043), a lower total protein
concentration (P = 0.023), but similar glycaemic profiles (% time
> 200, >140, >110, < 80 and < 60 mg/dl) and insulin dose.
Presence of diabetes, insulin regimen and dose did not influence
mortality. Glycaemia correlated with leucocyte count (r = 0.37,
P = 0.05), total protein concentration (r = 0.37, P = 0.049), but not
with renal and liver parameters. CGM detected peaks (e.g. when
starting total parenteral nutrition) and dales of glycaemia much
earlier than discontinous monitoring. CGM data correlated with
arterial blood glucose. There were no adverse events with the use
of the GlucoDay®.
Conclusions The GlucoDay® system, a good method to monitor
glucose excursions in ICU patients, was well tolerated. Continuous
glucose monitoring is mandatory for optimal titration of insulin
therapy in the ICU, as target glycaemia (80–110 mg/dl) was only
reached in 25% of the time. An i.v. insulin therapy is better than a




Insulin sensitivity and hepatic glucose production in sepsis
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Introduction We designed our pilot study to determine to what
extent insulin influences carbohydrate metabolism and the
associated thermogenesis in septic patients.
Methods Five septic patients complying with the inclusion criteria
(clinical, laboratory and haemodynamical signs of sepsis having
positive blood cultures) underwent the study procedure. Illness
severity was assessed using the APACHE II scoring system.
Exclusion criteria were hemodynamic instability treated by
administration of catecholamines and cortisol, changes in pH and
lactate level, hemodialysis or CVVHD.
The glucose rate of appearance (RA) was determined using the
stable isotope technique [6,6-2H2]-glucose, and tracer/tracee
ratio was measured by gas chromatography–mass spectrometry
(GCMS). A priming dose followed by a constant infusion of stable
isotope was used to maintain stable plasma enrichment. Basal
plasma glucose enrichment was measured after 3 hours of the
baseline period. Two step insulin clamps each with 120-min
duration were performed using a primed continuous regular insulin
infusion. This provided a steady-state infusion rate of
250 IU/min/m2 for the first step, and a five times higher infusion
rate for the second step. Arterial blood glucose concentration was
maintained at 5 mmol/l. There were taken seven blood samples at
5-min intervals for assessment of the average glucose enrichment
before the end of each clamp. A continuous recording of the
indirect calorimetry was performed using a Deltatrac II throughout
the baseline period of 60 min and for all steady-state periods of
clamps (last 40 min of each clamp step).
Results Statistical analysis was not performed due to the low
number of patients. Results are expressed as mean ± standard
deviation at basal conditions versus steady state of each clamp.
Total glucose disposal (mg/kg/min): was not calculated vs
2.57 ± 1.05 vs 4.25 ± 1.98, hepatic glucose production
(mg/kg/min): 2.48 ± 0.69 vs 0.31 ± 0.53 vs 0.66 ± 0.47, energy
expenditure (kJ/min): 8.23 ± 0.95 vs 8.52 ± 0.96 vs 8.99 ± 0.98,
glucose oxidation (mg/kg/min): was not calculated vs 1.08 ± 0.94
vs 2.69 ± 1.45.
These preliminary data show that basal gluconeogenesis
decreases in septic patients (in comparison with healthy people —
literature). Further decrease of hepatic glucose production is
present during both clamps, but it is not completely diminished in
spite of hyperinsulinaemia.
Conclusion Hyperinsulinaemia in septic patients does not
completely suppress hepatic glucose production, and glucose
remains the main energy substrate in sepsis.
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Insulin resistance and hyperglycemia are common in critical illness.
We recently demonstrated that strict maintenance of
normoglycemia with intensive insulin therapy during intensive care
reduced morbidity and mortality of surgical ICU patients [1]. Little
is known, however, about insulin signaling in critical illness. There
are two main insulin signaling pathways: the metabolic IRS-
phosphatidylinositol-3-kinase (PI3K) pathway, which is impaired in
type 2 diabetes, and the mitogenic MAPK pathway. The aim of the
present study is to examine the effect of intensive insulin therapy
on insulin signaling.
A random selection of 36 non-survivors, who had been randomized
to intensive (normoglycemic) or conventional (hyperglycemic)
insulin therapy, was comparable for age and severity, duration and
type of critical illness. The mean blood glucose levels were
5.6 ± 0.4 and 9.9 ± 0.9 mmol/l (P < 0.001) on a median daily
insulin dose of 44.2 and 14.4 IU (P = 0.005), respectively. Snap-
frozen postmortem liver and skeletal muscle biopsies were
homogenized and protein levels of signaling molecules were
quantified with immunoprecipitation (IRS1 + PI3K and SHC +
Grb2), western blotting (phosphorylated Akt) and ELISA
(phosphorylated p42/44MAPK).
In the muscle and liver, intensive insulin therapy significantly
stimulated the association of IRS with the p85 subunit of PI3K as
compared with conventional therapy. The phosphorylation of the
downstream signaling molecule Akt was increased in the muscle
but not in the liver. To study the effect of intensive insulin therapy
on the MAPK pathway, we measured the association of SHC with
Grb2 and the phosphorylation of the downstream activator p42/44
MAPK. The two therapy groups did not differ in the amount of
associated SHC-Grb2, in neither the muscle nor the liver. There
was also no detectable difference in phosphorylated p42/44
MAPK levels.
In conclusion, metabolic insulin resistance in the critically ill, as
revealed by an impaired PI3K pathway, can be overcome with
intensive insulin therapy in skeletal muscle but not in the liver.
Interestingly, liver insulin resistance is associated with an impaired
activation of Akt, but not its upstream regulator PI3K. The MAPK
pathway is not activated by intensive insulin therapy. Whether
unresponsiveness of the mitogenic signal transduction is due to
maximal stimulation of this pathway via other signals during critical
illness is being explored.
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tolerance in acutely ill severe patients evaluated by means of
bedside-type artificial pancreas
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Purpose To verify the importance of the role of blood glucose
(BG)-related factors to glucose tolerance in acutely ill severe
patients with glucose intolerance.
Materials and methods Thirty-four patients in whom BG levels
were controlled by means of a bedside-type artificial pancreas
(STG-22; NIKKISO Corporation, Japan) were investigated. The
target of BG control by STG-22 was set to 150 mg/dl. Glucose
tolerance was evaluated by the following five parameters: M value
(mg/kg/min), glucose disposal rate measured by the glucose
clamp method (GC) using STG-22; M/I value (ml mg/kg/min/mU),
M value divided by the blood insulin level (I), which indicates insulin
sensitivity; daily mean BG level (BGm) (mg/dl); I/E ratio, the
amount of administered insulin from STG-22 divided by
administered energy (glucose) (mU/kcal); and insulin clearance
(IC) (ml/kg/min), measured by GC with a two-step insulin infusion
rate (IIR). GC was performed with a clamped BG level of 80 mg/dl
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and IIR of 1.12 and 3.36 mU/kg/min. M1, M3 and I1, I3 indicate
the M value and I value when IIR is 1.12 and 3.36, respectively
(normal value of M1: 5–10). the first measurement of GC was
performed in acute conditions for all the patients, and the second
measurement was done 1 week after the first measurement for 20
patients. Organ dysfunction and endogenous insulin production
were evaluated by SOFA score and blood C-peptide reactivity
(CPR), respectively. Nutritional support for all the patients was
performed with total parenteral nutrition. Patients were classified in
four groups (A, B, C and D) according to M1 and BGm. Patients
with decreased M value (M1 < 5) were subdivided into two groups
(A [n = 23], increased BGm, 165 < BGm; B [n = 11], BGm
<165). Patients with normal M value (5 < M1) were subdivided
into two groups (C [n = 14], BGm <165; D, 165 < BGm).
Results (1) The BGm and I/E ratio in group A versus group B were
184 ± 15 vs 150 ± 15 and 51 ± 22 vs 24 ± 18 (P < 0.005),
respectively. However, there was no significant difference between
group A and group B in the amount of administered glucose,
SOFA score, M value (M1, M3), M/I value (M1/I1, M3/I3), IC, and
CPR. (2) The BGm and I/E ratio in group C versus group D were
142 ± 19 vs 172 ± 12 and 13 ± 11 vs 50 ± 46 (P < 0.01),
respectively. However, there was no significant differences
between group C and group D in the amount of administered
glucose, SOFA score, M value (M1, M3), M/I value (M1/I1, M3/I3),
IC, and CPR.
Interpretation There was discrepancy between the M value and
BGm, I/E ratio in group B and group D. The M value was measured
under a BG level of 80 mg/dl, while the target of the BG control
was set to 150 mg/dl. Therefore, the influence of BG-related
factors (BG itself or some factors closely related to BG — ex.
function of glucose transporter-2) to glucose tolerance was
considered in both group B and group D (increased [decreased]
glucose metabolism by those factors in group B [group D]).
Conclusions BG-related factors seem to have a significant role for
glucose tolerance. The artificial pancreas, STG-22, was
considered to be useful not only for BG control, but also for further
understanding and evaluation of complicated glucose metabolism
in acute severely ill patients.
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Introduction Numerous guidelines have been developed and
tested to implement tight glycaemic control in intensive care units.
However, most of these guidelines still require user interventions
and/or intuitive decisions of intensive care unit staff and do not
allow the establishment of an automated glycaemic control system.
To develop Closed Loop Insulin Infusion for Critically Ill Patients
(CLINICIP), the objective of the present study was to perform a
randomised controlled trial testing a fully automated algorithm for
the establishment of tight glycaemic control in critically ill patients
and to compare the results with routine treatment of glycaemia.
Methods In a randomized controlled fashion, 20 patients were
included into the trial. Patients were investigated after cardiac
surgery and for a period of up to 48 hours. Ten patients were
treated according to routine care of glycaemia (change of insulin
infusion rate according to actual glucose concentration in 1–4
hourly intervals) or using the fully automated model predictive
control (MPC) algorithm as implemented on a laptop computer
with hourly adjustment of the insulin infusion rate according to
information from blood glucose measurements and under
consideration of enteral and parenteral carbohydrate infusions. The
glucose target range for both treatments was defined between 80
and 110 mg/dl. In all patients, hourly arterial blood gas analysis
was performed and intravenous insulin regimen was adjusted
according to general routine care or MPC algorithm, respectively.
Analysis according to the last value carried forward was applied as
not all patients could be investigated for a period of 48 hours.
Results Glucose concentrations, after start of glycaemic
treatment, were comparable between both groups (routine care:
136 ± 35 mg/dl; MPC: 147 ± 32 mg/dl; mean ± standard
deviation [SD], not significant). No hypoglycaemic event (blood
glucose < 54 mg/dl) occurred in either group of the patients and
none of the experiments in the MPC group had to be terminated
because of a malfunction of the algorithm. During routine care
treatment an average blood glucose concentration of 145 ± 31 mg/dl
(mean ± SD) was measured. Average glucose concentration were
clearly lower in the MPC group with 109 ± 25 mg/dl (mean ± SD).
Confirming this result, 9.8% of the glucose measurements as
obtained using routine care compared with 51.6% of the glucose
concentrations as obtained using MPC treatment were within the
glycaemic target range.
Discussion These findings suggest that the software algorithm
MPC allows save implementation of tight glycaemic control in
postcardiac surgery critically ill patients.
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Introduction The implementation of intensive insulin therapy in the
critically ill has recently been shown to improve morbidity and
mortality [1,2].
Patients and methods We have performed a prospective
observational study to assess the effects, on all patients, of the first
6 months of an intensive insulin therapy protocol. We have studied
91 patients staying in critical care > 48 hours. This extended to
1233 patient-days and 7987 individual sugar estimations. For
intensive insulin therapy blood sugars were maintained between 4
and 7 mmol/l.
Results Fifty-two patients received intensive insulin therapy during
their admission, 39 did not. The demographics of the two groups
were well matched. The impact of the institution of the protocol
was assessed in two 3-month blocks. The mean blood glucose in
the intensive insulin therapy group was significantly lower than the
conventional therapy group (P < 0.0001, unpaired t test).
Glycaemic control failed to improve in the second 3 months in the
intensive therapy group (Table 1). There was a significant reduction
in blood sugars in the second 3 months for conventional control
(Table 1).
Conclusions Intensive insulin therapy resulted in sugar control
comparable with that published previously [2]. Sugar control in the
conventional group improved over the study period. This may be
due to the increased awareness of the importance of sugar control.
Use of intensive insulin therapy may lead to better sugar control
and improved morbidity and mortality in all patients, regardless of




Number of sugars Mean (SD) (mmol/l)
Intensive control
First 3 months 1300 6.7 (2.4)*
Second 3 months 2133 6.7 (2.2)*
Conventional control
First 3 months 1545 7.9 (3.0)**
Second 3 months 1936 7.2 (1.95)**
*P = 0.48, ** P = 0.0001.
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Introduction Hyperglycemia is common in critically ill patients.
Tight glycemic control (aimed at blood glucose levels of 4.4–6.1
mmol/l) improved the mortality and morbidity in postoperative
intensive care patients [1]. Tight glycemic control, however, bares
the risk of hypoglycemia. The present study was performed to
investigate whether the introduction of a nurse-driven tight
glycemic control protocol in two general ICUs increases the
incidence of (severe) hypoglycemia.
Methods All measured plasma glucose levels in all patients
admitted to a 28-bed academic ICU and to a 10-bed ICU of an
affiliated teaching hospital from 1999 to 2003 were retrospectively
collected from the hospital information systems. Severe hypo-
glycemia was defined as blood glucose levels < 2.2 mmol/l, and
hypoglycemia as blood glucose levels < 4.4 mmol/l. Comparisons
were made between the period before (1999–2001) and after
(2002–2003) implementation of tight glycemic control. Directly
after analysis of the aforementioned study results, an adjusted tight
glucose protocol was implemented in daily ICU practice at the end
of 2001.
Statistics Data are means ± standard deviation. Comparisons
between years were made by chi-square test. Statistical
significance was accepted for P < 0.05.
Table 1 (abstract P388)
Mean blood glucose values (mmol/l) and percentage of patients
developing (severe) hypoglycemia
Hospital 1999 2000 2001 2002 2003
Mean blood glucose
AMC 9.2 ± 3.2 9.0 ± 3.2 8.8 ± 3.0 7.8 ± 2.5* 7.4 ± 2.5*
GH 9.0 ± 3.6 9.2 ± 5.4 9.2 ± 4.8 8.8 ± 4.1* 8.5 ± 3.5*
% of patients with glucose < 2.2 mmol/l
AMC 0.6 2.1 1.9 3.6* 5.1*
GH 1.4 1.0 0.7 1.6* 2.2*
% of patients with glucose < 4.4 mmol/l
AMC 13.4 13.1 15.8 30.0* 38.8*
GH 12.4 12.0 11.4 17.3* 17.1*
* P < 0.05 compared with the period before tight glycemic control.
Results For all years, > 99% of data were retrieved in both
centres. In the AMC approximately 220,000 blood glucose levels
were collected (1999–2002: 3869 patients, 2002–2003: 2613
patients); in the GH approximately 35,000 blood glucose levels
were collected (1999–2001: 1639 patients, 2002–2003: 1098
patients).
Conclusions Tight glycemic control dramatically raises the
incidence of hypoglycemia. In parallel the incidence of severe
hypoglycemia also increases. Better glucose control regimens are
therefore needed to reduce the incidence of hypoglycemia during
tight glycemic control.
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Tight glycemic control in critically ill patients has been shown to
reduce ICU and hospital morbidity and mortality [1]. Adjunctive low
dose hydrocortisone (HC) therapy in septic shock (200–300
mg/day) might impair tight glycemic control. The degree of
metabolic impairment is possibly influenced by the way of HC
administration. However, recent Surviving Sepsis Campaign
guidelines do not favour either continuous HC administration
(cHC) or bolus HC administration (bHC) (4 × 50 mg or 3 × 100 mg)
[2]. The purpose of this observational study was to investigate the
effects of bHC on blood glucose (Glc) levels in patients with
septic shock. The protocol was approved by the local ethics
committee. Sixteen patients receiving cHC (200 mg/day) were
included. The course of Glc after discontinuing cHC followed by
administration of a bolus of 50 mg HC was investigated. Glc
values were recorded from charts 12 hours prior to bHC
application, straight before bolus application (baseline), and hourly
during a 6-hour period. Afterwards, cHC was resumed and Glc
measured three times 4 hours apart. Insulin dosage was not
adjusted as long as Glc remained <180 mg/dl. Nutritional support
was not changed during study period. Mean Glc calculated from all
values 12 hours prior to baseline was 131 mg/dl (mean, 95%
confidence interval: 121, 142). At baseline, Glc was 128 mg/dl
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(114, 141). Glc increased significantly from baseline until 6 hours
(P < 0.01, analysis of variance) with peak levels of 154 mg/dl
(132, 178) after 5 hours (P < 0.05 compared with baseline), and
returned to baseline values after 14 hours. The presented data
indicate that a bolus of 50 mg HC significantly aggravates
impairment of glucose homeostasis. It is conceivable that repetitive
HC application three or four times per day would make adequate
insulin therapy and glucose monitoring much more time consuming
and difficult. In conclusion, although a comparative study on
outcome between cHC and bHC does not exist, it seems prudent
to administer HC as a continuous infusion in septic shock patients
in order to maintain normoglycemia in these patients as tight as
possible.
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An appropriate activation of the hypothalamic–pituitary–adrenal
axis and cortisol response to critical illness is essential for survival.
Indeed, both high and low cortisol levels are associated with
increased mortality. We investigated the effect of intensive insulin
therapy (IIT), a treatment recently shown to reduce mortality and
morbidity of surgical ICU patients [1], on the cortisol response
versus conventional insulin therapy (CIT).
All patients included in the large randomized trial [1] who were
dependent on intensive care for more than 5 days (n = 451) were
selected for this study. Serum levels of total cortisol and cortisol-
binding globulin (CBG) were measured upon ICU admission, day
5, day 15 and the last day of intensive care. Free cortisol levels
were calculated from these data. Baseline characteristics were
similar for both patient groups. The two levels of blood glucose
control were well maintained throughout the study.
Total cortisol, CBG and free cortisol levels were comparable in
both groups on admission to the ICU. On day 5, day 15 and the
last day, IIT significantly lowered total cortisol levels. CBG levels
were similar except for slightly lower levels in the IIT group on the
last day. IIT thus significantly decreased free cortisol on day 5 and
day 15. Multivariate logistic regression analysis revealed that
reducing cortisol at least in part explained the survival benefit of IIT
[1]. Total and free cortisol levels were several-fold higher in
critically ill patients receiving exogenous hydrocortisone in so-
called ‘replacement dose’ as compared with patients who did not
require such a therapy. IIT appeared to largely exert similar effects
in patients with or without hydrocortisone therapy.
In conclusion, by reducing serum cortisol levels, intensive insulin
therapy beneficially affected outcome of critically ill patients.
Studies are ongoing to elucidate the mechanisms underlying this
effect.
Reference
1. Van den Berghe, et al.: N Engl J Med 2001, 345:1359.
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Introduction Application of intermitting hemofiltration (IHF) in
treatment of patients with acute renal failure (ARF) has significant
stress influence and leads to elimination of essential amounts of
cortisol and other adaptive hormones.
Materials Nineteen patients (11 males/eight females) 11–62 years
of age with ARF were examined. Forty-six IHF procedures were
performed with the mean duration 6.5 ± 0.6 hours; filtration volume
50.2 ± 2.6 (18–85) l; index 1.03 ± 0.8 (0.45–1.53). The filtration
rate was 128 ± 9 (27–260) ml/min. The cortisol concentration in
the plasma and the filtrate was measured by radioimmune assay.
Results The cortisol content in the plasma of controls (n = 32) was
334 ± 20 nM/l. At the beginning of the IHF procedures the cortisol
concentration in plasma of patients with ARF was 672 ± 83 nM/l
(n = 36; P < 0.001). At the end of the procedures the mean
plasma cortisol concentration increased to 1197 ± 199 nM/l
(P < 0.001). Cortisol concentrations in the effluent were
8303 ± 543, 7993 ± 532 and 8414 ± 416 nM/l at the beginning
of the procedure, at the end and in total effluent volume accordingly.
Conclusion The phenomenon of cortisol ‘hyperfiltration’ revealed
in this study may be explained by filtration of significant amounts of
this hormone from the surface of erythrocytes that need to be
investigated further.
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Effect of a single dose of etomidate on adrenal function in
patients with trauma
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Royal London Hospital, London, UK
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Studies investigating the relationship between adrenal insufficiency
in sepsis and the potential need for steroids have been complicated
by the use of etomidate, an anaesthetic agent that has been shown
to cause adrenal impairment. Controversy still exists regarding the
effects of a single dose of etomidate on adrenal function and a
temporal or dose-dependent effect may occur. In an attempt to
remove the confounding effect of sepsis on adrenal function, we
studied a group of severely injured trauma patients to determine
whether a single dose of etomidate effects adrenal function.
Trauma patients admitted to the intensive care unit of the Royal
London Hospital who had received etomidate as their induction
agent were enrolled within 36 hours of admission. Patients
received varying doses of etomidate on induction. Plasma cortisol
was measured at baseline and 60 min following a short ACTH
stimulation test (250 µg synthetic ACTH). Responders were
defined as having an increment in cortisol of > 250 nmol/l. Data
were analysed using an unpaired t test or chi-square test as
appropriate.
Twenty-two patients (17 male) with polytrauma were recruited.
Nine patients had impaired adrenal function. Overall, compared
with responders, there was no difference between dose of
etomidate received or time from induction (Table 1).
There was no difference in incidence of adrenal impairment in
those patients who had their adrenal function assessed pre or post
18 hours from receiving etomidate.
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In conclusion, patients with severe polytrauma who have received
etomidate commonly have adrenal impairment. The clinical
significance of these findings is unclear but it is not possible to
exclude an inhibitory effect of etomidate on adrenal function. Prior
to commencing steroids in the critically ill with adrenal
insufficiency, it is important to consider whether patients have
received etomidate.
Table 1 (abstract P392)
Non-responders Responders
n 9 13
Etomidate dose (mg) 15 (4) 15 (4)
Time to test (hours) 17 (9) 21 (6)
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Introduction Hydrocortisone differentially modulates inflammatory
mediators and expression of adhesion molecules. Previously, a
randomised controlled trial showed that hydrocortisone attenuates
cell interactions in septic shock [1]. However, the effect of ‘low’-
dose hydrocortisone treatment on platelet activation has not yet
been evaluated systematically.
Objective To evaluate the influence of hydrocortisone levels on
platelet activation in vitro.
Methods Citrated blood samples were drawn from healthy blood
donors (n = 25, 36% male, age: 40 ± 10 [mean ± standard
deviation]). Exclusion criteria were smoking, diabetes mellitus,
diseases and drugs interfering with cortisone levels or platelets.
After measuring the morning cortisol level, blood samples were
adjusted with hydrocortisone (Pharmacia, Erlangen, Germany) to
final concentrations of 4.5 µg/ml (group 1), 9 µg/ml (group 2, low
dose) and 90 µg/ml (group 3), respectively. The control group
received no additional hydrocortisone. Samples were incubated for
10 min at 37°C with fluorescence-labeled monoclonal antibodies
against CD62P, CD41, CD45, CD42b (all: Beckman-Coulter,
Krefeld, Germany) or PAC-1 (Becton Dickinson, San Jose, CA,
USA). To evaluate platelet reactivity 5 µM thrombin-receptor-
agonist-peptide-6 (TRAP-6; Bachem, Germany) or 2.5 µM
adenosine-di-phosphate (ADP; Sigma, Germany) were added.
Analyses were performed in a flow cytometer. The mean
fluorescence intensity (MFI) and percentage of CD45/41+
complexes was calculated. Determination of platelet aggregation
was performed by turbidimetric procedure (BCT; Dade Behring,
Marburg, Germany). Aggregation was induced with ADP (200
µM/l; Dade Behring), collagen (2 mg/l; Dade Behring) and
epinephrine (100 µM/l; Dade Behring). Intergroup differences
were compared by one-way analysis of variance.
Results The initial cortisol level was 11.6 ± 3.5 µg/dl. Hydro-
cortisone administration had no significant influence on expression
of PAC-1, CD62P and CD45/41+ complexes, with and without
stimulation. In contrast, we observed a significant lower expression
of CD42b in group 3 compared with the control group only without
activation (P = 0.047). A similar observation was made for CD41
expression (group 3 vs control: unstimulated: P = 0.035).
Differences between the control and groups 1 and 2 were not
significant with either activator. Aggregometry showed significant
later onset of maximum aggregation after activation with ADP and
collagen (group 3 vs control: collagen: P = 0.001; ADP:
P = 0.048).
Conclusion This in vitro study demonstrates that administration of
low-dose hydrocortisone neither reduces expression of
investigated platelet receptors nor attenuates begin of maximum
aggregation in doses recommended in septic shock. We therefore
conclude that ‘low’-dose hydrocortisone might not result in
impaired platelet function.
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Introduction Septic shock may be associated with relative adrenal
insufficiency. A replacement therapy with low doses of
corticosteroids has been proposed to treat septic shock.
Objective To describe the outcome of a cohort of septic shock
patients with a treatment strategy guided by a short corticotropin
test.
Design and setting An observational and prospective cohort of
severe septic shock patients treated in a general ICU of a
university hospital.
Materials and methods Thirty-three patients who fulfilled criteria
for severe septic shock. In all patients a short corticotropin test
(250 µg) with cortisol measured at 0, 30 and 60 min was
performed. The response to the test was considered whenever the
difference between baseline cortisol and pick cortisol was greater
than 9 mg/dl. Low-dose corticosteroids (hydrocortisone 50 mg,
intravenously, 6/6 hours) was given to all patients and maintained
only when the patient was a non-responder.
Main outcome measure Twenty-eight-day mortality.
Results The total mortality rate was 65% (21/32). The non-
survivors where older (68.5 ± 11.5 vs 53.9 ± 20.2, P = 0.014),
and had a higher baseline cortisol (27.5 ± 17.7 vs 17.0 ± 12.9 µg/dl,
P = 0.043). APACHE II score, pick cortisol, delta cortisol and
albumin where not different. There were 15 responders and 17
non-responders to the corticotropin test. In non-responders, the
mortality rate was 64% (11/17) and in responders it was 66%
(10/15). Responders had a higher baseline cortisol (29.1 ± 20.7
vs 19.2 ± 11.1 mg/dl, P = not significant), higher pick cortisol
(45.4 ± 21.9 vs 23.7 ± 10.3 µg/dl, P = 0.001) and higher delta
cortisol (16.3 ± 5.9 vs 4.7 ± 2.3 µg/dl, P < 0.001). Age, APACHE
II score and albumin were similar. Vasopressor therapy was
withdrawn in 20 patients and eight patients were responders
(40%). Among 12 patients not weaned from vasopressors, seven
(58%) were responders. Hypoalbuminemic (albumin < 2.5 g/dl)
and non-hypoalbuminemic patients had no differences among
measured variables. However, 60% (15/25) of hypoalbuminemic
but only 28% (2/7) of normoalbuminemic patients were non-
responders.
Conclusions Mortality rates among responders and non-
responders were equivalent and may indicate a beneficial effect of
low-dose hydrocortisone. Hypoalbuminemia may influence the
response to the corticotropin test once most hypoalbuminemic
patients were non-responders.
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Introduction Septic shock is frequently associated with relative
adrenal insufficiency (RAI). RAI increases mortality and
hydrocortisone supplementation improves survival in septic shock
patients. There is no consensus about RAI diagnosis criteria. With
the standard corticotropin stimulation test (SCST) (250 µg) ACTH
levels reaches 100 times the physiological concentration. A low-
dose corticotropin stimulation test (LDCST) (1 µg) is closer to
physiological ACTH levels.
Objective To determine whether a LDCST (1 µg) can reveal RAI in
septic shock patients when the SCST (250 µg) does not diagnose
RAI.
Methods A prospective cohort study conducted between October
2003 and May 2004 in an adult intensive care unit of a teaching
hospital in France. A baseline cortisol concentration was obtained
in septic shock patients. An intravenous injection of 1 µg cortico-
tropin (LDCST) followed 90 min later by an injection of 249 µg
corticotropin (SCST) was performed. Cortisol concentrations were
obtained 30 and 60 min after each test. All patients received
hydrocortisone (50 mg/6 hours intravenous bolus) and fludro-
cortisone (50 µg tablet once daily) while awaiting the results of
cortisol assesment. Patients were considered without RAI if Delta
max > 9 mg/dl. Delta max is defined as the difference between T0
and the highest value between T30 and T60 of each test.
Hydrocortisone and fludrocortisone were delivered for 7 days if the
patient had RAI on SCST and stopped in the other cases.
Results Twenty-three patients with septic shock were enrolled.
Their mean age was 60 ± 14 years; 16 were male. IGS II was
52 ± 21 and the SOFA score at admission was 9 ± 3. Sixteen
patients (63%) were admitted for nosocomial infection, 14 (61%)
for peritonitis, six (26%) for pulmonary infection and three for other
sites of infection. Seven patients died at day 28 (33%) and nine in
the intensive care unit (40%). Baseline cortisol levels were
12.69 ± 7.24 µg/dl. Twenty-one patients met the diagnosis criteria
of RAI with the LDCST and 18 with the SCST (Delta max LDCST:
10.78 ± 1.37; Delta max SCST: 17.44 ± 4.53). Three patients had
RAI with the LDCST but not with the SCST.
Conclusion The incidence of RAI was very high in our study
population with the SCST (78%). We found three patients without
RAI according to the SCST but showing impaired response to the
LDCST. The small number of patients in this situation does not
allow any conclusion about the best test to choose. It seems of
interest to enlarge our cohort of patients to draw clinically relevant
information.
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Introduction Sepsis is a common problem in our ICU, often
leading to hypotension requiring vasopressor support. Adrenal
dysfunction is thought to be common in septic patients. HIV-
related opportunistic infections are known to be the most common
cause of adrenal dysfunction. The prevalence of HIV in the
community we service is around 20%. We will present here the
preliminary results from a study on septic patients admitted to our
ICU. We have assessed HIV status and CD4 counts on
consecutive ICU admissions over a 4-month period All patients
requiring vasopressors have undergone a synacthen test.
Method A prospective, observational, experimental study at an
academic ICU. A presenting sample was taken over a 4-month
period. Ethics approval was obtained from the University Ethics
Committee.
Testing A 1 µg low-dose short synacthen test (SST). Baseline
bloods for renin, aldosterone, HIV and CD4. The laboratory was
blinded to patient details and the physician blinded to results. One
hundred and twenty-six patients enrolled and 40 synacthen tests
were carried out. Results were available for 68 patients and 20
synacthen tests as of 14 December 2004. No renin, aldosterone
and CD4 counts were available at submission of abstract.
Results Sixty-eight patients admitted to the ICU were enrolled and
followed up to D28 in 6 weeks. Twenty SSTs were performed for
refractory hypotension within 24 hours of initiating vasopressors.
The incidence of adrenal dysfunction (AD) was highest with a
stress cortisol (SC) < 690 nmol/l or a delta cortisol (D30/60)
< 250 nmol/l (89% in either case). Primary AD was more common
then secondary AD and tertiary AD combined (89% vs 11%). A
SC < 690 or a (D30/60) < 250 during a SST were more sensitive
than a SC of < 550 nmol/l in detecting AD (89% vs 74%). Hemo-
dynamic response (HR) is defined as an increase in MAP or
decrease in vasopressor requirements in the 24 hours post steroid
initiation. At a threshold of 10%, 68% responded to steroid
treatment. The median increase in MAP or vasopressor decrease
during the 24 hours post steroid initiation was 28%. There was no
significant difference in mortality between steroid-treated AD and
patients without AD (P = 0.91). Of the 68 patients, 17 were HIV-
positive and 51 were HIV-negative. The period prevalence
(1.5 months) is 25%. There was no significant difference in
mortality between HIV-negative and HIV-positive (without AIDS-
defining illnesses) patients (P = 0.29).
Conclusion There is a high incidence of AD in septic shock. The
most sensitive means of detection is a SC < 690 nmol/l or a
D30/60 < 250 nmol/l. Primary AD is much more common than
secondary AD. The increased mortality and haemodynamic
instability of AD is eliminated by steroid treatment. Finally, HIV
status alone does not impact on mortality in disease unrelated to
HIV/AIDS. On completion we will be able to comment on the
diagnostic performance of renin and aldosterone and their
relationship to AD and ARF and the CD4 count, and its ability to
predict mortality in HIV-positive patients
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The present study was carried out to evaluate the time course of
serum adrenocortical hormones and cytokines in critically ill
patients with sepsis and/or septic shock. To this end, 56 patients
(42 men) with a median age of 53 years (range 17–82 years) were
investigated. At study entry, the mean APACHE score was 20 and
the median SOFA score was 11. Blood was drawn to measure
cortisol, corticotropin (ACTH), dehydroepiandrosterone-sulphate
(DHEAS), IL-6 and tumor necrosis factor alpha (TNF-α) levels
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within 48 hours of the onset of sepsis and/or septic shock, and
thereafter every second day for 14 days, or until death or ICU
discharge. Median cortisol and DHEAS run in parallel and
remained unchanged during the study period (17, 18, 17, 14, 17
and 18 µg/dl, P = 0.42, 1.188, 1.145, 1.190, 1.220 and 873;
1.202 ng/ml, P = 0.97, respectively). Median ACTH increased
significantly during the entire observation period (21, 24, 28, 34,
32 and 43 pg/ml, P = 0.008). TNF-α levels were high and
decreased gradually (2, 2, 1, 0, 0 and 0 pg/ml, P < 0.001). IL-6
concentrations were high initially, but decreased abruptly during
the first week; thereafter, they reached a plateau (344, 215, 169,
118, 128 and 93 pg/ml, P < 0.001).
In conclusion, during the course of sepsis and/or septic shock,
serum glucocorticoids and adrenal androgens do not change.
During the first week, the hypothalamic–pituitary–adrenal axis is
activated by both ACTH and IL-6; the axis is subsequently
stimulated primarily by ACTH.
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Introduction In the past years many studies have demonstrated
the occurrence of relative adrenal insufficiency and immunologic
and hemodynamic effects of low-dose hydrocortisone in septic
shock. Despite this evidence, the optimal approach to ensure the
diagnoses is not yet clear.
Methods We conducted a prospective cohort study in two ICUs
from March 2003 to March 2004. The patients who developed
septic shock and were under mechanical ventilation had their
serum cortisol measured. The diagnoses of septic shock were
made in accordance with the criteria proposed by ACCP/SCCM.
The hydrocortisone was administrated every 6 hours (200 mg
intravenously daily) during 7 days or less, according to the
hemodynamic response and the relationship with the serum
cortisol level (≤ 25 µg/dl). Two criteria were used to make the
diagnoses: serum cortisol level ≤ 25 µg/dl and the weaning of
vasoative drugs in the first 24 hours or dose reduction in at least
50%. The APACHE II score and SOFA score were used to
evaluate the seriousness.
Results Fifty-nine patients were evaluated. Average age was
69 years, 30 (50.8%) were male. The average APACHE II score
was 24 and the SOFA score on the first day was 10.5. The
average plasma cortisol was 27.5 µg/dl (4–114). Cortisol
≤ 25 µg/dl was identified in 30 (50.8%) patients. The weaning
from vasoative drugs or the dose reduction in at least 50% was
observed in 25 patients. The sensitivity of a baseline cortisol
≤ 25 µg/dl associated with hemodynamic response to predict
adrenal insufficiency was 83.3% (95% confidence interval;
72.5–94). According to this criterion, relative adrenal insufiency
was diagnosed in 33.8% in this group.
Conclusion Adrenal insufiency appears to be common in septic
shock patients. Hemodynamic response to hydrocortisone linked
to a serum cortisol ≤ 25 µg/dl seems to be a good way to make the
diagnosis. Until we have the best cut-off value of serum cortisol
and a definitive response about the validity of the corticotropin test
in septic patients, the clinical response to corticosteroids should
be taken into consideration to make that diagnosis.
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Introduction Adrenal failure (AF) is known to develop during the
course of sepsis and to adversely affect the prognosis of the
patients. Neurological critically ill patients may additionally be
susceptible to development of AF due to disruption of the
hypotalamic–pituitary–adrenal axis.
Objectives To determine the response to the corticotropin
stimulation test with low dose (1 µg) and high dose (249 µg) in
septic patients and to compare the frequency of AF in the
neurological and non-neurological subsets.
Materials and methods Patients admitted to an ICU from May
2002 to November 2004, with septic shock, additionally registered
whether they had associated neurological diseases (head trauma,
acute cerebrovascular disorders, postoperative) or not, were
submitted to the corticotropin stimulation test. A baseline cortisol
level was first obtained, then patients received an intravenous
injection of 1 µg corticotropin (low dose) followed 60 min later by
an injection of 249 µg (high dose). The cortisol level was obtained
60 min after low-dose and high-dose corticotropin. The difference
between the higher and baseline cortisol level was registered as
∆max. We defined AF when the baseline cortisol level was lower
than 25 µg/dl or ∆max was lower than or equal to 9 µg/dl. The
EPiINFO version was used for data analysis, and P < 0.05 was
considered significant.
Results Eighty-two patients were enrolled, 47 were female. The
mean age was 71. The overall rate of baseline cortisol level lower
than 25 µg/dl was 79.3% (65/82) and ∆max lower than or equal to
9 µg/dl was 19.5% (16/82). The cortisol levels were significantly
higher in the neurological group than in the non-neurological
group, as presented in Table 1. The frequency of cortisol level
lower than 25 µg/dl was similar in the neurological and non-
neurological disease groups (33/43 vs 32/39 — odds ratio 1.37
[95% confidence interval, 0.41–4.83]), but the frequency of ∆max
< 9 µg/dl was higher in the neurological patients (9/39 vs 7/43),
although non-statistically significant (P = 0.2).
Conclusion Patients with septic and neurological diseases have
higher baseline and post-corticotropin cortisol levels than non-
neurological patients, but the frequency of AF is similar between
both groups.
Critical Care    March 2005 Vol 9 Suppl 1 25th International Symposium on Intensive Care and Emergency Medicine
Table 1 (abstract P399)
Baseline cortisol Low-dose cortisol High-dose cortisol 
n (µg/dl) (µg/dl) (µg/dl) ∆max (µg/dl)
Neurological disease 39 21.6 ± 13.1 37.5 ± 16.9 49.2 ± 21 27.5 ± 17.9
Non-neurological disease 43 15 ± 8.6 25.2 ± 10.7 33.7 ± 13.5 18.6 ± 11
Not significant P = 0.006 P = 0.0006 P = 0.001 P = 0.03
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Relative adrenal insufficiency in critically ill hematology
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J Cerman, M Cermanova, R Mottl, L Sobotka, J Maly
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Critical Care 2005, 9(Suppl 1):P400 (DOI 10.1186/cc3463)
Aim Sepsis is the most common cause of death of hematology
patients in intensive care units. The adrenal gland is potentially
involved in sepsis. Impaired functions of the adrenal gland can be
caused by hemorrhage, tumor infiltration, drugs and suppression
after glucocorticoid treatment. The goal of the study was to evaluate
adrenal functions in a group of critically ill hematology patients.
Patients and methods Forty critically ill patients with
hematological disease, mean age 57 ± 14 years, 22 of them
women. Mortality was 48%. The mean APACHE II score was 37
(22–48). We performed a 250 µg short intravenous corticotropin
test and we determined plasma concentrations of cortisol before
and 30 and 60 min after the test. According to the results patients
were classified as having adrenal insufficiency or not.
Results The incidence of the adrenal insufficiency depends on the
criteria used. Using a basal cortisol level lower than 414 nmol/l
(15 mg/dl), the incidence of adrenal insufficiency was 27.5% (11
patients). Using a basal cortisol level or cortisol response to
corticotropin lower than 250 nmol/l, the incidence of adrenal
insufficiency was 60% (20 patients). When we use both these
criteria, the incidence of adrenal insuficiency was 12.5% (five
patients) and all these patients died. Patients with adrenal
insufficiency had higher mortality.
Conclusion There is a high incidence of adrenal insufficiency in
critical ill hematology patients. These patients should undergo
evaluation of adrenal functions to reveal patients with a need of
hydrocortisone treatment.
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care unit: incidence and relationship to outcome
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The aim of the current study was to investigate the incidence of
relative adrenal insufficiency in a large cohort of critically ill
patients. Furthermore, we wished to assess the relationship of
adrenal function tests to outcome of patients admitted to an adult
medical and surgical ICU.
To this end, 151 (119 men) critically ill patients having various
principal diagnoses were studied. The median age was 52 years
(range 17–84 years). The median APACHE II score was 11. Blood
was sampled within 48 hours of admission for measurement of
serum concentrations of baseline cortisol and corticotropin
(ACTH). Immediately after, a low-dose (1 µg) ACTH stimulation
test was performed. Patients having stimulated cortisol levels
below 18 µg/dl were defined as non-responders to the test.
Median values for baseline cortisol and ACTH were 16.0 µg/dl
(range 0.3–61.3 µg/dl) and 16.8 pg/ml (range 0.9–166.4 pg/ml)
respectively. The median stimulated cortisol value was 22.4 µg/dl
(range 4.7–70.0 µg/dl) and the median increment in cortisol was
7.1 µg/dl (range 0.2–25.6 µg/dl). There was a positive correlation
between ACTH and baseline cortisol (r = 0.42, P < 0.001). Thirty-
nine (26%) patients were non-responders to the low-dose ACTH
stimulation test. Overall mortality was 26%. Non-survivors were
older (64 vs 24 years, P = 0.002), and had a higher APACHE II
score (13 vs 11, P = 0.007) compared with survivors. There were
no differences between the two groups with regard to baseline or
stimulated cortisol levels. Similarly, ACTH and the increment in
cortisol was comparable in the two groups.
In conclusion, this study involving a large number of severely ill
patients showed that the relative adrenal insufficiency syndrome is
quite common in the ICU; however, baseline or stimulated cortisol
concentrations do not differ between survivors and non-survivors
on admission to the ICU.
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Incidence of adrenal insufficiency within 10 days of traumatic
brain injury
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Critical Care 2005, 9(Suppl 1):P402 (DOI 10.1186/cc3465)
Adrenal insufficiency (AI) is common in septic shock, and the
physiologic replacement of hydrocortisone improves outcome [1].
Head injury (HI) has been shown to cause AI in the subacute
phase (>10 days) with a reported incidence of approximately 15%
[2,3], but there are no data on early AI, at times when it is most
likely to influence ICU management. Furthermore, analysis of
available data is confounded by variations in the definition of AI
[4,5]. We aim to describe adrenal function in the first 10 days after
injury using various suggested definitions of AI in critical care [4,5].
We retrospectively analysed patients who had a stimulation test
performed within 10 days of admission to our neurointensive care
unit. Tetracosactide (Synacthen) was administered as a 250 µg
bolus and cortisol levels measured at 0, 30 and 60 min. AI was
defined as a baseline cortisol level below 414 mmol/l and failure to
rise by 250 mmol/l after Synacthen administration. All patients who
showed AI or responded clinically to a trial of steroid therapy
received 200–400 mg hydrocortisone per day while on
vasopressor therapy.
One hundred and thirteen patients were analysed. Mean age was
35 ± 15 and 79% were male. Four percent, 25% and 70% had
mild, moderate and severe HI defined by the GCS on admission.
Mean APACHE II and ISS scores were 15 ± 6 and 24 ± 10. The
incidence of AI according to baseline cortisol level was 78%. The
cortisol level failed to rise in 48% and 27% of patients at time 30
and 60 min, respectively. Primary adrenal insufficiency defined by
both low baseline cortisol and failure to react to synacthen was
present in 28% and 13% of patients at time 30 and 60 min. All
patients had baseline cortisol levels below 690 mmol/l. Cortisol
remained below 500 mmol/l after stimulation in 49% and 22% of
patients at 30 and 60 min. The incidence of AI, using any of the
definitions in the literature, was unrelated to APACHE II or ISS
score or GCS on admission, or to ICU length of stay or outcome
(defined using the Glasgow Outcome Score).
A 60-min sampling time point may be more appropriate to evaluate
the response to Synacthen stimulation. During the first 10 days
after HI, secondary AI was present in 78% of patients and primary
AI in at least 15%. These incidences might be higher if less
stringent definitions are used. Injury and/or illness severity indices
do not predict AI. While AI was not predictive of outcome in this
study, all subjects with AI received steroid replacement. Such a
high incidence of AI may have major therapeutic implications.
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The purpose of the current study was to assess the pattern of
endocrine responses in patients undergoing elective major
abdominal surgery. To this end, 16 patients (nine women) with a
mean age of 71 ± 9 years (range, 48–87 years) were studied.
Underlying diagnoses included carcinoma of the pancreas (n = 5),
stomach (n = 4), colon (n = 4) and rectum (n = 3). Blood was taken
before surgery (day –1), immediately after the operation (day 0), and
on the two subsequent days (day 1 and day 2). At each sample time
cortisol (F), corticotropin (ACTH), triiodothyronine (T3), free
thyroxine (fT4), thyroid-stimulating hormone (TSH), and insulin-like
growth factor 1 (IGF-1) were determined. Serial measurements
were analyzed by one-way analysis of variance followed by Dunn’s
test for multiple comparisons, and the results are presented in Table
1 (median values or mean ± standard deviation).
Table 1
Day –1 Day 0 Day 1 Day 2 P value
F (µg/dl) 15 20 17 13 0.03
ACTH (pg/ml) 21 129 10 8 0.001
T3 (ng/dl) 100 ± 22 82 ± 18 72 ± 17 69 ± 15 0.001
fT4 (ng/dl) 1.3 ± 0.2 1.5 ± 0.3 1.4 ± 0.3 1.4 ± 0.3 NS
TSH (µIU/ml) 1.0 1.1 0.9 1.0 NS
IGF-1 (ng/ml) 75 46 58 49 0.001
NS, not significant.
In conclusion, major surgical stress results in a profound, albeit
transient, activation of the hypothalamic–pituitary–adrenal axis.
Furthermore, surgery leads to a suppression of thyroid and
somatotroph function, and this effect persists for more than 2 days.
The relationship between hormonal responses and patients’
outcome remains to be determined.
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Introduction The aim of this clinical trial is to examine the factors
that influence prognosis of acute rhabdomyolysis (ARM) in critically
ill ICU patients.
Methods We studied retrospectively 39 ICU patients with ARM.
Mean age: 47.8 ± 24.5 years, mean stay: 20.3 ± 11.5 days.
Underlying diseases: multiple trauma 26, complicated surgery 9,
status epilepticus 2, drug poisoning 2. All patients underwent
mechanical ventilation. Laboratory data included initial and peak
values, as well as frequent measurements at least twice a day, of:
serum creatinine (CR), creatine phoshokinase (CPK), blood urea
nitrogen (BUN), potassium, sodium, calcium, magnesium,
phosphate, white blood cell count (WBC), hematocrit (HT),
transaminases, bilirubin, lactate dehydrogenase (LDH), and
myoglobulin of urine and urine toxicology screen.
Results Intensive therapy began very early upon diagnosis with
intravenous administration of fluids, furosemide and/or mannitol
and bicarbonates besides etiological treatment, where was
possible. The initial value of CR was normal (≤ 1.3mg%) in 22
patients (56.4%). The mean percentage decrease in HT was 13.1
± 2.8% after 24 hours of hydration (showing approximately the
percentage of initial volume depletion). In 11 patients (28.2%)
CPK was >10,000 IU/l and in five patients (12.8%) > 20,000 IU/l.
BUN ≤ 50 mg% was initially found in 20 patients (51.3%) and
WBC <11,000/mm3 in 19 (48.7%). The urine pH (measured every
3–6 hours) had a value < 6.0 in two patients (5.1%), while 23
(59.0%) developed acute renal failure (ARF) and required
hemodialysis. Mortality rates: 8/39 (20.5%).
Conclusion (1) Normal initial CR, initial BUN < 50 mg%, initial
WBC <11,000/mm3 and less than 15% decrease of HT (volume
depletion) were associated with either normal renal function or a
slight ARF not requiring hemodialysis (P < 0.05). (2) An elevated
initial value of CPK >10,000 IU/l was associated with ARF
requiring hemodialysis (P < 0.01) [1], longer duration of
mechanical ventilation (P < 0.05), longer ICU stay (P < 0.05) and
higher mortality rates (< 0.05). (3) Contrarily, high values of urine
myoglobulin were not associated with severe ARF or elevated
mortality rates (P < 0.1).
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Background The optimal timing and treatment of patients with
femoral shaft fractures and associated head, thoracic, or
abdominal injury remains controversial. This study examines the
acute patient outcomes associated with the evolution of early total
care to damage control orthopaedics for multiply injured patients
with femoral shaft fractures.
Methods This study was a retrospective comparison of two
sequential protocols for the care of multiply injured patients with
femoral shaft fractures. From 1993 to 1998 our institutional
protocol for these patients consisted of early total care (ETC) with
intramuscular nailing or femoral traction within 24 hours. From 1998
to 2003 we placed femoral external fixation on all polytrauma
patients meeting specific injury criteria. Study inclusion criteria
included severely injured skeletally mature patients (closed physes)
with femoral shaft fractures. Patients were determined to be
severely injured if they presented with an ISS ≥ 25, AIS of the head
≥ 3, or hypotension. All included patients received fracture
stabilization within 24 hours of presentation. The cohort population
was compared with respect to age, sex, and ISS. Primary outcome
measures for comparison between these groups included mortality,
pulmonary complications (ARDS score), and multiple organ failure
(MOF score). The groups were also compared regarding operative
time, ICU length of stay, and hospital length of stay.
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Results During the ETC treatment period 102 patients with femur
shaft fractures were identified, 27 of which met the inclusion
criteria. During the DCO period 202 patients were identified, 38 of
which met the inclusion criteria. The patient groups were
comparable regarding age, gender, and injury severity score. There
was no difference between the groups in terms of ARDS
incidence, lung scores, MOF incidence, MOF score, ICU LOS, or
hospital LOS. The DCO group had a significantly shorter OR time.
Conclusion In our experience the method of fracture fixation (DCO
vs ETC) did not appear to impact the incidence of systemic
complications (ARDS and MOF) in the polytrauma patient with an
associated femoral shaft fracture. However, we feel that multi-
disciplinary care is facilitated with DCO and that the decreased initial
operative exposure appears to benefit specific subsets of patients.
The debate over the optimal timing and method of femur fixation will
continue until a treatment protocol can be validated based on a high-
quality study with a large number of patients. This study provides the
basis for a prospective, randomized, multicenter trail of DCO versus
ETC for femur shaft fractures in multiply injured patients.
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Critical Care 2005, 9(Suppl 1):P406 (DOI 10.1186/cc3469)
Intoxicated patients are not uncommonly admitted to the
emergency room (ER) due to unconsciousness. In Japan, ‘illegal
drug’ abuse has increased recently among young people.
Diagnosis of ‘illegal drug’ intoxication is often limited to information
from patients or surroundings. The purpose of this study was to
evaluate the efficacy of HPLC for the diagnosis of ‘illegal drug’
intoxication. The clinical records from six patients with ‘illegal drug’
intoxication who were admitted to our ER between 2000 and 2004
were reviewed. The HPLC system was performed and analyzed
using the reversed-phase isolated method. Results are presented
in Table 1. HPLC showed the spectrum of drugs from the patients’
samples. The chemical component of Rush and Sex Hyper is the
same, but they showed different peak retention times. Magic
Mushrooms made the varied peaks. Pure White has two chemical
components and the two peaks were recognized independently.
Pinky made two different peaks in urine. HPLC could be useful in
the diagnosis of ‘illegal drug’ intoxication. However, HPLC has
limitations. First, a control drug or a control spectrum is necessary
to compare with the spectrum of the patient’s sample. Second,
HPLC seems to be influenced by additional materials even if they
have the same chemical component. Third, we should choose a
suitable extract method and column. Because we used acetnitrile
not alcohol to extract Magic Mushrooms, HPLC showed many
peaks. Finally, urine is not adequate for ‘illegal drug’ analysis. 2C-I
in urine showed different peaks. Serum or gastric juice, before the
chemical component is metabolized, should be used.
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Intoxication with hydrofluoric acid is a very rare but mostly lethal
clinical condition. It is mainly caused by dermal exposure, with
ingestion extremely rare. Hydrofluoric acid is one of the strongest
acids known that has a strong lipophilic ability. Ingestions of more
than 20 mg/kg body weight are considered a lethal dose. Even
after dermal exposure, the fatal prognosis is caused by severe
electrolyte disturbances, especially hypocalcemia.
We report on a 50-year-old female with endogenous depression
who swallowed approximately 30 ml hexafluorosilicate (hydrofluoric
acid) during a night-time attempt to commit suicide. In the early
morning, the woman was found somnolent in a condition of
circulatory shock. She complained of severe abdominal pain. She
had to be intubated by the emergency doctor and was admitted to
the hospital. Physical examination of the mechanically ventilated
patient only revealed conjunctival irritation. Laboratory investiga-
tions showed severe electrolyte disturbances (hypokalemia,
hypocalcemia, hypophosphatemia decreased magnesium levels)
as well as severe metabolic acidosis. Within the next few hours,
disseminated intravascular coagulation and hyopalbuminemia
developed. Serum fluoride levels were 0.099 mmol/l or 1.98 mg/l
(normal values 0.0005–0.02 mmol/l or 0.1–0.4 mg/l). Urine fluoride
levels were 1.94 mg/l (normal values <1.0 mg/l). Gastroscopy
showed necrotic gastric mucosa without signs of bleeding. Topical
instillation of calcium was not performed due to the long time
interval from burn to treatment but intravenous calciumgluconate
was substituted immediately.
Despite fluid resuscitation, correction of the electrolyte
abnormalities, stabilisation of coagulation and substitution of
albumin, the clinical condition worsened. The patient had to be
defibrillated due to ventricular fibrillation about 30 times. Later on,
these episodes of ventricular fibrillation were becoming less
responsive to defibrillation although the electrolyte threshold had
already been corrected. After 12 hours, the patient died under
cardiopulmonary resuscitation.
On autopsy, severe burns were found in the esophageal and
gastric mucosa, hyperemic lesions were seen in the renal tubular
system as well as necrotic lesions in the cardiac musculature.
Besides the poor prognosis of a fluoride intoxication in this dosis,
the long time interval until treatment could be started seems to be
the main reason for the fatal outcome of this case.
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Table 1 (abstract P406)
Case Age (years) Sex Common name Component HPLC spectrum Peak time (min)
1 26 Male Rush 5-MEO-DIPT Recognized 7.6
2 24 Female Magic Mushrooms Psilocin Recognized Many peaks
3 20 Male Sex Hyper 5-MEO-DIPT Recognized 11.1
4 24 Male Pure White 2CT-2, 2CT-7 Recognized 11.3, 12.4
5 28 Male Sex Hyper 5-MEO-DIPT Recognized 11.1
6 17 Male Pinky 2C-I Recognized 10.6, 10.8
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Carbon monoxide (CO) poisoning is known to cause myocardial
toxicity and life-threatening arrhythmias. Corrected QT dispersion
(QTdc) of the ECG is an indirect measure of heterogeneity of
ventricular repolarisation, which may contribute to ventricular
arrhythmias.
The aim of the study was to evaluate the relationship between the
carboxyhemoglobin (COHb) level and QTdc during carbon
monoxide poisoning.
This study was prospectively performed in 104 patients who
diagnosed CO intoxication. Patients were assigned to two groups
according to COHb levels < 25% (Group I, n = 32) or COHb
> 25% (Group II, n = 72). In each ECG lead, the QT interval and
QRS duration were measured in the two groups and corrected for
heart rate (QTc) using Bazett’s formula (QT/RR1/2). QTdc is then
the difference between the leads with the shortest and longest
QTc intervals. Measurement of QT intervals were calculated at
admission and in 24-hour and 48-hour ECGs after admission.
Cardiac enzymes were measured at each stage. The myocardial
perfusion after exercise and at rest 4 hours after exercise were
determined in all patients 1 week after admission.
QT, QTc and QTd intervals were not significantly different in both
of groups each stage whereas the values of the QTdc after
24 hours were significantly greater than QTdc at admission in
Group II but not in Group I. Comparison of QTdc for the two
groups demonstrated significant differences after 24 hours
(P < 0.05) (Table 1). Plasma creatinine phosphokinase (CPK) and
CPK-MB levels at admission, and 24 and 48 hours later in Group II
were significantly higher than the other group (P < 0.05). Seven
patients in Group I and 23 patients in Group II had an extent of
myocardial ischemia on scintigraphy.
Table 1
Group I Group II 
(COHb < 25%) (COHb > 25%) P value
QTdc interval
Admission 95.68 ± 5.9 93.90 ± 7.8 0.44
24 hours after admission 90.55 ± 5.5 105.89 ± 12.1 0.005
48 hours after admission 90.30 ± 9.9 85.93 ± 11.7 0.32
QTc interval
Admission 450.49 ± 6.7 455.41 ± 4.35 0.13
24 hours after admission 429.29 ± 6.0 439.61 ± 6.9 0,69
48 hours after admission 431.61 ± 6.9 422.69 ± 8.1 0.68
The reduced threshold for arrhythmias in CO poisoning may be
due to inhomogeneous repolarization of ventricles, assessed by
QTdc. Measuring QTdc for monitoring after CO poisoning may be
suggestive of the potential danger of high levels of COHb to
cardiac-disabled individuals
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comparative study
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Shaare Zedek Medical Centre, Jerusalem, Israel
Critical Care 2005, 9(Suppl 1):P409 (DOI 10.1186/cc3472)
Introduction Urine output (UO) measurement is an essential part
of fluid balance management while caring for critically ill patients.
Moreover, it is the most reliable reflection of organ perfusion. The
traditional way of monitoring UO is by visual hourly readings of the
amount of urine accumulated in a ‘scaled container’ = Urinometer.
These vary according to nurses’ technical and visual inaccuracies.
Hypothesis An electronic flow meter (Urexact) will measure UO in
a much more accurate, efficient, user-friendly and ‘hands-off’
manner than the nurses/Urinometer.
Methods Adult ICU patients who were expected to be in the ICU
≥ 24 hours were enrolled. UO was measured hourly by the
standard Urinometer (nurse) or by the Urexact, for 10 hours each.
Hourly urine volume was validated in both techniques by a
‘measuring cylinder’ operated by a laboratory technician (accuracy
of ± 1 ml). Medical personnel completed a questionnaire regarding
satisfaction using the Urexact.
Results Eighty percent of the Urexact measurements were
accurate within ± 10% of the actual ‘cylinder measurement’ versus
only 65% of the Urinometer measurements. Eighty-six percent of
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the nurses graded the Urexact as a very-easy/easy instrument to
operate reliably, while saving time and avoiding urine contact.
Conclusions Urexact is an accurate, easy-to-use and time-saving
device, compared with the standard Urinometer. It is well accepted
by the ICU staff and allows them to measure UO without urine
contact. It has the potential to allow for fully computerized real-time
management of fluid balance.
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Introduction Computerized systems are becoming increasingly
important in critical care. Systems can record physiological data
automatically, leading to improved charting and reducing time
requirement for charting by nurses [1], and can perhaps impact
favorably on clinical decisions.
An additional potential advantage of computerized systems is the
ability to alert clinicians to various clinical occurrences, thus
improving care. This has been shown regarding hypokalemia in a
hospital-wide computerized system [2]. We examined the impact
of a computerized alert for a low potassium level in our general
ICU. We hypothesized that an alert provided by the computerized
system will reduce the response time of the clinical staff to
hypokalemia.
Methods The general ICU at the Sheba Medical Center is a 12-
bed ICU in a 1600-bed tertiary hospital. Three years ago a
computerized system was implemented (Metavision; IMDsoft Ltd,
Israel). The system receives and charts data automatically. The
system has an ‘Event Manager’ module that enables clinicians to
determine various indicators that will trigger an alert to the staff.
We created an alert that responds to a low potassium level by
presenting a message at the patient workstation indicating that a
low potassium measurement has been detected and consideration
should be given for supplemental potassium. The clinical staff
received a general update regarding the implementation of the
event without specific training. The event was introduced almost
2 years after the staff had been working with the computerized
system. We retrospectively looked at the time to treat (TTT) from
measurement of a potassium level lower than 2.9 meq/l during the
year before the event was implemented (Before event) and
compared this with the time period after the event was
implemented (After event). There was a statistically significant
reduction in the time to treat between the two time periods (Table 1).
Table 1
n Mean (min) Median (min)
Before event 542 85 52
After event 423 70 34
P < 0.01 P < 0.0001
Discussion A computerized alert that notifies clinicians of a low
potassium measurement can decrease the time to recognition and
treatment of hypokalemia, and thus improve care.
Conclusions Computerized alerts regarding laboratory results may
impact clinical care.
Acknowledgements ES and AP are consultants to IMDsoft.
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Introduction Metabolic alkalosis is a well-known acid–base
derangement in the ICU. Treatment with the carbonic anhydrase
inhibitor acetazolamide is indicated in selected cases. According
to the quantitative physicochemical approach described by
Stewart, correction of serum pH due to carbonic anhydrase
inhibition in the proximal tubule cannot be explained by excretion of
bicarbonate. pH is exclusively mediated by three independent
variables: pCO2, total concentration of weak acids, and the
difference between dissociated anions and cations (SID). We
therefore studied the mechanism of action of acetazolamide in
critically ill patients with a metabolic alkalosis according to the
Stewart approach.
Methods The study was approved by the local ethics committee
and the need for informed consent waived. Fifteen consecutive
ICU patients with metabolic alkalosis (pH > 7.48 and HCO3
> 28 mmol/l) were treated with a single administration of 500 mg
acetazolamide intravenously. Serum levels of strong ions,
creatinine, lactate, weak acids, pH and pCO2 were measured at 0,
12, 24, 48 and 72 hours. Main strong ions of the urine (sodium,
chloride and potassium) and pH were measured at 0, 3, 6, 12, 24,
48 and 72 hours. Strong ion difference (SID), strong ion gap (SIG)
and the Na–Cl effect were calculated. Effects of acetazolamide
were analyzed by comparing baseline variables and the time-
dependent changes by one-way analysis of variance for repeated
measures.
Results Eighty-seven percent of patients were mechanically
ventilated and 47% were treated with diuretics. Ventilator settings
and diuretic dose were not changed during the study period. Mean
APACHE II score was 21 (range 12–30) and hospital mortality
was 20% (SMR 0.57). Correction of serum pH (7.49 ± 0.01 to
7.46 ± 0.01; P = 0.001) was maximal at 24 hours and sustained
during the observation period. The parallel decrease in pCO2 was
not significant (5.7 ± 0.2 to 5.3 ± 0.2 kPa, P = 0.08). Also, there
was no significant change in the total concentration of weak acids.
Serum SID significantly decreased during the observation period
(41.5 ± 1.3 to 38.0 ± 1.0 mEq/l, P = 0.03) due to an increase in
serum chloride (105 ± 1.2 to 110 ± 1.2 mmol/l, P < 0.0001).
There was a very strong relation between the serum SID and the
Na–Cl effect (R2 = 0.99, P = < 0.001) The decrease in serum SID
was explained by a significant increase in the urinary excretion of
sodium without chloride in the first 24 hours (urinary [Na]/[Cl] 1.3
± 0.3 to 2.5 ± 0.5, P = 0.02).
Conclusions A single dose of acetazolamide effectively corrects
metabolic alkalosis in critically ill patients by decreasing the serum
SID. This effect is completely explained by the increased renal
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Introduction Base deficit (BD) quantifies a metabolic acidosis
without defining aetiology. Factors contributing to a metabolic
acidosis include lactic acid and unmeasured anions (together
known as tissue acid), hyperchloraemia and plasma albumin
concentration. An equation exists to quantify the effect of albumin
on BD; we have recently derived a similar equation for the effect of
chloride. After partitioning the BD for these factors, the residual BD
should reflect the contribution from tissue acid.
Aim In patients with meningococcal sepsis, we aimed to: (1)
validate this approach by comparing the agreement between tissue
acids derived from the partitioned BD with that from the
Stewart–Fencl method; and (2) use the partitioned BD to examine
the temporal profile of acid base disturbance during the first
48 hours of treatment.
Methods Sixty patients admitted to the intensive care unit with
meningococcal sepsis over 2 years were studied, median
(interquartile) weight 13 kg (10–20), median PIM risk of mortality
10.3% (6–16). Arterial blood was drawn at admission, and at 4, 8,
12, 18, 24 and 48 hours. BD was calculated from a standard
algorithm in the blood gas analyser, and tissue acid via the
Stewart–Fencl method.
Results (1) For the group as a whole, there was a strong
association between tissue acid derived from the partitioned BD
and the Stewart–Fencl method (r2 = 0.83). (2) A substantial
metabolic acidosis was present at admission (mean pH 7.31,
standard error of the mean 0.01, mean BD –8.9, standard error of
the mean 0.5), which persisted at 24 hours. The admission BD
was predominantly due to tissue acid, which was offset by an
alkalinising effect of hypochloraemia and hypoalbuminaemia
(Fig. 1). By 8 hours, chloride was now exhibiting an acidifying
effect, which was related to the amount of chloride administered in
the resuscitation fluids (r2 = 0.41).
Conclusion The partitioned BD provides an accurate measure of
tissue acid, and can be used to identify changes in the cause of a
metabolic acidosis over time.
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Objectives Whether systemic capillary leak can be monitored or
whether it exists at all remains controversial [1]. The aim of this
study was to investigate the origin of peripheral oedema in patients
with severe sepsis.
Materials and methods Ten patients fulfilling the severe sepsis
criteria [2], requiring mechanical ventilation, and having a high
(> 2 mm) oedema score were recruited [3], and observed daily, for
3 days. Subcutaneous oedema fluid (5 ml) was drained from the
patients’ back of the hand using a special, perforated 20G
intravenous cannula once a day. At the same time arterial blood and
urine were collected (5 and 10 ml, respectively). From oedema and
blood samples total protein, albumin and inflammatory markers
(PCT, CRP, tumour necrosis factor alpha, IL-6, IL-8), and from urine
microalbuminuria (MCR) levels were determined. Oedema was
considered due to capillary leak if the oedema protein (TPoe)/serum
total protein (TPs) ratio ≥ 0.65, and hydrostatic if < 0.65 [4]. Data
are presented as the mean ± standard deviation, or the median and
interquartile range (IQR) according to the data distribution.
Results In addition to clinical signs, all patients proved to be septic
as indicated by high inflammatory marker levels (Table 1). Increased
capillary leak was suggested by high oedema score, 3.3 ± 0.6 mm,
and elevated MCR. However, the TPoe/TPs ratio was 0.21 ± 0.16,




PCT (ng/ml) 8.0 1.0–23.3 < 0.5
CRP (mg/l) 135 89–234 <10
Tumour necrosis factor alpha (pg/ml) 14.2 6.1–43.2 < 8.1
IL-8 (pg/ml) 49.0 22.7–196.0 < 2.0
MCR (mg/mmol) 5.3 3.0–12.0 < 4.28
Discussion To our knowledge this is one of the first studies to
address the question of the origin of the oedema fluid in severe
sepsis. The low TPoe/TPs ratio found indicates mainly hydrostatic
forces in oedema formation. These preliminary results suggest that,
despite evidence of severe sepsis, the diagnosis of ‘increased
capillary leak’ cannot be made on the basis of the clinical signs of
severe peripheral oedema.
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Introduction The present study compares the changes of
extracellular mass (ECM) and body cell mass (BCM) in patients
with SIRS and severe sepsis with the aid of bioelectrical
impedance analysis.
Methods In the study, 32 mechanically ventilated SIRS patients
were included. The total body water balance and nitrogen balance
(NB) were evaluated everyday. ECM and BCM were measured in
kilograms, by bioelectrical impedance analysis at the first and 10th
ICU hospitalisation day. On the second measurement, 12 patients
(SIRS group) remained in SIRS with stable health status or
improvement, while 18 patients had severe sepsis (SEPSIS
group). Differences between the first and second measurement
were expressed as ∆ECM and ∆BCM. Alterations of all studied
parameters were compared between the two groups with the
student paired t test (P < 0.05).
Results BCM was significantly reduced from 23.7 ± 7.21 to
19.0 ± 7.01 (P = 0.048). The reduction in the SEPSIS group was
insignificant (from 21.8 ± 6.28 to 20.3 ± 5.74, P = 0.252). The
difference between the corresponding changes was not significant
(P = 0.2180).
ECM decreased non-significantly in the SIRS group (from
36.6 ± 9.91 to 35.3 ± 7.88, P = 0.666). On the contrary, ECM
increased significantly in the SEPSIS group (from 37.7 ± 11.94 to
49.2 ± 13.09, P < 0.0001). Changes of ECM differed significantly
between the two groups (P = 0.0011). The total body water
balance in the SIRS group (602.9 ± 2938.85) was significantly
lower than in the SEPSIS group (12,779.4 ± 8025.75) (P < 0.0001).
The NB was negative in both groups (SIRS: 1.5 ± 3.74; SEPSIS:
4.3 ± 4.23), but their difference was not significant (P = 0.7308).
Conclusions The present study shows that BCM and NB follow a
similar reduction pattern in both groups, although it is not
correlated. This finding could be related to the multivariate
influence on BCM (catabolism, immobilization, medication). It
seems that ECM changes reflect the process of the disease since
it decreased in the rather stable SIRS group and increased in the
deteriorating SEPSIS group.
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Objectives To describe post-cardiopulmonary bypass (post-CPB)
acid–base derangement in terms of the Fencl–Stewart strong ion
approach and the lactate:pyruvate ratio (LPR).
Methods A prospective observational study set in the PICU of a
university hospital. Arterial blood gas, serum lactate, pyruvate, and
electrolytes were measured on admission to the PICU following
cardiac surgery with CPB. LPR, corrected chloride (cCl =
140 × Cl/Na), and unmeasured anions or cations (strong ion gap)
were calculated using modified Fencl–Stewart equations. CPB
time, percent predicted mortality (PIM I), PICU mortality, and
duration of: ventilation; inotropic support; and PICU stay were
recorded. Data are reported as the median (range), or n (%), and
are analysed by Mann–Whitney and Fisher’s Exact tests. Ninety-
four children, median age 51 months (0.03–166), median weight
14 kg (2.1–50), were enrolled.
Results Surgery was performed for cyanotic heart disease in 41
children (44%) and acyanotic heart disease in 53 children (56%).
Median CPB time was 80 min (17–232). One child died (PICU
mortality 1%). Predicted mortality was 2% (SMR 0.50). The
median pH was 7.38 (7.17–7.61). Of 69 children with standard
bicarbonate < 22 mmol/l, the primary factor causing metabolic
acidosis was elevated cCl in 32 patients (46%), lactate in three
patients (4%), unmeasured anions in two patients (4%), and mixed
in 32 patients (46%). The median base excess (BE) was
–5.0 meq/l (–12.9 to –2.5), with chloride effect of –10.8 meq/l
(–24 to +1.2), free water effect of –0.6 meq/l (–3.3 to +1.8),
albumin effect of +3.5 meq/l (–0.6 to +6.8), and unmeasured
cation effect of +3.7 meq/l (–10.7 to +17). The median cCl was
113 mmol/l (101–126). Hyperchloraemia (cCl >110 mmol/l)
occurred in 66 children (70%) and was negatively associated with
use of adrenaline by infusion (P = 0.005). Median lactate was
1.9 mmol/l (0.7–9.1) and hyperlactataemia (> 2 mmol/l) occurred
in 41 children (44%). The median LPR was 18.8 (5.4–35) and LPR
was raised (> 20) in 42 children (45%). Hyperlactataemia plus
raised LPR was associated with use of adrenaline by infusion
(P = 0.0009), CPB time (P = 0.04), percent predicted mortality
(P = 0.05) and PICU stay (P = 0.03). Median albumin was 30 g/l
(16-44) and hypoalbuminaemia (< 35 g/l) occurred in 81 children
(86%). The median calculated strong ion gap was –3.8 mmol/l
(–18.4 to +9.1) (i.e. unmeasured cation predominance).
Conclusion In this group of children with low mortality post-CPB,
hyperchloraemia was primarily responsible for metabolic acidosis,
although both hyperlactataemia and raised LPR were common.
Both hypoalbuminaemia and unmeasured cations limited the
magnitude of the base deficit.
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Introduction Magnesium (Mg) is the fifth most common cation in
the body, considered, however, as the ‘forgotten cation’ in clinical
practice [1]. Mg deficiency is rather common in critically ill patients
and recent studies found that reductions in total serum Mg at
admission are associated with increased mortality [2]. Loss of Mg
can lead to vasoconstriction, especially of cerebral and coronary
arteries, while Mg appears to play a role in the scavenging of free
radicals and the prevention of reperfusion injury [3].
Aim An observational study on the evaluation of total serum Mg in
a tertiary 10-bed intensive care unit.
Patients Ninety-five patients admitted to the ICU over a 6-month
period: 30 polytrauma, 11 COPD, 12 stroke, nine liver transplan-
tation, 13 postoperative, five eclampsia and 15 miscellaneous.
Mean age: 43.2 years, length of stay: 9.2 days, APACHE II score:
11.3 ± 7.5, mortality: 34%.
Measurements and results Total serum Mg, calcium, phosphorus
and proteins were measured at admission and then every day until
discharge from the ICU. At admission, 15/30 polytrauma, 6/13
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postoperative, 4/12 stroke, 5/5 eclampsia, 8/9 liver transplanta-
tion, 2/11 COPD and 5/15 miscellaneous patients had <1.3 mg/dl
total serum Mg. Calcium and phosphorus deficiency was not
remarkable in any of the groups, while total proteins were found in
relatively low levels (< 3.5 mg/dl) in polytrauma and postoperative
patients. Low APACHE II score and negative outcome had a
relative correlation with low Mg levels in all groups, whereas Mg
replacement had not affected patients’ outcome. ICU length of stay
had no correlation to low Mg levels at admission.
Conclusion Hypomagnesemia at admission is relatively associated
with a worse prognosis, considering, however, that other major
factors (e.g. sepsis, MODS) play the first role in critically ill
patients’ outcome.
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